Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABCB1 "ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1" ENSG00000085563 "ATP binding cassette subfamily B member 1" P08183 7 87503017-87713323 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 101.7;intestine: 70.7" "Cell type enhanced" "Detected in many" "Cholangiocytes: 95.8;Distal enterocytes: 109.9;Microglial cells: 570.6;Paneth cells: 106.2;Proximal enterocytes: 204.6" "Cancer enhanced" "Detected in many" "renal cancer: 14.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 27.2;NK-cell: 17.9" "Group enriched" "Detected in many" 9 "NK-cells: 17.9;T-cells: 27.2" "Cell line enhanced" "Detected in some" "CACO-2: 67.3;HEK 293: 20.4;HEL: 37.7;Hep G2: 18.5;RPTEC TERT1: 24.2;SH-SY5Y: 78.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 12.2" "CAB001716, HPA002199, HPA074614" Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 39: CACO-2 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Plasma membrane" "Focal adhesion sites" "CAB001716: , HPA002199: AB_1844428, HPA074614: " "unprognostic (5.38e-3)" "unprognostic (2.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.06e-1)" "unprognostic (2.25e-2)" "unprognostic (9.99e-5)" "unprognostic (2.23e-3)" "unprognostic (5.65e-3)" "unprognostic (1.14e-1)" "unprognostic (5.17e-2)" "prognostic favorable (3.33e-4)" "unprognostic (5.19e-1)" "prognostic favorable (2.95e-4)" "unprognostic (2.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.83e-1)" "unprognostic (6.12e-2)" 2.6 101.7 14.1 3.9 13.6 1.9 3.6 13.7 17.6 6.4 5.3 16.6 26.4 11.0 3.6 3.1 5.0 15.5 1.9 15.3 15.6 33.7 28.0 6.4 3.2 17.6 14.4 2.2 2.0 1.4 0.5 2.3 19.7 4.2 18.2 2.2 1.2 3.1 0.2 1.5 70.7 9.8 15.1 4.2 2.1 0.9 19.3 2.7 1.9 1.4 3.5 3.6 1.7 14.3 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.1 4.3 0.0 0.0 67.3 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 20.4 37.7 4.2 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 24.2 0.2 0.9 78.9 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 4.0 0.0 0.9 7.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 11.1 0.0 27.2 0.8 2.7 6.8 0.0 2.5 1.7 6.6 0.2 17.9 0.0 0.1 0.0 2.5 14.1 13.6 13.7 17.6 15.3 15.6 17.6 14.4 19.7 15.1 19.3 14.3 17.1 0.0 3.0 3.9 9.9 0.8 0.1 0.0 1.2 1.9 0.4 3.9 3.0 95.8 0.6 49.7 0.0 5.8 24.7 109.9 5.9 13.8 27.3 0.6 0.6 52.9 0.0 7.8 16.1 1.9 0.2 3.7 0.0 0.7 3.8 0.3 2.5 38.4 0.4 0.0 11.4 15.8 0.0 0.6 1.2 3.8 0.9 1.6 0.0 570.6 0.2 0.2 32.0 6.0 3.2 8.1 106.2 0.0 4.6 0.2 204.6 57.7 0.7 1.1 0.0 0.4 1.3 0.4 0.9 0.2 0.6 9.9 24.5 0.1 19.9 0.3 ABCF2-H2BE1 ENSG00000285292 "ABCF2-H2BE1 readthrough" Q9UG63 7 151207837-151227166 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA020091, HPA021815, HPA030388" Approved Uncertain Cytosol NA NA 51000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Cytosol "HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558" 12.0 8.1 1.1 11.1 1.6 5.5 9.0 2.1 6.2 7.4 2.9 9.5 6.7 8.4 2.9 10.1 9.0 7.6 9.8 1.5 2.0 9.7 7.4 8.6 11.4 1.5 1.6 6.0 4.6 13.9 8.3 2.3 7.2 10.3 10.0 5.4 9.5 30.7 9.0 5.7 11.9 1.9 9.5 6.0 6.8 2.1 10.2 9.5 20.9 13.8 14.4 2.8 45.0 54.8 27.0 71.0 38.7 38.6 22.4 57.1 38.5 43.7 45.1 40.5 33.8 66.4 44.1 59.7 61.1 34.7 57.9 55.3 61.0 29.9 31.8 37.1 30.6 26.6 57.8 76.5 25.8 40.8 40.8 72.5 50.5 28.6 55.4 35.8 89.1 28.4 57.6 68.1 88.9 23.1 36.5 58.4 50.1 36.5 34.6 68.3 21.9 33.8 21.9 34.8 59.5 44.0 30.3 25.1 21.2 33.9 47.5 33.4 11.4 45.2 73.6 41.6 47.5 64.7 55.4 64.7 49.0 22.5 21.3 6.0 22.5 19.1 45.7 17.5 27.9 26.3 24.8 19.9 24.8 24.3 1.6 25.5 18.5 15.4 30.2 30.3 1.1 1.6 2.1 6.2 1.5 2.0 1.5 1.6 2.3 1.9 2.1 2.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ABCG2 "ABCP, BCRP, CD338, EST157481, MXR" ENSG00000118777 "ATP binding cassette subfamily G member 2 (Junior blood group)" Q9UNQ0 4 88090150-88231628 "Cancer-related genes, CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 88.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 106.7;Extravillous trophoblasts: 81.7;Hofbauer cells: 137.4;Microglial cells: 185.5;Proximal enterocytes: 216.6" "Cancer enhanced" "Detected in many" "glioma: 9.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 43.5;BEWO: 75.8;MCF7: 26.2;OE19: 58.6;RPMI-8226: 38.9;SuSa: 26.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB037299, HPA054719" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 28: BEWO - Transcription regulation" "Cluster 45: Enterocytes - Digestion" "Plasma membrane" Nucleoplasm "CAB037299: AB_476804, HPA054719: " "unprognostic (5.04e-1)" "unprognostic (3.05e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-3)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (9.14e-2)" "unprognostic (1.37e-1)" "unprognostic (3.01e-3)" "unprognostic (4.52e-2)" "unprognostic (1.67e-3)" "unprognostic (8.82e-3)" "unprognostic (7.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.92e-1)" 2.3 4.0 30.8 1.0 29.1 2.3 4.0 30.0 33.1 22.1 17.4 15.7 48.2 23.1 6.8 2.3 9.8 5.1 2.9 25.4 32.3 3.5 36.0 5.1 1.2 40.1 31.3 8.3 0.8 4.4 8.9 11.7 40.1 7.1 13.9 2.5 5.0 33.8 0.3 0.6 88.3 19.8 31.1 1.4 1.9 3.0 40.0 1.3 6.4 0.9 2.0 2.3 4.0 31.9 1.7 43.5 11.9 0.0 0.4 0.0 75.8 1.9 1.3 2.1 3.5 9.8 0.5 0.0 0.4 0.3 5.4 13.2 0.4 1.2 3.1 13.2 1.9 0.6 0.3 13.0 0.0 0.6 0.1 0.2 5.1 4.8 0.3 1.2 4.1 1.0 1.1 0.0 1.3 26.2 6.3 0.2 4.1 58.6 0.0 3.2 0.0 38.9 0.1 9.5 0.2 0.5 8.9 0.9 1.2 26.1 0.3 0.1 0.0 1.7 1.6 0.4 0.2 11.9 4.7 0.0 3.1 0.0 1.8 0.0 0.0 0.0 0.7 0.0 2.2 0.0 0.2 0.2 0.0 0.5 0.2 0.1 0.0 1.1 0.1 0.2 0.8 0.2 30.8 29.1 30.0 33.1 25.4 32.3 40.1 31.3 40.1 31.1 40.0 31.9 9.4 3.2 1.1 3.9 0.9 3.8 0.3 0.0 0.0 0.4 24.3 1.9 1.6 1.5 0.2 0.0 0.0 16.8 0.6 106.7 1.9 0.0 3.3 0.4 3.8 45.8 3.0 20.6 1.1 0.2 81.7 2.4 0.5 0.5 5.7 0.2 31.4 23.4 137.4 0.0 0.7 12.0 0.0 1.3 2.5 1.2 1.2 2.8 5.4 185.5 0.1 0.7 2.1 11.1 0.9 0.1 44.3 0.4 2.0 0.2 216.6 7.6 0.8 0.9 0.0 0.4 4.3 1.0 4.3 1.1 0.4 37.6 1.0 4.3 6.1 0.2 AC007998.2 ENSG00000267140 "Novel protein" 18 35443871-35497940 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 4.8" "Cell type enhanced" "Detected in single" "Endothelial cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 63 "HUVEC TERT2: 257.0" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "unprognostic (6.67e-3)" "unprognostic (5.32e-2)" "unprognostic (2.01e-1)" "unprognostic (3.51e-2)" "unprognostic (1.48e-2)" "unprognostic (2.24e-2)" "unprognostic (1.60e-1)" "unprognostic (7.77e-2)" "unprognostic (4.11e-2)" "unprognostic (1.04e-1)" "unprognostic (2.61e-1)" 1.8 0.2 0.1 1.8 0.2 0.5 3.3 0.1 0.2 2.6 0.2 0.9 0.5 0.8 0.2 0.9 3.2 1.7 0.6 0.2 0.2 0.5 0.1 1.5 4.8 0.2 0.2 0.3 0.5 0.1 0.0 0.5 0.2 0.1 0.8 0.0 0.1 0.7 0.9 0.2 0.6 1.7 0.1 0.8 0.5 0.2 0.2 0.4 1.8 1.4 1.4 1.6 0.1 0.2 0.6 0.4 0.6 0.0 0.0 0.0 0.5 0.3 0.0 0.8 0.6 1.1 0.0 0.6 0.7 0.2 0.0 1.3 0.9 0.0 0.2 0.2 1.2 4.1 0.3 2.4 0.5 0.6 1.6 0.0 0.5 0.2 0.3 0.7 257.0 0.0 0.1 0.1 0.0 0.3 0.1 1.1 0.1 0.0 0.0 0.1 0.2 1.6 0.2 0.5 1.1 0.2 0.3 0.7 0.0 0.9 0.0 0.0 0.7 0.6 0.1 0.0 0.8 0.5 0.4 2.0 0.3 1.1 0.2 0.1 0.0 0.4 0.0 0.0 0.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 AC015802.6 ENSG00000284526 "Novel protein" 17 76563710-76570544 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 25.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Alveolar cells type 2: 7.8;Endometrial ciliated cells: 17.7;Endometrial stromal cells: 17.9;Glandular and luminal cells: 12.7;Respiratory ciliated cells: 8.0" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 58.7;SK-MEL-30: 72.7" "Not detected" "Not detected" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 44: Endometrium - Transcription" 3.4 5.0 0.7 4.8 0.9 7.0 1.0 1.0 0.6 1.8 9.9 1.9 4.3 3.5 0.8 6.1 2.7 3.8 8.8 1.8 1.0 2.7 3.0 4.5 4.7 1.5 1.1 4.5 10.9 0.3 0.7 3.6 0.7 2.6 0.3 16.5 10.0 0.5 25.1 16.0 2.9 0.1 0.7 3.9 5.2 15.2 0.9 0.0 5.0 0.1 0.2 2.6 2.5 0.4 14.9 11.7 9.2 20.5 0.0 0.0 12.2 6.5 0.0 0.0 0.0 25.5 11.3 15.7 7.7 0.0 7.2 15.2 0.1 0.8 0.0 4.1 13.1 21.9 9.8 58.7 0.0 20.5 13.6 0.0 1.2 0.0 0.1 13.2 0.0 9.3 18.3 17.3 0.0 20.4 18.1 36.0 16.0 16.7 14.6 10.6 24.9 14.4 0.2 13.7 19.6 24.5 8.7 46.7 72.7 18.6 33.5 17.6 10.1 26.4 18.9 18.3 28.3 22.3 9.4 12.6 15.6 16.1 33.4 1.4 7.3 1.8 11.8 7.5 19.4 9.9 12.7 12.9 6.3 7.4 11.6 12.0 16.9 6.5 4.6 6.1 7.1 8.1 0.7 0.9 1.0 0.6 1.8 1.0 1.5 1.1 0.7 0.7 0.9 0.4 0.3 16.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.4 0.0 0.0 4.3 0.0 0.0 0.0 0.5 0.0 0.0 4.2 0.0 17.7 17.9 0.7 0.0 0.0 0.0 0.2 0.0 1.1 0.0 12.7 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.1 8.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.7 2.6 0.0 0.0 AC073610.1 ENSG00000272822 "Novel protein" 12 48903503-48957365 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.7;hTERT-RPE1: 4.4" HPA068942 Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 33: Fibroblasts - ECM organization" "Nucleoplasm, Nuclear bodies" "HPA068942: AB_2732124" "unprognostic (7.48e-2)" "unprognostic (6.47e-2)" "unprognostic (7.52e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (2.57e-3)" "unprognostic (1.26e-1)" "unprognostic (7.66e-2)" "unprognostic (7.25e-2)" "unprognostic (1.01e-2)" "unprognostic (6.24e-2)" "unprognostic (5.78e-2)" "unprognostic (1.01e-12)" "unprognostic (1.92e-2)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (9.06e-2)" 0.8 0.3 0.9 0.0 1.3 0.1 0.6 0.1 1.9 0.9 0.0 0.9 0.0 0.8 0.5 0.3 0.8 0.6 1.0 1.1 0.6 0.3 0.6 1.1 0.4 0.0 0.0 0.8 0.6 0.0 0.8 0.1 0.1 0.6 0.2 1.4 0.4 0.2 0.4 0.7 0.2 0.9 0.0 0.3 0.4 1.1 1.0 0.2 0.3 0.8 0.2 0.6 0.5 0.1 0.5 0.2 2.1 1.6 2.2 0.9 0.0 0.9 4.7 1.2 0.5 0.0 0.6 0.6 1.3 0.8 1.4 0.1 0.8 0.0 1.2 2.8 0.3 0.6 0.3 0.0 1.5 0.0 0.6 0.2 1.1 0.3 0.7 4.4 0.5 1.1 0.0 0.8 0.7 0.2 0.3 0.5 0.0 1.2 0.6 1.3 0.3 0.1 0.1 0.1 0.9 0.3 0.5 0.4 0.4 0.4 0.1 0.3 2.4 0.4 0.3 0.3 0.3 1.1 0.1 0.4 1.0 0.6 0.2 0.3 0.3 0.1 0.6 0.1 0.7 0.2 0.2 0.5 0.2 0.2 0.6 0.6 0.2 0.3 0.1 0.5 0.2 0.7 0.9 1.3 0.1 1.9 1.1 0.6 0.0 0.0 0.1 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 AC138696.1 ENSG00000264668 "Novel protein" 8 143247110-143276403 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.7;MOLT-4: 1.2" "HPA047232, HPA056268" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Nucleoli, Nucleoli rim" "Nucleoplasm, Plasma membrane" "HPA047232: , HPA056268: AB_2683082" "unprognostic (2.24e-2)" "unprognostic (2.10e-1)" "unprognostic (3.56e-3)" "unprognostic (1.87e-1)" "unprognostic (8.68e-3)" "unprognostic (1.14e-1)" "unprognostic (1.51e-1)" "unprognostic (9.80e-2)" "unprognostic (4.20e-1)" "unprognostic (3.27e-2)" "unprognostic (1.34e-1)" "unprognostic (1.03e-2)" "unprognostic (2.20e-2)" "unprognostic (3.99e-1)" "unprognostic (2.59e-2)" "unprognostic (4.06e-1)" 0.3 0.3 0.2 0.0 0.3 0.0 0.2 0.1 0.5 0.3 0.0 0.4 0.1 0.6 0.0 0.1 0.7 0.0 0.1 0.3 0.3 0.1 0.1 0.1 0.1 0.2 0.4 0.4 0.6 0.1 0.2 0.0 0.3 0.3 0.0 0.1 0.2 0.2 0.4 0.1 0.3 0.2 0.2 0.1 0.3 0.2 0.3 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.5 0.0 0.0 0.3 1.7 0.1 0.1 0.5 1.1 0.6 0.2 0.0 0.7 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.2 1.0 0.4 0.0 0.3 0.2 0.3 0.4 0.0 0.0 0.0 0.0 1.2 0.0 1.1 0.1 0.3 0.6 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.2 1.1 0.0 0.8 0.2 0.5 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.5 0.3 0.3 0.2 0.4 0.3 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACAA2 DSAEC ENSG00000167315 "Acetyl-CoA acyltransferase 2" P42765 18 49782164-49813953 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 1011.9" "Cell type enhanced" "Detected in all" "Distal enterocytes: 331.1;Hepatocytes: 810.5;Proximal tubular cells: 708.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042303 Approved Supported Mitochondria NA NA 3800000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA042303: AB_10794046" "unprognostic (7.94e-2)" "unprognostic (3.14e-2)" "unprognostic (2.20e-3)" "prognostic unfavorable (8.53e-4)" "unprognostic (2.92e-2)" "unprognostic (2.28e-2)" "unprognostic (7.63e-2)" "unprognostic (1.70e-1)" "unprognostic (7.97e-2)" "unprognostic (8.03e-3)" "unprognostic (1.72e-1)" "unprognostic (3.84e-1)" "prognostic favorable (1.36e-10)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (8.26e-3)" "unprognostic (3.41e-1)" 126.3 74.2 56.9 44.4 64.9 32.5 79.1 63.7 63.9 24.9 68.4 168.7 170.0 29.0 29.8 30.3 24.4 46.9 223.7 53.2 59.8 378.2 1011.9 48.9 36.6 65.1 61.4 34.8 54.1 35.1 34.9 29.6 64.0 26.4 109.6 31.9 20.3 34.0 165.3 28.0 165.2 44.5 62.8 33.6 37.4 37.7 64.3 39.9 55.8 236.6 31.9 41.6 28.6 64.2 3.9 70.5 110.0 97.5 129.9 69.5 57.4 35.2 52.4 53.6 41.2 146.3 58.9 61.1 73.5 117.5 56.7 4.8 176.8 21.0 51.4 190.5 50.4 45.5 79.0 171.4 62.5 0.7 78.3 91.7 6.7 84.8 26.2 44.6 90.0 87.7 42.5 54.7 147.5 81.8 2.7 89.7 101.5 24.8 26.7 150.8 233.0 217.6 177.7 2.8 163.4 130.9 2.7 76.2 5.6 82.1 45.7 60.0 48.1 49.8 60.5 67.8 36.4 112.3 139.7 157.3 35.0 85.7 47.1 53.0 87.4 96.1 99.2 106.5 123.0 43.2 58.3 88.7 103.2 36.3 50.2 73.2 8.3 120.0 108.1 50.1 76.4 112.7 56.9 64.9 63.7 63.9 53.2 59.8 65.1 61.4 64.0 62.8 64.3 64.2 28.4 38.5 47.3 11.8 31.4 3.6 14.2 15.5 11.4 6.7 25.0 25.5 189.9 234.4 23.7 55.2 4.2 36.5 48.2 331.1 295.4 148.5 71.2 7.9 33.9 30.0 40.1 53.6 1.7 45.7 56.0 47.3 23.9 7.7 45.1 63.3 41.4 810.5 109.6 1.7 4.6 73.0 24.4 64.8 18.5 153.9 48.1 50.6 19.6 13.1 57.2 62.2 106.1 4.5 8.7 101.8 161.2 37.2 41.2 9.8 226.6 708.0 26.4 29.5 19.7 42.1 34.9 51.1 42.7 11.1 4.8 27.0 52.2 93.0 144.8 9.6 ACSL6 "ACS2, FACL6, KIAA0837, LACS2, LACS5" ENSG00000164398 "Acyl-CoA synthetase long chain family member 6" Q9UKU0 5 131949973-132012243 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.6;brain: 32.0;retina: 45.8;testis: 20.7" "Cell type enhanced" "Detected in many" "Astrocytes: 229.2;Cone photoreceptor cells: 229.4;Erythroid cells: 110.5;Inhibitory neurons: 110.6;Rod photoreceptor cells: 130.0" "Group enriched" "Detected in some" 6 "colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 5 "T-cells: 1.6" "Group enriched" "Detected in some" 5 "SCLC-21H: 7.6;U-937: 6.2" HPA040470 Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA040470: AB_10794033" "unprognostic (1.99e-2)" "unprognostic (1.94e-1)" "unprognostic (3.55e-3)" "unprognostic (5.89e-2)" "unprognostic (6.97e-2)" "unprognostic (1.92e-2)" "unprognostic (8.38e-3)" "unprognostic (5.84e-2)" "unprognostic (8.69e-2)" "unprognostic (7.57e-2)" "unprognostic (9.28e-4)" "unprognostic (8.69e-2)" "unprognostic (3.22e-2)" "unprognostic (6.24e-3)" "unprognostic (1.79e-1)" "unprognostic (6.44e-3)" "unprognostic (1.70e-1)" 0.2 4.2 14.8 1.4 18.3 22.6 0.2 26.3 32.0 0.1 1.2 0.5 4.7 0.1 0.5 0.3 0.2 0.3 1.4 18.6 12.8 1.9 2.0 0.3 2.4 22.2 18.2 0.0 1.1 11.3 4.2 0.6 18.9 0.3 0.3 45.8 0.3 18.0 2.3 0.1 2.4 0.1 13.8 1.1 0.6 20.7 25.0 0.6 0.4 1.4 1.0 0.2 0.1 14.3 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.1 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.1 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.4 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.2 6.2 0.3 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.7 1.6 0.0 0.0 1.1 0.5 0.0 0.3 0.0 0.0 0.0 0.3 14.8 18.3 26.3 32.0 18.6 12.8 22.2 18.2 18.9 13.8 25.0 14.3 0.6 25.6 29.2 229.2 1.4 1.9 1.5 0.0 2.2 65.2 2.1 0.4 0.0 1.5 16.1 1.8 229.4 0.3 3.3 0.6 7.9 0.6 43.7 0.3 0.1 3.9 2.4 110.5 70.6 0.2 0.1 4.2 0.0 0.2 10.1 0.2 1.8 8.4 0.1 21.9 110.6 1.8 0.0 1.0 15.9 7.9 0.3 6.4 0.0 15.9 0.9 24.5 0.0 41.7 9.8 0.3 1.6 1.9 0.8 1.1 1.8 0.4 8.1 130.0 0.0 2.3 1.1 45.3 1.7 0.1 1.3 0.3 15.3 0.1 0.4 1.3 ACTRT3 ARPM1 ENSG00000184378 "Actin related protein T3" Q9BYD9 3 169766921-169769561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 47.5" "Cell type enriched" "Detected in many" 6 "Early spermatids: 1021.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 18.1;HSkMC: 11.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA035817, HPA035818" Approved Approved Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "HPA035817: AB_10671938, HPA035818: AB_2674801" "unprognostic (2.35e-1)" "unprognostic (9.39e-2)" "unprognostic (2.10e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (1.89e-2)" "unprognostic (1.75e-1)" "unprognostic (3.29e-1)" "unprognostic (1.24e-1)" "unprognostic (7.31e-4)" "unprognostic (2.64e-1)" "unprognostic (9.16e-2)" "unprognostic (4.41e-2)" "unprognostic (8.03e-2)" "unprognostic (8.49e-2)" "unprognostic (1.63e-1)" "unprognostic (8.25e-3)" "unprognostic (2.22e-1)" 1.6 0.9 1.7 0.7 2.1 0.4 1.1 2.6 4.5 1.4 2.0 0.9 1.1 1.1 0.8 1.0 2.0 0.9 1.2 2.2 2.0 2.4 2.7 1.1 0.8 2.1 3.5 1.6 0.6 1.2 1.3 1.0 2.2 1.2 0.8 0.8 0.6 1.9 0.7 0.4 0.8 1.6 1.8 0.4 1.2 47.5 2.5 0.8 1.5 0.7 0.9 1.7 0.7 2.6 4.0 2.5 0.2 1.1 18.1 5.5 0.0 4.7 3.0 3.1 2.6 0.0 5.2 0.0 6.5 5.9 2.0 2.5 1.5 2.5 3.3 2.9 1.7 9.3 1.9 0.5 3.0 1.1 0.9 11.8 0.6 3.8 0.7 2.0 5.8 0.9 0.0 0.0 5.7 2.0 0.2 0.1 4.5 3.5 5.3 0.6 0.0 0.1 3.3 1.0 3.1 2.1 5.9 1.4 0.1 0.6 2.5 4.1 2.4 0.0 0.0 2.5 0.0 0.4 0.2 0.2 1.1 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.9 0.3 0.0 0.3 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.7 2.1 2.6 4.5 2.2 2.0 2.1 3.5 2.2 1.8 2.5 2.6 0.9 0.0 1.5 0.3 0.1 0.4 1.3 1.6 1.2 1.6 0.4 0.4 0.7 0.0 2.0 0.0 2.1 1.7 0.1 0.2 1.9 2.3 1021.8 1.1 0.6 1.8 0.0 0.4 0.2 2.1 1.3 1.7 0.5 0.9 1.3 1.3 2.2 2.1 1.5 3.3 0.2 1.3 0.0 0.8 0.7 161.0 9.6 2.2 1.8 0.0 0.0 1.5 0.0 0.0 0.0 2.1 0.1 5.7 0.2 0.7 0.5 2.8 2.1 1.3 13.1 1.1 1.4 24.6 4.6 1.2 0.0 0.8 1.3 3.8 1.2 0.4 ADAM12 "MCMPMltna, MLTN" ENSG00000148848 "ADAM metallopeptidase domain 12" O43184 10 126012381-126388455 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "placenta: 166.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 102.2;Extravillous trophoblasts: 400.8;Oligodendrocyte precursor cells: 99.0;Syncytiotrophoblasts: 129.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "MAIT T-cell: 6.1" "Lineage enriched" "Detected in single" 62 "T-cells: 6.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 154.2;hTEC/SVTERT24-B: 94.3;U-2197: 93.2;U-251 MG: 86.2;U-87 MG: 70.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030866, HPA030867, HPA030868" Enhanced Supported "Plasma membrane" "Secreted in female reproductive system" NA NA 14000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 18: U-2197 - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" "Plasma membrane" "HPA030866: AB_2673636, HPA030867: AB_10602428, HPA030868: AB_2673638" "unprognostic (3.35e-1)" "unprognostic (1.05e-3)" "unprognostic (3.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.34e-2)" "unprognostic (2.16e-1)" "unprognostic (2.91e-6)" "unprognostic (2.17e-2)" "unprognostic (4.85e-2)" "unprognostic (1.30e-2)" "unprognostic (2.53e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.39e-14)" "unprognostic (3.11e-3)" "unprognostic (9.06e-3)" "unprognostic (4.70e-3)" "unprognostic (3.47e-3)" 11.4 0.1 2.0 6.0 4.0 0.1 4.6 1.6 2.1 18.2 3.5 0.4 0.2 6.3 0.0 0.4 0.2 11.8 0.7 1.0 2.5 1.0 0.2 1.3 3.2 6.0 2.7 8.8 0.5 0.1 1.1 166.5 3.1 0.3 0.6 0.3 1.1 0.0 0.1 0.4 0.5 4.3 1.8 1.6 0.5 0.9 10.4 1.8 0.3 0.0 3.5 11.6 0.5 3.0 16.8 2.5 6.5 0.1 18.7 38.3 0.0 42.7 3.5 14.2 35.5 0.0 0.0 0.0 0.0 154.2 30.0 0.0 0.2 1.4 15.5 1.9 0.6 0.2 25.1 0.0 2.9 0.0 33.2 47.0 0.0 94.3 2.9 27.1 0.0 0.0 0.0 0.2 11.8 0.0 0.0 0.0 0.1 0.0 2.8 0.0 4.8 4.4 0.4 44.1 0.5 28.4 5.0 0.0 0.7 2.5 0.1 0.1 0.0 50.9 16.9 93.2 86.2 0.0 0.5 0.0 70.7 0.1 32.3 0.0 0.0 0.0 0.3 0.0 6.1 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 2.0 4.0 1.6 2.1 1.0 2.5 6.0 2.7 3.1 1.8 10.4 3.0 0.5 0.0 1.9 22.5 0.3 1.5 0.4 3.0 0.0 2.1 1.7 3.6 2.3 0.0 0.5 0.0 102.2 14.0 0.5 0.7 0.0 8.0 10.9 10.7 16.6 1.6 0.0 0.0 7.4 1.1 400.8 34.5 0.5 1.8 49.5 7.8 2.5 0.2 15.5 6.7 19.0 1.0 4.1 0.6 3.1 1.7 16.8 0.8 1.8 14.0 9.0 3.3 1.0 99.0 52.2 2.2 0.1 0.7 0.3 1.0 0.7 0.4 6.5 30.5 0.0 5.1 13.4 6.0 5.0 0.0 0.6 129.2 4.7 28.1 0.9 0.5 AGAP1 "CENTG2, GGAP1, KIAA1099" ENSG00000157985 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 1" Q9UPQ3 2 235494043-236131800 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 53.9;retina: 54.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 304.0;Cone photoreceptor cells: 329.4;Excitatory neurons: 289.3;Oligodendrocyte precursor cells: 1438.1;Oligodendrocytes: 997.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Cell line enhanced" "Detected in many" "SCLC-21H: 78.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 68: Oligodendrocytes - Mixed function" "unprognostic (1.69e-1)" "unprognostic (2.32e-2)" "unprognostic (3.42e-1)" "unprognostic (5.43e-2)" "unprognostic (1.19e-1)" "unprognostic (4.80e-2)" "prognostic unfavorable (2.60e-5)" "unprognostic (1.36e-1)" "unprognostic (6.91e-2)" "prognostic unfavorable (9.75e-4)" "unprognostic (1.46e-1)" "unprognostic (2.10e-1)" "prognostic favorable (6.52e-5)" "unprognostic (5.56e-2)" "unprognostic (2.44e-2)" "unprognostic (6.32e-2)" "unprognostic (1.32e-2)" 5.3 4.7 30.7 3.4 34.4 1.9 8.3 7.6 29.6 5.7 0.0 12.5 7.0 5.2 8.9 6.6 6.7 5.6 5.9 34.0 33.0 7.7 2.6 5.6 1.7 44.6 24.1 5.5 6.5 8.9 7.1 6.9 48.2 4.8 11.2 54.7 4.2 5.0 8.4 3.7 8.6 10.5 10.9 1.9 6.7 6.6 30.5 1.5 9.1 9.2 1.9 6.2 3.4 53.9 17.3 13.6 20.9 9.8 15.1 9.7 13.1 8.6 9.1 9.9 7.5 14.0 31.3 0.1 3.6 14.9 37.2 4.3 15.8 20.4 12.3 0.3 8.1 26.4 12.5 10.5 6.0 0.1 17.5 14.1 19.3 20.4 15.9 7.1 6.8 6.1 13.8 1.0 12.6 22.2 0.5 3.0 9.1 14.9 6.2 3.6 10.6 16.8 10.8 20.4 78.9 19.9 7.3 17.1 9.5 11.4 9.8 4.1 6.8 11.8 12.0 9.8 11.7 5.4 0.1 0.8 18.4 0.2 12.7 0.0 0.0 0.0 0.6 0.0 1.2 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 30.7 34.4 7.6 29.6 34.0 33.0 44.6 24.1 48.2 10.9 30.5 53.9 16.0 6.4 15.5 100.6 0.2 4.1 3.7 6.2 5.2 304.0 19.4 11.7 22.9 2.8 8.7 11.0 329.4 9.7 5.5 23.3 3.9 21.4 9.4 24.0 12.0 13.3 16.3 0.4 289.3 15.0 1.5 19.5 4.6 15.8 20.8 12.7 7.9 6.3 1.4 119.5 219.0 17.8 12.2 0.6 3.8 2.9 5.0 2.1 1.8 139.6 1.6 33.3 9.2 1438.1 997.9 19.1 20.7 13.5 0.8 4.9 21.1 14.0 14.4 142.0 26.3 20.4 22.5 4.8 20.7 7.1 4.3 6.6 3.0 7.0 21.8 4.9 AGBL4 "CCP6, FLJ14442" ENSG00000186094 "ATP/GTP binding protein like 4" Q5VU57 1 48532854-50023954 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.4;retina: 5.9" "Group enriched" "Detected in some" 5 "Excitatory neurons: 1232.8;Inhibitory neurons: 630.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 5.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.1;SCLC-21H: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037994 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA037994: AB_10673036" "unprognostic (3.06e-2)" "unprognostic (2.76e-1)" "unprognostic (2.58e-2)" "unprognostic (3.31e-4)" "unprognostic (3.42e-4)" "unprognostic (1.72e-1)" "unprognostic (3.86e-3)" "unprognostic (2.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-1)" "unprognostic (5.85e-3)" "unprognostic (3.91e-2)" "unprognostic (1.51e-4)" "unprognostic (5.95e-2)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.85e-1)" 0.4 1.5 2.0 0.1 2.4 0.2 0.4 0.0 5.4 0.2 2.3 0.1 0.0 0.2 0.8 0.1 2.8 0.1 1.4 2.0 0.0 3.9 1.6 0.4 0.1 0.0 0.5 0.3 0.8 2.4 2.4 0.9 0.2 0.1 0.1 5.9 0.1 0.3 0.1 0.3 0.1 0.0 0.0 0.3 0.2 2.4 0.1 0.4 1.1 0.1 0.1 0.0 0.1 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.0 2.4 0.0 5.4 2.0 0.0 0.0 0.5 0.2 0.0 0.1 0.8 0.2 0.0 0.0 166.2 0.0 0.3 1.0 0.3 0.0 4.0 0.4 1.1 2.2 0.0 0.9 3.7 85.5 0.2 0.0 0.4 1.9 0.1 12.6 10.7 0.1 0.4 6.0 0.0 1232.8 0.2 0.1 0.5 0.0 0.2 0.0 0.2 0.4 0.1 0.1 5.0 630.3 0.5 2.0 0.0 0.0 9.1 0.3 0.0 0.0 40.3 0.0 2.4 0.0 142.2 19.2 0.0 0.1 0.7 0.0 0.3 0.0 4.4 10.5 22.6 0.0 0.7 0.3 19.9 10.4 0.0 0.0 0.1 0.0 0.4 0.1 0.2 ALDH18A1 "GSAS, P5CS, PYCS, SPG9" ENSG00000059573 "Aldehyde dehydrogenase 18 family member A1" P54886 10 95605941-95656711 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" "Kinase, Multifunctional enzyme, Oxidoreductase, Transferase" "Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 120.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 80.5;Granulosa cells: 81.6;Proximal enterocytes: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008333, HPA012604" Approved Enhanced Mitochondria NA NA 48000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "HPA008333: AB_1078125, HPA012604: AB_1844721" "unprognostic (5.97e-3)" "unprognostic (2.08e-2)" "unprognostic (5.75e-2)" "prognostic favorable (4.20e-4)" "unprognostic (1.60e-2)" "unprognostic (1.06e-1)" "unprognostic (8.30e-3)" "unprognostic (7.08e-2)" "unprognostic (4.06e-2)" "unprognostic (8.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.60e-9)" "unprognostic (1.02e-3)" "unprognostic (6.57e-2)" "unprognostic (1.29e-3)" "unprognostic (6.43e-2)" 15.3 16.1 12.2 21.2 12.6 16.7 20.2 12.4 13.1 33.4 21.0 51.9 89.3 18.5 30.9 21.0 21.9 25.2 11.5 12.2 13.6 17.7 24.3 10.8 22.0 12.4 14.7 16.7 61.8 33.5 28.2 26.3 13.1 24.2 49.3 11.4 120.1 24.9 4.3 22.4 73.1 26.3 12.7 12.1 40.5 11.7 14.0 17.2 37.5 5.5 26.9 25.2 14.3 13.1 66.5 61.6 57.9 152.7 76.0 72.9 62.2 75.6 112.8 75.1 93.7 124.4 51.6 223.7 68.9 119.7 36.2 85.6 117.1 77.8 84.6 64.0 92.0 71.2 40.5 177.9 49.7 125.6 76.1 77.0 46.8 61.5 119.1 124.5 79.9 82.6 67.5 46.0 57.1 95.0 114.5 80.5 68.6 109.2 60.7 105.9 66.3 76.9 88.3 49.7 57.5 56.9 60.1 47.1 56.9 66.0 70.5 57.9 66.7 31.1 49.0 80.9 88.2 52.4 41.7 135.8 60.4 142.8 40.7 0.1 2.6 0.2 27.3 5.2 28.7 23.0 24.5 28.3 9.6 16.1 20.7 23.1 0.5 26.3 8.3 5.9 25.8 15.5 12.2 12.6 12.4 13.1 12.2 13.6 12.4 14.7 13.1 12.7 14.0 13.1 4.6 6.4 9.2 7.2 12.6 11.2 8.3 8.9 14.2 6.3 15.6 12.4 4.6 11.5 14.3 20.2 0.0 43.9 6.7 80.5 1.9 13.7 1.3 12.7 18.1 8.0 19.8 17.9 15.7 21.1 31.6 16.2 18.8 16.9 8.2 81.6 5.3 27.3 11.5 10.1 13.6 41.3 8.2 3.5 3.8 1.6 9.3 3.5 16.0 11.2 2.6 7.1 8.2 17.6 12.8 11.7 56.4 12.0 30.1 18.4 79.4 8.4 15.2 3.4 0.0 10.5 10.1 8.2 9.9 17.6 8.1 30.2 9.0 10.8 38.7 9.4 ANKEF1 "ANKRD5, dJ839B4.6, FLJ21669" ENSG00000132623 "Ankyrin repeat and EF-hand domain containing 1" Q9NU02 20 9986126-10058303 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 14.0;testis: 14.6" "Group enriched" "Detected in many" 21 "Early spermatids: 323.1;Late spermatids: 383.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-266/84: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA041151 Approved Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 34: Spermatids - Unknown function" "Nucleoli fibrillar center, Plasma membrane, Cytosol" "HPA041151: AB_10796569" "unprognostic (4.72e-2)" "unprognostic (9.86e-2)" "unprognostic (2.31e-2)" "unprognostic (2.09e-1)" "unprognostic (5.38e-4)" "unprognostic (2.54e-1)" "unprognostic (1.83e-3)" "prognostic unfavorable (1.81e-4)" "unprognostic (3.21e-2)" "unprognostic (1.12e-1)" "unprognostic (3.28e-1)" "unprognostic (6.73e-2)" "prognostic favorable (4.44e-4)" "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.58e-4)" "unprognostic (3.11e-1)" 2.4 1.4 1.1 1.5 1.1 0.6 3.1 2.7 1.4 2.2 2.8 2.5 2.5 1.0 1.0 2.5 4.0 2.2 1.0 0.9 1.7 2.5 4.0 1.7 1.2 1.4 1.3 2.2 14.0 4.3 2.2 0.7 1.4 1.9 2.3 5.3 2.6 2.1 0.6 2.8 2.4 0.7 0.9 1.2 3.7 14.6 1.6 1.7 5.7 0.6 1.8 1.6 1.3 0.9 9.0 8.7 0.9 2.1 2.2 1.5 5.9 1.3 0.1 1.6 0.8 5.1 7.2 0.1 2.4 0.3 9.7 7.1 2.3 9.0 1.9 0.0 1.4 1.1 2.2 5.3 1.0 0.9 0.2 3.9 9.8 1.5 1.4 4.0 1.4 3.2 3.4 6.1 0.4 2.4 1.4 0.0 4.4 11.2 2.4 0.0 0.1 5.6 5.3 5.5 6.5 3.1 3.8 8.7 0.0 3.2 7.2 0.8 0.9 1.1 1.4 0.1 1.4 7.0 14.2 1.3 2.4 0.4 1.2 0.0 0.0 0.0 0.7 0.0 1.1 0.5 0.7 0.5 0.0 0.4 1.0 0.6 0.1 0.5 0.0 0.5 0.7 0.2 1.1 1.1 2.7 1.4 0.9 1.7 1.4 1.3 1.4 0.9 1.6 0.9 0.5 3.2 6.7 1.3 2.0 0.3 2.3 1.6 3.4 1.7 3.4 1.8 1.8 2.8 2.0 7.3 0.0 2.2 1.2 2.7 1.9 4.5 323.1 6.7 1.0 1.8 5.3 0.4 1.1 6.3 2.0 0.9 10.7 2.8 1.3 0.7 0.7 9.1 1.3 3.3 2.8 3.8 2.0 0.3 0.6 383.0 3.4 1.4 0.0 1.0 0.0 0.8 3.1 0.5 0.4 5.3 4.2 4.1 4.8 1.9 3.3 2.8 16.2 4.9 0.0 0.7 0.3 5.1 3.4 8.6 0.3 1.5 2.6 1.1 3.7 1.5 ARHGAP10 "FLJ20896, FLJ41791, GRAF2" ENSG00000071205 "Rho GTPase activating protein 10" A1A4S6 4 147732063-148072776 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Leydig cells: 137.6;Oligodendrocyte precursor cells: 124.7;Peritubular cells: 121.1;Rod photoreceptor cells: 132.9;Sertoli cells: 144.7;Smooth muscle cells: 107.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 16.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 80.2" HPA039589 Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 28: BEWO - Transcription regulation" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm "Nuclear membrane, Cytosol" "HPA039589: " "unprognostic (8.57e-3)" "unprognostic (1.34e-1)" "unprognostic (3.45e-2)" "unprognostic (1.38e-2)" "unprognostic (2.79e-1)" "unprognostic (3.41e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (2.23e-4)" "unprognostic (2.40e-2)" "unprognostic (2.00e-1)" "unprognostic (1.06e-1)" "unprognostic (2.57e-2)" "prognostic favorable (8.15e-5)" "prognostic unfavorable (6.26e-4)" "unprognostic (1.54e-1)" "unprognostic (1.02e-3)" "unprognostic (1.09e-2)" 35.0 11.4 4.6 7.0 6.3 3.3 22.6 2.0 7.1 35.1 9.8 47.0 4.9 16.9 9.8 35.7 35.1 13.0 38.7 6.0 2.6 9.7 7.9 15.1 5.8 3.1 4.7 33.4 9.2 16.0 6.2 10.7 3.5 26.0 8.0 14.4 11.1 20.0 38.6 22.2 16.6 13.3 3.6 9.8 26.3 11.8 5.5 11.3 16.9 33.1 6.7 44.2 30.8 4.1 21.0 8.3 4.4 9.2 33.2 45.1 46.0 28.3 23.5 17.9 13.8 21.6 11.8 0.0 4.7 24.4 15.0 10.1 16.4 23.4 21.5 11.4 10.9 7.2 6.2 0.7 51.2 7.1 8.0 23.4 17.9 22.3 19.0 22.7 22.0 6.0 1.0 38.3 32.3 25.5 4.5 0.0 4.1 13.9 4.0 8.1 12.7 24.5 12.3 19.0 10.7 5.1 7.4 29.6 7.9 19.0 3.7 0.6 21.9 16.8 12.9 10.3 13.8 14.2 1.8 0.1 25.5 0.9 15.1 0.0 1.7 16.7 5.3 0.1 10.5 0.0 4.1 6.2 3.0 0.0 1.2 6.0 0.2 5.3 0.1 0.1 5.4 2.4 4.6 6.3 2.0 7.1 6.0 2.6 3.1 4.7 3.5 3.6 5.5 4.1 18.5 3.2 4.1 5.5 1.5 14.4 7.9 7.0 16.5 7.1 13.0 15.4 64.8 5.7 3.5 1.8 43.8 29.0 11.1 0.2 0.0 5.8 13.6 16.3 83.5 11.8 0.0 1.3 63.3 16.0 48.2 45.6 11.2 31.8 1.3 21.7 4.2 13.0 20.9 3.3 26.7 0.4 0.0 6.2 33.7 10.2 137.6 24.2 5.4 46.9 58.4 8.2 8.2 124.7 2.1 14.0 0.1 121.1 3.2 4.5 0.8 15.0 1.3 132.9 144.7 22.7 107.3 4.7 13.3 15.7 10.2 12.7 16.0 9.1 1.1 3.1 ARHGEF39 "C9orf100, FLJ14642" ENSG00000137135 "Rho guanine nucleotide exchange factor 39" Q8N4T4 9 35658875-35675866 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 98.2;Erythroid cells: 16.6;Extravillous trophoblasts: 19.5;Late spermatids: 36.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in single" 4 "basal ganglia: 2.7" "Low region specificity" "Detected in all" HPA061299 Uncertain NA Yes "Cluster 16: MAIT-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 20: HeLa - Mitochondria" "Cluster 29: Early spermatids - Spermatogenesis" "HPA061299: AB_2684473" "unprognostic (2.93e-1)" "unprognostic (3.90e-1)" "unprognostic (3.31e-2)" "unprognostic (3.40e-2)" "unprognostic (1.65e-1)" "unprognostic (2.30e-1)" "unprognostic (3.25e-4)" "unprognostic (3.60e-2)" "unprognostic (8.55e-2)" "prognostic favorable (4.48e-4)" "unprognostic (1.14e-1)" "unprognostic (9.75e-2)" "unprognostic (6.04e-9)" "unprognostic (3.31e-3)" "unprognostic (3.38e-1)" "unprognostic (5.14e-2)" "unprognostic (1.46e-1)" 2.9 1.8 0.1 1.6 0.1 1.8 2.2 0.9 0.2 1.8 0.2 4.0 2.1 2.4 0.1 1.5 2.0 0.8 2.2 0.1 0.1 1.2 1.2 1.7 2.0 0.1 0.0 1.1 1.7 0.0 0.9 0.7 0.1 2.5 1.1 1.5 1.0 0.2 0.7 1.3 2.3 0.3 0.0 2.0 3.0 1.1 0.2 1.6 1.2 0.0 1.3 3.0 1.7 0.2 5.2 7.7 7.4 3.6 0.0 0.2 4.9 3.7 1.4 3.3 2.9 8.7 4.0 3.2 2.2 0.5 4.6 3.8 3.7 2.2 1.3 9.5 5.8 5.1 11.3 3.3 0.0 4.3 7.5 0.2 0.2 1.6 0.9 1.0 1.2 4.6 3.6 2.9 1.4 2.6 1.1 2.4 4.7 3.7 2.5 4.4 5.7 1.9 1.2 2.2 5.2 2.1 1.9 4.1 1.0 3.0 6.1 2.5 0.7 2.3 7.4 2.7 2.7 2.8 3.7 1.4 1.4 2.3 5.1 0.3 0.2 0.2 0.5 0.1 0.7 0.1 0.3 0.5 0.2 0.3 0.1 0.3 0.2 0.4 0.2 0.1 0.4 0.1 0.1 0.1 0.9 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.2 0.7 0.0 0.0 0.0 2.1 2.7 1.4 1.6 0.6 2.1 1.6 3.4 1.4 1.5 1.0 1.8 0.0 8.1 3.6 1.7 0.0 1.0 98.2 0.6 1.6 1.3 3.5 16.6 0.4 0.8 19.5 2.0 14.8 1.1 0.0 4.1 1.8 0.5 5.3 0.0 0.5 4.1 0.0 2.5 5.0 36.1 0.9 2.0 5.4 0.0 0.4 1.6 3.1 0.5 0.3 0.5 0.3 0.4 2.6 1.2 1.5 0.3 1.2 2.4 0.0 2.6 3.3 3.3 5.4 3.5 2.0 1.9 3.1 0.5 6.9 0.8 ARMC3 "CT81, FLJ32827" ENSG00000165309 "Armadillo repeat containing 3" Q5W041 10 22928024-23038523 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 12.9;choroid plexus: 34.5;fallopian tube: 44.6;testis: 33.6" "Cell type enhanced" "Detected in some" "Early spermatids: 364.4;Endometrial ciliated cells: 169.1;Late spermatids: 90.1;Respiratory ciliated cells: 204.6;Spermatocytes: 70.0" "Group enriched" "Detected in some" 5 "endometrial cancer: 4.0;ovarian cancer: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "CAPAN-2: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037823, HPA037824" Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "HPA037823: AB_2675689, HPA037824: AB_10671634" "unprognostic (8.11e-3)" "unprognostic (5.78e-2)" "unprognostic (6.63e-2)" "unprognostic (7.81e-3)" "unprognostic (1.01e-1)" "unprognostic (2.28e-1)" "unprognostic (5.23e-1)" "unprognostic (2.52e-1)" "unprognostic (2.50e-2)" "unprognostic (7.37e-3)" "unprognostic (4.02e-1)" "unprognostic (3.61e-2)" "unprognostic (2.97e-1)" "unprognostic (6.21e-3)" "unprognostic (9.53e-4)" "unprognostic (1.40e-2)" 0.0 0.0 3.3 0.0 3.9 0.0 0.0 2.4 1.5 1.3 34.5 0.0 0.0 1.5 0.1 0.1 44.6 0.0 0.1 3.0 3.7 0.4 0.0 3.5 0.0 11.4 12.9 0.0 0.3 0.0 1.3 0.0 8.5 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 7.7 0.0 0.0 33.6 4.6 0.1 0.3 0.1 0.0 0.0 0.0 8.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.3 3.9 2.4 1.5 3.0 3.7 11.4 12.9 8.5 7.7 4.6 8.3 0.0 0.0 1.1 8.1 0.0 0.0 0.0 6.0 0.0 0.0 0.1 0.1 0.3 0.0 22.4 0.0 6.2 0.0 0.1 0.0 0.0 0.4 364.4 169.1 1.4 0.8 0.0 0.0 9.1 0.0 0.0 0.4 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 12.2 0.0 0.0 90.1 3.4 1.5 0.0 2.8 0.0 0.0 0.0 1.5 9.0 0.0 0.0 3.8 0.0 0.3 0.0 1.5 204.6 1.1 0.0 0.0 3.0 70.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ARNTL "bHLHe5, BMAL1, JAP3, MOP3, PASD3" ENSG00000133794 "Aryl hydrocarbon receptor nuclear translocator like" O00327 11 13276652-13387266 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 63.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 11.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045962, HPA050938" Supported Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Vesicles "CAB045962: AB_11124144, HPA050938: AB_2681282" "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (9.00e-2)" "unprognostic (1.77e-1)" "unprognostic (3.72e-1)" "unprognostic (3.76e-2)" "unprognostic (8.92e-2)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "unprognostic (7.80e-2)" "unprognostic (1.34e-2)" "unprognostic (2.10e-1)" "unprognostic (2.77e-2)" "unprognostic (3.11e-2)" "unprognostic (7.08e-2)" 15.0 13.3 3.2 5.1 4.8 7.4 14.1 4.8 8.3 10.5 3.2 12.4 5.2 11.6 1.6 10.5 11.5 4.0 9.5 5.5 1.9 7.2 19.4 15.0 5.8 1.6 2.6 19.7 10.3 1.5 12.3 4.4 2.2 8.5 4.1 23.4 12.7 3.4 27.0 17.6 12.4 5.6 1.9 11.6 10.9 10.9 4.4 14.1 18.9 8.2 6.4 9.3 11.5 7.4 8.2 9.0 7.5 4.0 15.0 9.0 5.7 9.5 8.1 8.6 9.7 3.7 10.9 0.1 2.6 5.2 10.4 3.4 5.3 10.3 7.7 13.6 6.3 3.9 6.6 1.8 23.7 1.8 16.2 10.1 21.3 3.7 14.1 5.9 6.2 12.6 2.5 14.9 6.9 4.7 4.7 0.9 1.6 5.4 4.3 5.1 11.4 3.4 5.7 1.8 1.2 12.2 6.1 0.7 7.6 7.1 5.7 7.0 11.5 6.2 6.8 20.3 5.5 4.1 12.0 0.0 6.4 4.1 8.3 4.3 8.3 17.9 18.1 9.0 25.2 2.6 16.8 15.6 8.4 3.1 9.4 11.1 24.5 14.1 8.9 1.1 11.1 10.7 3.2 4.8 4.8 8.3 5.5 1.9 1.6 2.6 2.2 1.9 4.4 7.4 4.9 25.6 21.0 49.9 9.0 30.8 13.4 7.3 10.2 28.3 6.1 5.0 8.8 10.0 11.1 1.8 16.7 17.6 34.8 8.6 17.6 6.8 1.5 6.1 14.2 6.6 1.2 3.0 63.6 6.4 2.2 10.3 11.7 12.9 2.5 6.9 10.8 22.9 8.2 30.3 30.5 4.6 4.1 14.0 12.3 4.2 12.8 11.9 3.6 18.7 13.1 18.8 32.0 34.2 11.9 8.3 9.3 19.9 11.5 8.0 13.5 11.3 5.3 30.9 13.1 6.6 10.7 4.7 5.4 9.4 32.4 6.3 33.0 4.7 4.5 12.0 ATAD3C FLJ34599 ENSG00000215915 "ATPase family AAA domain containing 3C" Q5T2N8 1 1449689-1470163 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 19.8;Collecting duct cells: 20.2;Distal tubular cells: 45.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "RPMI-8226: 13.1" HPA065305 Approved Mitochondria NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA065305: AB_2685459" "unprognostic (9.23e-2)" "unprognostic (3.48e-2)" "unprognostic (3.20e-2)" "unprognostic (4.35e-3)" "unprognostic (1.11e-2)" "unprognostic (1.71e-2)" "unprognostic (3.79e-2)" "prognostic favorable (5.15e-4)" "unprognostic (1.23e-1)" "unprognostic (1.57e-1)" "unprognostic (1.22e-1)" "unprognostic (2.65e-1)" "unprognostic (3.80e-2)" "unprognostic (1.83e-1)" "unprognostic (5.74e-2)" "unprognostic (2.22e-1)" "unprognostic (2.12e-3)" 1.1 0.2 5.3 0.9 6.3 0.5 1.6 5.2 6.4 2.0 4.3 2.3 0.6 1.7 1.2 1.1 2.0 0.7 0.9 5.5 6.2 4.3 5.2 1.5 0.4 6.7 6.0 1.1 4.6 0.1 1.8 0.3 6.4 4.0 0.3 1.2 2.6 2.0 0.2 0.8 0.8 0.7 5.5 0.4 0.7 1.2 6.1 0.4 4.0 0.0 0.5 2.9 1.4 10.1 0.2 0.0 0.2 0.3 0.3 0.0 0.2 0.1 0.0 0.2 0.0 1.2 2.5 0.2 0.3 0.1 0.1 0.3 1.0 0.4 0.1 0.1 1.0 0.2 0.9 1.6 0.2 0.2 0.2 0.0 0.1 0.1 0.7 0.0 0.0 0.3 0.2 3.0 0.1 0.7 0.3 0.8 0.5 0.1 0.2 0.3 0.1 13.1 0.8 0.2 2.0 0.7 0.0 0.5 0.1 2.1 2.6 0.2 0.2 0.1 0.2 0.3 0.1 1.4 2.1 0.4 0.1 0.3 0.0 0.8 0.1 0.3 0.3 0.1 1.2 0.5 0.4 0.3 0.0 0.3 0.5 0.4 0.5 0.5 0.1 0.1 0.6 0.2 5.3 6.3 5.2 6.4 5.5 6.2 6.7 6.0 6.4 5.5 6.1 10.1 2.5 6.4 19.8 0.7 4.2 3.4 3.5 1.3 4.6 5.0 17.4 14.4 4.6 0.0 2.7 20.2 16.7 0.7 2.0 2.0 45.0 5.3 0.4 3.6 3.8 4.2 4.2 0.0 1.0 9.2 0.3 1.8 0.0 6.1 3.8 0.6 1.8 6.8 1.8 6.7 0.6 1.9 0.0 2.9 2.5 1.4 1.2 0.7 3.6 2.8 0.5 2.8 4.1 1.0 10.8 4.4 0.3 4.9 8.4 3.0 1.3 16.2 1.3 9.1 0.0 7.3 1.6 0.5 1.5 1.5 5.7 0.8 3.6 4.2 1.3 3.1 ATF7IP2 FLJ12668 ENSG00000166669 "Activating transcription factor 7 interacting protein 2" Q5U623 16 10326434-10483638 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 19.2" "Cell type enhanced" "Detected in all" "Spermatocytes: 145.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 14.2;THP-1: 13.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 3.3;hippocampal formation: 2.3" "HPA041156, HPA041228" Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" "HPA041156: AB_10795536, HPA041228: AB_10795586" "prognostic favorable (4.98e-4)" "unprognostic (3.87e-2)" "unprognostic (1.35e-2)" "unprognostic (6.31e-2)" "unprognostic (7.56e-2)" "unprognostic (2.87e-1)" "prognostic favorable (5.68e-5)" "unprognostic (2.47e-2)" "unprognostic (8.85e-2)" "unprognostic (2.32e-2)" "unprognostic (2.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.10e-3)" "unprognostic (2.43e-1)" "unprognostic (2.99e-1)" "unprognostic (2.41e-2)" "prognostic favorable (8.57e-5)" 1.8 6.7 2.4 4.2 1.7 5.7 1.5 0.7 3.6 3.0 0.9 1.9 3.0 1.4 3.6 1.5 4.8 1.3 5.2 3.0 1.8 2.4 9.2 2.1 8.8 1.0 0.9 2.2 5.6 0.6 1.2 3.2 1.2 1.4 2.0 4.7 0.8 1.7 1.6 2.9 2.0 2.2 1.0 5.1 6.2 19.2 1.6 10.7 3.7 1.3 8.6 5.1 1.1 2.7 0.7 1.6 1.3 4.3 3.3 3.8 6.9 1.7 0.3 0.4 0.0 0.5 7.2 0.0 3.5 0.0 1.4 1.0 6.3 1.5 0.4 6.2 4.3 8.4 1.3 6.0 1.6 7.8 3.5 4.2 1.4 0.1 0.0 1.7 2.9 13.1 14.2 0.0 4.0 1.3 9.9 6.1 7.0 9.6 1.5 13.0 0.0 4.3 1.4 3.3 0.0 0.8 6.8 1.3 0.7 4.3 2.4 13.9 1.6 0.0 1.9 0.1 0.0 2.8 7.3 1.2 0.0 4.8 1.9 0.1 0.5 0.0 4.5 1.0 11.6 2.4 4.6 4.4 1.6 3.6 3.8 4.3 0.1 3.5 1.0 2.5 7.2 2.0 2.4 1.7 0.7 3.6 3.0 1.8 1.0 0.9 1.2 1.0 1.6 2.7 28.5 12.8 16.2 26.1 62.1 11.5 11.6 37.3 19.9 18.5 11.0 8.4 53.9 7.2 22.8 12.9 100.1 60.1 38.9 15.4 99.7 16.8 30.7 24.2 8.2 17.6 23.2 30.9 71.4 10.9 60.5 12.8 81.1 14.9 1.3 19.9 13.2 115.2 23.6 5.0 45.5 14.6 24.4 23.6 23.5 31.6 7.5 33.5 16.0 82.4 13.8 38.2 24.7 39.7 8.4 6.7 20.7 6.8 37.1 6.1 10.0 39.0 88.7 35.4 13.1 6.0 13.2 145.8 89.2 19.6 19.5 27.1 46.0 17.3 16.8 21.7 ATXN7L2 "FLJ00381, MGC46534" ENSG00000162650 "Ataxin 7 like 2" Q5T6C5 1 109483479-109492804 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 7.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029827, HPA054952" Uncertain Approved "Nucleoli rim,Vesicles,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" "Nucleoli rim" "Vesicles, Cytosol" "HPA029827: AB_10602390, HPA054952: AB_2682647" "unprognostic (4.53e-2)" "unprognostic (6.55e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (7.65e-4)" "unprognostic (3.90e-2)" "unprognostic (4.61e-5)" "unprognostic (2.40e-4)" "unprognostic (1.75e-1)" "unprognostic (3.53e-2)" "unprognostic (8.07e-2)" "unprognostic (2.77e-4)" "unprognostic (2.85e-2)" "prognostic unfavorable (1.19e-8)" "unprognostic (3.70e-2)" "unprognostic (1.08e-1)" "unprognostic (8.27e-2)" "unprognostic (3.94e-3)" 1.2 2.7 1.3 0.7 1.4 3.0 1.1 1.3 2.7 1.9 0.7 1.2 0.5 2.0 0.1 1.2 1.4 0.8 1.3 2.5 1.0 2.0 1.7 1.0 0.9 1.1 1.1 1.9 1.0 0.3 2.1 0.4 1.0 1.2 0.1 0.1 0.9 0.4 7.9 1.7 1.4 0.3 0.9 2.2 1.0 5.2 1.3 1.5 2.2 1.6 0.5 1.3 1.2 1.4 1.8 1.4 0.9 3.6 1.2 2.2 2.5 1.3 1.6 2.6 1.8 3.0 1.2 4.8 2.0 1.6 0.7 2.1 1.9 1.8 0.3 4.4 2.7 2.6 3.0 1.3 0.8 4.0 6.0 2.4 0.9 2.8 0.0 1.1 0.6 5.1 4.5 2.6 0.5 5.8 7.1 5.2 5.6 1.9 2.0 4.9 2.3 3.4 0.9 1.9 8.4 3.4 1.4 4.5 2.2 0.2 0.8 4.1 0.3 1.9 5.5 1.8 5.3 1.7 1.2 4.6 2.2 3.3 4.8 0.0 0.8 1.1 2.3 1.1 2.2 1.0 1.9 2.5 0.6 1.3 1.7 1.6 0.9 1.4 0.8 0.4 1.8 1.0 1.3 1.4 1.3 2.7 2.5 1.0 1.1 1.1 1.0 0.9 1.3 1.4 1.0 0.0 0.5 5.5 2.4 0.6 1.4 1.3 1.8 3.5 1.4 0.9 1.9 1.5 2.1 1.8 2.1 1.4 1.6 1.4 0.0 1.4 3.5 0.8 2.4 1.3 1.8 0.8 4.7 1.8 1.5 1.7 1.1 1.0 4.5 2.3 1.8 1.1 0.6 3.3 3.9 1.1 2.0 1.2 1.0 1.0 1.2 0.6 0.0 1.0 0.4 0.9 1.0 3.0 1.8 1.5 1.4 1.5 2.9 0.7 0.7 0.6 0.3 2.0 0.0 2.5 4.8 4.2 4.9 1.3 0.9 3.1 2.6 3.5 0.9 0.9 B3GALT2 beta3Gal-T2 ENSG00000162630 "Beta-1,3-galactosyltransferase 2" O43825 1 193178730-193186613 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.2;gallbladder: 15.0;heart muscle: 21.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 46.6;Cardiomyocytes: 34.4;Excitatory neurons: 27.6;Inhibitory neurons: 28.3;Leydig cells: 31.7;Peritubular cells: 21.1" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "MAIT T-cell: 8.4" "Lineage enriched" "Detected in single" 53 "T-cells: 8.4" "Group enriched" "Detected in some" 4 "AF22: 18.3;ASC TERT1: 8.1;LHCN-M2: 12.6;WM-115: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078659 Approved "Plasma membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 17: WM-115 - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Plasma membrane" "HPA078659: AB_2686887" "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (1.91e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-1)" "unprognostic (1.58e-3)" "unprognostic (2.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.63e-1)" "unprognostic (2.44e-1)" "unprognostic (6.14e-4)" "unprognostic (4.41e-2)" "unprognostic (8.10e-3)" "unprognostic (2.72e-1)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-3)" 0.3 1.2 13.4 0.7 15.3 0.2 0.3 4.9 17.1 0.2 2.3 1.0 0.9 0.1 1.0 0.6 0.2 15.0 21.0 17.2 7.1 0.9 0.2 1.8 0.2 5.8 7.4 10.4 0.2 0.0 0.5 0.3 5.8 4.7 1.2 6.6 0.1 5.1 0.1 0.2 3.0 0.1 7.0 0.8 1.3 0.7 8.5 0.0 1.0 0.3 0.9 1.4 0.3 15.9 0.0 0.0 18.3 0.0 0.5 8.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 1.6 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.2 0.0 8.4 0.0 1.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.2 13.4 15.3 4.9 17.1 17.2 7.1 5.8 7.4 5.8 7.0 8.5 15.9 0.6 0.0 0.5 1.6 0.9 0.3 0.1 0.0 0.6 46.6 0.0 0.1 34.4 11.5 0.0 1.8 4.2 0.0 0.2 0.1 0.0 0.1 0.0 0.3 1.3 1.1 3.0 0.8 27.6 0.0 0.0 2.0 0.0 0.9 2.5 0.4 0.7 0.1 0.3 8.4 28.3 0.7 0.0 0.6 0.3 0.7 31.7 0.7 0.0 4.7 0.0 2.4 0.0 12.1 9.3 0.5 0.1 21.1 0.4 0.1 3.4 0.1 2.2 6.2 0.0 0.3 1.2 0.0 0.0 0.3 0.3 0.0 4.9 0.3 0.5 0.0 B3GLCT "B3GALTL, B3Glc-T, B3GTL" ENSG00000187676 "Beta 3-glucosyltransferase" Q6Y288 13 31199975-31332276 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Fucose metabolism" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 59.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (3.31e-2)" "unprognostic (2.53e-1)" "unprognostic (4.71e-2)" "unprognostic (6.17e-3)" "unprognostic (5.26e-2)" "unprognostic (1.29e-1)" "unprognostic (2.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.00e-1)" "unprognostic (2.91e-1)" "unprognostic (3.28e-3)" "unprognostic (6.74e-2)" "unprognostic (5.51e-3)" "unprognostic (2.26e-1)" "unprognostic (5.70e-2)" "unprognostic (3.81e-2)" "unprognostic (1.51e-1)" 3.7 2.0 8.6 3.1 11.4 3.9 4.6 6.2 7.8 3.5 12.8 3.1 2.8 12.9 3.9 3.0 6.0 3.5 18.2 8.2 6.9 6.6 3.4 3.7 3.8 6.9 11.2 4.8 3.1 8.1 3.0 7.0 7.1 3.5 3.3 8.0 3.8 6.2 4.7 3.4 2.9 12.7 8.0 3.5 3.4 3.8 13.2 4.9 4.9 2.8 5.6 2.5 3.5 8.0 4.8 6.7 27.1 4.9 5.1 5.1 4.4 11.6 13.0 13.9 9.8 3.5 13.2 19.4 8.3 13.6 26.2 7.9 6.1 7.5 12.9 59.8 11.7 1.3 5.9 5.1 3.2 7.8 10.1 5.9 8.4 8.0 6.8 14.2 12.5 9.5 3.5 3.0 11.0 6.1 11.7 2.4 7.9 7.0 4.1 10.4 8.8 0.6 6.2 6.7 2.5 11.0 10.0 4.7 13.2 6.3 2.3 8.9 17.6 14.0 9.4 6.5 11.7 2.4 5.6 7.3 4.5 5.8 18.9 1.7 0.4 1.3 2.4 0.4 3.5 1.3 1.5 2.7 0.4 0.6 1.2 1.6 0.2 1.4 0.4 0.4 0.9 1.4 8.6 11.4 6.2 7.8 8.2 6.9 6.9 11.2 7.1 8.0 13.2 8.0 4.5 0.0 3.1 0.0 6.6 0.0 3.6 0.0 14.2 10.6 5.1 3.4 23.7 2.8 0.6 9.2 16.7 0.3 7.9 2.5 1.9 4.3 12.1 9.2 5.3 6.5 1.2 1.7 0.0 4.6 2.1 9.0 5.6 4.2 0.0 3.3 8.9 5.5 3.6 0.0 0.0 1.5 0.0 3.2 0.0 2.5 1.5 3.3 0.0 0.0 0.9 5.8 6.2 0.0 0.0 5.6 2.3 3.4 6.4 2.3 2.6 2.6 1.5 4.3 13.1 4.1 5.2 2.1 13.5 7.7 0.0 0.3 6.5 2.3 1.7 1.6 B3GNT9 MGC4655 ENSG00000237172 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9" Q6UX72 16 67148104-67150998 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 12.9;Leydig cells: 11.5;Peritubular cells: 13.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SiHa: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052743, HPA062734" Approved Approved "Nucleoli fibrillar center,Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "Nucleoli fibrillar center" "HPA052743: AB_2681934, HPA062734: AB_2684854" "unprognostic (2.56e-2)" "unprognostic (2.22e-1)" "unprognostic (2.34e-2)" "unprognostic (1.07e-1)" "unprognostic (6.58e-2)" "unprognostic (1.11e-1)" "unprognostic (1.32e-3)" "unprognostic (3.28e-2)" "unprognostic (3.01e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "unprognostic (2.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.51e-2)" "unprognostic (1.15e-1)" "unprognostic (4.96e-3)" "unprognostic (7.56e-3)" 7.7 8.4 7.1 4.2 8.0 0.2 5.7 7.5 6.8 15.0 8.4 7.6 3.2 13.4 7.3 5.2 13.7 6.8 13.8 7.1 8.0 7.4 2.5 9.0 2.9 8.7 9.7 15.0 3.5 21.8 20.5 7.9 8.7 11.8 3.3 1.4 9.0 14.8 1.9 5.9 5.6 7.8 9.3 5.6 6.1 6.0 7.7 1.5 18.7 2.1 2.5 11.7 8.9 11.1 4.9 8.8 0.7 0.9 27.7 28.6 1.0 22.5 36.2 14.4 18.5 4.0 0.8 0.6 1.5 34.9 6.0 11.1 0.3 1.0 7.8 7.6 3.2 0.7 9.7 3.5 22.3 0.6 0.5 23.7 8.3 14.0 0.4 35.8 2.0 0.5 1.0 2.7 22.6 2.6 2.6 1.2 5.4 3.8 7.7 7.4 12.9 4.4 2.3 6.0 5.0 11.2 50.9 0.2 0.8 4.3 1.3 3.9 4.6 25.6 1.1 25.9 10.2 3.2 2.4 0.8 31.9 1.3 12.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 7.1 8.0 7.5 6.8 7.1 8.0 8.7 9.7 8.7 9.3 7.7 11.1 1.2 6.4 5.0 1.0 1.2 3.2 2.8 2.4 9.6 1.6 3.2 2.3 2.6 5.7 2.4 3.7 0.0 0.3 0.1 0.4 0.0 1.3 5.3 2.5 7.6 2.0 2.4 0.0 0.4 1.7 0.5 12.9 2.6 2.2 0.0 3.0 6.4 0.1 1.8 0.0 1.3 0.9 2.0 0.6 3.3 6.9 11.5 0.4 1.8 0.0 0.1 0.9 0.0 1.0 2.3 0.9 0.1 13.5 4.7 2.4 0.1 0.9 4.2 0.3 6.6 3.2 6.6 4.4 2.8 2.7 4.1 0.8 1.5 2.9 0.8 1.3 B4GALT2 beta4Gal-T2 ENSG00000117411 "Beta-1,4-galactosyltransferase 2" O60909 1 43978943-43991170 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007620, HPA047739" Supported Supported "Golgi apparatus,Vesicles" NA NA 3100000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus, Vesicles" "HPA007620: AB_2667879, HPA047739: AB_2680141" "unprognostic (1.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.15e-1)" "unprognostic (7.59e-2)" "unprognostic (1.19e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (2.96e-5)" "unprognostic (1.12e-2)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" "unprognostic (4.23e-3)" "unprognostic (7.58e-2)" "prognostic unfavorable (3.62e-5)" "unprognostic (6.54e-2)" "unprognostic (1.52e-1)" "unprognostic (7.66e-2)" "unprognostic (3.12e-3)" 29.0 19.0 61.4 13.0 55.0 6.6 24.6 48.0 70.1 28.4 44.0 43.7 12.5 31.0 9.6 32.4 20.0 14.9 40.8 58.4 51.6 24.6 38.8 19.6 5.9 53.6 53.6 19.6 51.5 14.2 24.7 10.1 53.0 31.2 10.2 8.9 27.3 23.8 61.0 32.8 15.2 26.3 52.6 12.0 22.4 22.6 55.2 3.1 14.3 33.2 6.8 37.0 26.8 52.6 61.6 38.4 45.3 76.0 51.3 54.5 37.8 54.2 55.9 54.8 50.9 30.4 51.4 38.4 31.6 112.3 52.5 39.9 36.8 72.8 14.0 39.6 80.2 23.2 37.8 66.9 43.2 20.6 0.8 47.0 79.1 39.3 71.4 55.3 65.5 15.9 51.7 25.3 46.7 45.3 15.3 18.6 65.6 35.7 56.7 44.3 48.2 62.7 33.9 29.3 72.7 58.5 31.1 89.4 38.5 16.9 38.6 17.5 39.3 90.8 102.4 63.8 78.5 7.6 17.8 15.9 40.4 16.9 64.6 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 61.4 55.0 48.0 70.1 58.4 51.6 53.6 53.6 53.0 52.6 55.2 52.6 9.7 0.0 8.8 7.5 2.2 7.8 10.3 10.8 1.8 13.3 15.0 18.9 14.0 7.2 7.4 14.7 4.2 2.0 1.2 10.2 1.9 13.3 16.4 6.2 16.2 10.4 16.3 1.3 8.0 20.6 8.0 15.2 13.7 8.7 0.0 23.8 6.1 18.7 2.3 18.5 5.6 22.6 2.0 1.0 3.3 6.7 16.4 1.5 3.6 1.0 1.6 15.0 0.0 5.0 9.8 27.3 6.1 12.4 5.0 25.9 6.4 8.8 4.4 12.2 6.6 9.8 14.3 6.2 15.6 7.6 12.6 0.5 1.7 21.1 15.3 16.1 B4GAT1 "B3GN-T1, B3GNT1, B3GNT6, BETA3GNTI, iGAT, iGNT" ENSG00000174684 "Beta-1,4-glucuronyltransferase 1" O43505 11 66345374-66347629 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 220.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 72.3;Horizontal cells: 158.2;Muller glia cells: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015484 Uncertain "Intracellular and membrane" NA NA 57000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 62: Horizontal cells - Visual perception" "HPA015484: AB_1845235" "unprognostic (1.80e-1)" "unprognostic (7.20e-2)" "unprognostic (1.70e-1)" "unprognostic (3.81e-2)" "unprognostic (3.96e-2)" "unprognostic (1.45e-1)" "unprognostic (9.23e-2)" "unprognostic (1.59e-1)" "unprognostic (2.65e-2)" "unprognostic (3.43e-3)" "prognostic favorable (3.55e-5)" "unprognostic (2.20e-1)" "unprognostic (3.50e-1)" "unprognostic (1.23e-1)" "unprognostic (2.02e-1)" "unprognostic (1.88e-1)" "unprognostic (2.76e-3)" 16.6 41.4 120.6 6.1 124.9 1.3 16.0 71.0 125.2 23.1 68.7 30.1 16.2 28.5 15.2 8.3 23.4 9.9 44.6 115.3 220.2 25.3 18.8 17.3 6.7 85.9 97.3 34.3 25.5 22.6 62.3 22.5 101.0 17.3 7.7 46.0 15.8 22.4 27.7 12.1 14.6 14.0 91.9 10.2 25.8 8.2 150.4 6.5 21.0 19.2 4.3 20.2 16.3 83.9 10.8 26.7 29.7 36.5 32.6 29.3 39.4 18.4 42.5 28.1 22.9 20.1 14.9 8.9 76.1 16.9 24.1 16.8 32.0 20.6 13.5 17.6 58.2 1.3 20.4 77.6 19.3 7.0 2.7 28.6 15.6 17.5 7.4 92.8 33.5 14.8 8.6 13.7 13.6 18.1 16.7 19.1 20.2 10.6 28.0 24.0 23.2 15.9 29.6 2.7 17.8 33.7 15.8 10.4 74.8 18.4 42.6 6.8 19.7 21.8 15.9 28.0 9.6 26.1 19.2 5.3 36.8 5.8 26.0 0.0 1.2 0.0 7.1 0.4 9.9 5.7 7.8 7.6 3.0 3.2 9.0 8.3 0.4 4.6 0.3 7.4 5.7 4.4 120.6 124.9 71.0 125.2 115.3 220.2 85.9 97.3 101.0 91.9 150.4 83.9 13.5 22.4 10.8 25.8 2.9 0.0 1.6 0.0 14.2 72.3 6.2 12.7 45.9 25.8 1.8 20.2 58.4 57.8 8.6 8.0 5.9 7.4 0.5 3.9 9.7 17.1 4.9 0.8 22.1 6.0 22.6 23.4 6.6 2.6 1.3 22.5 30.4 24.4 12.7 158.2 35.0 8.0 0.0 2.4 0.0 2.4 32.6 2.6 0.0 10.3 1.3 70.1 2.1 22.6 14.2 4.3 4.9 40.6 6.1 2.0 13.3 17.5 2.9 47.4 26.3 21.2 11.8 1.4 2.8 5.8 0.0 18.1 2.6 28.0 7.2 0.3 BLMH BH ENSG00000108578 "Bleomycin hydrolase" Q13867 17 30248203-30292056 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 130.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039548, HPA064307" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No 42000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nuclear bodies, Cytosol" "HPA039548: AB_10805479, HPA064307: AB_2685241" "unprognostic (6.85e-2)" "unprognostic (2.79e-1)" "unprognostic (1.48e-1)" "unprognostic (2.46e-1)" "unprognostic (1.76e-1)" "unprognostic (2.54e-2)" "unprognostic (3.91e-3)" "unprognostic (2.07e-1)" "unprognostic (2.05e-3)" "unprognostic (6.69e-3)" "unprognostic (1.95e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (1.22e-3)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" 20.6 13.5 13.4 18.2 15.0 18.1 20.4 15.9 17.6 19.1 14.5 18.8 12.4 21.2 21.1 28.3 14.7 18.4 15.6 13.5 15.2 22.0 14.0 16.0 26.0 15.6 14.1 13.9 26.8 21.7 9.7 27.4 15.4 14.4 15.4 14.7 15.6 14.4 28.8 130.3 18.3 22.4 14.7 20.6 16.2 15.9 14.2 36.3 16.5 19.0 26.9 17.9 21.5 16.2 40.3 62.9 61.5 41.6 40.6 43.8 27.8 36.5 24.0 59.1 50.8 93.2 11.9 119.5 63.3 31.1 26.1 27.1 135.5 52.8 50.1 31.5 101.4 73.5 54.6 80.0 58.3 136.1 43.2 50.5 3.5 46.5 26.5 47.1 87.2 98.2 157.9 47.6 24.6 31.0 168.1 98.6 57.2 0.0 29.2 143.0 154.5 78.9 46.8 35.6 135.1 48.4 32.6 63.2 42.2 106.6 42.9 68.5 54.5 35.0 69.2 16.0 66.0 55.8 124.1 159.3 26.7 0.2 47.6 0.0 8.8 1.5 15.3 6.2 25.3 6.5 18.2 20.2 10.1 7.3 16.4 17.8 1.2 16.3 3.3 10.1 20.0 9.9 13.4 15.0 15.9 17.6 13.5 15.2 15.6 14.1 15.4 14.7 14.2 16.2 21.0 3.2 12.6 13.4 8.8 15.9 16.7 10.6 19.4 20.2 10.3 6.6 17.8 12.8 4.0 11.0 12.5 49.6 15.6 7.6 7.9 17.4 8.4 7.4 28.2 24.0 18.0 22.5 19.0 14.2 38.0 18.3 11.2 7.0 43.8 30.5 25.7 6.9 25.0 13.5 20.9 8.4 6.1 18.9 7.1 6.6 16.1 13.0 10.6 18.7 12.2 9.9 22.6 29.1 22.6 7.2 9.6 24.8 20.0 13.0 11.5 20.0 5.5 15.7 6.6 12.9 19.7 14.9 29.1 24.0 12.6 27.5 20.9 34.8 11.5 7.6 BOLA3 ENSG00000163170 "BolA family member 3" Q53S33 2 74135400-74147912 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 173.9" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 313.2;Distal tubular cells: 352.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046393, HPA053162" Uncertain Supported "Nuclear bodies,Mitochondria,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear bodies, Mitochondria" Cytosol "HPA046393: , HPA053162: AB_2682063" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (1.83e-2)" "unprognostic (4.23e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.86e-3)" "unprognostic (8.03e-2)" "unprognostic (1.60e-2)" "unprognostic (4.03e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (9.90e-5)" "unprognostic (1.19e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (4.40e-1)" 35.6 39.3 52.1 22.6 54.3 40.8 31.4 58.9 66.1 20.2 55.0 46.5 33.8 24.5 25.1 31.7 20.8 11.9 101.0 52.7 56.5 59.8 33.7 23.5 22.2 57.0 53.8 16.6 44.7 56.2 29.6 14.2 56.0 25.4 37.6 35.7 39.7 23.7 117.8 16.6 28.9 22.6 54.7 21.9 41.1 15.8 53.7 24.8 28.8 173.9 21.6 27.1 24.3 55.3 102.8 134.0 44.8 46.2 81.5 78.3 113.9 92.5 54.5 104.0 72.0 176.6 45.4 67.2 79.7 82.4 99.3 53.2 107.9 135.4 95.8 126.5 172.8 85.4 88.3 269.8 76.1 167.3 39.0 62.2 96.6 100.9 124.2 45.9 79.4 144.3 183.2 73.7 116.0 163.6 136.4 123.1 66.9 196.8 198.6 88.5 120.1 132.0 138.8 106.2 70.4 40.7 68.3 106.8 123.3 62.0 62.6 102.8 42.6 83.9 142.9 93.8 185.4 67.5 135.3 92.7 87.6 131.8 73.8 14.7 14.2 3.9 68.3 29.9 75.7 45.4 92.7 72.6 37.8 44.5 79.3 68.7 3.0 51.7 33.5 65.1 91.2 40.6 52.1 54.3 58.9 66.1 52.7 56.5 57.0 53.8 56.0 54.7 53.7 55.3 54.7 9.6 29.8 8.5 33.2 22.7 44.5 111.8 43.3 29.9 82.0 109.5 313.2 44.3 50.1 84.6 16.7 54.9 42.8 125.4 352.1 93.2 20.0 67.0 46.2 45.5 76.1 138.2 14.3 111.4 167.5 48.6 58.1 61.5 25.4 31.9 36.4 113.3 113.9 26.9 15.0 128.3 83.4 32.1 28.9 10.2 32.9 32.2 99.6 3.7 59.4 61.8 62.8 7.5 7.7 95.0 70.9 46.3 76.1 50.9 85.6 266.4 51.2 52.6 19.7 39.6 64.4 66.8 80.5 101.0 16.9 22.3 45.1 83.0 176.2 52.0 BTBD11 "ABTB2B, FLJ33957" ENSG00000151136 "BTB domain containing 11" A6QL63 12 107318421-107659642 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 100.3" "Cell type enriched" "Detected in many" 9 "Inhibitory neurons: 266.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 25.0;Hep G2: 13.6;MOLT-4: 17.9;PC-3: 12.3;RT4: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055898, HPA061334" Supported Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Cytosol "HPA055898: AB_2682964, HPA061334: " "unprognostic (3.40e-2)" "unprognostic (4.06e-1)" "unprognostic (2.37e-1)" "unprognostic (7.85e-2)" "unprognostic (8.78e-3)" "unprognostic (4.82e-2)" "unprognostic (3.52e-1)" "unprognostic (2.12e-1)" "unprognostic (1.52e-1)" "unprognostic (5.92e-2)" "unprognostic (5.33e-2)" "unprognostic (1.78e-1)" "unprognostic (4.92e-8)" "unprognostic (2.66e-1)" "unprognostic (1.55e-1)" "unprognostic (3.33e-2)" "unprognostic (9.07e-3)" 0.4 0.7 7.2 2.7 4.3 4.4 2.9 5.5 10.9 8.1 5.9 0.6 0.7 0.9 1.2 29.4 0.3 0.9 0.6 2.9 13.2 4.2 1.1 0.6 2.9 24.3 16.0 0.1 0.8 100.3 3.5 2.0 24.4 3.4 0.6 1.9 5.6 1.3 0.5 11.1 1.4 0.5 11.4 1.4 0.6 0.7 21.7 17.2 18.9 0.2 3.3 1.7 11.1 5.3 0.1 25.0 5.0 0.0 1.8 0.5 0.0 0.6 0.0 0.2 0.0 0.3 4.0 0.0 6.1 0.1 2.4 9.2 5.1 9.5 0.3 0.0 1.6 0.0 0.1 13.6 0.0 0.2 0.1 2.0 4.0 0.0 2.9 3.8 0.7 10.5 0.0 0.0 0.2 0.9 17.9 2.0 5.3 0.5 12.3 0.0 8.1 0.0 0.0 11.4 6.8 2.5 0.0 0.2 0.0 0.4 0.5 0.7 1.0 0.1 0.2 0.0 2.0 0.1 0.0 0.1 6.4 2.6 0.0 0.9 0.4 0.5 1.0 0.1 3.5 0.0 1.1 0.6 0.7 0.1 1.4 1.3 1.3 0.1 0.3 0.1 0.6 0.6 7.2 4.3 5.5 10.9 2.9 13.2 24.3 16.0 24.4 11.4 21.7 5.3 0.3 0.0 0.0 17.3 0.3 5.2 3.7 2.5 6.8 3.5 0.7 3.2 2.9 0.0 3.0 0.0 0.0 0.2 1.2 0.0 0.0 0.8 0.0 1.2 1.9 0.3 3.5 1.3 8.7 0.0 0.0 1.5 0.0 2.3 0.0 0.0 0.0 0.9 0.3 1.7 266.4 0.4 0.0 0.6 4.3 0.0 0.6 1.7 0.0 1.0 1.8 0.2 3.1 12.5 1.9 0.3 0.0 4.1 0.7 2.8 0.2 0.9 0.3 0.4 0.0 0.0 1.1 0.1 0.2 27.5 7.7 0.4 4.5 3.4 0.4 3.4 C10orf90 "bA422P15.2, FATS, FLJ32938" ENSG00000154493 "Chromosome 10 open reading frame 90" Q96M02 10 126424997-126798708 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 112.1" "Cell type enriched" "Detected in some" 4 "Oligodendrocytes: 819.4" "Cancer enriched" "Detected in some" 5 "melanoma: 4.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SK-MEL-30: 118.8;U-2197: 36.1;U-266/84: 27.2;U-87 MG: 37.0;WM-115: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038648, HPA075229" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Plasma membrane, Cytosol" "HPA038648: AB_10672721, HPA075229: " "unprognostic (1.21e-2)" "unprognostic (3.34e-1)" "unprognostic (7.50e-2)" "unprognostic (2.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.30e-2)" "unprognostic (1.98e-3)" "unprognostic (5.06e-2)" "unprognostic (9.34e-3)" "unprognostic (3.73e-2)" "unprognostic (9.52e-2)" "unprognostic (1.22e-1)" "unprognostic (5.06e-11)" "unprognostic (2.69e-3)" "unprognostic (9.91e-3)" "unprognostic (1.26e-1)" "unprognostic (2.88e-1)" 0.7 0.0 30.4 0.1 74.4 0.0 4.7 41.9 47.7 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 29.9 37.4 0.3 0.1 0.0 0.0 60.4 53.8 0.1 0.2 0.0 0.3 0.3 57.0 0.0 0.1 0.0 10.6 0.0 0.1 1.1 0.1 0.0 29.8 0.0 0.0 6.5 68.0 1.1 0.3 0.4 0.7 0.0 0.0 112.1 0.3 0.1 0.0 0.0 0.8 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 2.3 0.0 1.6 0.0 0.9 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 2.6 0.0 0.0 0.0 0.0 118.8 0.0 0.0 0.2 0.0 4.7 0.0 36.1 0.7 0.0 27.2 0.0 37.0 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 74.4 41.9 47.7 29.9 37.4 60.4 53.8 57.0 29.8 68.0 112.1 0.2 0.0 0.0 24.5 0.1 0.0 0.0 0.0 0.0 0.0 3.0 2.7 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 120.5 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.6 0.0 0.0 0.0 0.0 142.7 0.3 0.0 0.0 3.7 0.0 0.0 0.0 181.0 819.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 1.3 0.5 0.0 0.0 4.2 0.1 0.0 0.0 0.0 C16orf46 FLJ32702 ENSG00000166455 "Chromosome 16 open reading frame 46" Q6P387 16 81053497-81077267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 5.9" "Cell type enhanced" "Detected in many" "Early spermatids: 94.7;Late spermatids: 112.4;Respiratory ciliated cells: 31.8;Spermatocytes: 32.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041136, HPA041379" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA041136: AB_10795535, HPA041379: AB_10794666" "unprognostic (7.73e-2)" "unprognostic (2.17e-1)" "unprognostic (2.59e-1)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (9.93e-2)" "unprognostic (1.81e-2)" "unprognostic (2.32e-3)" "unprognostic (5.11e-2)" "unprognostic (1.93e-1)" "unprognostic (8.06e-2)" "unprognostic (1.86e-1)" "unprognostic (8.54e-2)" "unprognostic (1.58e-1)" "unprognostic (3.53e-1)" "unprognostic (7.06e-3)" "unprognostic (8.72e-2)" 0.5 0.5 1.9 0.4 1.9 0.6 0.8 1.6 2.8 0.7 4.0 0.3 0.2 0.7 1.2 0.3 2.7 0.4 0.3 2.2 2.1 1.0 1.0 0.4 0.1 2.0 2.2 0.4 0.7 0.5 1.8 0.7 2.1 0.9 0.2 1.3 0.4 0.4 0.7 0.1 0.2 0.4 1.9 0.2 0.3 5.9 2.1 0.2 2.8 0.3 0.2 0.6 0.4 2.4 1.2 0.2 0.4 0.2 2.0 0.4 1.1 0.2 1.5 0.8 0.5 0.2 1.7 0.3 0.7 0.3 1.0 0.4 0.4 0.8 1.5 0.3 0.3 0.3 0.9 1.1 1.2 0.4 0.9 0.8 0.6 2.0 1.2 0.9 0.7 0.6 0.8 0.6 0.6 0.9 0.1 2.4 0.5 0.4 0.2 0.9 0.1 0.2 1.4 0.7 0.6 0.5 1.7 0.5 0.3 0.7 0.5 0.6 0.6 0.4 0.2 0.3 0.3 0.6 1.0 0.7 0.7 0.6 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.9 1.6 2.8 2.2 2.1 2.0 2.2 2.1 1.9 2.1 2.4 1.0 0.0 2.3 11.4 0.5 1.9 8.9 6.4 2.2 2.3 5.7 3.2 2.3 4.3 4.6 0.0 4.2 8.2 0.3 0.6 5.9 1.2 94.7 17.3 2.0 1.7 1.2 0.4 12.1 0.4 15.8 2.1 0.5 1.7 0.0 0.3 1.1 3.3 3.3 0.0 9.0 1.7 8.2 0.6 1.0 112.4 8.1 1.5 5.4 1.0 0.3 5.6 1.0 7.1 16.3 0.5 0.6 7.5 0.5 7.5 0.1 3.9 31.8 8.1 0.0 3.1 2.0 32.7 6.8 0.8 2.7 6.3 0.7 0.8 0.8 5.0 C17orf98 LOC388381 ENSG00000275489 "Chromosome 17 open reading frame 98" A8MV24 17 38835086-38841438 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 19.5" "Cell type enriched" "Detected in some" 8 "Early spermatids: 263.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "hTCEpi: 5.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA051696 Uncertain Approved "Nucleoli,Intermediate filaments" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 74: Testis - Spermatogenesis" "Cluster 30: Epithelial cell lines - Translation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Intermediate filaments" Nucleoli "HPA051696: AB_2681576" "unprognostic (2.30e-1)" "unprognostic (3.25e-4)" "unprognostic (1.46e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-3)" "unprognostic (1.14e-2)" "unprognostic (8.69e-3)" "unprognostic (2.56e-1)" "unprognostic (7.58e-2)" "unprognostic (9.02e-2)" 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.0 5.6 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.9 0.0 263.7 0.2 0.1 0.1 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.2 29.4 1.2 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 3.3 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 C7orf57 ENSG00000164746 "Chromosome 7 open reading frame 57" Q8NEG2 7 48035511-48061304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.0;choroid plexus: 6.4;fallopian tube: 13.9" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 52.7;Respiratory ciliated cells: 127.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 3.4;hTERT-HME1: 5.5;U-266/70: 3.2;U-698: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021286 Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 30: Epithelial cell lines - Translation" "Cluster 49: Ciliated cells - Cilium organization" "HPA021286: AB_1845760" "unprognostic (1.74e-2)" "unprognostic (4.82e-2)" "unprognostic (3.13e-2)" "unprognostic (1.28e-2)" "unprognostic (2.77e-3)" "unprognostic (3.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.32e-1)" "unprognostic (3.29e-1)" "unprognostic (1.37e-1)" "unprognostic (4.98e-2)" "unprognostic (2.88e-1)" "unprognostic (3.93e-5)" "unprognostic (5.17e-3)" "unprognostic (6.18e-2)" "unprognostic (3.42e-3)" "unprognostic (1.20e-1)" 0.0 0.0 0.7 0.0 0.8 0.2 0.1 0.5 0.3 0.4 6.4 0.0 0.1 0.4 0.0 0.8 13.9 0.0 0.1 0.7 0.9 0.1 0.0 2.2 0.0 4.0 3.8 0.0 0.0 0.6 0.2 0.0 2.3 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 3.7 0.9 0.0 0.2 0.0 0.1 0.0 0.4 2.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 1.3 0.0 0.1 0.1 3.4 0.2 0.0 0.5 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.5 0.2 0.3 3.2 0.5 1.9 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.5 0.3 0.7 0.9 4.0 3.8 2.3 2.9 0.9 2.0 0.0 0.0 3.0 0.3 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.1 1.0 0.0 15.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.9 52.7 0.6 0.2 0.0 0.0 0.5 0.0 0.1 0.6 0.0 1.1 2.5 0.0 0.0 0.0 0.1 0.0 0.5 0.0 6.1 0.0 0.4 3.5 0.0 0.3 0.0 0.0 0.0 1.1 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 127.6 0.9 0.0 0.0 2.7 16.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 CACNB1 CACNLB1 ENSG00000067191 "Calcium voltage-gated channel auxiliary subunit beta 1" Q02641 17 39173453-39197703 "FDA approved drug targets, Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 328.8;tongue: 216.0" "Cell type enhanced" "Detected in many" "Astrocytes: 20.9;Excitatory neurons: 14.3;Skeletal myocytes: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023343 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 37: Myocytes - Muscle contraction" "HPA023343: AB_1845866" "unprognostic (3.44e-2)" "unprognostic (1.89e-2)" "unprognostic (1.69e-3)" "prognostic unfavorable (3.80e-4)" "unprognostic (3.99e-2)" "unprognostic (1.52e-2)" "unprognostic (1.37e-2)" "unprognostic (2.80e-3)" "unprognostic (4.43e-1)" "unprognostic (1.04e-3)" "unprognostic (5.98e-2)" "unprognostic (3.38e-1)" "unprognostic (1.94e-11)" "unprognostic (7.62e-2)" "unprognostic (2.30e-1)" "unprognostic (1.34e-2)" "unprognostic (7.44e-3)" 5.7 3.6 17.8 2.6 23.7 1.4 5.6 0.0 31.7 12.2 0.0 7.6 1.5 6.3 5.4 6.8 6.9 2.1 7.5 23.4 10.9 3.2 0.9 9.3 2.5 4.4 5.9 6.7 2.6 1.6 7.7 1.7 13.0 8.1 2.5 5.5 13.5 5.4 328.8 12.1 4.1 2.9 1.0 4.7 3.7 7.6 5.0 4.4 6.8 216.0 1.8 6.5 6.5 20.4 6.1 2.7 3.3 7.6 3.6 4.4 0.1 3.6 4.4 3.3 4.1 2.0 6.0 10.4 3.6 5.4 4.7 5.6 3.2 5.9 2.4 5.0 3.7 1.5 7.4 0.8 7.4 0.2 0.9 4.9 1.9 6.9 7.8 4.3 2.4 6.4 0.9 8.9 3.5 1.7 7.6 2.8 2.4 0.9 1.9 5.1 10.9 4.6 1.3 1.9 8.3 5.0 2.1 11.2 3.5 1.2 7.9 4.1 3.4 5.9 6.8 4.4 3.7 4.1 1.5 1.7 4.8 0.0 2.4 0.0 0.4 0.0 0.6 0.1 0.9 0.0 0.6 0.8 0.1 0.0 0.2 0.3 0.0 0.6 0.1 1.0 0.1 0.2 17.8 23.7 0.0 31.7 23.4 10.9 4.4 5.9 13.0 1.0 5.0 20.4 1.4 3.2 3.2 20.9 0.8 2.9 0.7 2.3 2.8 3.1 1.5 1.1 1.7 0.0 2.2 0.0 0.0 0.1 4.0 7.1 0.0 0.6 4.2 1.1 3.3 1.5 0.0 0.4 14.3 0.9 0.1 4.9 2.6 1.7 0.0 2.1 0.4 0.1 1.0 0.0 8.3 1.4 4.1 0.8 5.1 2.4 1.8 1.6 5.4 1.0 0.6 7.2 1.0 2.5 2.1 1.5 1.0 1.2 2.3 2.4 0.0 0.0 0.8 1.4 0.0 13.4 7.0 2.9 0.8 1.1 3.0 0.1 4.6 1.6 1.0 1.1 CAP2 ENSG00000112186 "Cyclase associated actin cytoskeleton regulatory protein 2" P40123 6 17393505-17557790 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 577.1;tongue: 313.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 126.5;Excitatory neurons: 158.1;Inhibitory neurons: 137.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 26.1;basal ganglia: 40.9;cerebral cortex: 87.2;hippocampal formation: 50.2;white matter: 32.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 101.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050530, HPA054147" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA050530: AB_2681159, HPA054147: AB_2682400" "unprognostic (7.27e-2)" "unprognostic (5.71e-3)" "unprognostic (1.63e-2)" "unprognostic (1.55e-1)" "unprognostic (4.86e-1)" "unprognostic (2.23e-2)" "unprognostic (9.94e-2)" "unprognostic (3.58e-2)" "unprognostic (7.72e-2)" "unprognostic (1.65e-1)" "unprognostic (6.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-1)" "unprognostic (8.05e-2)" "unprognostic (1.75e-3)" 17.8 11.6 26.1 7.6 40.9 0.0 10.7 0.9 87.2 15.4 2.9 32.6 4.1 28.5 17.8 21.7 16.8 11.4 113.6 50.2 11.1 8.7 4.5 4.7 1.7 3.2 3.8 4.5 4.2 7.5 5.1 8.8 2.7 25.1 9.6 9.1 7.7 30.7 577.1 2.6 8.9 42.7 0.0 3.1 9.8 1.5 9.1 3.1 5.5 313.0 2.3 14.5 6.4 32.3 15.5 24.6 44.4 55.1 0.3 0.1 10.4 52.3 42.7 46.6 43.0 8.1 6.9 0.0 48.9 62.1 60.5 8.2 21.3 20.9 66.8 0.1 7.9 0.0 15.4 26.5 4.3 0.0 0.0 3.5 9.9 23.1 10.3 72.3 2.2 0.0 0.0 0.1 101.6 25.2 0.0 0.0 17.0 0.8 15.6 5.2 59.1 1.1 23.6 6.4 6.1 10.9 19.0 59.2 31.3 82.8 65.0 11.2 0.2 36.6 31.6 1.0 47.6 0.0 0.0 0.2 11.7 0.1 48.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 40.9 0.9 87.2 50.2 11.1 3.2 3.8 2.7 0.0 9.1 32.3 2.0 3.2 1.5 9.8 0.0 1.9 4.3 6.2 5.7 16.4 10.2 8.4 126.5 4.3 5.4 1.8 4.2 16.5 0.0 1.9 3.9 2.7 0.1 13.9 13.7 2.7 6.0 0.0 158.1 0.7 12.2 7.9 0.0 5.8 0.0 22.8 3.9 2.4 2.2 8.4 137.2 1.3 2.0 0.0 2.2 0.0 0.6 0.3 0.0 10.3 0.0 6.3 0.0 16.6 7.2 3.7 1.9 4.9 0.0 1.9 0.0 16.7 33.9 2.2 32.9 25.5 43.4 0.1 3.2 2.1 0.9 37.5 0.3 0.3 1.6 0.6 CAPN7 PalBH ENSG00000131375 "Calpain 7" Q9Y6W3 3 15206152-15252916 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004745, HPA046617" Uncertain Approved Centrosome,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 28: BEWO - Transcription regulation" "Cluster 46: Photoreceptor cells - Phototransduction" Cytosol Centrosome "HPA004745: , HPA046617: AB_2679721" "unprognostic (2.70e-2)" "unprognostic (2.79e-1)" "prognostic favorable (4.85e-5)" "unprognostic (1.85e-1)" "unprognostic (1.69e-2)" "unprognostic (1.41e-2)" "unprognostic (2.22e-3)" "unprognostic (2.72e-1)" "unprognostic (1.42e-1)" "unprognostic (2.76e-1)" "unprognostic (1.39e-1)" "unprognostic (5.29e-2)" "unprognostic (1.12e-3)" "unprognostic (3.24e-2)" "unprognostic (7.84e-2)" "unprognostic (5.66e-2)" "unprognostic (1.05e-2)" 13.9 11.9 4.6 11.6 5.9 13.2 16.6 12.5 5.4 16.9 9.3 12.1 12.9 16.1 14.9 11.4 14.4 11.1 11.6 4.1 8.1 15.2 19.1 12.1 14.3 5.9 5.7 19.8 15.3 20.1 9.2 12.9 5.5 14.1 12.2 28.5 13.9 12.7 25.3 11.6 13.6 13.8 6.0 11.4 14.0 12.1 6.8 16.9 23.5 16.5 15.7 10.2 9.8 9.7 14.3 18.5 15.1 9.5 26.0 20.1 51.4 18.1 20.8 22.1 16.7 13.3 10.0 24.6 12.3 20.7 13.6 9.7 22.5 23.3 19.0 23.7 17.5 30.8 24.8 17.7 19.3 25.1 15.0 13.9 33.2 28.7 14.1 20.9 15.9 23.3 30.3 25.1 21.6 20.8 17.9 10.5 14.5 20.7 17.7 10.2 25.1 17.1 16.4 25.8 12.2 15.8 29.5 15.7 20.8 19.2 27.9 25.8 14.4 19.8 14.9 25.9 21.4 17.2 37.1 12.4 18.1 18.0 17.5 4.6 3.0 5.1 3.3 2.5 5.3 3.5 3.6 2.8 2.9 3.1 4.9 4.6 1.8 3.6 4.4 2.4 3.0 3.0 4.6 5.9 12.5 5.4 4.1 8.1 5.9 5.7 5.5 6.0 6.8 9.7 15.8 12.8 23.6 44.1 35.0 21.4 13.5 10.6 47.3 42.7 20.3 16.0 33.2 8.6 20.6 1.8 56.3 21.2 21.7 11.2 9.8 12.6 15.5 32.2 31.5 19.0 20.9 14.9 60.2 16.9 12.6 27.6 30.1 29.9 15.8 28.9 14.6 20.8 12.2 55.5 65.8 11.3 4.1 11.9 23.0 14.8 24.8 20.9 21.4 49.6 18.4 31.2 10.3 73.9 86.0 13.0 6.9 26.4 52.8 20.0 16.7 15.2 34.9 98.1 39.5 31.5 24.8 26.8 17.8 29.7 23.2 26.1 34.2 21.1 11.8 14.3 CASD1 "C7orf12, FLJ21213, FLJ21879" ENSG00000127995 "CAS1 domain containing 1" Q96PB1 7 94509219-94557019 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 93.7;Inhibitory neurons: 108.5;Oligodendrocyte precursor cells: 122.6;Oligodendrocytes: 170.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044404 Uncertain Approved Nucleoplasm Yes No "Cluster 16: MAIT-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA044404: AB_10964353" "unprognostic (4.02e-2)" "unprognostic (4.16e-2)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (7.04e-2)" "unprognostic (7.90e-2)" "unprognostic (3.66e-2)" "unprognostic (2.18e-2)" "unprognostic (9.83e-2)" "unprognostic (4.74e-2)" "unprognostic (4.95e-3)" "unprognostic (2.16e-2)" "unprognostic (5.24e-2)" "unprognostic (4.01e-3)" "unprognostic (1.93e-1)" "unprognostic (7.07e-2)" "unprognostic (2.59e-3)" 11.1 25.3 11.4 9.6 14.0 6.0 15.7 11.1 12.9 11.3 4.8 16.5 6.5 14.1 14.6 6.3 11.0 10.0 17.1 14.9 17.4 12.4 9.0 11.3 12.5 8.8 10.7 16.4 9.8 13.8 8.7 12.3 12.9 13.9 19.3 22.1 20.3 9.4 14.1 3.8 6.1 11.0 11.3 10.6 7.3 13.1 14.6 11.2 16.0 19.6 10.8 9.1 4.3 14.0 5.5 10.4 34.7 12.9 10.4 12.3 5.9 7.2 12.8 7.9 10.2 6.5 13.2 13.9 18.5 9.8 14.1 3.0 8.8 2.5 15.4 22.2 7.1 12.3 8.5 11.9 8.8 20.5 0.0 11.4 9.2 7.2 10.3 15.4 12.6 16.0 6.7 29.3 19.6 8.0 28.5 11.6 17.7 7.7 8.2 19.3 28.0 10.8 15.9 14.9 13.1 44.5 11.4 20.7 7.4 24.9 5.4 12.8 6.7 19.6 15.5 16.2 10.6 28.0 28.1 28.5 10.7 4.7 12.9 0.0 0.2 0.0 0.6 0.2 1.6 0.6 0.9 0.8 0.4 0.5 0.9 0.7 0.0 0.6 0.2 0.3 0.6 0.2 11.4 14.0 11.1 12.9 14.9 17.4 8.8 10.7 12.9 11.3 14.6 14.0 26.2 28.9 26.3 76.0 15.4 4.6 5.8 5.8 4.0 56.4 14.4 12.8 21.1 17.2 12.8 20.2 18.8 14.2 14.6 29.7 3.9 5.1 3.4 18.0 13.1 16.4 7.2 4.6 93.7 5.6 5.7 14.6 5.1 9.9 10.2 23.7 16.1 13.3 8.8 67.3 108.5 30.2 2.0 9.8 5.5 7.0 11.5 10.8 24.9 61.8 7.1 23.3 10.3 122.6 170.3 6.8 11.8 9.8 9.2 10.0 0.6 10.8 18.1 31.4 19.7 41.2 12.2 9.6 12.8 4.7 4.5 16.8 12.2 25.8 19.5 4.5 CCDC107 MGC31967 ENSG00000159884 "Coiled-coil domain containing 107" Q8WV48 9 35658290-35661511 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016857, HPA050442" Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA016857: AB_10669751, HPA050442: AB_2681128" "unprognostic (3.70e-3)" "unprognostic (7.07e-3)" "unprognostic (3.60e-2)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.09e-2)" "unprognostic (4.13e-1)" "unprognostic (1.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.33e-2)" "unprognostic (1.89e-1)" "unprognostic (5.15e-1)" "unprognostic (1.96e-1)" "unprognostic (5.75e-2)" 91.6 61.0 35.1 19.1 34.6 7.8 75.3 37.4 40.6 48.5 36.0 117.8 19.2 74.2 31.1 25.1 60.6 15.3 90.3 34.5 35.3 37.7 50.3 43.6 15.4 35.5 35.7 32.3 62.7 12.8 33.0 13.9 36.0 55.9 16.8 13.9 26.6 29.2 64.4 32.5 47.1 28.2 34.7 41.2 74.4 17.1 37.3 26.0 31.4 22.4 14.4 76.6 39.1 35.0 17.9 15.7 12.8 16.3 63.3 40.3 7.4 29.5 26.4 18.5 17.2 7.2 5.2 11.5 12.8 38.9 47.6 5.9 9.6 14.2 13.6 34.4 15.3 5.5 25.1 18.3 15.0 8.5 20.1 24.1 16.6 19.8 15.3 34.4 13.1 19.2 7.2 21.7 23.4 11.6 9.5 12.6 9.5 12.6 48.2 13.7 2.9 9.3 62.8 9.6 8.4 14.0 15.2 21.1 15.4 9.5 11.1 10.4 16.7 29.5 16.3 21.6 27.3 9.6 15.4 23.1 54.6 13.5 26.2 33.3 39.3 20.1 128.7 43.2 168.8 79.5 111.6 113.8 45.0 79.5 53.2 74.2 7.8 69.3 25.9 123.8 140.8 75.1 35.1 34.6 37.4 40.6 34.5 35.3 35.5 35.7 36.0 34.7 37.3 35.0 68.7 67.3 25.0 11.1 104.8 70.2 38.0 76.9 8.6 31.9 39.2 65.3 0.7 60.1 48.4 82.8 8.4 15.0 175.2 143.9 17.6 74.1 7.6 33.5 34.1 36.1 88.1 15.8 8.6 140.2 66.2 60.0 121.8 30.5 34.3 24.4 53.9 77.3 90.9 32.0 10.2 100.5 69.2 46.9 185.9 28.3 59.4 82.0 113.8 13.1 43.5 57.2 133.9 7.5 10.8 86.7 108.6 102.3 53.3 45.3 146.7 66.9 48.2 34.1 118.3 33.7 135.3 37.9 63.1 17.8 66.9 13.8 132.7 44.9 51.7 29.5 CCDC65 "CFAP250, CILD27, DRC2, FAP250, FLJ35732, NYD-SP28" ENSG00000139537 "Coiled-coil domain containing 65" Q8IXS2 12 48904110-48931840 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 26.6;testis: 37.3" "Cell type enhanced" "Detected in many" "Early spermatids: 151.1;Endometrial ciliated cells: 92.7;Respiratory ciliated cells: 155.7;Spermatocytes: 85.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 8.7;MAIT T-cell: 9.1;memory CD4 T-cell: 7.5;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.6;naive CD8 T-cell: 6.2;T-reg: 4.8" "Lineage enriched" "Detected in single" 11 "T-cells: 9.1" "Cell line enhanced" "Detected in many" "HeLa: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038520, HPA057573" Uncertain Approved "Vesicles,Centriolar satellite" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "Centriolar satellite" "HPA038520: AB_10672714, HPA057573: AB_2683473" "unprognostic (3.06e-2)" "unprognostic (1.17e-1)" "unprognostic (4.22e-2)" "unprognostic (4.20e-3)" "unprognostic (1.44e-2)" "unprognostic (3.43e-2)" "unprognostic (2.86e-2)" "unprognostic (5.79e-3)" "unprognostic (3.23e-1)" "unprognostic (9.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.03e-4)" "unprognostic (1.69e-3)" "unprognostic (2.04e-1)" "unprognostic (7.80e-2)" "unprognostic (1.34e-2)" "unprognostic (6.16e-2)" 0.4 0.4 1.5 0.7 2.3 1.4 0.4 0.0 2.8 1.4 3.4 0.4 0.3 1.1 2.8 0.3 26.6 1.2 0.3 3.2 0.3 1.8 0.3 2.9 1.0 1.4 2.3 0.8 0.8 1.4 2.1 0.1 1.3 0.4 0.0 7.1 0.3 0.4 0.4 1.5 0.5 0.1 0.5 1.1 0.4 37.3 1.5 0.2 2.5 0.0 0.3 0.2 0.3 0.3 0.6 2.5 1.1 2.2 0.0 0.0 1.1 0.6 0.0 0.3 1.0 3.1 1.4 0.9 0.8 0.0 0.3 0.7 0.0 0.0 0.4 1.4 1.1 1.4 4.4 1.1 0.1 1.1 1.2 0.0 0.0 0.6 0.0 1.7 0.0 0.7 0.6 0.3 0.0 1.5 0.3 1.5 2.5 0.9 0.6 0.8 0.5 1.0 2.0 1.6 0.6 1.0 0.7 0.9 0.8 1.7 2.3 1.0 1.0 0.8 0.8 0.9 0.5 1.1 1.2 0.8 0.9 0.9 0.2 0.0 0.0 0.0 8.7 0.0 9.1 0.2 7.5 7.3 0.0 0.5 4.6 6.2 0.1 0.8 0.0 0.0 4.8 2.9 1.5 2.3 0.0 2.8 3.2 0.3 1.4 2.3 1.3 0.5 1.5 0.3 0.9 0.0 1.1 2.0 0.6 0.9 0.2 6.2 0.0 1.2 0.4 0.5 0.5 0.0 13.8 0.0 12.5 0.1 6.5 0.0 7.9 1.0 151.1 92.7 3.0 0.6 0.0 2.7 7.2 0.6 0.1 0.8 0.5 4.2 0.0 0.5 0.0 0.5 0.0 0.0 4.0 0.0 12.2 0.0 0.8 22.7 1.5 0.3 1.8 1.0 0.2 2.2 33.0 2.0 0.8 0.3 0.0 2.2 1.0 0.2 0.0 3.4 155.7 11.5 0.0 0.5 3.6 85.9 4.8 0.0 0.1 0.1 7.3 0.5 0.0 0.1 CCDC78 "C16orf25, FLJ34512" ENSG00000162004 "Coiled-coil domain containing 78" A2IDD5 16 722582-726954 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "fallopian tube: 50.3" "Group enriched" "Detected in some" 11 "Endometrial ciliated cells: 179.7;Respiratory ciliated cells: 240.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.2;U-266/70: 9.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.10e-1)" "unprognostic (6.48e-2)" "unprognostic (2.62e-4)" "unprognostic (1.02e-2)" "unprognostic (1.24e-1)" "unprognostic (2.58e-2)" "unprognostic (3.47e-2)" "unprognostic (2.06e-2)" "unprognostic (9.39e-2)" "unprognostic (1.48e-1)" "unprognostic (7.82e-3)" "unprognostic (6.14e-2)" "unprognostic (2.02e-2)" "unprognostic (2.45e-3)" "unprognostic (5.20e-1)" "unprognostic (1.44e-1)" "unprognostic (7.22e-3)" 0.4 1.1 2.6 1.7 3.4 1.4 0.4 4.6 3.9 3.3 3.5 0.2 0.3 1.7 0.1 0.5 50.3 0.9 0.6 3.4 3.0 0.9 0.1 10.0 2.2 7.1 7.6 0.5 1.0 0.7 4.9 0.5 4.7 0.6 0.3 0.8 1.1 0.7 0.5 0.7 1.9 0.1 5.1 2.1 1.1 0.6 2.6 0.9 0.6 0.2 0.8 0.9 0.3 3.3 1.8 3.1 1.1 5.4 1.1 1.2 2.8 1.1 2.2 0.5 0.1 0.8 2.8 2.0 0.4 0.3 1.0 1.7 2.8 1.1 0.1 9.0 2.1 2.3 4.8 1.4 0.8 1.5 1.5 2.5 0.4 0.1 3.3 2.4 0.2 3.7 1.4 2.4 0.8 8.6 0.0 4.5 1.5 1.3 0.8 2.1 0.9 6.6 2.5 1.7 12.2 2.1 0.9 3.6 0.9 0.9 4.5 1.7 0.9 1.5 0.5 0.4 0.3 9.9 4.7 1.9 0.8 3.2 2.6 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.6 3.4 4.6 3.9 3.4 3.0 7.1 7.6 4.7 5.1 2.6 3.3 0.1 0.0 0.0 2.6 1.9 0.0 0.1 17.9 0.0 3.5 0.7 0.6 0.5 0.0 17.7 0.0 0.0 0.0 3.4 0.2 1.9 0.0 0.0 179.7 2.1 0.1 0.0 0.4 1.4 0.2 0.1 0.2 1.1 2.4 0.0 0.0 0.0 0.0 0.9 3.3 1.0 0.0 18.3 0.6 0.0 0.1 0.3 0.5 0.0 1.0 0.1 0.7 2.1 1.0 2.0 0.3 0.0 0.0 0.2 0.6 0.0 0.2 240.7 0.2 0.0 0.0 7.6 0.8 0.9 0.0 0.1 0.0 1.4 0.1 0.1 0.2 CCDC88C "DAPLE, HkRP2, KIAA1509, SCA40" ENSG00000015133 "Coiled-coil domain containing 88C" Q9P219 14 91271323-91417844 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Guanine-nucleotide releasing factor" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 33.9" "Cell type enhanced" "Detected in many" "dendritic cells: 80.1;NK-cells: 142.2;Plasma cells: 93.2;Respiratory ciliated cells: 112.5;T-cells: 89.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 55.6;Karpas-707: 50.1;SCLC-21H: 53.6;U-266/70: 58.5;U-266/84: 76.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 5 "basal ganglia: 37.0" HPA005832 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Nucleoli fibrillar center" "HPA005832: AB_1079202" "unprognostic (7.28e-2)" "unprognostic (2.33e-3)" "unprognostic (7.23e-2)" "unprognostic (5.06e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.47e-4)" "unprognostic (3.07e-2)" "prognostic favorable (2.90e-4)" "unprognostic (1.48e-1)" "unprognostic (2.13e-1)" "unprognostic (4.77e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.80e-4)" "unprognostic (7.48e-2)" "unprognostic (2.22e-1)" "unprognostic (2.15e-2)" "unprognostic (4.35e-2)" 4.5 1.4 5.9 19.4 23.9 31.2 6.9 3.2 7.1 4.0 2.5 9.4 13.3 3.1 1.6 12.5 12.2 6.2 4.0 3.6 3.9 6.8 3.6 9.7 33.9 5.6 6.7 1.0 8.3 5.3 5.2 2.4 4.6 9.4 7.0 1.0 10.1 3.9 2.3 7.0 11.7 2.3 4.3 21.7 12.4 8.0 7.8 20.4 2.5 2.7 20.4 8.1 7.6 3.2 8.5 6.9 7.5 9.5 0.0 0.0 34.9 0.0 0.0 0.0 0.0 6.8 13.4 45.1 6.1 0.0 0.4 0.4 11.3 6.4 0.0 28.8 4.7 10.0 4.8 9.9 0.7 23.0 8.4 0.0 11.4 0.0 0.0 0.7 8.6 55.6 11.2 50.1 0.1 24.9 24.2 29.6 7.1 6.2 11.5 19.5 0.2 14.2 2.6 10.2 53.6 11.6 4.6 16.9 4.6 5.6 10.2 20.7 2.6 0.0 0.2 0.1 0.1 58.5 76.2 22.8 0.0 20.1 0.1 7.8 3.3 1.3 9.4 1.9 8.8 2.5 6.0 9.2 1.8 2.1 3.8 5.8 2.3 4.0 3.0 2.0 10.7 4.1 5.9 23.9 3.2 7.1 3.6 3.9 5.6 6.7 4.6 4.3 7.8 3.2 26.6 3.2 28.8 7.8 54.1 9.3 15.9 19.0 27.9 0.0 15.3 7.6 19.8 10.0 22.1 14.7 0.0 3.6 80.1 29.6 0.0 4.4 9.6 62.6 1.4 17.3 23.9 20.6 7.1 5.9 2.2 4.2 20.4 12.1 2.5 1.3 20.3 1.6 6.3 0.0 2.5 15.3 22.4 21.0 12.4 18.7 4.1 18.9 1.8 9.4 20.1 8.0 142.2 8.0 5.2 7.8 18.2 3.0 93.2 16.8 13.1 13.2 112.5 0.1 0.0 2.9 4.4 4.7 17.4 31.2 9.5 1.8 89.2 3.3 19.4 19.8 CCL20 "CKb4, exodus-1, LARC, MIP-3a, SCYA20, ST38" ENSG00000115009 "C-C motif chemokine ligand 20" P78556 2 227805739-227817564 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" "Antibiotic, Antimicrobial, Cytokine" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 162.6;lymphoid tissue: 165.5;urinary bladder: 192.8" "Group enriched" "Detected in many" 7 "Basal respiratory cells: 25281.7;Club cells: 7424.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 2.7" "Lineage enriched" "Detected in single" 9 "T-cells: 2.7" "Cell line enhanced" "Detected in many" "GAMG: 63.1;Hep G2: 35.7;NB-4: 25.7" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 28000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (2.40e-1)" "unprognostic (1.31e-3)" "unprognostic (1.30e-1)" "unprognostic (2.87e-2)" "unprognostic (7.06e-2)" "unprognostic (7.08e-3)" "prognostic unfavorable (9.29e-4)" "unprognostic (1.53e-3)" "unprognostic (1.37e-1)" "unprognostic (5.21e-1)" "prognostic unfavorable (2.73e-4)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.19e-8)" "unprognostic (1.39e-1)" "unprognostic (2.75e-1)" "unprognostic (1.63e-1)" "unprognostic (1.82e-1)" 10.1 0.3 1.9 31.8 2.2 7.3 0.7 3.6 2.7 23.9 0.2 19.7 16.4 13.7 0.8 12.2 2.7 162.6 2.0 1.9 1.5 9.1 20.1 35.4 6.2 1.9 1.4 0.9 1.8 0.2 0.2 1.3 2.1 2.8 27.0 1.8 5.0 0.5 0.6 8.2 26.6 4.7 1.5 0.4 11.2 2.1 2.6 2.6 0.6 0.2 165.5 192.8 4.6 3.5 0.5 1.4 0.7 0.9 3.2 6.0 0.9 0.4 2.1 0.2 0.8 3.9 0.6 1.3 4.4 0.0 63.1 0.7 0.2 8.7 1.4 0.9 1.5 0.2 3.3 35.7 2.4 4.7 0.4 10.1 1.8 2.0 2.4 1.0 0.0 1.2 0.3 5.1 0.5 0.4 0.3 25.7 1.8 5.3 0.8 0.7 8.6 1.0 0.3 15.4 0.6 0.5 0.3 1.5 0.9 0.8 1.4 5.7 2.3 3.3 4.1 7.2 0.7 1.0 3.2 2.1 5.0 3.5 6.6 0.0 0.1 0.0 0.0 0.0 2.7 0.1 1.1 0.6 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.2 0.4 0.1 1.9 2.2 3.6 2.7 1.9 1.5 1.9 1.4 2.1 1.5 2.6 3.5 2.8 48.1 108.5 0.0 5.6 118.8 554.4 25281.7 21.6 0.6 1.9 1.9 0.9 65.8 7424.9 18.4 0.0 0.5 2.4 135.0 0.0 310.9 16.0 51.9 44.4 5.1 57.9 0.0 0.0 2.9 0.5 9.2 50.4 517.8 5.7 0.0 0.0 1.7 29.1 1.7 0.0 161.0 2203.3 4.0 149.2 1.2 0.0 333.0 1.8 0.0 9.4 0.0 0.0 0.0 0.0 24.1 459.7 0.0 4.5 259.5 331.0 9.3 1477.8 0.2 0.0 0.7 115.1 1.2 1.2 224.9 64.8 0.8 68.2 0.0 121.9 1062.1 CCND2 ENSG00000118971 "Cyclin D2" P30279 12 4269771-4305353 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 354.3;Granulosa cells: 438.5;Langerhans cells: 255.3;Plasma cells: 371.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 152.4;HBEC3-KT: 136.6;HDLM-2: 238.8;Karpas-707: 287.9;RH-30: 202.7;RPMI-8226: 114.2" "HPA049138, HPA054196" Approved Enhanced Nucleoplasm Yes Yes "Cluster 16: MAIT-cells - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA049138: AB_2680650, HPA054196: AB_2682412" "unprognostic (2.98e-3)" "unprognostic (1.15e-1)" "unprognostic (7.21e-2)" "unprognostic (1.65e-2)" "unprognostic (1.70e-2)" "unprognostic (4.82e-2)" "unprognostic (4.94e-2)" "unprognostic (2.01e-3)" "unprognostic (3.16e-2)" "unprognostic (1.66e-2)" "prognostic favorable (2.52e-4)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (8.23e-2)" "unprognostic (4.52e-1)" "prognostic favorable (9.76e-5)" "unprognostic (7.06e-2)" 20.0 52.6 5.4 8.7 12.9 20.3 13.0 0.0 13.5 26.9 0.0 40.8 17.4 26.1 7.5 12.2 22.1 2.7 51.9 14.4 1.1 9.7 1.9 17.2 5.3 9.6 0.2 14.2 24.5 9.9 23.5 12.9 2.7 20.7 10.4 0.7 10.8 9.1 1.8 12.6 25.9 9.8 7.8 19.7 12.7 4.0 0.0 3.2 20.3 0.0 5.1 26.5 19.9 4.5 0.0 0.0 152.4 0.0 10.1 0.4 0.0 0.0 0.0 0.0 0.0 62.8 0.0 0.0 0.4 0.0 0.0 16.2 0.1 136.6 0.0 238.8 2.5 0.7 0.0 0.0 0.0 57.0 12.6 23.8 2.4 0.0 97.0 0.0 0.0 0.8 17.0 287.9 6.8 0.0 0.0 52.8 50.8 0.0 0.0 0.0 202.7 114.2 0.0 8.1 0.0 0.0 0.0 0.0 0.0 89.6 0.0 0.0 4.2 0.0 39.3 0.0 0.0 1.4 60.7 0.0 0.0 32.3 0.0 6.6 0.4 4.7 11.1 0.0 17.1 3.1 16.3 13.8 0.4 1.7 10.4 12.1 1.1 9.4 0.0 1.1 13.6 6.8 5.4 12.9 0.0 13.5 14.4 1.1 9.6 0.2 2.7 7.8 0.0 4.5 23.9 60.9 46.6 10.1 82.9 106.8 23.9 73.4 174.2 7.6 3.4 41.8 354.3 2.8 37.4 12.9 0.0 4.0 128.7 37.5 0.0 3.1 0.8 3.3 110.8 35.7 64.8 37.2 54.1 68.3 2.7 123.6 4.6 3.6 55.8 438.5 19.6 2.2 13.0 3.3 55.2 147.7 12.2 11.9 255.3 3.3 52.5 39.3 39.2 19.7 9.8 170.0 89.6 55.3 4.0 20.7 49.4 124.1 371.2 35.8 34.4 1.4 10.3 6.5 26.3 21.4 112.6 0.8 5.1 50.9 39.6 6.3 122.6 41.5 159.7 8.4 CCR5 "CC-CKR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22" ENSG00000160791 "C-C motif chemokine receptor 5" P51681 3 46370854-46376206 "CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.0" "Cell type enhanced" "Detected in some" "Kupffer cells: 5.5;Langerhans cells: 32.6;Macrophages: 12.8;T-cells: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 39.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "JURKAT: 1.4;Karpas-707: 6.8;U-266/84: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (4.32e-3)" "unprognostic (1.94e-3)" "unprognostic (1.89e-3)" "prognostic favorable (7.42e-5)" "unprognostic (1.80e-2)" "prognostic favorable (9.33e-5)" "unprognostic (3.38e-3)" "unprognostic (9.90e-3)" "unprognostic (7.65e-2)" "unprognostic (6.22e-2)" "unprognostic (1.36e-1)" "unprognostic (5.34e-2)" "unprognostic (1.14e-3)" "unprognostic (8.34e-2)" "unprognostic (4.69e-2)" "unprognostic (3.14e-2)" "unprognostic (2.42e-2)" 1.8 2.0 0.5 15.0 0.6 1.3 2.4 0.6 0.7 2.1 1.0 3.3 4.1 1.4 1.0 1.4 1.7 5.0 1.1 0.4 0.8 1.0 3.4 7.4 14.4 1.6 0.9 1.7 0.6 0.6 0.4 0.7 1.3 1.9 3.9 0.1 2.9 1.0 0.3 1.1 5.8 3.2 1.2 9.4 6.8 0.8 1.2 4.2 0.8 0.2 9.4 4.8 0.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 6.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 3.1 0.0 0.0 0.1 0.0 12.0 2.2 0.0 11.0 3.8 39.7 0.5 4.7 16.1 9.5 0.0 0.4 4.1 0.5 6.3 0.0 9.0 8.0 3.2 0.5 0.6 0.6 0.7 0.4 0.8 1.6 0.9 1.3 1.2 1.2 2.4 0.3 0.0 1.7 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.3 1.5 0.0 1.3 0.0 1.4 0.3 4.7 0.0 0.0 0.0 0.0 5.5 32.6 0.0 0.0 12.8 3.6 1.9 1.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 13.1 0.1 0.0 0.1 CD69 CLEC2C ENSG00000110848 "CD69 molecule" Q07108 12 9752486-9760901 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 169.1;lymphoid tissue: 94.4" "Cell type enhanced" "Detected in many" "B-cells: 1017.1;dendritic cells: 694.0;granulocytes: 1455.3;Plasma cells: 308.8;T-cells: 1185.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "NK-cells: 26.7;T-cells: 30.8" "Cell line enhanced" "Detected in some" "HL-60: 30.0;JURKAT: 19.5;K-562: 58.4;MOLT-4: 20.9;U-266/70: 22.5;U-698: 25.6;U-937: 97.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002503, HPA050525" Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 32: U-937 - Innate immune response" "Cluster 57: B-cells - Immune response" "CAB002503: AB_563625, HPA050525: AB_2681157" "prognostic favorable (3.31e-5)" "unprognostic (1.84e-2)" "unprognostic (1.80e-2)" "unprognostic (1.73e-2)" "unprognostic (1.66e-1)" "unprognostic (7.10e-3)" "unprognostic (4.76e-3)" "unprognostic (9.53e-3)" "unprognostic (9.73e-3)" "unprognostic (1.64e-2)" "unprognostic (1.96e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (7.87e-5)" "unprognostic (2.88e-2)" "unprognostic (3.32e-2)" "unprognostic (4.28e-2)" "unprognostic (1.65e-1)" 14.0 6.2 0.9 48.1 0.7 169.1 18.9 1.2 1.0 9.3 2.2 8.9 8.2 6.0 2.9 11.9 7.7 27.3 3.5 0.7 1.7 4.9 12.9 22.6 94.4 1.7 1.1 2.6 1.7 2.0 4.0 2.6 1.6 10.4 21.3 0.2 5.1 2.9 0.7 4.3 19.5 14.3 2.2 43.6 11.8 1.3 1.0 57.0 6.9 4.6 60.1 18.0 7.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 1.1 0.0 1.5 0.0 0.0 0.0 0.0 12.1 0.0 0.0 1.5 30.0 1.3 0.1 0.0 0.0 0.0 0.0 0.5 19.5 58.4 0.0 0.0 0.0 20.9 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.9 8.3 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 22.5 2.7 25.6 0.0 97.8 0.0 1.3 0.1 5.9 22.9 0.1 30.8 6.0 14.5 16.9 0.1 6.2 20.6 15.6 0.3 26.7 0.0 0.0 7.9 7.3 0.9 0.7 1.2 1.0 0.7 1.7 1.7 1.1 1.6 2.2 1.0 2.4 13.5 41.7 116.7 0.0 1017.1 18.5 3.8 0.0 10.8 0.1 11.8 14.7 2.0 7.2 5.0 1.8 0.0 0.9 694.0 1.1 0.0 1.1 0.4 5.7 3.6 14.3 0.0 33.7 0.0 0.0 0.3 15.4 63.7 16.7 1455.3 0.0 14.6 2.4 16.6 0.0 0.0 0.2 0.0 15.4 77.1 0.3 0.0 80.1 33.8 10.3 3.2 0.1 57.7 0.0 0.1 0.0 0.1 0.0 308.8 2.2 0.4 2.1 1.5 0.6 0.0 4.3 9.2 0.1 0.3 4.2 18.2 1.9 1185.9 0.0 0.9 3.3 CD96 TACTILE ENSG00000153283 "CD96 molecule" P40200 3 111292719-111665750 "CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 61.8" "Group enriched" "Detected in many" 4 "dendritic cells: 96.8;NK-cells: 58.7;T-cells: 199.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "gdT-cell: 74.0;MAIT T-cell: 117.2;memory CD4 T-cell: 67.0;memory CD8 T-cell: 85.3;naive CD4 T-cell: 68.7;naive CD8 T-cell: 81.8;NK-cell: 79.5;T-reg: 47.4" "Group enriched" "Detected in many" 5 "NK-cells: 79.5;T-cells: 117.2" "Cell line enhanced" "Detected in some" "HEL: 15.9;JURKAT: 18.2;MOLT-4: 68.7;RT4: 58.2;U-937: 59.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA066754 Enhanced NA NA 85000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA066754: AB_2685714" "unprognostic (1.06e-3)" "unprognostic (3.95e-3)" "unprognostic (4.16e-3)" "unprognostic (1.91e-5)" "unprognostic (4.72e-3)" "prognostic favorable (5.52e-4)" "unprognostic (2.12e-2)" "unprognostic (3.48e-2)" "unprognostic (6.06e-2)" "unprognostic (4.84e-3)" "unprognostic (2.44e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (2.02e-6)" "unprognostic (3.12e-1)" "unprognostic (4.42e-2)" "unprognostic (3.90e-2)" "prognostic favorable (5.23e-5)" 5.2 1.7 0.7 12.2 0.8 16.0 2.8 1.2 1.0 3.1 1.8 5.0 6.0 2.6 0.9 1.8 1.9 5.8 0.8 0.8 0.8 1.6 3.7 8.3 26.9 1.8 0.7 0.9 0.4 0.2 0.7 1.0 1.2 2.1 5.9 0.1 2.7 1.1 0.4 1.0 10.1 1.4 0.7 12.8 6.8 0.8 1.2 61.8 3.9 0.1 20.2 11.8 2.6 2.2 0.1 0.0 0.2 0.1 0.2 0.0 0.8 0.0 0.1 0.0 0.0 0.3 1.6 0.3 0.3 0.0 0.0 0.7 0.1 0.1 0.0 0.2 0.0 15.9 0.2 0.2 0.0 0.8 1.3 0.0 0.0 0.1 0.1 1.2 0.0 18.2 0.3 2.0 0.0 0.0 68.7 0.2 0.6 0.0 0.0 0.1 1.9 0.5 0.6 58.2 0.1 0.0 0.2 0.9 0.1 0.3 0.3 0.2 0.0 0.3 1.1 0.3 0.1 5.6 1.9 0.0 0.3 59.0 12.2 2.3 0.5 15.6 74.0 0.3 117.2 10.8 67.0 85.3 0.3 18.8 68.7 81.8 2.7 79.5 0.7 0.5 47.4 46.4 0.7 0.8 1.2 1.0 0.8 0.8 1.8 0.7 1.2 0.7 1.2 2.2 1.5 19.2 19.0 0.0 12.5 3.2 0.8 0.1 1.2 1.6 1.6 1.4 1.0 0.0 9.3 1.8 0.0 0.6 96.8 0.8 0.0 0.1 0.8 2.1 0.8 3.0 0.0 9.3 0.7 0.0 0.2 4.3 8.6 1.6 16.4 0.4 2.2 0.9 0.2 0.0 0.4 0.7 0.0 5.0 6.7 1.1 0.3 6.7 3.6 6.5 2.9 0.5 58.7 0.0 0.1 0.0 1.3 0.0 29.6 0.3 0.0 0.4 1.7 2.1 0.0 0.8 1.0 0.4 0.7 0.6 3.1 1.9 199.9 0.2 0.5 0.6 CDCA4 "FLJ20764, Hepp" ENSG00000170779 "Cell division cycle associated 4" Q9BXL8 14 105009573-105021083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 55.8" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 64.2;Cytotrophoblasts: 84.5;Extravillous trophoblasts: 154.5;Spermatogonia: 69.9;Suprabasal keratinocytes: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA064971 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA Yes "Cluster 16: MAIT-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "Plasma membrane, Cytosol" "HPA064971: AB_2685395" "unprognostic (2.22e-3)" "unprognostic (1.84e-1)" "unprognostic (2.69e-1)" "unprognostic (9.93e-3)" "unprognostic (1.42e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (4.19e-4)" "prognostic unfavorable (7.94e-4)" "unprognostic (4.20e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (6.67e-4)" "unprognostic (6.73e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (7.50e-2)" "unprognostic (1.24e-2)" 3.9 2.6 1.9 7.4 2.0 55.8 4.2 3.0 2.1 8.7 2.1 4.6 4.7 5.4 1.8 18.6 4.1 2.6 2.7 1.7 1.8 3.4 2.7 3.6 11.6 2.1 1.9 4.1 3.2 1.8 1.7 9.2 2.1 3.8 2.9 1.3 5.5 2.2 1.4 24.7 4.9 3.5 1.9 6.6 3.8 11.6 2.0 14.6 3.3 1.5 8.5 4.2 10.2 2.0 40.6 41.3 46.7 35.6 7.9 13.2 61.1 59.0 18.0 45.2 39.7 50.9 50.2 52.9 31.5 20.9 34.5 63.5 32.9 68.0 27.1 58.2 26.1 33.4 33.9 43.2 9.7 59.8 27.0 9.4 20.8 35.2 32.7 15.1 31.4 45.0 37.5 53.0 32.1 98.8 56.2 40.1 34.8 35.1 94.0 53.6 68.1 19.7 15.9 46.2 27.2 33.5 56.6 22.3 46.8 20.5 44.0 39.8 48.8 39.9 50.5 55.3 79.5 19.5 25.9 54.4 33.5 30.2 67.5 1.1 4.3 10.6 11.9 4.9 14.8 8.4 12.7 16.7 4.7 5.4 7.4 8.9 1.6 12.9 5.6 5.1 11.1 7.0 1.9 2.0 3.0 2.1 1.7 1.8 2.1 1.9 2.1 1.9 2.0 2.0 5.4 0.0 2.2 0.7 7.4 64.2 26.5 36.6 13.1 3.4 8.7 8.3 0.6 0.0 9.0 1.8 0.0 84.5 11.5 4.3 3.9 12.7 8.1 9.0 9.0 10.9 3.0 53.0 1.8 7.0 154.5 10.2 3.1 12.5 28.6 15.1 7.9 2.2 24.3 13.5 1.3 6.6 6.1 5.9 22.6 6.8 8.4 8.4 17.8 2.8 9.3 4.6 9.2 1.0 1.8 12.3 3.3 6.0 11.8 16.1 1.9 1.8 7.7 2.6 6.6 4.6 12.5 43.0 69.9 21.3 67.1 25.9 17.7 3.6 9.5 43.2 CDK6 PLSTIRE ENSG00000105810 "Cyclin dependent kinase 6" Q00534 7 92604921-92836573 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.1" "Cell type enhanced" "Detected in many" "Early spermatids: 215.9;Erythroid cells: 213.5;Late spermatids: 237.0;Oligodendrocytes: 235.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 378.4;REH: 173.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA002637, CAB004363" Enhanced Supported Nucleoplasm,Cytosol NA NA 26000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" Nucleoplasm Cytosol "CAB004363: AB_627242, HPA002637: AB_1846432" "unprognostic (1.29e-1)" "unprognostic (5.98e-3)" "unprognostic (9.07e-2)" "unprognostic (2.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.24e-2)" "unprognostic (3.39e-1)" "unprognostic (2.42e-3)" "unprognostic (7.19e-2)" "unprognostic (7.78e-3)" "prognostic unfavorable (3.86e-6)" "unprognostic (4.06e-2)" "unprognostic (4.09e-3)" "unprognostic (1.09e-1)" "unprognostic (7.88e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (2.33e-5)" 3.7 7.3 6.7 4.7 7.1 18.1 4.9 5.4 5.1 4.8 2.6 5.9 6.1 3.1 2.1 4.2 2.9 3.6 4.7 4.0 5.0 4.4 5.9 4.1 6.6 6.3 6.7 2.7 6.2 9.9 1.7 17.3 6.3 3.0 7.5 0.5 5.7 4.2 1.0 6.8 7.2 3.2 5.8 4.9 9.1 3.3 9.6 41.1 2.4 2.3 6.2 3.8 4.6 8.8 27.1 11.3 34.9 23.9 10.6 11.5 5.8 27.2 18.4 14.3 13.5 34.7 20.9 21.7 14.4 19.9 8.4 15.8 20.8 42.6 34.4 43.0 10.6 50.8 23.3 34.7 6.3 33.0 2.7 11.5 23.1 17.9 90.8 13.4 5.6 75.1 49.3 55.5 26.7 5.9 378.4 3.8 9.8 37.4 9.1 173.7 112.0 36.4 20.3 0.7 18.1 113.8 3.7 9.8 17.1 26.0 0.6 54.9 19.3 44.1 63.7 18.0 54.2 27.4 0.5 27.6 6.9 112.1 60.8 0.9 0.2 0.6 0.6 0.4 0.9 0.2 0.6 0.8 0.5 0.3 0.7 0.7 0.1 0.7 0.4 0.9 0.3 0.3 6.7 7.1 5.4 5.1 4.0 5.0 6.3 6.7 6.3 5.8 9.6 8.8 38.6 25.6 3.7 2.9 17.7 60.3 23.5 55.0 62.6 0.4 20.7 21.2 18.1 22.8 32.8 22.0 0.0 53.8 30.5 12.1 9.8 37.0 215.9 3.1 29.0 30.7 16.8 213.5 114.7 23.3 5.3 28.5 42.3 6.9 25.3 39.2 11.4 27.0 16.0 0.0 60.3 63.7 28.5 23.0 48.6 237.0 5.0 27.6 19.6 108.7 22.4 0.8 39.1 119.6 235.3 94.7 22.8 3.4 85.3 47.1 20.1 8.2 11.9 0.0 6.6 100.8 32.2 2.7 33.6 36.7 50.4 17.6 42.5 62.8 92.7 27.3 CDKL3 NKIAMRE ENSG00000006837 "Cyclin dependent kinase like 3" Q8IVW4 5 134286350-134371047 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.2" "Group enriched" "Detected in many" 6 "Early spermatids: 342.0;Late spermatids: 295.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027751 Uncertain Nucleoplasm,Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Vesicles" "HPA027751: AB_10601256" "unprognostic (4.70e-2)" "unprognostic (2.15e-2)" "unprognostic (2.35e-1)" "unprognostic (1.48e-1)" "unprognostic (1.43e-1)" "unprognostic (3.98e-2)" "unprognostic (3.43e-3)" "unprognostic (5.93e-2)" "unprognostic (2.12e-3)" "unprognostic (1.49e-1)" "unprognostic (8.47e-4)" "unprognostic (2.82e-1)" "unprognostic (9.85e-4)" "unprognostic (8.33e-2)" "unprognostic (4.88e-2)" "unprognostic (7.10e-3)" "unprognostic (3.43e-3)" 0.7 0.8 2.5 0.5 2.8 0.2 0.6 2.5 4.4 0.8 1.3 0.8 0.5 1.1 0.6 0.6 1.2 0.6 2.7 2.4 2.7 1.5 0.8 0.5 0.7 2.9 2.6 0.7 0.5 1.0 0.6 0.4 3.0 0.7 0.6 4.2 0.4 0.8 3.4 0.6 0.6 1.5 3.1 0.7 0.5 16.2 2.8 0.9 1.2 3.3 0.9 0.6 0.5 5.0 0.5 1.3 1.7 1.2 2.7 2.4 0.7 1.7 1.4 0.7 1.7 1.2 0.8 1.3 1.0 1.1 3.3 0.5 1.5 1.0 1.2 1.6 1.0 0.8 1.7 1.9 1.7 0.3 0.5 1.1 2.5 2.2 0.6 1.2 0.7 3.4 1.1 0.7 1.9 0.6 1.2 4.6 1.2 0.3 0.5 1.9 0.6 0.4 0.9 0.5 2.5 0.8 1.8 0.1 2.1 1.8 1.0 0.9 0.5 1.4 0.3 1.9 0.5 1.8 2.5 2.9 2.1 1.4 1.1 0.0 0.3 0.3 0.3 0.4 1.4 0.5 0.4 0.9 1.0 0.3 1.3 1.3 0.0 0.6 0.1 0.5 0.9 0.4 2.5 2.8 2.5 4.4 2.4 2.7 2.9 2.6 3.0 3.1 2.8 5.0 4.1 0.0 3.7 50.6 2.0 10.8 6.4 18.8 4.0 13.3 4.5 5.8 2.2 2.8 9.9 5.5 4.2 3.1 3.2 0.5 9.8 3.5 342.0 7.5 6.4 4.6 3.0 4.8 41.6 5.1 1.8 6.2 1.5 3.7 3.8 7.0 3.6 2.3 3.6 6.7 52.0 1.5 18.3 2.1 19.4 295.3 5.0 2.8 10.6 16.9 2.4 10.8 3.1 32.6 50.7 1.5 1.6 9.1 1.4 4.3 1.3 9.5 12.9 9.7 0.0 6.3 7.9 35.3 17.2 1.7 11.1 4.5 3.4 6.2 0.9 3.8 CEP290 "3H11Ag, BBS14, CT87, FLJ13615, JBTS5, KIAA0373, LCA10, MKS4, NPHP6, POC3, rd16, SLSN6" ENSG00000198707 "Centrosomal protein 290" O15078 12 88049016-88142099 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" Activator "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Joubert syndrome, Leber congenital amaurosis, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 150.5;Spermatocytes: 143.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB029995, HPA043918, HPA064397" Approved Supported Centrosome NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 1: K-562 - Erythropoiesis" "Cluster 46: Photoreceptor cells - Phototransduction" Centrosome "CAB029995: , HPA043918: AB_2678730, HPA064397: AB_2685255" "unprognostic (7.42e-2)" "unprognostic (4.02e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-1)" "unprognostic (3.26e-1)" "unprognostic (8.90e-2)" "unprognostic (1.45e-4)" "unprognostic (2.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "unprognostic (2.94e-2)" "unprognostic (7.25e-2)" "prognostic unfavorable (3.21e-6)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (2.44e-2)" "unprognostic (3.84e-3)" 5.2 5.1 2.7 4.0 3.4 2.8 5.0 3.1 3.8 7.9 1.9 6.3 1.5 6.4 2.7 2.4 8.0 2.6 4.5 2.8 2.9 7.1 3.6 5.0 3.6 2.8 3.0 12.3 4.6 9.0 8.4 3.3 3.0 6.8 2.6 7.2 3.5 2.1 2.9 3.7 4.6 2.9 2.7 4.5 4.8 8.6 2.9 4.3 7.3 1.2 2.6 6.0 4.9 4.3 8.3 4.9 9.8 2.0 4.2 16.1 3.8 8.2 6.6 5.8 5.0 7.3 3.3 7.6 3.6 6.1 9.1 6.4 2.7 5.2 9.1 4.2 4.7 7.5 4.5 4.7 7.6 10.0 3.4 8.3 3.3 12.5 10.4 11.3 11.3 6.5 15.4 1.4 11.0 3.8 5.7 6.2 2.5 1.3 8.5 4.5 11.6 5.1 4.9 6.1 4.7 8.3 5.0 2.5 6.4 7.6 11.3 3.3 10.0 9.5 5.5 8.1 10.7 6.0 10.4 8.2 3.5 3.7 3.9 0.0 0.0 0.1 0.6 0.1 0.8 0.2 0.7 0.5 0.0 0.3 0.7 0.5 0.0 0.5 0.2 0.6 0.5 0.0 2.7 3.4 3.1 3.8 2.8 2.9 2.8 3.0 3.0 2.7 2.9 4.3 29.0 86.6 32.1 56.2 22.5 6.4 16.9 17.5 17.1 65.9 15.1 16.5 50.0 25.8 35.2 29.5 102.2 13.0 28.6 8.4 7.9 26.0 70.6 89.0 57.0 24.6 4.9 12.4 91.8 13.1 8.8 26.1 14.3 32.1 19.0 56.2 13.9 5.7 13.9 65.6 93.7 17.4 34.6 6.3 7.4 29.4 28.6 13.5 14.2 30.9 11.4 35.0 33.0 67.3 100.4 19.0 6.5 37.6 22.5 9.2 6.9 11.0 81.8 150.5 32.9 42.5 32.2 143.9 53.5 6.4 5.5 5.6 23.7 46.1 15.8 9.4 CEP95 "CCDC45, DKFZp667E1824" ENSG00000258890 "Centrosomal protein 95" Q96GE4 17 64506865-64542461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052426, HPA052428, HPA061371" Approved Uncertain "Centriolar satellite,Cytosol" NA No "Cluster 16: MAIT-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" Cytosol "Centriolar satellite" "HPA052426: AB_2681827, HPA052428: AB_2681829, HPA061371: AB_2684495" "unprognostic (1.28e-2)" "unprognostic (9.12e-2)" "unprognostic (3.66e-3)" "unprognostic (4.09e-2)" "unprognostic (3.30e-2)" "prognostic favorable (5.78e-4)" "prognostic unfavorable (2.52e-5)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (1.54e-1)" "unprognostic (1.64e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (5.76e-5)" "unprognostic (3.48e-1)" "unprognostic (1.84e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" 8.4 6.4 8.1 11.7 10.2 42.5 17.5 20.5 10.8 12.8 15.4 11.7 13.5 23.4 15.9 9.4 16.6 13.0 8.5 8.5 8.6 10.4 11.3 11.3 20.1 10.4 10.7 25.6 14.4 10.4 6.3 9.5 10.7 14.6 14.6 40.4 9.6 11.7 9.5 23.1 11.8 12.5 8.9 14.0 13.9 19.0 8.3 18.9 21.3 6.9 16.4 9.7 7.9 16.2 18.5 10.7 26.3 22.8 8.6 15.4 23.7 9.6 10.9 12.8 16.9 14.4 11.3 28.7 6.1 13.3 13.2 25.3 21.2 15.9 24.9 7.3 15.6 27.2 28.2 30.8 21.1 28.9 15.3 18.9 19.8 14.2 30.7 18.5 10.9 29.1 31.5 21.5 12.5 21.4 40.3 23.4 14.8 20.9 14.2 31.6 46.1 21.0 16.5 28.4 14.9 28.0 11.8 22.0 30.2 39.1 20.2 25.0 12.7 27.6 23.9 11.5 13.1 23.6 18.5 31.4 11.6 21.5 19.0 0.6 2.7 2.1 2.9 2.9 7.1 3.5 3.6 4.3 3.0 3.7 5.9 4.0 0.9 2.0 2.8 2.9 3.2 1.8 8.1 10.2 20.5 10.8 8.5 8.6 10.4 10.7 10.7 8.9 8.3 16.2 14.9 41.7 26.3 44.7 29.4 16.2 25.6 14.3 40.5 29.9 17.9 20.2 17.6 14.3 29.4 3.7 45.9 9.4 25.1 18.1 7.9 18.6 58.0 45.9 28.9 13.8 7.7 26.5 47.5 11.8 10.8 23.5 18.8 44.8 29.7 31.9 13.2 8.9 8.5 18.5 56.2 13.8 8.2 10.3 12.8 18.5 20.8 16.6 12.4 23.4 15.2 21.3 15.5 42.7 46.7 14.1 10.4 21.4 21.1 15.4 20.2 6.8 53.1 84.8 13.1 41.3 21.6 38.8 27.5 28.4 20.3 6.6 23.7 23.8 19.7 21.9 CERK "dA59H18.2, dA59H18.3, DKFZp434E0211, FLJ21430, FLJ23239, hCERK, KIAA1646, LK4" ENSG00000100422 "Ceramide kinase" Q8TCT0 22 46684410-46738252 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064699 Approved Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 24: Non-specific - Transcription regulation" Vesicles "HPA064699: AB_2685327" "unprognostic (2.93e-2)" "unprognostic (1.93e-1)" "unprognostic (6.52e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (2.67e-2)" "unprognostic (1.49e-3)" "unprognostic (8.55e-2)" "unprognostic (3.60e-2)" "unprognostic (3.87e-1)" "unprognostic (1.35e-2)" "prognostic favorable (2.35e-4)" "unprognostic (2.26e-1)" "unprognostic (1.50e-3)" "unprognostic (1.27e-1)" "unprognostic (4.78e-1)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.58e-4)" 15.7 23.7 17.5 22.2 18.1 21.1 12.7 33.2 22.5 17.8 16.4 17.9 31.6 17.5 6.0 14.8 18.2 17.4 39.0 18.3 37.4 19.5 18.9 16.6 26.1 32.1 34.5 26.6 30.2 11.5 49.0 10.0 33.2 11.7 14.9 21.1 17.5 13.4 20.8 16.3 31.2 15.2 20.8 19.4 21.9 6.0 26.2 38.7 21.0 19.2 25.2 13.7 12.4 18.4 25.6 15.1 71.6 22.6 40.3 30.2 6.7 43.7 33.8 24.5 17.2 22.3 8.4 35.3 19.9 46.9 15.1 16.3 30.4 19.8 24.9 12.6 33.0 15.8 36.9 29.0 27.9 49.9 4.0 25.3 25.0 26.7 9.1 39.2 73.5 37.1 12.1 44.5 45.4 1.9 34.0 24.8 32.4 10.3 16.3 62.8 81.2 40.4 14.7 0.5 66.4 60.6 21.5 10.3 47.1 16.5 11.3 37.6 67.4 50.2 26.8 37.5 64.4 45.7 59.5 22.3 53.5 28.0 41.7 0.7 3.0 3.7 10.3 7.0 17.9 2.0 10.7 10.0 5.4 2.1 6.3 5.8 4.2 2.6 8.7 5.7 10.4 4.4 17.5 18.1 33.2 22.5 18.3 37.4 32.1 34.5 33.2 20.8 26.2 18.4 28.6 9.6 16.6 16.0 17.0 3.4 6.3 6.1 18.2 24.4 6.1 9.8 44.2 10.0 11.0 1.8 6.2 2.4 25.4 23.4 15.6 12.8 7.8 10.3 19.8 27.4 14.4 8.0 11.7 11.8 1.4 14.1 9.2 19.8 10.1 10.2 25.4 22.1 10.8 26.9 21.9 6.6 8.2 24.8 16.9 16.0 9.6 22.1 3.6 15.9 18.6 25.6 22.6 9.5 4.2 10.9 15.2 15.1 43.3 2.1 50.0 16.8 0.7 9.7 0.0 8.3 13.2 4.7 1.7 11.0 4.4 1.8 37.6 5.3 20.0 1.7 CFAP298-TCP10L "C21orf77, FLJ10932, LINC00846" ENSG00000265590 "CFAP298-TCP10L readthrough" 21 32402511-32612865 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019055, HPA028849" Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 1: K-562 - Erythropoiesis" "HPA019055: AB_1845701, HPA028849: AB_10602111" "unprognostic (3.42e-2)" "unprognostic (2.31e-1)" "unprognostic (6.98e-2)" "unprognostic (6.14e-3)" "unprognostic (2.01e-1)" "unprognostic (1.14e-2)" "unprognostic (2.42e-1)" "unprognostic (8.92e-2)" "unprognostic (2.81e-1)" "unprognostic (7.06e-2)" "unprognostic (3.36e-2)" "unprognostic (3.51e-1)" "unprognostic (4.37e-2)" "unprognostic (2.10e-1)" "unprognostic (3.70e-2)" "unprognostic (5.33e-2)" "unprognostic (1.11e-1)" 6.1 6.9 2.1 6.6 2.1 5.0 9.6 2.2 3.5 10.0 3.0 8.9 6.0 9.7 19.5 10.4 28.4 8.5 11.0 2.0 2.2 14.2 11.6 7.4 9.6 2.0 2.0 8.1 7.7 13.9 1.1 7.6 2.0 10.4 11.9 10.6 9.4 9.1 9.4 7.4 5.6 10.9 2.0 4.3 5.8 26.3 2.0 5.6 16.1 5.0 12.6 9.8 0.8 2.1 22.9 14.3 17.6 23.2 15.8 14.4 22.8 13.9 18.9 24.0 18.1 21.9 18.0 20.9 11.9 18.9 16.7 8.5 29.0 27.3 28.6 9.8 10.6 30.5 14.7 35.4 20.3 41.6 20.3 7.7 33.0 38.5 28.4 21.1 26.7 24.4 45.2 12.8 21.2 36.7 29.3 17.8 24.0 41.3 10.6 19.0 21.6 31.3 43.5 14.6 28.7 19.7 19.2 23.8 33.1 21.0 24.6 20.3 9.8 7.2 8.0 16.4 20.2 4.5 36.9 40.1 15.0 50.9 15.6 3.1 2.2 2.4 7.6 1.8 11.3 3.3 5.2 5.5 4.5 2.1 3.3 5.0 0.4 6.1 3.6 3.8 3.6 1.4 2.1 2.1 2.2 3.5 2.0 2.2 2.0 2.0 2.0 2.0 2.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFH "ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS" ENSG00000000971 "Complement factor H" P08603 1 196652043-196747504 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity" "Age-related macular degeneration, Cancer-related genes, Disease variant, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "liver: 1676.3" "Group enriched" "Detected in many" 4 "Fibroblasts: 448.0;Hepatocytes: 1114.8;Leydig cells: 283.9" "Cancer enriched" "Detected in all" 9 "liver cancer: 151.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 18.7" "Lineage enriched" "Detected in single" 26 "T-cells: 18.7" "Cell line enhanced" "Detected in many" "HHSteC: 123.1;HSkMC: 119.5;hTERT-RPE1: 374.9;RT4: 227.0" "CAB016385, CAB016769, HPA038922, HPA049176, HPA053326" Supported Approved Vesicles "Secreted to blood" NA NA 396000000000 100000000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 50: Fibroblasts - ECM organization" Vesicles "CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113" "unprognostic (2.40e-1)" "unprognostic (9.86e-2)" "unprognostic (1.22e-1)" "unprognostic (8.39e-2)" "unprognostic (5.40e-3)" "unprognostic (1.80e-1)" "unprognostic (3.75e-3)" "unprognostic (7.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.04e-1)" "unprognostic (9.08e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.92e-6)" "unprognostic (6.50e-3)" "unprognostic (4.49e-3)" "unprognostic (1.73e-1)" "unprognostic (1.37e-1)" 125.3 42.1 18.1 32.7 21.5 1.3 66.9 20.0 29.6 76.8 43.0 51.0 30.5 12.8 15.9 63.8 24.2 133.6 301.5 18.1 18.6 25.5 1676.3 70.8 27.4 19.3 19.0 165.1 14.0 6.4 16.0 26.1 19.9 23.0 80.2 4.3 126.7 24.0 21.1 74.5 52.1 32.5 19.5 13.9 46.9 14.3 21.6 12.1 102.5 84.0 25.9 149.9 27.0 21.1 0.0 64.9 0.0 0.0 96.5 54.7 0.1 25.8 63.1 3.5 13.5 0.1 11.9 0.3 9.6 0.1 0.2 2.2 0.0 23.6 2.6 1.3 0.0 20.0 74.7 0.0 123.1 0.9 0.3 119.5 0.3 18.4 7.9 374.9 79.2 0.0 74.4 2.7 89.4 0.1 0.5 0.1 0.4 0.0 0.1 0.2 89.8 21.0 0.0 227.0 0.0 0.1 0.4 0.0 0.1 0.6 0.1 0.0 5.6 73.6 0.9 0.8 0.8 0.8 0.0 0.3 13.1 0.2 5.8 0.0 0.1 0.0 2.0 0.0 18.7 0.0 6.6 4.0 0.2 0.0 0.4 1.5 0.7 0.0 0.0 0.0 0.0 1.1 18.1 21.5 20.0 29.6 18.1 18.6 19.3 19.0 19.9 19.5 21.6 21.1 73.9 9.6 17.6 0.7 4.2 44.2 63.6 140.6 14.2 2.4 1.3 3.4 10.9 35.8 141.1 5.5 0.0 0.0 3.1 0.1 0.0 6.2 2.6 2.3 3.8 49.8 0.0 52.6 0.6 0.8 0.0 448.0 8.6 1.9 3.8 6.9 47.8 1114.8 1.1 0.0 1.0 0.0 14.2 43.8 62.1 7.4 283.9 5.7 44.4 38.4 0.3 0.3 0.0 0.0 0.2 5.3 0.0 138.8 2.6 13.0 0.0 0.5 115.6 1.4 6.6 94.2 59.6 1.4 1.0 10.9 38.2 0.1 13.2 26.3 0.0 61.5 CHODL "C21orf68, FLJ12627, MT75, PRED12" ENSG00000154645 Chondrolectin Q9H9P2 21 17901263-18267373 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.5;lymphoid tissue: 14.1;testis: 31.0" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 38.6;Oligodendrocytes: 50.1;Skeletal myocytes: 28.3;Theca cells: 26.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 6.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 4 "MAIT T-cell: 1.5" "Lineage enriched" "Detected in single" 7 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "HDLM-2: 1.8;U-266/70: 2.8;U-266/84: 7.2;U-87 MG: 7.8" "Group enriched" "Detected in many" 4 "basal ganglia: 3.9;hypothalamus: 12.3;pons and medulla: 10.9" "Group enriched" "Detected in all" 4 "olfactory bulb: 66.4;spinal cord: 38.6" "HPA017282, HPA057559" Enhanced Approved Centrosome,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 36: Stromal cells - Cell proliferation" Cytosol Centrosome "HPA017282: AB_1846687, HPA057559: " "unprognostic (3.91e-1)" "unprognostic (3.18e-2)" "unprognostic (2.37e-2)" "prognostic unfavorable (1.18e-6)" "unprognostic (6.74e-2)" "unprognostic (6.82e-2)" "unprognostic (1.06e-3)" "unprognostic (6.79e-2)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.49e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" "unprognostic (1.36e-2)" "unprognostic (1.87e-1)" "unprognostic (4.83e-2)" "unprognostic (1.02e-1)" 3.3 2.0 1.6 1.1 1.4 0.0 1.1 0.7 1.6 0.2 0.8 2.8 1.6 0.6 1.1 0.9 0.5 0.8 3.7 1.7 5.4 3.6 0.0 0.3 0.4 11.5 2.6 0.6 0.1 0.3 2.5 1.9 10.8 5.6 3.5 0.6 0.5 1.8 0.6 2.3 1.0 0.3 1.6 14.1 0.7 31.0 10.2 0.3 1.1 1.7 1.2 0.7 1.1 3.8 0.0 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 1.8 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.4 0.1 1.4 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.7 0.6 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.0 2.8 7.2 0.2 7.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.5 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.3 0.1 1.6 1.4 0.7 1.6 1.7 5.4 11.5 2.6 10.8 1.6 10.2 3.8 1.7 0.0 0.0 5.2 1.0 4.0 0.8 0.8 3.4 1.1 1.0 1.3 0.5 0.0 0.9 0.0 0.0 0.2 0.9 0.0 1.9 0.4 5.0 1.4 38.6 1.5 0.0 0.0 5.5 0.0 0.2 4.6 0.0 0.8 0.0 12.3 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.8 4.0 3.1 0.1 1.8 4.7 0.0 0.4 0.0 12.5 50.1 0.0 0.0 1.9 3.1 0.2 0.0 0.3 0.3 0.1 0.0 28.3 10.5 1.3 1.7 0.5 2.3 0.5 1.3 26.7 0.1 0.3 CLIC5 DFNB102 ENSG00000112782 "Chloride intracellular channel 5" Q9NZA1 6 45880827-46080348 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Hearing, Ion transport, Sensory transduction, Transport, Vision" "Chloride channel, Ion channel, Voltage-gated channel" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 102.7;skeletal muscle: 289.7;tongue: 98.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 509.6;Cardiomyocytes: 285.7;Distal enterocytes: 164.2;Late spermatids: 93.8;Proximal enterocytes: 126.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 5.1" "Lineage enriched" "Detected in single" 17 "T-cells: 5.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.5;EFO-21: 9.2;HDLM-2: 4.7;REH: 11.9;U-266/70: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074371 Supported "Nuclear speckles,Plasma membrane" NA NA 400000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "Nuclear speckles" "HPA074371: " "unprognostic (4.95e-2)" "unprognostic (1.59e-2)" "unprognostic (8.84e-2)" "unprognostic (5.05e-2)" "unprognostic (2.44e-1)" "unprognostic (6.73e-2)" "unprognostic (3.37e-1)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (6.46e-2)" "unprognostic (5.50e-2)" "unprognostic (3.65e-1)" "unprognostic (6.77e-3)" "unprognostic (1.22e-1)" "unprognostic (1.99e-1)" "unprognostic (8.26e-2)" "unprognostic (1.01e-1)" 18.9 1.5 3.2 4.3 4.4 0.2 6.5 1.5 2.9 19.0 0.5 28.6 20.9 2.1 0.9 2.9 4.5 3.0 102.7 2.1 5.0 54.7 0.3 70.8 1.7 2.1 3.8 0.5 1.1 1.7 3.0 16.5 2.2 2.6 25.8 16.9 2.7 1.4 289.7 1.2 36.6 2.3 1.8 44.5 1.6 1.4 5.5 1.0 7.3 98.3 1.9 2.0 2.6 1.9 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 13.5 0.0 9.2 0.0 0.0 0.3 0.0 0.1 0.0 4.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.4 1.6 0.0 11.9 0.3 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.4 0.1 0.0 12.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.1 0.1 2.0 1.3 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 1.0 0.5 3.2 4.4 1.5 2.9 2.1 5.0 2.1 3.8 2.2 1.8 5.5 1.9 59.6 509.6 30.0 4.6 1.4 0.1 0.1 0.0 1.2 0.3 0.5 0.4 285.7 5.7 26.9 14.7 0.0 0.2 0.7 164.2 0.0 1.7 52.9 4.6 0.5 29.8 13.1 0.4 8.6 0.2 0.1 7.9 0.5 5.7 1.3 0.0 0.7 0.0 0.0 0.0 5.4 23.5 0.0 0.0 0.0 93.8 0.9 0.7 0.0 34.7 0.6 53.8 0.0 0.5 2.9 2.9 51.1 0.7 3.4 3.2 126.0 2.9 11.4 1.8 0.0 6.1 4.3 1.0 0.1 0.1 0.1 2.2 5.8 0.1 13.5 4.3 COLQ EAD ENSG00000206561 "Collagen like tail subunit of asymmetric acetylcholinesterase" Q9Y215 3 15450133-15521751 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Neurotransmitter degradation" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 17.9" "Cell type enhanced" "Detected in many" "Astrocytes: 17.3;Excitatory neurons: 45.1;Inhibitory neurons: 46.3;Late spermatids: 16.6;NK-cells: 15.5;Oligodendrocyte precursor cells: 18.1;Oligodendrocytes: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "MAIT T-cell: 60.9" "Lineage enriched" "Detected in many" 34 "T-cells: 60.9" "Group enriched" "Detected in some" 6 "BEWO: 11.5;HDLM-2: 3.8;U-937: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045876 Approved "Plasma membrane,Cell Junctions" "Secreted to blood" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "Cell Junctions" "HPA045876: AB_2679479" "unprognostic (4.08e-3)" "unprognostic (2.61e-2)" "unprognostic (2.13e-3)" "unprognostic (2.37e-1)" "unprognostic (2.11e-1)" "unprognostic (4.62e-2)" "unprognostic (1.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (1.28e-3)" "unprognostic (4.68e-1)" "unprognostic (7.00e-5)" "unprognostic (6.58e-2)" "unprognostic (1.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.30e-4)" 2.5 2.3 3.1 0.7 3.2 0.8 2.2 3.9 4.6 4.6 11.9 3.7 1.0 3.4 1.6 0.9 8.8 1.1 17.9 3.7 2.7 2.9 3.4 2.5 3.9 4.8 3.2 3.6 1.7 3.6 5.7 0.3 2.8 4.6 0.5 0.6 1.5 0.8 10.8 1.6 2.6 0.7 2.6 7.2 2.4 5.0 2.3 2.6 2.6 5.1 3.0 2.2 2.4 2.9 0.1 0.0 0.7 0.0 0.0 0.3 11.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 3.8 0.4 0.2 0.5 0.0 0.0 0.1 0.3 0.4 0.0 0.3 0.1 0.2 0.3 0.5 0.0 0.3 0.2 0.2 0.1 0.3 0.0 0.0 0.5 0.2 0.1 0.1 0.1 0.0 0.2 1.0 0.0 0.0 0.2 0.5 0.6 0.0 0.0 0.1 0.2 0.2 0.1 0.8 0.4 0.0 0.0 5.2 0.1 0.0 0.6 0.0 9.9 0.0 60.9 0.0 5.3 7.4 0.0 0.0 0.5 0.6 0.0 1.8 0.0 0.4 0.3 3.5 3.1 3.2 3.9 4.6 3.7 2.7 4.8 3.2 2.8 2.6 2.3 2.9 0.6 0.0 0.6 17.3 0.5 0.3 0.2 0.1 0.0 0.3 0.4 0.6 0.7 0.0 1.4 0.0 0.0 0.3 7.7 0.0 0.0 0.1 4.1 6.5 1.4 0.4 1.2 0.4 45.1 0.0 0.2 0.6 1.1 0.8 0.0 3.3 1.8 0.8 0.2 6.7 46.3 0.2 2.0 0.6 0.0 16.6 1.8 0.4 0.0 7.5 0.4 0.3 15.5 18.1 18.3 0.2 0.1 4.5 2.0 0.2 0.0 0.2 4.3 0.7 0.0 0.5 0.7 1.5 0.5 0.0 0.1 2.3 4.1 1.4 0.3 0.1 CPNE7 ENSG00000178773 "Copine 7" Q9UBL6 16 89575758-89597246 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0;epididymis: 19.3;pituitary gland: 14.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 11.2;Collecting duct cells: 20.2;Excitatory neurons: 9.3;Inhibitory neurons: 9.1;Spermatogonia: 10.2;T-cells: 9.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.9" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 4.9" "Lineage enriched" "Detected in single" 5 "T-cells: 4.9" "Cell line enhanced" "Detected in many" "HHSteC: 103.2;TIME: 58.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA043359 Uncertain NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" "HPA043359: AB_10794884" "unprognostic (6.77e-2)" "unprognostic (1.30e-2)" "unprognostic (1.43e-1)" "unprognostic (1.97e-1)" "unprognostic (3.08e-2)" "unprognostic (1.97e-1)" "unprognostic (1.82e-1)" "unprognostic (2.28e-3)" "unprognostic (2.55e-1)" "unprognostic (6.47e-2)" "unprognostic (5.88e-2)" "unprognostic (6.93e-2)" "prognostic unfavorable (9.52e-6)" "unprognostic (1.87e-2)" "unprognostic (1.17e-1)" "unprognostic (3.08e-1)" "prognostic favorable (7.22e-4)" 0.5 0.4 13.5 0.9 13.2 0.9 1.5 0.0 17.6 1.4 0.0 0.7 3.6 0.6 19.3 2.1 2.1 3.3 0.4 15.1 11.4 4.3 1.2 1.7 0.5 2.6 16.2 0.5 0.9 2.4 14.1 0.3 7.4 1.8 0.1 1.6 1.4 6.1 0.0 1.6 3.4 0.2 1.0 0.8 3.2 4.1 28.0 1.6 0.8 0.1 0.4 1.6 1.3 6.0 0.1 24.7 0.2 0.4 40.8 41.8 0.3 10.7 4.5 14.6 11.2 24.8 20.7 0.0 9.5 4.2 0.5 16.8 15.4 0.7 5.0 6.0 12.2 0.2 21.5 0.5 103.2 0.1 4.1 16.3 1.1 7.7 29.0 49.3 0.2 17.4 27.3 0.3 35.1 3.8 8.0 4.8 16.1 15.6 19.1 0.4 0.0 17.6 2.2 0.1 13.7 0.2 3.6 5.2 1.1 0.3 4.6 3.2 58.8 28.4 0.0 17.7 0.0 0.1 0.0 5.0 27.8 17.3 12.0 0.0 0.0 0.1 0.7 0.0 4.9 0.0 1.1 1.8 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.2 0.2 13.5 13.2 0.0 17.6 15.1 11.4 2.6 16.2 7.4 1.0 28.0 6.0 0.5 0.0 0.6 1.3 0.1 2.3 1.1 0.1 0.6 11.2 3.9 5.2 0.8 1.5 0.8 20.2 0.0 0.0 1.4 0.1 0.0 0.9 0.0 1.0 0.5 0.7 0.0 0.4 9.3 0.2 0.2 0.3 3.1 2.2 0.0 0.1 0.4 0.0 0.1 0.0 9.1 0.3 0.0 0.0 0.4 0.6 0.3 0.9 1.8 0.0 0.0 0.3 0.0 3.5 0.6 0.6 0.0 0.7 0.1 1.2 0.7 1.7 0.2 0.9 0.0 0.3 0.5 0.3 10.2 1.2 1.1 0.0 9.5 0.0 1.9 2.1 CREBZF ZF ENSG00000137504 "CREB/ATF bZIP transcription factor" Q9NS37 11 85657990-85682908 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HeLa: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021526, HPA063652" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Mitochondria" "HPA021526: AB_2670738, HPA063652: AB_2685075" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (6.46e-2)" "unprognostic (2.23e-3)" "unprognostic (2.21e-1)" "unprognostic (1.17e-2)" "unprognostic (1.19e-2)" "unprognostic (4.51e-2)" "unprognostic (1.04e-3)" "unprognostic (2.23e-3)" "unprognostic (1.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.34e-2)" "unprognostic (2.38e-3)" 17.1 12.4 9.8 12.9 11.1 9.7 16.8 18.3 15.4 15.9 11.3 12.8 14.1 21.3 12.2 10.1 15.1 10.3 8.2 10.1 9.9 8.8 10.8 15.4 18.7 10.6 10.0 21.7 14.8 11.8 8.7 13.2 11.1 12.9 13.7 27.9 16.4 10.2 9.9 17.2 16.4 10.3 10.5 17.2 12.7 6.1 10.3 13.6 16.3 6.8 15.3 12.1 14.9 13.5 5.6 12.4 18.4 7.6 8.4 8.8 13.7 9.8 6.0 8.4 11.0 15.6 22.5 16.4 9.1 5.8 22.1 19.6 12.7 6.2 14.1 9.3 11.9 14.9 53.1 7.2 5.7 14.1 8.0 7.8 12.2 8.5 11.8 11.5 5.3 10.8 11.7 18.6 10.1 7.9 12.0 27.5 6.8 16.3 8.7 19.2 15.7 10.1 9.2 10.7 14.5 12.4 12.6 19.3 4.2 11.6 20.8 20.8 6.3 17.4 10.7 24.3 11.0 6.4 7.6 16.8 4.1 10.4 10.9 0.3 0.1 0.1 0.4 0.1 0.7 0.2 0.3 0.3 0.2 0.2 0.4 0.4 0.2 0.4 0.3 0.2 0.6 0.1 9.8 11.1 18.3 15.4 10.1 9.9 10.6 10.0 11.1 10.5 10.3 13.5 30.3 19.2 21.5 58.1 41.9 41.3 21.6 12.4 31.3 97.5 35.1 20.6 13.9 17.2 17.9 22.0 91.8 16.9 53.1 30.0 9.8 13.2 34.5 27.6 31.1 25.1 39.4 30.1 57.6 8.6 14.9 34.7 46.9 34.0 22.2 64.3 23.2 29.5 9.9 90.9 60.7 23.8 10.2 19.2 27.3 16.6 30.7 15.6 33.8 25.3 24.8 47.9 46.4 56.8 114.5 9.2 22.8 33.4 39.1 29.5 29.8 8.0 22.5 113.5 13.1 34.6 30.9 27.4 11.4 27.7 41.3 14.4 43.0 51.9 25.7 26.5 CRYBA4 ENSG00000196431 "Crystallin beta A4" P53673 22 26621963-26630669 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.5;testis: 1.1" "Cell type enhanced" "Detected in some" "Early spermatids: 3.3;NK-cells: 1.0;Spermatogonia: 3.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.0;testis cancer: 2.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HEL: 7.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebral cortex: 4.3;hippocampal formation: 4.0" HPA071178 Supported NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA071178: AB_2686354" "unprognostic (6.69e-2)" "unprognostic (3.94e-3)" "unprognostic (5.61e-5)" "unprognostic (1.74e-2)" "unprognostic (5.57e-2)" "unprognostic (2.32e-2)" "unprognostic (2.71e-1)" "unprognostic (7.92e-2)" "unprognostic (3.50e-2)" "unprognostic (1.85e-1)" "unprognostic (9.05e-6)" "unprognostic (2.86e-1)" "unprognostic (1.20e-6)" "unprognostic (1.87e-2)" "unprognostic (7.23e-2)" "unprognostic (7.71e-2)" "unprognostic (3.70e-1)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.2 0.0 0.0 0.3 0.1 0.0 0.5 0.1 CRYGS CRYG8 ENSG00000213139 "Crystallin gamma S" P22914 3 186538441-186546702 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.5" "Cell type enhanced" "Detected in many" "Astrocytes: 5.2;Excitatory neurons: 5.4;Inhibitory neurons: 6.0;Microglial cells: 5.6;Oligodendrocyte precursor cells: 6.0;Oligodendrocytes: 7.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA035103, HPA063539" Supported Uncertain Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 43: Cardiomyocytes - Nuclear processes" Cytosol "HPA035103: AB_10696367, HPA063539: " "unprognostic (5.52e-4)" "unprognostic (1.29e-3)" "unprognostic (1.44e-2)" "unprognostic (5.45e-2)" "unprognostic (4.90e-2)" "unprognostic (5.85e-2)" "unprognostic (4.79e-2)" "unprognostic (1.73e-2)" "unprognostic (4.76e-2)" "unprognostic (1.12e-1)" "unprognostic (5.84e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.72e-9)" "unprognostic (1.10e-1)" "unprognostic (9.53e-2)" "unprognostic (3.67e-1)" "prognostic favorable (2.73e-4)" 1.1 2.0 6.5 1.0 6.9 2.8 1.6 8.0 10.5 1.8 6.9 1.7 1.1 1.6 1.5 1.2 1.5 0.8 2.1 6.5 7.2 2.3 2.1 1.5 2.2 6.5 6.8 1.2 2.1 0.7 1.4 0.9 7.0 1.5 2.0 8.1 1.2 1.4 1.1 1.1 1.9 1.3 6.3 2.8 1.5 2.1 6.8 4.8 1.2 0.6 1.7 1.7 1.6 7.3 0.3 0.7 1.5 1.1 1.5 1.7 0.0 0.2 0.4 0.5 1.0 0.2 0.6 1.5 1.3 1.2 0.6 1.0 0.8 1.1 1.6 1.0 1.8 1.7 0.2 1.1 0.6 1.1 1.3 1.9 1.2 0.3 0.8 1.7 1.5 1.6 0.4 0.8 1.2 0.4 0.8 0.5 0.0 0.5 0.3 1.7 0.2 0.8 0.5 1.0 0.5 0.6 0.2 0.7 0.3 1.0 0.9 0.9 2.2 0.4 0.3 0.5 1.0 1.7 1.1 1.8 0.7 0.5 0.6 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.5 6.9 8.0 10.5 6.5 7.2 6.5 6.8 7.0 6.3 6.8 7.3 1.2 0.0 1.7 5.2 0.7 0.3 0.3 0.7 0.6 1.1 0.9 1.5 3.0 1.5 0.9 0.0 2.1 0.2 0.6 0.5 0.0 0.6 0.2 0.3 0.6 1.0 0.0 3.2 5.4 0.2 0.2 0.9 2.6 0.5 1.3 0.9 2.5 1.3 0.4 1.7 6.0 0.8 2.0 0.3 1.2 1.3 0.3 1.1 0.0 5.6 0.1 0.5 1.0 6.0 7.6 0.2 0.4 0.7 0.1 0.3 0.8 0.2 0.5 3.2 0.0 0.8 0.8 2.4 0.9 0.4 0.1 0.3 0.8 0.9 1.2 0.2 CXCR6 "BONZO, CD186, STRL33, TYMSTR" ENSG00000172215 "C-X-C motif chemokine receptor 6" O00574 3 45940933-45948351 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.0" "Group enriched" "Detected in some" 6 "Extravillous trophoblasts: 74.1;T-cells: 58.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 445.8" "Lineage enriched" "Detected in many" 5 "T-cells: 445.8" "Cell line enhanced" "Detected in some" "BEWO: 2.9;CAPAN-2: 11.2;JURKAT: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (2.05e-3)" "prognostic favorable (4.92e-4)" "unprognostic (1.77e-3)" "prognostic favorable (6.74e-6)" "unprognostic (6.67e-2)" "prognostic favorable (2.16e-4)" "unprognostic (2.09e-2)" "unprognostic (1.51e-2)" "unprognostic (1.93e-2)" "unprognostic (3.65e-4)" "unprognostic (8.57e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (2.42e-5)" "unprognostic (2.25e-2)" "unprognostic (4.42e-2)" "unprognostic (3.46e-2)" "unprognostic (1.57e-2)" 1.7 1.7 0.4 7.1 1.3 1.6 3.3 0.5 0.6 2.8 0.8 4.1 4.4 1.1 1.6 2.7 2.3 5.9 1.0 0.5 1.3 0.9 4.0 4.0 17.0 2.3 0.7 2.1 1.5 0.3 0.4 10.8 2.2 1.5 3.7 2.7 1.9 0.8 10.2 0.7 9.5 1.1 1.6 13.3 8.7 0.5 1.2 4.9 1.4 0.0 10.8 7.2 1.6 2.4 0.2 0.0 0.0 0.2 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.8 11.2 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.2 0.3 0.0 0.2 0.6 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.2 0.7 0.0 1.4 0.2 0.6 0.3 1.0 0.5 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.5 0.2 92.8 0.2 445.8 0.3 26.5 112.1 0.1 0.2 1.3 16.0 0.8 89.8 0.4 0.6 87.0 24.7 0.4 1.3 0.5 0.6 0.5 1.3 2.3 0.7 2.2 1.6 1.2 2.4 0.3 0.0 0.0 0.0 1.1 1.0 0.1 0.0 0.0 1.1 0.2 0.1 0.7 0.0 0.0 0.0 2.1 8.4 4.2 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 5.3 0.0 0.0 74.1 1.2 1.5 0.1 1.3 0.0 1.4 0.8 0.8 0.0 0.0 0.2 0.0 2.8 1.8 0.0 0.0 0.8 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 5.5 0.1 0.0 0.1 0.0 4.7 0.0 0.2 0.3 0.0 0.0 0.1 1.1 10.3 58.5 0.0 0.1 0.1 CYB561 "CYB561A1, FRRS2" ENSG00000008283 "Cytochrome b561" P49447 17 63432304-63446354 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Transport" Translocase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 74.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "pons: 124.7" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 432.2;SK-BR-3: 209.2;T-47d: 168.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014753 Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 44: Endometrium - Transcription" "HPA014753: AB_1847364" "prognostic unfavorable (8.89e-5)" "unprognostic (2.90e-1)" "unprognostic (4.01e-1)" "prognostic favorable (2.95e-5)" "unprognostic (1.81e-3)" "unprognostic (3.82e-1)" "unprognostic (1.37e-2)" "unprognostic (8.47e-2)" "unprognostic (2.07e-1)" "unprognostic (3.91e-2)" "unprognostic (8.97e-2)" "unprognostic (6.38e-2)" "unprognostic (8.09e-3)" "unprognostic (1.16e-3)" "unprognostic (8.17e-2)" "unprognostic (1.50e-2)" "unprognostic (2.89e-1)" 14.8 125.6 22.2 12.3 24.4 4.1 32.8 6.8 23.1 45.0 70.6 26.4 36.6 12.3 57.2 51.9 55.8 17.3 16.2 20.4 33.2 24.5 21.0 30.9 8.3 17.2 23.2 9.4 118.0 76.1 74.1 16.2 124.7 63.3 21.1 9.8 85.0 37.8 6.0 37.3 31.9 9.2 9.8 8.7 48.1 6.0 28.0 3.5 40.8 4.6 12.8 16.4 27.4 17.9 99.3 31.9 2.6 20.5 11.5 52.7 43.3 10.3 12.0 12.3 4.9 29.2 96.9 0.2 23.0 75.5 3.3 83.1 20.3 8.0 4.8 26.1 8.7 12.7 20.4 2.0 21.7 1.3 4.3 8.6 84.1 11.2 1.5 17.9 23.9 0.1 41.2 17.7 4.0 140.3 0.5 4.9 20.9 80.5 49.9 0.3 0.2 31.0 40.0 49.8 73.7 432.2 26.0 209.2 10.4 7.3 168.6 6.2 3.6 25.9 29.4 60.6 3.1 0.4 0.4 0.1 22.6 5.1 14.0 0.3 2.0 0.2 19.2 5.7 24.6 0.6 14.4 13.2 2.1 0.6 1.3 4.2 5.2 20.3 7.7 0.1 0.0 5.8 22.2 24.4 6.8 23.1 20.4 33.2 17.2 23.2 124.7 9.8 28.0 17.9 14.6 28.9 37.8 3.6 3.5 16.4 23.7 16.0 26.2 6.1 37.4 24.6 12.8 20.0 36.7 23.9 0.0 25.1 7.0 22.2 3.9 41.1 6.9 74.5 12.5 18.3 21.6 3.4 14.1 50.5 29.2 15.0 30.1 53.9 15.9 7.3 11.4 11.1 4.7 0.0 10.7 31.7 18.3 7.0 9.8 6.2 3.7 4.1 3.6 9.4 6.0 5.2 2.1 0.5 0.6 30.8 11.4 3.4 15.3 41.6 32.1 11.9 68.5 26.8 6.6 5.1 7.6 6.9 7.2 34.2 27.8 24.8 11.4 0.4 26.2 22.6 CYB5A CYB5 ENSG00000166347 "Cytochrome b5 type A" P00167 18 74250846-74291973 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 889.6;liver: 2472.0" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 1371.0;Distal tubular cells: 2156.1;Hepatocytes: 3376.3;Proximal enterocytes: 1856.4;Proximal tubular cells: 3630.6" "Cancer enhanced" "Detected in all" "liver cancer: 43.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 1117.0;RT4: 513.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006333, HPA047548, HPA058547" Enhanced Enhanced Vesicles,Cytosol No No 1400000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Vesicles, Cytosol" "CAB006333: , HPA047548: AB_2680084, HPA058547: AB_2683750" "unprognostic (1.88e-1)" "unprognostic (1.28e-1)" "prognostic favorable (5.23e-4)" "unprognostic (1.08e-2)" "unprognostic (1.41e-1)" "unprognostic (9.14e-2)" "prognostic favorable (4.15e-4)" "unprognostic (7.79e-3)" "unprognostic (1.11e-1)" "unprognostic (3.33e-2)" "unprognostic (2.68e-2)" "unprognostic (1.65e-2)" "unprognostic (1.17e-1)" "unprognostic (1.95e-1)" "unprognostic (1.75e-1)" "unprognostic (4.64e-2)" "unprognostic (8.54e-2)" 309.5 109.6 38.4 31.2 39.7 25.3 253.5 42.2 45.2 86.0 37.6 146.5 438.2 44.9 176.2 78.1 81.9 301.2 84.8 37.5 38.8 889.6 2472.0 356.6 43.7 43.1 39.7 223.9 461.3 236.0 58.5 81.8 41.9 95.9 103.4 10.3 59.1 122.8 41.4 118.4 381.7 46.7 40.8 75.6 194.8 57.9 40.0 51.6 42.5 42.1 35.2 155.5 68.3 43.5 78.8 130.8 67.4 0.6 1117.0 198.2 89.5 52.6 113.8 111.0 163.8 156.2 82.7 95.6 36.7 97.6 54.4 170.6 0.1 73.1 86.9 179.8 91.7 34.9 65.6 418.1 174.6 67.3 44.1 334.1 57.4 63.0 32.3 66.0 63.6 85.8 58.6 35.0 93.7 140.9 38.3 80.5 30.4 110.0 86.8 93.6 21.9 2.3 111.9 513.2 190.4 79.7 51.4 137.1 65.8 56.6 271.5 63.7 57.9 0.6 85.8 26.6 68.1 24.6 109.2 30.3 67.0 19.2 64.3 4.1 29.5 7.5 51.3 36.3 116.2 93.7 55.6 60.2 53.7 112.7 54.5 68.6 3.7 36.3 45.7 47.8 48.8 43.2 38.4 39.7 42.2 45.2 37.5 38.8 43.1 39.7 41.9 40.8 40.0 43.5 169.7 637.8 1371.0 11.4 76.0 98.0 82.1 368.6 50.7 9.9 345.8 213.2 90.7 836.4 1053.2 842.4 4.2 229.3 29.4 197.0 2156.1 239.4 7.5 163.1 76.6 119.9 164.2 180.0 13.1 504.6 169.8 141.4 208.9 345.6 39.9 55.0 177.4 3376.3 97.4 8.4 12.6 236.5 457.7 128.6 72.9 26.7 158.1 60.8 90.7 10.3 224.1 39.2 32.0 14.1 22.7 266.7 358.9 149.7 33.4 142.0 1856.4 3630.6 619.5 14.0 52.6 49.6 85.0 15.3 42.0 141.2 223.9 44.5 52.6 1123.6 329.9 220.7 CYP27B1 "CYP1, P450c1, PDDR, VDD1" ENSG00000111012 "Cytochrome P450 family 27 subfamily B member 1" O15528 12 57762334-57768986 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 15.2;thyroid gland: 5.7" "Group enriched" "Detected in many" 5 "Exocrine glandular cells: 22.1;monocytes: 22.8;Proximal tubular cells: 36.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enhanced" "Detected in many" "hTERT-HME1: 13.6;RH-30: 22.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (8.59e-2)" "unprognostic (1.42e-1)" "unprognostic (8.89e-2)" "unprognostic (2.77e-2)" "unprognostic (4.16e-2)" "unprognostic (1.03e-2)" "unprognostic (1.28e-2)" "unprognostic (1.44e-1)" "unprognostic (2.10e-2)" "unprognostic (4.72e-2)" "unprognostic (2.51e-1)" "unprognostic (1.17e-2)" "unprognostic (1.75e-3)" "unprognostic (4.10e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (6.79e-4)" "unprognostic (5.67e-3)" 0.3 0.9 0.3 0.7 0.3 0.8 0.8 0.3 0.4 0.2 0.3 0.4 0.4 0.2 0.6 0.4 0.2 0.5 0.1 0.3 0.3 15.2 0.6 0.5 0.9 0.3 0.3 0.2 1.6 1.0 0.4 0.3 0.3 0.3 0.6 3.3 0.5 0.2 0.1 0.6 0.5 0.1 0.3 0.2 0.5 0.4 0.3 0.2 5.7 0.0 0.7 2.2 0.2 0.5 2.8 0.4 0.0 0.3 0.2 0.4 1.1 0.1 3.1 1.0 0.3 3.7 1.0 2.0 0.1 0.4 0.3 3.3 0.5 5.9 3.1 0.6 0.4 0.9 0.0 1.0 0.3 1.2 2.5 0.5 1.9 0.8 13.6 1.2 0.4 2.6 1.3 1.2 0.4 0.4 0.4 1.1 1.3 2.8 2.3 0.8 22.6 1.7 0.5 0.3 0.7 0.8 2.0 0.4 0.1 0.1 1.7 2.3 0.2 0.2 1.6 1.1 0.4 1.4 1.2 0.4 1.2 2.6 1.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.5 0.5 0.0 0.0 0.7 3.0 5.2 1.3 1.1 0.6 0.7 5.1 2.7 0.7 2.8 1.9 0.0 2.1 0.1 0.0 0.6 1.9 2.0 0.9 1.1 0.5 0.5 0.0 0.0 0.3 22.1 0.4 0.6 0.0 1.7 4.5 0.4 0.4 0.3 2.3 0.0 0.2 0.6 0.0 0.3 0.8 0.0 0.0 1.5 0.0 0.0 22.8 0.6 0.0 0.0 0.1 5.4 0.1 0.4 1.7 1.4 0.5 36.9 0.6 5.2 0.0 1.5 1.1 0.3 0.7 1.3 2.7 0.1 0.5 0.4 0.9 0.6 CYTH3 "ARNO3, cytohesin-3, GRP1, PSCD3" ENSG00000008256 "Cytohesin 3" O43739 7 6161776-6272644 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 66.5;Inhibitory neurons: 96.5;Microglial cells: 57.1" "Cancer enriched" "Detected in all" 5 "melanoma: 47.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "WM-115: 102.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013979 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 50: Fibroblasts - ECM organization" Cytosol Nucleoplasm "HPA013979: AB_1855799" "unprognostic (6.58e-2)" "unprognostic (1.37e-2)" "unprognostic (1.65e-2)" "unprognostic (5.75e-3)" "unprognostic (1.27e-3)" "unprognostic (1.27e-2)" "unprognostic (2.32e-2)" "unprognostic (2.63e-1)" "unprognostic (8.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (2.54e-2)" "unprognostic (1.73e-2)" "unprognostic (2.20e-1)" "unprognostic (4.41e-2)" "prognostic unfavorable (2.63e-5)" 28.8 9.5 16.9 5.4 17.7 7.7 26.5 16.3 20.9 16.4 11.8 18.3 16.5 17.5 6.6 14.0 15.6 11.8 28.5 18.5 15.3 14.2 4.1 19.7 5.4 14.4 15.5 13.9 7.5 11.5 9.8 31.7 15.4 10.2 6.9 5.7 11.9 8.6 15.2 21.6 16.7 12.1 14.2 10.9 13.9 18.6 16.6 5.8 27.7 19.7 4.7 13.8 15.9 17.5 64.7 16.1 15.0 10.4 68.4 80.0 21.2 37.4 32.3 36.1 34.2 25.0 31.3 8.7 22.1 75.5 46.4 59.5 10.4 27.1 23.8 0.6 14.8 2.4 19.8 3.2 32.4 2.7 4.0 57.0 12.1 19.3 27.6 16.2 6.4 12.6 10.3 1.4 26.7 10.6 2.2 11.5 10.4 8.6 21.5 11.5 40.0 5.0 28.0 7.7 9.6 18.4 23.2 79.7 67.0 12.7 4.8 18.1 23.3 24.6 64.4 26.9 23.2 2.9 1.1 9.1 7.9 6.9 102.8 0.3 0.2 0.0 0.9 0.0 2.5 0.1 0.4 1.0 0.1 0.2 0.0 0.6 0.1 1.5 0.2 0.8 0.3 0.2 16.9 17.7 16.3 20.9 18.5 15.3 14.4 15.5 15.4 14.2 16.6 17.5 40.1 16.0 5.8 14.7 3.1 15.2 2.1 1.8 4.0 6.5 9.2 7.5 17.4 2.8 3.2 3.7 8.4 15.4 8.7 9.7 5.9 4.1 14.1 9.4 10.2 14.6 3.0 2.1 66.5 2.8 9.1 24.0 8.2 15.9 12.7 15.8 18.5 1.4 11.9 15.2 96.5 5.5 4.1 4.1 10.9 16.7 16.4 5.9 32.0 57.1 1.9 10.8 3.1 23.1 10.8 10.0 5.4 13.2 4.4 3.9 14.6 1.4 3.7 2.0 39.5 6.1 39.2 24.3 11.2 7.0 11.4 15.2 10.2 10.9 7.1 2.1 DAB1 ENSG00000173406 "DAB adaptor protein 1" O75553 1 56994778-58546734 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8;intestine: 22.3;seminal vesicle: 10.0" "Group enriched" "Detected in some" 8 "Excitatory neurons: 460.3;Inhibitory neurons: 1170.3;Oligodendrocyte precursor cells: 814.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 2.1" "Lineage enhanced" "Detected in single" "T-cells: 2.1" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 54.0;HeLa: 18.6;NTERA-2: 23.4;RT4: 32.0;WM-115: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032329, HPA052033, HPA067495" Enhanced Enhanced Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "CAB032329: AB_638973, HPA052033: AB_2681703, HPA067495: AB_2685852" "unprognostic (7.88e-2)" "unprognostic (1.02e-1)" "unprognostic (8.54e-2)" "unprognostic (2.09e-4)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (7.30e-4)" "unprognostic (3.90e-1)" "unprognostic (3.07e-2)" "unprognostic (1.47e-2)" "unprognostic (2.06e-3)" "unprognostic (1.27e-1)" "unprognostic (2.00e-3)" "unprognostic (1.78e-1)" "unprognostic (2.01e-1)" "unprognostic (1.44e-2)" "unprognostic (5.67e-2)" 2.0 1.7 4.3 0.4 5.3 0.0 0.3 16.8 8.8 1.6 0.0 0.8 15.8 0.5 0.4 0.6 1.6 0.7 1.8 10.6 5.4 0.3 7.7 0.4 0.2 2.1 3.9 1.2 0.4 0.0 0.2 0.0 2.0 3.9 0.3 5.4 0.9 10.0 0.1 0.1 22.3 0.3 2.3 0.2 1.0 0.4 5.1 0.1 0.3 0.1 0.1 1.2 0.9 1.9 0.0 0.0 10.6 0.0 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.8 0.0 0.0 0.0 0.0 2.0 0.1 23.4 0.0 0.0 6.0 0.0 0.2 0.0 32.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.6 0.1 0.0 2.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 4.3 5.3 16.8 8.8 10.6 5.4 2.1 3.9 2.0 2.3 5.1 1.9 0.7 0.0 0.0 30.0 0.1 0.0 0.1 0.1 0.0 23.7 0.1 0.3 3.2 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 8.6 8.2 0.6 0.3 0.0 0.0 460.3 0.0 0.0 0.4 4.6 12.8 0.0 0.0 0.7 5.1 0.1 21.9 1170.3 1.9 6.1 0.3 0.0 4.7 3.4 0.1 0.0 22.5 0.0 1.0 1.0 814.8 26.5 0.0 0.0 2.6 0.0 0.1 101.1 0.2 0.0 0.8 0.0 0.1 0.9 0.2 0.5 0.0 0.0 0.7 0.6 0.0 2.1 0.0 DAB2IP "AF9Q34, AIP1, DIP1/2, KIAA1743" ENSG00000136848 "DAB2 interacting protein" Q5VWQ8 9 121567057-121785530 "Disease related genes, Predicted intracellular proteins" "Angiogenesis, Apoptosis, Cell cycle, Growth regulation, Immunity, Inflammatory response, Innate immunity, Stress response, Unfolded protein response" "Developmental protein, GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 81.7;HDLM-2: 64.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 44: Endometrium - Transcription" "unprognostic (3.82e-2)" "unprognostic (2.79e-1)" "unprognostic (2.62e-2)" "unprognostic (4.99e-3)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (2.31e-1)" "unprognostic (1.07e-1)" "unprognostic (1.08e-1)" "unprognostic (1.49e-2)" "unprognostic (3.09e-1)" "unprognostic (1.87e-1)" "prognostic favorable (4.00e-15)" "unprognostic (1.00e-2)" "unprognostic (2.07e-1)" "unprognostic (1.75e-2)" "unprognostic (2.81e-2)" 24.3 17.8 26.8 11.3 44.5 0.3 28.3 91.5 37.7 22.4 15.7 40.7 18.5 41.6 5.6 26.0 21.8 13.9 35.3 29.9 24.1 39.3 13.5 29.6 3.9 33.0 23.6 29.0 19.1 9.9 15.3 14.5 23.4 24.8 14.8 11.7 38.4 23.9 47.4 28.7 21.3 21.9 24.5 23.6 30.0 23.0 34.9 8.5 19.1 17.9 3.2 23.6 20.5 23.3 18.2 21.0 17.5 16.0 3.4 2.6 28.7 13.9 32.5 10.3 5.9 15.2 15.3 0.0 17.1 13.5 14.5 81.7 16.3 47.6 2.6 64.6 9.9 0.3 22.9 27.4 4.8 2.8 0.1 1.4 32.4 3.6 7.1 9.4 16.0 1.6 0.3 0.2 3.4 18.5 13.1 3.9 19.0 54.2 6.9 6.1 12.5 28.6 10.6 27.3 17.7 33.2 7.5 47.6 25.9 10.1 52.9 2.3 16.2 12.2 16.0 4.0 11.1 0.2 0.3 1.2 1.4 0.5 14.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 44.5 91.5 37.7 29.9 24.1 33.0 23.6 23.4 24.5 34.9 23.3 39.4 44.8 11.7 21.9 1.1 5.0 18.9 20.8 21.1 20.6 16.3 22.5 23.7 30.0 12.6 11.0 0.0 6.0 0.6 49.4 9.8 35.6 5.8 19.2 13.9 29.3 6.0 0.0 31.0 32.1 9.9 11.4 14.3 33.9 0.0 18.8 14.6 11.0 1.1 15.2 20.0 17.2 16.2 0.3 2.1 8.6 12.8 1.2 14.2 22.5 0.7 41.9 0.0 23.6 10.7 40.6 11.7 9.8 1.2 24.0 18.4 8.3 5.7 2.7 6.6 16.9 21.7 5.3 13.1 15.5 2.8 26.5 2.0 14.7 23.9 19.2 DBN1 D0S117E ENSG00000113758 "Drebrin 1" Q16643 5 177456608-177474401 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Actin-binding, Developmental protein" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 87.1;Pancreatic endocrine cells: 64.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 5.8;granulocytes: 9.4;T-cells: 14.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051452, HPA056940" Enhanced Supported Supported "Plasma membrane,Actin filaments" NA NA 2000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane, Actin filaments" "HPA051452: AB_2681489, HPA056940: AB_2683279" "unprognostic (3.81e-2)" "unprognostic (6.60e-3)" "unprognostic (2.88e-2)" "unprognostic (7.57e-3)" "unprognostic (9.32e-2)" "unprognostic (5.68e-2)" "unprognostic (2.01e-3)" "unprognostic (4.29e-2)" "unprognostic (1.73e-2)" "unprognostic (7.92e-2)" "unprognostic (2.94e-2)" "unprognostic (3.64e-1)" "prognostic favorable (8.28e-4)" "unprognostic (1.53e-1)" "unprognostic (4.56e-2)" "unprognostic (1.05e-1)" "unprognostic (1.76e-3)" 59.4 9.3 44.8 17.6 52.5 6.4 36.5 19.3 71.7 59.7 18.6 67.6 9.5 84.4 10.2 30.9 44.7 24.4 39.7 70.1 45.4 52.0 4.0 24.7 9.0 33.8 25.4 34.8 16.9 17.1 45.8 7.1 32.3 29.7 5.9 5.5 33.1 23.9 27.6 36.6 25.0 28.6 24.0 14.2 47.4 27.0 39.7 14.6 33.4 9.0 4.4 61.0 33.1 35.5 17.4 56.1 182.0 319.1 42.4 66.2 56.5 198.6 50.3 113.4 94.5 193.9 59.0 0.3 139.5 155.1 39.0 27.0 80.9 144.0 53.6 5.2 70.4 111.6 72.9 82.0 149.3 43.0 20.5 87.1 37.1 127.3 38.0 113.3 189.4 131.4 54.0 26.0 84.2 25.1 115.1 63.8 264.1 5.7 123.4 338.1 197.2 34.5 85.3 23.7 213.7 289.8 67.0 28.8 111.5 58.4 78.7 42.6 298.6 126.7 169.3 28.2 94.9 6.3 3.1 177.5 53.2 40.5 80.5 9.4 1.4 1.1 10.3 0.8 14.0 0.3 0.3 7.2 1.8 0.4 0.4 5.2 3.2 0.3 0.8 5.8 0.2 2.2 44.8 52.5 19.3 71.7 70.1 45.4 33.8 25.4 32.3 24.0 39.7 35.5 44.2 3.2 1.5 8.1 1.2 10.3 13.7 24.6 9.1 7.0 7.6 9.1 5.1 2.8 11.1 9.2 4.2 1.0 4.5 1.4 1.9 87.1 16.9 8.4 44.0 43.2 40.7 4.8 15.7 43.4 2.8 56.1 11.7 18.4 10.8 49.4 20.7 0.0 1.7 42.1 13.0 2.4 40.7 1.8 8.9 41.6 50.1 6.1 8.8 2.8 2.4 13.4 1.0 5.0 1.0 64.5 0.6 41.0 4.0 16.9 0.6 6.3 5.2 4.5 19.7 10.8 43.4 6.5 26.7 20.1 7.2 0.8 10.4 8.1 3.9 7.5 DCAF17 "C2orf37, FLJ13096" ENSG00000115827 "DDB1 and CUL4 associated factor 17" Q5H9S7 2 171434217-171485052 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Deafness, Diabetes mellitus, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053339, HPA055040" Uncertain Supported Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA053339: AB_2682119, HPA055040: AB_2682680" "unprognostic (1.60e-2)" "unprognostic (1.21e-1)" "unprognostic (4.05e-1)" "unprognostic (1.03e-2)" "unprognostic (1.60e-1)" "unprognostic (5.98e-2)" "unprognostic (5.60e-2)" "unprognostic (2.67e-2)" "unprognostic (2.30e-3)" "unprognostic (2.08e-2)" "unprognostic (1.45e-1)" "unprognostic (1.69e-1)" "unprognostic (1.12e-2)" "unprognostic (1.41e-1)" "unprognostic (4.27e-1)" "prognostic unfavorable (7.10e-4)" "unprognostic (2.79e-2)" 3.9 4.5 5.2 5.4 6.6 3.4 6.4 6.6 6.1 6.1 4.3 5.6 4.5 6.2 6.3 4.4 4.6 3.8 3.5 5.1 5.7 5.6 4.5 3.8 7.2 5.5 5.2 7.1 5.0 6.0 3.8 5.3 5.8 5.0 4.6 13.9 4.3 4.5 3.9 7.2 4.7 4.6 5.5 6.4 4.4 5.7 6.9 7.8 10.2 4.3 6.0 5.6 5.4 10.6 8.5 6.9 8.9 10.6 11.0 11.7 13.6 7.3 7.5 7.3 6.8 8.3 5.5 24.4 5.4 9.1 5.5 8.2 9.1 9.0 9.9 11.4 6.2 11.3 6.2 15.0 11.2 16.2 7.9 9.2 11.6 9.3 20.7 8.6 8.0 7.6 17.9 8.2 10.1 5.2 17.9 14.9 13.2 6.2 4.3 13.4 11.7 13.4 6.2 7.6 7.8 11.3 6.9 5.8 7.4 8.3 4.5 8.3 9.6 8.4 7.6 4.8 6.4 12.4 18.3 20.5 8.9 8.2 8.8 1.1 1.3 0.5 2.3 1.5 3.4 1.3 1.8 1.7 1.0 1.8 2.0 2.5 0.0 1.1 1.3 0.8 1.8 1.6 5.2 6.6 6.6 6.1 5.1 5.7 5.5 5.2 5.8 5.5 6.9 10.6 5.8 0.0 7.5 17.9 8.9 4.7 4.7 4.2 8.6 10.1 7.8 6.0 5.0 7.2 3.1 7.3 12.5 6.5 6.0 4.4 9.8 4.8 2.2 6.2 10.7 5.2 10.2 6.9 18.0 3.9 5.7 5.8 8.2 4.9 3.8 8.2 2.5 7.7 5.6 8.4 23.5 4.5 6.1 8.4 4.6 3.6 6.2 5.0 3.6 15.0 4.4 8.8 5.2 24.6 56.5 6.6 2.0 6.0 6.4 6.3 5.5 6.2 6.1 15.2 0.0 6.7 7.2 13.5 17.1 8.7 5.1 5.6 7.5 9.0 4.3 5.0 DHCR7 SLOS ENSG00000172893 "7-dehydrocholesterol reductase" Q9UBM7 11 71428193-71452868 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 161.1" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 77.9;Granulosa cells: 81.3;Hepatocytes: 156.1;Theca cells: 103.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044280 Approved Supported "Endoplasmic reticulum" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 15: Hepatocytes - Hemostasis" "Endoplasmic reticulum" "HPA044280: AB_10794893" "unprognostic (1.76e-1)" "unprognostic (1.50e-3)" "unprognostic (1.32e-2)" "unprognostic (7.16e-3)" "unprognostic (2.69e-1)" "unprognostic (2.18e-3)" "unprognostic (8.57e-3)" "unprognostic (3.02e-2)" "unprognostic (4.91e-2)" "unprognostic (1.13e-1)" "unprognostic (1.08e-2)" "unprognostic (5.45e-2)" "prognostic favorable (6.93e-7)" "unprognostic (1.73e-1)" "unprognostic (1.01e-1)" "unprognostic (8.15e-2)" "prognostic unfavorable (5.67e-4)" 23.7 97.2 28.1 13.0 35.4 46.7 36.3 42.4 37.0 16.2 15.6 21.1 48.1 10.6 59.2 42.2 12.5 8.9 28.8 28.8 35.8 16.3 161.1 21.8 6.0 55.3 38.8 54.4 16.6 24.4 18.4 8.3 55.8 21.6 14.4 8.7 27.8 7.1 13.6 68.2 19.3 9.9 34.4 9.6 19.1 31.0 38.0 4.7 11.9 13.2 9.4 7.9 22.7 58.9 126.4 112.3 106.7 118.9 49.0 75.8 33.7 50.9 134.1 43.1 114.5 419.8 401.5 87.1 79.0 48.6 376.2 235.9 128.8 276.7 44.5 33.5 98.7 33.4 89.3 183.1 127.8 63.7 15.6 89.2 122.1 159.3 108.4 34.6 63.8 112.7 159.6 180.7 43.2 341.1 52.4 72.6 154.1 124.9 67.4 46.9 150.6 377.3 162.3 187.3 144.7 53.9 48.4 157.6 113.9 51.4 153.2 34.5 60.4 11.5 62.4 3.7 61.5 59.3 78.7 95.8 33.8 110.9 48.9 5.6 2.1 1.9 10.5 1.4 12.6 6.5 8.9 9.8 2.8 5.4 11.0 13.0 1.1 5.8 1.5 7.1 6.0 6.9 28.1 35.4 42.4 37.0 28.8 35.8 55.3 38.8 55.8 34.4 38.0 58.9 7.1 3.2 19.1 7.2 7.1 0.8 10.1 77.9 3.4 8.4 21.8 14.9 13.1 15.7 39.2 22.0 12.5 15.5 11.9 9.9 7.9 36.9 0.1 3.9 1.5 11.8 9.5 5.2 3.2 49.9 27.6 12.8 11.7 9.3 0.0 81.3 7.9 156.1 11.9 0.0 4.5 12.3 54.9 3.8 3.3 1.7 8.4 5.6 5.4 1.0 5.8 21.2 4.1 5.0 14.7 26.7 11.5 4.9 10.0 16.5 8.9 3.8 7.6 8.7 13.1 3.9 9.0 0.5 7.0 11.9 1.1 54.2 13.8 103.6 15.0 9.5 DISP1 "DISPA, DKFZP434I0428, MGC13130, MGC16796" ENSG00000154309 "Dispatched RND transporter family member 1" Q96F81 1 222815022-223005995 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 47.7;Gastric mucus-secreting cells: 48.4;Inhibitory neurons: 54.4;Microglial cells: 204.2;Oligodendrocyte precursor cells: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 15.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051411 Uncertain Approved "Nuclear bodies" No No "Cluster 16: MAIT-cells - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 68: Oligodendrocytes - Mixed function" "Nuclear bodies" "HPA051411: AB_2681475" "unprognostic (2.10e-2)" "unprognostic (3.31e-1)" "unprognostic (7.00e-2)" "unprognostic (7.81e-2)" "unprognostic (7.82e-2)" "unprognostic (2.88e-1)" "unprognostic (2.71e-1)" "unprognostic (1.27e-1)" "unprognostic (2.28e-1)" "unprognostic (3.28e-1)" "prognostic favorable (5.00e-4)" "unprognostic (4.13e-1)" "prognostic favorable (3.86e-5)" "unprognostic (5.24e-2)" "unprognostic (2.38e-1)" "prognostic favorable (4.16e-4)" "unprognostic (9.69e-3)" 6.8 5.7 1.7 1.5 2.0 0.2 3.0 4.0 2.5 3.2 3.7 9.0 2.6 4.3 2.0 1.9 2.4 4.6 3.9 1.6 1.9 5.2 2.7 9.2 1.1 1.2 0.9 4.5 2.4 5.1 2.5 4.6 1.1 2.4 2.1 1.3 1.9 2.0 4.1 3.3 3.7 4.2 0.7 2.5 5.3 6.5 1.5 1.4 5.2 3.1 1.4 5.4 2.5 2.6 0.9 2.2 5.6 3.8 10.1 6.1 2.4 3.2 2.7 1.1 1.1 2.6 1.6 0.1 4.2 1.5 2.2 0.6 1.6 1.3 1.6 8.1 2.4 1.1 6.3 1.2 4.4 0.2 1.1 4.8 1.9 2.3 0.9 5.8 2.3 1.2 0.0 0.1 3.9 1.5 1.4 0.3 4.0 6.1 1.3 1.7 15.1 0.2 6.8 0.8 1.6 2.5 1.8 0.7 2.3 2.7 2.7 1.4 4.2 2.3 1.5 3.9 3.6 1.2 0.5 0.3 3.2 0.8 5.1 0.3 0.2 0.0 0.7 0.4 1.6 0.5 0.6 0.7 0.6 0.9 0.6 0.5 0.1 1.0 0.2 0.3 0.5 0.4 1.7 2.0 4.0 2.5 1.6 1.9 1.2 0.9 1.1 0.7 1.5 2.6 4.6 6.4 1.7 42.7 3.6 0.5 0.6 1.2 5.7 2.7 3.4 1.5 7.8 7.2 3.3 11.0 0.0 1.4 2.1 1.0 0.0 1.9 2.1 1.9 3.4 4.9 0.0 0.0 47.7 2.8 1.8 5.6 48.4 4.1 0.0 15.8 6.8 3.3 5.9 0.0 54.4 2.6 4.1 1.6 0.9 3.7 1.5 4.1 0.0 204.2 1.4 0.9 5.2 199.6 15.4 1.3 3.1 3.4 0.7 0.7 6.4 5.8 2.7 2.3 0.0 4.0 3.7 2.1 2.3 5.4 1.1 0.8 1.7 2.8 1.6 0.3 DKK2 ENSG00000155011 "Dickkopf WNT signaling pathway inhibitor 2" Q9UBU2 4 106921802-107283806 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 15.2" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 7.6;Fibroblasts: 18.7;Hofbauer cells: 16.8;Inhibitory neurons: 32.5;Langerhans cells: 11.8;Suprabasal keratinocytes: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 22.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "cerebral cortex: 1.5;midbrain: 5.0;pons: 6.3;thalamus: 5.7" "CAB009727, HPA052611" Uncertain Supported "Golgi apparatus" "Secreted in other tissues" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "CAB009727: AB_2091492, HPA052611: AB_2732576" "unprognostic (3.14e-3)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (3.21e-2)" "unprognostic (9.75e-2)" "unprognostic (3.68e-1)" "unprognostic (1.04e-3)" "unprognostic (2.47e-2)" "unprognostic (5.11e-1)" "unprognostic (5.21e-2)" "unprognostic (3.21e-1)" "unprognostic (3.52e-1)" "unprognostic (1.32e-1)" "unprognostic (1.42e-1)" "unprognostic (6.86e-2)" "unprognostic (3.22e-1)" "unprognostic (4.58e-2)" 1.4 0.8 0.4 0.4 1.4 0.0 3.0 0.0 1.5 15.2 1.2 1.7 0.0 1.0 0.4 1.2 0.5 0.7 2.2 0.7 0.6 0.2 0.2 5.3 0.7 0.9 4.5 4.4 0.2 0.6 1.5 2.8 0.3 2.3 0.5 0.4 1.3 1.7 1.9 4.7 0.3 0.6 0.2 1.3 0.1 0.1 2.3 1.0 0.9 1.2 3.0 0.2 0.8 0.8 0.0 0.0 3.6 0.0 0.6 0.3 0.0 0.1 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 1.5 0.7 0.6 0.9 4.5 0.3 0.2 2.3 0.8 2.6 0.0 0.0 0.3 0.0 7.6 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 1.8 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.1 5.4 0.0 0.0 5.2 0.0 0.2 18.7 0.0 0.1 0.0 0.0 3.3 0.0 16.8 0.0 32.5 0.0 0.0 0.3 11.8 0.0 4.1 0.3 7.2 2.8 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 7.4 0.0 0.8 2.0 0.0 0.0 DKK3 "REIC, RIG" ENSG00000050165 "Dickkopf WNT signaling pathway inhibitor 3" Q9UBP4 11 11956207-12009769 "Plasma proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 1224.0" "Group enriched" "Detected in many" 7 "Cardiomyocytes: 884.3;Muller glia cells: 1960.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 6.2;memory CD8 T-cell: 3.8" "Lineage enriched" "Detected in single" 62 "T-cells: 6.2" "Cell line enhanced" "Detected in many" "BJ: 418.9;BJ hTERT+: 643.0;fHDF/TERT166: 614.4;hTERT-RPE1: 370.2;TIME: 349.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011868, CAB024949" Approved Supported "Nuclear bodies,Vesicles,Cytosol" "Secreted in other tissues" No No 18000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 5: Muller glia cells - Visual perception" Vesicles "Nuclear bodies, Cytosol" "CAB024949: , HPA011868: AB_1847716" "unprognostic (4.24e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (7.84e-2)" "unprognostic (3.06e-3)" "unprognostic (6.58e-3)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-3)" "unprognostic (5.28e-2)" "unprognostic (4.51e-2)" "unprognostic (3.87e-2)" "prognostic unfavorable (6.31e-5)" "unprognostic (7.41e-3)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.02e-3)" 31.2 79.1 110.7 10.0 183.6 0.2 26.0 12.6 135.2 89.7 104.8 53.2 14.6 47.0 16.7 29.7 23.0 67.0 1224.0 147.7 80.2 17.0 5.6 123.7 8.5 95.1 54.3 38.1 18.2 34.2 38.2 25.0 46.8 59.4 13.0 204.1 30.9 78.1 7.8 29.7 24.6 43.1 83.9 33.2 31.7 30.9 99.9 4.7 16.4 18.8 5.4 40.9 48.3 121.6 1.5 13.1 18.1 0.1 15.3 29.7 0.6 418.9 643.0 182.4 205.5 9.6 3.2 0.0 44.8 614.4 96.8 64.4 1.5 181.9 69.5 0.1 0.5 0.0 1.7 0.0 113.6 0.0 0.3 45.3 60.0 61.9 151.3 370.2 195.3 0.0 0.2 0.4 256.4 0.0 0.1 0.4 8.6 0.0 0.5 0.1 1.2 0.1 62.5 0.6 0.5 53.2 2.0 0.0 0.2 47.9 0.2 0.5 349.7 107.5 82.8 11.2 110.3 0.1 0.0 0.3 18.1 0.0 103.5 0.0 0.0 0.0 0.5 0.0 6.2 0.0 0.6 3.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 110.7 183.6 12.6 135.2 147.7 80.2 95.1 54.3 46.8 83.9 99.9 121.6 5.8 3.2 3.0 94.3 0.1 45.6 59.5 70.3 93.4 31.6 3.2 103.2 884.3 0.0 12.8 0.0 12.5 0.5 0.4 0.0 0.0 0.8 104.3 0.7 8.4 32.9 1.8 0.0 90.4 0.2 0.8 106.1 7.1 0.6 1.3 17.0 66.8 0.4 20.4 13.5 83.7 0.1 0.0 1.3 12.5 88.5 20.5 1.4 64.0 38.4 0.0 1960.4 0.0 27.6 14.7 1.1 0.1 57.6 1.7 32.8 0.0 0.2 2.9 67.5 190.7 12.7 83.4 1.2 3.2 5.8 14.8 0.8 4.1 0.5 0.3 3.0 DNAJC1 "DNAJL1, ERdj1, MTJ1" ENSG00000136770 "DnaJ heat shock protein family (Hsp40) member C1" Q96KC8 10 21756548-22003769 "Predicted membrane proteins, Transcription factors" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013432 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Endoplasmic reticulum" "HPA013432: AB_1847797" "unprognostic (7.00e-2)" "unprognostic (9.81e-2)" "unprognostic (3.61e-1)" "unprognostic (5.12e-2)" "unprognostic (5.51e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (1.96e-5)" "unprognostic (3.81e-2)" "unprognostic (1.21e-1)" "unprognostic (3.46e-2)" "unprognostic (1.09e-1)" "unprognostic (9.36e-2)" "prognostic favorable (2.33e-4)" "unprognostic (4.44e-3)" "unprognostic (4.88e-2)" "unprognostic (1.45e-2)" "unprognostic (2.22e-2)" 17.6 16.9 9.9 16.3 11.2 18.3 20.0 10.6 13.1 17.8 15.0 20.6 28.3 15.5 13.4 16.3 14.2 17.7 15.8 9.0 12.9 23.0 36.9 24.0 15.6 12.1 11.1 14.0 38.5 45.6 19.6 19.9 12.4 23.7 18.7 7.1 40.7 16.3 12.7 14.3 22.4 15.8 11.5 15.2 28.6 9.4 11.3 13.1 29.0 11.2 13.0 26.5 15.2 12.7 38.5 24.5 53.9 20.1 49.3 34.9 23.4 50.9 22.1 20.8 32.7 33.8 33.1 16.9 21.9 31.2 31.2 36.1 12.3 25.7 11.5 88.6 41.1 40.3 18.8 20.3 119.5 3.0 16.5 35.8 46.5 24.7 28.3 30.4 27.8 16.4 42.7 93.6 23.8 39.2 9.6 12.9 7.1 33.2 20.3 13.8 18.8 62.3 29.1 9.1 11.3 17.1 37.7 62.2 38.1 58.7 19.8 42.8 42.7 20.3 43.5 34.4 29.3 29.8 10.0 11.7 30.3 126.1 12.3 11.8 16.6 7.0 36.2 16.6 36.5 8.4 20.2 29.1 15.3 12.3 12.9 16.5 9.3 34.2 30.9 39.6 15.8 15.0 9.9 11.2 10.6 13.1 9.0 12.9 12.1 11.1 12.4 11.5 11.3 12.7 56.4 35.3 26.9 73.4 46.7 38.7 64.8 26.6 30.1 27.9 67.9 76.1 16.9 57.2 31.0 31.3 45.9 16.7 92.9 52.4 27.4 73.6 47.6 40.9 74.6 54.7 38.3 49.0 134.4 74.2 92.6 67.4 59.7 58.3 41.8 14.3 52.8 84.5 55.0 38.7 77.1 75.8 28.5 43.7 52.5 19.6 94.8 44.2 67.6 112.4 46.9 37.4 99.9 91.5 137.7 80.6 49.2 67.0 202.7 71.2 57.9 80.1 23.9 149.1 59.2 49.3 56.7 232.2 109.5 45.3 44.2 35.3 81.5 41.0 55.8 71.9 DOLPP1 LSFR2 ENSG00000167130 "Dolichyldiphosphatase 1" Q86YN1 9 129081111-129090438 "Enzymes, Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 29.1;Proximal enterocytes: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019179 Approved Approved "Vesicles,Intermediate filaments" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 45: Enterocytes - Digestion" Vesicles "Intermediate filaments" "HPA019179: AB_1847827" "unprognostic (1.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.89e-1)" "unprognostic (6.12e-3)" "unprognostic (3.11e-1)" "unprognostic (2.63e-2)" "unprognostic (3.18e-1)" "unprognostic (3.10e-2)" "unprognostic (6.96e-2)" "unprognostic (7.12e-2)" "unprognostic (1.65e-1)" "unprognostic (4.37e-3)" "unprognostic (7.59e-3)" "unprognostic (2.38e-2)" "unprognostic (1.35e-1)" "unprognostic (4.69e-2)" "unprognostic (5.34e-2)" 5.6 11.4 12.2 6.3 13.4 8.1 5.8 13.0 13.8 6.6 8.7 15.5 26.2 5.3 6.0 19.2 5.5 5.8 4.6 12.1 12.5 6.0 22.4 5.0 6.6 13.3 13.4 5.2 10.4 8.7 6.2 7.6 14.3 8.5 12.5 3.8 9.9 4.7 4.9 10.5 22.6 5.3 13.1 7.8 10.8 8.1 13.5 10.1 5.4 4.8 6.6 6.0 8.3 15.2 8.7 33.6 31.4 29.6 10.3 9.1 36.2 20.9 12.2 39.3 22.0 42.9 28.4 16.7 18.2 13.0 30.2 61.8 32.6 17.8 16.6 19.9 20.6 22.0 22.3 34.5 18.8 23.0 26.4 9.5 24.4 25.5 20.3 8.9 17.5 30.7 37.3 16.2 11.4 44.7 26.5 24.8 27.4 64.7 28.2 30.8 25.3 31.2 14.2 14.1 35.9 24.2 27.1 24.1 9.4 18.4 44.8 15.0 14.5 33.5 16.4 33.4 29.0 20.3 41.6 25.3 15.3 4.6 22.8 7.9 8.2 12.6 10.2 10.5 25.2 11.4 12.6 12.6 10.5 7.7 12.5 11.9 1.7 11.2 11.0 15.8 13.6 8.9 12.2 13.4 13.0 13.8 12.1 12.5 13.3 13.4 14.3 13.1 13.5 15.2 3.1 6.4 6.3 4.2 3.9 2.3 3.0 6.9 1.2 3.7 7.3 5.2 2.1 10.0 6.3 1.8 6.2 18.8 2.8 29.1 1.9 7.1 0.5 3.9 5.0 3.4 3.6 13.0 3.1 9.6 14.2 3.9 10.2 5.4 5.7 3.8 5.3 18.3 7.5 3.3 4.4 10.1 6.1 2.9 1.9 0.5 2.1 2.7 5.4 1.0 4.2 8.6 6.2 3.5 6.4 6.6 16.2 4.1 6.7 3.8 42.0 4.1 3.2 3.7 0.0 3.1 4.0 6.3 9.7 11.0 4.0 16.4 4.4 8.1 13.5 4.1 DPP4 "ADCP2, CD26, DPPIV" ENSG00000197635 "Dipeptidyl peptidase 4" P27487 2 161992245-162074394 "CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 137.9;parathyroid gland: 155.7;placenta: 134.1;prostate: 107.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 140.3;Proximal enterocytes: 291.1;Proximal tubular cells: 101.4;Syncytiotrophoblasts: 172.0" "Cancer enhanced" "Detected in all" "prostate cancer: 55.2" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 52.3" "Lineage enriched" "Detected in many" 10 "T-cells: 52.3" "Cell line enhanced" "Detected in many" "ASC diff: 194.4;ASC TERT1: 212.6;BJ hTERT+: 207.0;RPTEC TERT1: 263.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB045970, HPA068778, HPA071236" Enhanced "Secreted to blood" NA NA 190000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "CAB045970: AB_11140529, HPA068778: , HPA071236: " "unprognostic (4.47e-2)" "unprognostic (4.47e-2)" "unprognostic (8.89e-2)" "unprognostic (3.36e-1)" "unprognostic (7.25e-2)" "unprognostic (5.40e-2)" "unprognostic (2.78e-1)" "unprognostic (3.54e-2)" "unprognostic (3.58e-1)" "unprognostic (4.73e-1)" "unprognostic (2.36e-1)" "prognostic unfavorable (1.98e-4)" "prognostic favorable (1.35e-6)" "unprognostic (4.68e-2)" "unprognostic (6.33e-2)" "prognostic favorable (4.99e-4)" "unprognostic (1.21e-2)" 13.3 3.1 0.2 5.3 0.2 0.6 8.4 0.1 0.6 10.9 0.1 14.6 107.0 3.6 4.0 3.0 7.4 6.7 3.4 0.2 0.1 94.9 57.2 16.0 5.8 0.2 0.2 3.5 3.5 155.7 0.1 134.1 0.3 107.3 16.9 0.1 84.5 23.5 1.5 5.7 137.9 3.0 0.1 11.2 7.6 1.3 0.8 12.4 5.0 3.9 4.4 5.7 3.5 0.4 0.2 0.2 1.0 0.0 194.4 212.6 0.6 37.7 207.0 10.9 37.2 38.0 1.0 0.0 13.6 71.0 30.2 1.1 0.4 0.0 6.2 12.3 0.0 0.0 0.0 57.1 77.0 0.0 0.0 22.0 0.1 66.3 0.5 9.1 6.6 0.7 0.0 0.0 3.6 0.0 3.6 0.5 2.0 1.3 72.7 0.0 0.0 0.6 263.3 0.0 0.1 0.4 0.0 0.0 0.0 4.4 0.0 0.3 37.0 21.8 1.1 0.7 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 6.6 0.0 52.3 0.2 16.2 10.7 1.2 0.0 15.7 6.6 0.4 5.3 0.0 4.0 2.0 4.7 0.2 0.2 0.1 0.6 0.2 0.1 0.2 0.2 0.3 0.1 0.8 0.4 10.8 6.4 26.0 0.3 2.1 4.1 0.4 0.1 0.0 1.8 0.2 0.8 3.3 12.8 2.8 14.7 10.4 140.3 10.4 27.4 1.9 3.0 15.0 2.3 7.1 9.4 55.2 0.4 31.6 0.0 59.1 35.3 2.0 68.0 13.9 5.3 9.3 34.5 14.5 0.0 6.3 16.4 0.0 0.9 7.6 7.9 0.0 4.8 5.4 3.7 1.1 0.0 1.0 2.5 0.7 1.4 23.8 0.0 2.1 32.7 291.1 101.4 2.2 0.1 0.0 2.1 1.5 4.0 1.1 0.1 4.1 172.0 25.8 29.2 29.1 0.3 DPY19L2 "FLJ32949, SPATA34" ENSG00000177990 "Dpy-19 like 2" Q6NUT2 12 63558913-63668939 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 65.6" "Group enriched" "Detected in many" 4 "Early spermatids: 329.9;Excitatory neurons: 124.1;Inhibitory neurons: 137.2;Late spermatids: 363.0;Oligodendrocyte precursor cells: 124.1;Spermatocytes: 143.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/84: 9.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA071264, HPA078305" Enhanced Approved Nucleoplasm,Mitochondria Yes No "Cluster 16: MAIT-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" Mitochondria Nucleoplasm "HPA071264: AB_2686375, HPA078305: " "unprognostic (1.97e-1)" "unprognostic (4.08e-1)" "unprognostic (4.46e-3)" "unprognostic (2.50e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-4)" "unprognostic (2.28e-2)" "unprognostic (2.14e-3)" "unprognostic (1.53e-1)" "unprognostic (3.64e-1)" "unprognostic (3.99e-3)" "unprognostic (1.97e-1)" "unprognostic (6.31e-3)" "unprognostic (4.22e-3)" "unprognostic (5.88e-2)" "unprognostic (8.90e-3)" "unprognostic (1.79e-1)" 6.7 5.3 4.0 0.5 3.9 3.0 4.7 7.0 6.9 11.4 6.6 5.2 0.6 7.8 4.1 1.4 6.4 2.8 19.2 3.0 4.3 12.7 0.2 1.3 0.9 2.4 3.0 11.0 2.7 9.0 10.5 1.2 1.5 9.3 1.3 14.4 1.6 4.7 0.5 1.6 1.7 3.5 0.8 1.7 2.9 65.6 3.3 0.7 13.1 0.6 0.6 6.3 5.1 4.2 1.0 2.6 2.2 5.4 0.6 0.0 0.2 1.8 1.8 2.4 3.1 0.4 0.8 2.8 1.8 0.7 2.9 0.4 2.7 0.3 3.6 1.5 1.7 4.6 1.4 1.7 0.5 3.4 1.4 1.5 0.1 1.1 0.0 6.1 0.8 2.2 1.9 2.9 3.9 1.7 0.2 1.4 2.1 0.4 2.4 0.0 1.8 0.0 4.6 0.5 7.0 0.7 0.6 0.2 1.0 0.9 1.9 0.9 0.5 3.2 4.2 0.5 4.6 7.5 9.3 0.0 3.4 1.6 3.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 4.0 3.9 7.0 6.9 3.0 4.3 2.4 3.0 1.5 0.8 3.3 4.2 6.7 3.2 0.0 23.2 0.2 0.5 2.9 0.1 2.2 49.6 1.9 1.8 32.3 1.5 3.8 12.9 14.6 2.0 0.3 0.1 5.9 0.4 329.9 5.6 7.1 1.7 0.0 7.2 124.1 0.0 1.3 2.2 0.5 2.1 2.5 1.2 1.4 0.1 0.3 3.3 137.2 0.1 6.1 0.0 0.4 363.0 7.2 0.4 7.2 11.2 0.1 9.2 0.0 124.1 5.0 0.2 0.0 8.6 0.5 2.9 0.0 6.4 11.6 6.7 26.3 3.8 19.9 143.3 4.9 0.2 0.4 1.4 0.8 3.6 0.1 1.1 DUOXA1 "FLJ32334, mol, NIP, NUMBIP" ENSG00000140254 "Dual oxidase maturation factor 1" Q1HG43 15 45117367-45129938 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 189.0;skin 1: 91.6;thyroid gland: 111.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 60.9;Alveolar cells type 2: 118.0;Club cells: 35.5;Glandular and luminal cells: 47.7;Respiratory ciliated cells: 36.9;Squamous epithelial cells: 53.6;Urothelial cells: 44.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 30.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HaCaT: 103.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA041578 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 11: Alveolar cells - Smell perception" "HPA041578: AB_10795691" "unprognostic (1.28e-1)" "unprognostic (1.32e-3)" "unprognostic (1.88e-1)" "unprognostic (2.66e-2)" "unprognostic (2.71e-1)" "unprognostic (6.87e-3)" "unprognostic (1.03e-1)" "unprognostic (4.45e-2)" "unprognostic (6.69e-2)" "unprognostic (3.68e-2)" "unprognostic (5.82e-2)" "unprognostic (1.86e-1)" "unprognostic (2.17e-5)" "unprognostic (8.11e-2)" "unprognostic (1.12e-2)" "unprognostic (4.69e-2)" "unprognostic (5.36e-2)" 1.1 5.0 0.2 1.3 0.5 0.1 4.0 0.7 1.1 32.1 0.0 0.9 0.8 4.6 49.3 189.0 5.7 4.3 2.1 0.5 0.3 0.8 0.3 64.3 0.1 0.6 0.1 1.1 0.4 5.0 0.7 0.8 0.8 21.6 0.5 0.1 27.5 12.0 0.5 91.6 0.8 0.2 0.1 0.1 43.6 0.2 0.7 0.7 111.1 0.0 17.9 23.3 77.4 2.9 10.6 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 103.9 0.0 0.2 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 14.5 0.0 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.7 1.1 0.5 0.3 0.6 0.1 0.8 0.1 0.7 2.9 0.0 60.9 118.0 1.0 0.0 9.4 18.8 26.9 18.2 0.6 1.4 1.7 0.5 0.0 35.5 0.0 2.1 2.4 0.0 3.3 0.0 2.0 0.1 28.7 4.0 0.8 3.0 0.0 0.7 3.1 0.1 1.6 8.6 47.7 1.3 0.3 0.0 0.0 0.3 0.0 0.4 0.1 4.1 0.0 1.2 0.0 0.3 0.8 0.0 0.0 0.6 0.1 0.0 0.5 1.8 1.9 3.3 0.0 0.0 13.4 0.0 0.0 36.9 0.1 0.0 0.7 1.1 0.0 0.9 53.6 21.9 3.0 0.6 0.1 0.4 44.2 DXO DOM3Z ENSG00000204348 "Decapping exoribonuclease" O77932 6 31969810-31972290 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 467.9;Late spermatids: 242.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046708 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA046708: AB_2679764" "unprognostic (4.56e-2)" "unprognostic (2.21e-1)" "unprognostic (1.80e-1)" "unprognostic (4.07e-3)" "unprognostic (1.93e-1)" "unprognostic (2.00e-3)" "unprognostic (3.43e-3)" "unprognostic (4.18e-3)" "unprognostic (3.10e-2)" "unprognostic (2.64e-3)" "prognostic favorable (5.87e-4)" "unprognostic (4.29e-2)" "prognostic unfavorable (4.77e-6)" "unprognostic (9.17e-2)" "unprognostic (7.24e-2)" "unprognostic (2.01e-1)" "unprognostic (2.23e-3)" 6.6 17.8 8.2 3.9 8.1 1.4 6.9 8.2 8.5 10.7 9.6 7.1 4.5 8.1 5.8 5.7 8.5 4.2 9.6 8.1 8.4 12.3 13.0 6.4 4.6 9.3 8.6 13.4 10.8 11.8 13.0 4.4 8.7 10.3 3.9 4.8 6.7 6.0 5.3 4.9 5.8 4.8 8.6 9.7 8.6 31.3 8.3 7.0 11.5 7.1 3.0 7.9 7.4 8.5 12.9 6.3 5.8 23.1 9.5 6.4 6.7 7.5 12.0 16.2 15.5 7.6 5.9 5.2 8.5 16.6 5.2 8.7 10.1 16.8 9.4 9.6 12.9 9.3 15.8 16.4 18.7 0.0 4.6 9.7 16.3 10.5 13.5 9.9 21.3 6.6 8.3 11.9 9.8 14.7 1.5 11.1 4.4 8.4 1.3 4.0 4.1 8.2 21.2 4.5 30.1 17.0 6.6 7.3 16.9 4.1 0.0 14.8 7.0 4.7 12.6 4.6 12.3 9.1 9.4 10.2 4.6 14.4 5.2 0.0 1.9 1.0 2.2 1.6 3.9 2.4 2.3 1.4 4.3 2.1 1.6 2.3 0.3 2.1 1.4 1.3 1.6 1.8 8.2 8.1 8.2 8.5 8.1 8.4 9.3 8.6 8.7 8.6 8.3 8.5 11.2 6.4 9.6 11.8 16.8 8.5 15.3 14.3 19.9 13.3 13.6 11.4 7.1 11.5 10.5 3.7 16.7 14.5 14.1 5.0 19.6 8.4 467.9 9.3 10.6 9.8 16.2 4.4 4.4 12.6 9.5 10.9 15.8 8.7 6.3 12.1 8.6 10.9 6.6 5.0 6.2 9.0 12.2 5.9 4.9 242.8 17.7 6.9 12.4 1.9 4.3 16.0 11.3 7.5 6.6 6.9 10.5 12.4 14.7 10.8 10.6 13.3 8.9 15.6 13.1 7.1 14.3 78.4 16.1 11.8 5.5 20.1 15.4 22.6 8.3 11.5 DYNLT3 "TCTE1L, TCTEX1L" ENSG00000165169 "Dynein light chain Tctex-type 3" P51808 X 37836757-37847571 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 738.3;Glandular and luminal cells: 265.2;Late spermatids: 445.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003938 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 44: Endometrium - Transcription" "HPA003938: AB_1847920" "unprognostic (1.27e-1)" "unprognostic (5.14e-2)" "unprognostic (1.00e-1)" "unprognostic (7.62e-2)" "prognostic unfavorable (4.77e-4)" "unprognostic (1.13e-1)" "unprognostic (5.15e-3)" "unprognostic (6.91e-2)" "unprognostic (2.72e-1)" "unprognostic (2.37e-1)" "unprognostic (3.59e-2)" "unprognostic (1.88e-1)" "unprognostic (3.65e-3)" "unprognostic (1.00e-2)" "unprognostic (1.69e-1)" "unprognostic (2.72e-1)" "unprognostic (2.69e-2)" 29.0 60.8 25.9 17.7 27.7 27.1 24.4 26.4 35.1 33.3 22.4 23.7 12.1 32.7 25.4 63.6 18.7 37.4 32.0 30.4 39.1 50.3 44.9 24.7 14.7 35.0 33.4 23.0 13.9 40.3 23.4 26.4 38.1 27.2 22.2 33.1 19.2 27.7 12.6 11.4 14.9 37.2 26.5 18.4 23.5 16.9 30.1 14.8 26.5 18.2 21.9 32.8 30.7 26.6 48.2 13.9 1.4 0.1 58.1 67.0 7.5 32.0 35.0 17.7 29.2 25.8 25.2 16.9 15.5 65.5 51.2 18.9 20.1 27.5 34.8 28.7 23.4 13.4 66.0 13.6 29.1 0.0 9.5 29.3 38.4 43.2 19.1 53.0 55.3 0.0 6.9 23.9 82.5 15.7 0.4 20.8 8.1 24.7 69.2 24.0 0.1 27.9 32.4 34.7 30.8 13.1 58.9 12.0 97.7 2.8 14.7 14.3 29.8 36.7 19.9 43.0 36.7 15.9 15.4 19.7 88.8 22.0 46.4 20.6 9.5 7.3 17.2 14.0 35.9 17.5 24.0 22.9 6.3 12.3 20.5 20.2 7.6 16.5 8.7 7.3 14.7 14.7 25.9 27.7 26.4 35.1 30.4 39.1 35.0 33.4 38.1 26.5 30.1 26.6 62.0 38.5 28.9 6.2 37.8 15.4 121.8 48.7 10.8 28.2 38.9 20.8 31.8 25.8 46.8 64.4 2.1 12.5 31.9 26.0 133.1 53.8 738.3 80.4 75.6 47.4 55.7 8.6 22.9 46.9 29.1 64.7 42.8 265.2 87.6 15.4 42.8 34.0 38.2 70.7 24.8 18.4 85.5 31.5 80.0 445.7 44.1 42.5 42.7 12.2 49.0 57.2 28.8 7.1 7.6 102.1 28.0 103.4 22.9 116.7 20.2 143.6 53.0 50.8 39.5 53.2 81.6 13.1 5.8 74.7 22.7 45.4 68.0 27.4 17.7 118.8 EAF1 ENSG00000144597 "ELL associated factor 1" Q96JC9 3 15427598-15450635 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.1" "Group enriched" "Detected in all" 6 "Early spermatids: 268.7;Late spermatids: 389.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 137.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059516, HPA060569, HPA069538" Supported Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA No "Cluster 16: MAIT-cells - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nuclear bodies" Vesicles "HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147" "unprognostic (1.26e-1)" "unprognostic (1.61e-2)" "unprognostic (6.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (3.22e-1)" "unprognostic (3.16e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (2.06e-2)" "unprognostic (5.17e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" 12.9 9.0 9.2 10.5 8.9 57.1 9.1 7.2 9.4 7.2 7.7 9.0 10.6 7.9 7.6 9.8 7.0 10.4 5.1 10.3 11.1 11.2 19.0 8.3 10.7 9.6 10.3 5.6 9.8 11.8 8.6 10.2 12.3 10.0 9.9 7.7 6.9 6.8 5.3 10.7 10.0 8.3 7.8 9.8 11.4 7.3 10.6 10.6 10.5 5.8 11.1 11.5 5.8 7.9 10.3 16.6 17.1 17.6 9.8 8.3 137.4 14.7 10.5 16.7 16.3 22.7 11.4 28.7 9.3 10.9 10.9 8.6 22.5 13.2 19.2 23.6 16.2 24.8 14.5 20.8 22.1 23.6 19.2 11.0 22.8 24.3 16.2 12.8 16.8 23.1 26.9 20.6 14.1 21.2 23.6 13.2 30.7 19.3 16.9 21.3 14.2 16.0 14.5 17.8 17.6 30.6 18.2 16.7 17.6 21.9 25.2 18.5 16.6 17.5 12.8 15.6 21.8 27.1 58.3 29.7 17.0 27.7 21.1 8.0 7.1 4.6 11.1 5.4 14.3 4.9 9.1 8.7 4.2 3.6 5.4 8.7 6.5 8.1 6.9 9.8 10.9 4.4 9.2 8.9 7.2 9.4 10.3 11.1 9.6 10.3 12.3 7.8 10.6 7.9 11.5 9.6 17.3 6.8 14.2 46.9 9.1 6.0 14.2 8.1 15.8 7.7 4.8 15.7 9.0 12.9 6.2 8.0 29.1 15.5 9.8 8.6 268.7 10.8 16.0 11.8 34.3 7.8 16.4 8.2 14.6 13.9 16.3 14.1 10.2 9.9 12.1 30.4 15.8 21.9 14.0 12.5 12.2 30.7 31.6 389.5 11.5 37.6 23.2 3.7 19.4 5.5 22.6 5.5 10.7 15.6 10.3 12.0 12.2 16.1 16.0 29.7 8.6 6.4 26.3 13.6 11.0 21.5 11.6 17.7 54.3 35.8 22.0 4.3 12.8 19.9 EID2 "CRI2, EID-2, MGC20452" ENSG00000176396 "EP300 interacting inhibitor of differentiation 2" Q8N6I1 19 39538707-39540161 "Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045477 Uncertain Supported Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm "HPA045477: AB_10959785" "unprognostic (5.91e-2)" "unprognostic (6.37e-3)" "prognostic favorable (9.73e-4)" "unprognostic (5.93e-2)" "unprognostic (6.50e-2)" "unprognostic (1.39e-1)" "unprognostic (2.52e-2)" "unprognostic (6.53e-2)" "unprognostic (6.02e-2)" "unprognostic (3.43e-1)" "unprognostic (6.88e-3)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.21e-1)" "unprognostic (2.79e-2)" "unprognostic (2.25e-2)" "unprognostic (1.55e-1)" "unprognostic (1.51e-1)" 10.5 17.9 13.3 8.8 14.5 6.4 8.5 13.3 19.5 7.7 11.9 9.1 6.8 11.0 8.1 9.2 8.4 6.2 10.1 14.3 15.6 12.6 10.8 8.4 9.1 13.8 11.8 8.4 7.8 12.6 13.0 14.3 14.1 9.0 6.6 15.7 7.7 8.0 11.1 7.4 9.0 9.8 12.5 9.5 8.8 9.0 12.8 14.2 8.3 10.4 8.4 7.8 6.5 12.6 25.0 33.4 31.1 21.2 24.7 15.3 4.6 29.3 22.0 22.5 23.2 21.2 7.7 25.4 23.5 20.6 15.1 10.5 29.0 21.3 29.0 24.6 36.5 11.4 19.1 25.5 24.5 19.9 16.1 18.0 13.3 18.7 14.4 17.8 26.6 49.0 18.8 17.2 19.8 16.5 29.0 17.5 17.4 30.1 14.0 26.6 29.7 11.9 28.9 22.8 29.0 20.6 31.8 12.6 21.0 20.9 17.1 12.9 19.2 14.3 51.0 19.1 22.3 26.9 33.8 32.1 13.3 18.5 11.8 0.0 0.4 0.7 0.8 0.5 0.8 0.5 1.0 1.0 0.5 0.5 1.0 1.4 0.1 0.3 0.5 0.5 0.2 0.4 13.3 14.5 13.3 19.5 14.3 15.6 13.8 11.8 14.1 12.5 12.8 12.6 16.4 19.2 9.2 2.6 7.3 10.1 4.5 2.4 6.2 23.9 11.2 15.6 19.1 17.2 4.0 14.7 10.4 48.9 14.0 6.5 1.9 5.2 3.2 18.3 23.3 14.4 7.2 4.2 7.4 5.0 5.3 10.0 5.1 12.4 1.3 14.4 13.2 12.9 10.8 26.9 8.0 5.3 0.0 8.1 6.5 1.3 10.2 7.8 8.8 3.7 7.5 31.1 12.3 5.0 8.6 6.2 7.4 13.2 7.2 5.3 5.9 9.5 5.5 20.7 6.6 9.7 12.7 11.3 8.8 5.2 7.5 19.4 11.3 25.2 7.5 2.6 ELOVL4 "CT118, SCA34, STGD2, STGD3" ENSG00000118402 "ELOVL fatty acid elongase 4" Q9GZR5 6 79914814-79947553 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Disease variant, FDA approved drug targets, Ichthyosis, Mental retardation, Neurodegeneration, Spinocerebellar ataxia, Stargardt disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 105.5;retina: 176.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 63.8;Cone photoreceptor cells: 148.0;Excitatory neurons: 55.3;Rod photoreceptor cells: 355.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "MAIT T-cell: 23.7" "Lineage enriched" "Detected in single" 238 "T-cells: 23.7" "Cell line enhanced" "Detected in many" "JURKAT: 41.2;MOLT-4: 32.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "unprognostic (1.67e-2)" "unprognostic (8.58e-3)" "unprognostic (2.38e-2)" "unprognostic (3.08e-6)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (1.27e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (3.46e-1)" "unprognostic (6.91e-3)" "unprognostic (3.39e-1)" "unprognostic (1.38e-2)" "unprognostic (3.45e-3)" "unprognostic (1.66e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (6.27e-4)" 0.7 2.0 7.1 1.1 7.0 0.1 4.1 10.0 15.4 3.5 9.7 1.8 0.6 2.2 1.0 10.6 0.7 1.6 0.9 7.8 9.9 1.5 0.1 0.3 0.4 14.4 5.3 1.7 0.5 10.8 6.4 1.7 15.0 4.0 1.0 176.7 2.8 1.7 0.2 43.1 0.8 2.7 4.3 0.5 0.9 5.7 7.4 105.5 1.5 0.5 1.7 1.2 4.0 7.2 0.0 0.8 10.8 12.0 8.8 8.5 1.6 5.6 6.1 4.7 10.2 1.5 0.0 0.0 1.0 7.7 19.3 1.1 14.1 7.9 3.5 0.0 18.2 0.4 2.2 0.0 8.1 4.4 1.7 6.9 2.9 4.8 4.9 6.8 7.8 41.2 0.0 0.0 10.0 1.9 32.8 0.0 10.4 0.0 5.6 0.0 15.5 0.0 0.1 0.0 14.2 4.2 6.0 9.6 1.7 7.4 3.8 0.3 0.8 2.1 4.1 3.2 4.3 7.2 15.3 0.0 5.0 0.0 3.3 0.0 0.0 0.0 2.3 0.0 23.7 0.0 3.3 3.9 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.2 0.9 7.1 7.0 10.0 15.4 7.8 9.9 14.4 5.3 15.0 4.3 7.4 7.2 0.7 0.0 0.0 7.5 0.2 11.3 2.3 7.5 15.4 63.8 0.7 1.7 0.9 0.0 3.9 0.0 148.0 0.9 1.7 0.0 0.0 0.1 6.3 0.3 7.0 2.2 8.9 0.0 55.3 0.0 1.5 6.5 0.0 0.1 0.0 1.5 0.0 0.0 0.2 42.1 53.0 0.5 6.1 0.3 1.5 2.1 1.2 0.2 3.6 8.4 0.1 50.7 0.0 20.1 8.6 0.0 1.1 3.4 0.3 3.1 0.0 2.3 0.5 355.3 0.0 2.0 4.3 15.4 15.4 14.8 37.8 1.0 2.6 1.3 0.2 0.7 ENO2 ENSG00000111674 "Enolase 2" P09104 12 6913745-6923698 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "retina: 1695.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 318.2;Cone photoreceptor cells: 312.8;Horizontal cells: 429.0;Rod photoreceptor cells: 787.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 9.9;MAIT T-cell: 11.3;memory B-cell: 6.8;memory CD4 T-cell: 13.1;memory CD8 T-cell: 11.4;naive B-cell: 4.4;naive CD4 T-cell: 8.2;naive CD8 T-cell: 8.6;neutrophil: 7.0;T-reg: 7.5" "Group enriched" "Detected in many" 7 "B-cells: 6.8;granulocytes: 7.0;T-cells: 13.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 537.4;U-87 MG: 398.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000063, HPA068284, HPA068721, CAB073539, CAB079023" Enhanced Supported Supported "Plasma membrane,Cytosol" NA NA 55000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 46: Photoreceptor cells - Phototransduction" "Plasma membrane, Cytosol" "CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: AB_2732119" "unprognostic (8.96e-2)" "unprognostic (8.28e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.28e-1)" "unprognostic (7.95e-3)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.48e-1)" "unprognostic (9.43e-2)" "unprognostic (1.58e-1)" "unprognostic (1.98e-1)" "unprognostic (2.02e-2)" "prognostic unfavorable (7.89e-11)" "unprognostic (7.61e-2)" "unprognostic (3.06e-1)" "unprognostic (8.10e-3)" "unprognostic (1.24e-1)" 25.6 46.7 280.8 20.0 289.7 9.6 20.2 291.2 400.7 55.9 97.5 74.0 10.2 40.1 12.6 15.3 40.2 17.9 53.7 295.0 289.4 27.8 7.7 33.8 26.3 289.4 189.9 29.7 9.0 43.6 124.4 10.4 282.2 34.9 15.5 1695.6 13.8 34.4 7.4 19.3 37.1 35.0 164.3 26.4 30.4 9.6 259.0 26.7 42.0 6.4 24.4 57.4 44.1 306.2 74.3 45.3 16.2 0.5 23.7 26.0 1.5 56.5 37.3 82.0 125.9 8.6 5.8 103.9 9.5 24.3 108.8 11.0 173.0 15.4 116.1 211.9 16.6 141.0 47.7 60.3 17.4 8.3 161.2 13.0 0.7 61.1 11.5 537.4 17.5 137.9 9.5 1.1 56.3 10.3 66.9 8.8 84.9 31.7 27.2 75.0 13.9 22.9 38.5 9.8 128.3 94.0 14.3 1.0 96.3 76.4 4.5 3.9 20.9 69.4 73.7 95.7 73.0 73.3 79.5 15.4 398.4 0.3 15.2 2.1 0.0 0.2 9.9 0.0 11.3 6.8 13.1 11.4 0.1 4.4 8.2 8.6 7.0 0.4 0.3 1.2 7.5 6.1 280.8 289.7 291.2 400.7 295.0 289.4 289.4 189.9 282.2 164.3 259.0 306.2 3.2 35.3 27.4 54.2 11.2 6.2 2.3 45.2 1.8 318.2 5.2 4.3 16.1 1.5 17.2 12.9 312.8 0.3 7.5 0.3 0.0 17.0 0.5 9.6 2.1 9.9 23.9 7.0 96.2 1.8 1.1 8.3 2.0 2.7 67.2 1.0 5.3 0.2 1.7 429.0 89.4 0.5 18.3 0.6 6.9 0.3 5.6 5.9 12.4 25.3 3.5 146.1 0.0 23.6 31.5 9.3 1.2 9.8 9.2 2.5 0.1 0.2 32.2 787.2 13.1 8.1 20.2 1.5 2.5 1.1 2.3 0.3 17.1 0.3 0.4 2.2 ERICH6 "C3orf44, ERICH6A, FAM194A, MGC39662" ENSG00000163645 "Glutamate rich 6" Q7L0X2 3 150659885-150703971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 29.7" "Group enriched" "Detected in some" 25 "Early spermatids: 96.1;Late spermatids: 56.0;Spermatocytes: 25.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 1.5;SH-SY5Y: 1.6;U-266/70: 1.7;U-266/84: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA048373 Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA048373: AB_2680375" "unprognostic (7.38e-2)" "unprognostic (3.89e-3)" "unprognostic (7.02e-3)" "unprognostic (2.52e-2)" "unprognostic (7.38e-3)" "unprognostic (1.86e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (4.44e-1)" "unprognostic (1.96e-1)" "unprognostic (8.44e-2)" "unprognostic (1.71e-2)" "unprognostic (1.80e-2)" "unprognostic (7.27e-2)" "unprognostic (2.21e-1)" "unprognostic (1.49e-2)" "unprognostic (3.16e-2)" 0.3 0.2 0.1 0.2 0.4 0.3 0.1 0.1 0.3 0.0 0.9 0.1 0.5 0.4 1.7 0.2 0.3 0.3 0.3 0.3 0.6 0.6 0.1 0.2 0.6 0.1 0.4 0.4 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.1 0.3 0.0 0.1 0.1 0.3 0.0 0.1 0.3 0.3 29.7 0.4 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.7 0.6 0.0 0.9 0.0 0.5 0.1 0.0 0.0 0.0 0.7 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.2 0.4 0.0 0.4 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.7 1.6 0.0 0.1 0.0 0.0 0.3 0.5 0.0 0.2 0.5 0.6 0.1 1.7 2.8 0.3 0.2 0.0 0.0 0.0 0.1 0.1 2.6 0.0 5.1 1.9 1.6 2.0 0.1 2.0 2.2 2.3 0.0 4.2 0.0 2.4 1.9 1.4 0.1 0.4 0.1 0.3 0.3 0.6 0.1 0.4 0.1 0.1 0.4 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 96.1 0.3 0.2 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 56.0 2.1 0.2 0.0 1.9 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.7 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 25.0 1.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 ESPN DFNB36 ENSG00000187017 Espin B1AK53 1 6424776-6461367 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing Actin-binding "Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 129.1;retina: 117.8;testis: 145.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 175.5;Early spermatids: 137.5;Late spermatids: 461.6;Muller glia cells: 272.5;Paneth cells: 186.3;Proximal enterocytes: 512.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebellum: 13.4;thalamus: 6.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 48.9;Hep G2: 81.5;SK-BR-3: 160.1;T-47d: 53.6" "Low region specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 2.6" "HPA028674, HPA060220" Enhanced Approved Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" Vesicles "HPA028674: AB_10601316, HPA060220: AB_2684224" "unprognostic (5.06e-2)" "unprognostic (1.18e-2)" "unprognostic (2.69e-1)" "unprognostic (1.28e-1)" "unprognostic (2.19e-2)" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (2.28e-1)" "unprognostic (1.16e-1)" "unprognostic (5.71e-2)" "unprognostic (7.48e-3)" "unprognostic (5.53e-2)" "unprognostic (6.26e-3)" "unprognostic (5.51e-2)" "unprognostic (1.16e-1)" "unprognostic (3.04e-2)" "unprognostic (1.17e-2)" 0.6 5.7 0.4 2.6 1.0 28.0 9.2 13.4 1.0 30.3 0.2 28.2 90.4 2.4 39.9 34.3 18.6 0.3 0.9 0.4 1.7 63.4 129.1 3.2 0.3 0.6 1.3 0.4 0.9 26.8 42.1 0.9 1.1 10.0 6.8 117.8 9.4 6.2 0.8 91.7 89.5 0.8 0.3 0.9 2.7 145.3 6.1 1.6 0.4 0.0 1.7 1.3 22.3 0.5 14.1 0.7 0.6 0.1 0.0 0.0 48.9 0.0 0.0 0.2 0.0 29.9 1.5 0.5 6.5 0.0 0.1 32.6 2.3 0.1 0.0 2.0 0.7 0.4 0.7 81.5 0.0 0.6 2.7 0.1 0.6 0.0 0.0 0.0 0.0 1.0 17.6 0.0 0.0 28.2 0.2 1.0 0.6 3.8 12.2 0.0 0.4 10.9 0.2 0.1 21.0 0.7 3.7 160.1 5.0 0.3 53.6 7.4 15.6 0.1 0.8 0.6 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 1.0 13.4 1.0 0.4 1.7 0.6 1.3 1.1 0.3 6.1 0.5 0.2 0.0 0.6 0.0 0.8 7.8 2.4 4.5 12.5 5.6 10.7 3.9 1.4 11.5 3.8 9.2 68.8 3.0 0.2 175.5 13.7 0.2 137.5 19.1 0.9 0.8 6.0 8.2 0.2 3.1 0.5 0.3 5.6 12.4 0.0 0.0 3.9 109.4 0.2 0.0 0.2 36.3 8.2 3.2 0.9 461.6 3.7 1.5 0.0 0.0 0.0 272.5 0.0 0.0 0.1 0.1 186.3 2.2 0.0 1.6 512.1 102.2 9.0 72.5 0.0 0.0 0.2 12.3 3.9 17.6 22.7 6.6 1.5 0.0 35.3 2.9 ESRP1 "FLJ20171, RBM35A" ENSG00000104413 "Epithelial splicing regulatory protein 1" Q6NXG1 8 94641074-94707466 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 107.2;Suprabasal keratinocytes: 79.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 138.3;BEWO: 101.1;CAPAN-2: 140.8;hTCEpi: 226.5;OE19: 142.6;RT4: 99.1;T-47d: 108.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023719, HPA023720, HPA067104" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 27: Mucus-secreting cells - Mucin production" "Nuclear bodies" Nucleoplasm "HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: AB_2685779" "prognostic unfavorable (9.28e-4)" "unprognostic (7.12e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (4.12e-1)" "unprognostic (6.99e-3)" "unprognostic (2.70e-1)" "unprognostic (2.61e-2)" "unprognostic (5.19e-2)" "unprognostic (5.51e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (4.48e-2)" "prognostic favorable (1.96e-8)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (4.96e-2)" "unprognostic (1.29e-1)" 0.2 0.0 0.0 5.2 0.0 0.0 24.2 0.0 0.0 15.5 0.0 57.1 25.2 3.4 29.6 64.2 21.3 8.5 0.1 0.0 0.0 8.5 0.4 15.8 0.0 0.0 0.1 0.1 42.6 28.4 7.2 12.2 0.0 19.9 62.8 0.0 25.9 10.0 0.1 60.6 22.0 2.5 0.0 0.0 38.6 0.6 0.4 5.2 36.6 0.0 15.3 22.5 28.8 0.0 138.3 0.0 0.0 0.2 0.0 0.0 101.1 0.0 0.0 0.0 0.0 44.6 140.8 0.0 3.8 0.0 0.1 81.6 3.8 70.9 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 226.5 0.0 1.4 0.0 0.0 10.7 0.0 0.0 0.0 67.3 1.9 0.4 12.4 142.6 3.4 0.0 0.0 18.3 17.4 99.1 35.1 0.3 0.0 21.0 14.0 21.4 108.0 0.9 0.0 0.1 0.2 0.1 0.3 12.0 13.8 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 38.5 36.7 0.0 0.6 44.6 18.9 30.4 35.9 0.0 29.4 18.0 1.0 21.5 32.4 27.6 0.0 55.1 0.5 76.2 13.7 19.6 12.9 47.1 3.7 0.9 33.1 0.0 2.6 27.5 69.1 0.9 58.1 46.5 1.3 0.0 0.4 0.1 6.0 0.0 0.4 107.2 16.2 0.0 3.2 10.3 0.0 0.5 24.9 0.0 0.6 0.0 0.0 0.5 0.4 21.7 48.1 0.7 1.8 25.1 25.5 0.3 35.0 0.0 0.0 0.0 1.2 0.6 0.9 71.3 79.1 62.1 0.8 0.0 73.9 40.1 ETNK2 "EKI2, FLJ10761" ENSG00000143845 "Ethanolamine kinase 2" Q9NVF9 1 204131062-204152044 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 108.1;liver: 235.5;testis: 125.0" "Group enriched" "Detected in many" 4 "Early spermatids: 417.0;Late spermatids: 1337.3" "Cancer enhanced" "Detected in all" "liver cancer: 32.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 53.8;MCF7: 55.1" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 8 "basal ganglia: 22.6" HPA057167 Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "HPA057167: AB_2683358" "unprognostic (1.64e-1)" "unprognostic (4.17e-2)" "unprognostic (2.56e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (1.95e-1)" "unprognostic (1.99e-2)" "unprognostic (1.13e-1)" "unprognostic (9.39e-3)" "unprognostic (4.28e-2)" "unprognostic (6.54e-2)" "unprognostic (4.35e-2)" "prognostic favorable (6.50e-4)" "unprognostic (5.50e-3)" "unprognostic (4.69e-2)" "unprognostic (2.00e-2)" "unprognostic (1.20e-1)" 14.4 6.1 12.8 2.1 12.5 2.8 17.4 7.9 12.0 18.8 28.3 5.7 1.9 10.8 29.9 23.9 13.1 5.3 6.3 10.6 14.0 108.1 235.5 3.3 2.1 10.5 13.4 36.1 9.5 18.5 25.6 4.3 11.1 13.7 2.1 5.7 27.7 16.2 2.0 20.3 3.7 6.5 8.5 7.2 4.9 125.0 15.1 3.7 10.6 4.1 9.3 10.0 26.0 7.5 11.3 3.8 11.0 20.9 4.0 1.3 10.9 11.4 25.2 15.6 6.8 19.2 5.4 0.4 18.4 2.8 18.2 9.9 19.7 15.9 10.7 0.4 17.3 0.2 2.5 30.6 16.2 0.5 0.7 5.4 53.8 3.2 0.7 8.0 11.1 11.9 1.6 0.4 2.0 55.1 3.2 0.3 23.0 0.4 8.4 0.8 13.0 0.4 13.4 4.3 2.9 15.4 7.2 33.6 5.4 35.1 32.5 0.7 0.7 4.4 23.8 1.0 8.4 0.5 0.2 0.5 0.3 0.6 6.3 0.0 0.1 0.0 2.2 0.0 2.1 0.0 0.5 1.3 0.0 0.1 1.3 1.6 0.1 0.8 0.0 0.0 0.3 0.6 12.8 12.5 7.9 12.0 10.6 14.0 10.5 13.4 11.1 8.5 15.1 7.5 1.3 0.0 0.0 1.3 1.0 4.1 13.8 8.2 1.8 4.2 12.3 11.6 1.1 4.3 2.5 3.7 4.2 6.1 1.6 0.1 39.2 9.5 417.0 4.5 1.9 2.1 1.2 13.5 1.2 6.3 9.2 6.4 1.1 3.2 8.9 47.4 6.8 196.9 0.8 0.0 2.9 0.1 2.0 6.5 1.1 1337.3 29.2 1.6 10.6 0.0 0.0 3.8 1.0 2.5 0.2 4.5 0.0 42.2 0.0 14.9 0.3 147.2 3.1 0.8 0.0 4.1 4.4 11.0 7.4 16.1 2.4 9.4 2.9 34.1 0.2 13.5 ETV3 PE-1 ENSG00000117036 "ETS variant transcription factor 3" P41162 1 157121191-157138474 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 361.2;monocytes: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004794, HPA073211" Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 44: HDLM-2 - Immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm Vesicles "HPA004794: AB_1078761, HPA073211: " "unprognostic (1.65e-1)" "unprognostic (2.37e-1)" "unprognostic (3.78e-2)" "unprognostic (4.39e-2)" "unprognostic (7.59e-2)" "unprognostic (5.23e-2)" "unprognostic (1.38e-2)" "unprognostic (3.30e-1)" "unprognostic (2.36e-2)" "unprognostic (5.37e-2)" "unprognostic (1.34e-2)" "unprognostic (8.02e-2)" "unprognostic (7.26e-3)" "unprognostic (1.18e-1)" "unprognostic (1.22e-1)" "unprognostic (8.97e-2)" "unprognostic (6.65e-2)" 13.7 7.7 6.6 11.1 6.6 24.0 12.1 7.9 20.1 8.3 5.3 8.7 15.1 9.3 7.5 15.6 7.8 12.7 7.4 8.3 8.1 6.6 6.6 12.6 10.1 7.7 6.5 11.5 6.4 23.9 5.0 12.8 7.0 10.2 9.5 5.7 9.2 8.5 9.4 31.5 14.6 10.1 7.1 10.0 10.0 9.4 7.4 10.8 7.9 8.8 12.5 17.6 11.4 7.1 11.9 11.4 11.6 10.1 17.3 11.3 9.9 10.9 11.4 10.5 9.7 12.2 11.6 14.2 13.4 13.4 5.6 18.0 12.8 16.7 13.8 31.0 8.1 11.9 12.2 6.7 10.3 19.0 18.1 12.5 19.2 15.7 13.3 8.5 11.1 8.8 13.9 10.2 12.0 15.7 5.8 10.7 38.6 16.9 8.7 8.7 13.8 16.3 8.1 43.9 9.8 19.0 11.9 28.1 29.5 20.7 14.4 20.7 18.8 13.5 11.9 13.2 13.7 24.6 13.5 16.7 15.5 10.9 45.2 6.3 4.6 3.3 4.5 4.2 6.2 2.1 3.9 4.5 4.5 2.4 3.9 3.5 5.4 4.2 4.2 1.2 3.3 2.6 6.6 6.6 7.9 20.1 8.3 8.1 7.7 6.5 7.0 7.1 7.4 7.1 22.9 35.3 16.2 3.6 20.4 70.4 18.4 20.2 71.7 2.3 18.2 14.4 9.4 5.7 24.3 12.9 10.4 7.5 37.2 22.1 0.0 6.4 9.4 18.1 18.0 19.4 10.7 5.9 8.1 6.3 9.0 16.3 15.3 29.5 22.2 6.4 15.4 8.3 8.7 1.7 6.9 12.5 10.2 13.2 361.2 7.3 4.1 69.0 16.0 5.6 97.0 3.9 10.3 6.0 4.4 10.4 13.4 4.5 25.3 16.5 16.0 3.2 29.7 6.3 13.1 16.4 15.4 10.2 9.4 64.2 78.7 14.9 40.4 6.0 14.4 51.4 F8 "DXS1253E, F8C, FVIII, HEMA" ENSG00000185010 "Coagulation factor VIII" P00451 X 154835788-155026940 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Blood coagulation, Hemostasis" "Disease variant, FDA approved drug targets, Hemophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 53.2" "Group enriched" "Detected in many" 10 "Adipocytes: 118.6;Endothelial cells: 120.4;Hepatic stellate cells: 371.2" "Cancer enhanced" "Detected in all" "renal cancer: 7.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 16.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB018777 Enhanced "Secreted to blood" NA NA 25000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 18: U-2197 - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "CAB018777: AB_640320" "unprognostic (2.09e-1)" "unprognostic (5.66e-4)" "unprognostic (4.94e-2)" "unprognostic (8.32e-5)" "unprognostic (1.26e-1)" "unprognostic (5.05e-2)" "unprognostic (6.05e-2)" "unprognostic (8.27e-2)" "unprognostic (6.58e-2)" "unprognostic (1.68e-1)" "unprognostic (1.67e-2)" "unprognostic (5.58e-2)" "unprognostic (1.24e-2)" "unprognostic (2.16e-3)" "unprognostic (1.69e-1)" "unprognostic (1.17e-2)" "unprognostic (4.44e-2)" 29.4 15.2 7.8 2.5 8.6 2.1 19.3 7.4 11.2 7.5 9.9 9.6 2.9 10.9 9.1 4.0 7.9 5.0 53.2 8.2 8.5 14.1 20.1 16.7 4.7 8.6 8.4 14.5 11.6 5.6 6.4 3.3 8.6 9.0 3.8 6.2 4.7 7.5 20.6 3.6 5.0 6.3 7.8 17.9 5.7 6.1 8.9 3.2 10.9 28.1 3.7 8.1 3.7 7.8 6.1 4.5 0.9 2.1 6.5 10.1 0.7 2.9 1.8 2.0 3.4 0.3 6.8 12.0 9.5 3.0 4.7 0.8 1.0 1.0 1.8 5.1 1.9 2.4 2.8 0.2 3.0 2.1 5.6 7.2 0.6 1.8 2.4 3.5 1.2 5.7 1.1 9.0 10.0 2.7 1.7 1.9 1.6 1.8 4.5 1.4 1.5 1.8 1.8 1.3 3.7 2.8 7.0 0.8 3.9 1.0 2.1 4.9 1.5 10.3 5.5 16.6 3.7 5.3 5.1 6.0 9.4 12.3 5.5 4.6 2.8 0.9 5.2 2.4 10.3 2.1 3.1 5.5 2.7 1.9 1.6 4.1 4.4 3.3 2.4 0.4 4.6 2.7 7.8 8.6 7.4 11.2 8.2 8.5 8.6 8.4 8.6 7.8 8.9 7.8 118.6 0.0 6.3 13.1 2.3 1.8 2.5 1.6 4.0 8.1 3.7 4.2 17.7 7.2 1.9 3.7 2.1 0.9 2.0 0.6 7.9 3.1 1.4 1.5 1.5 120.4 0.0 8.4 7.2 0.7 0.7 6.8 0.0 1.5 1.3 8.2 371.2 11.8 3.2 6.7 5.0 0.6 0.0 19.9 1.1 3.3 11.5 3.0 0.0 8.4 2.4 6.8 2.1 7.5 6.0 4.5 0.1 5.3 2.0 1.4 0.9 11.4 2.4 3.5 6.6 11.1 13.0 2.3 3.4 1.5 1.1 0.1 4.0 4.3 0.4 2.1 FAHD2B DKFZp434N062 ENSG00000144199 "Fumarylacetoacetate hydrolase domain containing 2B" Q6P2I3 2 97083583-97094882 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 235.0;Late spermatids: 212.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 8.8;NK-cells: 16.2;T-cells: 15.5" "Low cell line specificity" "Detected in many" "HPA042145, HPA044987" Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 34: Spermatids - Unknown function" "HPA042145: AB_2677873, HPA044987: AB_2679170" "unprognostic (6.55e-3)" "unprognostic (5.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (9.03e-3)" "unprognostic (4.13e-3)" "unprognostic (8.84e-3)" "unprognostic (1.59e-1)" "unprognostic (1.41e-1)" "unprognostic (8.65e-3)" "unprognostic (1.94e-1)" "unprognostic (7.67e-2)" "unprognostic (1.48e-1)" "unprognostic (5.03e-2)" "unprognostic (6.26e-3)" "unprognostic (2.04e-1)" 10.7 7.1 24.5 3.2 28.2 3.5 12.8 29.5 25.2 16.6 21.1 14.5 2.5 17.6 38.1 7.4 17.2 4.2 30.0 23.7 28.8 12.6 4.0 7.9 5.7 27.8 25.8 23.6 14.4 11.1 10.3 1.7 28.9 10.9 5.5 6.8 10.8 6.8 30.3 13.6 8.2 11.2 29.6 6.8 24.7 46.8 28.6 4.2 3.9 45.9 7.7 14.3 12.2 33.1 5.0 6.0 8.2 16.8 8.0 9.5 13.0 4.3 5.0 7.3 6.7 5.6 7.7 9.6 3.7 1.7 13.7 5.2 12.0 9.6 4.1 12.5 22.1 10.5 7.6 4.5 25.6 11.9 6.5 12.8 10.0 0.9 15.5 3.4 7.8 37.0 18.3 22.9 0.5 0.0 14.5 35.5 8.1 2.2 16.7 14.0 2.3 34.5 8.1 8.3 1.8 7.1 14.7 3.8 21.5 15.3 16.1 9.4 1.3 0.8 13.7 1.0 4.2 15.1 21.1 25.4 1.2 30.5 10.1 0.0 0.2 0.2 11.3 0.3 15.5 8.8 11.0 11.1 1.8 4.2 7.5 9.7 0.2 16.2 0.1 2.9 15.0 4.8 24.5 28.2 29.5 25.2 23.7 28.8 27.8 25.8 28.9 29.6 28.6 33.1 8.2 6.4 11.1 11.1 6.1 6.5 11.5 5.9 9.6 6.3 17.9 21.0 42.3 4.3 8.0 5.5 2.1 2.1 5.8 1.1 27.4 7.3 235.0 2.3 6.5 7.8 1.8 5.5 10.4 4.3 1.0 13.5 30.1 1.2 5.7 18.5 8.2 2.3 3.5 5.0 12.1 3.3 6.1 1.6 2.6 212.6 17.1 2.2 30.2 2.8 1.6 21.7 9.2 2.5 8.0 6.9 1.2 17.0 17.3 7.7 0.2 3.8 4.6 5.8 0.0 9.7 10.5 24.5 7.3 7.3 7.1 1.0 8.2 11.1 4.4 8.3 FANCE "FACE, FAE" ENSG00000112039 "FA complementation group E" Q9HB96 6 35452338-35467102 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 22.1;Extravillous trophoblasts: 104.8;Syncytiotrophoblasts: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB014893 Enhanced Supported Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 32: U-937 - Innate immune response" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "CAB014893: " "unprognostic (2.66e-1)" "unprognostic (8.01e-3)" "unprognostic (7.73e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (1.99e-1)" "unprognostic (2.80e-3)" "prognostic unfavorable (2.08e-9)" "unprognostic (8.90e-2)" "unprognostic (5.70e-3)" "unprognostic (8.41e-2)" "unprognostic (1.52e-1)" "unprognostic (2.91e-2)" "unprognostic (1.28e-1)" "unprognostic (1.70e-1)" "unprognostic (3.05e-1)" "unprognostic (2.44e-2)" "unprognostic (5.14e-2)" 4.6 1.5 2.6 3.2 2.5 5.8 5.0 2.8 3.1 7.1 2.0 3.1 2.1 3.7 3.4 8.6 4.8 1.5 3.3 2.3 2.9 2.1 1.3 4.1 4.5 2.7 2.6 7.8 3.5 4.0 3.1 9.3 2.6 3.8 3.0 1.8 4.3 2.7 11.0 13.8 3.5 3.1 2.4 3.8 3.4 8.7 2.7 2.6 3.0 3.1 5.7 4.0 7.7 2.7 9.9 4.2 12.8 27.6 9.2 15.9 34.6 11.4 9.6 14.8 12.1 11.1 5.3 33.0 7.5 6.7 11.2 7.2 13.7 9.8 13.9 11.0 11.9 23.8 11.7 6.8 4.8 12.6 8.2 10.1 28.6 17.7 27.7 3.9 8.7 12.6 21.3 11.6 12.2 11.4 5.8 16.6 4.7 10.6 7.0 18.8 12.3 12.1 3.1 10.0 12.1 11.4 6.4 9.1 10.0 11.9 8.8 43.7 5.6 16.7 14.5 10.9 18.1 7.4 29.3 11.6 3.9 24.3 16.8 0.0 0.2 0.2 0.4 0.1 0.7 0.1 0.6 0.9 0.1 0.5 0.3 0.3 0.0 0.5 0.1 0.4 0.3 0.2 2.6 2.5 2.8 3.1 2.3 2.9 2.7 2.6 2.6 2.4 2.7 2.7 7.0 6.4 0.0 1.0 2.4 8.8 4.1 4.7 1.8 1.1 2.0 2.8 2.7 0.0 1.6 0.0 0.0 22.1 2.0 1.6 0.0 1.7 0.3 1.9 2.4 3.7 1.2 2.5 0.4 0.8 104.8 2.8 1.1 3.4 0.0 5.2 1.4 0.7 6.0 0.0 0.9 3.6 0.0 0.8 1.3 0.6 1.5 1.4 1.8 2.8 0.5 1.9 1.0 0.5 1.0 1.1 0.4 0.7 3.1 5.8 1.1 0.3 0.1 2.0 0.0 4.0 3.4 8.2 13.2 4.6 7.1 46.7 2.2 3.4 4.4 3.5 FERMT2 "KIND2, mig-2, PLEKHC1, UNC112B" ENSG00000073712 "Fermitin family member 2" Q96AC1 14 52857268-52952435 "Predicted intracellular proteins" "Cell adhesion, Cell shape, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040505, HPA072965" Uncertain Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA 230000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Focal adhesion sites" "Nucleoplasm, Cytosol" "HPA040505: AB_10673300, HPA072965: " "unprognostic (4.38e-2)" "unprognostic (4.25e-2)" "unprognostic (8.00e-3)" "unprognostic (2.42e-2)" "unprognostic (2.51e-2)" "unprognostic (4.89e-3)" "unprognostic (2.50e-2)" "unprognostic (1.92e-1)" "unprognostic (4.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.58e-1)" "unprognostic (1.99e-1)" "unprognostic (3.87e-2)" "unprognostic (3.96e-3)" "unprognostic (7.69e-2)" "unprognostic (3.14e-1)" "unprognostic (1.73e-3)" 148.4 21.2 28.7 38.8 31.6 0.5 57.6 29.0 37.3 44.7 18.0 104.3 13.1 105.1 26.3 46.8 55.7 65.7 66.9 31.0 27.4 55.4 108.3 47.9 15.3 35.7 29.1 43.6 20.6 18.4 13.1 116.5 33.5 69.1 33.3 29.5 22.6 117.9 48.8 13.4 29.3 155.6 30.6 37.6 46.4 15.5 27.6 6.9 35.9 69.6 6.6 77.7 29.1 38.1 22.8 18.9 101.6 46.8 163.7 133.7 84.6 148.4 95.2 172.3 107.9 34.1 17.6 0.1 49.4 153.1 33.8 9.6 80.1 11.1 128.3 0.2 22.6 31.9 83.1 40.3 209.6 0.4 12.6 129.4 23.5 95.3 125.4 78.5 91.2 16.8 0.6 153.4 131.7 28.0 7.7 0.5 64.3 0.2 51.3 3.9 103.8 0.4 60.9 20.6 6.2 130.5 157.8 35.0 37.7 103.3 30.1 1.1 115.2 134.5 92.4 108.2 56.0 22.6 29.4 0.6 30.9 0.2 33.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 31.6 29.0 37.3 31.0 27.4 35.7 29.1 33.5 30.6 27.6 38.1 152.7 76.9 42.0 116.5 1.0 18.6 150.6 15.5 13.6 39.5 33.8 41.4 65.8 24.3 25.6 40.5 37.5 74.8 2.3 0.2 31.3 48.5 68.2 20.1 141.7 110.4 0.0 2.7 13.7 33.2 178.1 103.9 3.6 40.2 58.3 31.6 110.3 82.3 10.4 15.2 16.1 0.5 4.1 8.9 19.5 27.9 74.9 4.4 46.2 29.0 4.8 52.3 1.0 41.2 92.0 27.6 0.1 174.9 4.5 40.0 0.0 44.7 10.1 56.0 151.2 83.4 174.1 4.1 16.2 2.2 8.1 102.6 7.9 12.3 0.4 37.0 FKBP11 FKBP19 ENSG00000134285 "FKBP prolyl isomerase 11" Q9NYL4 12 48921518-48926474 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 495.0" "Cell type enriched" "Detected in many" 4 "Plasma cells: 1153.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "MAIT T-cell: 188.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 332.6;Karpas-707: 315.1;OE19: 527.2" "Low region specificity" "Detected in all" HPA041709 Enhanced Approved Centrosome NA NA 170000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 55: Plasma cells - Humoral immune response" Centrosome "HPA041709: AB_10794487" "unprognostic (7.45e-3)" "unprognostic (8.62e-2)" "unprognostic (2.40e-1)" "prognostic favorable (7.09e-4)" "unprognostic (1.70e-2)" "unprognostic (2.00e-1)" "unprognostic (3.46e-2)" "unprognostic (1.75e-1)" "unprognostic (7.64e-2)" "unprognostic (3.49e-3)" "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.15e-1)" "unprognostic (4.51e-1)" "unprognostic (2.79e-1)" "unprognostic (1.54e-1)" 25.6 17.6 4.0 60.2 4.1 34.5 34.5 3.7 4.9 42.4 5.6 57.2 70.8 17.4 86.4 16.2 19.1 25.4 13.1 3.8 12.0 13.8 59.4 23.9 55.4 5.7 6.3 13.8 495.0 4.7 47.2 15.6 5.2 28.9 53.3 2.1 160.2 32.7 2.4 8.0 55.9 26.2 3.8 76.4 70.6 6.1 9.6 16.4 22.9 0.4 77.4 49.2 17.3 4.8 13.6 24.7 3.0 4.5 116.0 141.3 3.8 123.2 183.3 128.0 154.5 78.3 88.3 192.8 2.2 226.8 1.1 60.6 31.6 60.4 77.0 39.1 7.7 6.6 24.7 0.3 332.6 3.2 3.3 165.0 109.8 99.2 171.4 67.2 75.4 53.1 3.0 315.1 49.9 44.7 26.3 5.1 7.4 527.2 33.9 76.5 3.3 280.7 21.0 2.3 35.0 10.6 36.6 66.5 24.4 4.0 2.0 7.0 49.2 21.0 2.8 2.1 2.3 132.3 122.2 108.1 16.1 3.9 33.0 6.0 1.0 2.8 115.7 1.3 188.3 50.5 80.5 92.7 1.9 25.7 38.8 69.9 4.1 26.7 1.1 39.3 33.4 36.3 4.0 4.1 3.7 4.9 3.8 12.0 5.7 6.3 5.2 3.8 9.6 4.8 22.3 16.0 19.1 5.2 229.8 28.3 56.0 48.6 39.3 5.5 45.0 43.3 2.3 30.0 42.8 9.2 39.6 21.5 130.9 23.1 7.9 23.7 18.4 19.2 117.8 32.3 25.1 20.6 5.3 171.7 80.7 64.1 31.6 31.0 12.7 34.0 40.4 96.6 10.9 1.7 3.7 227.7 16.2 15.1 26.1 17.4 27.7 10.1 272.1 0.0 8.0 1.8 158.6 1.5 1.8 59.8 14.3 13.9 1153.9 111.8 14.1 18.0 43.3 14.6 6.6 10.8 88.7 12.0 9.8 23.0 21.3 42.3 145.3 37.5 49.7 45.0 FLT4 "PCL, VEGFR-3, VEGFR3" ENSG00000037280 "Fms related receptor tyrosine kinase 4" P35916 5 180601506-180649624 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Adipocytes: 27.4;Endothelial cells: 27.1;Extravillous trophoblasts: 37.1;Hepatic stellate cells: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "MAIT T-cell: 3.8" "Lineage enriched" "Detected in single" 31 "T-cells: 3.8" "Cell line enhanced" "Detected in some" "AN3-CA: 10.1;BEWO: 12.4;HEK 293: 15.6;HL-60: 9.5;HUVEC TERT2: 9.9;JURKAT: 12.3;T-47d: 14.6;TIME: 15.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000099, HPA046519, HPA067906, HPA074389" Approved Supported "Nuclear speckles,Plasma membrane,Cell Junctions" "Secreted to blood" NA NA 20000000 290000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nuclear speckles, Plasma membrane" "Cell Junctions" "CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: " "unprognostic (7.35e-2)" "unprognostic (1.63e-1)" "unprognostic (9.45e-3)" "unprognostic (3.81e-1)" "unprognostic (9.26e-2)" "unprognostic (3.20e-3)" "unprognostic (1.13e-2)" "unprognostic (1.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.70e-1)" "unprognostic (2.13e-2)" "unprognostic (3.69e-1)" "unprognostic (1.88e-2)" "unprognostic (9.41e-3)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (1.32e-1)" 17.2 11.3 3.5 4.7 4.6 0.8 14.7 2.6 3.4 9.0 2.6 4.9 2.8 8.0 3.0 4.4 9.8 3.8 9.7 5.1 2.6 20.1 6.2 16.9 5.5 3.4 3.0 4.5 2.0 2.3 7.8 6.4 3.6 5.6 1.3 0.3 2.0 2.5 4.7 4.0 7.2 4.1 2.8 17.6 3.5 3.1 4.2 1.0 25.7 4.1 1.4 5.6 5.5 2.7 0.1 2.5 3.2 10.1 0.0 0.0 12.4 0.3 0.1 0.0 0.0 0.4 0.3 0.3 0.9 0.1 0.6 0.4 3.4 0.2 0.3 0.1 15.6 1.2 0.5 0.5 0.1 9.5 0.3 0.2 0.1 0.2 0.4 0.3 9.9 12.3 0.4 0.4 2.1 5.6 0.1 0.5 7.0 0.3 0.6 8.2 0.1 0.1 0.1 0.3 0.3 1.1 0.1 0.2 0.1 3.1 14.6 0.3 15.7 0.2 6.9 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.5 0.0 3.8 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 3.5 4.6 2.6 3.4 5.1 2.6 3.4 3.0 3.6 2.8 4.2 2.7 27.4 0.0 1.7 0.7 0.7 0.9 0.2 0.0 1.2 0.2 1.4 1.4 4.5 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.1 27.1 0.0 0.0 0.2 0.0 37.1 0.8 0.0 0.1 2.5 2.4 64.6 0.6 1.2 0.0 0.1 0.0 0.0 3.3 0.8 0.7 0.3 0.6 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.2 0.0 0.7 0.7 0.1 5.2 0.1 1.1 1.0 1.8 0.2 0.0 0.1 FP565260.6 ENSG00000280433 "Novel protein, similar to trafficking protein particle complex 10 TRAPPC10" 21 5155499-5165472 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.3;Collecting duct cells: 3.7;Glandular and luminal cells: 2.4;Pancreatic endocrine cells: 3.9;Proximal tubular cells: 3.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (1.36e-1)" "unprognostic (2.11e-3)" "unprognostic (1.01e-1)" "unprognostic (2.05e-1)" "unprognostic (5.60e-2)" "unprognostic (7.47e-2)" "unprognostic (9.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.94e-1)" "unprognostic (3.23e-2)" "unprognostic (2.13e-3)" "unprognostic (7.46e-2)" "unprognostic (2.15e-2)" "unprognostic (1.17e-1)" "unprognostic (2.62e-2)" "unprognostic (7.41e-2)" "unprognostic (7.71e-6)" 6.5 6.2 12.7 5.1 13.3 4.9 5.6 12.9 20.1 5.3 12.1 10.5 6.7 5.5 7.2 6.7 5.1 4.3 6.6 12.9 12.9 10.6 10.6 6.3 12.3 13.1 13.1 4.9 6.0 5.8 8.2 3.3 13.2 5.6 7.5 7.2 5.6 3.0 6.2 6.4 11.9 3.0 12.6 15.2 6.9 6.3 12.9 10.0 8.2 3.8 5.4 5.0 5.1 14.3 7.0 2.1 5.8 4.0 6.7 3.9 3.5 2.3 2.4 1.0 2.0 1.2 3.3 3.3 2.2 5.7 7.4 4.3 5.6 3.8 2.1 2.3 2.9 12.0 3.9 5.2 6.3 9.2 8.6 6.2 8.7 4.6 4.8 4.3 5.8 4.8 5.8 3.8 4.8 6.2 4.8 16.6 7.4 8.3 3.3 4.8 2.8 3.7 10.4 6.1 4.2 7.6 4.2 7.7 8.7 2.6 5.3 16.6 3.7 4.5 3.1 0.9 7.0 3.3 3.8 6.1 4.3 12.6 3.1 0.2 0.1 1.2 1.9 0.4 3.9 1.5 1.0 1.8 0.2 1.2 0.9 1.2 0.6 2.0 0.9 0.4 0.3 0.7 12.7 13.3 12.9 20.1 12.9 12.9 13.1 13.1 13.2 12.6 12.9 14.3 0.8 0.0 3.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.2 0.6 0.0 0.0 1.8 3.7 0.0 1.1 2.1 0.0 0.0 1.3 0.0 1.3 1.2 0.9 0.0 0.0 0.0 1.3 0.6 0.8 0.0 2.4 0.0 0.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 3.1 2.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 1.0 0.5 0.0 0.0 FYCO1 "FLJ13335, ZFYVE7" ENSG00000163820 "FYVE and coiled-coil domain autophagy adaptor 1" Q9BQS8 3 45917899-45995824 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 263.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 89.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035526, HPA057966" Uncertain Enhanced Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 15: RT4 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" Vesicles "HPA035526: AB_10672867, HPA057966: AB_2683567" "unprognostic (2.45e-1)" "unprognostic (6.62e-2)" "unprognostic (6.97e-3)" "unprognostic (1.14e-3)" "unprognostic (7.65e-2)" "unprognostic (1.23e-2)" "unprognostic (1.57e-2)" "unprognostic (4.53e-3)" "unprognostic (5.85e-2)" "unprognostic (8.85e-2)" "unprognostic (2.36e-1)" "unprognostic (2.98e-1)" "prognostic favorable (3.33e-11)" "unprognostic (2.90e-1)" "unprognostic (1.42e-1)" "unprognostic (2.89e-2)" "unprognostic (6.99e-2)" 16.7 13.0 10.5 9.7 12.0 6.5 13.4 9.6 9.4 23.1 11.3 42.0 8.0 25.6 10.3 21.3 15.4 18.7 66.8 8.6 10.3 10.7 10.8 14.7 8.6 15.5 10.8 23.1 12.7 20.3 7.6 8.2 14.8 19.3 10.7 33.0 14.9 22.9 263.3 19.3 14.4 28.2 15.1 10.2 20.4 3.3 11.9 10.5 16.5 104.6 8.2 39.6 16.9 15.1 10.8 10.3 3.0 13.0 27.9 21.8 4.9 10.2 23.7 13.1 14.6 5.6 9.3 7.9 5.6 14.2 12.7 7.9 8.5 17.0 15.7 3.3 9.0 11.4 8.7 6.3 19.0 8.8 7.9 24.3 16.7 21.1 20.5 20.3 26.7 13.4 7.4 11.3 9.5 6.7 9.0 5.5 4.5 8.8 9.8 3.1 8.3 4.4 15.9 37.2 2.2 3.4 6.4 20.0 17.6 4.4 9.7 5.7 20.8 5.0 5.9 17.0 5.7 6.4 4.4 2.7 17.2 11.1 9.6 0.7 0.5 0.3 2.0 0.5 2.7 0.2 1.2 2.1 0.2 0.2 0.5 0.7 0.4 1.5 0.3 1.3 1.2 0.7 10.5 12.0 9.6 9.4 8.6 10.3 15.5 10.8 14.8 15.1 11.9 15.1 9.5 28.9 13.7 12.4 4.8 4.1 4.8 5.6 3.4 11.2 8.5 4.8 89.3 8.6 13.0 16.5 35.5 4.3 8.7 6.8 3.9 8.8 0.1 6.4 8.9 9.3 9.6 6.9 0.8 8.3 2.2 14.0 12.8 11.2 2.5 14.9 11.4 9.2 4.1 0.0 0.8 7.6 2.0 5.8 4.6 1.6 12.8 5.1 10.6 10.3 4.0 20.0 6.2 8.0 21.2 11.0 2.5 17.7 3.0 17.3 8.7 6.2 18.6 37.1 6.6 20.8 12.8 2.3 0.8 8.4 4.1 2.9 12.7 6.1 6.2 7.9 FYN "MGC45350, SLK, SYN" ENSG00000010810 "FYN proto-oncogene, Src family tyrosine kinase" P06241 6 111660332-111873452 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Developmental protein, Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 382.6;dendritic cells: 291.6;NK-cells: 228.6;Oligodendrocyte precursor cells: 342.8;Proximal tubular cells: 212.2;T-cells: 275.8" "Cancer enhanced" "Detected in all" "glioma: 42.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 16 "NK-cells: 69.0;T-cells: 174.8" "Cell line enhanced" "Detected in many" "U-2197: 538.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005034, CAB018387, HPA023887, HPA063770" Approved Enhanced "Plasma membrane,Cytosol" NA NA 820000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane" Cytosol "CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: AB_2685119" "unprognostic (8.62e-3)" "unprognostic (8.25e-2)" "unprognostic (2.11e-1)" "unprognostic (2.00e-2)" "unprognostic (1.51e-1)" "unprognostic (2.43e-2)" "prognostic favorable (1.84e-4)" "unprognostic (4.60e-2)" "unprognostic (2.89e-2)" "unprognostic (2.92e-1)" "prognostic favorable (4.78e-4)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.43e-4)" "unprognostic (6.95e-2)" "unprognostic (3.10e-1)" "unprognostic (6.62e-3)" "unprognostic (2.40e-1)" 76.6 10.8 117.1 52.4 106.4 32.3 46.8 83.8 104.3 45.5 33.3 32.9 16.4 45.6 33.8 16.0 51.4 32.1 40.5 102.1 121.5 23.9 20.4 63.5 108.9 136.3 104.9 28.8 8.5 18.7 22.9 29.7 107.0 17.6 15.6 26.9 12.9 12.5 12.3 41.5 47.1 38.0 109.9 71.9 29.3 16.5 105.7 86.1 45.7 18.3 67.6 48.4 33.4 109.8 10.4 1.5 178.6 30.2 133.4 81.4 3.2 29.1 90.8 24.2 42.9 1.3 1.6 21.0 18.3 56.1 21.0 1.3 25.8 39.9 46.8 0.7 66.5 57.0 13.6 2.7 78.7 19.5 19.0 78.8 59.1 90.5 76.8 62.9 99.5 99.6 4.9 140.3 86.8 1.5 92.7 17.9 26.0 3.3 18.0 29.1 24.0 1.4 0.0 9.1 124.6 50.7 5.7 2.4 124.7 39.6 1.3 57.0 63.9 72.3 13.5 538.7 18.5 20.0 19.7 32.5 136.0 44.3 128.9 1.1 6.4 0.2 137.0 5.6 174.8 4.8 83.9 152.7 7.4 6.4 27.9 72.3 3.0 69.0 4.2 4.3 79.2 51.5 117.1 106.4 83.8 104.3 102.1 121.5 136.3 104.9 107.0 109.9 105.7 109.8 87.8 0.0 8.3 382.6 26.0 17.1 2.5 0.6 1.8 57.2 2.9 6.9 11.3 14.3 2.1 7.3 0.0 2.7 291.6 1.2 17.6 9.3 3.7 5.6 51.7 70.3 13.2 20.9 118.7 1.0 2.4 61.9 17.9 4.9 52.0 20.9 76.4 60.3 3.0 47.1 127.6 3.8 2.0 35.8 96.1 3.2 26.4 42.7 37.4 88.1 64.5 89.1 228.6 342.8 162.3 9.7 0.1 7.2 96.2 3.9 17.7 212.2 4.4 8.3 13.1 48.8 32.9 3.9 8.6 0.7 13.4 52.0 275.8 71.1 2.9 1.1 GFPT2 GFAT2 ENSG00000131459 "Glutamine-fructose-6-phosphate transaminase 2" O94808 5 180300698-180353336 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 112.4" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 30.4;Fibroblasts: 77.9;Skeletal myocytes: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 3.5" "Lineage enriched" "Detected in single" 35 "T-cells: 3.5" "Cell line enhanced" "Detected in many" "ASC diff: 119.1;ASC TERT1: 202.3;GAMG: 152.5;HSkMC: 130.7;hTEC/SVTERT24-B: 248.0;U-87 MG: 426.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056892, HPA059910" Uncertain Approved Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 50: Fibroblasts - ECM organization" Vesicles "HPA056892: AB_2683266, HPA059910: AB_2684157" "unprognostic (3.48e-1)" "prognostic unfavorable (9.09e-4)" "unprognostic (1.91e-2)" "unprognostic (1.08e-2)" "unprognostic (6.28e-2)" "unprognostic (3.39e-3)" "unprognostic (3.05e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (7.65e-2)" "unprognostic (2.73e-2)" "unprognostic (4.50e-2)" "unprognostic (2.94e-2)" "prognostic unfavorable (2.58e-14)" "unprognostic (3.67e-3)" "unprognostic (1.23e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (1.52e-3)" 112.4 7.0 14.2 18.6 14.8 0.1 23.0 19.7 17.6 24.8 14.1 18.0 1.6 15.9 7.7 5.7 35.8 16.4 27.8 14.9 16.8 6.8 2.1 25.2 2.8 27.8 15.7 33.4 12.4 4.6 5.1 6.5 21.5 15.6 3.2 2.9 7.1 8.2 4.6 8.4 11.3 11.3 16.8 1.9 14.6 8.6 15.7 1.2 10.8 7.1 3.5 38.3 17.9 20.4 0.1 27.7 21.5 28.0 119.1 202.3 2.3 3.5 0.7 2.3 0.8 0.7 0.1 0.0 1.4 23.2 152.5 0.4 11.8 0.2 1.4 2.6 4.2 0.0 13.7 0.0 49.4 0.0 0.2 130.7 1.0 248.0 0.7 41.7 40.7 1.0 0.0 0.4 107.7 4.2 0.1 0.0 45.7 0.3 12.3 0.6 0.2 0.0 0.0 0.0 1.0 1.6 43.0 0.8 1.4 25.0 1.9 0.3 19.5 67.9 10.7 44.3 52.2 0.1 0.1 0.0 426.7 0.0 1.5 0.0 0.0 0.0 0.7 0.0 3.5 0.0 0.3 1.2 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 14.2 14.8 19.7 17.6 14.9 16.8 27.8 15.7 21.5 16.8 15.7 20.4 4.1 3.2 4.8 13.4 0.8 7.4 0.4 0.2 3.4 0.0 3.2 6.3 3.0 5.7 3.2 1.8 0.0 1.1 3.5 0.4 1.9 1.0 5.7 2.0 30.4 1.9 0.0 0.0 20.0 0.8 0.5 77.9 6.6 1.9 1.3 0.4 1.4 0.0 0.5 0.0 12.1 0.5 0.0 0.3 9.6 3.5 10.2 1.7 8.8 4.7 0.0 6.1 0.0 10.6 6.5 0.4 0.0 18.8 2.5 1.7 0.0 0.4 1.5 0.1 0.0 27.3 17.6 10.1 8.3 1.7 4.3 2.7 8.9 0.0 0.1 0.6 GML LY6DL ENSG00000104499 "Glycosylphosphatidylinositol anchored molecule like" Q99445 8 142834247-142916506 "Predicted intracellular proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 56 "adrenal gland: 194.0" "Cell type enhanced" "Detected in some" "granulocytes: 4.5;Sertoli cells: 6.6;Spermatocytes: 24.2;Spermatogonia: 7.5" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 2.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" 0.0 194.0 0.0 0.2 2.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 24.2 7.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GNPDA1 "GNPDA, GNPI, GPI, HLN, KIAA0060" ENSG00000113552 "Glucosamine-6-phosphate deaminase 1" P46926 5 141991749-142013041 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 127.2;Proximal tubular cells: 102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 382.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000499, HPA046891" Uncertain Approved "Golgi apparatus,Vesicles" NA NA 930000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 4: Macrophages - Innate immune response" Vesicles "Golgi apparatus" "HPA000499: AB_1079005, HPA046891: AB_2679857" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (6.79e-2)" "unprognostic (1.04e-1)" "unprognostic (9.51e-2)" "unprognostic (8.89e-3)" "prognostic unfavorable (2.60e-6)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (3.45e-1)" "unprognostic (3.09e-1)" "unprognostic (1.58e-1)" "unprognostic (2.61e-1)" "unprognostic (1.16e-1)" "unprognostic (5.82e-2)" "unprognostic (9.66e-2)" "unprognostic (2.05e-3)" 18.8 38.4 26.9 17.3 28.8 8.1 20.9 26.2 35.2 26.7 27.7 19.7 29.5 28.7 51.9 13.6 18.4 22.3 17.3 28.1 30.8 76.4 16.6 17.6 22.7 27.0 27.7 31.8 11.3 27.9 20.5 22.2 29.3 22.2 21.9 17.7 14.6 28.3 26.4 14.8 22.5 29.2 27.0 30.9 14.5 18.8 29.7 24.9 27.8 25.7 19.8 33.3 17.1 30.7 42.6 61.0 23.2 115.8 77.1 51.9 54.6 32.6 78.7 84.7 95.8 91.3 49.2 0.2 72.9 23.6 382.3 44.0 109.9 98.0 74.8 32.9 46.5 31.3 33.1 65.5 137.2 86.4 39.2 63.5 56.9 54.5 144.8 63.2 91.6 80.6 37.3 110.1 93.0 27.2 66.8 9.8 88.0 62.8 121.4 25.5 76.3 94.3 81.8 114.8 20.6 54.0 65.0 67.8 127.9 67.5 54.6 26.5 43.3 50.9 33.3 76.9 47.5 61.2 126.9 47.1 74.2 29.3 45.0 0.3 48.6 7.1 37.2 59.1 77.9 19.4 30.0 34.2 51.7 11.1 35.3 38.8 12.7 15.8 56.3 29.6 27.6 40.2 26.9 28.8 26.2 35.2 28.1 30.8 27.0 27.7 29.3 27.0 29.7 30.7 10.5 9.6 14.9 10.7 8.2 6.0 40.8 20.9 21.1 11.6 12.6 17.8 12.6 12.8 20.1 18.4 8.4 26.7 11.1 6.9 35.2 29.3 1.1 5.8 19.8 14.6 15.0 9.9 11.5 14.2 48.6 22.8 7.7 9.6 12.0 30.8 15.4 7.4 127.2 6.7 12.7 6.2 12.2 60.2 10.7 3.6 19.9 48.5 14.2 12.2 23.5 40.5 15.5 7.1 11.5 21.6 7.1 26.7 7.8 32.9 19.4 102.3 8.0 7.9 0.0 10.4 11.7 10.4 17.0 17.6 7.4 29.7 16.6 64.8 9.1 34.7 GPHN KIAA1385 ENSG00000171723 Gephyrin Q9NQX3 14 66507407-67181803 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" "Multifunctional enzyme, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 62.4" "Group enriched" "Detected in many" 4 "Astrocytes: 493.0;Excitatory neurons: 686.5;Inhibitory neurons: 866.7;Oligodendrocyte precursor cells: 576.1;Oligodendrocytes: 597.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003116, CAB004419, HPA024694" Enhanced Approved Vesicles,Cytosol NA NA 6900 "Cluster 16: MAIT-cells - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles Cytosol "CAB004419: AB_627670, HPA003116: AB_1078963, HPA024694: AB_1849616" "unprognostic (8.37e-2)" "unprognostic (2.53e-2)" "unprognostic (2.42e-1)" "unprognostic (1.20e-1)" "unprognostic (5.14e-2)" "unprognostic (4.89e-3)" "unprognostic (8.29e-2)" "unprognostic (1.41e-2)" "unprognostic (1.42e-1)" "unprognostic (2.23e-1)" "unprognostic (2.49e-2)" "unprognostic (8.54e-2)" "prognostic favorable (5.25e-12)" "unprognostic (9.81e-2)" "unprognostic (2.27e-1)" "unprognostic (7.50e-2)" "prognostic unfavorable (4.61e-5)" 13.8 11.1 35.5 3.5 36.0 2.6 13.4 48.4 54.1 9.7 20.9 11.8 7.4 9.9 11.6 12.2 11.1 6.2 17.1 36.1 37.6 25.3 62.4 9.3 3.8 32.7 35.3 8.9 23.9 11.7 13.6 3.6 32.3 11.3 10.1 23.1 9.4 6.6 24.5 15.2 9.0 6.2 32.4 6.7 14.7 6.2 34.6 5.8 11.9 13.8 4.3 11.4 10.7 39.5 39.9 8.8 13.7 15.9 14.2 17.5 9.5 11.1 5.7 12.7 12.2 2.8 17.9 0.0 1.8 7.7 5.5 13.1 17.0 19.9 18.9 15.0 14.9 15.8 9.4 22.3 7.8 9.1 15.8 13.3 13.8 2.9 16.0 4.8 11.8 13.8 9.3 14.2 7.1 19.2 11.9 22.2 5.0 28.3 17.0 0.0 32.5 13.2 16.7 7.5 25.8 10.3 10.2 31.6 12.4 3.3 18.5 11.5 6.7 14.1 24.8 11.3 13.0 22.8 9.1 0.3 10.5 0.8 11.2 0.0 0.7 0.3 2.0 1.2 3.2 1.2 2.5 1.7 1.1 1.9 1.7 1.6 0.0 1.3 1.0 1.5 3.0 0.7 35.5 36.0 48.4 54.1 36.1 37.6 32.7 35.3 32.3 32.4 34.6 39.5 11.5 6.4 13.1 493.0 11.8 4.7 9.2 5.8 27.9 34.3 12.4 6.7 12.7 8.6 10.8 1.8 52.1 3.9 3.5 8.6 13.7 4.0 3.8 7.2 13.5 10.7 6.0 7.6 686.5 5.3 2.3 8.7 19.9 13.6 0.0 3.9 15.7 47.6 3.7 43.7 866.7 15.0 8.2 5.8 1.7 5.0 11.1 4.5 1.8 148.0 1.3 8.9 1.0 576.1 597.5 3.1 7.8 5.7 15.1 11.5 7.1 20.1 2.4 34.9 0.0 12.5 11.8 11.8 8.9 26.7 5.8 2.1 7.9 9.0 10.4 6.5 GPR137C "DKFZp762F0713, TM7SF1L2" ENSG00000180998 "G protein-coupled receptor 137C" Q8N3F9 14 52552836-52637713 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 14.6;epididymis: 8.1;retina: 17.3" "Group enriched" "Detected in many" 5 "Excitatory neurons: 85.5;Inhibitory neurons: 125.4;Oligodendrocyte precursor cells: 101.6;Oligodendrocytes: 137.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 9 "NK-cells: 1.5;T-cells: 1.4" "Cell line enhanced" "Detected in many" "SH-SY5Y: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003640, HPA030763" Uncertain Approved Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA003640: AB_2667025, HPA030763: AB_10602352" "unprognostic (1.39e-1)" "unprognostic (1.45e-1)" "unprognostic (1.23e-1)" "unprognostic (6.84e-2)" "unprognostic (8.50e-3)" "unprognostic (7.34e-3)" "unprognostic (5.95e-3)" "unprognostic (2.32e-2)" "unprognostic (4.41e-2)" "unprognostic (8.42e-4)" "unprognostic (2.20e-2)" "unprognostic (1.04e-1)" "unprognostic (7.88e-2)" "unprognostic (4.08e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.60e-1)" 0.5 0.7 5.3 0.2 3.8 0.9 0.5 14.6 7.2 0.6 0.0 0.4 0.7 0.8 8.1 0.4 0.3 1.1 1.0 4.0 5.5 0.4 0.6 0.8 0.4 5.9 5.9 0.7 0.2 0.4 1.5 0.4 5.0 0.7 0.4 17.3 0.2 0.4 0.5 0.2 0.3 0.4 2.4 1.0 0.4 2.9 8.4 0.3 0.6 0.6 0.1 0.4 0.3 7.7 0.8 0.3 6.6 6.4 1.7 0.6 2.7 3.3 2.2 3.2 7.8 0.9 1.4 0.2 1.9 2.2 6.5 1.5 2.5 0.5 4.5 0.4 1.7 0.3 1.5 0.4 0.1 0.1 1.1 0.4 0.0 2.8 0.2 0.6 1.5 1.1 0.9 2.3 4.4 3.8 0.1 0.6 1.1 0.4 4.1 1.2 4.3 0.3 1.0 4.8 7.4 9.1 1.3 0.2 0.1 2.7 4.4 0.0 0.0 6.8 7.6 5.5 2.3 0.4 1.6 0.8 1.5 0.1 1.9 0.0 0.0 0.0 1.0 0.0 1.4 0.0 0.5 1.4 0.0 0.0 0.3 0.5 0.1 1.5 0.1 0.0 0.5 0.2 5.3 3.8 14.6 7.2 4.0 5.5 5.9 5.9 5.0 2.4 8.4 7.7 2.8 0.0 1.3 20.2 0.7 0.6 0.7 0.1 2.2 22.4 1.4 1.4 2.5 1.5 0.1 0.0 2.1 0.3 0.4 0.4 0.0 0.3 2.3 3.4 1.6 3.8 1.2 0.0 85.5 0.2 0.3 1.9 1.1 6.2 0.0 5.6 2.2 0.5 0.5 6.7 125.4 0.7 0.0 2.2 0.8 1.5 0.6 0.9 1.8 21.5 0.2 5.4 1.0 101.6 137.4 0.0 0.0 0.7 1.0 1.8 0.1 0.2 0.1 20.2 0.0 1.1 1.7 6.9 5.1 1.3 0.9 0.1 1.2 1.2 0.1 0.5 GPR171 H963 ENSG00000174946 "G protein-coupled receptor 171" O14626 3 151197832-151203216 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.3" "Cell type enriched" "Detected in some" 4 "T-cells: 107.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 110.3" "Lineage enriched" "Detected in many" 15 "T-cells: 110.3" "Cell line enriched" "Detected in some" 25 "U-266/70: 27.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA067323 Supported NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA067323: " "unprognostic (6.82e-6)" "unprognostic (4.90e-3)" "unprognostic (7.10e-2)" "unprognostic (6.85e-4)" "unprognostic (2.80e-3)" "unprognostic (1.04e-3)" "unprognostic (4.19e-4)" "unprognostic (6.09e-2)" "unprognostic (4.93e-3)" "unprognostic (1.01e-3)" "unprognostic (8.84e-2)" "unprognostic (1.08e-1)" "unprognostic (4.72e-6)" "unprognostic (1.31e-1)" "unprognostic (4.17e-2)" "unprognostic (4.58e-2)" "unprognostic (1.02e-2)" 3.7 1.6 0.5 21.3 1.5 1.2 1.9 1.7 3.8 4.3 12.3 4.3 4.5 1.5 0.5 2.5 3.0 6.2 0.9 1.1 0.4 1.3 4.3 6.4 17.4 2.5 0.7 0.8 0.7 0.2 0.5 0.5 0.7 1.9 4.6 0.0 1.7 0.8 0.2 0.9 12.9 1.1 0.1 13.0 5.9 0.3 1.1 13.0 1.8 0.1 11.3 9.3 2.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.1 0.0 0.0 0.2 0.0 0.2 0.3 3.5 27.9 0.2 110.3 0.0 40.2 53.5 2.3 0.5 24.1 21.1 0.8 7.3 0.5 2.2 21.4 9.4 0.5 1.5 1.7 3.8 1.1 0.4 2.5 0.7 0.7 0.1 1.1 1.2 0.4 0.0 2.2 0.3 2.3 1.1 0.4 0.0 0.6 4.8 0.3 0.3 1.0 0.0 1.3 0.0 2.1 0.4 25.8 0.1 0.0 0.0 0.2 0.1 0.6 0.5 0.0 2.7 0.8 0.0 0.0 2.3 4.6 0.1 2.5 0.0 1.8 1.6 0.1 21.9 0.3 0.5 0.0 2.2 8.1 0.1 0.0 4.8 0.0 0.0 14.0 5.7 6.2 0.5 0.0 0.0 0.0 0.0 14.9 0.2 0.0 0.5 0.0 0.1 0.0 0.5 1.2 0.8 0.7 0.1 0.6 0.7 107.6 0.1 0.0 0.3 GPR180 ITR ENSG00000152749 "G protein-coupled receptor 180" Q86V85 13 94601857-94634661 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047250 Approved Approved Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "HPA047250: AB_2679998" "unprognostic (3.91e-3)" "unprognostic (3.28e-1)" "unprognostic (4.16e-3)" "unprognostic (2.95e-1)" "unprognostic (1.17e-2)" "unprognostic (1.40e-1)" "unprognostic (3.75e-3)" "unprognostic (2.57e-2)" "unprognostic (2.89e-2)" "unprognostic (6.71e-2)" "unprognostic (1.47e-1)" "unprognostic (2.86e-2)" "prognostic unfavorable (3.18e-5)" "unprognostic (2.49e-2)" "unprognostic (1.10e-1)" "unprognostic (8.47e-2)" "unprognostic (2.80e-2)" 5.8 2.3 3.0 2.4 3.6 0.9 2.6 4.5 4.5 2.7 4.1 2.1 2.0 2.4 1.8 1.7 2.5 1.8 1.8 3.4 3.2 2.5 6.9 2.4 2.4 2.8 3.0 2.4 3.1 2.5 3.5 3.6 3.1 2.5 2.5 7.0 2.8 2.3 1.8 1.9 1.6 2.8 3.6 2.2 2.7 1.1 3.2 2.6 3.6 1.8 2.6 2.3 1.5 3.6 14.6 3.6 5.1 5.4 10.5 11.4 2.1 9.7 7.7 9.3 12.3 4.4 9.8 4.8 4.1 8.4 6.4 9.0 7.3 6.9 12.7 12.7 4.6 9.4 4.9 0.0 8.3 13.6 7.3 6.5 5.8 5.7 7.7 8.3 9.6 6.8 2.7 2.3 9.3 2.1 6.9 3.0 3.3 10.4 4.0 7.8 6.8 2.0 10.4 4.3 7.4 5.3 4.5 9.9 12.2 6.4 7.0 5.5 8.7 5.7 4.6 6.8 8.2 3.8 4.2 2.2 9.5 10.9 7.9 0.1 0.5 0.1 0.8 0.3 1.4 0.5 0.9 0.6 0.9 0.5 1.1 0.9 0.0 0.5 0.4 0.6 1.2 0.4 3.0 3.6 4.5 4.5 3.4 3.2 2.8 3.0 3.1 3.6 3.2 3.6 9.0 3.2 4.1 20.2 6.1 6.0 5.4 11.2 7.4 12.5 7.4 5.5 6.8 7.2 7.8 12.9 31.3 8.7 9.3 3.8 5.9 8.3 1.0 11.1 8.9 8.3 10.3 3.6 47.6 10.2 27.8 11.8 9.7 9.0 5.1 9.2 9.7 30.8 10.5 18.5 30.5 9.8 6.1 4.4 4.9 0.7 9.6 5.3 7.2 18.7 4.1 15.4 9.2 40.7 26.3 9.6 3.7 5.7 16.0 10.6 3.0 7.5 16.8 22.0 6.6 6.3 10.6 3.5 10.6 6.4 4.7 4.1 6.6 3.6 5.5 5.0 GPR65 "hTDAG8, TDAG8" ENSG00000140030 "G protein-coupled receptor 65" Q8IYL9 14 88005135-88014811 "G-protein coupled receptors, Predicted membrane proteins" Apoptosis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.6;lymphoid tissue: 9.6" "Cell type enhanced" "Detected in many" "dendritic cells: 256.1;granulocytes: 317.8;Kupffer cells: 112.5;monocytes: 90.9;NK-cells: 319.3;T-cells: 192.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 5.7;HEL: 6.2;HL-60: 7.5;HMC-1: 9.0;RH-30: 11.5" "Not detected" "Not detected" "HPA072624, HPA077397" Enhanced Approved Nucleoli,Vesicles,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "Nucleoli, Cytosol" "HPA072624: , HPA077397: " "unprognostic (8.56e-2)" "unprognostic (8.65e-3)" "unprognostic (1.98e-3)" "unprognostic (3.59e-3)" "unprognostic (3.10e-1)" "unprognostic (3.55e-3)" "unprognostic (1.15e-1)" "unprognostic (3.01e-2)" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (4.99e-4)" "unprognostic (3.79e-1)" "unprognostic (4.46e-3)" "unprognostic (9.03e-2)" "unprognostic (3.80e-1)" 2.0 1.1 0.5 9.1 0.6 12.6 0.9 0.5 0.8 1.1 0.6 1.2 1.6 0.7 0.4 0.9 0.7 2.8 0.6 0.4 1.0 0.8 2.7 4.3 8.8 1.9 1.0 0.3 0.4 0.4 0.4 1.7 1.6 0.8 1.5 0.1 0.7 0.5 0.2 0.3 2.4 2.3 1.0 9.6 1.6 0.6 1.2 4.2 0.4 0.5 6.6 3.4 0.5 2.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.2 0.0 0.0 0.2 7.5 9.0 0.3 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.2 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 39.0 19.8 43.6 33.8 28.4 62.4 9.3 16.9 26.2 13.0 8.1 8.6 19.4 15.2 49.1 32.1 5.9 9.0 24.5 0.5 0.6 0.5 0.8 0.4 1.0 1.9 1.0 1.6 1.0 1.2 2.3 2.9 3.2 21.6 0.3 77.8 4.2 0.5 0.0 0.0 0.2 1.9 3.2 0.4 7.2 1.3 0.0 0.0 0.2 256.1 0.5 0.0 0.0 9.1 0.2 0.4 2.1 0.0 6.6 0.0 0.0 0.3 2.3 6.6 0.5 317.8 0.0 3.9 1.4 62.8 0.0 0.0 0.6 0.0 112.5 73.1 1.4 0.6 88.6 3.6 4.7 90.9 0.0 319.3 0.0 0.1 0.0 0.0 0.0 25.6 0.2 0.1 0.3 0.7 0.2 0.0 0.9 2.0 0.1 0.1 0.7 5.3 0.4 192.8 0.9 0.4 0.2 GPRIN3 "FLJ42625, GRIN3" ENSG00000185477 "GPRIN family member 3" Q6ZVF9 4 89236383-89307800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.8" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 78.7;Macrophages: 53.9;Sertoli cells: 78.9;T-cells: 76.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 102.6;RPMI-8226: 27.7;SCLC-21H: 27.2;U-266/70: 15.9;U-266/84: 13.2" "Region enhanced" "Detected in many" "basal ganglia: 16.2" "HPA043148, HPA057666, HPA059092" Enhanced Approved Nucleoplasm,Nucleoli No NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoli Nucleoplasm "HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902" "unprognostic (9.05e-2)" "unprognostic (4.92e-2)" "prognostic favorable (7.22e-5)" "unprognostic (2.89e-2)" "unprognostic (1.78e-1)" "unprognostic (1.07e-3)" "unprognostic (3.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.34e-3)" "unprognostic (3.13e-1)" "prognostic favorable (8.33e-4)" "unprognostic (1.91e-1)" "unprognostic (5.35e-2)" "unprognostic (3.93e-1)" "unprognostic (7.82e-4)" 2.7 1.2 4.1 9.0 9.5 7.8 1.4 17.8 3.1 2.2 0.9 5.3 6.2 1.4 0.7 0.9 0.9 3.5 4.0 2.2 7.3 3.9 2.0 6.9 10.2 4.3 6.5 3.2 5.1 0.6 2.9 1.0 4.5 0.8 7.1 3.5 1.5 0.6 1.0 0.6 5.3 1.4 4.1 7.1 3.6 0.4 5.0 2.8 1.3 3.2 7.9 2.7 1.0 5.9 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.4 0.0 0.0 0.0 2.8 0.1 2.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 102.6 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.7 0.0 27.7 0.3 0.1 27.2 0.6 0.0 0.1 1.1 1.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 15.9 13.2 0.1 0.5 0.0 0.0 0.0 0.3 0.0 2.8 1.0 3.8 0.2 2.7 2.2 0.9 0.0 1.1 1.1 0.0 1.9 1.5 0.0 3.4 1.0 4.1 9.5 17.8 3.1 2.2 7.3 4.3 6.5 4.5 4.1 5.0 5.9 11.1 0.0 22.6 10.1 6.7 1.1 0.9 0.1 0.0 12.2 1.6 1.7 20.3 8.6 5.0 3.7 0.0 0.2 51.2 17.4 1.9 2.0 0.2 5.8 3.4 11.7 78.7 6.5 21.7 9.4 0.1 3.0 15.8 15.0 7.6 12.2 1.8 0.4 18.7 26.9 32.7 38.0 0.0 28.2 29.0 0.0 0.3 53.9 1.8 41.2 7.4 1.0 23.7 26.2 0.5 1.3 11.0 1.2 48.6 0.3 16.3 1.9 0.7 10.8 78.9 3.3 32.7 0.1 0.8 0.3 1.0 0.3 76.9 0.7 26.2 0.5 GRAMD2B "FLJ21313, GRAMD3, NS3TP2" ENSG00000155324 "GRAM domain containing 2B" Q96HH9 5 126360132-126496494 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 73.2;Club cells: 45.8;Endometrial ciliated cells: 51.8;Endometrial stromal cells: 49.0;Extravillous trophoblasts: 46.5;Glandular and luminal cells: 153.2;Respiratory ciliated cells: 48.8;Syncytiotrophoblasts: 58.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.9;MAIT T-cell: 2.8;memory CD4 T-cell: 1.6;memory CD8 T-cell: 2.3;myeloid DC: 1.7;naive CD4 T-cell: 3.0;naive CD8 T-cell: 1.8;NK-cell: 1.1;plasmacytoid DC: 4.3;T-reg: 2.4" "Group enriched" "Detected in many" 6 "dendritic cells: 4.3;NK-cells: 1.1;T-cells: 3.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 114.1;CAPAN-2: 73.6;fHDF/TERT166: 75.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009678, HPA010095" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 44: Endometrium - Transcription" Cytosol "Nucleoplasm, Golgi apparatus" "HPA009678: AB_2112580, HPA010095: AB_1849952" "unprognostic (2.34e-1)" "unprognostic (4.01e-1)" "unprognostic (4.63e-2)" "unprognostic (3.42e-2)" "unprognostic (6.82e-2)" "unprognostic (1.95e-2)" "unprognostic (6.76e-2)" "unprognostic (3.84e-2)" "unprognostic (9.90e-2)" "unprognostic (7.42e-2)" "unprognostic (2.09e-2)" "unprognostic (3.78e-1)" "unprognostic (2.20e-3)" "unprognostic (3.56e-3)" "unprognostic (2.39e-1)" "unprognostic (9.24e-2)" "unprognostic (1.12e-2)" 12.8 16.0 56.5 6.9 57.1 1.6 38.7 54.1 55.1 32.2 47.7 28.6 29.6 29.4 15.5 8.9 34.3 10.9 11.7 49.4 54.6 32.9 24.4 11.3 7.4 61.3 64.7 30.3 8.9 8.7 10.0 24.7 55.2 16.9 29.8 6.6 23.1 23.7 3.8 27.3 36.0 22.1 64.9 6.1 16.4 4.1 54.0 13.2 40.4 5.6 11.2 13.8 16.3 60.5 66.1 3.7 3.0 14.6 62.4 21.5 19.4 71.2 114.1 28.7 37.2 2.6 73.6 0.0 26.4 75.4 0.7 17.5 0.9 27.6 30.9 6.1 4.8 3.1 8.2 3.9 14.2 0.0 2.3 34.6 10.4 29.2 9.4 36.4 0.2 0.0 0.0 0.0 50.7 6.7 0.0 0.9 3.1 13.7 4.6 1.3 17.6 14.3 38.8 69.1 1.1 0.1 11.9 6.0 21.2 12.8 22.9 4.2 6.6 6.6 2.1 11.6 12.7 3.9 3.5 0.1 1.4 0.0 19.2 0.2 0.4 0.0 2.9 0.4 2.8 0.5 1.6 2.3 1.7 0.2 3.0 1.8 0.3 1.1 0.3 4.3 2.4 1.2 56.5 57.1 54.1 55.1 49.4 54.6 61.3 64.7 55.2 64.9 54.0 60.5 10.2 16.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 25.5 73.2 0.0 0.0 45.8 40.5 0.0 32.3 10.0 0.0 23.5 14.1 0.0 51.8 49.0 3.2 0.0 0.0 0.0 8.7 46.5 8.7 0.0 153.2 3.8 4.9 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 2.8 0.0 0.0 18.3 48.8 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 58.6 4.7 2.8 0.0 0.0 GREM2 "CKTSF1B2, DAND3, FLJ21195, Prdc" ENSG00000180875 "Gremlin 2, DAN family BMP antagonist" Q9H772 1 240489573-240612155 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Cytokine, Developmental protein, Heparin-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 31.4;liver: 26.3" "Cell type enriched" "Detected in many" 9 "Syncytiotrophoblasts: 298.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "fHDF/TERT166: 32.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB009920 Approved "Secreted to blood" NA NA 12000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "CAB009920: AB_2279266" "unprognostic (2.01e-1)" "unprognostic (2.49e-1)" "unprognostic (7.41e-2)" "unprognostic (7.58e-3)" "unprognostic (2.82e-3)" "unprognostic (1.34e-1)" "unprognostic (8.18e-2)" "unprognostic (1.90e-1)" "unprognostic (1.31e-2)" "unprognostic (6.40e-2)" "unprognostic (2.78e-1)" "unprognostic (1.97e-2)" "unprognostic (3.07e-8)" "unprognostic (1.22e-1)" "unprognostic (2.36e-1)" "unprognostic (5.13e-2)" "unprognostic (1.38e-2)" 0.8 1.7 2.1 9.7 2.9 0.1 3.4 0.1 6.1 0.9 0.0 17.1 10.8 9.6 2.2 17.1 1.4 31.4 0.0 1.3 1.8 2.3 26.3 1.2 0.2 2.1 1.7 6.6 0.2 22.9 2.1 4.0 1.9 2.6 20.1 5.8 4.2 1.8 7.3 3.6 14.9 6.4 1.3 3.2 9.3 0.3 2.8 0.3 0.5 0.7 0.2 3.8 0.5 2.0 0.0 0.0 0.1 0.0 1.9 2.4 0.0 6.1 6.5 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 2.2 0.0 2.8 1.3 0.0 0.0 3.9 0.5 0.8 0.4 1.0 0.0 0.0 3.3 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 2.9 0.1 6.1 1.3 1.8 2.1 1.7 1.9 1.3 2.8 2.0 0.2 0.0 0.0 0.3 0.2 4.7 0.0 0.0 0.6 20.8 14.0 0.1 0.6 0.0 0.0 0.0 12.5 7.4 0.6 0.6 0.0 0.0 0.0 2.3 1.2 0.6 1.2 0.0 28.6 0.0 1.7 17.4 0.0 13.7 0.0 0.1 0.7 20.4 1.5 0.0 30.5 0.1 0.0 0.3 6.2 0.2 0.0 0.2 1.8 3.7 0.0 0.4 1.0 1.5 1.2 0.1 0.1 4.5 0.1 0.6 0.0 0.0 0.7 6.7 0.0 0.2 1.4 2.4 2.7 0.6 3.7 298.0 1.6 2.3 0.6 0.1 GSDMA "FLJ39120, GSDM, GSDM1" ENSG00000167914 "Gasdermin A" Q96QA5 17 39953263-39977768 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 58.9" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.7;Hofbauer cells: 5.0;Kupffer cells: 5.6;Macrophages: 2.6;Suprabasal keratinocytes: 2.7;Theca cells: 2.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.6" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HBEC3-KT: 4.1;hTCEpi: 2.7;hTERT-HME1: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023313, HPA064826" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA 44000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 30: Epithelial cell lines - Translation" "Cluster 4: Macrophages - Innate immune response" "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA023313: AB_1850378, HPA064826: AB_2685361" "unprognostic (1.32e-2)" "unprognostic (2.01e-1)" "unprognostic (2.95e-2)" "unprognostic (1.06e-1)" "unprognostic (3.62e-1)" "unprognostic (1.97e-1)" "unprognostic (7.77e-2)" "unprognostic (1.39e-1)" "unprognostic (3.24e-1)" "unprognostic (3.52e-2)" "unprognostic (2.71e-1)" "unprognostic (2.90e-2)" "unprognostic (1.06e-2)" "unprognostic (9.86e-2)" "unprognostic (7.45e-2)" "unprognostic (3.63e-2)" "unprognostic (3.79e-2)" 3.4 0.7 0.2 0.9 0.2 0.4 3.5 0.4 0.4 0.8 0.2 0.7 0.6 0.4 6.6 3.2 0.3 0.8 0.3 0.3 0.2 0.3 0.3 0.4 0.7 0.4 0.0 0.1 0.3 1.3 0.1 1.6 0.4 0.1 1.2 0.0 0.8 0.0 0.4 58.9 0.5 0.6 0.0 0.2 0.3 0.3 0.4 0.5 0.1 0.1 3.4 1.1 1.5 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.1 0.2 0.5 0.4 0.2 0.0 0.1 0.8 0.0 2.7 0.5 5.4 0.0 0.0 0.0 0.1 1.3 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.9 0.1 0.1 2.2 0.0 2.6 0.0 1.3 0.8 0.1 0.1 0.6 0.9 0.7 0.1 0.1 0.2 0.5 0.5 0.2 0.2 0.4 0.4 0.3 0.2 0.4 0.0 0.4 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 3.7 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.0 5.0 0.0 0.1 0.7 0.0 5.6 0.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.7 0.0 0.2 2.8 0.0 0.0 GYG1 GYG ENSG00000163754 "Glycogenin 1" P46976 3 148991408-149031775 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 560.0;tongue: 357.6" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 229.8;Early spermatids: 251.2;Late spermatids: 368.8;Spermatocytes: 296.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030497, HPA073229" Supported Approved Vesicles NA NA 30000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles "HPA030497: AB_10602326, HPA073229: " "unprognostic (2.68e-2)" "unprognostic (6.31e-3)" "unprognostic (3.21e-1)" "unprognostic (1.81e-1)" "unprognostic (6.19e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (6.15e-5)" "unprognostic (2.55e-2)" "unprognostic (2.71e-1)" "unprognostic (1.10e-1)" "unprognostic (7.75e-3)" "unprognostic (1.29e-1)" "unprognostic (3.56e-2)" "unprognostic (1.27e-2)" "unprognostic (1.96e-1)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" 40.3 31.1 30.1 31.3 32.2 219.8 33.8 33.1 39.4 36.5 28.7 152.2 16.7 64.1 38.7 53.6 52.6 23.9 117.8 29.9 44.0 29.0 18.6 41.1 24.8 37.0 39.7 43.8 42.7 25.2 31.5 23.0 39.0 47.3 25.6 34.3 39.7 64.4 560.0 21.2 37.7 68.1 35.9 59.2 50.7 115.1 33.6 18.0 21.1 357.6 23.0 86.1 30.8 38.3 62.7 39.8 29.0 32.6 78.5 81.7 39.5 90.2 74.4 128.3 119.2 52.3 62.2 0.1 43.5 105.1 68.4 18.8 76.7 39.8 128.6 21.1 33.3 47.6 16.7 59.9 70.7 49.1 68.8 45.1 63.8 42.7 53.3 66.8 74.7 30.7 29.8 109.8 74.7 110.3 9.6 38.9 34.9 48.3 32.2 26.7 43.8 89.3 35.7 57.6 23.7 11.3 47.6 64.6 54.4 27.3 64.4 51.4 62.9 65.4 19.4 47.4 66.9 98.7 59.1 44.4 55.1 74.3 21.7 22.7 58.1 42.4 39.4 59.6 73.1 15.9 25.7 41.3 64.0 14.0 13.8 23.5 27.0 44.3 67.9 25.3 39.4 50.1 30.1 32.2 33.1 39.4 29.9 44.0 37.0 39.7 39.0 35.9 33.6 38.3 27.7 12.8 11.1 16.3 28.3 12.1 22.4 27.7 12.5 9.4 22.5 17.1 229.8 15.7 21.9 33.1 18.8 36.5 50.4 9.9 27.4 43.4 251.2 7.9 15.2 32.6 14.4 12.2 9.8 77.6 47.2 45.0 17.3 9.5 18.3 19.7 45.3 13.5 95.3 6.7 11.3 19.0 26.4 87.1 26.3 368.8 53.1 56.2 40.9 6.5 56.2 132.1 36.0 11.6 5.4 31.6 14.3 76.8 104.1 45.9 15.0 17.3 16.1 7.0 65.7 35.8 50.3 296.7 52.2 23.1 14.9 29.3 61.2 33.8 15.2 19.6 GZMK "PRSS, TRYP2" ENSG00000113088 "Granzyme K" P49863 5 55024256-55034570 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 99.6" "Group enriched" "Detected in many" 4 "dendritic cells: 136.3;T-cells: 301.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 741.6;NK-cell: 505.5" "Group enriched" "Detected in many" 199 "NK-cells: 505.5;T-cells: 741.6" "Cell line enriched" "Detected in single" 10 "JURKAT: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA063181, HPA065895" Enhanced "Secreted to blood" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA063181: AB_2684955, HPA065895: " "prognostic favorable (8.68e-4)" "unprognostic (3.26e-3)" "unprognostic (2.23e-2)" "unprognostic (1.83e-3)" "unprognostic (2.61e-2)" "unprognostic (1.12e-3)" "unprognostic (1.03e-3)" "unprognostic (8.13e-3)" "unprognostic (3.50e-2)" "unprognostic (4.53e-2)" "unprognostic (9.74e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.06e-4)" "unprognostic (2.04e-1)" "unprognostic (2.42e-1)" "unprognostic (1.21e-2)" "unprognostic (1.00e-1)" 3.0 3.9 0.1 19.4 0.1 10.5 4.9 0.1 0.4 4.3 0.3 3.4 1.6 4.0 4.5 3.0 2.0 11.6 2.0 0.1 0.2 1.7 10.7 5.9 99.6 0.5 0.2 2.7 1.0 0.8 0.5 0.5 0.3 3.2 4.6 0.0 4.6 1.0 0.2 0.6 7.3 2.2 0.2 30.4 6.5 1.2 0.3 11.9 2.3 0.3 27.8 8.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.9 1.1 164.3 1.0 741.6 0.5 100.2 457.3 0.5 0.5 4.9 77.4 3.1 505.5 0.9 0.9 7.0 95.5 0.1 0.1 0.1 0.4 0.1 0.2 0.5 0.2 0.3 0.2 0.3 0.3 3.8 3.2 7.0 0.0 10.7 1.5 0.1 0.0 1.8 0.0 1.5 1.7 0.1 2.8 0.6 0.0 0.0 0.0 136.3 0.1 0.0 0.0 1.3 0.8 0.4 0.8 0.0 4.4 0.0 0.0 0.0 1.2 4.1 0.8 2.5 0.0 8.6 1.5 0.2 0.0 0.0 0.0 0.0 10.3 2.5 1.2 0.0 6.4 1.8 0.0 5.1 0.0 29.9 0.0 0.1 0.0 0.0 0.0 45.1 0.1 0.2 0.8 0.0 0.0 0.0 1.8 1.7 0.0 0.3 0.2 0.6 0.3 301.9 0.0 0.0 0.1 HBQ1 HBQ ENSG00000086506 "Hemoglobin subunit theta 1" P09105 16 180459-181179 "Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "bone marrow: 25.6" "Cell type enriched" "Detected in some" 9 "Erythroid cells: 399.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 6 "granulocytes: 1.3;T-cells: 1.3" "Group enriched" "Detected in some" 8 "HEL: 22.4;Hep G2: 15.8;K-562: 56.5" "Low region specificity" "Detected in all" HPA062473 Enhanced Approved "Lipid droplets" NA NA 160000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "Lipid droplets" "HPA062473: AB_2684774" "unprognostic (4.24e-1)" "unprognostic (3.38e-1)" "unprognostic (2.11e-2)" "unprognostic (2.20e-2)" "unprognostic (1.30e-1)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.75e-2)" "unprognostic (2.33e-1)" "unprognostic (8.92e-2)" "unprognostic (2.02e-3)" "unprognostic (8.24e-2)" "unprognostic (1.68e-1)" "unprognostic (1.02e-1)" "unprognostic (5.55e-1)" 0.3 0.1 3.1 0.0 3.2 25.6 0.1 0.8 4.7 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.6 2.8 1.7 0.5 0.4 0.9 0.0 0.8 1.2 0.1 0.0 0.0 0.7 0.8 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 3.6 0.1 1.9 3.1 0.0 0.2 0.0 0.0 0.0 0.2 2.2 0.0 1.3 0.4 4.1 0.0 0.0 0.7 0.1 0.0 0.0 0.2 3.8 0.0 0.0 0.5 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 22.4 1.0 15.8 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 1.3 56.5 0.0 0.0 0.2 2.5 0.0 2.9 0.0 0.2 0.2 0.0 0.4 0.8 0.0 0.5 2.9 0.0 0.0 0.7 0.0 0.1 0.9 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.3 0.2 0.4 0.9 0.0 0.0 0.2 0.6 1.3 0.0 0.0 0.1 0.0 4.3 3.1 3.2 0.8 4.7 2.8 1.7 0.8 1.2 1.3 0.6 3.1 2.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.1 1.1 0.0 0.0 0.0 0.0 399.8 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.7 0.7 0.3 0.4 0.0 0.0 0.0 0.0 0.9 0.0 4.1 0.3 7.6 3.6 0.0 0.6 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 6.0 36.1 0.0 0.1 0.3 0.6 1.2 0.3 0.0 HELZ "DHRC, HUMORF5, KIAA0054" ENSG00000198265 "Helicase with zinc finger" P42694 17 67070444-67245989 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028276 Approved Approved "Nucleoli,Nucleoli rim,Plasma membrane,Actin filaments" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoli, Nucleoli rim" "Plasma membrane, Actin filaments" "HPA028276: AB_10601814" "unprognostic (3.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.56e-3)" "unprognostic (1.29e-1)" "unprognostic (4.83e-2)" "unprognostic (4.71e-2)" "unprognostic (5.85e-2)" "unprognostic (5.31e-2)" "unprognostic (3.60e-2)" "unprognostic (1.16e-1)" "unprognostic (1.51e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-3)" "unprognostic (1.42e-1)" "unprognostic (1.24e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" 6.3 6.6 3.8 8.5 4.9 12.5 6.6 12.0 5.7 7.6 8.4 5.8 4.8 7.4 6.1 4.7 6.1 7.1 6.1 3.6 6.9 6.9 10.9 6.8 9.8 4.1 5.2 12.3 7.8 12.0 6.1 11.2 4.0 6.1 6.6 14.3 6.2 6.2 9.1 4.4 5.9 7.5 3.3 9.1 6.5 10.8 5.5 15.4 8.7 14.0 8.9 6.6 5.0 3.3 10.3 10.0 12.3 12.3 14.8 8.4 18.7 9.0 8.8 11.8 12.4 14.7 7.9 21.2 7.2 12.0 7.4 10.5 23.3 11.3 18.4 8.2 7.3 27.2 10.7 12.5 7.1 22.3 15.6 9.8 10.5 11.4 14.1 8.8 18.1 15.6 19.1 12.9 9.8 13.0 29.0 7.6 7.4 9.2 9.7 19.3 21.6 9.2 9.1 14.3 12.0 11.0 14.3 11.5 15.2 16.9 13.7 13.7 16.1 14.5 16.6 8.0 8.1 10.7 13.4 15.5 7.2 13.7 15.5 2.3 3.3 2.8 5.1 2.8 6.3 1.7 3.1 3.2 2.8 2.8 1.9 2.6 2.3 2.6 1.9 2.2 3.0 2.3 3.8 4.9 12.0 5.7 3.6 6.9 4.1 5.2 4.0 3.3 5.5 3.3 42.9 19.2 37.1 89.1 44.3 32.1 24.6 30.2 29.6 50.8 32.8 23.6 31.1 24.3 30.2 27.6 93.8 32.9 95.8 29.4 7.9 19.1 5.2 49.4 55.8 32.3 38.3 48.8 93.1 14.2 42.8 30.9 38.7 118.5 33.7 51.9 61.8 52.1 31.9 67.3 112.1 30.2 16.2 79.4 28.8 10.5 38.8 55.4 14.2 107.7 62.0 24.0 104.0 134.2 72.6 19.2 23.1 42.9 67.1 29.3 27.7 14.6 26.1 54.9 13.1 45.9 34.0 36.0 26.0 33.6 20.2 18.3 71.0 32.6 26.3 45.8 HNRNPA2B1 HNRPA2B1 ENSG00000122566 "Heterogeneous nuclear ribonucleoprotein A2/B1" P22626 7 26171151-26201529 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport" "Ribonucleoprotein, RNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001666, HPA005812, CAB012403, HPA065537" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA 11000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB012403: , HPA001666: AB_1850836, HPA005812: AB_2667441, HPA065537: AB_2685507" "unprognostic (1.19e-1)" "unprognostic (4.45e-1)" "unprognostic (2.33e-1)" "unprognostic (6.39e-2)" "unprognostic (5.64e-2)" "unprognostic (8.04e-3)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.25e-2)" "unprognostic (9.12e-3)" "unprognostic (4.35e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (5.12e-4)" "prognostic unfavorable (8.01e-5)" "unprognostic (6.74e-2)" "unprognostic (3.36e-2)" "unprognostic (2.02e-1)" "unprognostic (1.56e-2)" 367.0 421.3 101.3 151.4 105.4 77.6 314.1 110.9 140.3 403.5 106.4 381.8 124.8 404.3 116.1 417.6 376.3 62.4 463.6 99.7 106.4 530.8 388.5 364.9 184.1 106.4 105.0 527.8 350.2 80.8 337.6 118.9 108.2 300.8 127.5 131.1 325.1 79.2 764.9 280.5 419.0 84.2 102.3 447.5 353.4 370.5 105.4 174.8 367.2 92.0 172.5 339.9 360.8 111.7 202.5 101.8 491.6 312.7 110.7 117.5 249.6 255.8 110.7 149.6 183.6 159.8 338.5 210.2 104.2 180.1 218.8 300.0 196.3 268.7 288.5 74.9 191.2 232.6 309.9 212.1 72.9 374.6 359.4 123.6 192.4 156.3 253.3 194.6 161.1 273.9 210.9 250.4 280.4 229.1 216.5 817.2 320.7 81.7 117.7 239.5 122.1 159.3 287.0 335.8 190.7 245.6 203.5 291.8 127.7 393.6 326.3 359.7 222.0 193.2 265.6 184.6 253.7 367.0 296.0 308.7 149.9 453.8 316.5 0.0 1.7 1.3 4.8 1.0 4.0 2.7 3.0 0.8 0.8 0.8 2.7 2.6 0.6 3.3 0.8 1.6 1.0 0.5 101.3 105.4 110.9 140.3 99.7 106.4 106.4 105.0 108.2 102.3 105.4 111.7 717.8 487.2 591.0 194.6 667.5 738.5 797.7 793.2 560.5 469.4 361.0 361.3 702.1 316.0 665.8 343.9 298.2 971.6 707.7 435.1 461.8 568.0 128.2 465.8 640.8 600.5 491.4 683.2 123.3 452.2 939.9 602.7 449.6 591.1 644.7 680.5 333.4 382.8 613.1 312.9 147.2 533.1 496.4 388.5 681.9 150.0 411.0 640.3 393.1 157.4 572.0 545.4 484.1 198.0 320.6 438.2 438.7 390.0 751.0 520.4 428.4 506.8 608.0 547.0 440.4 599.4 726.5 596.9 490.6 573.8 600.5 1082.8 701.7 652.2 541.4 632.1 HSP90AA1 "FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA" ENSG00000080824 "Heat shock protein 90 alpha family class A member 1" P07900 14 102080742-102139699 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 2527.6" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 12150.7;Urothelial cells: 5781.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002058 Approved Supported Cytosol NA NA 71000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "CAB002058: " "prognostic unfavorable (5.59e-4)" "unprognostic (3.77e-2)" "unprognostic (1.78e-2)" "unprognostic (9.25e-2)" "unprognostic (2.53e-1)" "unprognostic (1.05e-3)" "prognostic unfavorable (3.09e-5)" "unprognostic (7.79e-3)" "unprognostic (5.71e-2)" "unprognostic (7.81e-3)" "unprognostic (3.68e-2)" "unprognostic (1.65e-2)" "prognostic favorable (1.18e-5)" "unprognostic (1.04e-1)" "unprognostic (2.54e-1)" "unprognostic (1.43e-1)" "unprognostic (1.12e-1)" 362.9 439.5 1188.2 299.3 1221.3 459.2 438.6 1272.5 2527.6 282.1 1284.0 289.7 191.3 239.6 318.6 262.0 560.3 363.7 460.6 1213.8 1334.7 452.4 380.5 376.1 321.9 1283.8 1324.0 350.4 273.5 421.8 355.5 420.6 1351.6 348.4 311.1 1127.6 371.1 319.5 405.8 224.8 244.2 306.2 1216.2 217.6 297.5 541.9 1274.3 404.8 223.3 434.9 376.7 406.5 232.8 1639.1 1348.6 1832.2 1142.0 794.2 678.0 567.7 1512.1 1466.0 709.0 1779.5 994.1 1123.6 1245.6 1671.5 1323.1 960.7 1164.7 1471.2 3319.0 1452.5 3215.8 1227.4 1091.9 1291.8 1029.3 1444.3 334.9 1936.9 950.0 539.4 604.6 1140.3 416.2 1107.1 998.6 1764.9 1818.9 838.8 1634.1 1850.8 2087.7 891.1 1191.0 2500.5 1709.3 1968.2 1550.2 715.1 1030.3 1738.2 1497.0 1077.2 1860.4 1389.6 848.2 1903.9 1790.2 765.2 708.2 1234.6 786.5 1860.0 2826.4 783.5 2534.1 2402.7 1167.3 1182.5 1521.0 184.4 87.6 112.1 195.4 128.5 254.9 128.4 162.4 202.2 104.9 127.8 119.2 174.8 57.5 252.6 124.9 208.0 177.8 113.5 1188.2 1221.3 1272.5 2527.6 1213.8 1334.7 1283.8 1324.0 1351.6 1216.2 1274.3 1639.1 1571.4 1137.8 696.7 255.6 934.0 1340.7 12150.7 814.1 748.4 1185.6 1215.2 1173.1 2257.3 684.9 1020.6 513.1 2103.8 1415.1 1091.2 905.8 342.4 1210.5 662.9 2972.0 1350.8 1163.8 947.3 1502.3 158.9 867.6 1909.7 1632.5 788.5 2209.5 916.4 1026.8 341.3 554.4 1348.0 723.5 216.2 992.2 703.9 618.8 3110.7 442.6 732.0 2305.3 1300.2 267.0 773.6 1548.1 356.3 96.5 435.3 779.9 1021.6 722.9 1227.4 3791.1 552.2 896.4 2827.3 3623.6 618.0 1112.4 1974.9 3800.9 2142.4 830.1 1113.7 2050.2 3196.2 972.6 1028.8 5781.1 HTR6 "5-HT6, 5-HT6R" ENSG00000158748 "5-hydroxytryptamine receptor 6" P50406 1 19664875-19680966 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "brain: 9.7" "Cell type enhanced" "Detected in single" "Excitatory neurons: 1.6" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Group enriched" "Detected in many" 4 "basal ganglia: 9.7;cerebral cortex: 2.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 2.0" "Low region specificity" "Detected in many" HPA068165 Uncertain NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA068165: " "unprognostic (2.34e-2)" "unprognostic (1.84e-1)" "unprognostic (7.19e-3)" "unprognostic (3.84e-5)" "unprognostic (1.38e-4)" "unprognostic (2.69e-2)" "unprognostic (1.36e-1)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (5.33e-3)" "unprognostic (8.63e-2)" "unprognostic (5.47e-4)" "unprognostic (1.28e-1)" "unprognostic (2.49e-1)" "unprognostic (6.13e-3)" "unprognostic (2.02e-1)" 0.0 0.0 1.2 0.2 9.7 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 9.7 0.0 2.4 0.7 0.1 0.1 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFT140 "gs114, KIAA0590, WDTC2" ENSG00000187535 "Intraflagellar transport 140" Q96RY7 16 1510427-1612072 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 27.8;Late spermatids: 25.6;Respiratory ciliated cells: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 3.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042197 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "HPA042197: AB_2677895" "unprognostic (1.53e-1)" "unprognostic (1.53e-1)" "unprognostic (1.30e-1)" "unprognostic (5.21e-3)" "unprognostic (2.27e-1)" "unprognostic (2.87e-2)" "unprognostic (5.27e-3)" "unprognostic (3.28e-2)" "unprognostic (2.63e-1)" "unprognostic (4.35e-3)" "unprognostic (1.08e-1)" "unprognostic (1.52e-1)" "unprognostic (2.77e-2)" "unprognostic (7.55e-2)" "unprognostic (8.95e-2)" "unprognostic (2.91e-3)" "unprognostic (6.22e-3)" 5.5 8.9 10.1 2.2 10.3 1.8 7.0 10.5 13.2 11.3 20.8 7.4 3.4 9.6 4.9 4.1 15.3 5.3 4.9 9.8 11.8 10.4 3.8 8.7 2.4 10.2 14.8 12.6 7.7 8.4 15.7 3.1 9.8 9.5 1.3 6.4 6.0 5.3 2.7 5.6 4.8 2.5 10.2 4.1 6.8 15.3 11.6 3.2 22.9 1.0 1.1 12.0 7.2 8.3 2.0 12.4 9.5 9.6 8.0 5.9 5.4 2.6 9.5 2.7 3.3 3.4 9.9 3.8 7.3 3.9 3.6 7.5 1.7 1.5 1.9 3.3 7.6 2.3 9.3 8.3 6.9 1.3 4.7 8.4 5.9 3.2 4.2 10.5 2.0 7.6 2.6 2.2 2.1 12.0 6.9 3.9 10.4 2.5 2.9 6.3 3.4 5.7 8.3 6.2 18.0 10.0 2.9 5.0 3.9 5.1 17.4 5.1 3.9 2.2 7.0 4.0 1.1 6.8 2.6 2.4 3.7 0.8 2.9 0.0 0.4 0.2 0.4 0.2 3.7 0.6 0.6 1.4 0.6 0.2 1.9 3.0 0.0 1.1 0.3 0.5 0.1 0.8 10.1 10.3 10.5 13.2 9.8 11.8 10.2 14.8 9.8 10.2 11.6 8.3 2.9 12.8 11.5 19.9 1.2 1.7 2.9 4.0 4.6 3.7 6.8 6.0 4.0 5.7 6.1 11.0 25.0 7.8 2.2 2.1 1.9 3.2 21.7 27.8 5.9 2.1 5.4 2.5 12.7 1.0 1.3 4.5 7.1 6.2 1.3 11.5 2.2 0.9 2.3 8.4 12.4 6.1 8.2 0.6 0.7 25.6 4.7 1.4 0.0 13.1 0.4 5.6 0.0 6.6 4.9 2.1 1.5 4.1 0.7 1.4 1.0 3.5 31.2 17.2 0.0 3.1 3.0 20.9 7.5 2.0 1.1 2.2 1.6 6.2 3.5 1.5 IGHJ2 ENSG00000211904 "Immunoglobulin heavy joining 2" 14 105865199-105865250 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "cervix: 48.7;intestine: 127.5;lymphoid tissue: 174.5" "Cell type enriched" "Detected in single" 6 "Plasma cells: 3.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "medulla oblongata: 3.8" "Group enriched" "Detected in some" 18 "MAIT T-cell: 49.0;naive B-cell: 12.6" "Group enriched" "Detected in many" 45 "B-cells: 12.6;T-cells: 49.0" "Group enriched" "Detected in some" 25 "Daudi: 3.8;K-562: 1.1" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.03e-3)" "unprognostic (2.87e-2)" "unprognostic (1.81e-2)" "unprognostic (1.27e-2)" "prognostic favorable (1.05e-4)" "unprognostic (7.40e-2)" "unprognostic (6.38e-2)" "unprognostic (1.82e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.33e-6)" "unprognostic (4.31e-2)" "unprognostic (1.68e-1)" "unprognostic (5.48e-2)" "unprognostic (4.60e-1)" 2.0 0.0 0.2 0.0 0.5 13.3 20.5 0.2 2.0 48.7 0.1 87.2 0.0 5.4 17.9 18.0 2.1 0.8 0.1 0.2 0.4 1.2 12.0 0.0 7.6 3.8 0.8 7.7 18.9 0.6 0.0 0.0 0.5 15.0 127.5 0.0 0.0 7.1 0.0 0.0 0.0 5.8 0.6 18.8 18.2 0.1 0.5 19.6 5.1 0.0 174.5 6.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 49.0 1.3 0.4 1.6 0.4 12.6 0.0 0.2 0.2 0.0 0.6 0.0 0.0 17.1 0.2 0.5 0.2 2.0 0.2 0.4 3.8 0.8 0.5 0.6 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV11-55 ENSG00000211641 "Immunoglobulin lambda variable 11-55 (non-functional)" A0A075B6I3 22 22201663-22202161 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.1" "Cell type enhanced" "Detected in some" "Late spermatids: 3.5;Plasma cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Daudi: 8.6;U-698: 2.7" "Immunoglobulin genes" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.22e-1)" "unprognostic (6.16e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.5 0.2 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IKZF3 "Aiolos, ZNFN1A3" ENSG00000161405 "IKAROS family zinc finger 3" Q9UKT9 17 39757718-39864312 "Predicted intracellular proteins, Transcription factors" "B-cell activation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 12.1;lymphoid tissue: 41.0" "Group enriched" "Detected in many" 4 "B-cells: 108.1;dendritic cells: 76.5;granulocytes: 47.9;NK-cells: 121.5;Plasma cells: 80.2;T-cells: 99.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 13.2;T-cells: 28.8" "Cell line enhanced" "Detected in some" "Daudi: 69.0;Karpas-707: 35.6;U-266/70: 41.7;U-266/84: 50.0;U-698: 108.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA024377, HPA073266" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm Cytosol "HPA024377: AB_1859477, HPA073266: " "unprognostic (5.43e-3)" "prognostic favorable (6.85e-6)" "unprognostic (6.10e-2)" "unprognostic (1.01e-1)" "unprognostic (2.93e-2)" "prognostic favorable (4.16e-4)" "unprognostic (1.36e-2)" "unprognostic (3.14e-3)" "prognostic favorable (5.42e-4)" "unprognostic (8.03e-3)" "unprognostic (1.65e-1)" "unprognostic (3.19e-1)" "prognostic unfavorable (7.38e-4)" "unprognostic (9.13e-2)" "unprognostic (2.20e-1)" "unprognostic (5.51e-2)" "unprognostic (1.05e-3)" 1.0 0.8 0.3 18.8 0.2 5.9 1.8 0.7 0.6 1.5 0.6 3.3 3.5 1.0 0.7 1.5 0.7 3.0 0.5 0.7 0.1 0.6 2.0 3.1 36.5 0.5 0.1 0.7 0.4 0.1 0.2 0.3 0.4 1.0 3.1 0.3 2.2 0.3 0.5 0.9 12.1 0.8 0.1 22.3 6.2 1.6 0.4 23.0 0.9 0.3 41.0 4.5 0.7 1.0 0.2 0.2 0.2 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.3 69.0 0.1 0.0 0.1 0.3 0.1 0.2 0.0 15.6 0.3 4.2 0.4 0.2 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.0 4.1 1.8 35.6 0.0 0.2 6.2 2.4 0.2 3.9 0.1 0.3 0.2 12.7 0.0 4.2 0.4 0.2 1.2 0.5 0.1 0.1 0.2 0.8 0.3 0.3 0.5 0.2 0.1 41.7 50.0 108.1 0.1 0.2 0.1 1.0 0.2 0.8 26.3 0.1 28.8 13.2 11.0 20.3 0.1 11.9 4.5 12.2 1.1 4.5 0.3 0.6 18.9 8.7 0.3 0.2 0.7 0.6 0.7 0.1 0.5 0.1 0.4 0.1 0.4 1.0 1.1 9.6 21.8 0.3 108.1 0.1 2.2 0.0 0.0 1.7 1.2 0.9 4.0 1.5 5.6 1.8 0.0 0.1 76.5 0.2 0.0 0.1 12.8 1.9 0.9 2.4 0.0 4.0 0.6 0.0 0.4 2.3 3.1 3.9 47.9 0.4 4.2 1.2 0.1 0.0 0.4 0.1 0.0 6.3 0.0 11.8 0.0 4.4 0.0 2.8 3.3 0.2 121.5 0.0 0.1 1.2 0.1 0.0 80.2 1.8 0.0 0.3 0.7 1.7 0.0 4.0 1.2 6.3 2.3 0.6 0.1 0.3 99.9 0.1 0.0 1.6 IL12RB1 "CD212, IL12RB" ENSG00000096996 "Interleukin 12 receptor subunit beta 1" P42701 19 18058995-18098944 "CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 24.6" "Cell type enhanced" "Detected in some" "dendritic cells: 35.1;Kupffer cells: 13.9;NK-cells: 69.0;Plasma cells: 15.3;T-cells: 31.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 18.8;HDLM-2: 35.2;Karpas-707: 57.8;U-698: 15.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA074414 Approved "Plasma membrane" "Intracellular and membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "HPA074414: AB_2686687" "unprognostic (7.70e-3)" "prognostic favorable (3.41e-4)" "unprognostic (9.08e-3)" "unprognostic (1.18e-4)" "unprognostic (2.91e-1)" "unprognostic (1.33e-3)" "unprognostic (2.27e-1)" "unprognostic (8.99e-2)" "unprognostic (1.65e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (2.94e-1)" "prognostic unfavorable (5.90e-5)" "unprognostic (1.49e-1)" "unprognostic (2.21e-2)" "unprognostic (4.34e-2)" "unprognostic (2.93e-2)" 2.1 1.2 1.0 15.2 1.8 9.3 0.9 1.0 2.1 1.0 1.7 3.1 4.5 0.7 0.8 1.6 0.8 3.5 0.7 1.1 1.1 0.9 2.2 5.8 24.6 2.5 1.5 0.6 0.5 1.3 0.5 1.6 2.3 0.8 2.9 0.5 1.7 0.6 0.7 1.6 7.0 1.9 1.1 16.2 4.1 0.8 2.3 6.6 0.7 0.2 14.1 4.0 0.5 3.7 0.3 0.1 0.1 0.2 0.0 0.1 0.8 0.1 0.1 0.5 1.0 0.3 2.2 18.8 0.1 0.2 0.7 0.3 0.0 0.0 0.0 35.2 0.2 2.2 0.6 0.3 1.0 0.9 3.1 0.1 0.0 0.5 0.0 0.2 0.1 5.1 0.3 57.8 0.0 0.2 9.7 0.3 0.1 0.1 0.0 6.7 0.1 0.8 0.0 0.1 0.4 0.0 0.2 0.2 0.2 0.1 0.4 9.7 0.4 0.5 0.4 0.2 0.2 6.6 11.0 15.2 0.6 12.1 1.1 8.5 12.5 9.2 50.9 34.7 64.0 11.5 34.8 41.7 14.7 9.1 19.3 34.0 14.7 40.9 34.0 8.1 53.0 24.3 1.0 1.8 1.0 2.1 1.1 1.1 2.5 1.5 2.3 1.1 2.3 3.7 0.5 0.0 3.0 0.3 9.6 0.3 2.1 0.1 0.6 0.0 0.3 0.5 1.0 1.5 0.6 0.0 0.0 0.2 35.1 0.1 0.0 0.0 0.5 0.5 0.2 0.5 0.0 5.2 0.8 0.0 0.8 0.7 3.1 0.7 4.5 0.0 0.4 0.1 6.4 0.0 0.4 0.0 0.0 13.9 4.0 0.0 0.0 11.7 0.0 3.7 11.9 0.0 69.0 0.0 2.6 0.1 0.0 0.0 15.3 0.5 0.4 0.2 0.2 0.0 0.0 0.7 0.3 0.4 0.1 0.0 0.9 0.1 31.5 0.0 0.2 1.3 IL23R IL-23R ENSG00000162594 "Interleukin 23 receptor" Q5VWK5 1 67138907-67259979 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 1.6;testis: 1.5" "Cell type enhanced" "Detected in some" "Early spermatids: 11.1;Enteroendocrine cells: 3.0;Late spermatids: 6.0;T-cells: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 8 "MAIT T-cell: 21.7" "Lineage enriched" "Detected in single" 29 "T-cells: 21.7" "Cell line enhanced" "Detected in some" "HL-60: 2.4;HMC-1: 9.1;K-562: 3.6;U-2197: 13.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA056427 Uncertain NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 18: U-2197 - ECM organization" "Cluster 24: Non-specific - Transcription regulation" "HPA056427: AB_2683129" "unprognostic (4.01e-3)" "unprognostic (8.04e-2)" "unprognostic (3.49e-2)" "unprognostic (6.41e-2)" "unprognostic (1.96e-1)" "unprognostic (3.16e-3)" "unprognostic (1.57e-1)" "unprognostic (2.22e-3)" "unprognostic (1.71e-1)" "unprognostic (1.88e-1)" "unprognostic (1.66e-2)" "unprognostic (1.40e-1)" "unprognostic (8.64e-5)" "unprognostic (1.43e-1)" "unprognostic (3.02e-1)" "unprognostic (2.73e-2)" "unprognostic (6.41e-3)" 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.9 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.3 0.4 1.5 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 2.4 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 13.8 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 21.7 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.6 1.6 0.0 0.0 11.1 0.2 0.1 0.1 3.0 0.0 0.3 0.2 0.0 0.1 0.5 0.1 0.0 0.1 0.7 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.2 6.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.2 0.0 0.2 0.7 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.3 0.0 4.2 0.0 0.4 0.2 IL26 "AK155, IL-26" ENSG00000111536 "Interleukin 26" Q9NPH9 12 68201349-68225810 "Plasma proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.0" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.6;T-cells: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HDLM-2: 13.5" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 35700 "Cluster 16: MAIT-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (2.71e-1)" "unprognostic (8.87e-2)" "unprognostic (3.26e-5)" "unprognostic (7.10e-2)" "unprognostic (5.90e-2)" "unprognostic (2.96e-1)" "unprognostic (3.69e-5)" "unprognostic (3.80e-1)" "unprognostic (5.08e-2)" "unprognostic (1.12e-3)" "unprognostic (1.79e-2)" 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 3.8 0.1 0.0 0.0 IL2RG "CD132, CIDX, IMD4, SCIDX1" ENSG00000147168 "Interleukin 2 receptor subunit gamma" P31785 X 71107404-71112108 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Cancer-related genes, Disease variant, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 118.0;lymphoid tissue: 346.4" "Cell type enhanced" "Detected in many" "B-cells: 186.1;dendritic cells: 199.0;Distal enterocytes: 202.0;NK-cells: 310.0;Paneth cells: 133.2;Plasma cells: 221.2;T-cells: 289.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "Karpas-707: 2316.2" "HPA046641, HPA049691" Enhanced Approved Vesicles NA NA 13000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 58: T-cells - T-cell receptor" Vesicles "HPA046641: AB_2679733, HPA049691: AB_2680851" "unprognostic (2.97e-3)" "unprognostic (4.24e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.73e-4)" "unprognostic (8.25e-2)" "unprognostic (1.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" "unprognostic (1.91e-3)" "unprognostic (1.23e-2)" "unprognostic (4.36e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (2.28e-7)" "unprognostic (1.73e-1)" "unprognostic (4.69e-2)" "unprognostic (4.89e-2)" "unprognostic (9.54e-2)" 12.8 6.2 2.7 132.2 2.4 87.3 14.1 2.5 6.3 10.2 4.0 98.9 50.4 7.5 7.5 15.1 6.8 28.2 4.6 2.3 2.8 7.1 20.6 51.7 235.6 3.6 2.7 4.9 4.1 1.9 1.5 16.9 4.2 7.8 118.0 0.5 19.0 5.9 2.6 15.4 82.8 12.3 3.1 119.4 41.4 2.2 3.0 346.4 5.8 6.3 306.9 46.4 5.5 3.8 1.2 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.0 4.7 9.1 187.3 13.5 0.0 0.7 1.7 0.4 0.0 0.0 160.3 0.2 23.6 0.3 0.3 0.2 99.3 4.0 0.0 0.0 0.0 0.1 0.1 0.0 220.5 43.3 2316.2 0.0 0.0 356.4 193.7 0.4 0.9 0.1 79.5 0.8 20.0 0.0 0.7 0.2 0.3 2.3 0.1 0.5 0.0 0.0 3.5 0.4 0.0 1.0 0.0 0.5 132.1 242.2 119.6 2.1 397.4 0.9 540.5 102.2 169.7 1204.7 239.5 1179.9 604.7 1086.3 1250.7 243.5 603.0 742.0 943.1 773.0 1190.3 177.0 368.9 1422.2 1494.0 2.7 2.4 2.5 6.3 2.3 2.8 3.6 2.7 4.2 3.1 3.0 3.8 3.3 3.2 11.2 0.0 186.1 8.2 8.1 13.1 1.2 0.0 1.5 1.7 0.9 4.3 4.2 0.0 0.0 0.5 199.0 202.0 0.0 1.2 0.1 0.8 0.7 5.8 77.7 27.1 0.0 2.3 0.3 4.2 13.7 0.7 39.3 0.4 6.1 2.1 31.1 0.0 0.0 24.5 4.1 25.2 116.7 0.0 0.0 45.4 42.7 1.0 91.1 0.1 310.0 0.0 0.1 28.0 133.2 0.4 221.2 4.3 88.8 1.1 2.3 0.4 0.0 1.3 2.6 0.0 0.1 1.8 6.8 0.3 289.5 0.0 18.6 8.9 IL4I1 FIG1 ENSG00000104951 "Interleukin 4 induced 1" Q96RQ9 19 49889654-49929539 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 18.3;testis: 26.8" "Group enriched" "Detected in many" 5 "Langerhans cells: 295.1;monocytes: 682.5" "Cancer enhanced" "Detected in all" "ovarian cancer: 35.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 103.4" "Group enriched" "Detected in many" 6 "monocytes: 36.8;T-cells: 103.4" "Cell line enhanced" "Detected in many" "EFO-21: 34.3;HDLM-2: 62.4;Karpas-707: 47.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA045598 Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" "Cluster 3: Monocytes - Immune response regulation" "Nucleoplasm, Cytosol" "HPA045598: AB_10969138" "unprognostic (6.23e-2)" "unprognostic (1.32e-2)" "unprognostic (8.39e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (5.61e-2)" "unprognostic (3.74e-3)" "unprognostic (7.03e-2)" "unprognostic (2.52e-2)" "unprognostic (3.84e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.23e-10)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" "unprognostic (6.44e-2)" "unprognostic (2.11e-3)" 1.6 0.6 0.4 18.3 0.6 4.2 0.9 0.8 0.6 1.1 0.7 1.7 4.1 1.6 0.2 0.6 3.9 2.0 0.5 0.6 0.5 4.8 1.2 2.4 9.3 1.7 0.9 0.4 0.7 0.2 0.6 1.9 1.8 0.8 1.4 0.1 0.9 0.5 0.3 1.3 2.7 1.5 1.0 4.1 3.1 26.8 1.2 3.4 0.5 0.2 6.7 4.5 0.5 2.3 1.0 1.2 0.8 0.7 0.0 0.8 0.3 0.5 2.0 1.4 2.1 0.7 1.9 3.5 34.3 0.4 2.9 0.5 0.4 0.0 0.2 62.4 0.2 1.6 0.1 0.5 0.1 1.2 12.3 1.0 0.4 0.6 0.1 0.4 2.6 0.4 0.4 47.3 0.1 0.4 0.7 2.1 0.4 0.9 0.1 1.0 0.9 3.6 2.5 3.2 0.7 0.8 0.5 0.9 0.5 0.2 0.4 2.8 2.9 7.1 1.0 0.1 1.0 4.1 9.7 2.0 1.0 0.5 0.7 0.3 22.0 0.3 6.4 36.8 103.4 0.4 13.2 11.5 11.6 0.2 0.3 0.1 0.5 1.3 5.3 1.3 0.7 8.8 0.4 0.6 0.8 0.6 0.6 0.5 1.7 0.9 1.8 1.0 1.2 2.3 0.8 0.0 0.0 0.0 3.6 9.7 0.6 9.8 0.0 0.1 1.2 1.3 0.5 0.0 5.5 3.7 0.0 0.4 1.0 0.2 0.0 3.5 75.4 2.9 0.6 6.7 0.0 0.0 0.4 4.0 0.7 1.3 0.5 2.1 1.3 0.1 1.1 0.2 97.4 0.0 0.4 0.3 6.1 3.0 295.1 18.4 0.3 38.8 3.6 1.9 682.5 0.1 1.0 0.0 0.4 0.5 0.1 0.4 0.7 1.4 0.3 2.7 1.6 0.2 0.0 0.2 2.5 45.2 3.6 0.4 8.2 0.8 6.3 0.0 0.2 2.1 IL7R "CD127, IL7RA" ENSG00000168685 "Interleukin 7 receptor" P16871 5 35852695-35879603 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 183.7" "Group enriched" "Detected in many" 4 "monocytes: 271.8;T-cells: 973.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 102.1;MAIT T-cell: 369.5;memory CD4 T-cell: 213.8;memory CD8 T-cell: 151.1;naive CD4 T-cell: 179.5;naive CD8 T-cell: 124.6;NK-cell: 113.2" "Group enriched" "Detected in all" 33 "NK-cells: 113.2;T-cells: 369.5" "Cell line enhanced" "Detected in many" "BJ: 99.8;BJ hTERT+ SV40 Large T+: 87.7;fHDF/TERT166: 187.7;HBF TERT88: 168.3;REH: 406.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB010215, HPA067550" Supported "Plasma membrane" "Intracellular and membrane" NA NA 610000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 14: REH - Unknown function" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane" "CAB010215: AB_673727, HPA067550: " "unprognostic (2.93e-3)" "unprognostic (3.38e-2)" "unprognostic (3.82e-3)" "unprognostic (5.58e-3)" "unprognostic (3.06e-2)" "unprognostic (1.74e-1)" "unprognostic (2.51e-3)" "unprognostic (5.53e-2)" "unprognostic (1.12e-1)" "unprognostic (9.29e-3)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (1.76e-2)" "unprognostic (5.64e-2)" "unprognostic (3.27e-3)" "unprognostic (2.22e-1)" "unprognostic (1.78e-1)" 11.2 14.4 1.5 137.6 1.8 14.0 20.4 7.4 2.7 12.0 1.0 17.3 15.0 3.9 1.6 11.0 5.7 32.4 2.2 2.0 2.5 4.5 12.5 63.9 139.4 1.8 0.5 2.2 5.3 0.8 1.7 2.9 1.6 8.7 20.4 0.9 3.3 3.1 4.1 3.8 56.8 5.6 0.6 70.1 34.1 4.7 4.4 183.7 7.6 1.7 123.0 48.0 7.1 6.2 0.6 0.4 0.7 0.4 0.7 0.6 0.6 99.8 50.6 87.7 51.3 0.5 0.6 9.6 0.3 187.7 15.9 16.0 0.2 6.0 168.3 8.6 1.1 3.2 10.3 0.0 1.5 0.6 7.2 1.6 0.0 18.7 4.3 2.4 2.6 0.7 0.7 0.9 71.3 0.2 2.3 1.0 0.3 0.3 4.6 406.2 5.2 0.6 0.0 5.3 0.4 0.2 15.9 1.7 0.2 0.3 0.6 0.4 7.0 34.5 58.4 14.8 13.4 0.6 0.2 10.4 17.4 9.2 27.8 4.3 1.6 1.0 102.1 1.2 369.5 1.5 213.8 151.1 0.7 2.1 179.5 124.6 7.3 113.2 1.5 1.8 39.7 87.7 1.5 1.8 7.4 2.7 2.0 2.5 1.8 0.5 1.6 0.6 4.4 6.2 8.9 16.0 16.0 0.0 47.4 11.6 2.7 0.0 5.2 0.0 8.6 6.1 4.9 0.0 2.5 0.0 0.0 0.2 136.0 0.6 0.0 1.0 0.1 1.1 0.4 13.2 0.0 16.4 0.0 2.0 0.2 11.6 53.5 1.2 19.6 0.2 13.2 4.4 10.6 0.0 0.0 0.5 0.0 10.6 98.5 0.8 0.0 58.8 21.4 2.8 271.8 0.0 11.3 0.0 0.0 0.1 1.4 0.0 93.5 1.4 0.0 0.8 5.8 0.0 0.0 5.5 7.9 0.2 0.1 1.5 10.4 0.3 973.8 0.4 0.4 3.5 IQCH FLJ12476 ENSG00000103599 "IQ motif containing H" Q86VS3 15 67254786-67502260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.5" "Cell type enhanced" "Detected in many" "Astrocytes: 27.4;Early spermatids: 59.4;Excitatory neurons: 26.5;Late spermatids: 37.3;Respiratory ciliated cells: 30.3;Spermatocytes: 48.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040845 Uncertain Approved Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA040845: AB_10672898" "unprognostic (2.69e-1)" "unprognostic (2.94e-3)" "unprognostic (3.11e-2)" "unprognostic (5.89e-5)" "unprognostic (2.48e-1)" "unprognostic (9.83e-2)" "unprognostic (2.57e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-1)" "unprognostic (3.25e-1)" "unprognostic (5.37e-2)" "unprognostic (1.70e-1)" "unprognostic (1.51e-3)" "unprognostic (2.81e-1)" "unprognostic (3.81e-2)" "unprognostic (6.16e-3)" "unprognostic (6.42e-2)" 0.3 1.1 0.7 0.3 0.8 0.1 1.6 0.7 1.4 0.9 4.2 0.5 0.2 0.8 2.6 0.5 6.8 0.6 0.9 0.7 1.8 2.2 1.0 0.9 0.4 2.5 2.2 0.3 0.7 3.7 2.0 0.4 1.6 0.6 0.7 5.0 0.6 0.8 0.5 0.6 0.1 0.3 2.0 0.4 1.1 11.5 1.9 1.0 4.1 0.0 0.2 0.7 0.3 1.4 1.7 1.6 0.8 1.3 1.1 2.6 0.6 0.9 0.7 1.3 0.9 0.1 1.9 1.2 0.8 1.5 1.5 2.8 2.6 1.0 2.3 0.2 1.2 0.3 1.6 0.2 1.7 0.5 0.3 1.7 1.1 2.9 2.8 1.3 0.5 3.1 2.6 1.1 1.0 1.8 0.4 0.4 0.9 1.0 1.1 0.3 1.2 1.3 1.6 0.7 2.6 0.7 1.2 1.6 4.8 1.6 4.3 0.3 1.2 1.5 0.7 2.4 1.0 2.5 3.2 0.3 3.1 1.3 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.8 0.7 1.4 0.7 1.8 2.5 2.2 1.6 2.0 1.9 1.4 0.7 3.2 1.1 27.4 0.3 1.3 1.0 1.6 1.8 1.5 2.7 2.2 1.1 0.0 2.8 1.8 8.4 0.2 0.3 0.4 0.0 1.0 59.4 15.9 1.1 0.9 0.0 0.4 26.5 0.8 0.5 0.7 8.2 2.0 0.0 0.7 0.0 0.0 0.3 1.7 18.2 0.5 4.1 0.0 0.7 37.3 0.9 0.3 0.0 8.4 1.0 1.1 0.0 9.0 9.5 0.7 0.0 0.7 0.5 0.3 0.2 2.2 30.3 5.4 0.0 1.5 0.6 48.8 18.2 1.2 0.4 0.3 0.4 4.2 0.4 1.0 ITGAE "CD103, HUMINAE" ENSG00000083457 "Integrin subunit alpha E" P38570 17 3714628-3801188 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.5;intestine: 5.9;lung: 6.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "memory CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 6 "T-cells: 3.7" "Cell line enriched" "Detected in single" 22 "MOLT-4: 12.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036313, HPA052147" Enhanced NA NA 38000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "HPA036313: AB_10795355, HPA052147: " "unprognostic (9.81e-2)" "unprognostic (1.78e-3)" "unprognostic (7.86e-2)" "prognostic favorable (1.04e-4)" "unprognostic (2.17e-1)" "unprognostic (1.45e-2)" "unprognostic (2.91e-1)" "unprognostic (8.02e-2)" "unprognostic (2.92e-2)" "unprognostic (1.10e-1)" "prognostic favorable (5.78e-4)" "unprognostic (3.34e-2)" "prognostic unfavorable (1.13e-8)" "unprognostic (8.40e-3)" "unprognostic (1.15e-1)" "unprognostic (1.82e-2)" "prognostic favorable (3.56e-4)" 0.2 0.0 0.2 1.1 0.6 6.5 0.7 0.0 0.5 0.3 0.1 1.7 3.6 0.2 0.2 0.8 0.5 1.7 0.0 0.1 0.1 0.0 0.1 6.6 0.5 0.1 0.2 0.4 0.1 0.1 0.0 0.1 0.1 0.3 1.5 0.0 1.2 0.4 0.0 0.4 5.9 0.2 0.1 0.8 2.8 0.7 0.2 4.2 0.3 0.0 1.5 0.9 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.5 12.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.6 1.6 0.1 0.5 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 1.1 0.5 0.2 0.6 0.0 0.5 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.2 32.7 6.4 25.7 10.4 65.4 30.0 38.9 74.2 33.0 15.8 45.0 58.5 59.6 38.6 33.9 14.7 8.4 27.6 62.5 25.1 92.0 35.6 54.5 39.8 35.3 34.0 28.2 36.2 8.9 65.6 58.5 42.4 18.8 47.0 67.4 22.8 42.8 53.2 53.0 6.7 7.8 25.1 67.1 42.3 44.9 40.3 26.8 50.8 58.7 1.9 54.1 61.1 53.5 9.0 15.7 56.8 21.3 29.7 61.1 48.8 40.3 81.5 31.3 19.6 26.3 21.3 43.7 107.3 33.3 53.8 41.3 13.1 68.0 35.0 39.3 38.5 ITPKA "IP3-3KA, IP3KA" ENSG00000137825 "Inositol-trisphosphate 3-kinase A" P23677 15 41493393-41503551 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.5;intestine: 18.1" "Cell type enhanced" "Detected in some" "Distal enterocytes: 51.4;Early spermatids: 45.4;Gastric mucus-secreting cells: 34.1;Late spermatids: 166.4;Proximal enterocytes: 35.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "MAIT T-cell: 1.4" "Lineage enriched" "Detected in single" 11 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "Hep G2: 33.6;OE19: 18.2" "Low region specificity" "Detected in all" HPA040454 Enhanced Approved Approved "Vesicles,Plasma membrane" No No "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 31: Spermatids - Spermatogenesis" Vesicles "Plasma membrane" "HPA040454: AB_10672897" "unprognostic (5.91e-2)" "unprognostic (2.16e-3)" "unprognostic (4.19e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (6.77e-4)" "unprognostic (2.25e-2)" "unprognostic (2.69e-2)" "unprognostic (1.01e-1)" "unprognostic (3.58e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.76e-9)" "unprognostic (2.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.12e-3)" "unprognostic (2.10e-2)" 0.2 7.3 21.4 0.7 26.7 0.4 0.2 13.8 36.5 1.3 10.9 10.7 17.6 0.3 0.1 0.3 0.5 0.2 2.6 28.7 12.4 0.2 1.7 0.5 0.1 10.9 12.0 0.3 1.9 2.0 0.4 0.3 11.6 0.8 2.7 0.3 1.4 0.3 4.4 0.4 18.1 0.3 11.3 0.2 10.9 10.4 12.1 0.0 0.2 0.0 0.0 0.6 0.9 20.4 7.1 1.9 0.3 7.9 0.0 2.5 14.3 4.3 3.4 2.8 2.9 16.3 0.3 0.0 3.5 0.4 6.3 0.8 3.4 0.3 0.2 6.6 4.3 9.9 4.7 33.6 12.6 3.4 0.5 0.2 0.2 2.7 0.8 1.6 0.2 1.3 12.9 1.9 1.0 4.7 0.3 6.5 0.9 18.2 5.6 1.7 1.4 0.6 0.3 0.4 0.7 1.5 3.2 0.0 0.3 0.0 0.9 5.0 0.3 6.9 7.1 7.7 11.8 1.0 10.8 0.0 12.6 13.2 2.3 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 21.4 26.7 13.8 36.5 28.7 12.4 10.9 12.0 11.6 11.3 12.1 20.4 0.1 0.0 0.0 3.3 0.5 0.1 0.3 0.1 0.0 0.0 0.3 0.0 1.4 0.0 0.1 0.0 0.0 0.6 0.1 51.4 0.0 0.1 45.4 0.3 2.4 0.5 0.0 0.8 23.7 0.7 0.5 0.3 34.1 0.3 0.0 1.0 0.4 0.3 0.2 0.0 0.8 12.0 0.0 0.0 0.0 166.4 2.5 0.4 0.0 1.9 0.0 7.9 0.0 1.5 2.9 0.8 16.1 1.5 0.1 0.1 35.8 0.1 0.1 0.2 6.6 0.3 0.5 14.4 4.9 0.0 0.0 0.1 0.4 0.1 18.7 0.2 ITPRIPL1 KIAA1754L ENSG00000198885 "ITPRIP like 1" Q6GPH6 2 96325317-96330517 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.8" "Group enriched" "Detected in many" 10 "Early spermatids: 170.7;Late spermatids: 145.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 12.9" "Lineage enriched" "Detected in many" 5 "T-cells: 12.9" "Cell line enhanced" "Detected in many" "HEK 293: 30.9;HEL: 32.0;MOLT-4: 34.5;RPMI-8226: 33.0;U-698: 35.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 34: Spermatids - Unknown function" "unprognostic (1.26e-3)" "unprognostic (3.56e-3)" "unprognostic (4.78e-2)" "unprognostic (9.43e-2)" "unprognostic (2.22e-1)" "unprognostic (6.56e-4)" "unprognostic (3.04e-2)" "unprognostic (2.87e-1)" "unprognostic (6.50e-2)" "unprognostic (5.36e-2)" "unprognostic (8.99e-2)" "unprognostic (1.29e-1)" "unprognostic (2.41e-5)" "unprognostic (4.97e-2)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (6.39e-2)" 3.4 0.4 0.5 2.9 1.0 1.1 3.8 3.2 0.7 0.9 0.3 0.9 1.2 0.5 0.5 1.5 0.8 1.6 1.3 0.5 0.5 0.5 0.5 1.4 3.9 0.9 0.5 0.4 1.4 0.5 0.4 1.2 0.8 2.0 0.9 0.9 7.5 1.5 1.5 0.8 1.7 1.0 0.6 2.6 1.2 27.8 0.6 5.1 0.7 2.0 4.2 1.5 1.2 0.8 0.0 0.0 7.3 0.1 0.8 1.9 8.3 1.6 8.7 7.2 14.1 3.3 0.3 0.0 0.1 3.1 0.1 0.7 25.4 0.0 8.1 15.7 30.9 32.0 0.2 14.4 3.9 0.1 0.0 5.4 0.0 8.3 0.0 0.0 4.7 20.4 0.0 10.6 0.2 0.0 34.5 5.0 10.5 0.0 0.0 22.7 23.1 33.0 0.3 0.0 21.2 14.2 0.0 0.0 0.1 4.4 0.0 5.3 2.4 0.0 0.8 0.1 0.1 15.4 21.4 35.3 4.1 0.0 6.8 0.4 0.2 0.0 10.2 0.2 12.9 1.6 3.3 9.7 1.2 0.4 0.7 4.1 0.1 2.7 0.0 0.5 6.3 2.3 0.5 1.0 3.2 0.7 0.5 0.5 0.9 0.5 0.8 0.6 0.6 0.8 9.4 3.2 0.0 0.0 2.3 0.3 4.8 1.8 2.2 0.7 3.6 2.9 0.7 2.8 3.5 0.0 4.2 0.9 6.9 1.0 0.0 0.1 170.7 0.2 0.6 2.7 0.0 1.7 0.2 0.2 2.3 0.9 0.5 0.1 0.0 0.8 0.0 0.0 2.1 0.0 0.0 0.3 0.0 0.3 2.4 145.2 1.2 1.8 1.8 0.0 0.3 4.3 11.3 0.0 0.0 0.3 0.1 0.7 7.6 3.3 0.0 0.3 0.8 1.7 6.6 0.6 2.9 3.6 2.8 1.7 1.0 0.4 14.8 0.3 0.4 1.3 KCNH3 "BEC1, elk2, Kv12.2" ENSG00000135519 "Potassium voltage-gated channel subfamily H member 3" Q9ULD8 12 49539030-49558337 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 39.4;pituitary gland: 25.7" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 11.4;Excitatory neurons: 58.2;Inhibitory neurons: 19.2;Late spermatids: 10.6;Respiratory ciliated cells: 10.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.8" "Group enriched" "Detected in many" 21 "amygdala: 29.6;basal ganglia: 25.6;cerebral cortex: 39.4;hippocampal formation: 30.6;white matter: 24.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.8;AN3-CA: 3.5;HMC-1: 3.4;RPTEC TERT1: 9.1;U-2 OS: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051088 Approved Nucleoplasm,Mitochondria NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Mitochondria" "HPA051088: AB_2681340" "unprognostic (5.69e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-4)" "unprognostic (8.24e-3)" "unprognostic (7.54e-2)" "unprognostic (2.38e-2)" "unprognostic (3.63e-2)" "unprognostic (2.66e-1)" "unprognostic (9.91e-3)" "unprognostic (5.28e-2)" "unprognostic (6.39e-5)" "unprognostic (1.68e-1)" "unprognostic (1.07e-4)" "unprognostic (5.52e-3)" "unprognostic (2.67e-1)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" 0.3 2.9 29.6 0.0 25.6 0.2 0.6 0.0 39.4 0.8 0.0 0.2 0.1 0.6 0.1 0.1 5.8 0.3 0.8 30.6 1.3 3.4 0.3 1.0 0.5 0.0 0.2 0.3 1.3 2.6 25.7 0.0 0.6 0.7 0.0 0.0 0.3 0.3 0.1 0.3 0.3 0.0 0.0 1.4 0.3 2.8 1.4 0.2 1.3 0.0 0.2 0.1 0.3 24.8 0.4 5.8 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.2 1.7 0.6 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 9.1 0.0 0.9 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 29.6 25.6 0.0 39.4 30.6 1.3 0.0 0.2 0.6 0.0 1.4 24.8 0.1 0.0 0.5 4.9 0.0 0.1 0.2 0.5 0.0 0.1 0.1 2.0 1.0 5.7 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.2 6.0 11.4 0.4 0.1 2.4 0.0 58.2 0.0 0.1 0.6 0.0 0.5 0.0 2.4 0.7 0.0 0.0 1.7 19.2 0.0 0.0 0.6 0.5 10.6 0.3 0.6 0.0 1.0 0.7 0.4 2.1 6.0 2.6 0.1 0.1 1.2 0.1 0.0 0.0 0.2 10.9 0.3 0.0 0.4 0.3 1.1 3.4 0.0 0.3 0.0 0.7 0.0 0.2 0.0 KCTD1 C18orf5 ENSG00000134504 "Potassium channel tetramerization domain containing 1" Q719H9 18 26454910-26657401 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 106.4;Distal tubular cells: 117.4;Excitatory neurons: 283.7;Squamous epithelial cells: 109.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 106.6;HaCaT: 113.5;hTCEpi: 100.6;RPTEC TERT1: 97.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057808, HPA062486" Approved "Nucleoplasm,Nucleoli,Cytokinetic bridge,Centriolar satellite" Yes NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "Nucleoli, Cytokinetic bridge, Centriolar satellite" "HPA057808: , HPA062486: " "unprognostic (1.15e-3)" "unprognostic (5.66e-2)" "unprognostic (2.35e-4)" "prognostic unfavorable (2.22e-4)" "unprognostic (3.65e-3)" "unprognostic (7.43e-2)" "unprognostic (2.03e-3)" "unprognostic (6.77e-2)" "unprognostic (2.74e-1)" "unprognostic (1.88e-3)" "unprognostic (5.68e-3)" "unprognostic (1.77e-2)" "prognostic favorable (4.60e-8)" "unprognostic (3.87e-3)" "unprognostic (7.39e-2)" "unprognostic (1.50e-1)" "unprognostic (8.02e-2)" 7.8 16.5 21.7 2.7 41.5 0.6 32.4 14.0 44.3 19.2 9.5 9.7 4.1 14.2 22.6 50.6 50.2 8.4 23.8 31.2 10.3 28.8 3.5 5.5 2.7 9.8 13.6 15.1 7.4 12.0 10.8 11.4 9.2 21.6 10.6 18.4 19.9 22.6 5.1 61.1 3.7 12.5 10.2 3.9 10.3 5.9 13.7 17.6 19.9 6.9 14.3 13.0 36.9 29.6 17.5 55.1 106.6 11.6 61.8 9.7 13.4 14.3 21.5 22.0 21.9 5.1 19.1 2.9 52.2 30.5 18.0 113.5 20.5 30.6 20.6 2.2 8.7 3.1 10.2 8.2 11.1 1.7 4.7 16.7 100.6 6.2 41.4 28.0 21.0 24.1 1.3 1.2 16.0 24.5 16.3 5.2 10.5 57.1 27.1 8.5 5.7 2.3 97.8 25.2 10.3 40.5 20.7 27.5 8.7 61.3 24.1 4.0 11.7 24.4 6.8 4.8 15.0 4.8 4.1 0.4 8.7 11.0 36.8 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 41.5 14.0 44.3 31.2 10.3 9.8 13.6 9.2 10.2 13.7 29.6 3.0 3.2 4.1 80.0 0.7 31.7 55.9 17.2 106.4 5.0 27.3 29.7 13.9 8.6 15.0 25.8 8.4 45.5 0.8 6.2 117.4 8.3 28.0 47.0 7.8 2.9 1.2 0.8 283.7 3.6 7.6 5.5 7.1 42.4 0.0 66.3 2.5 1.7 4.4 21.9 66.1 4.3 20.3 0.8 1.7 12.0 5.3 1.2 23.2 16.9 0.4 21.4 1.0 81.4 42.1 11.8 2.4 3.0 6.6 36.4 0.4 10.7 29.3 5.9 0.0 2.7 6.2 1.8 5.1 109.0 44.5 33.2 1.0 6.3 4.0 51.2 KDSR "DHSR, FVT1, SDR35C1" ENSG00000119537 "3-ketodihydrosphingosine reductase" Q06136 18 63327726-63367228 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Oxidoreductase "Cancer-related genes, Disease variant, Palmoplantar keratoderma, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 90.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003673, HPA044884" Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 29: U-266 - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" "CAB003673: AB_425440, HPA044884: AB_2679131" "unprognostic (4.44e-2)" "unprognostic (8.57e-2)" "unprognostic (2.52e-2)" "unprognostic (4.56e-2)" "unprognostic (5.88e-3)" "unprognostic (7.50e-3)" "unprognostic (1.80e-2)" "unprognostic (2.66e-1)" "unprognostic (2.97e-1)" "unprognostic (1.97e-1)" "unprognostic (2.70e-2)" "unprognostic (6.81e-2)" "prognostic favorable (9.53e-6)" "unprognostic (3.32e-2)" "unprognostic (5.77e-2)" "unprognostic (2.22e-1)" "unprognostic (2.16e-3)" 32.3 22.4 12.8 8.1 19.9 4.8 25.4 19.5 16.7 26.9 12.3 24.6 7.0 22.7 20.8 22.4 18.9 12.6 20.7 12.7 16.4 20.1 36.7 21.5 7.0 20.6 17.7 21.3 15.7 13.1 12.1 8.5 20.0 16.3 7.4 7.0 22.8 11.6 16.7 44.5 15.1 13.3 17.6 8.4 16.4 6.1 16.6 7.1 17.2 8.9 6.8 23.9 23.4 22.4 14.9 6.5 6.7 7.5 52.6 39.0 13.0 48.8 29.7 10.5 13.9 2.7 10.0 15.1 20.3 19.1 17.4 64.6 8.7 27.3 12.8 28.6 14.5 11.6 8.7 3.4 40.1 22.0 7.8 37.4 50.7 16.8 47.9 19.3 10.5 9.9 9.5 21.0 28.1 6.2 23.6 9.7 8.0 3.7 23.5 15.5 19.7 21.9 29.0 9.6 8.5 16.4 23.4 11.3 21.9 8.8 6.1 12.1 24.9 44.0 10.6 14.8 21.3 90.4 44.9 8.7 33.2 13.0 13.4 0.1 5.2 0.5 6.5 8.1 26.6 5.7 13.6 10.2 8.0 4.7 9.3 6.1 1.3 14.2 3.9 3.8 19.1 5.3 12.8 19.9 19.5 16.7 12.7 16.4 20.6 17.7 20.0 17.6 16.6 22.4 53.1 35.3 49.1 21.9 30.1 158.6 131.7 47.0 122.3 37.4 63.4 63.6 27.7 62.9 43.5 38.6 27.1 58.8 15.6 34.6 15.6 50.7 1.0 43.9 53.0 48.1 20.4 17.4 19.1 36.7 70.4 82.0 26.5 64.9 26.0 52.3 51.8 88.3 36.4 40.4 24.2 31.8 42.7 32.2 47.7 6.5 71.1 39.9 56.9 14.0 31.5 56.5 13.4 21.6 57.0 47.4 44.6 70.7 24.5 104.3 43.4 39.6 41.2 41.1 32.9 73.7 48.4 1.3 5.2 89.7 143.1 91.4 37.7 51.1 40.3 94.7 KEAP1 "INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454" ENSG00000079999 "Kelch like ECH associated protein 1" Q14145 19 10486125-10503558 "Cancer-related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 178.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005558, CAB025337" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Centriolar satellite" Cytosol "CAB025337: , HPA005558: AB_1079175" "unprognostic (1.98e-1)" "prognostic favorable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.02e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-2)" "unprognostic (2.64e-2)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (5.22e-3)" "unprognostic (2.04e-1)" "unprognostic (9.99e-2)" "unprognostic (1.29e-1)" "unprognostic (7.71e-3)" "unprognostic (5.06e-1)" "unprognostic (8.18e-2)" "unprognostic (1.60e-2)" 31.3 41.2 54.8 20.5 61.6 20.4 30.3 61.8 60.9 32.7 49.7 37.6 26.5 31.3 22.2 55.4 28.9 24.3 60.7 53.2 59.4 32.5 60.9 25.3 23.2 61.4 60.5 25.3 32.8 24.3 30.0 17.0 60.3 36.8 16.5 16.4 34.7 24.9 178.2 38.7 27.5 18.7 58.8 32.2 33.2 20.5 59.6 23.0 35.6 75.7 18.5 41.4 36.3 68.4 58.0 102.8 27.2 35.1 55.8 45.4 30.3 48.1 35.9 46.6 41.6 73.7 54.2 82.9 122.9 53.3 34.8 49.7 55.6 36.9 23.7 78.3 61.7 126.3 29.9 87.9 54.5 65.4 63.9 50.0 51.0 53.5 25.1 39.1 46.3 23.7 79.1 135.4 41.6 79.9 46.1 177.8 80.8 54.2 88.6 84.6 34.8 95.1 30.4 67.4 75.3 40.4 66.8 42.4 42.1 23.9 37.8 82.3 56.5 72.9 41.0 86.0 57.0 86.8 113.0 81.1 58.0 78.5 56.0 36.4 37.9 41.4 55.3 33.8 53.1 26.3 38.5 52.0 45.4 11.7 23.6 33.7 20.9 42.5 34.6 31.4 50.2 41.8 54.8 61.6 61.8 60.9 53.2 59.4 61.4 60.5 60.3 58.8 59.6 68.4 18.3 28.9 20.8 5.5 13.8 21.9 24.4 40.3 27.9 21.5 15.7 11.4 24.0 21.5 25.4 11.0 8.4 27.3 11.6 33.2 13.7 32.8 27.5 13.4 17.1 27.8 26.9 45.2 5.3 36.3 25.2 23.5 18.8 13.3 12.0 22.8 35.3 34.4 29.0 26.9 5.9 21.4 40.7 15.1 13.4 43.9 29.2 16.1 10.6 3.7 41.8 43.0 7.2 11.6 18.3 29.8 27.1 25.9 26.6 33.3 36.8 24.9 17.2 13.9 13.1 17.7 22.4 21.2 16.6 34.7 22.0 26.8 20.1 29.6 31.5 24.8 KHDRBS1 "FLJ34027, p62, Sam68" ENSG00000121774 "KH RNA binding domain containing, signal transduction associated 1" Q07666 1 32013868-32060850 "Predicted intracellular proteins" "Cell cycle, mRNA processing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005355, HPA051280, HPA056813" Supported Enhanced Nucleoplasm NA NA 110000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "CAB005355: AB_631869, HPA051280: AB_2681417, HPA056813: AB_2683240" "unprognostic (1.31e-1)" "unprognostic (3.01e-2)" "unprognostic (1.22e-2)" "unprognostic (1.55e-1)" "unprognostic (2.09e-1)" "unprognostic (6.55e-2)" "prognostic unfavorable (3.68e-5)" "unprognostic (5.01e-2)" "unprognostic (2.51e-3)" "unprognostic (4.03e-2)" "unprognostic (2.17e-2)" "unprognostic (1.91e-3)" "prognostic unfavorable (9.32e-4)" "unprognostic (1.08e-1)" "unprognostic (1.45e-1)" "unprognostic (1.26e-1)" "unprognostic (7.03e-2)" 59.8 47.4 36.3 67.0 38.8 93.3 61.7 44.7 37.4 59.5 34.8 62.9 62.3 82.6 47.2 57.3 70.3 48.6 56.8 36.6 39.7 54.0 50.6 52.1 94.1 40.7 38.7 110.6 50.9 61.7 38.3 63.7 38.1 55.1 57.3 58.5 45.2 55.8 45.9 57.3 59.2 65.6 44.1 64.0 52.3 42.2 37.2 112.2 63.8 40.6 96.7 62.2 47.6 46.7 204.6 121.0 272.6 201.6 92.5 115.4 159.5 120.7 152.1 221.5 185.5 136.2 178.1 302.9 131.5 153.5 128.4 139.2 221.9 165.1 225.6 181.7 188.8 191.1 111.8 188.0 121.5 256.2 123.8 127.6 92.7 168.9 132.8 145.6 212.6 183.1 251.0 136.5 172.6 132.6 379.2 218.7 277.0 127.3 144.3 300.1 230.2 257.7 156.0 203.7 185.7 241.7 175.7 148.8 157.2 192.9 177.3 183.7 160.5 143.9 154.5 155.3 205.9 140.3 163.5 296.0 149.2 202.3 112.1 5.8 5.7 5.9 7.8 8.9 11.7 9.9 9.2 8.2 7.8 8.0 9.8 9.5 5.0 8.0 7.5 8.9 9.3 3.0 36.3 38.8 44.7 37.4 36.6 39.7 40.7 38.7 38.1 44.1 37.2 46.7 130.6 38.5 77.4 40.8 181.9 147.6 200.3 58.8 183.2 94.8 111.1 109.9 104.4 97.2 89.8 69.9 50.1 192.7 131.9 87.9 84.1 96.2 24.7 122.5 154.4 125.7 117.8 131.6 46.0 103.1 234.5 132.4 103.5 127.0 128.1 224.5 99.6 64.6 120.8 63.9 48.1 101.1 28.5 141.9 148.4 21.7 111.2 139.2 108.5 36.5 142.6 142.6 105.0 43.7 59.6 107.1 76.2 124.1 141.8 136.4 74.5 123.8 93.3 89.3 92.1 140.4 157.9 198.2 122.7 173.8 130.6 173.5 161.7 138.7 152.0 167.1 KIAA1217 "DKFZP761L0424, ETL4, SKT" ENSG00000120549 KIAA1217 Q5T5P2 10 23694746-24547848 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 108.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 609.1;Inhibitory neurons: 1251.8;Oligodendrocyte precursor cells: 255.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 82.6;Karpas-707: 75.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004941 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 28: BEWO - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Cytosol" "HPA004941: AB_2130659" "unprognostic (3.60e-2)" "unprognostic (7.55e-3)" "unprognostic (1.20e-1)" "unprognostic (2.73e-2)" "unprognostic (1.27e-1)" "unprognostic (4.45e-3)" "unprognostic (1.60e-3)" "unprognostic (2.03e-3)" "unprognostic (1.87e-2)" "unprognostic (4.62e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.69e-1)" "unprognostic (1.84e-3)" "unprognostic (5.27e-2)" "unprognostic (2.44e-1)" "unprognostic (2.97e-1)" "unprognostic (1.22e-1)" 28.4 16.5 9.8 3.5 12.1 0.2 30.5 2.2 9.6 15.7 42.2 13.1 12.9 6.0 13.3 30.9 16.9 14.7 17.8 27.5 2.0 18.0 17.5 14.4 2.6 6.0 11.2 13.1 13.6 42.8 6.5 20.9 5.7 20.5 14.7 23.7 39.2 22.5 108.4 17.6 11.3 3.3 0.5 7.5 17.4 15.7 4.2 12.6 33.6 52.7 9.3 12.1 19.1 17.2 19.5 9.7 3.8 0.1 2.4 6.8 82.6 3.7 6.0 8.6 18.2 16.6 30.3 1.0 18.6 7.6 17.6 31.5 4.7 36.2 9.5 7.2 3.4 0.4 23.1 19.4 4.2 0.0 0.3 25.3 22.8 19.0 5.2 3.9 0.0 1.7 0.0 75.7 4.4 6.8 10.8 0.6 8.5 18.9 8.7 0.8 22.0 16.2 20.1 25.3 2.4 1.3 9.4 31.4 0.0 38.3 15.2 0.0 20.3 13.1 14.1 52.9 4.9 33.4 30.4 0.1 43.4 0.5 0.6 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.8 12.1 2.2 9.6 27.5 2.0 6.0 11.2 5.7 0.5 4.2 17.2 149.7 38.5 34.4 27.4 1.0 121.3 74.1 58.0 145.1 13.6 38.8 39.0 39.1 24.3 73.7 33.1 8.4 50.2 0.4 52.5 3.9 32.3 33.7 64.5 19.6 34.4 23.9 0.0 609.1 26.2 21.2 23.3 50.0 85.9 1.3 6.6 25.0 24.8 5.3 0.0 1251.8 22.8 26.4 14.6 7.8 11.3 17.7 1.3 1.8 30.0 0.0 93.6 0.0 255.9 10.3 24.1 22.7 33.1 3.1 36.8 15.4 6.3 36.9 3.1 13.1 19.6 20.4 0.8 1.1 96.4 51.0 65.1 2.2 14.2 19.4 43.7 KLF12 "AP-2rep, AP2REP, HSPC122" ENSG00000118922 "Kruppel like factor 12" Q9Y4X4 13 73686089-73995056 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 9 "Astrocytes: 319.3;Excitatory neurons: 211.9;Inhibitory neurons: 562.2;Microglial cells: 208.9;Oligodendrocyte precursor cells: 760.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064146, HPA075652" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Cytosol "HPA064146: AB_2685198, HPA075652: " "unprognostic (1.49e-1)" "unprognostic (7.65e-2)" "unprognostic (7.79e-2)" "prognostic unfavorable (5.03e-6)" "unprognostic (1.35e-1)" "unprognostic (3.01e-1)" "unprognostic (9.22e-2)" "unprognostic (8.59e-2)" "unprognostic (5.19e-2)" "unprognostic (3.70e-2)" "unprognostic (2.60e-2)" "unprognostic (3.47e-2)" "unprognostic (1.01e-3)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (1.02e-1)" "unprognostic (6.67e-3)" 2.9 1.9 4.1 6.1 2.9 3.0 2.9 5.5 5.3 2.3 2.7 3.7 1.5 3.6 11.2 2.0 2.8 3.0 5.3 5.6 4.5 5.5 9.9 2.6 11.3 3.3 4.9 5.2 0.9 0.8 3.4 0.8 3.6 2.5 2.9 8.9 1.4 3.2 3.6 1.6 3.6 3.4 3.1 7.6 2.7 1.6 5.1 10.3 1.6 8.5 9.8 2.6 2.0 3.5 0.0 1.4 13.6 0.0 7.5 16.3 0.1 5.4 2.7 5.9 6.2 1.1 3.4 10.5 2.5 8.1 2.3 3.7 3.6 4.2 15.7 6.9 4.9 0.4 6.3 0.0 2.4 7.0 2.5 14.3 1.1 8.4 6.7 11.4 11.9 8.0 0.0 2.6 18.0 1.1 13.6 0.0 1.9 0.5 2.7 7.4 4.9 0.1 3.3 0.2 3.2 13.8 3.8 1.7 6.3 5.0 0.4 1.1 0.1 11.4 3.5 5.2 2.6 7.0 9.6 3.3 20.2 0.0 5.9 0.6 0.0 0.0 2.0 0.2 2.4 0.8 1.7 2.3 0.2 0.7 1.2 1.9 0.0 1.4 0.3 0.4 0.9 0.8 4.1 2.9 5.5 5.3 5.6 4.5 3.3 4.9 3.6 3.1 5.1 3.5 6.6 6.4 1.8 319.3 30.5 4.2 1.3 4.3 0.6 20.8 5.4 6.2 18.7 5.7 3.7 3.7 37.5 0.1 35.4 3.0 3.9 2.1 0.8 4.6 18.8 8.4 0.0 7.8 211.9 0.0 0.1 12.3 2.0 6.3 0.0 29.2 5.0 20.3 0.1 8.4 562.2 1.5 10.2 8.0 12.1 1.6 20.8 5.0 3.6 208.9 6.4 11.2 43.3 760.0 25.4 0.4 3.2 28.6 21.9 3.3 0.2 7.0 6.0 13.1 0.0 12.2 18.1 0.5 3.5 0.7 6.7 0.1 40.3 4.9 3.9 1.8 KLRB1 "CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A" ENSG00000111796 "Killer cell lectin like receptor B1" Q12918 12 9594551-9607916 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 47.4;lymphoid tissue: 36.4" "Group enriched" "Detected in many" 9 "dendritic cells: 642.3;NK-cells: 1855.8;T-cells: 790.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in all" "MAIT T-cell: 2177.1" "Group enriched" "Detected in all" 140 "NK-cells: 756.7;T-cells: 2177.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA039113 Approved Uncertain Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm Cytosol "HPA039113: AB_10674979" "prognostic favorable (3.51e-5)" "unprognostic (1.23e-3)" "unprognostic (7.03e-3)" "prognostic favorable (1.42e-5)" "unprognostic (1.69e-1)" "prognostic favorable (6.99e-5)" "unprognostic (1.54e-3)" "unprognostic (7.15e-3)" "unprognostic (4.12e-1)" "unprognostic (8.23e-3)" "unprognostic (3.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "prognostic favorable (5.61e-4)" "unprognostic (1.17e-2)" 3.1 1.7 0.7 17.8 0.8 47.4 5.1 0.3 0.8 4.2 0.2 7.7 10.7 1.6 1.4 3.2 1.5 10.7 0.7 0.6 0.7 1.4 11.3 6.7 20.1 0.6 0.6 1.0 0.4 0.2 0.3 1.4 0.6 2.1 8.1 0.1 0.8 1.0 0.7 0.8 20.1 1.6 0.6 28.9 10.1 0.6 0.6 5.7 1.3 0.9 36.4 10.6 1.3 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.3 0.0 0.4 0.2 9.5 2.2 1.1 519.7 2.1 2177.1 1.6 307.4 346.1 1.9 1.5 17.1 98.0 10.5 756.7 3.6 3.9 77.9 285.3 0.7 0.8 0.3 0.8 0.6 0.7 0.6 0.6 0.6 0.6 0.6 0.8 6.1 0.0 8.9 0.0 19.0 9.7 0.9 0.0 1.2 0.0 5.2 2.5 1.0 4.3 1.3 0.0 0.0 0.4 642.3 1.7 0.0 0.6 0.0 1.9 1.5 6.2 0.0 118.1 0.4 0.0 0.1 7.9 12.2 2.4 0.0 0.0 45.3 10.1 0.9 0.0 0.6 1.0 0.0 36.2 15.8 0.0 0.0 13.2 24.9 0.0 28.1 0.0 1855.8 2.5 0.1 0.0 3.3 0.0 23.0 1.1 0.9 2.0 0.0 0.0 0.0 1.6 4.1 0.0 0.1 1.2 8.8 1.0 790.5 0.0 2.0 1.3 KLRG1 "2F1, CLEC15A, MAFA, MAFA-L" ENSG00000139187 "Killer cell lectin like receptor G1" Q96E93 12 8950044-9010760 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 10.4" "Group enriched" "Detected in many" 4 "dendritic cells: 93.7;granulocytes: 118.9;NK-cells: 164.8;T-cells: 109.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "gdT-cell: 390.9;MAIT T-cell: 461.3" "Lineage enriched" "Detected in all" 22 "T-cells: 461.3" "Cell line enhanced" "Detected in many" "HEL: 25.1;NTERA-2: 22.1;U-937: 17.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051403, HPA076494" Approved Enhanced Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA051403: , HPA076494: AB_2686800" "unprognostic (1.54e-2)" "unprognostic (8.42e-4)" "unprognostic (1.06e-1)" "unprognostic (1.28e-1)" "unprognostic (2.94e-1)" "unprognostic (1.53e-4)" "unprognostic (3.05e-1)" "unprognostic (2.27e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-2)" "unprognostic (3.45e-3)" "unprognostic (6.88e-2)" "unprognostic (1.71e-2)" "unprognostic (2.05e-2)" "unprognostic (4.17e-2)" "unprognostic (4.96e-2)" "unprognostic (7.86e-2)" 4.1 1.7 2.4 3.8 2.6 3.0 2.5 4.3 2.9 1.3 1.4 1.5 1.0 1.2 2.1 1.0 1.0 3.3 2.0 2.1 3.2 1.4 3.0 2.2 10.4 2.5 3.4 1.0 0.5 0.4 1.1 0.6 2.3 1.1 1.9 1.3 1.6 0.7 1.7 1.0 2.2 1.6 1.7 8.8 1.6 1.1 2.6 2.5 1.0 1.8 5.0 2.4 0.8 3.8 0.2 3.1 1.6 2.3 3.0 0.7 1.4 0.5 0.3 0.4 1.1 1.1 1.1 4.9 0.1 0.4 2.1 0.2 3.3 0.5 0.4 3.6 1.9 25.1 0.4 1.6 0.8 1.1 1.6 1.4 0.4 0.5 0.0 0.4 7.6 2.5 1.4 0.4 0.2 0.7 1.0 2.0 22.1 1.0 1.7 1.2 1.0 0.0 0.5 0.4 0.4 4.4 1.1 0.5 1.6 4.3 0.3 1.7 0.8 0.7 1.0 0.6 1.4 1.4 4.1 2.6 1.8 17.3 0.2 17.5 2.6 1.5 390.9 2.9 461.3 4.2 85.1 237.7 8.2 5.0 23.5 147.7 5.7 20.9 5.4 3.9 8.7 99.7 2.4 2.6 4.3 2.9 2.1 3.2 2.5 3.4 2.3 1.7 2.6 3.8 12.7 0.0 4.3 2.9 4.7 0.4 0.4 0.0 4.0 5.0 1.0 0.9 2.8 1.5 0.1 0.0 8.4 1.0 93.7 0.1 1.9 0.7 1.6 0.8 0.6 2.9 1.2 24.6 3.8 0.2 0.5 1.3 0.5 0.5 118.9 0.9 25.7 2.0 3.4 5.0 3.6 0.1 0.0 9.1 1.4 3.1 0.6 3.7 1.8 2.8 5.4 1.8 164.8 9.5 6.2 0.3 0.1 0.0 16.9 0.2 0.3 3.1 0.1 3.9 0.0 2.1 1.0 7.8 7.3 1.3 0.0 0.3 109.3 0.7 0.6 0.1 LATS2 ENSG00000150457 "Large tumor suppressor kinase 2" Q9NRM7 13 20973036-21061586 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 139.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039191, HPA049037" Approved Supported "Centriolar satellite,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 44: Endometrium - Transcription" "Centriolar satellite, Cytosol" "HPA039191: AB_2676385, HPA049037: AB_2680609" "unprognostic (2.77e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (6.22e-3)" "unprognostic (3.38e-2)" "unprognostic (2.51e-2)" "unprognostic (1.84e-2)" "unprognostic (1.88e-1)" "unprognostic (2.16e-3)" "unprognostic (4.48e-1)" "unprognostic (6.57e-3)" "unprognostic (8.03e-2)" "unprognostic (4.92e-2)" "unprognostic (7.85e-2)" "unprognostic (1.66e-2)" "unprognostic (1.25e-1)" "unprognostic (7.97e-2)" "unprognostic (1.11e-2)" 19.8 12.2 3.9 7.3 4.3 15.1 12.4 4.8 3.7 10.1 7.7 13.1 2.9 12.2 3.0 11.5 9.7 15.1 11.5 5.3 3.3 9.9 9.8 12.4 5.3 5.4 4.6 11.0 10.2 4.3 2.3 13.9 4.5 9.8 4.3 1.3 6.1 8.8 16.7 7.7 6.2 13.1 4.1 11.2 7.8 14.6 5.1 2.4 13.5 13.3 3.3 14.2 8.9 4.7 6.8 7.4 16.0 9.7 18.4 24.1 14.6 22.1 22.8 22.5 19.2 21.1 10.0 0.0 10.5 33.8 8.8 9.6 9.5 10.1 33.1 3.8 2.5 12.4 9.4 16.0 28.6 3.4 4.2 36.0 18.1 14.9 9.9 11.3 32.0 2.8 2.3 0.5 28.9 11.7 0.4 11.6 3.8 7.0 3.5 2.9 28.5 0.0 16.3 3.1 0.3 0.0 17.4 11.3 23.9 13.9 9.8 6.4 40.6 23.8 15.9 17.7 14.1 2.9 1.7 0.0 5.7 3.8 18.6 0.1 0.5 0.5 0.4 0.4 0.9 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.9 0.4 0.2 0.0 0.0 0.1 3.9 4.3 4.8 3.7 5.3 3.3 5.4 4.6 4.5 4.1 5.1 4.7 36.6 41.7 9.9 12.1 2.8 32.9 14.7 8.5 21.6 0.4 12.5 11.0 24.3 15.7 10.5 5.5 0.0 24.8 21.0 6.5 3.9 10.1 139.4 40.3 30.4 35.1 0.0 8.2 0.6 7.3 8.9 37.2 8.6 62.1 5.1 9.8 44.6 19.6 9.9 0.0 0.6 1.9 6.1 17.9 49.3 13.7 25.4 26.0 17.8 21.5 11.0 4.9 13.4 2.0 8.8 18.6 2.8 34.6 8.9 21.7 0.6 9.5 11.6 1.0 6.6 32.3 30.0 8.8 14.5 9.9 25.3 48.0 8.1 7.9 1.5 15.2 LIN52 C14orf46 ENSG00000205659 "Lin-52 DREAM MuvB core complex component" Q52LA3 14 74084796-74201235 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 47.5;Inhibitory neurons: 65.4;Oligodendrocyte precursor cells: 60.3;Oligodendrocytes: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000900, HPA001777" Uncertain Approved "Nuclear speckles" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear speckles" "HPA000900: AB_2135058, HPA001777: AB_2666431" "unprognostic (2.34e-2)" "unprognostic (6.51e-3)" "unprognostic (1.86e-1)" "unprognostic (1.94e-1)" "unprognostic (7.90e-3)" "prognostic favorable (6.60e-4)" "prognostic unfavorable (6.08e-5)" "unprognostic (2.48e-3)" "unprognostic (9.34e-2)" "unprognostic (8.65e-2)" "unprognostic (1.39e-3)" "unprognostic (3.18e-1)" "unprognostic (1.74e-3)" "unprognostic (1.20e-2)" "unprognostic (8.28e-2)" "unprognostic (2.43e-2)" "unprognostic (1.04e-1)" 8.0 7.8 8.4 5.4 8.4 3.5 6.3 8.8 10.1 5.8 7.8 4.5 6.5 7.0 5.7 4.9 5.5 4.9 10.2 8.3 10.0 19.3 6.6 5.0 6.1 9.2 8.9 8.5 3.4 6.8 5.7 5.0 9.3 6.4 5.7 10.7 3.9 5.6 5.6 3.8 5.8 6.8 7.9 5.1 4.3 7.5 8.9 10.7 5.1 10.0 6.3 5.8 3.9 8.5 10.5 7.7 26.8 12.8 15.5 6.6 10.5 17.5 16.7 23.0 25.7 14.0 9.6 5.9 5.3 8.6 9.2 9.2 20.4 6.9 35.1 49.1 8.1 9.1 8.9 20.0 16.6 9.4 12.7 8.2 7.7 12.2 15.9 6.3 11.0 18.6 9.7 27.8 11.4 13.4 14.9 12.3 7.7 13.8 12.3 19.0 25.1 9.6 6.0 6.2 19.0 15.5 16.4 12.0 13.7 9.9 16.3 13.5 6.3 10.8 20.3 11.5 14.8 18.2 41.8 13.2 12.5 10.7 18.4 6.2 6.4 20.6 10.7 6.6 16.6 8.7 9.3 10.7 8.6 9.4 13.7 12.5 3.2 11.4 4.8 7.9 13.9 10.1 8.4 8.4 8.8 10.1 8.3 10.0 9.2 8.9 9.3 7.9 8.9 8.5 5.6 9.6 9.0 39.8 10.4 4.8 3.2 3.2 11.4 8.8 7.6 5.3 10.0 10.0 6.6 5.5 8.4 6.3 8.8 3.5 7.9 3.1 0.8 5.9 6.6 7.4 3.0 16.4 47.5 2.4 5.2 8.1 6.1 6.7 2.5 9.0 6.4 12.2 6.3 16.8 65.4 6.0 4.1 4.3 3.7 1.6 5.3 4.5 0.0 26.2 6.6 10.8 10.3 60.3 60.4 2.4 5.0 9.8 27.3 3.3 10.9 22.4 6.2 7.5 6.6 8.1 6.4 16.3 10.4 10.3 5.5 8.8 8.2 3.7 4.7 1.4 LMAN2L "DKFZp564L2423, VIPL" ENSG00000114988 "Lectin, mannose binding 2 like" Q9H0V9 2 96705929-96740064 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026600 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA026600: AB_1852939" "unprognostic (3.02e-1)" "unprognostic (2.34e-1)" "unprognostic (2.17e-3)" "unprognostic (1.83e-2)" "unprognostic (2.19e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-2)" "unprognostic (4.21e-2)" "unprognostic (2.43e-2)" "unprognostic (1.80e-1)" "unprognostic (6.91e-3)" "unprognostic (1.16e-1)" "unprognostic (5.30e-2)" "unprognostic (8.14e-2)" "unprognostic (2.17e-1)" "unprognostic (1.52e-1)" "unprognostic (3.29e-1)" 10.1 11.0 16.5 4.9 17.4 1.3 12.2 16.6 20.0 15.8 15.9 14.4 5.6 13.8 17.2 9.5 17.1 6.7 19.2 16.6 21.9 17.9 18.1 9.8 5.9 18.1 17.7 21.1 11.9 13.7 17.3 11.6 17.9 15.0 10.6 7.7 10.9 13.6 16.7 11.0 8.2 15.6 16.7 8.6 10.8 11.2 22.9 9.1 15.5 19.1 7.1 13.2 12.5 17.2 21.1 33.3 25.6 26.6 31.9 15.1 23.4 19.3 23.9 39.9 43.5 57.4 15.7 10.2 71.4 47.8 99.2 25.1 36.9 30.2 50.2 27.1 20.4 8.9 21.4 49.0 20.1 15.3 14.3 17.4 28.2 30.5 9.6 34.7 23.7 17.2 20.3 20.5 25.5 14.5 11.0 14.5 13.9 14.9 36.0 23.1 21.1 11.6 32.9 10.9 16.2 8.5 21.8 16.6 20.1 46.8 19.8 26.4 17.3 31.8 22.7 25.1 25.9 13.3 46.1 8.6 18.8 18.1 26.3 37.8 17.5 22.4 14.0 10.6 32.0 20.0 16.2 18.9 14.5 16.9 19.6 16.6 9.5 15.9 16.0 20.8 14.8 18.5 16.5 17.4 16.6 20.0 16.6 21.9 18.1 17.7 17.9 16.7 22.9 17.2 4.7 12.8 6.8 12.4 3.2 3.4 5.4 11.1 2.2 3.1 10.5 7.6 12.2 5.7 6.3 12.9 6.2 17.9 5.2 5.4 9.8 13.7 20.6 4.6 6.9 6.1 9.5 6.5 13.4 7.8 10.4 11.8 2.0 5.6 5.1 16.8 9.3 10.7 9.9 1.7 13.4 5.0 0.0 5.6 1.4 18.0 6.8 2.7 3.6 7.5 12.3 12.2 6.2 11.1 11.0 7.5 3.8 8.6 3.1 4.5 4.6 10.1 6.3 5.1 13.1 4.4 8.1 13.3 14.0 2.5 2.7 13.4 4.0 8.6 6.5 2.1 LONRF3 "FLJ22612, RNF127" ENSG00000175556 "LON peptidase N-terminal domain and ring finger 3" Q496Y0 X 118974614-119018355 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 16.9;Gastric mucus-secreting cells: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 3.8" "Lineage enriched" "Detected in single" 7 "T-cells: 3.8" "Cell line enhanced" "Detected in many" "GAMG: 12.2;K-562: 13.8;OE19: 15.2;PC-3: 16.0;SiHa: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050422, HPA061162" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 41: Macrophages - Immune response" Nucleoplasm "Plasma membrane" "HPA050422: AB_2681122, HPA061162: AB_2732658" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.24e-1)" "unprognostic (1.92e-1)" "unprognostic (4.24e-2)" "unprognostic (1.64e-1)" "unprognostic (6.06e-3)" "unprognostic (1.29e-2)" "unprognostic (3.21e-1)" "unprognostic (8.01e-2)" "prognostic unfavorable (4.32e-4)" "unprognostic (4.29e-2)" "unprognostic (2.31e-3)" "unprognostic (6.34e-2)" "unprognostic (6.16e-2)" "unprognostic (1.70e-1)" "unprognostic (1.27e-3)" 3.3 3.3 1.2 1.9 1.1 4.5 1.4 6.6 2.8 1.5 0.0 3.5 2.3 1.9 1.2 1.4 2.0 2.4 2.3 3.3 1.0 2.8 12.7 6.4 0.8 0.9 1.9 1.6 7.0 0.7 0.9 0.8 1.0 1.9 4.3 2.8 4.8 2.4 8.8 0.7 2.0 1.5 1.5 0.6 4.0 1.7 2.0 0.3 8.2 3.9 1.0 3.6 0.7 1.1 5.0 6.9 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 6.0 0.0 3.5 0.0 12.2 0.0 1.3 0.0 0.1 0.1 3.7 6.6 11.8 6.9 3.7 5.7 0.7 0.0 0.0 0.0 0.0 2.1 1.7 0.5 13.8 0.0 0.9 5.5 0.0 2.3 0.0 15.2 16.0 0.0 3.1 0.0 4.2 2.1 0.2 0.0 14.5 0.4 11.8 0.1 0.0 4.5 0.3 0.1 0.2 0.0 7.9 1.4 6.3 0.0 3.2 5.4 3.4 0.0 0.4 0.0 2.4 0.0 3.8 0.0 1.1 0.8 0.0 0.0 0.5 0.8 0.5 0.0 0.0 0.0 0.4 0.3 1.2 1.1 6.6 2.8 3.3 1.0 0.9 1.9 1.0 1.5 2.0 1.1 2.2 6.4 13.4 7.8 0.4 1.5 16.9 0.2 1.8 3.3 0.8 1.9 4.4 0.0 6.1 1.8 0.0 0.5 5.3 11.2 1.9 3.0 1.6 4.4 6.4 3.3 1.2 0.4 1.8 4.3 0.0 8.0 17.3 13.0 6.3 0.1 2.2 4.1 2.7 1.7 6.0 4.6 0.0 4.7 7.7 1.0 0.9 9.5 3.6 9.4 0.5 3.7 2.1 3.5 0.2 5.2 8.8 1.5 1.3 7.2 1.6 1.5 0.3 0.3 0.0 9.9 2.0 2.4 4.6 1.6 0.1 0.4 2.7 0.2 3.7 12.5 LTK TYK1 ENSG00000062524 "Leukocyte receptor tyrosine kinase" P29376 15 41503637-41513887 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.2;lung: 15.1;salivary gland: 11.8" "Cell type enhanced" "Detected in some" "Distal enterocytes: 25.3;Gastric mucus-secreting cells: 18.8;Hepatic stellate cells: 11.4;Intestinal goblet cells: 7.9;Proximal enterocytes: 15.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "MAIT T-cell: 5.7;plasmacytoid DC: 5.0" "Group enriched" "Detected in many" 10 "dendritic cells: 5.0;T-cells: 5.7" "Cell line enhanced" "Detected in some" "HEL: 5.0;NB-4: 9.7;RH-30: 4.6;THP-1: 14.7" "Low region specificity" "Detected in many" HPA059545 Approved Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 43: THP-1 - Innate immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "HPA059545: AB_2684057" "unprognostic (9.47e-4)" "unprognostic (5.52e-4)" "unprognostic (1.51e-1)" "unprognostic (2.49e-1)" "unprognostic (4.12e-1)" "unprognostic (5.65e-3)" "unprognostic (1.74e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-2)" "unprognostic (2.81e-3)" "unprognostic (9.36e-3)" "unprognostic (5.36e-2)" "unprognostic (4.68e-2)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" 0.8 0.6 1.0 1.4 1.6 4.6 0.5 1.2 1.8 0.9 0.6 5.2 12.5 0.2 0.0 0.3 0.4 2.4 1.7 1.3 0.7 4.0 2.9 15.1 1.2 0.6 0.6 0.1 0.3 0.6 0.7 10.4 0.7 0.4 5.7 0.1 11.8 0.3 1.8 1.4 13.2 0.3 0.6 5.5 9.9 2.5 0.8 0.4 0.7 0.0 2.1 0.7 0.7 0.9 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.6 0.8 1.2 2.2 0.0 0.0 0.0 0.6 0.0 0.0 2.6 0.0 0.4 0.2 1.3 5.0 0.1 0.0 2.0 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.0 1.9 0.0 1.8 0.0 0.0 9.7 0.4 1.8 0.2 0.2 4.6 0.1 0.0 0.0 0.4 2.9 0.1 0.2 0.0 2.6 0.2 14.7 0.0 0.0 0.2 0.1 0.0 0.3 0.2 0.2 0.0 0.5 0.8 0.0 0.0 0.0 0.4 0.0 5.7 0.5 0.3 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 1.0 1.6 1.2 1.8 1.3 0.7 0.6 0.6 0.7 0.6 0.8 0.9 0.3 0.0 0.0 0.3 1.6 0.1 0.0 0.4 0.0 0.0 0.2 0.1 0.8 2.8 0.9 0.0 0.0 0.3 5.5 25.3 0.0 0.0 2.8 0.1 0.4 1.8 1.8 3.2 2.9 0.2 1.5 0.2 18.8 0.2 0.0 0.3 11.4 0.5 0.1 0.0 0.2 7.9 0.0 1.9 0.6 2.1 0.0 0.4 3.6 0.0 0.4 0.0 1.0 0.5 0.4 0.7 5.5 0.0 2.7 0.0 15.3 0.0 5.6 0.0 0.0 0.3 0.5 2.2 1.2 0.0 0.1 0.4 4.0 0.0 3.8 0.0 LYAR "ZC2HC2, ZLYAR" ENSG00000145220 "Ly1 antibody reactive" Q9NX58 4 4267701-4290154 "Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 102.1" "Cell type enhanced" "Detected in all" "Early spermatids: 223.1;NK-cells: 197.8;Spermatocytes: 718.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035880, HPA035881" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Nucleoli rim" Nucleoplasm "HPA035880: , HPA035881: AB_10669980" "unprognostic (2.81e-1)" "unprognostic (3.79e-1)" "unprognostic (2.64e-2)" "unprognostic (6.22e-3)" "unprognostic (1.44e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (3.20e-5)" "unprognostic (1.08e-3)" "unprognostic (2.92e-2)" "prognostic favorable (8.82e-4)" "unprognostic (5.05e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (4.36e-10)" "unprognostic (4.94e-2)" "unprognostic (1.61e-1)" "unprognostic (5.90e-2)" "unprognostic (2.72e-1)" 14.8 8.4 7.8 19.8 8.4 20.4 11.2 8.2 13.0 10.0 7.1 10.8 8.8 9.1 5.7 15.9 10.4 8.2 15.6 8.0 9.0 8.8 10.4 11.8 24.3 9.0 8.6 12.4 9.6 5.3 8.4 11.1 8.9 7.8 10.1 11.1 7.3 6.7 21.2 9.2 9.3 9.0 7.9 18.7 7.9 102.1 8.5 12.8 6.7 11.7 17.8 18.8 10.8 9.3 59.9 30.8 26.7 39.3 22.9 26.0 46.1 53.2 18.1 53.7 37.1 97.1 75.6 158.9 37.5 23.0 86.2 37.0 100.6 55.4 69.8 28.6 74.8 159.2 29.5 109.0 38.7 184.4 41.4 20.5 34.4 61.8 103.9 13.9 47.2 89.1 217.9 51.2 37.8 60.5 63.4 236.6 134.0 62.1 99.2 96.2 48.6 76.4 24.4 40.7 63.4 27.4 29.0 31.0 55.8 34.0 32.3 54.4 44.7 53.3 42.7 70.2 169.1 36.2 59.1 250.4 36.5 154.7 44.2 37.3 26.4 24.4 73.5 26.8 85.5 21.7 48.2 80.3 19.5 15.0 22.1 47.9 7.6 30.3 39.2 14.3 25.4 30.2 7.8 8.4 8.2 13.0 8.0 9.0 9.0 8.6 8.9 7.9 8.5 9.3 29.1 16.0 23.5 6.8 26.9 120.1 59.2 19.9 27.9 10.1 15.7 32.9 20.9 14.3 25.6 1.8 8.4 47.7 128.9 11.5 9.8 24.9 223.1 17.7 29.4 32.3 10.7 46.3 3.6 19.8 55.6 31.9 9.7 12.7 21.5 31.5 14.3 11.2 35.8 15.2 4.2 16.1 4.1 30.4 34.0 113.4 34.2 44.7 21.4 2.8 35.2 14.1 197.8 6.0 9.3 30.0 11.4 26.7 36.1 117.5 3.0 7.4 19.2 30.2 39.5 34.4 27.9 718.6 36.6 36.0 115.8 20.2 135.3 46.8 28.9 64.1 MANEAL FLJ31434 ENSG00000185090 "Mannosidase endo-alpha like" Q5VSG8 1 37793847-37801137 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 16.5;Enteroendocrine cells: 30.5;Horizontal cells: 26.9;Inhibitory neurons: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 139.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063423 Approved "Golgi apparatus" "Intracellular and membrane" NA NA 47000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Golgi apparatus" "HPA063423: AB_2685011" "unprognostic (8.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-1)" "unprognostic (1.55e-1)" "unprognostic (7.92e-2)" "prognostic favorable (5.28e-4)" "prognostic unfavorable (3.32e-4)" "unprognostic (3.02e-1)" "unprognostic (1.03e-2)" "unprognostic (7.67e-2)" "unprognostic (6.27e-3)" "unprognostic (1.08e-1)" "unprognostic (1.17e-3)" "unprognostic (8.29e-3)" "unprognostic (1.87e-1)" "unprognostic (3.28e-2)" "unprognostic (2.26e-1)" 1.1 7.1 16.3 2.1 16.7 0.2 5.0 12.3 18.2 2.9 4.6 6.1 3.5 1.9 6.5 4.7 2.8 1.3 1.3 16.6 21.4 3.6 9.1 3.0 1.2 16.1 17.0 1.2 10.1 5.9 19.3 0.9 20.0 4.2 6.3 13.3 3.6 2.7 4.0 4.1 3.5 2.3 11.9 1.9 4.6 2.7 20.1 1.3 5.6 2.6 1.9 2.3 2.4 13.6 24.0 30.1 5.4 57.1 7.3 2.7 51.7 4.4 26.0 22.1 9.6 50.3 55.0 40.0 18.8 3.1 26.1 5.4 11.1 5.9 7.9 47.5 23.7 29.4 25.5 41.0 0.5 42.3 23.4 0.9 30.6 1.2 1.1 30.7 0.6 7.1 17.5 30.4 3.5 47.8 11.9 0.1 18.1 57.0 31.8 18.2 39.0 46.2 13.1 62.8 139.8 42.4 63.0 2.0 23.6 1.0 27.3 4.4 3.5 31.0 19.0 30.2 41.0 43.6 45.0 13.1 5.1 13.7 23.2 0.0 0.0 0.0 0.3 0.0 0.9 0.1 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 16.3 16.7 12.3 18.2 16.6 21.4 16.1 17.0 20.0 11.9 20.1 13.6 1.1 3.2 2.7 0.3 1.0 0.5 1.1 0.3 2.2 16.5 4.3 4.3 1.1 1.5 0.6 3.7 4.2 0.2 1.1 2.3 0.0 1.6 0.2 1.1 0.7 0.8 30.5 0.0 9.0 6.0 2.0 1.0 1.1 2.5 0.0 1.8 0.0 5.0 0.9 26.9 12.1 3.7 0.0 0.8 0.4 0.0 0.3 0.5 3.6 3.7 0.0 5.0 0.0 9.5 2.7 2.4 2.3 0.0 2.4 1.7 1.1 0.4 0.2 9.5 0.0 0.7 0.4 0.0 1.5 1.5 0.0 0.1 0.7 0.5 4.1 1.3 MAPK8 "JNK, JNK1, PRKM8, SAPK1" ENSG00000107643 "Mitogen-activated protein kinase 8" P45983 10 48306639-48439360 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 160.5;Excitatory neurons: 199.1;Inhibitory neurons: 218.2;Oligodendrocyte precursor cells: 233.7;Oligodendrocytes: 163.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004463, CAB069396" Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 44: HDLM-2 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "CAB004463: AB_675868, CAB069396: AB_1619977" "unprognostic (7.49e-2)" "unprognostic (1.47e-1)" "unprognostic (2.74e-2)" "unprognostic (1.46e-1)" "unprognostic (3.07e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (8.66e-4)" "unprognostic (4.23e-2)" "unprognostic (5.98e-2)" "unprognostic (4.31e-3)" "unprognostic (2.33e-1)" "unprognostic (6.06e-2)" "prognostic favorable (8.66e-4)" "unprognostic (1.58e-1)" "unprognostic (9.95e-2)" "unprognostic (1.85e-2)" "unprognostic (1.01e-3)" 7.2 6.7 11.3 7.0 12.6 11.3 13.8 18.3 12.8 8.8 4.5 9.0 10.4 11.0 7.7 9.4 7.5 9.2 7.2 12.5 9.4 13.6 15.6 6.7 7.8 11.6 9.7 11.0 7.5 8.6 7.9 8.3 13.1 8.3 9.9 21.9 9.6 8.2 11.7 6.5 11.2 9.6 8.8 6.7 8.1 13.1 10.9 13.8 14.1 9.6 9.6 8.3 7.0 12.8 29.2 7.2 21.8 12.8 11.3 10.4 16.5 37.9 23.6 20.0 17.8 7.7 19.2 10.9 10.5 21.3 10.7 13.1 10.2 15.2 31.2 45.4 16.5 15.9 6.8 12.7 16.0 24.2 13.2 9.5 18.5 14.4 21.8 12.5 22.0 22.4 25.1 14.5 13.2 8.6 22.1 15.4 14.4 10.0 4.7 17.8 25.8 12.6 17.1 11.1 38.3 34.8 13.5 11.9 16.1 14.8 12.4 11.4 16.7 14.4 31.9 14.6 30.4 6.2 18.0 16.4 14.3 24.9 8.7 0.0 1.1 1.4 1.1 1.1 2.1 0.6 1.7 1.3 1.0 0.8 1.7 1.0 0.8 1.3 1.4 1.8 1.1 1.0 11.3 12.6 18.3 12.8 12.5 9.4 11.6 9.7 13.1 8.8 10.9 12.8 21.2 3.2 17.1 145.3 21.9 44.7 50.6 19.3 20.5 56.2 34.4 17.7 10.0 22.8 18.0 7.3 31.3 15.5 22.3 19.1 11.7 28.9 160.5 25.7 21.9 22.0 31.0 12.4 199.1 25.3 7.4 21.8 16.3 42.9 12.0 25.8 10.4 22.3 9.8 70.7 218.2 16.5 28.5 11.0 34.9 99.2 14.6 18.4 21.4 93.7 25.4 18.9 11.3 233.7 163.0 35.9 22.5 10.1 31.2 39.3 25.4 24.3 16.6 34.6 6.6 23.0 24.5 28.1 28.1 17.5 36.7 15.7 21.6 41.0 11.9 45.5 MAST1 "KIAA0973, SAST" ENSG00000105613 "Microtubule associated serine/threonine kinase 1" Q9Y2H9 19 12833951-12874952 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 37.7;pituitary gland: 23.3;retina: 15.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 24.7;Cone photoreceptor cells: 43.8;Excitatory neurons: 64.7;Inhibitory neurons: 70.3;Oligodendrocyte precursor cells: 22.1;Rod photoreceptor cells: 20.4" "Cancer enhanced" "Detected in many" "glioma: 3.5" "Region enhanced" "Detected in many" "cerebral cortex: 37.7" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 9 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "AN3-CA: 23.3;SCLC-21H: 40.5;SH-SY5Y: 20.2;U-266/70: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028181, HPA073106" Enhanced Supported Vesicles,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles Cytosol "HPA028181: AB_10603872, HPA073106: AB_2732218" "unprognostic (6.32e-2)" "unprognostic (3.66e-2)" "unprognostic (3.93e-2)" "unprognostic (2.83e-5)" "unprognostic (1.72e-1)" "unprognostic (4.19e-2)" "unprognostic (2.38e-1)" "unprognostic (8.72e-2)" "unprognostic (1.04e-1)" "unprognostic (3.64e-1)" "unprognostic (8.89e-3)" "unprognostic (3.43e-2)" "unprognostic (3.84e-3)" "unprognostic (1.19e-1)" "unprognostic (7.04e-2)" "unprognostic (2.49e-2)" "unprognostic (1.96e-1)" 0.0 2.2 6.5 0.3 12.1 0.3 0.1 7.3 37.7 0.2 0.0 1.2 0.3 0.0 0.0 0.2 0.1 0.2 0.2 8.3 2.4 0.1 0.6 0.1 0.1 11.2 1.1 0.3 0.6 0.5 23.3 0.0 9.5 0.2 0.1 15.4 0.2 0.0 0.0 3.7 0.4 0.0 0.0 0.1 0.6 5.0 1.2 0.8 0.1 0.0 0.0 0.2 0.3 3.0 3.6 1.6 1.5 23.3 0.0 0.0 1.9 0.2 0.1 0.3 0.9 0.8 1.5 5.8 2.6 0.0 3.9 0.1 6.8 0.1 0.1 4.1 4.5 0.5 5.8 2.6 0.0 1.3 1.2 0.5 0.1 0.8 0.7 1.3 0.0 15.2 5.2 3.0 0.0 0.8 2.4 0.6 6.9 0.6 7.2 15.9 4.6 8.3 0.3 0.2 40.5 20.2 0.8 1.4 4.3 1.2 3.8 2.1 0.0 2.8 4.2 3.1 0.8 16.7 14.5 3.7 5.1 3.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 6.5 12.1 7.3 37.7 8.3 2.4 11.2 1.1 9.5 0.0 1.2 3.0 0.5 0.0 2.4 7.8 0.2 0.9 1.6 0.6 0.6 24.7 0.8 2.5 1.0 0.0 0.3 0.0 43.8 0.6 0.4 0.6 0.0 0.4 14.0 0.2 0.2 1.3 0.0 0.0 64.7 0.5 0.6 1.3 0.0 0.3 1.3 0.5 1.1 0.5 0.2 15.2 70.3 0.1 0.0 1.0 1.2 8.2 0.6 0.7 5.4 6.5 0.1 3.7 0.0 22.1 3.0 0.3 2.5 1.2 0.0 1.0 0.9 0.2 1.0 20.4 0.0 2.0 0.5 8.0 5.2 0.7 1.4 0.3 1.0 0.4 0.7 1.2 MATN2 ENSG00000132561 "Matrilin 2" O00339 8 97868840-98036724 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 201.0;Peritubular cells: 258.8;Theca cells: 297.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "MAIT T-cell: 5.2" "Lineage enriched" "Detected in single" 7 "T-cells: 5.2" "Cell line enhanced" "Detected in many" "BJ: 72.5;BJ hTERT+ SV40 Large T+: 78.6;BJ hTERT+ SV40 Large T+ RasG12V: 106.7;HaCaT: 114.4;HBF TERT88: 100.6;SuSa: 67.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033879 Approved "Secreted to extracellular matrix" NA NA 1500000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" "CAB033879: AB_2141502" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (9.99e-2)" "unprognostic (2.14e-1)" "unprognostic (4.98e-1)" "unprognostic (5.35e-2)" "unprognostic (7.18e-2)" "unprognostic (5.22e-2)" "unprognostic (2.77e-1)" "unprognostic (2.07e-3)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (2.04e-2)" "unprognostic (1.69e-1)" "unprognostic (6.31e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (6.65e-2)" 54.4 51.0 24.3 30.2 22.5 1.8 43.6 17.6 23.2 194.4 19.3 67.5 58.5 147.0 101.6 32.8 46.9 40.1 110.2 20.0 23.4 39.3 24.6 15.2 18.0 24.1 30.5 116.4 11.3 28.0 9.9 177.9 26.3 104.9 57.8 45.7 42.6 171.9 4.0 62.8 80.6 98.1 18.3 5.9 23.7 31.2 23.4 4.9 271.4 28.5 15.4 103.0 139.2 30.8 24.1 10.8 23.3 2.5 60.7 3.6 15.0 72.5 17.6 78.6 106.7 13.0 8.4 0.1 7.0 29.2 3.5 114.4 2.3 4.4 100.6 0.0 2.9 0.8 6.1 0.9 14.0 0.0 0.0 13.6 9.5 16.1 0.8 22.1 0.5 1.3 0.1 0.2 4.1 11.2 0.0 0.7 7.1 0.3 3.7 0.0 2.4 11.4 5.7 5.3 16.0 1.5 11.5 0.2 19.8 67.3 10.9 1.4 0.6 5.2 31.5 16.1 11.0 0.9 0.2 0.2 18.8 0.4 5.9 0.0 0.1 0.1 0.2 0.4 5.2 0.0 0.7 0.9 0.8 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 24.3 22.5 17.6 23.2 20.0 23.4 24.1 30.5 26.3 18.3 23.4 30.8 27.8 3.2 1.3 11.1 0.3 37.3 10.1 6.2 80.2 6.3 3.8 45.8 29.1 18.6 3.0 16.5 54.2 1.2 0.2 20.6 0.0 9.9 86.0 4.2 22.6 32.4 23.4 3.2 6.4 0.0 1.1 113.1 5.1 5.0 0.0 43.5 201.0 11.0 1.6 0.0 11.5 25.4 0.0 5.0 7.7 108.6 103.5 0.9 28.4 19.7 2.0 8.1 0.0 86.0 59.8 3.2 18.2 258.8 0.0 6.5 118.7 3.4 1.6 52.9 13.1 97.2 17.1 2.5 2.6 7.3 8.5 2.5 2.0 297.5 27.4 1.8 ME1 ENSG00000065833 "Malic enzyme 1" P48163 6 83210402-83431051 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 71.8;Excitatory neurons: 117.1;Inhibitory neurons: 70.6;Kupffer cells: 74.4;Muller glia cells: 100.6;Oligodendrocyte precursor cells: 123.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "MAIT T-cell: 16.0" "Lineage enriched" "Detected in many" 10 "T-cells: 16.0" "Cell line enhanced" "Detected in many" "CACO-2: 139.4;OE19: 158.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006493 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3600000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 21: OE19 - Mitochondria" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Plasma membrane" Cytosol "HPA006493: AB_1078272" "unprognostic (7.21e-2)" "unprognostic (3.99e-2)" "unprognostic (2.24e-1)" "unprognostic (3.12e-3)" "prognostic unfavorable (7.73e-4)" "unprognostic (7.98e-3)" "prognostic unfavorable (4.57e-5)" "unprognostic (3.24e-1)" "unprognostic (4.44e-3)" "unprognostic (1.41e-3)" "unprognostic (7.10e-3)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.81e-7)" "unprognostic (4.07e-2)" "unprognostic (2.49e-1)" "unprognostic (1.85e-2)" "unprognostic (4.51e-2)" 41.4 44.4 13.4 5.2 15.4 0.4 29.9 14.5 18.1 8.0 8.5 7.7 21.7 4.2 6.5 28.6 4.2 15.5 18.6 13.1 17.4 3.6 9.8 8.8 4.2 15.0 19.1 10.8 3.4 19.9 12.5 2.9 18.3 8.4 11.0 30.0 10.3 17.2 34.7 14.4 10.4 7.8 13.4 7.3 23.8 16.1 16.8 5.6 6.7 30.5 4.5 15.3 12.0 13.5 29.0 59.1 1.4 0.0 48.0 44.4 0.1 18.4 47.0 19.2 37.1 139.4 24.9 0.0 46.8 43.4 38.2 29.8 43.4 16.4 20.9 0.0 24.4 0.0 33.8 0.0 61.4 14.3 50.3 49.0 32.3 38.7 26.3 32.1 30.4 0.0 20.4 0.1 26.4 32.7 0.0 16.2 0.0 158.3 23.0 0.0 48.5 27.9 56.8 13.7 5.8 14.9 31.2 45.7 1.0 25.0 0.0 34.5 32.4 11.9 14.1 3.9 0.1 10.9 13.3 0.1 0.0 0.0 35.9 0.0 1.6 0.0 0.8 0.3 16.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 13.4 15.4 14.5 18.1 13.1 17.4 15.0 19.1 18.3 13.4 16.8 13.5 0.9 19.2 12.1 71.8 0.6 1.9 5.1 12.5 6.8 17.1 2.5 0.9 41.0 7.2 12.7 5.5 2.1 0.6 0.5 12.7 1.9 12.3 5.5 0.7 6.8 2.3 0.0 0.0 117.1 9.5 0.9 8.5 62.7 0.2 0.0 11.2 4.2 12.1 7.1 13.5 70.6 4.1 8.2 74.4 25.6 6.5 25.7 16.7 0.0 23.4 5.5 100.6 0.0 123.6 38.6 15.0 4.5 37.2 0.5 5.2 15.2 3.1 7.2 7.5 0.0 4.5 8.3 7.5 2.3 22.3 3.4 0.8 1.8 33.6 8.9 3.3 MELTF "CD228, FLJ38863, MAP97, MFI2, MGC4856, MTf, MTF1" ENSG00000163975 Melanotransferrin P08582 3 196988621-197029817 "CD markers, Plasma proteins, Predicted intracellular proteins" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 35.1;salivary gland: 68.7" "Cell type enhanced" "Detected in some" "Breast glandular cells: 21.1;Breast myoepithelial cells: 20.6;Collecting duct cells: 14.7;Ductal cells: 28.3;Hofbauer cells: 15.4;Pancreatic endocrine cells: 66.4" "Cancer enhanced" "Detected in all" "melanoma: 32.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 162.1;SK-MEL-30: 201.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA004880 Approved "Intracellular and membrane" NA NA 41000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA004880: AB_1853844" "unprognostic (8.68e-3)" "unprognostic (3.68e-2)" "unprognostic (1.75e-2)" "unprognostic (7.68e-3)" "unprognostic (1.06e-2)" "unprognostic (1.08e-2)" "unprognostic (5.53e-2)" "unprognostic (1.64e-3)" "unprognostic (1.20e-2)" "unprognostic (1.23e-1)" "unprognostic (3.68e-3)" "unprognostic (8.14e-2)" "prognostic unfavorable (6.99e-11)" "unprognostic (2.29e-1)" "unprognostic (2.11e-1)" "unprognostic (5.75e-2)" "unprognostic (2.09e-2)" 10.0 1.7 2.3 3.8 1.7 2.3 7.4 2.1 3.8 8.1 27.2 4.0 2.4 6.8 0.7 2.9 8.6 1.6 7.5 2.5 1.9 35.1 1.6 1.9 1.9 0.6 2.8 1.2 4.6 10.3 2.9 1.5 0.4 4.1 2.1 0.3 68.7 5.5 1.1 16.4 9.9 1.2 0.5 1.1 1.7 3.4 6.5 2.9 3.1 1.0 1.6 3.2 7.3 2.0 162.1 34.6 0.4 1.2 4.8 6.0 4.0 2.8 1.5 5.2 6.3 9.8 23.6 4.5 33.3 5.6 4.5 49.6 1.8 0.1 2.3 7.4 10.8 5.6 7.9 4.1 30.5 0.8 30.8 33.0 4.3 4.3 0.4 0.2 0.8 8.9 4.3 30.5 3.1 9.8 9.3 0.0 3.6 6.9 22.5 13.4 5.3 2.0 0.8 1.5 3.1 11.3 32.5 2.8 201.4 3.8 9.5 4.8 1.2 1.2 26.8 5.5 19.9 5.3 46.0 4.5 3.9 9.5 0.2 0.0 0.1 0.0 0.2 0.2 0.8 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 2.3 1.7 2.1 3.8 2.5 1.9 0.6 2.8 0.4 0.5 6.5 2.0 0.8 0.0 1.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 21.1 20.6 0.0 0.0 1.8 14.7 0.0 0.2 1.0 0.0 0.0 28.3 0.0 3.2 6.1 0.6 0.0 0.0 0.0 5.7 0.3 3.7 0.0 4.4 0.0 3.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.6 0.0 0.0 0.0 0.0 66.4 0.0 0.0 1.7 0.0 0.0 0.5 1.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.5 0.5 0.1 0.0 0.0 METTL24 "C6orf186, dJ71D21.2" ENSG00000053328 "Methyltransferase like 24" Q5JXM2 6 110245928-110358272 "Predicted secreted proteins" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "smooth muscle: 14.2" "Group enriched" "Detected in some" 4 "Astrocytes: 30.0;Excitatory neurons: 23.8;Inhibitory neurons: 28.7;Late spermatids: 8.6;Oligodendrocyte precursor cells: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "MAIT T-cell: 3.5" "Lineage enriched" "Detected in single" 29 "T-cells: 3.5" "Cell line enhanced" "Detected in some" "HHSteC: 1.0;SCLC-21H: 1.6;SuSa: 1.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA037441, HPA037442" Uncertain "Secreted - unknown location" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA037441: AB_10670933, HPA037442: AB_10696931" "unprognostic (6.62e-2)" "unprognostic (1.15e-1)" "unprognostic (9.31e-3)" "unprognostic (5.02e-2)" "unprognostic (5.21e-3)" "unprognostic (1.46e-1)" "unprognostic (6.12e-2)" "unprognostic (2.06e-1)" "unprognostic (3.98e-1)" "unprognostic (1.42e-1)" "unprognostic (8.45e-2)" "unprognostic (5.96e-2)" "unprognostic (1.54e-4)" "unprognostic (4.08e-2)" "unprognostic (1.23e-2)" "unprognostic (1.63e-2)" "unprognostic (4.78e-3)" 1.8 1.6 1.4 1.6 2.3 0.0 1.7 2.1 1.9 3.9 8.1 5.9 1.4 7.5 2.2 4.0 6.0 5.8 3.0 1.7 1.8 3.9 0.9 1.6 0.1 1.6 2.2 5.6 1.3 2.5 2.1 0.4 1.4 4.9 4.2 1.4 0.4 7.1 0.0 0.5 2.1 14.2 2.0 0.7 2.4 2.1 1.8 1.0 1.3 1.1 0.6 4.7 1.6 1.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 2.3 2.1 1.9 1.7 1.8 1.6 2.2 1.4 2.0 1.8 1.2 0.0 0.0 0.0 30.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.9 0.4 1.5 0.1 0.0 0.0 23.8 0.0 0.0 0.8 0.0 0.4 0.0 0.5 0.0 0.0 0.0 1.7 28.7 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 3.7 0.0 0.6 0.0 31.7 5.4 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.3 2.1 0.0 1.0 0.0 0.0 0.3 0.1 0.0 0.0 MGAT4A "GnT-4a, GnT-Iva" ENSG00000071073 "Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A" Q9UM21 2 98619106-98731132 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 96.0" "Cell type enhanced" "Detected in many" "Microglial cells: 175.2;Proximal enterocytes: 132.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 127.2;HUVEC TERT2: 48.3;JURKAT: 86.5;TIME: 78.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007608 Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 28: BEWO - Transcription regulation" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA007608: AB_10602008" "prognostic unfavorable (4.30e-4)" "unprognostic (1.15e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.48e-8)" "unprognostic (1.35e-1)" "unprognostic (2.28e-2)" "unprognostic (3.82e-3)" "unprognostic (1.89e-1)" "unprognostic (3.76e-1)" "unprognostic (3.58e-1)" "unprognostic (2.80e-2)" "unprognostic (2.32e-2)" "unprognostic (4.17e-2)" "unprognostic (1.50e-1)" "unprognostic (4.62e-2)" "unprognostic (4.04e-2)" "unprognostic (2.04e-1)" 11.2 7.8 13.2 20.8 17.8 96.0 12.5 26.1 15.6 8.9 15.1 24.4 29.5 5.8 3.7 6.3 7.0 12.7 7.6 13.1 15.2 27.5 9.7 16.9 21.1 16.4 15.8 3.2 38.8 28.0 9.8 19.6 15.5 7.5 25.5 5.4 25.9 6.4 3.8 4.1 43.8 11.5 18.1 8.1 11.3 6.3 15.5 20.5 8.7 4.7 18.2 13.1 4.7 22.9 8.8 1.7 3.4 7.3 0.0 0.0 127.2 0.0 0.1 0.9 0.0 21.0 10.6 0.0 18.9 0.0 2.4 0.4 7.2 1.0 0.2 10.6 7.9 0.5 0.0 36.7 0.2 17.8 6.4 0.0 4.7 0.0 0.7 0.3 48.3 86.5 1.6 9.2 0.0 17.3 39.3 30.9 1.1 7.6 1.4 9.8 0.0 10.5 24.8 17.6 10.4 3.3 2.5 32.2 4.8 9.2 7.6 23.8 78.8 0.0 4.0 0.1 2.6 3.2 7.6 2.2 0.0 26.7 0.6 7.0 5.1 12.7 20.8 1.0 27.5 3.6 25.2 23.7 3.8 2.5 32.6 27.2 14.0 15.3 2.5 17.1 16.0 12.5 13.2 17.8 26.1 15.6 13.1 15.2 16.4 15.8 15.5 18.1 15.5 22.9 80.8 54.5 25.7 19.2 22.7 9.9 21.1 6.1 11.4 19.8 28.2 15.6 13.4 11.5 17.6 22.0 4.2 6.2 116.9 92.4 21.5 20.8 12.7 14.2 3.8 39.8 53.0 6.3 58.0 29.8 77.9 7.2 19.4 35.1 13.3 5.1 18.9 10.4 57.2 48.8 48.6 41.3 34.6 33.9 18.3 17.5 2.5 54.5 10.6 175.2 21.0 13.4 89.6 36.7 42.0 21.6 58.2 2.2 31.4 17.8 132.4 27.3 7.1 4.8 6.6 6.8 4.9 2.5 7.7 8.6 10.5 14.9 112.2 0.7 40.9 30.2 MINDY4 "C7orf67, FAM188B, FLJ22374" ENSG00000106125 "MINDY lysine 48 deubiquitinase 4" Q4G0A6 7 30771417-30892387 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Collecting duct cells: 12.9;Endometrial ciliated cells: 36.7;Endometrial stromal cells: 8.9;Respiratory ciliated cells: 18.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019475, HPA030129, HPA030130" Approved Supported Vesicles,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 1: K-562 - Erythropoiesis" "Cluster 49: Ciliated cells - Cilium organization" "Vesicles, Cytosol" "HPA019475: AB_1848806, HPA030129: AB_10599621, HPA030130: AB_10601565" "unprognostic (2.96e-1)" "unprognostic (1.27e-1)" "unprognostic (2.62e-1)" "unprognostic (2.10e-2)" "unprognostic (1.64e-1)" "unprognostic (4.07e-1)" "unprognostic (6.01e-3)" "unprognostic (3.81e-2)" "unprognostic (5.25e-3)" "unprognostic (1.97e-1)" "unprognostic (5.59e-3)" "unprognostic (2.96e-2)" "unprognostic (1.92e-1)" "unprognostic (9.55e-2)" "unprognostic (1.12e-2)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" 6.7 3.7 2.1 1.2 3.5 2.4 4.4 0.4 4.2 5.7 10.6 4.6 1.3 5.4 8.4 2.9 11.5 5.6 4.7 1.9 1.8 4.9 2.1 9.5 1.2 2.8 4.5 8.9 3.4 4.8 5.6 3.3 2.2 5.9 2.1 2.1 3.1 8.1 2.3 3.2 2.2 5.9 1.8 1.2 3.2 9.0 2.4 1.2 6.7 3.5 0.9 4.3 3.7 2.5 2.4 6.0 3.1 9.5 2.7 10.3 4.5 3.5 6.0 2.6 2.2 0.0 4.4 0.0 3.9 2.3 3.6 2.6 2.1 2.0 2.5 0.0 3.5 1.9 3.2 0.0 3.3 2.7 1.3 5.3 3.1 7.7 1.5 0.2 3.8 1.7 19.2 1.1 2.2 0.0 1.5 0.8 8.9 8.5 1.4 0.4 0.0 0.6 7.1 1.2 5.7 7.7 2.3 12.5 1.3 3.5 6.4 2.0 2.3 0.1 1.4 2.7 1.5 2.5 3.5 0.0 4.9 0.1 11.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 2.1 3.5 0.4 4.2 1.9 1.8 2.8 4.5 2.2 1.8 2.4 2.5 5.2 9.6 3.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 2.4 0.0 0.0 1.8 12.9 0.0 2.3 0.5 0.0 3.9 2.8 0.0 36.7 8.9 2.3 0.0 0.0 0.0 1.3 4.1 2.7 0.0 3.9 2.5 4.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 2.4 18.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.2 4.1 0.0 0.0 MKNK1 MNK1 ENSG00000079277 "MAPK interacting serine/threonine kinase 1" Q9BUB5 1 46557407-46616843 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Translation regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 128.6" "Cell type enhanced" "Detected in all" "Hofbauer cells: 142.8;Microglial cells: 100.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB027355, CAB037310, HPA071293" Approved Supported Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 36: HEL - Hemostasis" "Cluster 4: Macrophages - Innate immune response" Nucleoplasm "CAB027355: AB_2266303, CAB037310: AB_1854049, HPA071293: AB_2686382" "unprognostic (4.05e-3)" "prognostic favorable (7.05e-4)" "unprognostic (5.28e-2)" "unprognostic (3.47e-2)" "unprognostic (1.64e-1)" "unprognostic (7.38e-2)" "prognostic unfavorable (1.24e-5)" "unprognostic (3.50e-2)" "unprognostic (1.77e-1)" "unprognostic (2.60e-1)" "unprognostic (1.50e-1)" "unprognostic (2.14e-2)" "prognostic unfavorable (1.51e-5)" "unprognostic (7.02e-2)" "unprognostic (3.19e-2)" "unprognostic (4.67e-1)" "unprognostic (5.67e-3)" 30.6 21.8 15.5 23.5 14.4 30.3 23.1 19.0 18.0 22.8 17.0 27.4 15.6 18.5 12.0 23.5 21.4 16.1 22.3 15.1 14.6 17.5 21.8 31.5 17.0 14.2 13.3 19.0 128.6 12.0 18.4 22.1 14.4 19.4 17.7 3.9 16.7 8.5 23.9 18.0 24.9 18.4 13.7 48.1 23.1 12.4 16.6 22.6 16.2 23.9 13.8 20.1 20.7 16.5 34.1 21.7 13.5 15.7 12.0 17.9 18.0 16.7 16.4 20.7 27.1 26.4 13.5 23.1 20.2 17.8 23.0 38.5 23.8 27.5 23.1 37.7 21.4 47.8 28.3 21.7 17.3 25.4 34.8 22.0 17.7 25.2 13.4 10.8 24.1 26.2 24.7 16.6 12.2 21.5 18.3 21.8 9.9 19.6 24.8 16.7 30.5 22.1 20.2 35.2 10.4 9.0 32.3 27.9 25.6 26.5 21.5 28.6 18.5 7.6 1.4 22.2 19.9 12.6 23.7 21.2 14.6 31.9 13.4 9.7 26.3 36.1 15.3 25.7 44.7 9.9 12.9 14.2 13.1 11.6 9.2 13.9 69.7 11.2 20.6 9.7 10.6 14.5 15.5 14.4 19.0 18.0 15.1 14.6 14.2 13.3 14.4 13.7 16.6 16.5 20.3 12.8 21.5 41.4 15.3 13.9 17.8 15.2 9.1 19.4 17.8 12.3 19.2 15.7 17.8 22.0 2.1 21.6 23.7 27.9 7.9 18.9 15.5 12.5 12.8 18.3 16.8 21.9 42.2 37.1 34.2 20.5 11.7 13.3 12.0 22.8 18.2 22.7 142.8 18.5 52.7 12.0 4.1 84.5 61.0 23.8 21.5 49.9 10.6 100.2 26.7 5.2 21.6 21.6 8.5 32.3 17.7 36.5 13.3 19.5 27.8 15.7 11.1 5.0 6.6 31.2 15.0 15.3 17.2 22.6 11.1 18.5 25.2 35.1 15.0 29.6 MMRN2 "EMILIN3, EndoGlyx-1, FLJ13465" ENSG00000173269 "Multimerin 2" Q9H8L6 10 86935540-86969481 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 11 "Adipocytes: 229.3;Endothelial cells: 127.1;Hepatic stellate cells: 182.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "CAPAN-2: 89.2;HUVEC TERT2: 196.6;TIME: 237.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020741 Approved Vesicles "Secreted to extracellular matrix" NA NA 84000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "HPA020741: AB_1848154" "unprognostic (4.17e-1)" "unprognostic (7.87e-2)" "unprognostic (6.67e-3)" "unprognostic (3.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.08e-2)" "unprognostic (1.75e-3)" "unprognostic (1.43e-1)" "unprognostic (2.09e-2)" "unprognostic (3.11e-2)" "unprognostic (1.81e-2)" "unprognostic (1.34e-1)" "unprognostic (6.17e-3)" "unprognostic (1.54e-3)" "unprognostic (1.25e-1)" "unprognostic (6.44e-2)" "unprognostic (1.66e-1)" 63.2 13.9 14.0 10.1 12.7 1.5 54.5 11.5 12.5 20.6 11.0 14.2 10.5 28.1 13.8 16.9 22.7 16.6 38.8 11.4 11.9 22.0 8.6 32.1 9.7 13.6 12.4 23.1 10.5 10.6 7.6 73.8 13.7 14.1 8.9 3.0 26.6 28.7 26.8 38.9 13.8 27.3 13.2 34.6 11.9 15.3 15.8 6.5 25.8 32.5 13.3 32.3 19.1 12.0 11.4 2.9 0.4 0.2 1.2 6.3 7.1 4.1 11.1 4.8 6.8 6.4 89.2 0.1 39.5 7.6 11.6 21.9 0.0 5.2 6.4 8.1 0.0 2.3 10.2 0.2 0.9 0.0 4.6 1.5 26.4 5.7 38.6 13.0 196.6 2.4 2.1 35.0 1.8 7.1 0.4 4.4 2.0 0.4 4.9 0.2 0.1 0.1 2.0 17.5 4.8 0.0 3.1 3.7 1.4 0.9 14.9 1.2 237.1 1.9 11.0 1.9 0.1 2.6 4.0 0.1 5.8 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.0 12.7 11.5 12.5 11.4 11.9 13.6 12.4 13.7 13.2 15.8 12.0 229.3 0.0 5.8 1.6 0.3 9.4 0.9 0.0 4.6 0.2 1.4 2.0 13.2 5.7 0.7 1.8 0.0 0.7 0.4 0.0 0.0 0.1 1.0 0.3 0.4 127.1 0.0 2.7 0.9 0.0 0.1 8.1 0.0 0.5 0.0 0.2 182.0 4.1 1.7 0.0 1.2 0.0 0.0 6.5 4.4 2.8 2.5 0.7 3.6 15.9 0.0 0.7 0.0 1.0 0.1 0.0 0.0 3.0 0.1 0.6 0.5 0.2 0.0 0.6 6.6 3.9 9.4 1.8 2.3 2.2 7.7 0.3 0.8 3.6 0.2 1.0 MPPED2 "239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638" ENSG00000066382 "Metallophosphoesterase domain containing 2" Q15777 11 30384493-30586872 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 24.5;thyroid gland: 24.6" "Cell type enhanced" "Detected in many" "Astrocytes: 155.7;Cone photoreceptor cells: 285.7;Excitatory neurons: 108.1;Horizontal cells: 82.4;Oligodendrocyte precursor cells: 345.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 21.6;HAP1: 12.2;JURKAT: 10.9;RT4: 9.0;SH-SY5Y: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062575 Approved Nucleoli,Vesicles,Mitochondria NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoli "Vesicles, Mitochondria" "HPA062575: AB_2684797" "unprognostic (9.60e-3)" "unprognostic (6.12e-3)" "unprognostic (3.70e-3)" "unprognostic (4.56e-2)" "unprognostic (5.46e-2)" "unprognostic (5.04e-2)" "unprognostic (1.46e-1)" "unprognostic (2.32e-1)" "unprognostic (1.57e-2)" "unprognostic (1.13e-1)" "unprognostic (7.98e-4)" "unprognostic (6.82e-2)" "unprognostic (2.47e-7)" "unprognostic (3.64e-3)" "unprognostic (2.50e-1)" "unprognostic (2.22e-2)" "unprognostic (2.57e-2)" 2.0 5.2 6.3 0.5 13.3 0.3 4.1 4.7 10.5 24.5 0.9 4.9 0.7 6.4 5.6 0.9 8.9 1.0 3.7 11.9 13.0 9.6 0.4 0.4 0.2 19.6 10.3 0.5 1.6 3.2 11.0 1.6 11.7 12.6 0.6 16.0 10.3 7.4 5.1 0.7 1.0 3.6 4.9 2.3 1.7 1.7 9.5 3.6 24.6 1.5 0.3 3.3 5.1 6.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 12.2 0.0 0.0 0.0 2.6 0.0 0.2 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.9 0.0 0.3 3.5 0.1 0.1 0.0 3.4 0.2 0.0 9.0 0.1 6.5 0.0 0.0 3.6 1.3 1.8 0.0 0.1 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 0.2 0.1 0.4 0.5 0.0 0.0 0.7 0.0 0.2 0.0 0.1 6.3 13.3 4.7 10.5 11.9 13.0 19.6 10.3 11.7 4.9 9.5 6.8 3.1 0.0 2.2 155.7 1.8 1.0 51.7 2.6 2.8 26.7 3.6 5.2 5.2 0.0 1.0 46.0 285.7 0.3 0.5 0.1 25.4 4.2 2.1 35.6 1.5 6.3 0.0 1.3 108.1 0.0 0.2 2.6 0.0 13.8 5.1 12.1 0.7 0.2 4.1 82.4 56.0 0.3 2.0 22.5 3.6 1.6 0.3 2.7 5.4 13.1 0.5 44.0 0.0 345.8 7.9 0.1 0.1 3.4 0.5 19.3 0.0 3.1 3.0 18.5 0.0 1.2 7.1 0.1 2.1 1.5 1.1 0.5 0.8 0.4 0.0 28.4 MRPL10 "L10MT, MGC17973, MRP-L10, MRP-L8, MRPL8, RPML8" ENSG00000159111 "Mitochondrial ribosomal protein L10" Q7Z7H8 17 47823272-47831541 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021234, HPA029885" Enhanced Enhanced Mitochondria NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" Mitochondria "HPA021234: AB_1854098, HPA029885: AB_2673233" "unprognostic (6.84e-3)" "unprognostic (1.03e-1)" "unprognostic (8.05e-2)" "unprognostic (9.09e-3)" "unprognostic (1.97e-1)" "unprognostic (4.01e-3)" "prognostic unfavorable (6.67e-4)" "unprognostic (5.21e-2)" "unprognostic (1.03e-1)" "unprognostic (8.91e-2)" "unprognostic (1.38e-1)" "unprognostic (6.16e-2)" "unprognostic (1.29e-1)" "unprognostic (2.82e-1)" "unprognostic (1.87e-2)" "unprognostic (1.60e-1)" "unprognostic (6.87e-2)" 32.1 32.8 35.6 14.4 36.6 24.7 29.7 36.9 39.7 30.1 33.2 40.9 25.6 31.4 22.8 27.1 29.8 21.9 58.1 34.9 36.7 31.2 29.9 20.1 26.2 36.5 36.0 48.8 41.0 28.9 17.3 23.2 36.2 24.8 23.1 21.7 22.1 25.5 64.2 23.8 26.7 26.5 35.7 28.2 36.2 20.1 37.4 25.9 23.1 52.4 26.9 37.9 25.4 36.8 36.8 80.0 33.4 33.0 78.3 71.3 61.6 32.2 54.0 54.2 46.4 155.7 49.2 59.1 71.9 42.0 36.0 33.6 48.3 62.6 48.0 57.6 76.4 47.2 41.7 110.0 67.4 42.8 25.5 80.8 53.2 64.4 90.7 63.7 52.9 58.4 64.8 56.6 42.3 73.3 43.2 55.0 55.1 64.0 76.5 34.7 63.7 66.5 59.9 35.8 39.2 63.2 23.9 26.9 68.7 62.9 81.2 45.5 32.3 47.5 39.0 32.3 45.1 100.1 82.4 48.0 41.4 32.3 32.4 29.8 37.3 18.5 61.6 39.6 59.1 31.8 42.4 55.3 43.0 36.6 35.6 42.2 14.5 26.6 32.9 26.0 52.5 42.0 35.6 36.6 36.9 39.7 34.9 36.7 36.5 36.0 36.2 35.7 37.4 36.8 17.1 6.4 13.6 4.2 19.2 12.5 20.8 42.5 27.9 15.3 25.3 31.5 31.5 20.0 19.5 14.7 6.2 90.5 50.9 17.9 46.9 43.8 22.0 7.9 16.3 21.7 8.5 30.3 5.4 54.7 60.0 23.3 20.4 11.0 8.8 31.8 20.7 15.6 41.7 32.0 6.6 20.7 32.6 31.4 10.8 30.5 24.5 17.3 16.0 2.8 31.8 24.4 44.3 7.1 8.2 40.4 14.7 24.0 22.8 18.4 30.8 47.5 6.1 13.7 6.6 17.5 28.0 23.2 29.2 24.1 12.5 77.3 48.5 49.4 31.9 18.8 MST1R "CD136, CDw136, PTK8, RON, SEA" ENSG00000164078 "Macrophage stimulating 1 receptor" Q04912 3 49887002-49903873 "CD markers, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 62.3;stomach 1: 42.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 25.6;Distal enterocytes: 53.9;Gastric mucus-secreting cells: 108.6;Intestinal goblet cells: 25.7;Pancreatic endocrine cells: 31.2;Paneth cells: 30.3;Proximal enterocytes: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 39.3;CAPAN-2: 98.8;HaCaT: 56.3;HBEC3-KT: 59.4;hTCEpi: 83.4;RT4: 67.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA007657, HPA008180, CAB008972" Enhanced Approved Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291" "unprognostic (3.84e-3)" "unprognostic (3.86e-1)" "unprognostic (1.92e-1)" "unprognostic (7.33e-3)" "unprognostic (3.82e-2)" "unprognostic (2.32e-1)" "unprognostic (8.07e-3)" "unprognostic (1.54e-2)" "unprognostic (4.12e-2)" "unprognostic (2.15e-1)" "unprognostic (1.24e-3)" "unprognostic (2.28e-1)" "unprognostic (8.08e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-1)" "unprognostic (8.00e-3)" "prognostic favorable (2.33e-5)" 5.1 0.3 1.1 5.1 1.1 0.2 3.8 1.1 1.7 5.7 1.3 26.5 25.2 1.3 1.2 17.5 1.7 11.4 3.2 1.1 0.9 3.4 1.1 9.5 2.5 0.9 0.8 1.0 5.8 0.1 2.7 0.8 0.9 4.7 20.1 0.2 5.4 1.0 1.3 62.3 23.9 2.0 0.8 1.6 42.6 8.4 0.9 8.8 3.4 0.7 5.6 9.2 11.5 1.0 39.3 14.4 0.1 0.6 0.0 0.0 2.2 0.5 0.1 0.0 0.0 4.1 98.8 1.7 8.8 0.5 0.1 56.3 0.0 59.4 0.0 0.9 1.0 0.1 25.9 0.9 0.9 0.0 1.2 0.3 83.4 0.2 11.7 0.2 0.1 0.2 0.8 0.3 0.0 5.1 0.1 0.1 0.3 33.1 34.6 2.9 0.0 1.1 35.8 67.9 1.0 0.1 11.5 22.6 0.2 0.1 17.7 0.9 0.3 0.0 0.3 0.3 0.1 0.5 0.2 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 1.1 1.1 1.7 1.1 0.9 0.9 0.8 0.9 0.8 0.9 1.0 1.6 25.6 10.3 0.7 1.0 8.8 2.2 14.2 6.8 0.0 2.8 2.5 1.0 0.0 10.6 0.0 0.0 0.1 0.2 53.9 0.0 6.4 15.4 2.9 0.8 0.6 4.2 0.0 1.1 10.0 0.4 0.8 108.6 5.3 0.0 0.1 0.0 0.0 0.1 0.0 1.1 25.7 2.0 0.0 1.4 10.5 0.3 0.5 0.0 1.0 0.6 0.0 1.0 2.0 0.1 31.2 30.3 0.0 0.5 2.2 27.6 0.1 7.6 0.0 0.0 0.5 0.9 1.3 1.5 3.2 4.7 0.0 0.5 0.0 20.1 6.2 MTCP1 "P13MTCP1, p8MTCP1, TCL1C" ENSG00000214827 "Mature T cell proliferation 1" P56278 X 155064034-155147937 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Erythroid cells: 3.2;Respiratory ciliated cells: 2.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA032040 Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Plasma membrane" "HPA032040: AB_2674122" "unprognostic (2.42e-2)" "unprognostic (2.07e-2)" "unprognostic (1.14e-1)" "unprognostic (6.29e-3)" "unprognostic (8.30e-2)" "unprognostic (4.10e-1)" "unprognostic (2.40e-5)" "unprognostic (9.30e-2)" "unprognostic (1.17e-1)" "unprognostic (4.94e-2)" "unprognostic (5.72e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (4.52e-8)" "unprognostic (1.55e-3)" "unprognostic (1.06e-2)" "unprognostic (1.39e-2)" "unprognostic (1.75e-2)" 1.0 2.1 0.8 1.9 1.1 2.8 1.8 1.7 1.4 1.3 1.1 1.6 2.0 1.7 2.7 1.2 1.4 1.3 1.4 0.8 1.0 1.8 2.5 1.2 2.5 1.1 0.9 2.3 2.6 1.0 1.7 1.0 1.0 1.7 2.0 2.5 1.6 1.4 1.2 4.2 1.8 1.4 0.9 1.9 2.0 5.3 1.0 1.9 1.9 0.7 2.5 1.4 0.9 1.2 1.2 3.9 1.9 3.1 1.2 1.0 2.1 2.4 1.2 1.5 3.7 3.5 6.0 2.2 2.4 0.5 2.4 3.9 2.6 2.8 1.9 1.5 2.5 1.0 13.6 1.9 1.1 2.4 2.5 1.9 1.3 2.5 2.4 1.8 1.4 3.8 0.9 3.9 1.1 1.7 3.2 5.1 0.9 1.5 0.6 3.4 2.0 5.1 2.0 1.7 0.9 1.4 1.7 1.0 1.7 1.3 1.8 1.1 1.5 1.8 3.0 1.7 1.9 8.6 4.1 4.4 3.4 2.9 2.6 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.8 1.1 1.7 1.4 0.8 1.0 1.1 0.9 1.0 0.9 1.0 1.2 0.5 0.0 1.5 0.0 0.5 0.3 0.3 0.7 0.6 0.0 0.6 0.5 1.4 1.5 1.4 0.0 0.0 0.2 0.8 0.6 0.0 0.8 0.0 0.7 0.3 0.5 1.8 3.2 0.0 1.2 0.4 0.6 0.0 0.6 0.0 2.2 0.4 2.0 0.4 0.0 0.0 0.0 0.0 1.0 0.3 0.6 1.2 0.8 1.8 0.0 1.0 0.0 1.0 0.0 0.0 1.0 0.2 0.4 0.9 0.3 0.3 0.3 2.4 0.0 0.0 0.6 0.4 0.6 0.2 0.4 0.9 0.3 0.7 0.8 0.5 0.1 MTFP1 "HSPC242, MTP18" ENSG00000242114 "Mitochondrial fission process 1" Q9UDX5 22 30425623-30429054 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 69.7;Exocrine glandular cells: 52.2;Plasma cells: 43.5;Undifferentiated cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077396 Approved Mitochondria NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Mitochondria "HPA077396: AB_2686837" "unprognostic (2.19e-2)" "unprognostic (1.18e-1)" "unprognostic (3.12e-1)" "unprognostic (6.20e-2)" "unprognostic (4.86e-2)" "unprognostic (1.72e-3)" "unprognostic (1.52e-3)" "unprognostic (8.98e-2)" "unprognostic (2.07e-1)" "unprognostic (1.65e-1)" "unprognostic (6.37e-3)" "unprognostic (1.54e-1)" "unprognostic (1.49e-1)" "unprognostic (6.40e-2)" "unprognostic (3.06e-2)" "unprognostic (3.84e-1)" "unprognostic (1.66e-2)" 12.9 15.6 8.7 10.1 9.1 14.2 11.6 11.1 9.9 8.3 16.8 17.1 16.8 3.8 15.1 19.8 3.4 8.1 26.2 9.0 10.2 38.9 31.9 11.9 16.5 9.9 9.7 5.0 19.0 21.8 8.1 11.4 9.3 13.5 12.9 23.4 10.1 4.9 26.2 7.6 13.4 4.7 9.1 20.9 19.7 4.0 10.8 7.8 8.5 19.3 14.8 13.7 7.6 8.6 91.9 69.5 23.8 37.1 5.1 4.1 27.2 8.6 8.2 51.3 78.5 33.6 52.4 99.5 25.3 6.0 41.3 46.5 74.0 77.6 34.7 56.2 96.5 26.7 38.6 64.9 14.8 66.7 52.7 7.6 25.7 31.4 47.4 15.7 43.5 45.1 51.2 35.5 16.3 109.5 63.3 71.8 41.5 82.9 73.2 85.6 23.1 87.3 61.0 24.8 40.6 44.5 19.9 90.6 35.6 16.9 28.8 31.4 18.4 55.9 72.4 27.6 26.3 17.8 15.5 86.1 22.4 75.9 23.7 0.2 14.3 0.1 49.2 17.1 65.5 34.0 39.6 42.3 20.3 23.7 41.7 48.2 1.8 14.0 11.6 10.5 36.0 25.6 8.7 9.1 11.1 9.9 9.0 10.2 9.9 9.7 9.3 9.1 10.8 8.6 5.3 6.4 3.0 3.9 21.7 5.6 1.8 12.0 6.2 0.0 10.1 3.7 4.4 7.2 6.7 3.7 0.0 13.4 14.8 33.2 15.6 69.7 0.1 1.9 1.4 5.8 8.4 9.2 0.8 52.2 30.4 2.5 20.9 2.6 9.5 0.4 5.0 11.1 17.6 0.0 2.7 28.1 2.0 10.3 9.6 0.2 0.6 6.4 3.6 1.0 36.6 0.0 10.3 0.5 0.3 40.3 13.8 0.4 43.5 3.5 28.3 11.8 1.9 0.0 0.0 1.5 5.1 0.6 2.1 16.5 5.5 16.8 29.6 0.7 45.3 2.2 MTR cblG ENSG00000116984 "5-methyltetrahydrofolate-homocysteine methyltransferase" Q99707 1 236795260-236921278 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" "Methyltransferase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 100.0;Glandular and luminal cells: 130.9;Inhibitory neurons: 106.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044474, HPA054915" Approved Supported Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 44: Endometrium - Transcription" Cytosol "HPA044474: AB_10966696, HPA054915: AB_2732589" "unprognostic (2.12e-1)" "unprognostic (1.03e-1)" "unprognostic (6.96e-2)" "unprognostic (1.99e-1)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "unprognostic (4.87e-1)" "unprognostic (1.02e-1)" "unprognostic (2.48e-2)" "unprognostic (3.34e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-1)" "unprognostic (1.67e-2)" "unprognostic (8.84e-3)" "unprognostic (1.88e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (8.10e-2)" 9.1 6.6 4.3 6.9 5.4 4.6 8.0 5.2 5.4 10.1 6.5 11.1 4.8 10.2 10.5 5.0 11.9 8.9 15.0 4.9 4.6 12.7 6.0 7.1 8.1 6.7 5.3 14.6 13.0 20.2 6.4 11.6 6.9 7.6 5.0 5.6 6.4 9.1 16.6 9.3 7.1 8.7 4.8 9.4 9.0 9.0 4.8 10.0 13.4 18.1 7.0 10.3 7.6 6.5 17.6 11.0 13.0 8.8 22.6 20.3 15.3 14.9 14.8 18.8 19.0 12.6 12.5 40.0 13.2 16.6 8.7 10.6 18.4 13.1 20.4 19.8 13.7 23.7 14.2 18.3 15.1 37.2 13.3 28.9 7.0 22.9 17.9 11.5 22.3 19.8 33.1 16.4 13.1 10.1 19.6 10.3 16.2 12.9 5.4 20.9 24.8 24.2 11.2 21.3 11.1 27.8 17.7 11.9 14.8 9.3 16.7 13.0 28.8 24.1 9.1 19.6 18.8 34.4 12.3 22.7 17.2 21.1 26.2 0.6 0.5 1.5 1.1 0.8 2.3 0.7 1.4 1.4 0.7 0.8 1.4 1.5 0.0 0.9 0.5 0.5 0.9 0.9 4.3 5.4 5.2 5.4 4.9 4.6 6.7 5.3 6.9 4.8 4.8 6.5 23.0 57.7 35.0 53.8 25.8 8.2 8.3 8.3 17.1 0.0 10.7 11.9 100.0 20.0 10.9 40.5 0.0 24.2 25.9 3.4 1.9 13.8 9.8 57.5 80.1 21.4 8.4 23.5 87.7 14.8 9.2 22.8 15.8 130.9 30.4 35.0 15.4 10.8 14.4 0.0 106.8 7.7 4.1 16.6 6.8 6.2 23.9 17.1 10.6 47.8 15.3 0.0 19.6 62.8 73.6 12.3 8.0 33.1 20.3 14.9 9.7 9.1 13.3 0.0 6.6 39.4 23.2 17.2 22.0 11.5 5.1 22.6 26.1 40.2 12.0 6.4 MTSS2 "ABBA, ABBA-1, LOC92154, MTSS1L" ENSG00000132613 "MTSS I-BAR domain containing 2" Q765P7 16 70661204-70686053 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 372.5" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 48.0" "Cancer enhanced" "Detected in all" "glioma: 26.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 299.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048531, HPA066469" Approved Supported "Focal adhesion sites" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 20: HeLa - Mitochondria" "Cluster 38: Extravillous trophoblasts - Unknown function" "Focal adhesion sites" "HPA048531: AB_2680430, HPA066469: AB_2685671" "prognostic unfavorable (2.85e-4)" "unprognostic (8.85e-2)" "unprognostic (7.01e-2)" "unprognostic (5.99e-2)" "unprognostic (3.21e-1)" "unprognostic (2.98e-1)" "unprognostic (1.86e-1)" "unprognostic (1.82e-1)" "unprognostic (5.30e-2)" "unprognostic (1.31e-1)" "unprognostic (5.59e-3)" "unprognostic (3.88e-1)" "unprognostic (2.92e-3)" "unprognostic (9.87e-2)" "unprognostic (9.92e-2)" "unprognostic (6.74e-2)" "unprognostic (2.25e-2)" 31.7 40.5 299.2 20.9 295.8 9.4 26.9 283.7 279.1 66.1 102.2 89.2 14.3 78.9 6.1 50.7 47.4 29.0 36.7 296.0 324.9 25.3 106.0 47.2 10.1 372.5 316.2 35.6 13.7 12.8 25.0 36.0 311.5 42.1 8.2 25.6 30.6 37.1 81.1 32.6 27.4 60.0 254.5 58.3 29.9 10.8 313.2 42.5 21.3 29.9 7.9 46.6 46.0 278.5 67.2 157.4 38.9 40.4 31.6 31.2 146.4 98.8 122.0 83.0 68.5 63.8 41.9 0.8 34.6 155.5 33.0 136.9 42.5 43.2 31.5 1.2 56.9 23.2 137.7 299.9 278.1 35.0 1.1 129.3 92.6 38.6 133.0 35.7 27.6 35.0 88.8 1.4 74.8 164.1 33.4 177.8 34.2 22.6 33.1 70.6 72.5 0.4 72.4 99.0 91.1 61.0 210.5 90.6 27.2 36.6 69.9 67.2 41.9 64.3 72.6 59.0 62.7 23.4 6.4 1.2 58.3 1.0 22.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 299.2 295.8 283.7 279.1 296.0 324.9 372.5 316.2 311.5 254.5 313.2 278.5 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 48.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 MVB12B "C9orf28, FAM125B, FLJ00001" ENSG00000196814 "Multivesicular body subunit 12B" Q9H7P6 9 126326829-126507041 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 99.3" "Cell type enriched" "Detected in many" 6 "Oligodendrocytes: 505.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043683, HPA049383" Approved "Golgi apparatus,Vesicles" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus, Vesicles" "HPA043683: AB_2678616, HPA049383: AB_2680737" "unprognostic (3.50e-1)" "unprognostic (1.12e-1)" "unprognostic (6.82e-2)" "unprognostic (9.59e-3)" "unprognostic (4.77e-2)" "unprognostic (1.13e-1)" "unprognostic (4.22e-2)" "unprognostic (4.45e-3)" "unprognostic (4.33e-1)" "unprognostic (1.05e-1)" "prognostic favorable (7.89e-4)" "unprognostic (2.82e-1)" "unprognostic (1.66e-3)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (5.79e-2)" "unprognostic (1.12e-3)" 5.8 5.2 32.5 4.5 63.6 12.3 4.8 58.6 44.5 6.4 27.6 8.2 3.7 6.8 3.0 4.1 9.9 3.8 5.4 32.0 40.1 4.4 4.2 18.0 6.9 81.1 59.4 6.4 3.2 7.7 8.3 15.0 68.4 6.6 6.2 6.2 3.1 8.4 24.6 5.0 5.5 6.4 57.2 11.1 6.4 5.7 56.7 8.4 5.8 13.0 2.6 7.9 5.0 99.3 4.8 6.5 34.6 19.1 1.2 0.4 20.4 4.0 3.1 7.0 1.3 5.6 0.3 0.0 2.4 3.8 10.3 2.1 10.7 1.9 4.3 8.0 6.7 1.7 1.1 24.6 2.7 3.2 1.5 2.6 3.5 1.4 0.1 5.8 5.4 25.5 0.0 0.0 5.2 3.9 5.3 10.0 7.6 0.8 8.6 7.6 18.9 0.0 0.3 19.5 8.7 15.9 6.4 4.6 4.1 14.4 4.6 19.2 7.9 7.8 5.8 4.4 8.2 0.1 0.0 1.9 2.2 14.2 4.2 0.0 0.8 0.1 1.4 0.2 2.5 0.1 0.6 2.3 1.0 0.2 0.1 1.0 0.0 0.0 0.2 0.0 0.0 0.9 32.5 63.6 58.6 44.5 32.0 40.1 81.1 59.4 68.4 57.2 56.7 99.3 6.3 6.4 7.3 75.4 1.8 3.6 3.2 1.0 6.8 9.4 3.3 3.6 3.6 4.3 1.3 1.8 4.2 12.4 4.7 8.8 0.0 1.6 0.8 6.2 3.0 5.8 2.4 1.7 64.5 1.4 2.6 3.1 2.6 2.4 7.0 5.5 2.2 6.2 1.6 10.1 58.2 2.5 6.1 23.3 6.2 2.7 2.8 10.2 0.0 74.9 3.9 9.1 2.1 56.8 505.6 1.0 5.5 6.4 2.2 1.2 0.9 0.3 6.9 5.3 0.0 2.6 2.7 3.4 6.4 2.9 2.6 3.4 10.9 0.8 3.0 1.6 NAE1 "APP-BP1, APPBP1, ula-1" ENSG00000159593 "NEDD8 activating enzyme E1 subunit 1" Q13564 16 66802875-66873256 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatogonia: 219.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041178, HPA042041" Enhanced Approved Nucleoplasm,Microtubules,Centrosome NA NA 100000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "Microtubules, Centrosome" "HPA041178: AB_10964773, HPA042041: AB_10964772" "unprognostic (3.22e-2)" "unprognostic (1.73e-1)" "unprognostic (1.79e-2)" "unprognostic (1.13e-1)" "unprognostic (2.00e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (3.92e-8)" "unprognostic (2.31e-1)" "unprognostic (5.58e-2)" "unprognostic (3.12e-3)" "unprognostic (5.34e-2)" "unprognostic (3.85e-2)" "unprognostic (7.09e-3)" "unprognostic (2.50e-1)" "unprognostic (1.84e-1)" "prognostic favorable (9.44e-5)" "unprognostic (1.97e-1)" 23.9 28.3 26.0 26.0 26.0 38.8 32.5 28.8 29.6 23.0 27.1 31.9 32.4 32.9 35.2 30.3 26.8 24.2 29.7 25.5 27.1 26.5 28.6 22.5 36.1 25.8 26.1 35.6 27.3 41.5 22.6 28.4 27.1 28.8 35.3 33.9 25.9 26.7 35.0 33.1 33.2 30.3 27.0 22.2 21.6 47.1 27.1 35.0 32.3 33.0 31.6 28.6 22.1 30.3 107.6 81.1 140.4 139.4 55.1 78.9 116.9 79.9 80.3 115.6 139.8 99.5 80.9 118.1 89.1 60.4 74.8 105.6 107.7 96.5 162.0 43.8 122.1 83.9 53.6 153.9 63.2 157.3 100.7 64.0 69.6 92.8 80.7 61.0 82.5 141.2 201.9 40.3 89.9 37.5 165.7 177.7 196.2 83.4 144.6 175.7 167.8 157.7 89.1 92.6 151.3 110.6 239.5 50.7 94.7 86.0 54.2 105.2 64.7 80.2 80.1 84.7 93.9 75.3 125.3 423.8 72.3 103.0 99.7 2.8 6.0 13.4 27.3 5.8 34.9 18.2 29.0 30.1 8.2 14.4 31.0 31.4 2.7 17.1 6.5 12.2 27.4 18.3 26.0 26.0 28.8 29.6 25.5 27.1 25.8 26.1 27.1 27.0 27.1 30.3 29.2 32.1 32.2 23.5 30.1 33.0 66.6 87.2 17.1 52.0 28.4 31.4 30.7 18.6 53.4 31.3 12.5 101.3 33.9 28.0 39.2 70.0 4.6 27.7 23.2 30.7 22.9 38.9 41.3 60.2 70.9 38.4 20.9 22.9 35.4 55.9 19.2 21.3 28.6 50.5 40.7 33.3 67.1 10.4 13.5 14.3 48.7 16.2 49.8 17.8 25.7 68.4 51.5 33.2 39.8 65.0 114.3 54.2 32.0 68.8 34.7 48.2 44.8 35.9 19.7 41.0 63.7 145.4 219.3 33.6 32.1 52.4 36.9 49.4 42.5 49.5 NCR3 "1C7, CD337, LY117, NKp30" ENSG00000204475 "Natural cytotoxicity triggering receptor 3" O14931 6 31588895-31593006 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 4.0;intestine: 5.6;lymphoid tissue: 16.1" "Group enriched" "Detected in some" 10 "B-cells: 43.6;dendritic cells: 110.4;NK-cells: 166.9;T-cells: 55.5" "Cancer enhanced" "Detected in many" "testis cancer: 2.6" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 274.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 2.0;HEL: 2.7;NB-4: 10.9;U-698: 1.7" "Low region specificity" "Detected in many" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (3.99e-3)" "unprognostic (9.23e-4)" "unprognostic (1.23e-3)" "unprognostic (2.49e-4)" "unprognostic (2.15e-1)" "unprognostic (2.57e-4)" "unprognostic (5.99e-2)" "unprognostic (1.15e-2)" "unprognostic (1.40e-2)" "unprognostic (3.62e-2)" "unprognostic (1.67e-1)" "unprognostic (1.81e-1)" "unprognostic (2.21e-4)" "unprognostic (1.72e-1)" "unprognostic (1.83e-1)" "unprognostic (8.17e-2)" "unprognostic (1.43e-1)" 0.5 0.0 0.0 2.9 0.0 4.0 0.2 0.0 0.1 0.1 0.0 0.4 0.3 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 1.0 1.8 5.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.1 0.2 5.6 0.0 0.0 16.1 0.4 0.7 0.1 2.0 0.3 0.0 4.9 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.2 0.5 0.0 98.8 0.1 274.3 65.2 12.1 53.9 0.3 51.8 5.7 30.1 0.9 76.6 0.6 0.6 20.3 31.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.7 0.0 1.9 0.0 43.6 3.4 0.0 0.0 0.6 0.0 0.3 0.4 0.1 0.0 1.3 0.0 0.0 0.1 110.4 0.1 0.0 0.0 0.5 0.1 0.2 0.5 0.0 2.7 0.0 0.0 0.2 0.3 0.5 0.1 8.9 0.0 1.4 0.4 0.4 0.0 0.0 0.0 0.0 2.5 2.9 0.2 0.3 1.2 3.6 0.0 1.6 0.0 166.9 0.0 0.1 0.0 0.1 0.0 2.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.6 0.7 0.1 1.7 0.1 55.5 0.0 0.1 0.0 NEK7 ENSG00000151414 "NIMA related kinase 7" Q8TDX7 1 198156994-198322420 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 140.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 172.6;Oligodendrocyte precursor cells: 131.2;Oligodendrocytes: 153.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 554.5;fHDF/TERT166: 753.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015520, HPA018193" Approved Supported Nucleoplasm Yes No "Cluster 16: MAIT-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "HPA015520: AB_1854371, HPA018193: AB_1854372" "unprognostic (2.08e-1)" "unprognostic (2.98e-2)" "unprognostic (1.65e-1)" "unprognostic (5.38e-2)" "unprognostic (4.26e-2)" "unprognostic (3.00e-2)" "unprognostic (2.14e-2)" "unprognostic (5.47e-2)" "unprognostic (4.77e-2)" "unprognostic (3.21e-1)" "unprognostic (1.46e-3)" "unprognostic (2.82e-1)" "unprognostic (1.13e-2)" "unprognostic (1.26e-2)" "unprognostic (1.74e-1)" "unprognostic (2.05e-2)" "unprognostic (1.56e-1)" 63.8 49.9 48.3 29.3 58.7 11.1 27.7 45.9 53.3 26.1 35.7 30.0 21.1 26.6 19.7 31.2 22.3 27.2 140.4 39.5 56.1 29.3 30.0 41.6 30.8 61.1 51.3 29.6 20.3 25.1 12.3 42.1 60.0 27.1 23.3 19.6 22.3 36.5 56.6 14.9 25.3 32.2 59.7 32.1 20.1 13.7 49.1 27.7 26.8 63.7 23.6 30.9 20.1 64.2 47.8 12.3 14.8 6.0 37.5 42.6 17.4 554.5 227.6 218.7 102.9 23.0 46.2 17.1 39.4 753.3 12.6 29.0 22.7 30.3 220.8 56.0 32.7 23.6 48.7 9.6 45.3 40.2 46.3 26.7 25.3 144.8 43.5 82.2 42.4 140.0 18.8 41.2 102.3 15.1 34.7 23.4 8.4 37.5 9.9 18.5 36.5 30.7 37.3 24.5 9.5 17.0 92.1 53.0 63.5 20.6 38.8 36.0 95.7 61.8 52.0 178.6 58.9 29.3 28.5 11.8 26.9 36.3 48.7 1.8 2.2 3.3 2.9 1.8 12.8 1.4 3.2 4.1 2.0 1.9 2.7 3.1 6.0 3.6 1.6 1.3 6.0 1.4 48.3 58.7 45.9 53.3 39.5 56.1 61.1 51.3 60.0 59.7 49.1 64.2 34.3 28.9 30.7 78.0 32.4 51.4 15.0 10.2 33.6 8.2 22.8 18.2 172.6 10.0 18.7 18.4 14.6 15.0 32.9 25.8 11.7 10.6 2.8 21.6 20.9 29.3 19.8 32.6 17.0 19.6 15.9 30.0 18.8 19.6 8.8 11.8 40.4 23.5 17.5 3.3 34.6 19.5 8.2 49.5 51.6 3.3 29.2 35.5 30.2 124.6 29.0 11.4 15.5 131.2 153.5 50.1 19.3 38.4 28.5 30.6 25.1 16.6 27.9 24.2 19.7 28.1 35.9 7.7 6.0 29.2 49.2 64.3 41.6 28.7 15.6 33.1 NEO1 "HsT17534, IGDCC2, NGN, NTN1R2" ENSG00000067141 "Neogenin 1" Q92859 15 73051710-73305205 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 231.8;Excitatory neurons: 124.5;Oligodendrocyte precursor cells: 120.1;Oligodendrocytes: 439.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009320, HPA027804, HPA027805, HPA027806" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 390000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 12: NES - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Plasma membrane" "Golgi apparatus" "CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006" "unprognostic (1.90e-1)" "unprognostic (2.38e-2)" "unprognostic (7.60e-3)" "unprognostic (3.76e-2)" "unprognostic (5.44e-1)" "unprognostic (3.83e-2)" "unprognostic (8.30e-2)" "unprognostic (2.31e-1)" "unprognostic (3.22e-1)" "unprognostic (3.30e-2)" "unprognostic (5.51e-2)" "unprognostic (8.05e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.51e-1)" "unprognostic (1.41e-1)" "unprognostic (1.33e-2)" "unprognostic (3.75e-1)" 9.6 7.4 28.9 8.9 43.8 1.5 16.7 38.1 31.4 18.2 10.7 46.0 27.3 19.6 9.9 11.5 21.9 19.6 7.8 29.4 29.2 23.4 8.7 15.9 3.9 34.6 38.0 24.8 17.2 41.8 6.7 1.7 35.6 33.0 55.1 19.5 18.3 36.0 30.9 37.5 26.5 23.3 28.7 5.3 22.9 13.5 36.6 7.2 18.2 24.8 6.2 10.5 9.6 60.0 8.9 42.9 50.1 33.2 29.6 8.6 12.5 3.3 4.1 8.2 1.7 6.4 42.8 2.5 4.9 9.4 30.8 1.9 35.3 19.5 3.5 15.8 26.0 29.0 0.5 6.0 8.6 0.8 0.9 21.3 35.4 1.6 16.2 9.5 0.0 22.3 0.2 53.9 2.0 26.8 10.5 0.7 47.9 6.7 3.6 23.9 26.8 5.8 15.8 23.7 22.7 32.1 40.2 17.6 20.7 39.9 18.6 5.3 0.1 38.0 19.9 12.5 9.3 22.8 45.2 6.2 8.2 8.3 10.9 0.0 0.0 0.1 0.4 0.0 0.7 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 28.9 43.8 38.1 31.4 29.4 29.2 34.6 38.0 35.6 28.7 36.6 60.0 3.1 9.6 10.4 231.8 2.3 14.1 8.2 20.7 13.6 15.7 14.2 18.2 6.9 21.5 11.4 22.0 14.6 0.5 4.8 55.6 1.9 11.6 3.3 14.4 13.4 3.4 60.1 3.0 124.5 6.4 0.8 14.6 20.9 24.6 0.0 11.8 5.7 8.9 0.9 10.1 72.8 51.2 10.2 1.2 2.7 7.1 31.7 1.2 10.6 62.8 0.1 12.5 2.1 120.1 439.4 9.9 40.0 62.8 2.6 11.5 39.6 15.5 12.7 21.9 6.6 22.2 10.2 11.8 20.3 14.7 25.4 0.3 6.0 3.1 60.5 7.2 NEUROG3 "Atoh5, bHLHa7, Math4B, ngn3" ENSG00000122859 "Neurogenin 3" Q9Y4Z2 10 69571698-69573422 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "brain: 5.4;intestine: 2.6" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 9.5;Enteroendocrine cells: 5.3" "Cancer enhanced" "Detected in some" "stomach cancer: 1.4" "Group enriched" "Detected in some" 20 "cerebral cortex: 4.5;hippocampal formation: 5.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "THP-1: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA039785 Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 43: THP-1 - Innate immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear speckles" Nucleoplasm "HPA039785: AB_10795114" "unprognostic (1.22e-2)" "unprognostic (7.33e-2)" "unprognostic (3.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.10e-1)" "unprognostic (1.65e-2)" "unprognostic (5.85e-5)" "unprognostic (4.58e-2)" "unprognostic (4.19e-1)" 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 4.5 0.0 0.0 0.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 4.5 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 NFIX NF1A ENSG00000008441 "Nuclear factor I X" Q14938 19 12995475-13098796 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 410.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 145.2;Oligodendrocytes: 140.9;Skeletal myocytes: 174.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 149.5;fHDF/TERT166: 211.3;U-138 MG: 191.5;U-2197: 185.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007533 Supported Supported Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "HPA007533: AB_2667855" "unprognostic (3.32e-1)" "unprognostic (1.37e-2)" "unprognostic (2.84e-1)" "unprognostic (2.20e-1)" "unprognostic (2.29e-1)" "unprognostic (8.12e-2)" "prognostic favorable (4.66e-4)" "prognostic favorable (2.35e-4)" "unprognostic (1.26e-1)" "unprognostic (2.01e-2)" "unprognostic (3.25e-1)" "unprognostic (2.63e-2)" "unprognostic (1.08e-2)" "unprognostic (3.46e-2)" "unprognostic (2.92e-2)" "unprognostic (3.06e-2)" "unprognostic (4.38e-2)" 76.4 14.9 30.4 19.7 80.2 14.9 48.0 99.8 97.7 67.2 4.0 60.4 20.9 88.5 10.9 72.4 69.5 53.9 60.9 54.0 15.0 8.9 20.3 50.0 6.2 50.9 45.1 73.8 23.8 13.2 18.9 11.8 39.4 85.0 19.7 11.7 150.4 60.0 410.3 99.2 24.3 67.8 45.6 11.3 37.3 16.0 46.9 11.6 31.0 138.2 6.2 45.0 52.7 105.2 39.2 16.2 1.0 119.9 111.7 149.5 1.3 48.1 68.6 45.7 31.8 1.3 3.3 0.6 13.4 211.3 31.4 17.5 12.8 37.4 20.1 25.8 19.7 20.2 7.6 17.2 53.8 8.5 10.3 99.0 10.9 44.1 24.6 80.3 12.4 8.6 6.7 6.2 29.3 12.1 14.9 5.7 0.5 8.6 132.3 43.5 22.2 23.1 0.4 8.5 17.9 47.6 34.5 0.3 43.0 0.0 22.7 17.3 12.2 191.5 23.5 185.1 68.5 4.5 1.7 0.3 49.9 12.1 62.0 0.1 0.1 0.0 0.5 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 30.4 80.2 99.8 97.7 54.0 15.0 50.9 45.1 39.4 45.6 46.9 105.2 19.5 12.8 59.3 62.7 6.8 58.8 45.5 22.4 134.9 13.3 57.9 74.2 33.2 27.1 15.9 14.7 4.2 0.2 3.7 16.5 1.9 24.3 64.0 12.1 40.1 20.0 12.1 145.2 69.0 12.7 0.3 89.7 32.6 3.0 3.8 4.3 17.9 33.9 1.0 0.0 38.1 25.8 2.0 4.1 15.2 43.1 112.2 5.8 26.6 17.8 1.9 93.7 0.0 52.3 140.9 15.2 12.0 126.0 2.5 60.3 8.4 10.0 19.0 3.0 6.6 174.7 38.3 15.6 13.2 99.4 51.4 0.3 3.8 56.0 29.5 31.8 NLE1 "FLJ10458, NLE" ENSG00000073536 "Notchless homolog 1" Q9NVX2 17 35128730-35142304 "Predicted intracellular proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018807 Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Nucleoplasm "HPA018807: AB_1848658" "unprognostic (9.19e-2)" "unprognostic (8.40e-2)" "unprognostic (4.69e-2)" "unprognostic (4.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (8.64e-8)" "unprognostic (8.67e-3)" "unprognostic (1.98e-1)" "unprognostic (1.26e-2)" "unprognostic (6.49e-2)" "unprognostic (3.90e-2)" "unprognostic (2.00e-1)" "unprognostic (4.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (6.39e-4)" 7.3 7.4 5.0 5.8 5.0 6.2 8.8 5.1 5.3 7.4 3.4 5.6 4.0 6.8 2.9 8.4 7.4 3.1 4.2 5.0 4.5 6.5 7.3 4.6 6.8 4.7 4.0 12.0 23.7 3.9 4.2 4.9 4.0 6.0 4.0 2.5 7.6 4.6 8.0 6.8 5.1 4.1 3.5 6.2 7.6 4.4 5.0 6.6 5.1 3.5 5.4 7.4 5.8 4.6 15.9 36.8 12.5 22.7 6.9 11.4 19.6 14.0 12.7 24.4 19.3 26.1 14.8 34.9 18.6 12.0 18.0 21.0 26.8 35.6 15.1 5.6 44.2 14.9 18.2 33.2 10.3 29.9 12.0 12.9 19.0 25.6 38.3 10.7 15.5 33.9 42.4 12.7 14.6 22.1 47.1 25.5 23.6 13.5 16.6 37.6 20.9 38.5 14.3 14.8 25.6 14.8 13.1 13.4 17.1 11.1 32.4 22.4 14.5 13.3 18.3 13.0 47.4 9.8 7.8 29.1 9.3 24.9 25.8 0.1 2.2 0.0 4.0 2.4 6.2 3.4 3.8 4.2 3.4 4.6 5.2 3.5 0.3 1.8 1.2 0.8 2.1 2.2 5.0 5.0 5.1 5.3 5.0 4.5 4.7 4.0 4.0 3.5 5.0 4.6 4.7 3.2 1.1 0.3 8.6 8.7 8.6 7.4 9.6 4.7 12.3 14.0 2.6 10.0 3.7 3.7 2.1 12.1 2.4 3.9 0.0 8.9 1.0 2.1 5.4 5.0 4.9 8.8 1.3 15.4 20.9 7.4 6.6 2.8 3.8 9.4 5.3 6.6 7.6 1.7 1.5 8.1 2.0 4.6 2.6 5.4 4.1 2.8 1.8 1.0 3.8 1.9 2.1 1.0 0.7 8.5 3.6 4.9 5.1 8.6 3.4 7.1 2.8 3.1 0.0 6.5 7.2 4.2 6.5 12.5 10.1 4.9 4.1 9.2 13.4 5.5 NMU ENSG00000109255 "Neuromedin U" P48645 4 55595229-55636698 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 100.2;skin 1: 38.5;vagina: 30.7" "Group enriched" "Detected in many" 4 "Squamous epithelial cells: 212.4;Suprabasal keratinocytes: 73.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "MAIT T-cell: 3.6;memory CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 37 "T-cells: 3.6" "Cell line enhanced" "Detected in many" "Daudi: 90.2;HaCaT: 382.6;K-562: 311.3;Karpas-707: 135.7" "Group enriched" "Detected in some" 8 "hypothalamus: 1.1;pons and medulla: 4.5" "Low region specificity" "Detected in some" HPA025926 Uncertain "Secreted in other tissues" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA025926: AB_1854539" "unprognostic (4.42e-2)" "unprognostic (1.00e-1)" "unprognostic (5.83e-2)" "prognostic unfavorable (2.60e-5)" "unprognostic (1.08e-1)" "unprognostic (5.19e-2)" "unprognostic (7.12e-2)" "unprognostic (7.29e-3)" "unprognostic (9.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.03e-2)" "unprognostic (3.00e-1)" "prognostic unfavorable (4.07e-10)" "unprognostic (1.61e-1)" "unprognostic (5.66e-2)" "unprognostic (2.54e-2)" "unprognostic (5.55e-2)" 0.1 0.3 0.4 0.7 0.5 9.7 1.5 0.6 1.1 12.3 0.0 1.4 0.8 0.1 0.0 100.2 0.2 0.0 0.2 0.3 2.8 0.2 0.0 0.8 0.5 1.1 2.6 0.1 0.1 0.0 2.3 0.8 0.8 0.2 0.8 0.1 14.3 0.2 0.1 38.5 1.4 0.2 3.0 0.1 4.0 2.2 6.8 1.7 2.5 0.0 7.7 0.1 30.7 0.4 41.3 0.3 22.1 5.6 0.0 0.0 0.0 0.0 0.0 2.9 7.8 0.3 61.5 90.2 8.6 0.0 8.5 382.6 46.1 3.3 2.3 5.6 25.1 0.6 36.0 0.0 0.0 0.0 0.3 0.0 4.2 0.0 3.0 10.0 0.4 6.4 311.3 135.7 0.3 9.9 1.2 0.2 11.7 7.5 11.4 0.2 0.0 0.5 1.9 0.4 19.5 49.0 30.9 0.8 0.1 4.2 20.9 0.1 2.7 0.2 27.5 0.3 54.5 39.1 0.3 0.0 18.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.6 1.1 0.3 2.8 1.1 2.6 0.8 3.0 6.8 0.4 0.0 0.0 2.3 0.0 0.6 16.3 0.6 16.2 4.0 0.2 0.9 1.3 0.1 0.0 8.0 0.0 0.0 2.0 0.0 0.6 0.0 0.1 0.4 3.9 0.3 0.7 0.0 14.5 0.2 0.2 0.1 4.4 29.6 5.8 1.3 0.9 0.0 0.1 0.3 0.0 17.2 0.8 20.3 0.0 1.6 0.3 0.0 0.2 3.6 0.0 0.1 2.0 0.0 1.0 0.2 2.4 0.2 0.0 1.2 0.4 0.0 0.0 7.0 0.0 0.0 0.0 1.2 5.8 10.0 212.4 73.6 0.1 0.7 0.2 2.6 12.0 NPB "PPL7, PPNPB" ENSG00000183979 "Neuropeptide B" Q8NG41 17 81900745-81902905 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 8.1" "Group enriched" "Detected in many" 6 "Spermatogonia: 41.5;Syncytiotrophoblasts: 97.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.2;PC-3: 3.4;RH-30: 1.8;SH-SY5Y: 2.7;U-2 OS: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 44: HDLM-2 - Immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "unprognostic (2.44e-2)" "unprognostic (6.21e-2)" "unprognostic (2.90e-1)" "unprognostic (3.47e-3)" "unprognostic (9.42e-2)" "unprognostic (1.46e-1)" "unprognostic (3.31e-1)" "unprognostic (1.92e-1)" "unprognostic (3.55e-2)" "unprognostic (5.40e-2)" "unprognostic (5.86e-2)" "unprognostic (1.96e-1)" "unprognostic (6.06e-2)" "unprognostic (3.71e-1)" "unprognostic (4.32e-1)" 0.3 0.1 2.2 0.0 1.8 0.0 0.2 2.6 2.4 0.4 0.0 0.2 0.0 0.3 0.0 0.3 0.3 0.0 0.4 1.5 7.1 0.3 0.8 0.1 0.1 5.2 5.0 0.5 0.1 0.2 0.3 0.2 4.3 0.2 0.0 0.2 0.2 0.1 0.2 0.4 0.5 0.1 3.8 0.4 0.6 1.5 6.2 0.2 0.1 0.0 0.1 0.2 0.3 8.1 0.2 0.8 0.6 0.1 0.1 0.1 0.5 0.3 0.1 0.2 0.0 0.4 0.0 0.2 0.1 0.1 0.4 0.0 0.3 0.1 0.2 2.2 0.0 0.4 0.1 0.0 0.1 0.0 0.2 0.0 0.7 0.2 0.1 0.4 0.0 0.4 0.6 0.0 0.1 0.1 0.0 0.4 0.2 0.1 3.4 0.1 1.8 0.0 0.0 0.2 0.4 2.7 0.2 0.0 0.3 1.0 0.0 0.0 0.2 0.2 2.3 0.0 0.2 0.1 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.8 2.6 2.4 1.5 7.1 5.2 5.0 4.3 3.8 6.2 8.1 1.1 0.0 0.0 1.3 0.4 2.5 0.6 1.8 1.2 1.0 3.3 6.6 0.0 1.5 0.6 0.0 0.0 2.1 0.1 1.2 1.9 0.9 1.5 0.8 3.0 0.9 0.0 0.0 0.4 0.2 3.6 3.3 4.6 0.3 0.0 2.6 1.1 0.2 1.2 0.0 1.2 0.4 0.0 2.6 1.6 3.8 5.0 0.2 5.4 0.0 0.1 0.4 0.0 1.0 4.5 1.8 3.7 2.6 0.2 0.9 0.9 2.1 0.7 1.2 0.0 1.0 3.4 10.7 41.5 1.3 1.1 97.0 0.4 0.5 0.6 0.4 NPDC1 "CAB-, CAB1, DKFZp586J0523" ENSG00000107281 "Neural proliferation, differentiation and control 1" Q9NQX5 9 137039463-137046179 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 397.0;Endothelial cells: 307.2;Enteroendocrine cells: 281.6;Hepatic stellate cells: 406.2;Intestinal goblet cells: 589.1" "Cancer enhanced" "Detected in all" "prostate cancer: 146.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 12.3;MAIT T-cell: 14.7;memory CD4 T-cell: 19.0;memory CD8 T-cell: 18.9;T-reg: 15.9" "Lineage enriched" "Detected in many" 5 "T-cells: 19.0" "Cell line enhanced" "Detected in many" "MCF7: 138.4;RPMI-8226: 132.8;T-47d: 140.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008189 Approved Approved Nucleoplasm,Cytosol NA NA 240000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 27: Mucus-secreting cells - Mucin production" Nucleoplasm Cytosol "HPA008189: AB_1854584" "unprognostic (6.94e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (2.01e-5)" "prognostic favorable (6.19e-5)" "unprognostic (2.06e-1)" "unprognostic (4.83e-3)" "unprognostic (1.24e-1)" "unprognostic (4.35e-2)" "unprognostic (8.65e-2)" "unprognostic (1.53e-1)" "prognostic favorable (3.18e-4)" "unprognostic (2.40e-1)" "unprognostic (2.65e-2)" "unprognostic (1.23e-2)" "unprognostic (2.35e-1)" "unprognostic (4.20e-2)" "unprognostic (8.84e-2)" 129.5 45.7 140.8 12.2 128.1 3.4 133.0 110.6 181.3 130.5 55.0 93.1 23.4 121.6 4.3 53.7 148.6 24.9 149.1 143.3 143.1 75.9 23.7 115.4 13.0 138.9 142.3 68.2 81.2 23.0 266.0 21.1 131.3 260.5 13.4 9.2 137.4 35.1 34.0 56.4 72.1 16.9 120.7 145.2 126.2 35.3 142.9 2.9 68.4 12.4 3.9 97.9 90.5 114.7 33.6 41.9 10.1 67.1 23.7 23.8 2.8 68.7 23.0 16.9 6.7 17.1 18.5 30.3 50.7 28.6 4.6 122.4 8.6 20.5 1.6 25.0 40.4 13.6 123.7 12.9 33.3 11.9 0.3 16.5 31.9 8.7 17.9 43.1 43.6 13.2 0.7 0.8 3.5 138.4 1.0 1.1 21.1 111.0 68.1 19.9 0.0 132.8 28.6 22.7 77.2 50.0 18.4 65.3 46.5 3.6 140.1 17.9 73.9 12.4 21.6 84.1 21.0 0.1 0.4 1.4 17.7 1.2 10.5 0.0 0.6 0.9 12.3 0.1 14.7 0.1 19.0 18.9 1.1 0.0 0.5 3.1 0.0 0.2 0.1 3.4 15.9 3.3 140.8 128.1 110.6 181.3 143.3 143.1 138.9 142.3 131.3 120.7 142.9 114.7 397.0 0.0 7.7 64.3 3.4 23.6 77.6 15.0 31.3 97.5 174.0 139.7 18.3 71.4 19.8 29.5 16.7 1.1 5.5 122.2 0.0 52.5 1.8 39.0 27.7 307.2 281.6 19.3 71.7 66.0 1.3 61.2 153.9 101.3 0.0 9.2 406.2 1.9 22.2 62.2 64.7 589.1 18.3 21.0 20.0 6.9 161.2 6.6 30.2 37.5 3.0 38.5 1.0 38.2 39.0 33.0 106.0 145.6 1.4 234.9 37.5 0.7 7.5 62.0 39.5 23.9 38.9 2.8 19.0 15.9 23.7 1.8 12.3 9.1 98.1 103.1 NR1D1 "ear-1, hRev, Rev-ErbAalpha, REVERBA, REVERBalpha, THRA1, THRAL" ENSG00000126368 "Nuclear receptor subfamily 1 group D member 1" P20393 17 40092793-40100589 "Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 325.5" "Cell type enhanced" "Detected in all" "Squamous epithelial cells: 95.5;Suprabasal keratinocytes: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 18.5" "Group enriched" "Detected in many" 6 "monocytes: 5.5;T-cells: 18.5" "Cell line enhanced" "Detected in all" "Karpas-707: 60.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007935 Uncertain Supported "Nuclear bodies" NA Yes "Cluster 16: MAIT-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 2: Karpas-707 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" "Nuclear bodies" "HPA007935: AB_10601277" "unprognostic (1.38e-2)" "unprognostic (3.46e-2)" "prognostic unfavorable (1.94e-4)" "unprognostic (2.53e-1)" "unprognostic (2.24e-2)" "unprognostic (1.05e-1)" "unprognostic (4.50e-2)" "unprognostic (1.03e-1)" "prognostic favorable (1.36e-4)" "unprognostic (1.93e-3)" "unprognostic (9.93e-3)" "unprognostic (2.73e-1)" "unprognostic (9.15e-3)" "unprognostic (4.54e-3)" "unprognostic (2.49e-1)" "unprognostic (3.09e-1)" "unprognostic (1.34e-1)" 72.3 53.7 23.5 6.3 27.0 5.4 63.1 52.9 49.7 109.6 10.6 53.3 14.3 35.8 4.5 42.5 27.7 7.1 60.8 24.9 17.2 38.0 43.2 49.2 9.3 18.1 20.9 71.3 24.3 9.0 32.0 6.0 15.9 40.5 4.0 50.4 52.9 16.3 99.0 325.5 23.0 7.5 12.9 11.6 31.5 12.5 34.0 6.3 32.1 38.1 5.4 42.5 96.5 25.2 5.5 7.8 1.6 6.2 9.0 6.2 2.2 11.9 19.5 3.9 4.9 5.1 19.5 6.7 6.9 13.8 12.9 15.4 4.1 18.0 2.9 5.6 4.1 4.8 7.9 13.5 14.6 7.2 6.9 13.5 12.8 13.3 28.2 12.6 4.9 7.7 7.2 60.6 3.8 3.8 10.7 6.1 3.0 10.8 12.3 7.5 2.2 20.7 5.4 4.9 5.1 2.9 7.6 9.7 12.4 2.7 4.6 5.8 4.7 17.2 16.7 14.1 9.5 21.5 35.7 2.6 23.4 4.0 13.6 0.0 0.5 0.0 4.4 2.0 18.5 1.7 5.5 6.4 1.1 2.1 4.8 3.5 0.2 1.0 5.5 1.4 8.0 1.8 23.5 27.0 52.9 49.7 24.9 17.2 18.1 20.9 15.9 12.9 34.0 25.2 16.4 3.2 2.0 17.3 5.7 64.5 47.5 20.5 67.2 71.4 9.4 15.1 5.7 8.6 11.9 1.8 4.2 2.6 4.9 26.0 7.9 16.1 2.3 25.4 30.6 18.6 8.3 3.6 7.1 11.8 1.2 26.5 31.1 64.2 2.5 2.7 6.8 31.8 2.5 42.1 6.2 7.2 8.2 3.4 19.4 1.5 21.8 7.7 19.6 8.4 1.2 39.0 5.2 5.0 1.2 26.0 14.7 38.7 10.5 35.4 58.8 7.9 5.0 29.7 6.6 9.6 19.4 2.0 11.1 95.5 81.1 2.3 11.9 13.7 6.0 28.7 NR1D2 "BD73, EAR-1r, Hs.37288, HZF2, REVERBB, REVERBbeta, RVR" ENSG00000174738 "Nuclear receptor subfamily 1 group D member 2" Q14995 3 23945286-23980617 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 135.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053868, HPA054798" Approved Approved Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA053868: AB_2682284, HPA054798: AB_2616453" "unprognostic (8.64e-2)" "unprognostic (9.96e-3)" "unprognostic (2.27e-1)" "unprognostic (2.46e-1)" "unprognostic (8.67e-2)" "unprognostic (2.09e-2)" "unprognostic (2.04e-1)" "unprognostic (3.61e-2)" "unprognostic (2.60e-1)" "unprognostic (6.79e-3)" "unprognostic (2.21e-1)" "unprognostic (5.73e-2)" "prognostic favorable (4.47e-7)" "unprognostic (2.36e-3)" "unprognostic (1.23e-1)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" 15.4 16.0 14.1 10.9 13.7 15.3 20.9 26.8 21.5 13.7 8.7 13.7 13.6 24.9 13.8 15.8 16.8 14.5 31.7 14.2 14.8 21.8 29.5 14.1 14.7 13.1 15.2 31.2 17.0 52.8 11.9 8.7 13.7 17.5 11.3 34.4 32.4 24.7 54.5 14.0 13.9 13.3 13.7 18.7 14.8 7.4 17.3 12.2 54.2 50.4 14.2 10.6 12.4 18.8 22.5 5.0 11.5 10.9 11.8 12.6 7.1 32.7 42.7 17.8 19.7 3.7 21.6 16.0 10.7 46.0 27.8 14.7 14.6 21.4 36.9 5.8 16.9 2.6 11.3 4.5 24.6 8.6 2.3 16.9 22.1 21.7 55.4 32.9 12.3 9.3 5.8 56.3 14.2 12.9 4.7 2.7 12.5 18.2 24.8 4.1 18.6 11.1 9.9 30.6 11.8 26.2 23.9 13.6 29.2 18.5 11.9 7.4 24.5 46.2 47.0 30.2 37.6 27.4 39.4 7.4 26.3 12.6 27.5 0.0 0.3 0.0 1.4 1.1 2.6 1.0 1.6 1.3 0.4 0.7 1.1 1.1 0.1 0.5 0.6 0.4 1.0 0.4 14.1 13.7 26.8 21.5 14.2 14.8 13.1 15.2 13.7 13.7 17.3 18.8 51.8 12.8 7.5 51.6 39.6 33.3 34.7 14.5 59.2 82.5 29.7 23.9 39.5 17.2 17.5 20.2 39.6 11.1 43.0 17.1 7.9 11.3 10.0 77.5 49.8 38.9 28.5 3.8 58.6 15.1 2.5 47.7 35.7 135.2 8.2 33.2 15.4 33.1 9.6 95.9 62.0 18.2 26.4 12.8 32.0 11.3 34.2 26.8 28.4 32.8 12.6 62.8 11.3 44.2 57.5 19.8 10.3 42.5 28.5 41.4 17.9 11.9 16.0 53.6 32.9 46.8 45.5 7.6 10.9 42.0 33.5 6.8 44.4 37.0 12.1 31.1 NR2C1 "TR2, TR2-11" ENSG00000120798 "Nuclear receptor subfamily 2 group C member 1" P13056 12 95020229-95073628 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035040, HPA035041, HPA067767" Supported Supported "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Cell Junctions, Cytosol" "HPA035040: AB_2674426, HPA035041: AB_2674427, HPA067767: AB_2685898" "unprognostic (2.44e-1)" "unprognostic (8.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.51e-1)" "unprognostic (3.56e-3)" "unprognostic (3.01e-2)" "prognostic unfavorable (5.18e-5)" "unprognostic (1.30e-2)" "unprognostic (1.29e-2)" "unprognostic (1.86e-1)" "unprognostic (3.83e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (2.31e-1)" "unprognostic (1.42e-1)" "unprognostic (2.16e-1)" "prognostic favorable (5.62e-5)" 8.3 10.4 4.9 5.0 5.6 9.3 7.7 14.0 9.3 9.3 8.2 8.6 5.6 10.3 9.9 5.4 10.2 4.4 10.0 5.1 5.1 6.6 10.0 8.6 5.5 4.7 4.9 9.9 8.2 6.1 7.2 5.8 5.6 6.7 6.2 15.6 5.2 7.5 14.3 6.1 7.6 7.8 4.6 9.2 6.1 11.9 5.6 5.7 11.9 5.5 5.3 8.1 7.4 6.9 11.4 13.9 23.0 10.2 5.8 10.0 30.5 10.9 7.9 10.6 9.9 12.2 6.2 13.8 3.8 7.3 6.8 11.8 10.7 8.6 8.1 6.0 23.1 16.7 11.5 15.4 11.1 11.3 7.0 10.2 7.0 7.9 9.5 13.3 11.6 16.8 12.9 5.2 12.9 8.3 12.4 26.0 14.5 9.1 24.0 11.7 15.0 8.1 12.3 13.9 11.1 8.8 17.6 7.4 8.4 11.8 12.9 7.5 10.9 8.6 8.4 10.7 6.2 7.7 13.1 13.0 2.1 13.0 4.2 0.3 2.4 2.1 3.9 2.6 5.0 2.0 3.1 3.3 3.7 2.3 4.0 2.8 1.5 2.1 2.3 3.6 2.3 2.3 4.9 5.6 14.0 9.3 5.1 5.1 4.7 4.9 5.6 4.6 5.6 6.9 18.7 35.3 15.4 28.4 14.4 8.3 14.4 7.8 15.4 44.8 7.6 7.5 18.5 8.6 5.6 11.0 18.8 15.3 19.9 10.3 3.9 11.6 25.2 14.8 23.3 15.5 7.2 15.6 55.4 9.4 12.7 17.4 16.3 18.8 10.1 28.0 13.2 12.7 9.5 25.2 73.4 11.4 12.2 11.1 9.5 6.4 43.8 10.9 14.2 34.7 10.7 14.9 12.3 26.2 51.1 18.7 9.9 30.1 13.7 9.4 5.8 8.1 19.6 49.6 6.6 17.3 14.6 67.0 25.9 12.1 7.4 7.8 15.0 18.0 13.3 20.2 NR3C2 "MLR, MR" ENSG00000151623 "Nuclear receptor subfamily 3 group C member 2" P08235 4 148078762-148444698 "Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 265.8;Excitatory neurons: 275.7;Inhibitory neurons: 269.9;Microglial cells: 176.1;Oligodendrocyte precursor cells: 230.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 1.8" "Lineage enriched" "Detected in single" 6 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 9.7;HUVEC TERT2: 6.0;Karpas-707: 6.9;PC-3: 6.1;RPTEC TERT1: 7.8;TIME: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009155, HPA074979" Enhanced Supported Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "CAB009155: AB_2155949, HPA074979: AB_2686724" "unprognostic (2.75e-3)" "unprognostic (2.63e-2)" "unprognostic (6.70e-3)" "unprognostic (1.52e-1)" "unprognostic (4.09e-1)" "unprognostic (7.82e-3)" "unprognostic (1.04e-2)" "unprognostic (1.11e-2)" "unprognostic (1.14e-1)" "unprognostic (4.35e-2)" "unprognostic (4.97e-2)" "unprognostic (2.39e-1)" "prognostic favorable (3.10e-11)" "unprognostic (1.42e-1)" "unprognostic (1.87e-1)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" 4.6 4.5 4.5 3.7 5.6 1.0 4.8 9.2 11.7 5.6 4.0 21.8 8.7 6.2 3.8 3.1 5.9 5.8 9.4 13.7 3.5 12.1 8.5 7.3 3.1 3.0 5.9 14.7 7.6 12.5 5.5 1.8 3.0 3.7 26.2 8.5 10.7 4.3 12.1 3.0 15.3 4.9 3.2 5.2 8.3 4.3 6.1 2.9 19.7 14.1 2.1 5.9 3.3 4.8 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.4 0.0 0.0 1.4 2.6 1.0 0.2 0.0 1.3 0.7 0.1 0.2 2.3 0.2 0.6 0.0 0.0 1.7 0.3 0.1 0.0 0.0 0.0 9.7 6.0 0.9 0.0 6.9 2.0 0.0 0.0 0.0 0.1 1.2 6.1 0.5 0.0 0.1 7.8 0.1 0.1 0.0 0.0 1.4 0.6 0.1 0.7 0.0 8.7 4.3 2.5 0.1 0.8 0.0 0.0 0.1 1.4 0.6 1.0 0.0 0.0 0.0 0.5 0.0 1.8 0.1 0.7 0.4 0.0 0.2 1.0 1.1 0.0 0.0 0.2 0.0 0.2 0.1 4.5 5.6 9.2 11.7 13.7 3.5 3.0 5.9 3.0 3.2 6.1 4.8 11.9 28.9 13.9 265.8 5.1 2.0 2.2 0.4 6.2 10.3 6.2 5.8 20.3 7.2 6.7 11.0 18.8 0.9 1.0 76.1 9.8 3.0 68.2 2.1 1.1 8.2 18.0 0.0 275.7 5.8 0.5 5.9 13.7 2.6 5.7 6.4 8.6 7.0 0.6 13.5 269.9 44.6 6.1 2.9 2.4 41.8 4.4 1.7 7.2 176.1 1.2 8.1 1.0 230.2 95.7 3.2 26.8 3.8 0.8 1.8 26.4 2.3 4.7 9.6 0.0 14.7 5.1 1.8 5.6 2.6 1.7 0.1 4.9 1.8 21.5 2.1 NRIP1 RIP140 ENSG00000180530 "Nuclear receptor interacting protein 1" P48552 21 14961235-15065936 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 219.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 92.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029785, HPA046571, HPA060036" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 14: REH - Unknown function" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nucleoli" Cytosol "HPA029785: , HPA046571: AB_2679704, HPA060036: AB_2684193" "unprognostic (5.60e-2)" "unprognostic (1.87e-1)" "unprognostic (5.20e-3)" "unprognostic (4.64e-3)" "unprognostic (7.98e-2)" "unprognostic (2.59e-2)" "unprognostic (2.74e-1)" "unprognostic (2.75e-3)" "unprognostic (8.94e-3)" "unprognostic (1.55e-1)" "unprognostic (2.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-2)" "unprognostic (6.53e-2)" "unprognostic (1.07e-1)" "unprognostic (2.72e-1)" "unprognostic (2.80e-1)" 30.4 10.2 5.8 10.2 5.2 26.4 14.2 14.9 6.9 24.7 6.5 18.2 16.8 18.2 13.4 9.4 21.4 10.3 5.4 6.4 8.1 15.9 26.9 8.9 8.7 4.8 4.5 13.3 14.4 7.4 3.2 14.6 5.3 10.3 18.1 31.8 6.1 8.4 22.3 4.1 18.3 20.1 6.4 13.1 8.9 8.1 6.7 17.0 5.6 23.8 7.2 14.1 8.4 8.3 22.1 43.5 34.6 0.0 17.4 11.3 12.6 26.1 11.7 16.0 12.5 8.7 17.3 0.1 14.5 23.3 7.9 11.0 2.2 15.6 33.9 0.0 10.0 33.4 15.3 27.2 10.5 16.7 6.7 14.1 21.3 17.6 20.5 17.8 12.6 4.8 24.1 17.4 11.4 11.8 7.8 0.1 14.5 8.8 13.9 92.4 28.0 0.8 9.8 35.8 3.2 0.1 21.7 11.3 8.8 27.7 27.2 12.9 22.0 13.7 9.1 21.4 10.8 8.5 0.2 0.1 29.0 0.0 6.8 0.0 0.4 0.2 0.3 0.2 1.8 0.3 0.3 0.4 0.6 1.0 0.5 0.2 0.1 0.5 0.5 0.6 0.2 0.2 5.8 5.2 14.9 6.9 6.4 8.1 4.8 4.5 5.3 6.4 6.7 8.3 33.2 48.1 37.6 60.7 27.4 18.6 122.6 16.2 22.8 33.9 52.9 26.8 18.3 21.5 40.9 29.5 50.1 16.4 20.7 50.1 9.8 23.0 15.8 60.9 99.1 43.0 37.7 24.2 123.7 27.6 120.8 42.3 26.5 130.9 31.5 94.0 27.1 44.7 45.7 21.9 95.0 41.6 18.3 50.4 21.9 19.3 37.6 57.9 8.8 219.2 40.4 56.2 27.8 102.1 78.2 31.4 42.6 27.1 10.1 49.5 43.0 36.5 15.9 63.1 32.9 112.1 38.6 12.1 6.3 23.1 18.8 14.1 19.9 71.0 47.7 99.8 NRN1 NRN ENSG00000124785 "Neuritin 1" Q9NPD7 6 5997999-6007605 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 98.9;parathyroid gland: 81.0" "Cell type enhanced" "Detected in many" "Adipocytes: 262.9;Endothelial cells: 115.3;Excitatory neurons: 71.9;Extravillous trophoblasts: 64.7;Hepatic stellate cells: 160.3" "Cancer enhanced" "Detected in all" "glioma: 38.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "MAIT T-cell: 2.6;neutrophil: 2.2" "Group enriched" "Detected in many" 7 "granulocytes: 2.2;T-cells: 2.6" "Cell line enhanced" "Detected in many" "ASC diff: 140.0;ASC TERT1: 107.6;fHDF/TERT166: 147.5;JURKAT: 134.8;REH: 196.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 23000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 14: REH - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "unprognostic (6.24e-2)" "unprognostic (2.47e-2)" "unprognostic (1.35e-2)" "unprognostic (1.22e-1)" "unprognostic (1.26e-2)" "unprognostic (5.57e-2)" "unprognostic (4.70e-3)" "unprognostic (2.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.49e-1)" "unprognostic (1.67e-2)" "unprognostic (3.35e-1)" "prognostic unfavorable (4.79e-5)" "unprognostic (1.26e-1)" "unprognostic (2.04e-1)" "unprognostic (2.90e-1)" "unprognostic (4.37e-3)" 66.4 5.1 49.1 6.4 44.9 0.5 64.2 46.0 80.8 16.2 17.0 21.3 3.7 9.4 4.0 8.2 13.6 11.2 19.7 98.9 27.7 8.2 4.4 15.6 9.6 30.4 29.9 4.7 2.9 81.0 12.3 42.1 32.5 10.1 4.7 23.4 8.7 7.4 17.3 18.8 10.8 10.5 22.1 15.7 10.3 0.6 60.1 3.6 9.4 16.1 3.5 13.8 17.0 45.9 16.7 0.6 1.4 0.1 140.0 107.6 19.1 2.6 0.0 11.8 16.1 0.2 0.1 0.0 2.5 147.5 25.0 0.5 43.3 0.0 11.4 26.1 21.2 13.7 0.0 0.0 0.0 58.0 43.7 17.3 0.0 10.5 0.0 0.1 57.4 134.8 0.2 0.6 42.5 0.1 89.7 2.6 0.1 0.0 0.0 196.3 47.7 0.4 0.2 0.2 24.9 9.2 0.0 0.8 13.9 0.2 0.4 16.4 12.1 56.4 1.6 21.4 36.5 0.1 2.2 0.9 85.8 0.2 8.9 0.0 0.1 0.0 0.1 0.1 2.6 0.3 0.2 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.2 0.0 0.1 49.1 44.9 46.0 80.8 98.9 27.7 30.4 29.9 32.5 22.1 60.1 45.9 262.9 0.0 1.3 7.2 1.6 10.5 0.1 0.0 1.2 6.7 1.4 2.4 2.5 1.5 0.0 0.0 2.1 1.5 1.0 0.0 0.0 0.1 0.1 0.0 0.1 115.3 0.0 0.0 71.9 0.5 64.7 15.9 0.0 0.1 0.0 0.0 160.3 0.9 1.8 3.3 3.0 0.0 0.0 4.1 21.5 0.4 0.9 1.4 16.0 8.4 0.5 4.5 0.0 13.6 8.3 0.2 0.0 0.0 1.4 0.4 0.0 0.0 0.0 20.2 0.0 4.4 18.3 0.4 0.3 0.6 11.2 1.4 1.9 0.1 0.0 0.7 NSG1 "D4S234E, NEEP21, P21" ENSG00000168824 "Neuronal vesicle trafficking associated 1" P42857 4 4348140-4419058 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 95.7;pituitary gland: 135.1;skin 1: 120.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 222.4;Cytotrophoblasts: 120.2;Granulosa cells: 128.8;Melanocytes: 291.7;Suprabasal keratinocytes: 178.2" "Cancer enriched" "Detected in many" 4 "melanoma: 61.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 45.2;MAIT T-cell: 61.9;memory CD4 T-cell: 42.2;memory CD8 T-cell: 37.1;naive CD8 T-cell: 27.6" "Lineage enriched" "Detected in many" 57 "T-cells: 61.9" "Cell line enhanced" "Detected in many" "HAP1: 84.7;SCLC-21H: 168.6;SH-SY5Y: 82.5;SK-MEL-30: 80.9;TIME: 204.6;U-698: 75.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 52: Non-specific - Transcription" "unprognostic (3.21e-3)" "unprognostic (2.33e-1)" "unprognostic (5.29e-3)" "unprognostic (7.60e-2)" "unprognostic (8.06e-2)" "unprognostic (1.49e-1)" "unprognostic (1.32e-3)" "unprognostic (3.47e-2)" "unprognostic (2.06e-1)" "unprognostic (1.91e-3)" "prognostic favorable (9.49e-4)" "unprognostic (2.50e-1)" "unprognostic (6.85e-2)" "unprognostic (4.21e-2)" "unprognostic (7.33e-2)" "unprognostic (2.85e-1)" "unprognostic (7.41e-2)" 5.0 25.3 29.0 4.2 33.1 1.0 6.0 59.6 50.7 17.1 5.3 7.9 6.8 7.8 2.1 30.7 20.1 1.3 5.9 18.4 95.7 4.4 0.5 1.5 3.2 57.1 64.8 46.3 1.8 0.1 135.1 18.3 58.8 22.8 7.1 32.3 6.7 18.2 0.7 120.9 5.8 6.9 24.2 2.2 8.0 16.0 45.4 9.5 0.5 3.0 3.5 13.3 30.1 24.2 0.2 0.1 0.8 0.5 0.0 0.0 14.6 0.3 0.0 0.2 0.0 1.3 0.4 0.0 10.4 0.5 3.3 2.4 84.7 5.5 0.4 0.0 3.0 0.0 0.2 0.0 4.1 0.0 0.0 0.1 12.0 0.0 2.3 0.0 14.6 22.3 0.0 0.1 1.3 0.0 6.8 0.5 10.1 0.1 0.4 0.1 0.0 0.4 0.0 4.8 168.6 82.5 0.6 0.2 80.9 7.0 0.9 0.3 204.6 0.0 13.0 0.2 0.3 0.1 0.4 75.9 0.1 0.2 0.4 0.2 0.1 0.1 45.2 0.1 61.9 0.1 42.2 37.1 0.1 0.1 10.4 27.6 1.0 0.9 0.2 0.1 4.5 15.7 29.0 33.1 59.6 50.7 18.4 95.7 57.1 64.8 58.8 24.2 45.4 24.2 1.6 9.6 0.0 5.9 0.4 86.8 83.4 47.9 31.3 222.4 0.7 24.3 0.0 0.0 13.2 0.0 4.2 120.2 6.0 0.0 0.0 0.0 31.2 10.3 1.4 2.1 2.4 0.0 16.6 0.0 15.2 24.9 0.0 16.4 1.3 128.8 1.8 0.0 8.2 8.4 32.2 0.0 4.1 0.0 13.6 44.2 3.1 1.3 291.7 6.5 0.4 6.4 20.6 1.5 4.0 0.1 0.2 5.7 0.7 19.9 0.0 20.4 1.7 24.3 0.0 0.2 10.8 2.9 14.4 44.8 178.2 76.8 17.0 96.0 0.3 77.0 NTN4 ENSG00000074527 "Netrin 4" Q9HB63 12 95657807-95791189 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 181.5" "Cell type enhanced" "Detected in many" "Collecting duct cells: 198.6;Hepatic stellate cells: 369.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 12 "MAIT T-cell: 1.6" "Lineage enriched" "Detected in single" 16 "T-cells: 1.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 513.8;hTERT-HME1: 205.8;PC-3: 189.6;TIME: 289.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA049832 Approved "Secreted to extracellular matrix" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA049832: AB_2680905" "unprognostic (3.08e-1)" "unprognostic (2.17e-1)" "unprognostic (2.33e-1)" "unprognostic (4.15e-2)" "unprognostic (2.11e-2)" "unprognostic (1.42e-1)" "unprognostic (1.67e-1)" "unprognostic (3.03e-2)" "unprognostic (8.71e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (9.50e-4)" "unprognostic (2.85e-1)" "prognostic favorable (8.12e-9)" "unprognostic (3.52e-2)" "unprognostic (7.08e-2)" "unprognostic (1.93e-1)" "prognostic favorable (6.67e-5)" 24.4 17.3 6.4 5.7 7.5 0.1 72.9 4.4 10.5 26.5 12.0 16.5 12.0 12.7 15.3 15.6 34.4 22.4 66.8 8.9 5.7 107.6 26.7 70.2 2.9 5.9 8.7 86.1 62.5 13.3 7.6 11.9 5.7 42.4 18.1 0.6 32.6 59.1 12.6 8.8 17.5 15.0 6.1 181.5 48.7 12.1 6.2 6.2 14.4 19.9 6.5 49.5 14.4 8.7 26.7 71.3 2.0 0.1 28.5 45.0 3.0 49.7 513.8 67.1 78.2 56.1 48.8 0.0 3.5 105.3 88.1 42.2 0.6 15.3 34.0 0.0 4.3 2.3 12.7 11.1 1.7 0.0 0.1 1.1 43.5 75.0 205.8 72.9 133.3 0.4 0.0 0.1 25.4 20.0 0.2 0.3 1.1 7.9 189.6 0.2 0.6 0.1 64.8 133.4 0.3 0.6 60.5 77.1 1.3 2.3 22.2 0.1 289.3 25.9 9.5 101.3 5.2 0.1 0.1 0.0 5.9 0.0 5.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 7.5 4.4 10.5 8.9 5.7 5.9 8.7 5.7 6.1 6.2 8.7 31.9 41.7 123.2 6.2 3.8 4.7 120.5 15.2 39.3 1.8 77.6 55.4 44.8 44.3 30.8 198.6 0.0 6.2 1.3 4.4 5.9 36.7 10.3 36.4 3.2 35.5 0.0 2.7 28.1 28.0 3.6 33.7 23.0 28.1 1.3 25.9 369.5 10.2 0.4 0.0 70.6 37.2 4.1 26.3 3.7 3.8 2.1 2.6 7.2 20.6 0.6 0.3 0.0 112.6 1.8 36.7 4.0 3.4 0.9 108.9 1.5 84.3 38.0 0.2 26.3 119.0 73.9 1.9 0.6 5.9 2.3 1.6 3.3 1.4 6.4 127.0 ODF2L KIAA1229 ENSG00000122417 "Outer dense fiber of sperm tails 2 like" Q9ULJ1 1 86346824-86396342 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 335.7;Respiratory ciliated cells: 361.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028020, HPA028095, HPA028333" Uncertain NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "HPA028020: AB_10601670, HPA028095: AB_10611385, HPA028333: AB_10601007" "unprognostic (4.81e-2)" "unprognostic (3.11e-1)" "unprognostic (1.03e-1)" "unprognostic (4.72e-2)" "unprognostic (2.92e-2)" "unprognostic (3.80e-3)" "unprognostic (5.61e-3)" "unprognostic (2.25e-1)" "unprognostic (2.08e-3)" "unprognostic (1.07e-1)" "unprognostic (6.27e-2)" "unprognostic (5.25e-2)" "prognostic unfavorable (4.69e-7)" "unprognostic (2.40e-1)" "unprognostic (5.86e-2)" "unprognostic (2.40e-1)" "unprognostic (5.04e-3)" 22.6 20.2 14.0 14.0 15.8 17.1 23.0 16.8 20.0 21.7 14.3 18.4 8.3 18.1 23.3 17.6 23.7 15.2 13.4 14.2 12.7 24.5 7.1 22.9 16.6 13.2 14.8 18.8 11.4 7.2 28.1 10.1 8.1 20.0 14.8 41.2 15.5 10.5 5.2 11.9 22.8 9.7 9.0 36.5 8.7 13.3 15.2 21.9 22.1 3.7 13.2 15.3 17.6 16.8 30.0 7.9 19.7 15.1 21.0 35.8 20.6 28.6 17.4 27.6 32.0 6.2 16.3 0.7 26.3 15.3 35.2 15.3 8.1 16.7 23.6 14.1 12.8 7.3 24.5 0.6 15.9 13.1 9.3 16.5 20.2 41.7 11.4 19.9 45.3 19.8 10.2 6.8 16.4 4.0 15.7 13.8 24.1 6.5 14.5 21.0 14.8 3.2 27.7 40.0 19.5 14.1 25.8 26.2 54.9 30.7 8.5 12.6 41.7 23.0 21.4 31.8 29.4 1.9 1.0 12.3 5.4 6.7 26.5 5.6 2.2 13.6 26.1 3.4 51.5 20.9 30.2 21.0 2.4 21.2 19.3 18.8 6.3 14.8 4.1 12.7 31.8 4.9 14.0 15.8 16.8 20.0 14.2 12.7 13.2 14.8 8.1 9.0 15.2 16.8 72.9 93.0 76.2 22.5 54.0 25.0 54.6 49.0 15.4 139.3 67.0 49.3 12.0 21.5 133.2 80.9 141.8 7.3 73.9 23.1 23.5 61.9 48.5 335.7 57.3 78.7 41.3 16.6 119.1 27.1 35.1 52.5 13.3 70.6 36.7 55.9 72.8 3.9 15.5 57.2 107.2 68.5 42.7 21.2 19.7 10.3 24.8 18.6 56.9 38.4 21.8 28.8 80.3 29.1 49.9 55.9 28.1 28.6 38.9 16.5 9.3 23.1 361.9 120.3 19.7 24.3 32.1 64.0 27.4 19.2 17.3 2.9 106.4 60.6 28.2 67.3 P2RY11 P2Y11 ENSG00000244165 "Purinergic receptor P2Y11" Q96G91 19 10111693-10115372 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hofbauer cells: 37.8;NK-cells: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 18.9" "Group enriched" "Detected in many" 5 "NK-cells: 13.9;T-cells: 18.9" "Cell line enhanced" "Detected in many" "HEK 293: 29.7;NB-4: 33.7" "Low region specificity" "Detected in many" HPA014232 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 63: NK-cells & T-cells - Immune response" "HPA014232: AB_1854883" "unprognostic (1.13e-1)" "unprognostic (3.12e-2)" "unprognostic (2.76e-3)" "unprognostic (2.61e-3)" "unprognostic (1.82e-1)" "unprognostic (2.79e-2)" "unprognostic (2.34e-1)" "unprognostic (5.56e-2)" "unprognostic (2.23e-1)" "unprognostic (1.93e-1)" "unprognostic (2.04e-3)" "unprognostic (2.22e-2)" "unprognostic (4.32e-3)" "unprognostic (1.76e-2)" "unprognostic (3.78e-2)" "unprognostic (1.58e-1)" "prognostic favorable (1.77e-4)" 7.1 4.5 8.0 3.8 9.2 5.6 7.0 8.4 12.4 8.9 4.7 9.4 4.1 6.2 0.7 8.2 10.6 1.1 6.1 8.5 7.5 12.1 10.1 7.4 6.8 9.0 7.7 9.2 7.6 0.6 9.5 1.1 8.3 11.7 0.8 1.6 7.3 1.2 9.0 16.9 10.9 0.7 7.1 15.0 7.3 10.9 10.0 1.4 11.3 0.3 2.0 9.8 8.4 8.2 5.2 4.8 1.7 6.5 2.5 2.0 10.6 1.9 1.0 1.1 2.1 5.7 3.0 9.8 2.6 0.5 0.8 8.2 1.7 5.0 0.2 4.3 29.7 7.7 8.4 3.3 3.7 3.5 14.8 3.7 4.1 1.6 2.7 2.0 0.7 6.2 3.5 13.8 1.1 7.5 6.8 33.7 11.7 4.9 3.9 10.5 3.3 5.6 2.1 6.5 7.3 12.1 1.2 4.1 14.7 0.7 3.6 14.2 2.0 7.1 2.8 11.6 3.8 25.6 20.0 3.1 4.8 20.8 6.3 3.5 1.7 0.1 7.3 2.0 18.9 1.2 1.0 6.9 0.8 0.6 0.7 5.5 0.5 13.9 1.2 0.2 1.5 4.9 8.0 9.2 8.4 12.4 8.5 7.5 9.0 7.7 8.3 7.1 10.0 8.2 2.3 6.4 3.7 0.0 3.3 4.8 2.6 2.6 0.6 7.6 3.8 3.2 1.7 5.7 2.6 1.8 2.1 1.8 7.3 4.4 1.9 1.2 0.3 3.8 3.6 2.8 3.6 3.2 0.0 1.1 1.4 1.9 4.6 5.0 3.8 4.2 2.2 3.6 37.8 6.7 0.0 5.2 4.1 2.4 3.3 0.4 3.4 8.7 1.8 0.0 0.8 1.9 22.6 0.0 0.0 1.5 1.6 1.2 2.9 4.1 1.2 1.5 3.5 6.0 0.0 6.8 2.7 1.8 3.6 1.3 4.0 1.4 9.3 5.1 5.6 1.7 PA2G4 ENSG00000170515 "Proliferation-associated 2G4" Q9UQ80 12 56104537-56113910 "Enzymes, Plasma proteins, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation, Translation regulation" "Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011711, CAB012428, HPA016484" Supported Approved Cytosol NA NA 2300000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "CAB011711: AB_732060, CAB012428: , HPA016484: AB_1854912" "unprognostic (5.53e-2)" "unprognostic (1.06e-1)" "unprognostic (2.35e-2)" "unprognostic (2.34e-2)" "unprognostic (3.87e-1)" "unprognostic (6.03e-3)" "prognostic unfavorable (6.31e-7)" "unprognostic (4.25e-3)" "unprognostic (2.77e-1)" "unprognostic (3.79e-3)" "unprognostic (2.29e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (4.59e-7)" "unprognostic (1.17e-1)" "unprognostic (2.01e-1)" "unprognostic (1.32e-1)" "unprognostic (4.67e-2)" 78.4 59.6 46.7 89.3 50.4 132.9 76.2 50.7 58.0 64.8 43.0 78.7 74.1 64.7 48.2 132.5 64.7 43.7 76.9 48.6 51.8 62.1 72.8 62.5 96.6 49.4 48.3 71.2 75.1 83.7 36.3 69.2 51.0 53.2 90.5 38.3 63.9 55.4 144.0 106.1 69.7 68.4 49.8 61.2 65.5 63.1 48.9 123.4 61.4 92.5 120.7 105.3 76.9 57.2 429.6 374.8 248.9 275.5 112.5 169.8 499.6 441.3 209.7 530.9 293.8 464.7 307.5 850.8 291.2 209.6 155.9 343.5 574.2 493.1 510.9 243.9 517.6 659.1 242.5 400.4 219.7 898.8 232.4 172.5 247.2 460.2 410.8 218.1 327.3 292.0 812.8 380.7 294.7 383.5 700.8 496.2 410.9 264.5 460.9 569.3 449.8 577.2 272.0 315.7 372.8 225.6 290.5 451.6 275.0 183.1 488.7 343.5 264.8 256.3 364.7 300.3 495.5 234.4 345.1 822.1 232.3 532.6 340.9 34.3 87.0 54.6 129.9 96.0 174.7 98.0 136.8 141.3 102.1 81.3 129.7 131.2 13.8 151.5 82.0 98.6 170.9 155.9 46.7 50.4 50.7 58.0 48.6 51.8 49.4 48.3 51.0 49.8 48.9 57.2 135.7 54.5 91.2 9.8 136.3 368.5 244.7 187.4 224.8 56.2 151.9 165.7 37.3 118.7 161.3 130.6 18.8 232.0 163.1 123.4 193.7 235.8 530.6 127.1 218.4 154.2 93.3 552.1 12.8 249.1 321.7 139.5 112.7 142.2 170.9 103.7 107.8 197.5 208.6 33.7 13.0 159.0 99.7 124.2 127.8 238.9 132.0 126.2 129.9 6.5 155.4 117.1 178.2 10.6 14.8 269.3 100.8 126.7 163.5 360.7 118.6 264.7 103.6 48.8 144.7 188.1 191.7 344.6 110.9 295.2 362.7 193.5 176.2 132.2 254.1 242.7 PAK3 "bPAK, hPAK3, MRX30, MRX47" ENSG00000077264 "P21 (RAC1) activated kinase 3" O75914 X 110944285-111227361 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Allosteric enzyme, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 31.9;pancreas: 42.7;pituitary gland: 13.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 104.1;Excitatory neurons: 364.0;Inhibitory neurons: 323.5;Oligodendrocyte precursor cells: 165.9;Peritubular cells: 81.3" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.7" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 5 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "EFO-21: 10.8;HAP1: 9.9;HDLM-2: 12.4;NTERA-2: 9.7;SCLC-21H: 12.4;SH-SY5Y: 7.7;U-2197: 7.6;U-251 MG: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044791, HPA060219" Approved Approved Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA044791: , HPA060219: AB_2684223" "unprognostic (1.80e-2)" "unprognostic (1.54e-1)" "unprognostic (1.80e-2)" "unprognostic (3.27e-4)" "unprognostic (2.46e-1)" "unprognostic (5.63e-3)" "unprognostic (7.29e-2)" "unprognostic (3.23e-2)" "unprognostic (1.27e-2)" "unprognostic (3.01e-1)" "unprognostic (6.80e-3)" "unprognostic (1.66e-1)" "unprognostic (1.89e-4)" "unprognostic (5.71e-3)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-2)" 1.0 5.2 16.9 1.6 16.2 0.1 5.2 0.0 17.6 2.3 0.0 0.7 0.2 5.4 5.8 0.7 2.5 1.6 0.3 17.8 31.9 0.7 0.2 0.9 1.7 1.6 0.0 6.2 42.7 0.1 13.7 0.6 6.0 3.4 0.7 7.0 2.2 4.8 1.6 1.3 0.5 4.7 0.4 2.0 2.0 2.6 13.2 0.6 6.2 0.4 0.8 0.9 0.7 2.8 0.0 0.7 1.4 0.0 0.0 0.0 0.0 0.3 0.4 1.1 0.0 0.0 0.0 0.0 10.8 1.2 1.6 0.0 9.9 0.6 1.3 12.4 0.4 0.0 1.3 0.0 0.0 0.0 0.4 0.3 0.0 0.1 2.2 5.7 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.2 9.7 0.0 2.2 0.1 4.3 0.0 0.8 0.0 12.4 7.7 0.0 0.4 0.0 6.6 0.0 0.0 0.0 0.7 4.7 7.6 13.6 0.1 0.1 0.1 1.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.9 16.2 0.0 17.6 17.8 31.9 1.6 0.0 6.0 0.4 13.2 2.8 0.9 3.2 1.1 16.0 0.6 0.3 13.3 0.2 0.0 104.1 6.9 10.4 1.0 20.0 0.7 0.0 0.0 0.3 0.2 0.2 0.0 4.7 4.4 1.0 10.8 2.3 3.6 0.0 364.0 13.1 0.4 10.3 10.2 1.7 1.3 21.9 1.4 0.2 0.2 6.7 323.5 0.3 0.0 0.3 5.7 7.0 34.2 1.1 0.0 17.8 0.7 27.5 1.0 165.9 12.0 5.3 0.0 81.3 1.0 1.7 0.0 0.6 0.0 6.0 0.0 1.6 7.8 1.4 1.4 0.3 1.1 6.7 2.4 29.2 0.3 0.9 PARP2 "ADPRTL2, ARTD2" ENSG00000129484 "Poly(ADP-ribose) polymerase 2" Q9UGN5 14 20343615-20357904 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052003 Approved Supported Nucleoplasm,Nucleoli NA Yes "Cluster 16: MAIT-cells - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "HPA052003: AB_2681689" "unprognostic (3.93e-1)" "unprognostic (7.92e-2)" "unprognostic (4.12e-1)" "unprognostic (1.24e-1)" "unprognostic (3.40e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (6.48e-4)" "unprognostic (1.97e-2)" "unprognostic (4.43e-2)" "unprognostic (9.35e-3)" "unprognostic (1.44e-2)" "unprognostic (1.42e-2)" "unprognostic (3.37e-3)" "unprognostic (2.83e-1)" "unprognostic (9.19e-2)" "unprognostic (1.91e-1)" "unprognostic (2.89e-2)" 17.7 21.1 21.1 10.7 22.0 26.8 17.5 21.4 31.4 18.1 16.4 19.3 12.8 20.9 17.8 14.6 17.5 10.0 17.1 22.5 21.0 15.5 17.2 13.5 14.5 19.5 18.9 22.9 17.9 11.1 21.0 12.9 19.8 13.9 14.0 26.4 14.2 13.4 32.4 19.2 14.2 15.8 19.0 16.5 16.3 23.8 19.8 11.9 16.7 27.1 17.9 13.8 15.3 22.1 55.5 39.5 59.7 45.3 19.4 18.4 43.4 60.2 32.5 74.8 91.8 36.8 51.3 40.4 26.5 19.0 64.8 50.1 78.3 27.5 87.8 32.4 38.3 37.2 46.6 63.3 17.3 77.9 20.4 12.5 23.0 45.5 51.1 20.5 38.5 48.0 39.2 53.4 52.3 33.5 40.1 33.0 33.0 62.8 60.0 49.7 79.7 26.5 30.0 28.2 41.3 28.3 65.3 36.8 17.9 37.4 34.2 25.8 26.6 45.3 68.1 31.5 48.1 49.3 67.7 53.4 19.0 33.3 51.4 1.9 5.0 0.5 8.9 4.8 11.7 6.8 8.4 7.9 5.5 4.1 9.0 8.6 0.1 7.6 2.6 5.6 5.3 4.8 21.1 22.0 21.4 31.4 22.5 21.0 19.5 18.9 19.8 19.0 19.8 22.1 12.1 25.6 6.5 7.2 9.5 6.5 10.5 16.1 18.8 29.2 7.4 10.0 14.0 5.7 19.9 7.3 12.5 25.8 10.2 4.5 7.9 12.8 9.3 9.9 13.3 11.0 4.8 30.3 17.6 8.7 22.2 11.6 7.7 11.3 8.2 18.4 6.8 10.1 11.9 30.3 15.5 5.0 14.2 4.6 5.1 9.8 11.5 6.6 8.8 9.4 4.2 20.7 6.2 6.0 9.3 10.1 4.5 17.0 19.1 4.5 5.3 7.4 28.0 23.2 6.6 9.8 18.5 20.9 41.5 11.3 4.8 14.9 6.2 16.7 7.4 7.0 PARP8 "ARTD16, FLJ21308, pART16" ENSG00000151883 "Poly(ADP-ribose) polymerase family member 8" Q8N3A8 5 50665899-50846519 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 78.2" "Cell type enhanced" "Detected in many" "dendritic cells: 124.9;Excitatory neurons: 197.9;Inhibitory neurons: 139.3;Microglial cells: 112.4;Oligodendrocyte precursor cells: 158.3;T-cells: 157.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 91.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049183 Approved Approved "Nucleoplasm,Midbody ring,Cytosol" Yes No "Cluster 16: MAIT-cells - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 43: THP-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Midbody ring, Cytosol" "HPA049183: AB_2680667" "unprognostic (1.22e-2)" "unprognostic (2.53e-1)" "unprognostic (1.77e-1)" "unprognostic (1.05e-1)" "unprognostic (2.12e-1)" "unprognostic (6.33e-2)" "unprognostic (8.86e-3)" "unprognostic (7.27e-2)" "unprognostic (1.86e-2)" "unprognostic (8.96e-2)" "unprognostic (2.85e-1)" "unprognostic (6.81e-2)" "unprognostic (9.63e-2)" "unprognostic (2.84e-2)" "unprognostic (4.42e-2)" "unprognostic (4.23e-2)" "prognostic favorable (1.12e-4)" 11.7 13.1 4.6 26.8 8.8 78.2 9.2 0.0 7.9 8.3 0.3 8.8 14.5 6.6 4.2 7.7 9.9 25.7 6.9 14.7 12.6 7.0 8.0 19.8 42.0 3.4 4.5 11.6 12.2 13.8 4.9 12.4 0.1 11.3 9.3 4.6 10.3 7.4 4.8 7.6 15.0 8.4 2.7 43.6 20.2 9.1 7.7 19.2 43.1 2.1 22.5 14.5 5.4 2.0 24.8 0.1 12.2 18.8 3.2 5.7 18.0 4.3 15.7 4.1 12.0 0.9 33.5 14.8 16.9 0.5 43.3 12.4 2.1 13.1 10.0 20.2 15.9 10.6 9.2 1.1 6.3 28.1 0.2 6.8 10.9 8.5 6.0 24.6 0.2 23.1 1.6 9.1 5.9 8.8 31.8 32.5 12.3 0.4 6.0 15.4 24.0 17.1 7.6 12.8 13.0 19.0 13.8 21.6 3.7 17.6 1.0 91.2 0.0 1.0 15.4 1.2 12.6 6.9 0.2 29.5 13.8 7.6 17.7 27.4 13.7 31.9 43.6 4.0 70.6 13.4 34.3 50.5 9.2 16.7 20.9 34.9 28.6 39.5 2.9 4.2 22.5 22.7 4.6 8.8 0.0 7.9 14.7 12.6 3.4 4.5 0.1 2.7 7.7 2.0 6.2 32.1 21.1 29.4 51.7 8.0 5.2 12.7 26.2 13.6 10.4 6.5 5.6 14.3 19.1 22.0 0.0 22.5 124.9 17.2 7.9 14.2 28.7 11.8 8.4 3.9 15.0 7.4 197.9 10.2 6.4 13.4 46.9 10.6 14.5 12.6 6.8 5.0 14.3 6.7 139.3 4.2 8.2 26.1 16.9 15.3 1.2 27.1 8.8 112.4 43.4 0.7 93.7 158.3 7.3 18.7 8.4 3.0 65.0 7.7 8.2 4.3 25.6 2.1 6.6 12.3 13.0 12.8 6.0 14.3 4.0 24.8 157.3 6.5 9.6 13.7 PARVA "FLJ10793, FLJ12254, MXRA2" ENSG00000197702 "Parvin alpha" Q9NVD7 11 12377563-12535356 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion, Cell shape, Chemotaxis, Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 229.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005964 Approved Supported "Actin filaments,Focal adhesion sites,Cytosol" NA NA 7300000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Actin filaments, Focal adhesion sites" Cytosol "HPA005964: AB_1079569" "unprognostic (3.87e-2)" "unprognostic (7.38e-2)" "unprognostic (3.30e-2)" "prognostic favorable (1.76e-4)" "unprognostic (7.37e-3)" "unprognostic (1.38e-2)" "unprognostic (6.78e-2)" "prognostic unfavorable (8.19e-4)" "unprognostic (1.76e-2)" "unprognostic (2.80e-2)" "unprognostic (1.70e-2)" "unprognostic (9.82e-2)" "unprognostic (6.73e-2)" "unprognostic (6.58e-3)" "unprognostic (1.35e-1)" "unprognostic (1.50e-1)" "unprognostic (3.82e-2)" 61.8 17.6 9.3 22.7 9.0 0.1 40.9 7.2 10.1 53.9 16.5 92.4 17.5 71.8 16.7 42.8 38.8 31.9 34.3 9.8 11.6 23.0 16.9 28.8 6.4 11.0 7.3 31.9 36.0 16.9 11.7 35.9 8.4 50.6 38.4 8.9 20.9 68.9 8.1 14.0 26.1 95.5 11.3 11.3 42.5 6.8 8.6 4.6 17.9 11.7 9.1 55.0 28.2 11.0 34.0 33.1 30.2 39.4 147.8 110.6 69.1 126.5 130.1 87.7 81.6 24.7 51.8 0.0 41.1 229.5 9.9 20.7 0.4 66.4 104.0 0.6 14.9 0.1 42.4 18.7 114.7 0.1 0.9 91.3 22.3 37.1 57.4 107.5 110.9 0.0 0.1 0.3 131.8 20.4 0.0 0.2 14.2 20.2 26.4 0.0 75.2 0.2 44.9 32.8 4.8 0.1 97.6 39.1 65.5 66.9 18.4 0.9 138.2 105.1 43.8 57.2 35.4 0.1 0.1 0.2 58.5 0.1 118.3 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 9.0 7.2 10.1 9.8 11.6 11.0 7.3 8.4 11.3 8.6 11.0 37.0 99.3 33.0 47.3 1.1 13.8 25.0 29.3 20.5 4.3 24.4 24.8 45.1 18.6 27.0 27.6 0.0 39.9 0.7 39.6 39.2 56.1 0.9 26.9 62.5 33.3 27.1 0.0 31.4 67.1 92.2 59.1 24.5 35.9 5.1 34.8 39.7 19.1 6.5 0.0 34.9 26.2 18.3 1.8 8.8 2.5 41.0 2.0 46.2 36.5 1.0 25.3 0.0 30.7 1.0 51.7 25.4 51.9 0.2 33.5 23.1 38.1 54.8 2.5 52.6 32.6 60.6 1.1 3.4 20.2 8.9 19.0 2.3 25.1 32.4 25.1 PCDHGA4 PCDH-GAMMA-A4 ENSG00000262576 "Protocadherin gamma subfamily A, 4" Q9Y5G9 5 141355021-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.0;Skeletal myocytes: 1.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 7.4;BJ: 4.3;HSkMC: 4.3;HUVEC TERT2: 4.3;U-87 MG: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.27e-2)" "unprognostic (4.55e-3)" "unprognostic (2.00e-2)" "unprognostic (6.54e-4)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (1.02e-1)" "unprognostic (1.20e-2)" "unprognostic (5.62e-2)" "unprognostic (3.76e-1)" "unprognostic (6.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.94e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.31e-4)" 1.7 1.3 1.6 0.4 1.8 0.0 0.9 3.7 1.7 1.3 0.0 0.9 0.2 1.6 0.8 0.4 0.9 0.8 1.5 2.9 1.5 0.4 0.3 1.0 0.1 2.1 2.4 1.6 2.1 2.3 1.0 0.8 1.7 1.1 0.3 1.5 0.8 1.1 0.7 0.5 0.3 1.5 2.0 0.3 0.4 0.7 2.1 0.2 0.7 1.0 0.1 0.7 0.8 2.5 0.0 0.1 0.8 0.4 3.3 7.4 0.0 4.3 3.4 0.2 0.8 0.0 0.1 0.7 1.4 3.7 1.3 0.0 0.1 0.1 0.4 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.3 4.3 0.1 0.0 0.0 2.6 4.3 0.0 0.1 0.2 1.8 0.6 0.2 0.2 0.1 0.0 0.2 0.3 1.2 0.1 0.2 0.0 0.6 1.3 0.2 0.2 0.9 0.3 1.6 0.0 2.8 1.8 0.5 2.4 0.3 0.1 0.2 0.1 6.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.8 3.7 1.7 2.9 1.5 2.1 2.4 1.7 2.0 2.1 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 PCID2 FLJ11305 ENSG00000126226 "PCI domain containing 2" Q5JVF3 13 113177536-113208715 "Predicted intracellular proteins" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 204.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069107, HPA073074" Uncertain Approved Nucleoplasm,Nucleoli NA Yes "Cluster 16: MAIT-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 43: THP-1 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA069107: AB_2686088, HPA073074: AB_2686568" "unprognostic (2.53e-2)" "unprognostic (2.94e-2)" "unprognostic (4.02e-1)" "unprognostic (1.26e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (7.80e-5)" "unprognostic (1.73e-3)" "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (1.47e-1)" "unprognostic (3.02e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (4.24e-6)" "unprognostic (1.41e-2)" "unprognostic (5.41e-3)" "unprognostic (1.45e-1)" "unprognostic (6.28e-2)" 22.2 29.0 16.6 15.8 17.4 15.5 22.9 19.0 18.8 27.0 18.3 25.2 12.1 23.0 23.0 19.3 25.9 17.1 37.7 16.8 17.3 20.1 23.8 18.6 25.8 16.4 16.6 33.7 23.9 19.1 22.6 15.5 16.4 24.7 18.5 10.7 23.8 19.2 29.1 18.9 20.2 21.8 16.5 24.7 24.4 45.3 17.6 24.4 20.8 24.4 23.0 23.9 22.4 18.8 62.9 26.3 39.1 34.7 70.2 52.3 27.4 47.2 70.7 64.4 59.1 51.9 57.7 50.2 30.7 64.5 81.6 38.8 62.9 42.8 71.2 44.3 62.1 64.8 68.1 45.9 70.0 110.4 25.5 43.3 46.6 40.4 71.1 51.4 51.3 68.5 50.4 19.9 73.6 30.3 59.4 77.9 38.9 115.1 33.2 53.4 43.4 48.0 58.8 31.3 52.0 31.9 29.5 72.2 55.9 39.3 39.9 133.4 33.5 19.0 68.7 27.9 36.2 30.4 30.4 70.4 65.3 74.1 44.2 28.2 25.5 20.0 68.9 34.4 81.6 39.7 58.0 72.5 26.0 39.5 52.2 54.6 3.9 22.6 33.2 24.8 64.7 54.7 16.6 17.4 19.0 18.8 16.8 17.3 16.4 16.6 16.4 16.5 17.6 18.8 26.5 19.2 16.7 16.3 28.4 21.5 29.1 37.8 17.6 23.6 25.5 32.3 27.8 21.5 23.7 14.7 16.7 30.2 38.5 7.8 27.4 22.8 52.8 26.8 35.7 26.2 7.8 32.8 43.6 13.8 24.7 33.8 18.8 21.7 10.8 39.0 18.9 18.4 20.2 37.0 33.7 15.6 16.2 18.2 14.0 18.1 41.3 17.2 16.0 26.2 24.0 19.0 38.1 25.1 40.4 18.1 15.8 40.6 16.8 46.3 13.6 23.6 30.4 23.8 19.7 37.4 30.9 204.4 72.7 17.6 24.7 31.1 43.7 33.0 20.1 25.3 PCNA ENSG00000132646 "Proliferating cell nuclear antigen" P12004 20 5114953-5126626 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction" DNA-binding "Cancer-related genes, Deafness, Disease variant, Dwarfism, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 383.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000148, HPA030521, HPA030522, HPA030523" Enhanced Enhanced Nucleoplasm No Yes 170000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199" "unprognostic (5.21e-2)" "prognostic favorable (1.86e-5)" "unprognostic (2.96e-2)" "unprognostic (2.43e-1)" "unprognostic (3.17e-1)" "unprognostic (5.60e-3)" "prognostic unfavorable (2.61e-4)" "unprognostic (1.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.89e-2)" "unprognostic (1.01e-2)" "unprognostic (9.78e-2)" "prognostic unfavorable (3.03e-6)" "unprognostic (2.12e-2)" "unprognostic (2.29e-1)" "unprognostic (7.11e-3)" "unprognostic (7.46e-2)" 31.2 47.2 23.2 85.2 26.0 383.2 51.0 26.8 29.7 41.5 26.8 89.0 70.7 38.1 30.9 81.2 39.1 34.8 30.6 23.0 24.4 43.7 55.3 37.5 168.8 25.1 24.0 37.7 32.8 42.4 25.1 69.8 26.0 32.2 93.7 94.1 40.3 38.3 27.9 62.8 72.9 47.9 26.8 54.0 53.9 62.3 23.3 219.9 42.0 26.8 137.3 51.0 42.3 30.0 769.1 591.4 585.0 253.7 136.1 126.6 409.5 491.6 288.3 453.7 640.0 465.3 594.2 773.4 155.7 177.5 395.2 558.8 350.7 594.4 413.2 231.7 386.8 543.7 207.8 1098.3 57.8 753.7 233.0 92.6 138.2 387.2 91.7 95.3 263.3 503.6 493.9 631.2 449.7 278.3 1450.6 829.3 439.9 592.0 322.9 787.9 514.1 622.5 208.5 441.1 500.8 339.4 345.1 524.6 351.9 213.9 371.2 378.0 177.2 324.3 373.3 461.5 572.0 317.2 981.6 1313.9 145.9 707.4 426.2 5.0 23.2 18.5 36.5 23.3 45.7 33.5 45.7 37.1 32.6 29.2 41.6 37.3 7.7 43.6 24.7 29.9 48.1 36.7 23.2 26.0 26.8 29.7 23.0 24.4 25.1 24.0 26.0 26.8 23.3 30.0 32.4 44.8 26.0 2.9 40.6 67.7 44.4 121.4 44.3 42.1 27.5 45.2 14.5 21.5 60.5 58.8 27.1 171.5 44.3 42.9 60.7 51.6 176.0 30.2 21.4 34.8 19.9 189.0 4.3 39.6 175.6 38.7 21.9 27.7 22.7 53.1 29.6 27.1 96.7 32.0 5.9 53.9 75.3 24.2 33.4 109.1 36.1 32.7 37.4 3.7 47.6 74.0 23.7 4.0 13.5 28.3 20.3 40.3 56.6 23.3 33.3 46.1 44.1 97.1 52.6 29.2 46.1 149.1 101.1 65.5 49.7 66.4 48.6 29.6 84.5 40.4 PCNT "KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4" ENSG00000160299 Pericentrin O95613 21 46324141-46445769 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 239.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 6 "dendritic cells: 4.6;granulocytes: 6.0;T-cells: 8.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016820, HPA019887, HPA032101" Uncertain Supported "Centriolar satellite,Centrosome,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 37: Myocytes - Muscle contraction" Centrosome "Centriolar satellite, Cytosol" "HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: AB_2674151" "unprognostic (9.07e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (1.30e-2)" "unprognostic (5.35e-2)" "unprognostic (3.40e-3)" "unprognostic (1.27e-2)" "unprognostic (2.59e-1)" "unprognostic (9.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.59e-3)" "unprognostic (3.86e-2)" "unprognostic (1.95e-2)" "unprognostic (5.83e-2)" "unprognostic (2.90e-1)" "unprognostic (3.36e-1)" "unprognostic (5.86e-2)" 9.7 11.1 7.6 5.9 10.5 17.7 8.9 4.2 11.9 8.6 5.3 10.7 4.1 8.2 4.3 11.7 8.5 3.6 28.3 6.0 5.4 7.7 10.9 8.2 8.2 9.0 3.9 9.6 7.8 4.3 20.3 3.5 9.5 8.2 4.3 4.6 9.7 4.2 239.2 12.3 10.1 4.4 2.6 11.5 9.5 25.6 4.7 12.5 8.4 52.0 5.5 9.6 9.2 7.4 15.4 11.6 18.0 11.1 8.9 8.8 11.3 11.6 8.0 11.3 10.0 14.2 9.7 15.2 7.3 13.4 15.3 10.8 14.6 9.9 7.8 44.9 20.4 40.2 24.1 11.3 3.1 20.6 16.1 4.8 7.5 15.2 7.6 5.5 8.8 15.8 20.9 22.4 15.8 25.4 20.6 21.3 18.0 13.9 8.0 25.3 7.2 13.5 8.7 16.3 22.1 9.8 25.4 15.7 8.0 4.4 14.8 16.0 12.1 20.4 10.2 11.7 18.9 19.3 17.2 16.4 12.6 19.9 11.1 6.0 0.6 1.2 1.5 0.5 4.6 0.3 0.7 4.8 2.0 0.1 0.5 8.8 0.4 0.4 1.0 4.6 0.8 2.0 7.6 10.5 4.2 11.9 6.0 5.4 9.0 3.9 9.5 2.6 4.7 7.4 10.5 28.9 32.0 19.9 8.6 8.3 5.7 7.0 13.6 15.0 8.9 8.6 35.7 10.0 15.3 0.0 6.2 6.4 36.7 14.0 0.0 7.1 20.4 17.0 19.9 10.1 15.6 36.2 38.1 7.6 7.4 13.1 25.0 17.8 16.4 25.4 7.1 9.0 23.3 23.5 39.0 11.2 4.1 6.9 5.5 25.6 12.8 12.7 0.0 17.8 14.7 6.8 25.7 10.6 21.9 5.7 5.7 12.0 31.4 4.2 5.7 4.1 13.0 11.1 26.3 61.3 14.2 40.5 39.8 25.0 7.1 6.4 18.8 15.1 10.4 5.1 PDE5A ENSG00000138735 "Phosphodiesterase 5A" O76074 4 119494397-119628804 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Allosteric enzyme, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 66.1;Inhibitory neurons: 58.3;Oligodendrocyte precursor cells: 56.8;Peritubular cells: 104.9;Smooth muscle cells: 80.9" "Group enriched" "Detected in all" 4 "prostate cancer: 7.0;thyroid cancer: 27.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 47.5;HHSteC: 65.9;hTERT-RPE1: 24.6" "Region enhanced" "Detected in all" "cerebellum: 18.2" "Low region specificity" "Detected in all" "HPA004729, HPA012873" Approved Approved Cytosol NA NA 850000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol "HPA004729: AB_1079588, HPA012873: AB_1855124" "unprognostic (6.95e-2)" "prognostic favorable (5.20e-4)" "unprognostic (1.28e-1)" "unprognostic (1.56e-1)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (7.36e-2)" "unprognostic (2.58e-2)" "unprognostic (2.29e-2)" "unprognostic (6.97e-2)" "unprognostic (2.05e-2)" "unprognostic (2.54e-1)" "unprognostic (2.16e-2)" "unprognostic (1.52e-2)" "unprognostic (8.98e-2)" "unprognostic (8.71e-3)" "prognostic unfavorable (1.17e-4)" 15.4 11.3 0.9 10.9 3.5 2.1 9.6 4.9 3.7 32.7 12.6 37.0 15.5 14.4 41.5 41.3 22.9 10.4 12.8 1.4 3.6 5.9 1.5 22.1 6.4 4.9 8.2 5.4 12.4 8.3 3.5 13.2 5.2 59.8 25.9 9.6 9.8 49.8 6.9 5.0 18.9 11.4 0.0 5.8 9.6 9.4 3.4 3.7 16.8 5.6 3.5 14.6 15.8 1.9 16.7 0.8 11.0 1.2 3.7 5.5 1.9 10.7 47.5 0.5 1.0 1.0 1.3 1.6 0.5 13.4 3.0 5.8 3.5 1.7 1.3 0.4 7.4 18.5 2.6 0.9 65.9 3.9 1.7 6.1 3.3 1.1 0.1 24.6 1.4 3.7 2.0 2.9 1.6 0.9 5.0 0.6 2.3 1.8 2.8 0.7 5.9 4.3 4.1 4.9 4.3 8.8 13.0 15.3 1.3 8.1 2.7 2.1 2.5 6.2 5.2 3.4 1.5 4.1 2.0 1.5 5.9 1.0 0.9 0.0 0.0 0.0 0.1 0.0 0.5 0.4 0.3 0.1 0.0 0.3 0.1 0.2 0.4 0.2 0.1 0.1 0.1 1.2 0.9 3.5 4.9 3.7 1.4 3.6 4.9 8.2 5.2 0.0 3.4 1.9 7.8 6.4 3.9 19.9 1.3 3.4 2.8 1.1 5.7 8.1 11.0 8.4 5.5 14.3 3.7 1.8 14.6 0.4 0.9 15.5 0.0 15.8 30.6 5.0 12.6 7.8 2.4 0.0 66.1 2.9 0.3 28.1 1.1 3.9 1.3 1.6 0.7 0.9 0.3 5.0 58.3 9.5 2.0 0.0 3.5 11.5 20.8 11.3 5.4 40.3 1.3 28.5 2.1 56.8 41.1 3.9 10.3 104.9 1.4 3.6 7.9 0.5 0.8 5.8 19.7 5.5 80.9 5.4 6.3 3.5 2.4 0.3 1.7 7.0 11.1 2.6 PDGFB "SIS, SSV" ENSG00000100311 "Platelet derived growth factor subunit B" P01127 22 39223359-39244982 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 75.0;Endothelial cells: 60.6;Langerhans cells: 44.3;Macrophages: 25.5;Pancreatic endocrine cells: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 10.0" "Lineage enriched" "Detected in many" 7 "T-cells: 10.0" "Cell line enhanced" "Detected in many" "A-431: 33.8;EFO-21: 69.2;HUVEC TERT2: 52.6;SK-BR-3: 53.5;TIME: 68.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011604, HPA011972, CAB018341" Supported Approved Vesicles "Secreted to blood" NA NA 4390000 950000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "CAB011604: AB_2162180, CAB018341: AB_2162187, HPA011972: AB_1855134" "unprognostic (4.96e-2)" "unprognostic (8.94e-3)" "unprognostic (8.41e-2)" "unprognostic (2.66e-1)" "unprognostic (9.84e-2)" "unprognostic (4.46e-3)" "unprognostic (4.34e-1)" "prognostic unfavorable (3.67e-5)" "unprognostic (3.22e-2)" "unprognostic (2.07e-1)" "unprognostic (1.05e-1)" "unprognostic (8.68e-2)" "unprognostic (1.84e-3)" "unprognostic (5.12e-3)" "unprognostic (7.47e-2)" "unprognostic (6.50e-2)" "unprognostic (1.03e-1)" 32.6 6.4 14.7 7.1 10.7 0.4 24.0 10.3 22.2 7.5 4.8 20.6 4.9 8.9 5.2 6.2 7.2 11.7 31.2 12.0 9.8 17.0 3.7 28.1 7.4 13.6 12.4 3.8 8.8 8.9 4.0 40.2 12.0 7.6 3.5 0.8 10.6 5.2 18.7 10.3 9.1 9.2 10.6 6.6 7.9 3.4 16.0 2.1 16.1 11.0 1.6 8.5 6.6 9.4 33.8 2.6 8.4 0.0 0.0 0.0 9.9 0.1 0.4 0.2 0.0 13.0 10.3 0.0 69.2 0.0 3.1 12.4 0.5 2.8 0.0 0.1 0.2 0.7 1.1 4.8 4.3 0.0 18.1 0.0 0.3 0.0 0.4 0.9 52.6 0.0 1.3 6.1 1.9 13.7 0.1 0.1 3.2 8.1 3.4 0.0 0.3 22.8 27.7 0.1 0.2 0.0 0.6 53.5 0.2 6.0 24.3 0.1 68.1 0.1 6.4 0.1 7.5 0.1 0.4 0.3 0.1 1.5 31.3 0.0 0.0 0.0 7.3 0.1 10.0 0.0 4.3 5.6 0.0 0.0 3.6 1.9 0.1 0.0 0.4 1.3 2.3 2.1 14.7 10.7 10.3 22.2 12.0 9.8 13.6 12.4 12.0 10.6 16.0 9.4 75.0 0.0 1.1 0.0 0.6 2.8 1.2 3.8 1.2 0.7 5.1 7.1 3.1 0.0 1.3 7.3 0.0 7.3 4.0 0.1 0.0 20.0 1.3 4.0 0.7 60.6 1.8 0.0 2.8 3.6 6.5 1.6 0.0 5.6 0.0 13.1 16.8 1.4 7.7 0.0 0.9 0.7 4.1 2.6 44.3 0.1 0.6 25.5 1.8 14.0 1.1 0.3 0.0 0.0 0.2 54.7 0.0 0.0 0.0 2.7 0.1 1.9 0.9 0.1 6.6 4.7 9.6 0.3 1.6 1.1 1.4 4.5 2.0 1.2 0.1 0.6 PER3 ENSG00000049246 "Period circadian regulator 3" P56645 1 7784320-7845177 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 137.8;Bipolar cells: 241.0;Horizontal cells: 124.5;Rod photoreceptor cells: 138.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-937: 36.0" "Low region specificity" "Detected in all" HPA019530 Approved Supported Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" Cytosol "HPA019530: AB_1855201" "unprognostic (5.11e-2)" "prognostic favorable (7.14e-4)" "unprognostic (2.45e-2)" "unprognostic (2.97e-3)" "unprognostic (1.74e-1)" "prognostic favorable (1.34e-4)" "unprognostic (3.87e-1)" "unprognostic (5.53e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "unprognostic (4.11e-2)" "unprognostic (8.96e-2)" "prognostic favorable (2.20e-5)" "unprognostic (1.16e-1)" "unprognostic (1.20e-1)" "unprognostic (3.46e-1)" "unprognostic (1.62e-1)" 13.9 11.1 10.1 4.6 14.1 0.7 12.6 46.1 15.9 12.4 3.1 18.4 6.4 19.0 10.6 17.0 12.6 12.2 22.3 9.6 9.9 12.5 25.6 12.0 4.7 12.7 13.9 18.5 17.0 19.8 16.9 2.7 14.4 15.6 6.6 55.9 25.4 20.5 28.7 13.4 9.4 10.7 11.8 9.0 17.4 8.8 14.4 4.6 23.3 24.3 7.2 10.3 10.4 26.0 7.2 2.1 6.1 1.8 1.1 0.6 1.8 3.0 5.5 5.5 7.6 8.6 27.7 3.2 1.6 12.4 9.4 3.3 22.1 1.4 8.3 0.2 1.2 22.7 8.3 1.3 6.8 0.7 7.6 3.0 2.4 6.0 6.1 11.4 2.0 1.6 18.7 5.8 2.4 5.7 12.7 10.2 3.3 16.0 5.9 11.0 2.2 0.2 3.1 1.3 7.9 8.5 26.3 0.1 11.0 6.1 6.6 1.0 4.2 14.9 21.4 4.6 4.0 0.8 0.5 2.7 10.5 36.0 21.2 0.3 0.6 0.4 1.5 0.7 1.8 0.6 0.7 1.4 0.7 0.2 0.6 0.7 0.0 0.3 1.3 0.5 1.3 0.6 10.1 14.1 46.1 15.9 9.6 9.9 12.7 13.9 14.4 11.8 14.4 26.0 45.0 19.2 12.1 137.8 3.9 30.1 13.1 4.3 40.5 241.0 14.3 17.3 17.0 8.6 9.9 9.2 81.3 1.7 3.0 5.0 9.8 3.2 16.5 4.4 19.6 17.5 6.6 0.0 42.8 4.8 0.5 33.6 20.4 4.3 26.0 6.9 10.8 28.1 9.4 124.5 64.1 4.0 12.2 8.5 14.8 5.8 12.5 11.2 12.4 40.3 3.4 91.2 2.1 62.4 91.6 5.7 1.6 27.4 3.3 9.7 5.0 5.2 9.7 138.5 6.6 39.2 25.4 22.2 23.2 32.9 25.6 0.5 5.9 11.5 1.7 8.6 PHACTR2 "C6orf56, KIAA0680" ENSG00000112419 "Phosphatase and actin regulator 2" O75167 6 143536845-143831185 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "choroid plexus: 164.2;placenta: 83.8" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 214.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 82.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031719, HPA031720, HPA031725" Approved Approved "Golgi apparatus,Plasma membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "Plasma membrane" "HPA031719: AB_10696055, HPA031720: AB_10670553, HPA031725: AB_10610279" "unprognostic (3.25e-3)" "unprognostic (1.07e-1)" "unprognostic (4.39e-2)" "unprognostic (5.25e-2)" "unprognostic (1.90e-2)" "unprognostic (8.38e-2)" "unprognostic (3.19e-2)" "unprognostic (9.92e-2)" "unprognostic (7.46e-2)" "unprognostic (3.61e-2)" "unprognostic (2.49e-1)" "unprognostic (2.80e-1)" "prognostic favorable (1.99e-4)" "unprognostic (3.60e-1)" "unprognostic (5.08e-2)" "unprognostic (9.92e-2)" "unprognostic (1.17e-1)" 11.6 25.4 7.0 7.8 9.0 7.6 5.5 4.3 5.7 8.1 164.2 8.5 7.5 9.9 3.6 22.0 5.7 8.4 12.4 10.0 4.9 5.9 7.9 15.7 7.8 12.3 10.3 6.5 4.9 13.1 4.0 83.8 15.1 10.3 8.5 2.7 6.0 6.9 4.5 2.7 6.1 9.8 3.5 13.5 12.0 6.5 16.5 2.7 15.5 7.3 6.7 7.6 6.4 4.5 21.9 13.5 3.6 26.6 3.7 8.0 15.3 18.0 27.2 7.7 9.6 23.9 9.5 1.2 47.5 51.7 5.4 6.5 2.0 17.9 9.1 18.1 8.5 35.5 14.7 14.0 6.1 9.1 10.5 11.2 9.8 7.7 24.9 11.8 47.0 6.7 10.2 0.1 12.4 24.0 1.3 2.1 26.8 7.7 3.8 3.3 26.3 0.2 9.3 19.2 5.2 5.2 20.0 26.1 0.3 13.4 9.8 13.1 82.2 34.9 18.2 15.2 11.8 0.2 0.1 0.3 8.6 9.5 3.2 6.0 3.5 6.7 3.3 2.5 12.3 0.4 4.0 4.4 3.3 0.2 2.4 1.6 1.8 3.5 2.7 3.2 5.5 1.9 7.0 9.0 4.3 5.7 10.0 4.9 12.3 10.3 15.1 3.5 16.5 4.5 160.9 214.7 94.5 41.4 11.7 24.2 16.0 19.5 47.3 37.0 14.2 13.8 71.8 32.9 73.2 22.0 2.1 84.7 27.5 58.9 13.7 30.5 10.1 49.6 43.7 158.6 21.6 32.8 55.2 22.5 49.8 144.8 54.6 64.7 38.7 34.9 157.1 27.6 35.4 101.0 133.8 19.2 24.4 121.1 40.2 23.2 103.2 52.5 24.9 77.8 71.7 10.3 15.5 5.5 20.9 49.4 22.3 120.0 10.6 63.3 20.2 24.8 51.1 3.0 98.6 95.9 83.5 3.1 2.3 33.0 17.2 52.5 51.3 127.9 26.3 30.9 PIANP "C12orf53, DKFZp547D2210, PANP" ENSG00000139200 "PILR alpha associated neural protein" Q8IYJ0 12 6693791-6700815 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 90.4" "Group enriched" "Detected in some" 4 "Bipolar cells: 16.1;Excitatory neurons: 24.4;Horizontal cells: 18.5;Inhibitory neurons: 23.9;Oligodendrocyte precursor cells: 16.1;Peritubular cells: 13.9;Spermatogonia: 6.7" "Group enriched" "Detected in many" 4 "glioma: 14.7;testis cancer: 7.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 9.9;HAP1: 9.8;hTERT-RPE1: 16.2;NTERA-2: 20.8;SH-SY5Y: 19.4;U-2 OS: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010631 Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 5: NTERA-2 - Transcription" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "HPA010631: AB_10603680" "unprognostic (1.82e-1)" "unprognostic (9.21e-3)" "unprognostic (1.62e-2)" "unprognostic (7.65e-2)" "unprognostic (1.34e-1)" "unprognostic (3.03e-2)" "unprognostic (6.58e-2)" "unprognostic (1.07e-1)" "unprognostic (1.70e-1)" "unprognostic (6.41e-3)" "unprognostic (1.92e-2)" "unprognostic (3.89e-1)" "unprognostic (3.30e-3)" "unprognostic (3.26e-3)" "unprognostic (1.16e-1)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" 0.4 5.4 66.0 0.9 54.9 0.0 0.8 14.6 90.4 17.8 0.0 4.8 0.6 21.1 2.2 0.8 7.5 1.7 1.0 59.8 56.9 0.9 0.2 1.0 1.1 12.1 36.1 3.3 0.7 5.4 15.6 0.3 23.1 5.5 0.6 7.9 0.8 5.5 0.2 0.5 3.0 5.1 7.3 0.6 2.3 4.0 40.6 0.0 0.9 0.4 0.4 3.7 10.1 52.9 0.0 0.5 7.4 1.4 0.2 0.4 0.2 2.0 9.9 5.1 4.6 0.1 0.2 0.2 0.0 3.5 0.8 0.2 9.8 0.3 2.4 0.3 1.3 0.4 0.3 0.0 0.3 0.4 0.3 1.2 0.0 2.0 0.0 16.2 0.0 3.0 0.0 0.3 0.5 0.2 0.3 0.3 20.8 0.0 0.1 1.4 0.1 0.2 0.1 0.1 2.6 19.4 0.1 0.1 0.0 1.3 0.1 0.0 0.0 5.2 10.5 5.5 1.4 0.2 0.0 0.3 7.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.0 54.9 14.6 90.4 59.8 56.9 12.1 36.1 23.1 7.3 40.6 52.9 0.2 0.0 0.0 3.6 0.1 0.3 0.0 0.0 0.0 16.1 0.0 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.8 0.3 3.5 0.2 0.0 0.0 24.4 0.0 0.0 1.9 0.0 0.1 0.0 0.1 0.0 0.0 0.1 18.5 23.9 0.0 0.0 0.0 0.2 1.1 2.1 0.0 0.0 3.7 0.0 3.9 0.0 16.1 3.1 0.0 0.0 13.9 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 1.6 0.1 6.7 0.0 0.1 0.1 0.3 0.0 0.0 0.1 PIFO "C1orf88, FLJ23853, pitchfork" ENSG00000173947 "Primary cilia formation" Q8TCI5 1 111346600-111353013 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "fallopian tube: 174.2" "Group enriched" "Detected in many" 4 "Early spermatids: 430.6;Endometrial ciliated cells: 495.3;Late spermatids: 458.1;Respiratory ciliated cells: 990.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 3.4;RPTEC TERT1: 4.7;RT4: 5.9;SuSa: 7.9;T-47d: 3.8;U-87 MG: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 12: NES - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (3.18e-3)" "unprognostic (3.23e-2)" "unprognostic (7.33e-2)" "unprognostic (3.03e-3)" "unprognostic (6.00e-2)" "unprognostic (7.43e-4)" "unprognostic (8.78e-7)" "unprognostic (6.43e-3)" "unprognostic (7.28e-2)" "unprognostic (9.07e-3)" "prognostic favorable (2.48e-4)" "unprognostic (3.32e-2)" "prognostic favorable (1.44e-4)" "unprognostic (6.03e-3)" "unprognostic (4.73e-2)" "unprognostic (6.37e-2)" "unprognostic (6.83e-2)" 1.0 2.8 8.6 0.7 9.1 0.1 5.7 8.2 9.2 4.3 36.5 5.1 0.6 7.4 12.5 3.5 174.2 3.5 9.3 8.5 10.8 8.3 0.0 12.9 0.3 14.3 15.0 3.3 6.4 15.1 9.8 2.9 13.7 12.2 1.1 5.1 3.1 6.0 0.1 1.4 1.1 4.7 12.2 0.4 4.4 24.8 10.8 1.7 15.0 0.9 0.6 5.4 0.8 14.0 0.0 0.0 0.5 0.6 0.6 0.7 1.0 0.0 1.2 0.2 0.0 0.8 1.1 0.0 0.2 0.0 1.1 0.0 0.8 0.2 0.0 1.4 0.2 0.0 0.1 0.9 0.4 0.0 0.0 0.4 3.2 0.0 0.0 3.4 0.0 0.2 0.2 0.1 2.0 0.3 0.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 4.7 5.9 2.2 0.2 0.0 0.1 0.1 7.9 3.8 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.4 3.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.4 0.2 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 9.1 8.2 9.2 8.5 10.8 14.3 15.0 13.7 12.2 10.8 14.0 0.3 3.2 18.5 3.3 0.5 4.2 9.1 71.5 1.8 0.7 6.0 12.6 17.3 0.0 83.2 5.5 4.2 11.6 0.1 0.0 21.5 13.0 430.6 495.3 5.8 1.6 3.0 0.0 0.5 2.0 4.4 3.7 1.5 9.0 0.0 3.8 0.7 0.1 1.2 0.0 1.4 0.0 77.3 0.0 0.7 458.1 5.9 1.5 8.8 0.0 0.0 11.8 0.0 0.5 0.6 1.2 0.0 3.4 0.4 6.2 0.0 36.3 990.5 5.4 6.6 4.6 22.8 127.1 10.5 0.5 2.8 7.0 1.0 8.4 0.1 4.3 PLA2G2C UBXN10-AS1 ENSG00000187980 "Phospholipase A2 group IIC" Q5R387 1 20161253-20186518 "Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "intestine: 1.2" "Group enriched" "Detected in some" 4 "Early spermatids: 2.9;Late spermatids: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.6;U-698: 2.0;U-937: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted - unknown location" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 32: U-937 - Innate immune response" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (3.02e-3)" "unprognostic (2.75e-2)" "unprognostic (5.76e-2)" "unprognostic (3.00e-4)" "unprognostic (9.44e-3)" "unprognostic (6.55e-3)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "unprognostic (3.92e-1)" "unprognostic (1.80e-1)" "unprognostic (1.46e-1)" "unprognostic (1.22e-2)" "unprognostic (4.84e-2)" "unprognostic (1.67e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (8.16e-2)" 0.1 0.0 0.4 0.1 0.2 0.4 0.0 0.7 0.5 0.1 0.3 1.2 0.2 0.4 0.2 0.7 0.1 0.1 0.1 0.5 0.3 0.0 0.0 0.1 0.2 0.3 0.3 0.2 0.0 0.1 0.0 0.1 0.2 0.4 0.3 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.4 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.2 0.9 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 2.0 0.1 1.7 0.0 0.5 0.3 0.0 0.4 0.1 0.8 0.1 0.3 0.4 0.5 0.1 0.2 0.1 0.6 0.3 0.0 0.2 0.0 0.1 0.4 0.2 0.7 0.5 0.5 0.3 0.3 0.3 0.2 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.3 0.1 0.0 0.0 1.1 0.0 0.1 0.2 0.0 0.6 0.0 9.8 0.3 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 PLCB1 "KIAA0581, PLC-I, PLC154" ENSG00000182621 "Phospholipase C beta 1" Q9NQ66 20 8077251-8968360 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.3" "Cell type enhanced" "Detected in many" "Astrocytes: 563.5;Excitatory neurons: 2569.1;Inhibitory neurons: 1774.0;Oligodendrocyte precursor cells: 783.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 74.3" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 45.5;Hep G2: 68.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004275, CAB005334, HPA034743, HPA057910" Enhanced Approved "Plasma membrane" NA NA 6600 "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" "CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: AB_2674311, HPA057910: AB_2683552" "unprognostic (2.32e-1)" "unprognostic (1.02e-1)" "unprognostic (6.63e-2)" "unprognostic (9.77e-2)" "unprognostic (9.87e-2)" "unprognostic (2.37e-1)" "unprognostic (1.27e-4)" "unprognostic (1.13e-1)" "unprognostic (3.16e-2)" "unprognostic (1.91e-1)" "unprognostic (7.12e-3)" "unprognostic (6.57e-2)" "unprognostic (2.87e-3)" "unprognostic (3.20e-2)" "unprognostic (4.41e-2)" "unprognostic (1.71e-2)" "unprognostic (2.12e-1)" 9.3 8.9 11.7 5.7 52.3 4.8 7.6 0.0 74.3 8.2 0.0 18.1 7.2 9.3 3.5 5.4 9.6 8.5 11.7 17.4 0.0 13.2 4.3 5.0 1.8 0.0 0.1 3.7 14.7 44.3 4.3 19.6 0.0 13.4 4.1 7.1 29.0 18.8 14.4 2.6 5.7 8.1 0.0 3.6 8.0 3.0 9.8 6.8 3.8 11.0 0.9 15.9 6.7 23.8 0.2 1.2 4.8 0.3 8.7 16.1 6.3 20.2 13.1 5.2 3.1 45.5 5.0 2.2 8.2 3.9 0.3 0.0 3.7 0.0 3.8 0.0 4.4 1.0 3.5 68.7 2.2 1.1 0.7 1.1 0.8 7.1 0.0 6.5 10.6 13.0 7.1 26.0 0.1 6.2 1.0 3.3 15.0 10.6 6.6 14.7 0.0 12.1 4.0 16.8 16.9 7.2 0.1 4.1 0.9 17.1 19.9 6.6 1.9 16.8 7.5 1.3 12.7 19.4 24.5 33.9 8.6 12.6 29.5 0.3 1.3 1.2 1.4 0.3 2.0 0.1 0.4 0.5 0.1 0.2 0.2 0.4 0.8 1.1 0.1 0.3 0.1 0.2 11.7 52.3 0.0 74.3 17.4 0.0 0.0 0.1 0.0 0.0 9.8 23.8 74.8 0.0 3.4 563.5 1.1 1.9 20.8 2.3 8.0 7.6 8.1 23.2 26.9 7.2 2.6 16.5 0.0 2.4 16.8 1.3 33.2 1.2 9.9 42.1 5.1 54.6 0.0 6.5 2569.1 13.4 2.8 25.8 3.6 83.6 1.3 0.2 26.4 2.8 0.8 1.7 1774.0 2.1 0.0 8.2 1.2 4.3 3.4 9.1 7.2 211.7 12.2 18.2 15.5 783.1 34.8 1.8 0.5 3.8 6.1 20.2 0.1 9.4 9.9 4.1 0.0 7.4 13.3 4.7 5.6 2.5 1.7 1.8 15.4 1.1 1.2 18.9 PLCD1 ENSG00000187091 "Phospholipase C delta 1" P51178 3 38007496-38029642 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 89.5;Theca cells: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 25.3;fHDF/TERT166: 26.3;hTCEpi: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009913, HPA020107, HPA021677" Approved Approved Microtubules NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" Microtubules "CAB009913: AB_2163388, HPA020107: AB_1855318, HPA021677: AB_1855319" "unprognostic (1.75e-3)" "unprognostic (1.01e-2)" "unprognostic (4.29e-2)" "unprognostic (1.45e-2)" "unprognostic (3.44e-1)" "unprognostic (9.67e-3)" "unprognostic (1.55e-1)" "unprognostic (7.25e-3)" "unprognostic (3.95e-1)" "unprognostic (1.45e-1)" "unprognostic (2.80e-1)" "unprognostic (2.24e-1)" "prognostic favorable (9.25e-11)" "unprognostic (1.50e-1)" "unprognostic (7.71e-2)" "unprognostic (2.93e-1)" "unprognostic (7.88e-2)" 14.8 12.9 14.3 4.6 16.1 4.3 10.6 15.4 15.6 15.9 9.7 15.7 4.9 11.5 4.2 26.2 9.8 5.6 7.2 12.8 19.0 10.1 5.4 11.3 6.6 20.3 18.5 12.7 6.0 3.9 9.3 3.8 19.6 9.1 10.1 2.8 13.0 8.8 2.9 18.5 8.3 5.6 19.4 7.2 8.3 32.6 16.9 9.1 8.3 4.1 6.6 15.7 19.0 21.9 1.0 2.7 9.4 2.6 25.3 22.2 2.8 2.8 11.1 4.2 6.4 1.0 2.3 0.6 1.4 26.3 2.9 15.0 4.8 3.0 1.3 3.9 1.2 0.5 1.7 4.7 14.7 0.0 1.6 18.0 31.6 12.9 1.7 9.4 8.2 2.2 16.3 1.3 9.6 1.2 2.2 1.1 2.4 5.5 2.7 0.9 1.3 3.6 5.1 5.0 0.1 2.6 0.8 12.4 3.2 3.1 2.7 1.2 4.4 2.5 6.3 6.7 0.1 5.2 2.2 0.6 6.4 0.1 1.3 14.6 2.7 0.2 13.0 3.7 15.2 1.3 16.9 12.8 3.8 0.6 10.1 7.9 9.9 5.9 2.2 2.0 16.6 7.4 14.3 16.1 15.4 15.6 12.8 19.0 20.3 18.5 19.6 19.4 16.9 21.9 5.2 3.2 7.5 22.9 3.6 2.8 12.4 9.6 8.0 0.9 5.4 6.1 4.7 8.6 7.3 9.2 2.1 1.8 4.2 89.5 3.9 11.4 1.7 3.3 11.3 8.1 4.9 3.6 1.9 3.0 5.1 10.2 6.6 3.8 4.5 3.6 20.0 4.1 4.0 3.3 2.3 28.3 10.2 3.8 14.5 3.6 12.8 4.3 1.8 3.7 3.4 13.3 1.0 7.1 2.2 4.1 34.7 14.3 5.9 13.2 10.0 5.8 6.2 1.7 6.6 5.4 7.2 3.1 3.7 12.6 5.8 0.8 7.4 53.4 11.3 14.7 PLCG1 "NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1" ENSG00000124181 "Phospholipase C gamma 1" P19174 20 41136960-41196801 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction, Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 4.7;MAIT T-cell: 6.4;memory CD4 T-cell: 4.1;memory CD8 T-cell: 3.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 4.3;NK-cell: 3.4;T-reg: 3.8" "Group enriched" "Detected in many" 9 "NK-cells: 3.4;T-cells: 6.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004277, HPA036681, HPA036682" Approved Enhanced Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 58: T-cells - T-cell receptor" Cytosol "CAB004277: AB_628119, HPA036681: AB_2675245, HPA036682: AB_2675246" "unprognostic (2.77e-1)" "unprognostic (1.35e-1)" "unprognostic (1.65e-1)" "unprognostic (4.31e-2)" "unprognostic (5.82e-2)" "unprognostic (2.09e-2)" "unprognostic (4.45e-3)" "unprognostic (1.25e-2)" "unprognostic (2.29e-2)" "unprognostic (1.16e-1)" "prognostic favorable (4.72e-4)" "unprognostic (3.32e-1)" "unprognostic (2.73e-3)" "unprognostic (1.82e-1)" "unprognostic (2.65e-1)" "unprognostic (9.27e-2)" "unprognostic (2.79e-2)" 33.3 22.4 36.2 21.7 37.3 10.0 31.8 43.8 41.3 42.5 27.8 25.2 17.8 36.1 13.7 18.9 31.9 19.9 31.9 35.6 32.9 23.2 9.7 32.4 36.4 34.8 36.2 42.6 11.4 13.3 21.6 23.8 34.2 30.2 13.7 10.9 20.2 20.5 18.5 31.5 28.8 22.9 32.0 30.0 19.4 26.3 39.5 60.5 45.0 20.3 24.0 30.4 32.0 38.6 16.6 20.8 97.2 71.6 38.0 26.5 30.9 26.7 34.1 52.4 44.3 50.1 5.4 37.0 31.9 29.1 55.0 30.2 42.7 47.8 30.4 10.5 22.7 2.6 36.4 59.6 28.9 14.7 9.7 34.1 26.3 38.8 30.0 47.2 59.4 77.3 28.0 23.6 48.0 123.8 90.7 11.5 36.2 21.3 37.6 71.1 70.8 18.2 28.7 30.1 34.4 65.7 47.8 22.1 48.4 54.1 25.8 17.0 64.6 124.4 40.3 40.2 32.9 26.1 12.4 30.3 29.7 15.6 52.9 0.0 0.0 0.0 4.7 0.0 6.4 0.2 4.1 3.9 0.0 0.5 4.3 4.3 0.0 3.4 0.0 0.0 3.8 3.0 36.2 37.3 43.8 41.3 35.6 32.9 34.8 36.2 34.2 32.0 39.5 38.6 33.4 16.0 7.0 69.2 5.1 5.6 1.8 5.3 14.8 4.3 4.7 5.8 9.6 1.5 3.8 3.7 10.4 1.9 7.4 9.4 0.0 3.3 7.0 5.4 16.9 24.2 1.8 2.1 9.7 1.6 2.0 11.5 10.2 10.3 1.3 19.8 11.7 3.1 4.0 3.3 9.1 9.5 4.1 2.9 4.3 7.2 15.2 1.7 3.6 16.9 1.2 6.7 2.1 13.0 16.4 3.3 4.8 18.4 6.3 2.3 7.8 3.0 1.8 5.1 13.1 8.5 10.2 15.9 13.0 6.1 7.0 0.8 17.0 5.7 6.4 0.9 PLCXD2 FLJ31579 ENSG00000240891 "Phosphatidylinositol specific phospholipase C X domain containing 2" Q0VAA5 3 111674676-111846447 "Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.3;retina: 14.8" "Cell type enhanced" "Detected in many" "Collecting duct cells: 60.7;Distal tubular cells: 160.4;Hepatocytes: 168.6;Proximal tubular cells: 196.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 3.8;NK-cells: 1.1;T-cells: 1.8" "Cell line enhanced" "Detected in many" "HBF TERT88: 7.1" "Low region specificity" "Detected in all" HPA055947 Uncertain Approved Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA055947: AB_2682981" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (7.26e-2)" "unprognostic (2.42e-1)" "unprognostic (3.09e-2)" "unprognostic (2.76e-2)" "unprognostic (1.36e-1)" "unprognostic (4.64e-1)" "unprognostic (3.47e-1)" "unprognostic (1.99e-2)" "unprognostic (3.38e-2)" "unprognostic (2.04e-1)" "prognostic favorable (1.23e-7)" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "prognostic favorable (2.99e-4)" 0.3 0.3 2.6 1.6 2.9 4.6 0.2 0.7 7.3 0.3 0.0 1.2 2.8 0.3 0.2 0.5 0.2 0.7 0.3 3.9 1.6 0.6 1.0 0.6 2.9 4.1 4.5 0.2 0.6 0.1 1.4 1.0 4.1 0.3 1.5 14.8 0.9 0.2 0.2 0.6 2.7 0.3 2.2 1.6 0.9 1.0 3.5 2.7 1.3 0.1 2.2 0.5 0.3 1.9 2.3 2.1 2.0 0.9 0.0 0.1 0.6 4.0 1.9 3.7 3.2 1.4 1.1 1.7 2.0 0.2 1.2 5.6 0.8 3.7 7.1 0.5 1.0 0.4 4.1 1.3 0.3 0.5 2.0 0.0 0.7 1.2 2.2 3.4 2.0 2.1 0.0 4.0 0.4 0.2 1.2 0.4 0.7 1.5 5.1 1.1 2.8 1.6 1.7 2.3 0.4 3.4 0.8 0.5 0.8 2.2 0.3 0.1 2.0 0.8 5.0 0.4 0.8 4.8 0.7 0.3 0.4 0.3 0.2 0.3 0.0 0.0 1.8 0.0 1.8 0.3 0.9 1.8 0.1 0.4 0.4 0.9 0.1 1.1 0.0 3.8 0.9 0.3 2.6 2.9 0.7 7.3 3.9 1.6 4.1 4.5 4.1 2.2 3.5 1.9 0.4 19.2 2.2 3.3 2.3 0.1 9.9 17.1 7.4 0.8 2.9 1.8 3.7 22.8 3.5 60.7 4.2 0.0 8.4 1.6 160.4 44.2 11.9 0.9 0.2 0.7 25.1 0.0 11.7 50.1 0.0 0.4 7.1 1.5 0.0 5.4 0.4 168.6 0.0 6.7 6.0 7.8 2.0 1.6 0.0 12.0 0.3 1.8 0.0 3.7 0.0 0.0 2.1 7.5 0.9 50.1 0.2 0.4 3.9 7.9 1.0 196.6 1.0 3.5 0.0 0.0 1.7 0.5 0.5 2.2 0.1 0.0 5.3 0.5 1.5 14.1 PLPP2 "LPP2, PAP-2c, PPAP2C" ENSG00000141934 "Phospholipid phosphatase 2" O43688 19 281040-291403 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cholangiocytes: 204.5;Ductal cells: 352.1;Proximal enterocytes: 209.8;Rod photoreceptor cells: 234.9;Urothelial cells: 205.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 3.2;MAIT T-cell: 6.6" "Lineage enriched" "Detected in single" 41 "T-cells: 6.6" "Cell line enhanced" "Detected in many" "A549: 144.1;CAPAN-2: 154.6;OE19: 255.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055540, HPA058428" Uncertain Supported "Plasma membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane" "HPA055540: AB_2682839, HPA058428: " "prognostic unfavorable (4.55e-4)" "unprognostic (8.91e-3)" "unprognostic (1.06e-1)" "prognostic favorable (3.21e-8)" "unprognostic (2.95e-1)" "unprognostic (1.36e-1)" "unprognostic (3.83e-3)" "unprognostic (5.48e-2)" "unprognostic (1.59e-1)" "unprognostic (5.67e-2)" "unprognostic (1.18e-3)" "unprognostic (3.85e-1)" "unprognostic (3.53e-3)" "unprognostic (1.06e-2)" "unprognostic (1.71e-1)" "unprognostic (1.30e-3)" "unprognostic (1.36e-3)" 4.8 13.2 37.7 8.5 61.6 0.0 36.9 57.1 50.0 63.4 26.2 40.5 62.7 16.8 8.4 27.2 81.8 52.4 1.7 38.8 43.5 11.5 3.7 8.3 1.4 57.3 53.6 2.7 37.3 19.5 11.8 3.6 56.2 31.7 32.1 29.6 105.7 32.9 0.6 53.2 51.0 6.4 44.8 4.7 50.3 7.6 49.2 5.2 5.7 0.5 6.0 36.5 14.2 83.9 85.5 144.1 2.1 0.1 0.0 0.3 0.2 8.2 0.0 25.3 18.9 41.7 154.6 0.0 88.3 11.9 0.1 45.3 0.0 17.6 11.1 0.8 2.6 0.0 55.9 0.0 28.6 0.0 5.5 5.2 7.6 12.7 16.7 53.4 4.2 0.0 0.7 0.1 0.0 98.5 0.4 0.1 61.5 255.8 0.0 0.0 0.0 2.4 62.1 13.7 17.4 40.9 23.3 38.3 60.3 5.8 50.0 2.5 4.5 55.7 36.5 0.5 61.9 0.8 101.7 70.4 15.5 0.0 46.9 0.0 0.0 0.0 3.2 0.0 6.6 0.0 1.3 1.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 37.7 61.6 57.1 50.0 38.8 43.5 57.3 53.6 56.2 44.8 49.2 83.9 17.0 6.4 7.5 0.0 1.5 0.0 134.2 0.0 8.0 19.7 137.1 149.9 0.0 204.5 35.3 22.0 10.4 0.5 2.7 77.0 3.9 352.1 0.3 115.2 9.2 15.2 8.5 0.0 0.0 139.5 15.1 3.0 91.3 90.1 1.3 0.0 0.0 0.5 0.9 16.8 0.0 38.8 0.0 1.0 0.0 1.6 0.0 1.9 0.0 0.0 2.6 21.7 0.0 0.0 0.0 128.8 85.2 0.0 1.6 97.4 209.8 1.4 91.1 234.9 0.0 0.8 2.7 0.6 35.1 20.3 0.0 0.8 3.5 0.1 87.2 205.8 PNP "NP, PUNP" ENSG00000198805 "Purine nucleoside phosphorylase" P00491 14 20468954-20477089 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 333.9;epididymis: 594.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 360.6;Erythroid cells: 227.3;Syncytiotrophoblasts: 646.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 531.3;U-937: 593.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001625 Enhanced Supported Cytosol NA NA 58000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "HPA001625: AB_1854577" "unprognostic (1.20e-3)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" "unprognostic (1.70e-1)" "unprognostic (3.10e-1)" "unprognostic (7.06e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (4.94e-3)" "unprognostic (3.87e-2)" "unprognostic (7.45e-2)" "unprognostic (1.85e-2)" "unprognostic (2.21e-1)" "prognostic favorable (2.24e-4)" "unprognostic (1.69e-1)" "unprognostic (7.54e-2)" "unprognostic (2.46e-1)" "unprognostic (1.64e-3)" 78.6 24.8 16.1 46.8 16.6 333.9 34.6 22.6 22.7 25.3 18.9 52.2 120.3 14.2 594.8 87.4 18.2 56.8 29.0 17.7 19.6 206.8 98.0 48.6 46.7 20.3 18.1 5.0 23.2 32.0 19.8 132.6 20.1 15.0 61.8 27.1 22.6 27.4 7.3 29.6 60.3 38.7 23.1 44.5 50.6 7.4 21.1 33.5 17.8 10.0 64.4 100.4 41.5 20.1 86.1 113.4 24.0 53.9 26.0 21.0 71.8 85.2 40.3 68.2 67.0 66.1 76.5 227.1 96.8 45.5 81.5 89.9 125.2 159.8 89.5 75.0 109.6 189.1 89.9 109.3 24.2 531.3 94.7 14.4 57.4 206.0 91.0 37.8 295.9 141.0 95.4 137.4 86.7 79.1 157.6 311.3 67.5 215.7 186.1 130.2 35.9 88.3 243.7 79.6 101.9 22.6 163.4 205.0 13.2 32.6 75.5 92.5 240.0 46.1 62.6 105.1 148.4 63.1 113.3 258.9 39.3 593.0 4.6 12.0 30.6 10.3 39.8 27.3 73.6 25.7 44.2 45.0 48.1 28.8 27.6 35.9 3.7 38.5 26.6 27.3 16.7 31.1 16.1 16.6 22.6 22.7 17.7 19.6 20.3 18.1 20.1 23.1 21.1 20.1 149.6 0.0 23.5 5.9 50.3 84.6 67.4 12.6 112.7 4.7 56.3 62.6 3.5 27.1 13.4 82.8 14.6 360.6 45.2 61.1 39.2 43.2 1.3 36.0 12.7 139.4 46.4 227.3 0.6 51.5 41.8 32.4 106.5 65.3 57.7 5.0 24.3 30.6 70.9 16.8 1.1 51.3 18.3 18.1 58.4 0.8 0.3 83.3 30.2 3.7 13.2 78.8 29.9 3.0 0.9 130.8 83.9 0.7 88.6 27.5 41.2 118.9 10.5 18.1 0.0 23.9 41.3 0.4 0.7 114.7 63.9 646.2 62.3 3.1 51.4 77.1 POLR1E "FLJ13390, FLJ13970, PAF53, PRAF1, RPA49" ENSG00000137054 "RNA polymerase I subunit E" Q9GZS1 9 37485948-37503697 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022527, HPA052400" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 32: Non-specific - Translation" "Nucleoplasm, Nucleoli fibrillar center" "HPA022527: AB_1854924, HPA052400: AB_2681815" "prognostic favorable (2.27e-4)" "unprognostic (2.09e-1)" "unprognostic (9.90e-3)" "unprognostic (1.10e-2)" "unprognostic (7.16e-3)" "unprognostic (2.07e-1)" "unprognostic (1.09e-2)" "unprognostic (7.14e-2)" "unprognostic (1.04e-1)" "unprognostic (2.48e-1)" "unprognostic (2.80e-1)" "unprognostic (2.48e-1)" "unprognostic (1.07e-1)" "unprognostic (4.96e-2)" "unprognostic (5.23e-1)" "unprognostic (1.58e-1)" "unprognostic (4.24e-2)" 20.8 15.3 9.4 14.6 9.7 13.1 24.0 9.7 9.0 22.7 7.0 17.9 8.5 24.3 14.8 13.9 20.0 12.6 18.4 8.8 10.6 8.4 29.7 11.9 19.3 9.0 9.5 42.4 27.9 11.5 9.4 8.3 9.4 14.0 10.9 8.9 18.0 17.4 19.1 15.7 10.9 22.5 10.2 10.9 15.0 9.1 9.6 17.0 13.7 10.5 21.6 17.9 17.0 10.4 58.5 53.7 29.0 46.2 53.2 67.8 18.9 50.6 19.5 51.2 45.0 46.4 18.9 84.1 23.8 58.5 34.9 23.8 71.5 60.0 64.2 81.9 33.6 40.4 68.0 33.3 39.7 78.2 27.5 72.7 20.9 100.4 85.7 32.2 26.5 46.0 107.5 36.0 45.6 28.0 54.5 26.8 51.7 39.7 43.5 47.8 26.7 40.5 26.7 21.4 41.3 33.9 33.7 26.7 43.8 23.8 26.0 51.4 18.3 60.3 91.9 52.3 102.2 19.5 29.6 87.7 20.8 48.8 51.2 0.0 3.5 2.2 14.2 6.0 22.7 10.1 13.5 14.5 5.6 11.5 16.6 14.7 1.1 13.1 5.2 3.9 8.0 7.5 9.4 9.7 9.7 9.0 8.8 10.6 9.0 9.5 9.4 10.2 9.6 10.4 7.2 0.0 8.4 1.6 20.4 28.3 23.7 10.9 21.1 7.0 13.2 15.2 8.6 14.3 7.4 0.0 4.2 15.6 20.0 4.3 7.9 13.8 5.6 5.4 20.1 7.1 1.8 15.4 1.8 21.6 21.4 16.1 8.6 6.7 8.8 14.0 3.9 18.7 7.4 3.3 2.4 7.7 6.1 10.3 8.0 10.7 14.9 8.1 5.4 3.7 9.2 9.2 12.3 1.5 2.1 14.1 3.0 15.1 28.3 23.6 3.1 5.9 4.1 6.9 0.0 22.1 15.9 20.6 23.5 14.0 17.8 8.3 23.7 31.9 11.9 12.7 POMT1 LGMD2K ENSG00000130714 "Protein O-mannosyltransferase 1" Q9Y6A1 9 131502789-131523806 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 64.5;Spermatocytes: 71.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065252 Uncertain "Golgi apparatus" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA065252: AB_2685445" "unprognostic (2.00e-3)" "unprognostic (2.02e-1)" "unprognostic (1.60e-1)" "unprognostic (5.09e-3)" "unprognostic (1.67e-1)" "unprognostic (7.97e-2)" "unprognostic (5.35e-3)" "unprognostic (1.14e-1)" "unprognostic (9.76e-3)" "unprognostic (2.84e-1)" "prognostic favorable (3.90e-5)" "unprognostic (8.36e-2)" "prognostic favorable (4.68e-5)" "unprognostic (2.41e-2)" "unprognostic (1.61e-1)" "unprognostic (4.72e-2)" "unprognostic (2.12e-1)" 15.7 20.9 16.6 7.6 16.7 6.6 16.2 18.4 21.0 21.1 15.0 24.8 9.0 17.1 7.2 15.2 18.4 9.3 24.5 25.5 16.0 25.5 24.4 15.6 8.3 16.0 16.2 25.6 25.9 15.5 31.3 9.7 16.5 28.4 6.5 8.1 20.1 8.7 32.9 17.5 19.9 7.1 14.2 22.2 20.4 63.7 16.9 7.1 19.0 13.4 5.4 16.5 17.1 15.5 9.8 17.4 10.5 26.4 19.3 13.5 24.5 12.1 17.0 21.3 14.1 15.8 14.7 2.5 16.9 26.4 8.6 24.1 17.3 16.6 5.9 16.2 21.6 4.2 28.5 7.8 23.1 13.1 10.5 10.8 10.0 12.3 5.0 17.6 15.1 16.4 13.4 15.6 23.2 27.6 15.8 25.2 6.7 9.6 21.1 15.7 13.8 24.6 18.1 1.5 15.0 14.1 25.1 26.8 13.0 5.8 31.4 17.7 20.9 13.8 2.2 28.6 10.3 7.3 7.0 5.2 8.7 29.1 13.0 0.0 2.8 3.4 5.2 3.0 7.7 1.9 5.0 5.3 4.0 2.6 4.8 3.6 0.6 3.2 2.9 2.4 5.2 4.0 16.6 16.7 18.4 21.0 25.5 16.0 16.0 16.2 16.5 14.2 16.9 15.5 5.9 9.6 16.0 18.6 7.1 4.5 4.9 7.2 5.7 13.2 7.8 8.6 9.7 10.0 8.7 12.9 8.4 20.8 6.5 12.9 1.9 10.7 64.5 9.6 7.3 8.0 7.8 1.3 21.5 6.7 12.9 9.0 9.2 9.9 2.5 15.1 11.0 10.1 10.8 21.9 25.9 8.4 10.2 5.4 5.9 33.0 8.7 5.6 5.4 15.9 7.5 12.3 5.2 18.6 11.1 8.1 6.0 10.1 6.8 4.9 14.2 7.5 6.8 16.6 6.6 7.5 7.2 71.6 9.6 5.7 3.0 17.5 9.0 6.2 9.1 2.6 PPIL1 CYPL1 ENSG00000137168 "Peptidylprolyl isomerase like 1" Q9Y3C6 6 36854827-36874803 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 58.7;Extravillous trophoblasts: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062916 Supported Nucleoli NA NA 21000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoli "HPA062916: AB_2684904" "unprognostic (3.51e-2)" "unprognostic (2.33e-1)" "unprognostic (2.64e-3)" "unprognostic (1.11e-2)" "unprognostic (1.87e-1)" "unprognostic (1.81e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (2.01e-1)" "unprognostic (3.37e-2)" "prognostic favorable (4.90e-4)" "unprognostic (6.58e-2)" "unprognostic (5.49e-2)" "unprognostic (8.99e-2)" "unprognostic (1.30e-1)" "unprognostic (2.30e-1)" "unprognostic (3.39e-2)" "unprognostic (2.15e-2)" 12.4 21.7 20.3 19.1 21.9 11.4 18.4 22.6 27.3 15.0 23.8 14.7 13.2 15.7 19.1 17.0 23.0 10.7 42.8 20.0 25.2 18.9 21.5 10.5 21.9 22.0 22.0 17.7 14.3 21.7 12.0 22.3 23.3 16.8 17.6 29.1 19.5 17.6 18.5 9.5 11.3 22.9 24.1 9.5 12.9 23.2 22.2 18.6 33.2 20.7 24.6 20.5 8.0 22.8 69.2 50.0 111.2 78.5 19.7 31.5 77.5 60.9 41.0 82.7 70.0 89.7 39.7 87.7 75.5 41.9 105.5 55.4 135.1 92.7 96.2 81.3 114.6 102.7 33.6 147.7 53.5 89.3 40.8 24.7 48.7 62.3 118.9 31.8 75.5 79.1 202.4 48.0 63.3 71.2 101.9 69.8 92.3 108.5 57.9 79.4 100.2 92.0 63.2 53.5 140.0 68.5 41.8 51.4 102.5 83.5 76.3 100.2 44.0 66.7 69.0 58.5 98.8 57.0 145.2 153.0 23.7 183.7 139.4 1.6 4.8 1.3 14.7 6.2 19.7 10.3 12.1 13.9 9.2 7.4 13.4 15.9 1.2 7.3 3.4 7.8 10.2 9.8 20.3 21.9 22.6 27.3 20.0 25.2 22.0 22.0 23.3 24.1 22.2 22.8 5.7 6.4 7.5 2.9 10.8 3.1 18.6 12.2 5.7 16.9 9.0 10.5 45.8 8.6 8.3 5.5 4.2 58.7 6.6 3.3 23.5 25.7 32.0 10.3 14.2 12.3 3.6 22.7 6.5 20.3 72.3 12.2 7.7 7.7 10.8 16.3 5.0 8.2 30.1 16.8 8.6 11.4 4.1 3.3 3.6 11.7 6.8 6.4 7.2 1.9 9.2 41.0 11.3 7.5 5.4 22.1 5.5 12.4 15.0 13.5 3.3 17.1 13.5 15.5 6.6 6.1 12.8 25.7 51.0 10.6 4.5 25.3 9.2 21.1 11.9 8.6 PPP1R13B "ASPP1, KIAA0771, p53BP2-like, p85" ENSG00000088808 "Protein phosphatase 1 regulatory subunit 13B" Q96KQ4 14 103733195-103847575 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 106.1;Granulosa cells: 83.4;Inhibitory neurons: 105.9;Late spermatids: 78.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006394, CAB015454" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 14: REH - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Cytosol "CAB015454: AB_2252775, HPA006394: AB_1079668" "unprognostic (1.20e-1)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.45e-1)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (1.25e-2)" "prognostic favorable (1.41e-4)" "unprognostic (3.22e-3)" "unprognostic (5.13e-2)" "unprognostic (5.39e-2)" "unprognostic (1.62e-3)" "prognostic favorable (3.28e-11)" "unprognostic (1.68e-1)" "unprognostic (1.69e-1)" "unprognostic (1.97e-2)" "unprognostic (2.23e-1)" 7.0 4.7 3.4 3.2 4.2 0.7 7.4 6.6 8.5 6.8 4.0 7.7 7.1 7.6 2.1 11.6 9.8 4.7 21.2 7.6 3.9 6.9 5.0 9.9 2.7 1.2 2.0 10.9 8.3 7.8 6.5 6.0 1.7 10.7 5.6 8.0 10.2 5.3 7.5 12.5 7.6 5.2 0.3 11.3 10.1 19.1 3.8 2.0 23.4 6.2 5.1 8.0 7.1 4.2 4.9 4.2 0.5 5.4 0.9 0.4 1.9 3.2 2.3 4.0 1.8 3.3 4.4 1.1 11.7 2.2 4.9 9.8 5.8 3.7 3.5 2.2 4.0 0.0 1.3 5.7 3.6 0.5 4.4 1.0 4.4 0.3 4.7 1.7 7.9 2.8 0.7 1.7 2.7 20.3 0.0 0.5 1.0 12.3 5.1 11.3 3.2 2.7 7.8 12.7 6.6 16.9 9.9 7.3 2.5 2.6 18.4 0.7 7.1 2.9 4.0 2.4 3.0 4.0 5.8 8.4 1.8 2.9 1.4 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 4.2 6.6 8.5 7.6 3.9 1.2 2.0 1.7 0.3 3.8 4.2 35.1 19.2 39.5 31.0 7.1 13.5 16.6 6.9 18.8 15.8 31.3 20.6 45.4 14.3 11.8 7.3 12.5 2.9 11.9 26.9 3.9 7.9 58.0 37.9 7.9 30.3 15.6 2.7 106.1 6.4 1.0 7.7 37.8 48.5 0.0 83.4 14.3 9.0 2.9 15.2 105.9 14.2 6.1 1.6 5.7 78.4 4.4 3.0 3.6 49.6 0.4 5.8 1.0 31.7 33.2 6.8 18.7 20.3 6.3 13.1 14.6 7.8 8.3 12.9 6.6 10.9 6.7 17.8 15.1 24.1 12.9 2.2 9.0 8.7 15.8 13.7 PRDM1 "BLIMP1, PRDI-BF1" ENSG00000057657 "PR/SET domain 1" O75626 6 105993463-106109939 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 55.2" "Cell type enhanced" "Detected in many" "dendritic cells: 199.8;Langerhans cells: 199.2;Plasma cells: 786.9;T-cells: 184.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 11.1;gdT-cell: 22.1;MAIT T-cell: 34.0;memory CD4 T-cell: 20.5;memory CD8 T-cell: 20.2;naive CD8 T-cell: 11.3;neutrophil: 12.5;T-reg: 29.4" "Group enriched" "Detected in many" 5 "granulocytes: 12.5;T-cells: 34.0" "Cell line enhanced" "Detected in many" "Karpas-707: 212.1;RPMI-8226: 42.4;U-266/70: 81.5;U-266/84: 57.0" "Region enriched" "Detected in single" 6 "olfactory bulb: 3.6" "Low region specificity" "Detected in many" "HPA030033, HPA075427" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Nucleoli Nucleoplasm "HPA030033: AB_10601050, HPA075427: " "unprognostic (9.60e-2)" "unprognostic (3.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.98e-2)" "unprognostic (4.03e-1)" "unprognostic (3.77e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (2.42e-1)" "unprognostic (1.81e-1)" "unprognostic (3.50e-2)" "unprognostic (7.56e-2)" "prognostic unfavorable (9.81e-5)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (2.45e-3)" "unprognostic (7.90e-2)" 6.6 2.1 1.6 20.0 1.6 20.3 6.8 5.5 1.8 15.7 3.1 15.2 9.2 17.2 1.3 55.2 5.5 12.7 1.7 1.5 2.8 2.5 4.5 10.1 15.9 3.2 1.8 4.9 1.9 2.5 1.4 5.1 2.7 3.4 17.2 1.3 9.3 2.4 4.3 9.1 12.6 5.5 2.4 13.6 15.2 1.2 2.9 4.2 9.0 2.2 27.8 19.6 20.2 3.4 1.4 0.5 1.1 0.0 1.6 2.1 0.2 7.2 23.3 2.3 3.7 1.4 9.2 2.0 0.4 13.8 0.3 0.5 0.0 3.6 2.5 21.7 0.1 0.4 4.9 0.0 3.6 0.8 1.6 2.3 11.6 3.3 9.7 0.7 2.9 1.0 1.4 212.1 0.4 0.0 0.1 0.5 0.8 1.4 0.0 0.5 0.0 42.4 2.1 0.3 0.0 0.3 1.0 0.9 0.0 1.6 1.0 2.4 1.5 3.1 1.8 2.1 7.2 81.5 57.0 4.9 5.1 1.3 2.1 2.4 0.8 11.1 22.1 1.2 34.0 2.5 20.5 20.2 0.5 1.0 1.8 11.3 12.5 4.7 0.3 0.4 29.4 2.6 1.6 1.6 5.5 1.8 1.5 2.8 3.2 1.8 2.7 2.4 2.9 3.4 93.1 0.0 5.1 0.3 42.1 19.5 8.6 15.0 3.4 0.6 2.8 3.4 1.5 0.0 19.1 3.7 52.1 0.7 199.8 129.8 0.0 0.3 0.9 15.9 101.0 41.1 1.8 6.1 1.8 0.2 0.7 18.5 19.4 62.6 3.8 9.9 6.4 2.5 19.8 0.0 19.2 15.0 10.2 38.0 199.2 0.3 0.0 64.5 37.4 23.4 30.4 0.5 89.6 0.5 0.1 7.8 103.7 1.2 786.9 4.0 3.2 0.3 13.0 1.1 0.0 5.3 30.1 0.5 2.3 43.9 41.5 0.7 184.3 1.6 8.7 91.9 PROCR "CCD41, CD201, EPCR" ENSG00000101000 "Protein C receptor" Q9UNN8 20 35172072-35216240 "Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 126.8" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 114.2;Fibroblasts: 83.4;granulocytes: 63.1;Hepatic stellate cells: 74.6;Sertoli cells: 170.9;Syncytiotrophoblasts: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 385.0;HUVEC TERT2: 611.1;TIME: 365.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 8.9" HPA039461 Enhanced NA NA 980000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 50: Fibroblasts - ECM organization" "HPA039461: AB_10673359" "unprognostic (1.51e-1)" "unprognostic (1.03e-1)" "unprognostic (4.12e-2)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (4.69e-2)" "unprognostic (4.69e-2)" "unprognostic (1.84e-1)" "unprognostic (1.52e-1)" "unprognostic (4.76e-2)" "unprognostic (5.22e-2)" "unprognostic (4.27e-1)" "prognostic unfavorable (7.62e-6)" "unprognostic (3.37e-2)" "unprognostic (2.29e-1)" "unprognostic (1.05e-1)" "unprognostic (2.19e-2)" 126.8 23.1 6.8 19.6 7.3 8.6 53.9 12.0 7.7 31.2 14.6 25.2 16.3 36.2 13.4 12.0 42.9 21.2 43.5 7.0 6.8 15.6 6.8 19.8 10.0 8.9 7.3 18.0 12.6 6.1 8.6 31.3 8.8 19.5 21.4 1.8 8.7 17.3 10.1 25.2 21.4 28.4 7.5 27.5 23.2 5.0 8.9 3.0 26.0 10.3 4.0 34.2 28.4 10.1 15.2 88.9 0.2 9.2 93.6 76.1 20.2 20.8 90.4 33.7 65.2 115.2 76.7 2.9 63.3 21.0 93.6 48.5 20.2 131.8 27.8 0.7 27.5 33.2 19.8 4.7 22.8 1.3 385.0 65.1 48.8 159.0 131.1 49.2 611.1 1.1 11.8 4.2 35.3 5.0 1.1 1.6 12.2 18.8 90.4 0.6 16.7 0.4 58.3 5.8 2.7 1.2 11.3 23.9 18.8 11.0 8.1 5.0 365.5 86.0 43.2 32.8 35.4 0.3 1.1 0.9 99.1 33.5 18.6 5.0 1.5 0.8 8.2 1.8 14.8 0.9 2.5 5.2 7.8 1.3 0.6 5.9 4.0 3.3 1.3 1.3 2.2 2.2 6.8 7.3 12.0 7.7 7.0 6.8 8.9 7.3 8.8 7.5 8.9 10.1 19.9 0.0 12.6 2.3 0.5 13.9 18.5 10.1 10.2 0.5 1.1 4.4 2.4 5.7 4.9 5.5 0.0 12.1 2.0 0.5 1.9 32.2 1.6 1.0 24.0 58.8 6.0 2.7 3.6 16.4 114.2 83.4 1.5 0.9 63.1 15.9 74.6 1.9 21.9 1.7 2.5 0.7 0.0 1.6 8.8 1.0 15.5 13.5 3.6 9.4 2.2 0.3 7.2 0.5 5.6 15.6 0.5 2.6 0.6 9.7 9.8 6.3 1.8 0.6 170.9 4.3 45.9 20.4 19.7 2.8 8.4 69.0 4.4 4.2 2.0 11.9 PRR5 "FLJ20185k, PP610, Protor-1" ENSG00000186654 "Proline rich 5" P85299 22 44668547-44737681 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 91.3;NK-cells: 77.2;Proximal tubular cells: 55.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "monocytes: 19.1;T-cells: 28.6" "Cell line enhanced" "Detected in many" "U-266/70: 99.2;U-266/84: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054072 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "HPA054072: AB_2682369" "unprognostic (2.63e-2)" "unprognostic (6.63e-3)" "unprognostic (2.61e-2)" "prognostic favorable (2.47e-5)" "unprognostic (1.83e-2)" "unprognostic (3.99e-2)" "unprognostic (7.52e-2)" "unprognostic (1.37e-1)" "unprognostic (8.98e-2)" "unprognostic (5.13e-2)" "unprognostic (1.34e-1)" "unprognostic (2.36e-1)" "unprognostic (1.65e-1)" "unprognostic (2.48e-3)" "unprognostic (1.55e-1)" "unprognostic (1.09e-1)" "unprognostic (2.00e-1)" 16.2 2.4 7.2 3.2 7.7 7.2 12.2 5.9 11.3 8.4 11.9 6.0 8.6 3.8 2.1 7.6 4.3 2.9 3.5 7.9 9.7 11.5 18.5 3.5 3.9 8.1 8.2 4.0 6.2 2.3 16.1 4.5 8.5 7.9 2.4 0.4 5.7 3.8 0.8 7.4 9.4 1.1 5.9 20.5 5.2 5.1 10.5 2.3 4.5 1.2 2.5 6.9 7.1 5.8 8.1 9.6 2.0 6.8 0.2 0.3 25.0 7.0 6.2 4.2 3.4 24.4 3.4 0.0 5.2 8.2 4.9 7.2 2.1 7.1 0.7 0.2 19.9 15.9 1.3 28.5 5.8 2.9 5.8 2.9 7.9 0.4 2.2 1.0 0.2 3.7 10.1 0.5 0.9 21.4 1.1 4.6 1.3 11.4 1.4 0.7 4.5 14.5 1.4 3.8 7.0 1.0 1.9 11.4 9.5 5.5 5.3 2.8 0.0 0.1 11.0 1.0 0.1 99.2 31.3 0.2 0.0 6.4 0.8 0.5 0.3 0.1 24.8 3.4 28.6 1.6 8.3 18.8 0.7 0.9 3.5 13.0 0.6 5.6 19.1 0.4 14.8 6.8 7.2 7.7 5.9 11.3 7.9 9.7 8.1 8.2 8.5 5.9 10.5 5.8 6.0 0.0 3.9 11.4 9.2 8.3 12.0 2.1 4.0 0.7 13.6 13.2 2.0 10.0 2.3 5.5 0.0 32.1 50.3 20.5 5.9 5.2 0.5 4.4 5.4 12.5 9.6 91.3 2.0 7.9 3.3 23.2 8.2 4.7 7.6 5.4 21.4 19.9 32.1 0.0 1.8 22.8 2.0 13.5 8.2 0.5 5.3 7.7 8.8 3.7 3.0 6.0 77.2 1.0 0.2 8.4 7.6 3.8 29.0 24.2 50.9 55.2 1.4 1.5 0.0 11.4 5.3 0.3 20.4 8.0 8.5 44.1 37.1 51.8 25.5 13.5 PRSS35 "C6orf158, dJ223E3.1, MGC46520" ENSG00000146250 "Serine protease 35" Q8N3Z0 6 83512534-83525704 "Enzymes, Predicted secreted proteins" "Serine protease homolog" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 50.5" "Cell type enriched" "Detected in some" 36 "Muller glia cells: 410.9" "Group enriched" "Detected in some" 4 "glioma: 2.8;testis cancer: 4.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 9 "MAIT T-cell: 19.5" "Lineage enriched" "Detected in single" 195 "T-cells: 19.5" "Cell line enhanced" "Detected in some" "BJ hTERT+: 10.4;CACO-2: 86.3;HAP1: 12.8;RPTEC TERT1: 24.6;SuSa: 17.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 2.9;cerebellum: 3.6;cerebral cortex: 5.8;hippocampal formation: 5.3;olfactory bulb: 2.7" "HPA038787, HPA038788" Uncertain "Secreted in female reproductive system" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 39: CACO-2 - Unknown function" "Cluster 5: Muller glia cells - Visual perception" "HPA038787: AB_10675951, HPA038788: AB_2676208" "unprognostic (6.17e-2)" "unprognostic (8.75e-2)" "unprognostic (1.19e-2)" "unprognostic (2.63e-2)" "unprognostic (1.16e-1)" "unprognostic (4.03e-2)" "unprognostic (3.70e-4)" "unprognostic (6.08e-2)" "unprognostic (1.18e-3)" "unprognostic (2.33e-2)" "unprognostic (7.01e-2)" "unprognostic (9.07e-2)" "unprognostic (3.88e-6)" "unprognostic (7.15e-3)" "unprognostic (5.81e-2)" "unprognostic (2.82e-2)" "unprognostic (3.54e-4)" 1.3 2.4 2.9 0.1 3.8 0.0 0.3 1.7 6.8 2.9 1.5 0.1 0.3 1.3 1.1 0.3 1.4 4.2 4.4 3.2 2.1 3.1 0.4 1.3 0.7 1.8 1.9 10.2 0.3 0.3 1.1 3.6 1.8 1.1 0.3 50.5 0.3 0.4 0.1 0.2 0.1 1.5 1.8 0.7 0.3 3.1 2.6 0.1 0.4 0.1 0.1 1.3 0.5 2.2 0.0 0.5 1.9 0.0 0.1 0.0 0.0 0.3 10.4 1.0 2.0 86.3 0.0 0.0 0.1 0.4 0.0 0.0 12.8 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 3.1 0.0 1.2 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 1.6 0.4 8.2 0.0 0.0 0.0 24.6 0.0 0.0 1.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 19.5 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.9 3.8 1.7 6.8 3.2 2.1 1.8 1.9 1.8 1.8 2.6 2.2 0.3 3.2 0.5 8.1 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 1.5 0.0 0.0 1.8 0.0 0.3 0.0 0.1 9.8 0.1 0.1 0.0 0.3 0.8 1.8 0.0 0.2 0.0 0.0 4.4 0.0 0.0 0.0 0.9 0.0 0.3 0.4 6.7 0.2 0.0 0.0 0.0 0.0 0.2 1.2 0.1 0.0 1.0 0.0 410.9 0.0 1.0 0.1 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 11.4 6.6 0.1 3.7 0.1 0.5 0.0 0.0 0.1 0.7 5.1 0.0 0.0 PVRIG "C7orf15, CD112R, MGC2463" ENSG00000213413 "PVR related immunoglobulin domain containing" Q6DKI7 7 100218241-100221490 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 10.7;lymphoid tissue: 38.1" "Cell type enhanced" "Detected in some" "B-cells: 3.4;granulocytes: 2.5;Horizontal cells: 3.3;NK-cells: 4.1;Plasma cells: 1.9;T-cells: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 33 "gdT-cell: 233.3;MAIT T-cell: 277.1;memory B-cell: 139.3;memory CD4 T-cell: 153.0;memory CD8 T-cell: 231.4;naive B-cell: 124.3;naive CD4 T-cell: 169.5;naive CD8 T-cell: 167.1;NK-cell: 263.0;T-reg: 136.0" "Group enriched" "Detected in all" 39 "B-cells: 139.3;NK-cells: 263.0;T-cells: 277.1" "Group enriched" "Detected in some" 28 "Daudi: 96.5;JURKAT: 55.9;MOLT-4: 107.2;U-698: 32.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA047497 Uncertain Approved "Nucleoli,Endoplasmic reticulum" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "Nucleoli, Endoplasmic reticulum" "HPA047497: AB_2680069" "unprognostic (1.63e-2)" "unprognostic (1.28e-2)" "unprognostic (2.21e-3)" "unprognostic (5.13e-2)" "unprognostic (9.89e-2)" "unprognostic (1.53e-3)" "unprognostic (1.35e-3)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.81e-1)" "unprognostic (5.58e-2)" "unprognostic (5.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.17e-1)" "unprognostic (2.43e-2)" "unprognostic (4.12e-1)" "unprognostic (2.71e-3)" 0.7 0.3 0.7 6.4 3.2 1.7 0.3 3.7 3.1 0.3 0.0 1.0 0.8 0.4 0.0 0.5 0.4 0.8 0.2 0.5 1.2 0.5 1.3 1.2 18.8 4.7 1.9 0.8 0.7 0.0 0.2 0.1 2.4 0.4 0.1 0.6 1.1 0.0 2.5 0.3 10.7 0.0 0.1 24.2 1.9 0.8 2.8 38.1 0.7 0.0 4.5 1.0 0.5 6.7 0.3 2.0 1.0 0.3 0.0 0.0 2.6 0.2 0.0 0.0 0.0 0.1 0.2 96.5 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.0 55.9 0.2 0.4 0.0 0.2 107.2 0.0 0.3 0.1 0.2 0.4 0.1 1.2 0.0 0.2 2.1 0.5 0.0 0.1 0.0 0.7 0.1 0.2 0.2 0.1 0.8 0.1 0.0 0.2 0.1 32.0 0.0 0.1 0.0 0.9 0.7 0.3 233.3 1.1 277.1 139.3 153.0 231.4 0.7 124.3 169.5 167.1 5.7 263.0 1.0 1.1 136.0 104.4 0.7 3.2 3.7 3.1 0.5 1.2 4.7 1.9 2.4 0.1 2.8 6.7 0.0 0.0 0.6 0.3 3.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.2 2.5 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 PZP CPAMD6 ENSG00000126838 "PZP alpha-2-macroglobulin like" P20742 12 9148840-9208395 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "liver: 81.6" "Group enriched" "Detected in some" 4 "Early spermatids: 26.2;Hepatocytes: 26.4;Late spermatids: 11.0;Oligodendrocyte precursor cells: 8.5;Respiratory ciliated cells: 24.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.0;liver cancer: 0.9" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "gdT-cell: 1.1;MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Group enriched" "Detected in some" 9 "HeLa: 5.7;SiHa: 2.5" "HPA041403, HPA041471" Supported "Secreted to blood" NA NA 15000000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "HPA041403: AB_10804003, HPA041471: AB_10795636" "unprognostic (8.48e-3)" "unprognostic (1.12e-2)" "unprognostic (2.28e-1)" "unprognostic (8.54e-4)" "unprognostic (4.79e-1)" "unprognostic (3.50e-2)" "unprognostic (2.04e-4)" "unprognostic (4.57e-2)" "unprognostic (2.18e-1)" "unprognostic (2.55e-2)" "unprognostic (9.71e-2)" "unprognostic (4.95e-2)" "unprognostic (1.08e-5)" "unprognostic (5.49e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (9.81e-3)" 0.2 0.0 0.4 0.0 1.3 0.1 0.2 0.9 0.6 0.2 0.6 0.0 0.0 1.3 0.1 0.0 1.2 0.0 0.7 0.9 0.6 0.2 81.6 0.8 0.0 2.3 6.7 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.6 0.0 2.3 1.0 0.0 0.1 0.1 0.0 0.1 0.1 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.1 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.9 0.6 0.9 0.6 2.3 6.7 3.9 0.9 1.0 1.3 1.9 3.2 0.0 3.3 0.1 0.0 0.0 0.6 0.0 0.8 0.0 0.0 1.6 0.0 2.7 0.0 2.1 0.0 1.4 0.0 0.0 0.0 26.2 4.7 0.2 2.1 0.0 0.0 3.7 0.0 0.0 0.1 0.0 1.7 0.0 0.0 1.8 26.4 0.0 0.0 2.9 0.0 0.0 0.3 0.0 11.0 0.0 0.2 0.0 2.8 0.0 0.0 2.1 8.5 4.6 0.0 0.0 0.4 0.7 0.0 0.0 0.0 24.7 0.6 0.0 0.3 0.4 0.5 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 RAB6B ENSG00000154917 "RAB6B, member RAS oncogene family" Q9NRW1 3 133824235-133895882 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 138.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 30.8;Erythroid cells: 79.2;Excitatory neurons: 60.5;Horizontal cells: 67.3;Inhibitory neurons: 54.1" "Cancer enhanced" "Detected in all" "glioma: 18.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 4 "MAIT T-cell: 7.3" "Lineage enriched" "Detected in single" 47 "T-cells: 7.3" "Cell line enriched" "Detected in many" 4 "HEL: 226.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017713, HPA059131" Uncertain Approved "Golgi apparatus" NA NA 2200000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "Golgi apparatus" "CAB017713: , HPA059131: AB_2683916" "unprognostic (2.87e-2)" "unprognostic (6.33e-3)" "unprognostic (4.53e-3)" "prognostic unfavorable (9.01e-4)" "unprognostic (3.61e-1)" "unprognostic (5.14e-2)" "unprognostic (1.73e-4)" "unprognostic (3.12e-2)" "unprognostic (4.26e-2)" "unprognostic (4.80e-2)" "prognostic favorable (3.97e-6)" "unprognostic (9.00e-2)" "unprognostic (1.26e-1)" "unprognostic (1.49e-2)" "unprognostic (8.10e-2)" "unprognostic (9.53e-2)" "unprognostic (6.05e-3)" 6.8 11.1 45.7 2.8 72.6 12.0 4.4 0.4 138.0 2.9 0.0 6.8 2.4 3.0 2.1 4.2 16.2 3.2 20.8 71.8 31.3 7.1 0.9 3.1 3.3 74.6 43.1 2.1 4.4 24.9 12.0 1.7 55.7 2.7 2.1 29.4 10.1 5.9 2.7 1.5 2.9 8.4 3.7 5.9 5.5 4.0 21.5 1.4 5.2 2.8 2.0 1.6 2.2 63.1 0.1 3.0 5.8 14.9 10.1 10.3 0.5 3.0 6.3 7.2 0.8 1.6 1.5 0.2 6.3 2.4 21.2 0.4 13.8 0.4 3.6 0.2 8.6 226.6 3.5 0.5 1.2 1.4 8.5 3.1 2.9 1.1 0.2 0.1 2.9 8.3 53.4 0.6 1.1 5.5 0.7 21.3 18.0 10.8 2.2 0.2 0.4 2.3 4.0 1.3 47.2 10.1 4.4 4.2 26.7 22.5 16.8 9.7 3.7 6.5 15.5 3.2 5.4 5.6 1.5 0.5 0.7 0.5 5.6 0.0 0.0 0.0 0.6 0.0 7.3 0.1 0.1 1.7 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.8 45.7 72.6 0.4 138.0 71.8 31.3 74.6 43.1 55.7 3.7 21.5 63.1 2.0 0.0 0.0 25.8 0.2 1.3 2.2 0.5 0.6 10.5 2.0 2.3 30.8 1.5 2.8 1.8 2.1 0.3 0.6 2.2 3.9 3.6 0.1 2.3 0.9 3.5 0.0 79.2 60.5 1.3 0.7 3.7 2.0 1.3 0.0 12.4 7.9 0.1 0.2 67.3 54.1 0.2 0.0 0.6 1.1 0.2 1.8 0.4 1.8 16.9 0.1 10.2 0.0 17.1 9.6 2.5 1.1 6.8 0.1 2.0 0.0 1.5 9.3 21.3 0.0 4.1 13.8 0.9 12.7 0.8 1.4 0.3 1.1 2.2 0.0 0.6 RAD54B RDH54 ENSG00000197275 "RAD54 homolog B" Q9Y620 8 94371960-94475115 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 7.0" "Cell type enhanced" "Detected in many" "Astrocytes: 29.0;Cone photoreceptor cells: 27.1;Excitatory neurons: 45.8;Inhibitory neurons: 19.0;Oligodendrocyte precursor cells: 39.7;Oligodendrocytes: 25.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 1.9" "Group enriched" "Detected in many" 10 "B-cells: 1.0;T-cells: 1.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA007087 Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA007087: AB_1856040" "unprognostic (1.68e-3)" "unprognostic (2.51e-1)" "unprognostic (2.31e-2)" "unprognostic (8.84e-3)" "unprognostic (4.15e-2)" "unprognostic (1.44e-1)" "unprognostic (5.56e-8)" "unprognostic (1.96e-2)" "unprognostic (1.77e-2)" "unprognostic (5.39e-2)" "unprognostic (2.30e-2)" "unprognostic (2.64e-1)" "unprognostic (2.04e-12)" "unprognostic (5.86e-2)" "unprognostic (5.23e-1)" "unprognostic (9.08e-2)" "unprognostic (6.68e-5)" 0.6 0.7 1.3 1.7 2.0 2.0 1.9 2.1 2.1 2.4 1.7 1.5 1.4 1.1 2.1 1.4 5.0 0.7 0.6 1.2 1.6 0.8 1.4 0.7 2.7 1.6 1.9 1.0 0.8 0.7 1.2 1.4 1.6 1.6 2.1 7.0 0.8 2.0 0.3 1.8 1.2 1.1 1.3 0.9 1.5 3.6 1.7 4.2 1.1 0.3 3.0 1.2 0.9 1.6 20.5 15.7 20.9 11.2 1.6 2.5 11.0 16.2 8.9 22.7 23.1 8.1 14.8 14.5 25.3 4.3 11.7 12.7 18.7 7.7 24.6 17.5 11.9 23.2 8.1 7.7 1.5 8.4 8.5 0.8 1.8 11.7 14.9 4.5 8.3 14.7 16.6 8.9 24.6 10.6 28.5 5.7 13.5 23.4 14.4 7.1 21.3 8.7 8.9 9.8 12.0 8.0 11.6 2.8 9.7 17.9 14.9 6.1 5.8 14.8 7.6 16.7 18.1 4.5 12.2 7.8 7.7 15.9 15.4 0.0 0.0 0.0 0.5 0.0 1.9 0.7 0.9 0.4 0.0 1.0 0.8 1.1 0.0 0.1 0.1 0.0 0.6 0.3 1.3 2.0 2.1 2.1 1.2 1.6 1.6 1.9 1.6 1.3 1.7 1.6 0.5 0.0 0.5 29.0 1.7 0.4 0.9 1.7 1.2 9.1 1.1 1.1 1.8 1.5 0.6 3.7 27.1 2.0 0.5 0.7 1.9 0.8 0.3 11.5 1.6 1.3 1.2 3.8 45.8 0.8 3.2 1.3 3.1 5.6 0.0 3.3 3.3 2.0 1.5 0.0 19.0 1.1 0.0 0.6 0.6 0.4 3.4 0.9 0.0 9.4 0.6 4.4 1.0 39.7 25.9 0.7 0.4 2.2 3.9 0.4 0.2 1.4 3.3 17.5 0.0 1.0 1.7 9.4 13.1 3.7 0.6 0.3 2.6 3.0 2.3 0.7 RARG "NR1B3, RARC" ENSG00000172819 "Retinoic acid receptor gamma" P13631 12 53210567-53232980 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 141.6;skin 1: 121.4" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 42.7;Squamous epithelial cells: 69.9;Suprabasal keratinocytes: 55.8;Urothelial cells: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 18.8" "Group enriched" "Detected in all" 4 "dendritic cells: 6.7;T-cells: 18.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 101.0;MCF7: 110.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053883 Supported Supported Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "HPA053883: AB_2682292" "unprognostic (7.29e-2)" "unprognostic (1.95e-2)" "unprognostic (6.11e-2)" "prognostic unfavorable (3.68e-6)" "unprognostic (2.53e-1)" "unprognostic (5.43e-2)" "unprognostic (2.28e-1)" "unprognostic (1.08e-2)" "unprognostic (3.54e-3)" "unprognostic (7.21e-3)" "unprognostic (3.78e-3)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.08e-6)" "unprognostic (5.41e-3)" "unprognostic (1.98e-2)" "unprognostic (5.94e-3)" "unprognostic (7.41e-2)" 17.4 16.2 10.2 5.7 9.7 3.7 19.4 13.0 10.9 55.0 10.8 22.7 2.5 23.3 6.0 141.6 27.2 15.7 17.3 9.7 9.5 12.5 3.2 15.2 5.9 10.3 10.0 20.5 8.5 7.2 8.7 9.5 9.3 26.9 7.8 3.9 30.6 16.2 6.9 121.4 10.4 13.0 10.0 10.2 14.5 4.8 9.5 5.1 22.6 10.6 22.5 26.2 69.3 10.0 22.8 24.7 5.5 50.9 55.0 46.8 1.7 23.2 50.0 29.7 23.3 8.3 101.0 0.5 12.5 93.6 16.2 74.3 18.4 44.6 7.4 5.7 9.4 3.3 18.6 7.4 23.2 0.0 9.1 34.8 63.9 28.5 6.4 74.7 12.7 4.6 0.8 9.8 11.9 110.3 1.3 1.1 16.3 30.4 42.7 7.3 1.9 18.1 8.9 37.1 4.4 22.9 47.0 50.6 32.1 6.8 43.9 1.4 13.8 35.4 16.5 23.6 1.5 4.2 2.6 1.8 43.4 3.8 51.3 1.8 3.1 0.9 7.4 0.9 18.8 2.0 6.5 5.4 6.7 0.6 5.2 4.7 0.0 2.3 0.0 0.6 1.8 4.0 10.2 9.7 13.0 10.9 9.7 9.5 10.3 10.0 9.3 10.0 9.5 10.0 10.7 3.2 7.0 21.2 2.5 34.2 24.1 21.6 42.7 0.5 18.0 15.6 3.7 11.5 11.1 3.7 2.1 7.5 6.2 3.2 0.0 10.5 0.1 3.6 14.4 11.0 1.8 0.8 2.5 5.1 1.2 19.6 13.7 3.4 1.3 0.3 20.3 0.1 2.7 0.0 3.0 2.1 12.2 4.1 13.3 0.5 5.3 4.9 8.8 6.5 1.8 3.6 5.2 7.1 0.7 14.3 4.4 5.3 3.0 19.2 0.2 0.5 3.9 5.2 6.6 9.5 22.0 0.8 5.6 69.9 55.8 1.8 7.2 0.4 5.5 45.7 RBFOX2 "FOX-2, HNRBP2, HRNBP2, RBM9" ENSG00000100320 "RNA binding fox-1 homolog 2" O43251 22 35738736-36028824 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 378.7;Inhibitory neurons: 418.1;Oligodendrocyte precursor cells: 237.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006240, HPA006455, HPA075862" Approved Supported Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA006240: AB_1079750, HPA006455: , HPA075862: " "unprognostic (3.17e-1)" "unprognostic (4.80e-2)" "unprognostic (9.30e-2)" "unprognostic (3.21e-3)" "unprognostic (3.42e-1)" "unprognostic (2.74e-2)" "unprognostic (2.28e-1)" "unprognostic (2.14e-1)" "unprognostic (1.42e-2)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "unprognostic (1.43e-1)" "unprognostic (1.02e-1)" "unprognostic (5.78e-3)" "unprognostic (2.13e-2)" "unprognostic (1.53e-2)" "unprognostic (6.08e-2)" 28.4 21.9 16.4 12.3 21.7 0.2 27.0 38.8 41.9 49.0 0.0 59.2 11.7 67.5 21.6 34.7 40.4 25.2 37.0 24.3 11.7 18.7 25.8 25.6 5.9 6.9 3.3 63.0 18.7 26.2 27.5 32.6 5.2 31.4 21.4 15.5 23.7 29.7 77.1 23.7 23.4 52.7 1.1 9.9 28.9 25.7 7.3 10.0 28.5 44.3 8.5 43.1 36.5 17.8 46.2 27.4 110.3 64.8 62.4 111.2 36.8 89.9 123.6 67.1 72.0 60.1 21.3 28.2 41.2 108.9 41.9 46.5 40.2 41.7 95.9 19.2 36.6 16.7 26.5 22.3 18.8 4.4 11.6 77.3 53.1 59.6 73.3 64.8 86.8 7.0 13.7 3.9 80.3 14.0 4.5 2.7 40.5 19.7 42.0 7.6 92.0 7.9 50.1 47.5 34.1 106.0 110.3 15.5 31.0 57.0 16.9 6.8 105.5 96.4 54.4 54.7 41.2 2.8 9.4 38.3 42.7 6.8 51.1 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.4 21.7 38.8 41.9 24.3 11.7 6.9 3.3 5.2 1.1 7.3 17.8 34.3 67.3 38.5 189.4 1.0 37.1 50.6 57.3 57.5 20.8 31.4 34.5 62.2 31.5 40.4 27.6 0.0 69.9 0.9 17.9 35.2 53.0 24.8 17.8 60.8 45.9 57.0 0.8 378.7 32.1 89.1 67.8 15.8 25.0 2.5 30.6 40.7 26.0 10.5 117.8 418.1 24.7 18.3 1.3 14.7 9.4 79.6 1.8 16.0 183.6 2.6 16.9 0.0 237.2 130.0 77.4 10.7 93.3 1.4 57.4 22.5 18.7 20.9 6.7 52.6 74.5 93.3 42.2 25.6 31.0 33.8 29.0 2.5 48.2 23.8 61.1 RBM24 "dJ259A10.1, FLJ30829, RNPC6" ENSG00000112183 "RNA binding motif protein 24" Q9BX46 6 17281361-17293871 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 142.1;skeletal muscle: 313.0;tongue: 105.7" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 193.2" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 58.7;RH-30: 59.7;T-47d: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA066927, HPA067231" Enhanced Enhanced Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm Cytosol "HPA066927: AB_2685750, HPA067231: AB_2685808" "unprognostic (9.05e-3)" "unprognostic (2.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.67e-3)" "unprognostic (1.53e-1)" "unprognostic (4.54e-4)" "unprognostic (3.34e-2)" "unprognostic (1.33e-2)" "unprognostic (2.97e-3)" "unprognostic (3.38e-2)" "unprognostic (2.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.45e-1)" "unprognostic (1.16e-2)" "unprognostic (3.06e-2)" "unprognostic (1.08e-2)" "unprognostic (2.33e-4)" 5.4 0.5 3.7 1.7 4.1 0.1 3.7 0.1 5.7 13.9 2.5 9.7 1.6 31.2 16.8 7.4 24.0 2.6 142.1 4.5 4.9 0.9 1.1 1.3 0.5 1.6 1.9 2.1 0.2 2.1 5.5 0.6 0.7 9.9 7.4 0.4 4.1 5.8 313.0 1.4 3.6 29.3 0.6 1.2 2.1 4.2 3.0 0.8 2.1 105.7 0.3 8.8 3.6 2.2 1.5 9.3 12.0 0.0 0.0 0.0 0.0 18.7 6.8 12.4 13.0 0.0 1.1 0.0 5.7 13.4 19.5 0.0 11.5 0.4 22.3 0.0 0.4 0.0 1.0 6.4 0.5 0.0 1.1 6.4 0.0 2.4 0.5 15.8 1.6 0.0 0.0 0.0 58.7 2.8 0.0 0.2 4.1 0.0 1.4 0.1 59.7 0.0 0.0 0.0 7.8 0.9 0.2 0.0 0.2 9.3 28.2 0.4 0.0 4.2 10.0 0.0 16.2 0.0 0.0 0.1 0.3 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 4.1 0.1 5.7 4.5 4.9 1.6 1.9 0.7 0.6 3.0 2.2 1.1 0.0 0.0 0.0 0.0 1.1 0.2 1.1 0.0 2.3 3.2 0.8 193.2 0.0 1.8 0.0 0.0 0.1 0.1 4.3 0.0 0.0 0.6 33.5 13.6 1.5 4.8 0.0 11.6 0.0 13.4 6.4 0.0 9.9 1.3 0.5 0.4 0.0 0.3 1.7 6.6 4.5 0.0 0.0 0.7 1.9 0.0 0.3 1.8 1.9 0.0 0.7 0.0 0.5 0.4 0.3 2.2 0.7 0.0 0.3 0.0 0.6 21.9 0.0 6.6 23.9 19.7 0.4 7.3 0.2 1.0 0.8 0.5 0.0 3.0 0.1 RBMS1 "C2orf12, DKFZp564H0764, HCC-4, MSSP-1, MSSP-2, MSSP-3, SCR2, YC1" ENSG00000153250 "RNA binding motif single stranded interacting protein 1" P29558 2 160272151-160493807 "Predicted intracellular proteins" "DNA replication" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 398.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047943, HPA061791" Enhanced Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Cytosol "HPA047943: AB_2797235, HPA061791: AB_2684611" "unprognostic (2.81e-1)" "unprognostic (2.44e-2)" "unprognostic (3.78e-2)" "unprognostic (1.38e-3)" "unprognostic (2.50e-1)" "unprognostic (6.81e-3)" "prognostic unfavorable (4.45e-4)" "unprognostic (6.17e-2)" "unprognostic (4.85e-2)" "unprognostic (1.14e-1)" "unprognostic (7.16e-3)" "unprognostic (6.70e-2)" "prognostic unfavorable (1.33e-7)" "unprognostic (1.84e-3)" "unprognostic (1.50e-1)" "unprognostic (2.36e-1)" "unprognostic (2.32e-1)" 58.2 22.6 8.7 43.3 13.3 35.8 34.5 9.7 11.9 36.6 17.2 38.9 12.8 51.7 12.6 28.9 31.6 34.1 41.0 7.2 10.7 36.5 22.3 47.7 28.3 13.8 12.3 44.1 10.2 50.4 16.0 83.8 15.0 24.0 15.8 6.8 19.2 28.6 16.4 29.4 20.5 56.9 10.9 40.7 20.1 10.4 13.4 26.1 23.0 23.8 22.0 57.0 31.6 10.2 50.5 18.2 63.9 8.4 90.2 155.6 77.1 62.7 89.1 42.4 43.8 50.9 36.9 0.4 76.3 106.6 20.0 30.0 31.1 46.0 69.2 40.9 23.2 18.9 44.2 41.0 82.3 30.8 1.1 187.9 35.6 73.7 32.8 56.7 67.5 15.1 1.2 23.0 103.2 39.4 28.8 31.2 39.3 8.3 40.1 21.6 55.7 25.5 64.9 61.1 8.3 21.7 39.1 22.9 60.2 78.8 11.7 47.9 81.7 75.3 47.7 69.7 57.5 12.2 0.7 21.2 60.7 46.2 49.2 4.0 20.5 26.2 8.6 12.0 29.5 0.9 14.9 13.3 13.7 1.9 24.1 10.9 44.4 13.7 6.9 7.6 2.7 11.0 8.7 13.3 9.7 11.9 7.2 10.7 13.8 12.3 15.0 10.9 13.4 10.2 102.8 112.2 97.8 12.1 37.3 91.1 110.0 59.1 55.2 3.0 44.7 43.2 62.3 18.6 48.1 69.9 0.0 99.1 83.9 0.4 25.4 24.5 59.2 39.8 141.4 126.0 0.0 38.3 132.7 47.3 112.6 161.8 36.7 42.0 20.3 40.8 162.8 29.1 126.3 1.7 136.1 0.5 22.4 123.4 80.2 15.5 88.9 103.8 55.2 153.6 81.2 20.8 93.7 116.1 19.7 96.4 1.3 98.9 23.3 107.0 0.3 36.4 54.1 1.4 78.9 113.6 185.9 6.7 14.5 47.3 82.5 398.3 113.0 53.4 0.5 175.5 RGPD8 "RanBP2alpha, RANBP2L1" ENSG00000169629 "RANBP2 like and GRIP domain containing 8" O14715 2 112368369-112434488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 15.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Early spermatids: 24.3;Excitatory neurons: 9.8;Late spermatids: 10.1;Microglial cells: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 16.2;hTEC/SVTERT24-B: 13.4" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 36: HEL - Hemostasis" "Cluster 59: Non-specific - Transcription" "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "unprognostic (3.62e-1)" "unprognostic (7.61e-2)" "unprognostic (2.65e-1)" "unprognostic (7.15e-3)" "unprognostic (3.17e-3)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (2.57e-1)" "unprognostic (9.18e-3)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.70e-1)" "unprognostic (1.05e-2)" 4.3 1.8 2.7 2.8 3.6 10.6 4.5 8.6 7.6 2.8 4.5 2.1 1.6 3.1 5.4 1.4 2.2 2.9 1.8 3.7 3.5 2.4 5.1 3.3 2.4 2.2 2.4 3.2 3.0 2.2 2.6 3.3 1.9 2.6 2.3 7.9 2.5 2.9 1.7 3.8 2.1 2.6 1.1 3.0 1.7 15.6 2.6 3.2 2.4 2.2 3.0 2.6 1.6 5.5 6.1 2.6 4.3 2.6 1.6 3.6 0.1 2.4 1.9 2.3 1.5 5.3 0.4 0.0 1.7 4.0 2.0 2.9 12.3 1.7 2.4 8.7 4.0 16.2 4.5 4.1 2.2 0.1 0.2 0.6 2.2 13.4 3.4 5.7 1.9 2.8 8.4 0.4 3.6 2.5 8.7 2.1 3.0 0.9 3.7 0.0 0.5 0.1 1.3 2.5 2.7 0.5 8.1 0.1 1.7 3.0 1.2 6.8 8.9 1.3 1.8 6.9 4.4 0.0 0.0 0.0 0.5 2.9 0.3 1.3 0.4 0.4 1.0 0.3 1.4 0.5 0.7 0.9 0.4 0.6 1.0 0.6 0.3 0.5 0.8 0.7 0.4 0.3 2.7 3.6 8.6 7.6 3.7 3.5 2.2 2.4 1.9 1.1 2.6 5.5 1.0 9.6 3.6 1.6 2.8 0.4 0.4 0.2 5.2 0.8 0.3 0.3 8.0 1.5 1.9 0.0 2.1 0.2 0.7 0.1 0.0 0.5 24.3 0.6 0.5 1.5 0.0 2.5 9.8 1.1 0.1 2.2 2.6 0.6 5.1 0.6 0.7 0.2 0.4 0.0 7.0 0.4 0.0 0.6 0.8 10.1 0.3 2.0 0.0 9.4 2.3 0.4 0.0 7.5 5.2 0.9 0.0 0.0 2.4 0.0 0.0 0.1 6.7 0.7 0.0 0.9 0.9 6.8 2.7 2.7 0.0 0.4 3.1 0.0 0.0 0.3 RHOF "ARHF, FLJ20247, RIF" ENSG00000139725 "Ras homolog family member F, filopodia associated" Q9HBH0 12 121777754-121803403 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 273.9;Langerhans cells: 224.9;monocytes: 241.2;Pancreatic endocrine cells: 191.7;Paneth cells: 279.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 129.0;HDLM-2: 177.1;PC-3: 147.3;RPTEC TERT1: 127.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045912, HPA076019" Enhanced Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA045912: , HPA076019: AB_2732299" "unprognostic (1.26e-1)" "unprognostic (8.73e-2)" "unprognostic (2.05e-1)" "unprognostic (3.40e-2)" "unprognostic (1.90e-1)" "unprognostic (4.26e-5)" "unprognostic (1.38e-3)" "unprognostic (2.37e-4)" "unprognostic (1.34e-1)" "unprognostic (5.51e-2)" "unprognostic (1.10e-4)" "unprognostic (1.10e-1)" "unprognostic (5.01e-3)" "unprognostic (1.30e-1)" "unprognostic (2.02e-2)" "unprognostic (7.51e-4)" "unprognostic (1.14e-1)" 6.5 13.3 11.5 26.6 9.9 47.4 5.5 21.6 12.0 14.3 10.6 24.3 31.8 13.2 21.8 11.7 10.0 9.8 15.0 10.4 11.0 16.2 3.9 20.6 41.0 13.0 12.2 8.9 6.1 7.7 5.1 5.7 13.4 9.2 19.3 9.9 11.5 9.8 11.8 9.2 32.3 11.5 8.7 33.3 28.2 9.0 10.6 25.6 14.6 2.8 31.4 9.1 7.3 11.7 58.3 69.2 12.4 15.3 4.4 6.4 5.6 5.3 5.2 2.5 4.4 28.8 129.0 6.3 42.6 6.0 1.4 8.6 23.2 33.7 2.2 177.1 8.0 37.9 47.5 27.7 10.1 38.6 25.8 9.0 7.5 5.4 2.9 23.8 17.6 44.7 5.6 9.9 1.4 41.7 50.7 56.7 10.4 13.6 147.3 26.5 0.7 10.8 127.9 4.9 9.9 9.4 38.5 4.5 2.6 5.6 19.9 15.0 21.4 4.0 40.1 12.5 1.5 12.3 7.6 20.0 5.0 42.9 2.6 23.8 10.9 41.5 97.0 36.5 92.7 55.5 77.2 82.5 31.0 45.2 59.5 73.2 24.4 61.4 69.8 74.3 90.2 43.3 11.5 9.9 21.6 12.0 10.4 11.0 13.0 12.2 13.4 8.7 10.6 11.7 3.1 38.5 10.7 1.0 54.1 8.7 1.9 5.5 3.4 8.1 9.3 3.8 1.5 15.7 11.3 23.9 0.0 2.7 111.8 273.9 41.1 34.0 20.2 16.5 5.6 3.5 6.7 12.2 5.3 55.3 3.9 5.3 50.4 37.1 20.8 13.1 10.0 4.0 14.4 0.0 3.9 28.6 2.0 10.9 224.9 53.8 4.1 40.3 21.4 3.7 241.2 4.7 103.0 1.0 1.2 191.7 279.6 2.2 39.4 3.8 121.6 15.1 13.5 9.7 6.6 2.6 4.5 17.7 2.9 2.5 13.2 5.5 99.2 23.4 17.3 44.3 RHOU "ARHU, CDC42L1, DJ646B12.2, fJ646B12.2, FLJ10616, hG28K, WRCH-1, WRCH1" ENSG00000116574 "Ras homolog family member U" Q7L0Q8 1 228735479-228746664 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 119.2;Endometrial stromal cells: 100.4;Extravillous trophoblasts: 91.5;Oligodendrocytes: 139.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 99.2;MOLT-4: 46.5;RT4: 43.3;THP-1: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049592 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 28: BEWO - Transcription regulation" "Cluster 44: Endometrium - Transcription" "HPA049592: AB_2680827" "unprognostic (7.90e-2)" "unprognostic (1.18e-2)" "unprognostic (1.76e-2)" "unprognostic (8.26e-3)" "unprognostic (3.26e-2)" "unprognostic (2.57e-1)" "unprognostic (3.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.47e-2)" "unprognostic (2.00e-1)" "unprognostic (1.53e-1)" "unprognostic (6.21e-2)" "prognostic favorable (3.56e-5)" "unprognostic (4.20e-1)" "unprognostic (1.69e-1)" "unprognostic (1.52e-1)" "unprognostic (1.87e-2)" 29.2 11.1 21.9 5.6 34.2 8.4 16.5 25.9 39.8 17.0 14.6 15.2 23.6 13.8 5.7 6.1 18.9 16.8 12.2 21.8 24.9 11.4 26.0 13.8 3.8 28.6 31.3 25.6 18.6 13.8 7.3 17.5 27.1 17.8 9.9 2.3 18.5 10.4 37.3 6.2 23.9 8.5 25.4 15.4 22.5 9.5 31.9 4.7 13.7 5.0 1.1 18.3 8.9 41.5 1.0 2.5 7.9 0.6 1.8 0.9 99.2 0.5 0.9 0.6 0.4 11.0 14.8 0.0 5.8 1.3 0.5 0.6 2.9 0.0 0.5 16.0 5.6 0.1 0.7 3.4 11.0 8.1 0.9 0.5 0.8 0.2 0.5 0.1 0.2 4.0 0.0 0.0 0.5 2.5 46.5 8.5 2.5 13.5 0.9 0.2 2.5 1.3 0.4 43.3 2.9 8.7 0.9 6.7 0.0 16.9 0.0 29.9 0.7 0.1 1.2 0.0 0.1 2.3 10.6 0.0 0.0 20.5 5.2 0.0 0.3 0.4 0.4 0.5 0.8 0.0 0.3 0.6 0.4 0.0 0.0 0.2 0.0 0.1 0.2 0.4 0.0 0.1 21.9 34.2 25.9 39.8 21.8 24.9 28.6 31.3 27.1 25.4 31.9 41.5 76.4 16.0 16.4 16.6 0.7 4.6 3.6 0.5 0.0 4.5 27.4 18.9 77.3 38.6 15.6 1.8 0.0 25.9 5.1 82.1 0.0 4.7 0.7 119.2 100.4 28.9 3.0 3.2 13.6 8.9 91.5 28.9 20.4 83.7 0.0 56.8 30.7 40.8 21.9 8.4 6.9 10.3 4.1 28.3 38.6 3.1 1.8 29.9 16.0 5.6 15.1 5.5 1.0 24.6 139.5 5.1 35.7 1.2 1.9 23.0 64.3 1.2 21.0 0.9 0.0 21.5 10.2 1.5 2.8 0.3 3.3 33.9 5.9 1.2 9.6 18.6 RIMKLA "FAM80A, MGC47816, NAAGS-II, RP11-157D18.1" ENSG00000177181 "Ribosomal modification protein rimK like family member A" Q8IXN7 1 42380792-42424232 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 15.0;retina: 11.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 25.9;Cone photoreceptor cells: 43.8;Distal enterocytes: 46.3;Excitatory neurons: 39.1;Horizontal cells: 35.3;Inhibitory neurons: 35.9;Rod photoreceptor cells: 24.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.4;JURKAT: 5.8;Karpas-707: 8.3;SCLC-21H: 9.9;U-266/70: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027826 Uncertain Uncertain "Nucleoli fibrillar center" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoli fibrillar center" "HPA027826: AB_10603992" "unprognostic (4.04e-2)" "unprognostic (1.61e-1)" "unprognostic (3.68e-3)" "unprognostic (9.84e-2)" "unprognostic (2.49e-2)" "unprognostic (1.06e-1)" "unprognostic (2.63e-3)" "prognostic favorable (1.43e-4)" "unprognostic (8.89e-2)" "unprognostic (3.76e-1)" "unprognostic (9.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.22e-3)" "unprognostic (3.99e-2)" "unprognostic (7.07e-2)" "unprognostic (1.63e-2)" "unprognostic (3.44e-1)" 0.2 0.2 2.9 0.4 3.6 0.0 0.2 3.7 15.0 0.1 0.0 3.0 0.3 0.1 0.0 0.1 0.2 0.5 3.2 4.5 2.3 0.8 0.1 1.9 0.1 5.7 2.2 0.0 1.0 2.2 1.2 0.2 6.2 0.5 3.2 11.2 0.5 0.2 0.7 0.2 0.4 0.6 1.2 0.2 1.0 0.7 6.2 0.0 0.6 1.0 0.0 0.4 0.2 6.3 0.0 0.7 0.1 6.4 0.1 0.0 1.3 0.0 0.0 0.2 0.5 0.3 0.2 0.0 1.4 0.0 1.2 0.0 4.2 0.0 0.3 3.7 2.5 0.3 0.1 1.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 8.3 0.0 0.3 2.0 0.0 3.5 0.5 5.1 0.0 0.2 0.3 0.6 1.7 9.9 4.2 0.3 0.3 0.1 0.7 0.3 1.9 0.0 0.0 0.4 0.0 0.7 7.4 4.4 5.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 2.9 3.6 3.7 15.0 4.5 2.3 5.7 2.2 6.2 1.2 6.2 6.3 0.9 16.0 3.9 1.3 0.2 0.6 1.1 1.0 0.0 25.9 0.9 1.0 14.4 1.5 1.1 1.8 43.8 1.4 0.3 46.3 1.9 3.3 5.3 0.4 0.0 2.2 11.4 0.0 39.1 4.8 20.1 0.5 0.5 0.1 0.0 0.3 0.7 0.0 1.0 35.3 35.9 8.0 2.0 0.3 1.4 10.5 0.3 0.3 5.4 2.8 0.0 5.1 0.0 7.1 3.9 9.4 14.2 0.0 0.1 1.7 0.3 3.7 0.2 24.6 0.0 0.8 0.6 1.1 4.8 0.0 0.1 1.6 0.7 0.3 5.2 1.0 ROR2 "BDB, BDB1, NTRKR2" ENSG00000169071 "Receptor tyrosine kinase like orphan receptor 2" Q01974 9 91563091-91950228 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 18.4;Endometrial stromal cells: 19.3;Fibroblasts: 14.4;Inhibitory neurons: 18.6;Microglial cells: 15.9;Oligodendrocyte precursor cells: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 6 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "AF22: 24.5;HHSteC: 63.1;HSkMC: 52.2;U-266/70: 38.3;U-266/84: 27.5" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 7 "cerebellum: 7.2;spinal cord: 3.7" HPA021868 Uncertain NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA021868: AB_1856406" "unprognostic (9.38e-3)" "unprognostic (4.69e-1)" "unprognostic (2.26e-1)" "unprognostic (8.48e-3)" "unprognostic (1.23e-1)" "unprognostic (2.38e-1)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (8.03e-2)" "unprognostic (2.03e-1)" "unprognostic (5.76e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (9.86e-7)" "unprognostic (2.16e-3)" "unprognostic (9.13e-2)" "prognostic unfavorable (4.28e-8)" "unprognostic (1.25e-2)" 6.9 5.7 0.8 3.9 0.6 0.1 4.4 0.4 0.5 18.7 28.2 32.7 2.2 23.7 1.5 8.2 11.6 8.6 11.1 1.4 0.8 1.4 0.5 5.5 0.5 1.7 2.1 13.9 1.6 16.6 1.6 3.5 0.9 13.9 2.2 1.0 1.6 13.3 0.3 4.2 7.7 11.0 1.2 3.3 12.8 3.4 1.2 3.0 5.6 0.7 1.0 17.5 10.6 0.7 0.0 0.2 24.5 0.0 5.3 0.5 6.8 0.4 6.3 4.0 7.8 0.0 0.0 0.0 0.1 0.8 3.9 0.2 5.2 0.0 1.7 0.0 4.2 0.0 18.3 0.0 63.1 0.0 0.0 52.2 0.0 5.6 0.0 0.0 0.0 0.2 14.7 0.0 0.0 0.4 0.1 3.6 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 7.2 0.6 0.0 0.0 5.0 14.8 0.0 0.0 0.0 4.8 2.0 0.0 38.3 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.4 0.5 1.4 0.8 1.7 2.1 0.9 1.2 1.2 0.7 0.3 0.0 0.0 1.6 0.1 3.1 11.3 0.9 1.2 1.4 3.7 3.0 8.2 1.5 0.2 0.0 0.0 0.4 0.0 0.5 0.0 2.5 4.5 18.4 19.3 1.4 3.0 0.0 1.4 1.5 0.2 14.4 2.6 7.5 1.3 0.1 0.4 0.0 0.8 0.0 18.6 2.8 0.0 0.0 4.8 8.6 5.9 0.4 5.4 15.9 1.6 7.4 0.0 27.6 0.4 0.6 1.6 9.1 0.1 8.6 0.0 0.0 0.2 0.5 6.6 0.0 2.9 2.3 14.3 0.1 2.3 0.4 0.7 0.4 0.8 5.3 RORA "NR1F1, ROR1, ROR2, ROR3, RZRA" ENSG00000069667 "RAR related orphan receptor A" P35398 15 60488284-61229302 "Disease related genes, Human disease related genes, Metabolic proteins, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Receptor" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 82.8" "Cell type enhanced" "Detected in many" "Astrocytes: 2125.3;Excitatory neurons: 627.1;Inhibitory neurons: 1056.8;Microglial cells: 757.0;Oligodendrocyte precursor cells: 1524.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 26.7" "Cell line enhanced" "Detected in many" "Karpas-707: 73.2;U-266/70: 41.7;U-266/84: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009861, HPA074448" Approved Supported Nucleoli NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoli "CAB009861: AB_2180141, HPA074448: " "unprognostic (1.57e-1)" "unprognostic (4.76e-2)" "unprognostic (2.22e-1)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" "unprognostic (2.91e-3)" "unprognostic (4.08e-3)" "unprognostic (2.02e-2)" "unprognostic (1.13e-1)" "unprognostic (9.93e-2)" "unprognostic (1.34e-1)" "prognostic favorable (5.42e-6)" "unprognostic (6.94e-2)" "unprognostic (1.35e-1)" "unprognostic (2.55e-1)" "unprognostic (4.62e-2)" 8.2 38.0 19.9 6.2 11.7 17.5 13.6 51.1 13.1 10.5 10.2 6.9 2.6 6.0 4.7 17.3 6.8 9.1 7.2 3.7 12.6 12.6 28.7 11.2 6.2 7.8 36.0 9.9 14.0 10.1 7.6 2.9 5.9 5.7 3.5 37.8 8.5 5.5 41.4 82.8 6.3 5.4 4.5 9.3 6.2 13.9 49.6 4.3 12.8 20.3 7.5 5.2 9.2 4.2 0.1 0.8 2.7 0.0 3.4 1.7 0.9 1.3 1.5 1.2 1.4 1.8 0.5 0.0 0.6 3.4 3.6 0.5 6.1 2.6 2.2 2.9 5.2 0.0 0.4 2.9 1.3 0.0 0.3 7.8 0.6 3.3 0.0 1.1 11.6 11.2 0.2 73.2 5.1 0.2 0.6 0.0 2.1 1.9 1.1 0.1 2.4 1.1 2.4 0.5 1.9 4.4 0.3 0.6 0.1 7.3 0.0 0.0 0.3 10.1 4.5 4.2 0.1 41.7 62.1 0.2 17.0 0.0 1.2 0.2 0.1 0.0 23.2 0.0 26.7 1.4 17.4 16.0 0.0 0.1 5.4 11.5 0.5 6.5 0.1 0.7 16.3 4.7 19.9 11.7 51.1 13.1 3.7 12.6 7.8 36.0 5.9 4.5 49.6 4.2 32.5 41.7 31.7 2125.3 23.4 185.2 30.1 17.0 55.2 167.5 24.7 16.1 26.3 30.0 23.4 58.8 454.5 0.7 185.3 1.4 13.7 21.4 148.8 26.9 52.9 40.8 18.5 42.5 627.1 12.3 1.9 69.4 11.7 36.1 2.5 7.9 34.2 97.2 0.8 126.2 1056.8 3.3 10.2 9.1 35.8 97.1 46.6 8.3 60.5 757.0 4.7 50.4 250.3 1524.0 114.9 8.2 0.5 87.3 88.7 24.0 0.7 44.6 16.0 160.0 39.5 57.9 32.2 1.9 3.8 73.2 423.4 4.7 237.6 11.5 2.1 61.9 RORC "NR1F3, RORG, RZRG, TOR" ENSG00000143365 "RAR related orphan receptor C" P51449 1 151806071-151831845 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Receptor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 86.2;skeletal muscle: 128.0" "Cell type enhanced" "Detected in many" "Distal tubular cells: 35.2;Hepatocytes: 47.8;Proximal enterocytes: 32.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 4.1" "Immune cell enriched" "Detected in many" 6 "MAIT T-cell: 50.3" "Lineage enriched" "Detected in many" 44 "T-cells: 50.3" "Cell line enhanced" "Detected in some" "HDLM-2: 23.8;Karpas-707: 11.5;MOLT-4: 6.3;RPMI-8226: 6.0;SK-BR-3: 5.7;T-47d: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065620 Supported "Nuclear bodies" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 44: HDLM-2 - Immune response" "Cluster 30: Mammary glandular cells - Lactation" "Nuclear bodies" "HPA065620: AB_2685521" "unprognostic (6.51e-2)" "unprognostic (7.78e-2)" "prognostic favorable (1.83e-4)" "unprognostic (9.20e-2)" "unprognostic (3.05e-4)" "unprognostic (6.29e-5)" "unprognostic (1.13e-3)" "unprognostic (8.94e-2)" "unprognostic (1.67e-1)" "unprognostic (7.88e-2)" "unprognostic (3.78e-2)" "unprognostic (2.42e-1)" "prognostic favorable (2.94e-5)" "unprognostic (2.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.80e-2)" 2.9 4.9 0.2 1.8 0.1 0.4 7.5 4.1 0.3 6.5 5.2 9.3 11.6 1.9 4.6 5.4 21.2 3.7 11.6 0.2 0.4 18.8 86.2 12.7 0.9 0.9 1.6 0.3 59.2 33.5 18.3 0.0 0.7 15.8 9.2 0.0 41.0 11.0 128.0 24.7 13.9 0.3 0.8 1.3 19.8 10.7 0.4 52.7 26.4 58.8 2.4 3.0 3.4 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.1 0.0 0.0 0.0 23.8 0.0 0.0 2.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 11.5 0.0 0.3 6.3 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.1 0.0 0.0 0.2 0.1 5.7 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 50.3 0.0 8.0 7.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 5.8 1.2 0.2 0.1 4.1 0.3 0.2 0.4 0.9 1.6 0.7 0.8 0.4 0.4 0.1 6.4 6.0 0.3 0.8 2.0 4.4 3.1 3.4 0.0 18.4 9.8 5.9 21.5 5.3 16.5 0.0 0.0 1.8 12.0 35.2 8.3 0.4 15.3 2.6 0.7 9.6 5.3 0.1 7.0 0.0 0.3 17.3 18.9 0.0 0.3 1.8 47.8 0.1 0.0 0.0 20.0 16.2 2.7 0.3 0.9 0.6 0.6 3.6 0.0 0.2 0.0 0.0 0.0 0.0 3.2 16.0 0.4 0.3 5.0 32.9 17.1 10.5 0.0 0.0 4.2 0.5 0.2 0.0 5.0 3.0 0.0 6.8 0.1 15.3 3.5 RPL7L1 dJ475N16.4 ENSG00000146223 "Ribosomal protein L7 like 1" Q6DKI1 6 42879616-42889925 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046049, HPA050478" Approved Nucleoli,Mitochondria NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoli, Mitochondria" "HPA046049: AB_10964167, HPA050478: AB_2681138" "unprognostic (1.03e-3)" "unprognostic (4.37e-2)" "unprognostic (3.37e-1)" "unprognostic (7.97e-2)" "unprognostic (7.73e-3)" "unprognostic (4.26e-2)" "prognostic unfavorable (8.53e-5)" "unprognostic (2.56e-1)" "unprognostic (2.98e-2)" "unprognostic (3.78e-2)" "unprognostic (2.08e-1)" "unprognostic (1.39e-1)" "unprognostic (2.94e-2)" "unprognostic (7.53e-2)" "unprognostic (1.06e-1)" "unprognostic (7.31e-3)" "unprognostic (4.58e-2)" 37.2 39.5 26.1 31.7 28.0 22.6 40.2 27.2 33.5 28.2 20.6 30.4 25.4 30.0 34.0 35.4 34.2 21.5 30.8 28.7 27.3 37.7 48.4 25.2 34.4 23.7 24.1 33.6 32.2 45.4 29.1 31.7 24.2 33.7 34.1 20.0 28.0 27.7 45.5 33.9 23.4 33.4 24.0 27.1 28.6 16.1 26.6 37.1 35.9 44.4 42.8 35.6 27.0 25.9 155.6 48.4 84.2 135.5 77.5 99.5 57.1 121.3 87.8 115.0 94.6 120.4 57.6 231.4 107.0 102.6 93.4 72.5 193.4 147.6 189.4 121.9 144.6 123.7 64.5 109.9 85.2 192.5 91.6 102.5 110.6 151.0 144.7 77.5 114.7 100.2 243.1 77.6 106.2 113.3 110.5 124.2 85.1 472.2 70.3 124.9 94.3 147.1 89.7 96.6 160.1 97.8 103.7 78.2 131.3 66.1 105.0 183.1 110.1 110.5 91.9 88.4 211.3 96.7 163.8 343.2 61.7 178.7 117.7 7.3 13.1 12.4 16.0 15.8 20.3 14.9 15.7 17.0 12.5 17.4 16.5 16.0 2.8 19.7 14.9 14.5 14.3 13.6 26.1 28.0 27.2 33.5 28.7 27.3 23.7 24.1 24.2 24.0 26.6 25.9 56.2 76.9 103.0 12.7 69.3 57.1 89.3 70.6 67.7 62.6 49.2 61.8 42.2 61.5 71.2 42.3 33.3 88.2 77.7 23.9 86.1 92.2 12.6 68.4 96.6 71.6 94.4 73.0 25.9 66.9 84.1 67.5 42.8 44.9 51.2 120.6 51.8 65.0 53.0 72.3 23.3 44.4 54.9 45.0 34.4 12.5 79.2 44.5 30.2 8.4 75.8 78.6 64.9 12.5 15.6 81.3 30.8 71.5 56.1 83.8 25.1 79.8 71.3 69.7 52.6 89.9 64.0 54.9 75.6 65.8 60.2 80.0 65.6 117.8 52.5 58.9 RTL6 "dJ1033E15.2, DKFZp761O17121, LDOC1L, Mar6, Mart6, SIRH3" ENSG00000188636 "Retrotransposon Gag like 6" Q6ICC9 22 44492583-44498233 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 11.1;Collecting duct cells: 12.9;Ductal cells: 8.4;Endometrial stromal cells: 12.9;Granulosa cells: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005697 Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" Cytosol "HPA005697: AB_1079244" "unprognostic (1.24e-1)" "unprognostic (1.55e-1)" "unprognostic (1.57e-2)" "unprognostic (1.65e-1)" "unprognostic (5.71e-3)" "unprognostic (1.57e-1)" "unprognostic (9.64e-3)" "unprognostic (5.40e-2)" "unprognostic (5.40e-2)" "unprognostic (2.36e-2)" "unprognostic (2.12e-1)" "unprognostic (3.57e-2)" "unprognostic (1.65e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" 10.6 12.1 21.3 7.2 19.2 3.2 8.9 15.1 18.9 11.2 8.3 12.5 8.8 15.7 12.1 8.2 16.6 11.0 15.3 20.1 17.4 9.3 3.2 9.4 6.3 18.8 20.0 19.2 11.0 17.8 8.7 5.1 17.1 9.8 9.1 9.6 7.2 13.6 15.5 3.4 8.4 16.9 18.8 7.5 9.7 11.2 21.9 14.2 10.2 18.0 4.8 10.4 5.4 17.2 13.8 18.9 23.9 31.9 18.3 14.8 6.3 17.9 21.1 24.6 19.2 6.3 8.0 0.0 10.9 33.5 18.5 11.8 16.3 17.7 15.1 6.5 31.8 0.0 35.8 0.0 22.6 1.8 8.7 16.2 16.8 22.5 17.3 33.4 22.3 21.6 7.8 0.1 16.9 24.3 44.4 4.1 14.7 15.1 20.0 12.1 12.7 0.0 21.1 15.8 25.6 30.0 29.2 14.0 18.1 11.5 14.0 19.3 23.1 19.2 25.7 25.7 14.5 8.3 3.5 0.0 28.5 4.5 29.2 0.0 0.7 0.0 1.8 0.3 1.9 0.0 1.0 1.5 0.5 0.0 0.4 1.0 0.0 0.4 0.4 0.0 0.2 1.1 21.3 19.2 15.1 18.9 20.1 17.4 18.8 20.0 17.1 18.8 21.9 17.2 5.8 0.0 5.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.1 6.5 0.0 0.0 2.5 12.9 0.0 2.9 4.8 0.0 0.0 8.4 0.0 7.4 12.9 4.0 0.0 0.0 0.0 6.5 2.7 3.5 0.0 8.1 0.0 13.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.0 0.0 0.0 1.7 0.0 0.0 5.7 7.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.2 1.8 5.2 0.0 0.0 RTN4R NOGOR ENSG00000040608 "Reticulon 4 receptor" Q9BZR6 22 20241415-20283246 "Disease related genes, Human disease related genes, Predicted membrane proteins" Receptor "Disease variant, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.3;liver: 12.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 12.1;Excitatory neurons: 14.1;Muller glia cells: 11.3" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 10 "amygdala: 8.0;basal ganglia: 20.0;cerebellum: 20.9;cerebral cortex: 24.3;hippocampal formation: 12.7" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 10.8" "Lineage enriched" "Detected in many" 9 "T-cells: 10.8" "Cell line enhanced" "Detected in many" "NB-4: 38.2;REH: 53.9;SCLC-21H: 31.3;SK-MEL-30: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012443 Supported "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA 1900000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 56: Bipolar cells - Visual perception" "Plasma membrane, Focal adhesion sites" "Actin filaments" "CAB012443: " "unprognostic (1.28e-1)" "unprognostic (1.28e-2)" "unprognostic (8.29e-2)" "unprognostic (6.58e-2)" "unprognostic (3.49e-1)" "prognostic unfavorable (7.73e-4)" "unprognostic (2.19e-1)" "unprognostic (1.56e-1)" "unprognostic (3.44e-1)" "unprognostic (8.90e-3)" "unprognostic (1.21e-2)" "unprognostic (9.89e-2)" "unprognostic (1.80e-2)" "unprognostic (1.34e-2)" "unprognostic (1.30e-1)" "unprognostic (5.02e-2)" "unprognostic (3.07e-1)" 1.6 2.6 8.0 0.5 20.0 0.6 1.0 20.9 24.3 3.6 0.0 1.6 2.2 5.1 0.0 3.5 1.9 0.1 2.7 12.7 0.0 2.1 12.8 2.2 0.4 0.5 0.0 2.4 3.7 0.4 4.9 0.4 0.3 1.5 0.1 0.6 2.0 0.4 0.6 7.9 2.1 0.2 0.0 8.5 1.8 1.9 0.4 0.8 3.5 0.2 0.2 0.5 2.8 1.8 7.9 3.8 2.3 5.5 0.0 0.0 1.2 0.8 0.0 0.6 0.3 6.0 2.2 0.4 2.5 0.1 3.7 12.8 1.4 3.2 0.0 0.2 13.4 0.1 3.2 0.9 1.3 0.3 0.4 0.0 4.1 0.0 0.3 0.0 0.0 3.7 0.4 0.3 0.0 11.0 4.1 38.2 8.7 2.3 6.7 53.9 0.0 0.4 0.5 3.3 31.3 5.0 3.7 2.7 25.9 0.5 3.1 1.1 0.0 0.5 14.2 0.1 0.2 0.1 1.0 0.9 0.4 7.8 0.1 0.0 0.0 0.0 4.6 0.0 10.8 0.0 4.0 4.6 0.2 0.1 2.4 5.1 0.0 0.8 0.0 1.2 3.0 1.7 8.0 20.0 20.9 24.3 12.7 0.0 0.5 0.0 0.3 0.0 0.4 1.8 1.4 3.2 0.0 7.5 0.2 5.1 4.0 1.6 1.8 12.1 2.9 2.4 2.2 0.0 0.6 0.0 4.2 0.2 1.9 3.0 0.0 2.9 2.0 1.2 4.8 2.0 0.0 0.4 14.1 4.3 7.6 1.6 0.0 1.6 0.0 0.4 1.1 3.0 1.3 6.7 2.6 2.6 0.0 0.0 0.7 0.5 0.3 1.7 1.8 2.8 0.7 11.3 2.1 2.5 2.4 3.4 0.4 0.0 0.1 3.9 0.6 0.0 0.0 4.9 0.0 0.2 1.0 0.1 1.2 2.0 5.5 0.0 2.5 0.1 2.1 3.5 RYR2 "ARVC2, ARVD2, VTSIP" ENSG00000198626 "Ryanodine receptor 2" Q92736 1 237042184-237833988 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Cardiomyopathy, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 132.0" "Group enriched" "Detected in many" 10 "Cardiomyocytes: 2180.6;Excitatory neurons: 1320.5;Inhibitory neurons: 790.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.7;HEK 293: 8.5;K-562: 2.3;NB-4: 2.7;NTERA-2: 3.1;U-937: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020028 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Plasma membrane, Cytosol" "HPA020028: AB_1856528" "unprognostic (5.23e-3)" "unprognostic (2.15e-2)" "unprognostic (5.02e-4)" "unprognostic (6.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (1.45e-3)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (0.00e+0)" "unprognostic (2.36e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" 0.7 0.7 9.1 0.8 15.9 0.0 0.6 8.7 24.0 1.5 0.0 2.0 0.2 0.7 0.4 2.9 0.7 1.9 132.0 10.5 0.0 0.1 0.1 1.8 0.1 0.0 0.0 2.9 8.4 0.0 1.8 1.2 0.0 2.9 0.5 6.5 0.5 1.7 0.1 0.3 0.5 0.7 0.0 1.3 1.5 1.1 0.0 0.1 4.4 0.3 0.0 1.2 0.4 13.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.9 0.3 0.0 0.0 7.7 8.5 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 2.3 0.4 0.0 0.0 0.0 2.7 3.1 0.6 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 9.1 15.9 8.7 24.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.2 0.0 0.5 17.0 0.0 0.4 0.0 0.0 0.0 74.2 0.3 0.1 2180.6 0.0 1.3 1.8 10.4 0.1 0.1 0.0 0.0 0.0 21.1 0.2 3.4 10.6 3.5 0.0 1320.5 2.9 0.1 53.6 0.0 0.5 0.0 0.5 1.1 0.0 0.1 1.7 790.6 0.0 0.0 0.0 0.2 15.3 1.2 1.3 8.8 48.7 0.0 1.3 0.0 29.7 140.6 0.4 0.0 0.0 0.1 0.0 1.0 0.2 0.7 5.3 0.0 0.5 21.6 5.8 2.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 S100A5 S100D ENSG00000196420 "S100 calcium binding protein A5" P33763 1 153537147-153541765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 3.6;thyroid gland: 5.2" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;Distal tubular cells: 3.9;Extravillous trophoblasts: 8.5;Langerhans cells: 3.1;Theca cells: 6.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 11.7" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 3.0;granulocytes: 1.4;T-cells: 4.6" "Cell line enhanced" "Detected in many" "OE19: 34.3;RPTEC TERT1: 11.9;RT4: 19.9;SCLC-21H: 17.3" "Region enriched" "Detected in many" 86 "olfactory bulb: 980.0" "Region enriched" "Detected in single" 15 "olfactory bulb: 5.6" HPA064184 Approved Nucleoplasm Yes NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "HPA064184: AB_2685206" "unprognostic (6.09e-2)" "unprognostic (2.92e-2)" "unprognostic (8.92e-2)" "unprognostic (1.63e-5)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (1.52e-3)" "unprognostic (4.11e-2)" "unprognostic (2.69e-1)" "unprognostic (7.39e-3)" "unprognostic (3.08e-2)" "unprognostic (2.20e-2)" "unprognostic (1.07e-2)" "unprognostic (9.53e-2)" "unprognostic (5.70e-2)" "unprognostic (4.68e-3)" 0.2 0.1 0.3 0.1 0.3 0.7 0.2 0.9 0.8 0.3 0.1 0.2 1.5 0.6 0.1 0.9 0.5 1.0 0.1 0.3 0.4 2.9 0.0 0.5 1.5 0.4 0.3 0.1 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.1 3.6 0.3 0.0 0.3 0.4 1.2 0.1 0.4 0.7 5.2 0.1 0.4 1.1 0.3 0.4 2.2 5.7 0.0 0.0 0.6 0.4 0.4 1.0 1.3 0.7 1.4 0.6 4.2 0.0 3.7 2.1 0.4 1.7 0.1 1.0 0.9 0.5 0.0 2.7 2.6 0.2 0.4 0.0 3.5 0.0 1.1 2.7 0.8 0.5 0.5 0.0 0.7 0.2 3.0 0.2 0.5 1.3 0.2 34.3 9.7 0.0 1.8 1.1 11.9 19.9 17.3 0.0 0.2 9.0 0.8 1.5 0.0 0.5 0.4 0.1 1.3 2.6 1.7 0.0 0.9 0.0 0.5 0.7 0.4 0.0 0.7 1.4 1.2 0.1 4.6 0.5 2.6 1.3 1.8 0.3 1.4 0.6 1.2 0.0 0.4 3.0 3.9 0.7 0.3 0.3 0.9 0.8 0.3 0.4 0.4 0.3 0.5 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.2 3.7 0.0 0.1 0.2 0.1 3.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 8.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.0 0.6 3.1 0.0 0.3 0.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.2 1.2 0.0 0.0 0.1 0.2 0.0 0.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.0 0.3 0.6 6.8 0.3 0.6 SCRIB "KIAA0147, SCRB1, Vartul" ENSG00000180900 "Scribble planar cell polarity protein" Q14160 8 143790920-143815773 "Disease related genes, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 100.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015463, CAB022081, HPA023557, HPA064312" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cell Junctions" "Nucleoplasm, Rods & Rings" "CAB015463: AB_2238926, CAB022081: , HPA023557: AB_2671238, HPA064312: AB_2685242" "unprognostic (1.24e-1)" "unprognostic (1.94e-2)" "unprognostic (7.78e-2)" "unprognostic (8.95e-2)" "unprognostic (3.77e-1)" "unprognostic (3.96e-2)" "unprognostic (1.14e-3)" "unprognostic (1.86e-2)" "unprognostic (2.46e-1)" "unprognostic (2.56e-1)" "unprognostic (8.22e-2)" "unprognostic (1.87e-1)" "unprognostic (2.16e-3)" "unprognostic (3.46e-3)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (1.83e-1)" 18.7 17.1 11.5 7.2 10.8 5.6 23.6 6.0 10.4 45.6 0.0 32.3 9.1 24.7 0.9 100.5 26.0 3.4 24.6 8.7 2.7 27.7 25.4 21.3 4.0 10.7 8.1 23.0 38.8 5.2 24.8 5.0 5.9 28.4 3.4 1.0 40.2 5.2 54.3 68.3 26.5 2.0 4.9 22.9 30.0 26.4 9.0 3.0 24.6 1.7 3.9 27.8 52.6 15.3 55.7 33.1 12.7 20.5 5.1 6.9 33.0 30.9 5.3 11.2 9.1 15.3 29.8 24.2 39.7 7.2 4.6 52.4 7.9 32.9 1.7 30.8 58.5 24.6 30.5 26.1 10.8 13.0 14.8 5.1 29.9 9.4 5.5 5.1 11.5 19.8 42.2 6.4 7.5 93.0 38.1 26.9 15.7 25.0 55.1 44.5 10.6 25.0 5.6 45.5 29.6 27.1 31.4 30.5 33.6 4.5 41.5 28.2 25.7 10.1 64.1 25.2 44.7 31.6 31.0 23.8 13.1 9.5 19.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.5 10.8 6.0 10.4 8.7 2.7 10.7 8.1 5.9 4.9 9.0 15.3 12.3 0.0 9.9 33.0 4.4 8.5 5.0 10.2 13.6 11.3 16.8 17.0 11.1 11.5 8.3 14.7 14.6 11.0 9.7 28.7 3.9 8.6 1.5 14.0 7.7 7.8 13.8 13.7 5.0 9.4 6.3 7.3 29.6 27.3 0.0 17.9 3.6 8.8 6.5 5.0 6.2 17.8 18.3 6.0 4.1 0.7 9.0 6.6 8.8 6.5 5.0 10.0 5.2 12.1 15.2 11.5 22.8 9.8 5.6 9.3 16.9 4.5 9.9 16.0 13.1 12.0 8.7 9.4 10.0 19.9 10.7 5.1 7.3 8.0 23.2 7.1 SEC24C KIAA0079 ENSG00000176986 "SEC24 homolog C, COPII coat complex component" P53992 10 73744372-73772161 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA040196, HPA040213" Supported Supported Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA040196: AB_10796449, HPA040213: AB_10796451" "unprognostic (5.06e-2)" "unprognostic (1.00e-2)" "unprognostic (2.17e-1)" "unprognostic (3.54e-1)" "unprognostic (8.46e-2)" "unprognostic (7.23e-2)" "unprognostic (9.06e-2)" "unprognostic (4.55e-2)" "unprognostic (1.64e-1)" "unprognostic (2.46e-2)" "unprognostic (1.02e-1)" "unprognostic (1.35e-1)" "unprognostic (7.71e-2)" "unprognostic (8.34e-3)" "unprognostic (2.11e-1)" "unprognostic (3.35e-2)" "unprognostic (1.77e-2)" 27.8 42.9 20.1 31.6 21.2 16.2 27.4 23.1 26.8 42.5 20.7 34.2 27.4 36.4 33.2 69.0 30.7 24.0 34.5 20.4 21.2 29.8 45.8 30.5 31.4 21.4 20.1 33.2 34.9 50.5 45.4 36.4 20.9 37.7 27.6 29.1 36.9 31.1 49.7 35.8 31.7 32.1 18.3 37.1 34.1 27.7 22.7 35.2 34.0 33.9 43.3 35.5 38.8 23.0 72.7 71.8 55.6 99.9 59.2 48.3 45.6 53.6 90.4 70.4 65.7 67.2 47.9 57.3 43.3 72.0 48.1 61.4 78.3 70.7 60.4 76.6 55.6 53.1 50.5 71.2 47.0 80.7 71.1 41.5 76.8 61.8 76.4 89.2 73.6 44.6 64.1 80.8 69.9 64.7 60.4 55.3 34.8 68.3 259.2 65.2 45.0 47.0 46.5 40.8 20.0 51.7 41.9 144.6 60.1 51.7 106.3 70.6 72.7 29.5 53.1 57.7 62.5 82.0 85.9 84.0 84.0 80.8 35.0 28.2 15.8 13.6 27.4 21.4 35.5 12.6 16.2 21.6 18.1 9.4 11.7 15.8 11.5 22.4 19.1 14.8 10.9 22.7 20.1 21.2 23.1 26.8 20.4 21.2 21.4 20.1 20.9 18.3 22.7 23.0 12.1 35.3 28.6 16.3 11.6 8.7 4.7 11.5 6.2 15.1 17.0 14.9 2.3 14.3 17.6 14.7 16.7 17.8 18.6 24.7 3.9 15.1 8.8 10.9 13.0 11.0 19.2 5.9 14.6 19.4 16.4 9.7 19.9 17.0 22.2 20.1 16.4 19.9 17.1 15.2 15.7 18.4 8.2 11.7 8.4 6.0 11.8 12.4 5.4 6.5 12.3 10.3 17.5 14.1 16.8 23.8 14.4 11.7 21.9 10.8 20.0 10.4 8.2 14.7 6.6 10.0 9.7 10.3 8.3 11.5 11.4 25.2 16.9 14.7 16.1 10.9 SEPTIN8 "KIAA0202, SEP2, SEPT8" ENSG00000164402 "Septin 8" Q92599 5 132750819-132807241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 393.6" "Cell type enhanced" "Detected in some" "Adipocytes: 7.0;Cardiomyocytes: 14.1;Cytotrophoblasts: 31.0;Extravillous trophoblasts: 12.1;Fibroblasts: 9.5;Hofbauer cells: 12.1;Smooth muscle cells: 8.8;Syncytiotrophoblasts: 10.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005665, HPA036534" Enhanced Approved "Actin filaments,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 15: RT4 - Unknown function" "Cluster 24: Non-specific - Transcription regulation" Cytosol "Actin filaments" "HPA005665: AB_1079910, HPA036534: AB_2797226" "unprognostic (2.06e-2)" "unprognostic (1.13e-1)" "unprognostic (9.24e-2)" "unprognostic (7.10e-3)" "unprognostic (2.70e-1)" "unprognostic (2.15e-2)" "unprognostic (2.86e-2)" "unprognostic (1.41e-2)" "unprognostic (1.58e-2)" "unprognostic (2.97e-2)" "unprognostic (2.38e-2)" "unprognostic (3.12e-1)" "prognostic unfavorable (6.98e-5)" "unprognostic (2.86e-2)" "unprognostic (4.30e-1)" "unprognostic (8.04e-3)" "unprognostic (2.70e-1)" 26.9 19.5 192.8 18.0 273.3 8.3 22.2 279.1 238.2 28.2 111.6 26.3 26.2 18.8 18.5 34.0 21.4 25.2 33.0 188.3 218.5 34.8 13.0 26.2 14.9 319.9 262.0 25.2 23.3 23.9 22.3 44.3 304.7 20.5 26.9 74.6 33.4 20.6 10.9 49.7 25.8 21.3 238.1 14.8 26.8 6.9 250.4 18.0 32.3 12.4 18.6 36.1 31.1 393.6 55.8 26.4 37.3 76.7 50.8 49.5 122.0 58.9 56.2 54.7 66.5 46.6 39.2 0.3 51.1 57.3 32.4 42.3 70.5 96.4 59.9 71.3 50.8 54.4 35.5 40.5 37.2 19.4 76.0 35.9 30.6 25.3 35.8 53.5 77.4 47.7 84.6 10.6 29.7 53.0 63.3 18.2 19.8 33.7 17.0 57.4 43.5 4.7 32.0 141.1 50.0 31.0 50.0 11.5 32.9 107.4 100.6 25.4 80.9 60.6 39.2 15.1 42.5 14.3 14.3 2.0 38.7 28.6 46.5 0.5 1.0 0.0 2.0 0.6 2.0 0.4 1.6 2.5 1.2 0.1 0.4 1.0 0.0 0.2 0.3 0.0 1.9 1.0 192.8 273.3 279.1 238.2 188.3 218.5 319.9 262.0 304.7 238.1 250.4 393.6 7.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 31.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 12.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 10.1 0.6 0.0 0.0 0.0 SESN1 "PA26, SEST1" ENSG00000080546 "Sestrin 1" Q9Y6P5 6 108986437-109094819 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 137.2;Excitatory neurons: 134.9;Inhibitory neurons: 127.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "B-cells: 48.0;NK-cells: 58.9;T-cells: 74.6" "Cell line enhanced" "Detected in all" "BEWO: 80.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073659 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 28: BEWO - Transcription regulation" "Cluster 4: Macrophages - Innate immune response" "Nucleoli fibrillar center" Nucleoplasm "HPA073659: AB_2686622" "unprognostic (2.22e-1)" "unprognostic (5.97e-2)" "unprognostic (1.02e-1)" "unprognostic (3.52e-2)" "unprognostic (1.17e-1)" "prognostic favorable (6.47e-5)" "unprognostic (2.68e-1)" "unprognostic (6.91e-2)" "unprognostic (1.01e-1)" "unprognostic (8.33e-2)" "unprognostic (1.83e-3)" "prognostic favorable (2.07e-4)" "unprognostic (3.54e-2)" "unprognostic (1.65e-1)" "unprognostic (1.08e-1)" "unprognostic (5.72e-2)" "unprognostic (7.95e-2)" 30.7 26.6 29.1 23.2 30.7 50.2 42.3 29.8 35.9 29.9 29.8 31.6 20.2 31.7 26.6 22.7 32.5 18.5 36.2 31.1 29.4 16.7 29.2 25.6 33.8 27.9 27.9 62.6 31.6 50.3 25.8 53.4 28.7 25.1 23.9 25.0 18.3 23.6 151.2 43.1 38.1 32.9 28.7 37.0 31.0 42.0 29.9 21.9 32.1 140.0 33.8 28.3 28.2 30.8 3.5 5.7 25.7 12.2 32.1 40.6 80.5 13.8 15.7 4.7 9.0 10.9 3.6 29.3 11.4 10.2 3.7 4.1 7.0 27.6 5.8 2.6 34.7 13.0 6.9 40.9 19.7 5.1 12.7 44.2 43.0 8.5 13.7 20.5 24.7 8.3 9.7 20.5 23.3 6.9 11.3 16.4 10.6 5.7 3.6 9.0 7.3 13.7 10.1 17.4 6.3 12.7 7.5 4.7 5.7 41.3 4.5 33.5 15.3 3.6 7.1 3.3 4.5 20.5 12.5 12.0 7.9 12.8 7.9 11.9 2.7 3.4 34.4 6.3 74.6 13.3 32.4 27.3 2.7 48.0 39.6 20.8 10.0 58.9 8.7 5.4 15.1 20.3 29.1 30.7 29.8 35.9 31.1 29.4 27.9 27.9 28.7 28.7 29.9 30.8 13.9 64.1 22.4 79.0 37.3 6.5 4.9 7.4 25.0 23.8 14.2 14.5 30.0 17.2 15.2 14.7 45.9 57.8 22.9 12.7 9.8 4.3 137.2 10.3 15.2 9.8 15.5 24.2 134.9 5.3 13.7 21.9 28.5 8.2 3.8 17.4 10.8 14.7 44.9 26.9 127.7 10.0 2.0 43.1 11.3 104.8 34.5 56.5 16.0 71.2 9.4 39.1 25.7 64.3 119.1 3.1 11.9 35.3 26.2 9.4 7.8 9.3 26.4 44.3 26.3 43.9 15.9 18.4 16.2 25.4 8.4 44.6 41.8 102.9 13.6 4.3 SH2D1A "DSHP, EBVS, IMD5, LYP, MTCP1, SAP, XLP, XLPD" ENSG00000183918 "SH2 domain containing 1A" O60880 X 124227868-124373197 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 48 "lymphoid tissue: 262.5" "Group enriched" "Detected in some" 7 "dendritic cells: 77.6;NK-cells: 138.0;T-cells: 108.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 54 "gdT-cell: 120.2;MAIT T-cell: 162.9;memory CD4 T-cell: 90.4;memory CD8 T-cell: 175.8;naive CD4 T-cell: 91.2;naive CD8 T-cell: 108.3;NK-cell: 162.2;T-reg: 125.3" "Group enriched" "Detected in many" 70 "NK-cells: 162.2;T-cells: 175.8" "Group enriched" "Detected in some" 6 "HDLM-2: 101.1;JURKAT: 193.0;Karpas-707: 201.3;MOLT-4: 257.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA072265 Approved Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "HPA072265: " "prognostic favorable (2.03e-4)" "unprognostic (1.18e-3)" "unprognostic (4.35e-3)" "unprognostic (9.66e-5)" "unprognostic (1.60e-1)" "unprognostic (1.86e-3)" "unprognostic (9.25e-3)" "unprognostic (3.34e-2)" "unprognostic (1.88e-2)" "unprognostic (2.80e-3)" "unprognostic (9.33e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.94e-6)" "unprognostic (1.27e-1)" "unprognostic (9.00e-2)" "unprognostic (2.36e-1)" "unprognostic (3.14e-3)" 1.4 1.1 0.0 10.8 0.1 5.4 1.2 0.1 0.2 0.9 0.1 1.6 1.5 0.6 0.6 1.1 0.5 4.1 0.3 0.1 0.1 0.4 2.8 3.2 38.4 0.2 0.1 0.4 0.2 0.2 0.2 0.3 0.1 1.1 1.5 0.0 1.3 0.3 0.3 0.4 2.5 0.6 0.2 14.7 2.7 0.2 0.1 262.5 0.7 1.2 16.6 5.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 101.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 193.0 0.0 201.3 0.0 0.0 257.2 4.6 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 32.7 33.3 0.0 0.2 0.0 0.0 1.4 0.6 0.1 120.2 0.5 162.9 1.1 90.4 175.8 0.5 0.2 91.2 108.3 2.4 162.2 1.2 0.8 125.3 91.3 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 1.1 3.2 4.7 0.0 3.0 1.5 0.1 0.0 0.0 0.0 0.7 0.8 0.2 1.5 0.0 0.0 0.0 0.1 77.6 0.0 0.0 0.0 0.0 0.5 0.2 0.7 0.0 7.4 0.1 0.0 0.0 2.0 1.1 0.2 3.8 0.0 3.6 0.9 0.1 0.0 0.0 0.0 0.0 5.6 4.4 0.0 0.0 4.3 5.4 0.0 2.3 0.0 138.0 0.5 0.2 0.0 0.0 0.0 14.1 0.2 0.0 0.5 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.2 1.0 0.1 108.9 0.0 0.0 0.0 SLC17A3 NPT4 ENSG00000124564 "Solute carrier family 17 member 3" O00476 6 25833066-25882286 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 164.3" "Cell type enriched" "Detected in some" 13 "Proximal tubular cells: 197.8" "Cancer enriched" "Detected in some" 17 "renal cancer: 57.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 210 "RPTEC TERT1: 114.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (5.31e-3)" "unprognostic (1.56e-2)" "unprognostic (2.51e-1)" "unprognostic (4.65e-2)" "unprognostic (5.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.07e-1)" "unprognostic (2.34e-1)" "unprognostic (1.34e-1)" "unprognostic (4.49e-1)" 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 164.3 37.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 114.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 1.8 0.0 0.0 0.2 0.1 7.9 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.1 15.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 197.8 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.8 0.2 0.0 0.1 SLC38A5 "JM24, SN2" ENSG00000017483 "Solute carrier family 38 member 5" Q8WUX1 X 48458537-48470260 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "pancreas: 237.2" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 196.3;Erythroid cells: 74.3;Exocrine glandular cells: 80.8;Pancreatic endocrine cells: 129.4;Plasma cells: 62.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 214.0;HBEC3-KT: 326.7;HeLa: 300.0;hTCEpi: 237.8;Karpas-707: 282.8;RPMI-8226: 539.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047411 Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 25: RPMI-8226 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Vesicles, Plasma membrane" Cytosol "HPA047411: AB_10964355" "unprognostic (2.81e-1)" "unprognostic (4.87e-2)" "unprognostic (7.92e-3)" "unprognostic (1.58e-1)" "unprognostic (1.29e-3)" "unprognostic (1.26e-1)" "unprognostic (7.75e-2)" "unprognostic (5.79e-2)" "unprognostic (1.52e-1)" "unprognostic (3.80e-3)" "prognostic unfavorable (2.13e-4)" "unprognostic (2.99e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (1.27e-3)" "unprognostic (1.45e-1)" "unprognostic (2.86e-1)" "unprognostic (2.20e-1)" 4.2 1.9 29.9 13.0 21.8 55.7 2.5 22.6 26.3 9.4 10.6 13.2 13.3 4.2 2.7 10.2 4.9 3.7 6.1 21.6 22.5 1.8 0.9 25.3 8.8 30.4 23.1 6.7 237.2 0.4 0.9 1.1 28.0 5.6 16.2 3.4 9.3 8.6 0.6 21.3 9.2 7.0 22.0 13.8 15.9 0.7 30.4 8.5 20.3 1.3 9.1 9.4 8.7 21.1 143.0 0.3 0.1 1.6 2.8 11.6 0.3 9.4 0.0 0.3 0.1 0.4 0.3 147.8 0.2 61.7 0.3 214.0 164.4 326.7 0.0 47.4 0.2 80.7 300.0 102.4 23.2 166.7 0.2 22.0 237.8 2.9 0.6 0.2 2.8 35.5 150.7 282.8 32.2 0.2 36.3 57.9 74.2 0.0 0.7 131.5 0.7 539.6 0.0 0.1 13.1 0.7 0.1 0.9 0.2 1.1 0.5 6.9 4.7 0.6 0.4 0.4 0.4 0.4 1.0 53.0 1.6 0.8 0.7 0.1 0.4 0.4 17.3 0.6 24.2 11.4 18.6 16.4 2.3 8.9 8.7 11.3 0.5 9.6 0.1 13.1 21.7 9.1 29.9 21.8 22.6 26.3 21.6 22.5 30.4 23.1 28.0 22.0 30.4 21.1 2.3 0.0 0.6 0.3 15.4 26.6 2.7 196.3 17.1 3.2 0.2 0.3 0.4 0.0 33.6 5.5 18.8 0.2 6.7 9.9 0.0 5.5 0.4 1.1 9.1 11.8 0.0 74.3 0.3 80.8 0.6 8.9 3.6 2.7 4.5 1.0 0.4 0.4 2.4 0.0 0.5 17.5 4.1 0.3 3.9 1.3 2.5 2.1 8.8 32.8 1.8 0.3 8.2 0.5 0.2 129.4 5.5 1.2 62.3 4.5 1.2 0.0 4.2 0.3 0.0 0.7 4.6 0.1 0.4 6.4 8.5 0.0 9.5 4.6 21.4 1.9 SLC39A7 "D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7" ENSG00000112473 "Solute carrier family 39 member 7" Q92504 6 33200445-33204439 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 168.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053999 Approved Supported "Endoplasmic reticulum" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "Endoplasmic reticulum" "HPA053999: AB_2682338" "unprognostic (3.63e-2)" "unprognostic (1.23e-1)" "unprognostic (1.21e-1)" "unprognostic (3.24e-2)" "unprognostic (8.95e-2)" "unprognostic (2.51e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (4.87e-2)" "unprognostic (9.92e-2)" "unprognostic (7.20e-3)" "unprognostic (3.29e-1)" "unprognostic (2.40e-1)" "unprognostic (1.99e-2)" "unprognostic (4.80e-1)" "unprognostic (1.50e-1)" "unprognostic (8.22e-3)" "unprognostic (1.12e-2)" 52.5 73.7 2.2 3.6 2.4 2.4 51.1 2.5 2.7 51.0 5.4 66.7 7.2 60.8 8.6 47.1 44.4 5.8 63.2 2.0 2.8 45.1 75.0 64.9 3.0 3.1 2.6 40.9 98.7 12.8 74.1 8.2 3.2 55.8 8.7 1.9 90.9 7.5 31.5 38.4 58.5 8.3 2.5 47.7 71.4 29.0 3.2 2.8 67.2 2.8 4.4 42.4 41.2 2.9 10.7 9.6 8.6 8.2 25.8 15.9 13.2 17.8 25.3 23.1 23.1 16.7 6.6 5.1 11.9 22.9 12.4 7.5 8.3 14.5 9.7 16.6 10.1 9.4 10.0 25.1 18.2 10.0 30.7 16.0 13.6 15.1 20.6 13.5 11.7 8.3 15.5 7.7 10.2 9.8 4.3 7.4 8.1 23.2 9.9 5.7 6.8 12.2 14.0 5.8 6.8 5.1 8.6 37.2 13.2 5.4 25.0 10.3 10.9 13.1 17.4 8.2 9.8 18.3 15.1 3.9 7.5 8.7 15.0 2.2 1.8 2.0 3.3 1.1 4.4 1.2 2.0 1.2 0.7 1.2 1.8 1.7 0.8 2.1 1.0 1.3 1.0 1.5 2.2 2.4 2.5 2.7 2.0 2.8 3.1 2.6 3.2 2.5 3.2 2.9 40.0 25.6 34.8 7.2 23.4 36.1 29.4 53.6 19.4 27.4 36.7 18.5 33.1 34.3 54.7 25.8 29.2 103.0 22.9 75.5 5.9 73.8 0.8 26.9 47.3 40.9 25.3 28.4 4.3 86.1 129.1 64.4 66.8 53.7 20.8 29.5 28.2 34.4 42.9 11.8 5.9 135.1 48.8 14.8 35.3 2.7 46.0 22.1 40.9 5.6 23.7 42.9 24.7 8.5 8.3 67.8 54.9 42.9 91.6 60.2 56.0 25.9 28.3 26.8 19.7 35.4 43.0 9.4 11.5 26.0 40.9 168.7 23.1 69.2 61.7 51.3 SLC44A3 "CTL3, MGC45474" ENSG00000143036 "Solute carrier family 44 member 3" Q8N4M1 1 94820342-94895246 "Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "MAIT T-cell: 1.8" "Lineage enriched" "Detected in single" 18 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "OE19: 35.9;RPTEC TERT1: 101.4;RT4: 69.5" "Region enhanced" "Detected in single" "pons and medulla: 1.1" "Low region specificity" "Detected in all" HPA047433 Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA047433: AB_2680046" "unprognostic (8.06e-2)" "unprognostic (7.65e-2)" "unprognostic (4.63e-3)" "unprognostic (3.57e-2)" "unprognostic (1.53e-2)" "unprognostic (2.37e-1)" "unprognostic (1.14e-1)" "unprognostic (4.03e-2)" "unprognostic (1.94e-1)" "unprognostic (1.46e-1)" "unprognostic (5.78e-2)" "unprognostic (2.44e-2)" "prognostic favorable (7.63e-5)" "unprognostic (9.09e-2)" "unprognostic (8.28e-2)" "unprognostic (5.95e-2)" "unprognostic (3.31e-3)" 2.2 8.8 15.7 6.2 15.3 0.1 8.1 17.9 16.9 8.8 14.0 31.5 26.1 7.2 6.6 9.4 8.0 10.9 3.9 14.8 17.0 29.3 6.3 10.3 0.8 20.7 16.4 1.7 27.0 5.2 15.0 3.4 16.4 10.8 35.4 4.3 23.4 7.7 0.2 6.0 28.0 2.8 17.6 0.9 29.3 2.5 15.7 4.9 5.2 0.6 2.2 22.1 6.5 18.3 23.4 3.2 0.8 0.0 2.5 3.2 15.9 0.4 3.4 0.8 3.7 21.4 5.8 0.0 15.4 0.4 6.9 7.7 3.5 5.5 1.4 0.0 4.1 0.0 1.2 1.7 1.1 0.0 0.0 9.9 5.1 1.6 0.0 6.3 0.4 0.0 0.0 0.0 1.4 3.4 0.0 0.3 1.0 35.9 0.8 1.8 0.7 1.3 101.4 69.5 10.4 17.0 1.0 10.8 7.8 7.3 6.2 0.7 0.0 0.5 3.5 1.5 0.2 0.0 0.0 0.0 2.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 15.3 17.9 16.9 14.8 17.0 20.7 16.4 16.4 17.6 15.7 18.3 0.4 25.6 6.7 26.1 0.6 3.1 27.8 14.6 4.0 0.7 15.6 8.3 5.7 37.1 22.7 12.9 0.0 15.9 0.1 18.2 15.6 33.4 32.5 12.8 3.2 1.3 16.3 0.0 1.4 27.8 0.8 3.8 16.3 22.5 1.3 5.3 0.7 2.1 1.3 0.0 4.6 32.2 20.3 0.3 0.4 5.3 5.0 0.8 5.4 2.8 1.0 17.0 0.0 5.5 2.0 38.3 36.5 10.9 0.0 12.9 22.8 38.6 11.4 0.2 0.0 9.6 3.4 0.1 0.2 10.2 3.8 6.7 0.8 4.1 42.8 30.3 SLC4A10 "NBCn2, NCBE" ENSG00000144290 "Solute carrier family 4 member 10" Q6U841 2 161424332-161985282 "Metabolic proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 21.3;choroid plexus: 121.4;retina: 34.3" "Group enriched" "Detected in some" 4 "Excitatory neurons: 604.4;Inhibitory neurons: 560.9" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Region enhanced" "Detected in many" "cerebral cortex: 21.3" "Immune cell enriched" "Detected in some" 8 "MAIT T-cell: 63.3" "Lineage enriched" "Detected in single" 65 "T-cells: 63.3" "Cell line enriched" "Detected in single" 11 "Karpas-707: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034755, HPA076725" Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA034755: AB_10670296, HPA076725: " "unprognostic (4.64e-4)" "unprognostic (3.88e-1)" "unprognostic (2.88e-2)" "unprognostic (3.65e-2)" "unprognostic (1.19e-2)" "unprognostic (7.89e-3)" "unprognostic (5.99e-4)" "unprognostic (1.12e-1)" "unprognostic (2.27e-1)" "unprognostic (1.64e-1)" "unprognostic (2.50e-2)" "unprognostic (9.27e-2)" "unprognostic (5.65e-2)" "unprognostic (9.23e-3)" "unprognostic (1.87e-1)" "unprognostic (2.10e-3)" "unprognostic (2.26e-1)" 0.0 2.0 6.3 0.7 10.3 0.2 0.2 0.2 21.3 0.1 121.4 1.8 0.3 0.0 1.3 0.0 0.6 0.4 0.0 11.8 1.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.5 0.0 1.3 0.0 0.0 0.2 1.3 34.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.2 0.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.5 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 2.5 0.0 63.3 0.0 1.2 7.8 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.5 6.3 10.3 0.2 21.3 11.8 1.1 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 21.2 0.1 0.0 0.0 0.0 0.0 116.3 0.0 0.0 0.6 0.0 0.0 0.0 8.4 0.0 2.6 1.1 0.0 0.0 18.3 0.0 0.0 0.3 0.0 0.0 604.4 0.0 0.0 0.0 0.5 0.0 2.5 0.0 1.8 0.6 0.0 0.0 560.9 2.8 0.0 0.6 0.0 10.5 0.0 0.1 0.0 16.9 0.5 2.8 1.0 129.2 16.5 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 9.4 0.0 0.3 0.0 SLC7A4 "CAT-4, HCAT3, VH" ENSG00000099960 "Solute carrier family 7 member 4" O43246 22 21028718-21032840 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 15.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 21.2;Endometrial ciliated cells: 16.4;Glandular and luminal cells: 32.0;Intestinal goblet cells: 8.9;Ionocytes: 12.2;Syncytiotrophoblasts: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "BEWO: 140.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA031023 Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 28: BEWO - Transcription regulation" "Cluster 44: Endometrium - Transcription" "HPA031023: AB_10669669" "unprognostic (1.02e-3)" "unprognostic (4.34e-2)" "unprognostic (6.75e-2)" "unprognostic (1.27e-1)" "unprognostic (3.82e-2)" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (3.91e-2)" "unprognostic (3.68e-2)" "unprognostic (2.51e-2)" "unprognostic (2.58e-2)" "unprognostic (1.21e-3)" "unprognostic (9.69e-2)" "unprognostic (2.87e-1)" "unprognostic (1.62e-1)" "unprognostic (1.32e-2)" "unprognostic (4.00e-3)" 2.7 2.6 3.1 0.2 2.6 0.0 1.0 3.8 2.8 1.5 4.5 1.1 1.0 1.0 0.3 5.6 1.1 1.3 1.1 2.3 3.8 0.4 0.3 0.8 0.3 1.8 2.6 0.3 0.2 0.5 4.7 3.3 4.5 2.5 0.9 0.3 2.2 3.2 0.4 1.6 1.2 0.3 0.3 0.5 1.4 15.4 4.8 0.3 0.0 0.0 0.5 1.1 0.6 0.7 0.0 0.0 0.0 0.1 0.0 0.0 140.5 0.0 0.0 0.3 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.5 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.0 1.3 0.5 0.3 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.2 3.1 2.6 3.8 2.8 2.3 3.8 1.8 2.6 4.5 0.3 4.8 0.7 0.0 6.4 1.9 0.3 0.0 0.0 0.3 7.4 0.6 0.5 0.7 0.6 0.3 1.5 3.1 0.0 0.0 21.2 0.0 0.5 0.0 0.0 0.3 16.4 2.1 0.3 1.2 0.0 1.4 0.4 7.7 2.0 1.1 32.0 4.5 0.7 1.1 0.0 1.4 0.0 0.8 8.9 12.2 0.0 0.0 1.8 1.8 0.1 0.0 1.0 0.0 2.0 0.0 0.0 0.1 0.8 0.3 0.7 0.0 0.5 0.3 0.0 2.6 0.1 0.0 0.3 0.4 0.3 1.5 1.8 0.0 10.1 0.7 0.0 0.6 0.6 SLC9A1 "APNH, NHE1, PPP1R143" ENSG00000090020 "Solute carrier family 9 member A1" P19634 1 27098809-27166981 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Deafness, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 76.5;stomach 1: 65.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 81.5;Gastric mucus-secreting cells: 160.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022371, HPA048532, HPA052891" Enhanced Supported "Plasma membrane" NA NA 21000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 15: RT4 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981" "unprognostic (6.18e-2)" "unprognostic (1.59e-1)" "unprognostic (2.21e-1)" "unprognostic (8.48e-2)" "prognostic unfavorable (7.47e-4)" "unprognostic (2.70e-2)" "unprognostic (4.33e-3)" "unprognostic (3.18e-2)" "unprognostic (9.74e-2)" "prognostic unfavorable (7.10e-4)" "unprognostic (3.44e-2)" "unprognostic (6.95e-2)" "unprognostic (2.05e-2)" "unprognostic (1.27e-2)" "unprognostic (1.60e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-2)" 9.6 10.7 6.1 10.4 14.7 11.5 9.0 2.8 10.8 10.9 0.2 18.6 29.3 10.9 8.0 11.0 7.6 16.9 13.7 2.3 5.3 5.8 2.4 13.2 7.0 13.8 4.7 7.0 8.6 20.7 8.2 21.9 11.2 9.0 13.6 4.5 76.5 19.4 4.6 10.5 19.0 10.7 0.5 11.6 65.9 10.1 10.4 6.3 9.5 4.9 6.7 15.1 9.2 2.4 32.3 10.7 9.9 10.1 21.8 15.7 60.8 25.9 38.5 21.7 23.5 13.0 20.0 14.4 21.9 33.4 10.5 38.9 9.8 62.4 13.4 17.4 9.4 21.9 7.1 5.5 66.1 13.1 16.0 19.7 29.5 36.5 50.7 15.8 36.3 9.8 6.3 13.4 32.3 18.7 6.8 6.4 14.0 38.2 21.9 11.8 9.0 6.7 10.9 46.3 11.4 3.7 21.5 28.4 12.6 10.0 13.3 7.9 39.9 23.0 9.4 21.7 14.5 12.6 8.6 4.3 24.6 14.1 13.5 0.0 0.6 0.6 0.7 0.3 1.5 0.1 0.8 0.7 0.2 0.3 0.5 0.6 2.0 0.1 0.6 0.0 0.3 0.8 6.1 14.7 2.8 10.8 2.3 5.3 13.8 4.7 11.2 0.5 10.4 2.4 13.5 6.4 14.8 6.5 7.9 31.2 17.9 14.6 13.1 7.4 21.7 23.2 13.5 7.2 8.3 11.0 0.0 40.3 11.9 81.5 0.0 9.1 26.5 13.8 15.9 9.7 12.5 0.4 14.1 12.5 19.4 12.7 160.0 26.5 27.3 7.5 6.8 1.2 12.9 20.2 14.1 15.0 4.1 5.7 5.1 14.4 9.3 12.7 7.2 8.4 4.3 8.2 12.3 4.0 4.6 28.1 43.1 13.2 4.8 9.6 38.9 1.2 5.9 3.8 6.6 20.8 9.8 3.6 4.4 15.0 25.1 52.9 9.8 4.8 18.3 18.3 SLC9A6 "KIAA0267, NHE6" ENSG00000198689 "Solute carrier family 9 member A6" Q92581 X 135973841-136047269 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 40.3;Horizontal cells: 48.8;Inhibitory neurons: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059445, HPA059590" Enhanced Supported Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 18: U-2197 - ECM organization" "Cluster 62: Horizontal cells - Visual perception" Vesicles "HPA059445: AB_2684021, HPA059590: AB_2684075" "unprognostic (1.35e-1)" "unprognostic (8.28e-3)" "unprognostic (4.36e-1)" "unprognostic (4.93e-2)" "unprognostic (1.84e-1)" "unprognostic (1.19e-1)" "unprognostic (2.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (7.07e-2)" "unprognostic (5.30e-2)" "unprognostic (1.75e-1)" "unprognostic (4.49e-2)" "unprognostic (5.06e-2)" 5.1 6.3 11.6 5.6 11.9 4.6 3.3 1.2 15.7 5.6 0.0 6.0 8.5 6.4 3.3 6.3 5.7 5.5 8.6 12.7 19.0 6.9 4.5 6.7 5.7 7.8 4.4 8.0 3.8 10.4 2.2 4.7 8.9 4.0 6.1 14.4 4.1 4.9 7.5 4.7 7.8 7.4 3.4 5.7 5.8 5.8 15.3 5.6 6.7 7.1 6.6 5.6 1.6 4.2 20.0 10.5 9.1 3.8 14.8 14.2 17.3 15.9 16.9 13.3 27.9 9.2 15.5 14.8 35.2 18.4 19.8 11.6 14.3 14.0 19.1 11.7 12.9 4.0 15.3 5.3 7.9 11.6 13.3 7.7 11.6 22.0 10.8 9.4 11.2 12.5 7.5 20.5 14.9 8.7 15.5 3.4 6.0 7.1 14.0 10.4 16.0 15.2 9.4 9.8 9.5 7.2 11.4 1.2 8.9 8.8 4.5 8.7 16.4 16.5 10.9 24.5 20.7 9.6 23.8 12.7 10.0 19.4 9.4 2.0 5.0 3.0 6.4 7.0 11.1 4.1 7.1 5.9 5.8 2.6 7.6 5.7 2.0 5.1 6.0 3.5 6.9 5.4 11.6 11.9 1.2 15.7 12.7 19.0 7.8 4.4 8.9 3.4 15.3 4.2 4.3 3.2 5.4 22.9 5.9 7.5 1.4 6.2 7.4 14.2 2.7 3.4 11.2 12.8 4.0 12.9 8.4 2.5 6.1 8.9 0.0 4.3 0.8 4.2 4.1 4.9 10.7 5.0 40.3 6.0 2.4 5.1 8.6 6.8 1.3 4.6 8.2 9.6 9.9 48.8 42.0 4.0 8.2 13.0 7.0 1.4 5.6 9.8 8.8 15.9 8.2 12.9 4.1 19.6 22.7 6.1 6.0 4.5 3.8 2.0 10.3 6.0 3.1 7.8 0.0 5.1 8.4 9.0 11.9 7.0 6.8 2.9 8.9 3.1 6.0 3.1 SMIM33 ENSG00000283288 "Small integral membrane protein 33" A0A1B0GW64 5 139470778-139474772 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.1;salivary gland: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 7: Non-specific - Mitochondria" 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.4 0.3 0.2 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.2 0.1 0.4 0.3 0.2 0.1 0.2 0.1 0.3 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 SMYD5 "NN8-4AG, RAI15, RRG1, ZMYND23" ENSG00000135632 "SMYD family member 5" Q6GMV2 2 73214222-73227221 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015514, HPA049002" Uncertain Approved Mitochondria NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA015514: AB_2669205, HPA049002: AB_2680595" "unprognostic (1.75e-1)" "unprognostic (3.39e-1)" "unprognostic (5.22e-2)" "unprognostic (6.66e-3)" "unprognostic (3.86e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (6.58e-7)" "unprognostic (1.28e-1)" "unprognostic (1.60e-2)" "unprognostic (3.84e-2)" "unprognostic (3.84e-1)" "unprognostic (2.49e-1)" "unprognostic (3.03e-2)" "unprognostic (3.94e-1)" "unprognostic (1.47e-1)" "unprognostic (1.91e-1)" "unprognostic (2.40e-1)" 13.3 19.1 27.2 12.1 27.8 11.6 14.8 24.3 30.5 15.5 22.0 12.5 7.3 14.4 19.4 14.1 19.5 7.3 17.9 28.2 28.0 18.8 15.2 9.8 13.1 28.9 26.5 28.3 18.4 17.9 15.4 13.1 28.8 15.4 11.3 13.0 12.2 13.4 17.7 14.5 12.4 14.5 25.9 16.2 11.4 17.4 26.9 8.2 14.3 13.0 16.0 17.5 13.1 26.9 24.3 45.2 27.0 25.9 19.3 28.4 45.7 22.8 23.0 43.4 26.6 59.4 24.4 43.1 20.9 38.6 52.1 24.4 42.2 49.4 39.1 26.3 29.7 41.8 19.5 65.9 26.0 41.5 16.5 24.0 31.4 39.7 47.3 19.2 26.7 33.9 44.9 20.2 27.9 34.1 38.8 27.1 42.2 50.8 36.3 25.6 50.6 35.5 28.6 34.6 17.4 25.9 20.7 30.7 26.4 24.4 25.0 14.7 18.5 29.7 46.3 36.5 38.1 22.0 17.7 38.2 33.5 35.2 24.3 0.0 1.4 0.0 5.1 3.9 11.1 6.0 7.0 6.8 3.2 6.2 7.0 7.7 0.0 4.5 4.3 3.0 3.1 4.5 27.2 27.8 24.3 30.5 28.2 28.0 28.9 26.5 28.8 25.9 26.9 26.9 4.1 3.2 5.6 5.2 5.6 5.1 3.9 2.3 1.8 10.2 5.4 6.7 7.2 2.8 4.4 5.5 4.2 9.0 3.4 2.4 1.9 8.5 0.5 2.8 4.2 4.9 0.0 9.5 5.0 8.8 10.4 4.5 2.6 3.7 7.0 9.5 2.9 4.8 5.9 5.0 5.2 4.4 4.1 2.4 2.5 2.9 2.8 2.7 5.4 2.8 3.7 4.0 4.1 1.5 3.5 5.6 1.5 3.0 3.1 5.0 1.3 8.1 1.3 5.3 6.6 4.0 4.6 6.7 11.1 5.7 3.4 4.8 4.5 4.6 5.6 3.6 SNX32 "FLJ30934, SNX6B" ENSG00000172803 "Sorting nexin 32" Q86XE0 11 65833834-65856896 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 37.8;choroid plexus: 15.0" "Cell type enhanced" "Detected in some" "Astrocytes: 25.5;Early spermatids: 11.3;Excitatory neurons: 48.4;Inhibitory neurons: 34.2;Late spermatids: 12.3;Oligodendrocyte precursor cells: 12.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 4.5;HSkMC: 5.8;REH: 1.9;SH-SY5Y: 2.3;U-266/70: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041775 Uncertain Uncertain "Cell Junctions,Focal adhesion sites" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Cell Junctions, Focal adhesion sites" "HPA041775: AB_10797268" "unprognostic (6.74e-4)" "unprognostic (1.06e-1)" "unprognostic (1.67e-2)" "unprognostic (4.50e-5)" "unprognostic (1.00e-1)" "unprognostic (9.28e-2)" "unprognostic (7.30e-2)" "unprognostic (9.17e-3)" "unprognostic (2.70e-1)" "unprognostic (2.87e-1)" "unprognostic (5.08e-2)" "unprognostic (1.52e-1)" "unprognostic (3.64e-4)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (9.80e-2)" "unprognostic (5.36e-2)" 0.3 0.1 22.8 0.1 24.0 0.3 0.3 17.1 37.8 0.6 15.0 1.0 1.0 0.7 0.2 0.1 0.7 0.8 0.2 23.7 17.8 0.2 0.0 0.1 0.1 18.1 18.2 0.7 0.1 0.2 0.4 0.0 18.3 0.2 0.4 1.1 0.0 0.1 0.0 0.4 0.5 0.5 16.9 0.2 0.2 2.1 18.7 0.4 0.1 0.2 0.2 0.4 0.2 23.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.5 5.8 0.1 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.4 0.2 0.1 0.0 0.0 1.9 0.0 1.8 0.0 0.0 0.0 2.3 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 7.0 1.2 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.7 0.0 0.3 0.2 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 22.8 24.0 17.1 37.8 23.7 17.8 18.1 18.2 18.3 16.9 18.7 23.1 0.3 0.0 0.6 25.5 0.6 0.4 0.3 0.0 1.2 2.4 0.7 1.0 0.8 0.0 0.6 0.0 0.0 0.1 0.1 0.6 0.0 0.1 11.3 0.3 3.6 0.6 0.0 0.8 48.4 0.0 0.4 0.9 1.1 0.5 3.8 2.8 0.4 0.0 0.3 0.0 34.2 0.8 0.0 0.3 0.3 12.3 0.3 0.2 1.8 3.7 0.0 0.9 1.0 12.1 10.2 0.2 0.5 1.2 0.5 0.2 3.9 0.4 0.7 0.6 0.0 1.0 0.8 6.1 1.7 0.5 0.4 0.0 0.7 1.3 1.7 0.1 SOAT2 ACAT2 ENSG00000167780 "Sterol O-acyltransferase 2" O75908 12 53103486-53124535 "Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 19.5" "Cell type enriched" "Detected in some" 5 "Proximal enterocytes: 14.3" "Group enriched" "Detected in some" 8 "liver cancer: 5.2;testis cancer: 5.5" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 5 "T-cells: 1.1" "Group enriched" "Detected in some" 5 "CACO-2: 9.5;Hep G2: 22.6;U-266/70: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 45: Enterocytes - Digestion" "unprognostic (2.53e-1)" "unprognostic (2.72e-3)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (1.30e-4)" "unprognostic (3.88e-3)" "unprognostic (9.26e-2)" "unprognostic (4.20e-2)" "unprognostic (1.32e-1)" "unprognostic (3.29e-1)" "unprognostic (1.06e-2)" "unprognostic (2.53e-1)" "unprognostic (1.83e-2)" "unprognostic (9.05e-2)" "unprognostic (2.37e-1)" "unprognostic (7.58e-3)" "unprognostic (3.28e-1)" 0.3 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.8 0.0 0.2 11.6 0.4 0.2 0.1 0.6 0.4 0.1 0.0 0.0 0.4 2.9 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.4 0.1 0.0 0.3 19.5 0.0 0.0 2.1 0.2 0.2 0.0 0.1 0.2 0.1 0.2 0.3 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.4 9.5 0.1 0.0 0.0 0.5 0.0 0.8 0.0 0.0 0.7 0.0 0.0 1.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.4 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 7.2 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.7 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 1.5 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 1.3 0.0 0.0 0.0 0.2 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 2.5 0.0 0.0 0.0 14.3 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.6 0.0 0.3 0.0 SORBS3 "SCAM-1, SH3D4, vinexin" ENSG00000120896 "Sorbin and SH3 domain containing 3" O60504 8 22544986-22575788 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 169.4;Late spermatids: 505.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015849 Approved Uncertain "Focal adhesion sites,Cytosol" NA NA 7700 "Cluster 16: MAIT-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 39: CACO-2 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "Focal adhesion sites" "HPA015849: AB_1857365" "unprognostic (6.15e-3)" "unprognostic (2.09e-2)" "unprognostic (2.34e-1)" "unprognostic (3.90e-3)" "unprognostic (1.72e-1)" "unprognostic (9.30e-2)" "unprognostic (2.51e-2)" "unprognostic (2.44e-2)" "unprognostic (5.83e-3)" "unprognostic (1.70e-1)" "prognostic favorable (4.88e-4)" "unprognostic (4.21e-2)" "unprognostic (3.08e-3)" "unprognostic (7.41e-2)" "unprognostic (1.58e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.53e-5)" 173.3 65.3 59.3 26.2 59.7 5.1 129.0 67.6 72.6 156.9 49.9 105.2 29.9 124.0 23.6 65.5 118.8 38.7 105.8 53.0 55.3 84.8 121.2 111.9 21.1 85.0 60.6 125.6 49.3 35.7 73.3 66.6 65.6 127.2 34.9 11.4 88.7 48.5 64.7 106.8 71.2 53.7 61.7 80.0 63.7 128.2 65.7 7.6 93.8 37.3 13.4 103.5 133.9 57.6 83.0 101.8 54.6 61.9 86.4 114.4 55.7 83.0 127.8 95.0 58.8 103.6 36.2 0.7 55.3 130.1 38.3 69.7 82.5 75.7 48.9 58.1 36.2 6.9 58.3 48.4 98.2 0.8 0.5 72.6 55.6 33.3 48.4 105.2 74.6 42.7 18.4 2.6 68.4 32.8 7.1 2.4 19.3 14.1 42.5 79.0 36.8 7.7 43.7 15.8 3.1 48.9 40.4 9.8 52.7 56.8 16.7 29.2 116.9 83.8 59.8 61.9 59.3 1.7 2.5 11.5 49.0 19.4 58.3 0.0 2.5 0.6 11.4 4.7 23.4 0.8 12.6 13.4 8.1 1.3 12.7 7.6 0.5 5.8 1.1 2.7 0.6 5.2 59.3 59.7 67.6 72.6 53.0 55.3 85.0 60.6 65.6 61.7 65.7 57.6 89.6 19.2 7.2 27.1 5.8 29.2 24.6 23.3 39.9 2.7 29.0 27.8 12.2 31.5 18.3 12.9 0.0 24.1 4.7 53.5 9.8 21.3 169.4 10.9 39.5 51.9 14.6 2.1 3.8 19.2 30.5 48.8 8.6 20.5 17.2 19.3 79.9 49.5 35.3 5.0 4.5 35.2 8.2 39.0 31.5 505.8 61.2 23.8 24.9 13.1 5.7 21.9 3.1 19.6 7.6 26.2 53.2 58.6 3.7 38.8 65.1 26.0 10.7 3.5 59.2 23.1 84.1 7.0 8.0 25.3 21.3 20.5 19.7 7.1 31.3 23.7 SPOCK2 "KIAA0275, testican-2" ENSG00000107742 "SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2" Q92563 10 72059034-72089032 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 220.1;lymphoid tissue: 114.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 288.4;Bipolar cells: 116.5;dendritic cells: 86.4;Inhibitory neurons: 81.1;Microglial cells: 75.9;NK-cells: 90.6;T-cells: 195.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 117.5;MAIT T-cell: 198.8;memory CD4 T-cell: 115.9;memory CD8 T-cell: 93.5;naive CD4 T-cell: 87.8;naive CD8 T-cell: 89.4;T-reg: 174.3" "Lineage enriched" "Detected in all" 8 "T-cells: 198.8" "Group enriched" "Detected in some" 7 "Hep G2: 50.2;SCLC-21H: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044605 Enhanced "Secreted to blood" NA NA 34000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 24: Non-specific - Transcription regulation" "HPA044605: AB_10965991" "prognostic favorable (4.05e-4)" "unprognostic (3.11e-3)" "unprognostic (2.92e-2)" "unprognostic (2.29e-1)" "unprognostic (2.77e-2)" "prognostic favorable (1.95e-5)" "unprognostic (4.18e-2)" "unprognostic (9.04e-2)" "prognostic favorable (4.72e-4)" "prognostic unfavorable (7.19e-4)" "unprognostic (4.53e-3)" "unprognostic (2.29e-1)" "unprognostic (1.46e-3)" "unprognostic (5.59e-2)" "unprognostic (5.49e-2)" "unprognostic (3.19e-3)" "unprognostic (2.24e-2)" 9.4 46.6 152.6 44.5 108.0 58.1 3.8 160.4 143.2 4.2 2.8 7.6 9.2 4.0 3.1 3.3 6.2 15.3 10.0 117.4 150.1 68.0 2.7 86.5 67.3 212.1 157.7 7.1 1.6 2.0 44.0 3.4 220.1 4.7 5.4 33.4 3.3 5.6 5.1 1.8 32.3 4.4 127.9 29.1 13.6 25.1 207.3 114.4 10.4 6.7 45.3 9.9 3.8 95.6 0.2 0.4 0.3 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 8.2 0.3 1.4 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.8 0.2 1.4 50.2 1.6 0.4 1.2 0.1 0.4 0.0 0.0 0.2 0.1 2.7 0.1 0.8 0.0 0.3 0.9 0.3 0.1 0.0 0.2 0.2 0.3 0.1 0.0 0.3 68.2 4.1 0.1 1.5 0.4 0.3 0.0 1.9 0.2 0.0 0.3 0.3 0.1 0.7 1.7 7.3 0.3 0.1 0.2 0.6 0.4 0.2 117.5 1.2 198.8 23.6 115.9 93.5 0.3 18.3 87.8 89.4 13.5 14.4 0.4 3.5 174.3 48.4 152.6 108.0 160.4 143.2 117.4 150.1 212.1 157.7 220.1 127.9 207.3 95.6 17.3 288.4 10.0 51.9 54.6 3.8 0.4 2.1 0.0 116.5 1.9 2.0 3.1 1.5 4.1 14.7 6.2 0.1 86.4 2.4 0.0 3.6 8.1 2.5 1.0 29.9 4.9 3.6 39.6 0.8 0.1 8.4 3.6 1.0 3.8 0.2 7.9 0.4 0.2 3.3 81.1 1.3 2.0 1.6 7.9 10.5 5.3 5.5 5.4 75.9 4.1 5.0 90.6 28.6 8.3 0.0 4.4 6.0 34.2 0.5 0.1 0.5 2.4 17.6 0.0 17.9 2.4 6.3 1.1 0.5 4.4 0.4 195.1 0.8 0.7 0.3 SPON1 "f-spondin, KIAA0762" ENSG00000262655 "Spondin 1" Q9HCB6 11 13962723-14268133 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 101.4" "Cell type enhanced" "Detected in many" "Astrocytes: 399.9;Endometrial stromal cells: 78.9;Muller glia cells: 141.9" "Cancer enriched" "Detected in all" 5 "ovarian cancer: 199.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "MAIT T-cell: 3.3" "Lineage enriched" "Detected in single" 33 "T-cells: 3.3" "Group enriched" "Detected in some" 36 "EFO-21: 213.7;RPTEC TERT1: 604.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038584, HPA077546" Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge" "Secreted to blood" Yes No 11500000 28000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoli, Microtubule ends" "Nucleoplasm, Actin filaments, Cytokinetic bridge" "HPA038584: AB_10697394, HPA077546: AB_2732351" "unprognostic (1.66e-1)" "unprognostic (1.03e-2)" "unprognostic (8.36e-2)" "unprognostic (8.72e-2)" "unprognostic (1.52e-1)" "unprognostic (3.76e-2)" "unprognostic (1.82e-1)" "unprognostic (8.20e-2)" "unprognostic (1.05e-1)" "unprognostic (5.93e-2)" "unprognostic (6.45e-2)" "unprognostic (1.07e-1)" "prognostic favorable (3.12e-4)" "unprognostic (7.22e-3)" "unprognostic (7.89e-2)" "unprognostic (4.65e-2)" "prognostic unfavorable (1.88e-4)" 54.2 16.9 25.8 18.6 33.7 0.1 19.5 26.3 22.3 43.8 7.8 31.8 31.6 36.5 15.2 17.3 63.1 101.4 30.6 28.2 28.3 12.2 2.0 49.2 1.6 25.6 33.6 23.9 4.6 0.8 10.0 41.3 26.4 16.9 46.6 63.8 7.0 8.8 0.8 8.8 28.4 46.9 14.9 8.3 28.8 2.5 34.0 1.7 5.2 1.6 1.2 51.5 12.5 21.8 0.1 0.1 0.4 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 9.8 0.2 0.2 213.7 0.0 0.2 0.4 0.0 0.0 0.0 0.3 1.9 0.0 0.1 0.1 0.0 0.0 0.1 11.4 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.7 0.0 0.1 1.7 0.0 0.1 604.1 0.1 0.1 0.2 0.0 0.0 0.0 4.1 0.0 0.1 2.6 0.2 0.7 0.5 0.3 0.3 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.0 0.6 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 25.8 33.7 26.3 22.3 28.2 28.3 25.6 33.6 26.4 14.9 34.0 21.8 0.2 0.0 2.3 399.9 13.5 0.0 17.3 0.0 1.2 13.5 2.0 5.5 1.9 5.7 0.0 0.0 2.1 3.4 4.8 38.9 3.9 4.3 1.5 36.1 78.9 2.5 16.7 0.0 17.0 2.0 4.2 41.2 0.5 61.5 2.5 1.8 2.5 0.2 1.9 1.7 16.8 24.0 0.0 0.3 0.0 1.3 4.4 1.0 0.0 11.2 0.5 141.9 20.6 62.4 1.6 6.8 20.6 30.1 0.9 9.0 18.4 2.1 0.7 26.8 6.6 5.8 7.0 0.4 0.8 0.6 0.0 4.9 7.8 1.1 40.9 9.4 STN1 "bA541N10.2, FLJ22559, OBFC1" ENSG00000107960 "STN1 subunit of CST complex" Q9H668 10 103877569-103918184 "Disease related genes, Human disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 37.4;Distal tubular cells: 41.1;Ductal cells: 34.6;Exocrine glandular cells: 79.2;Pancreatic endocrine cells: 62.9;Theca cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037924, HPA037925" Supported Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA037924: AB_10671636, HPA037925: AB_10672469" "unprognostic (1.50e-1)" "unprognostic (4.22e-2)" "unprognostic (2.18e-2)" "unprognostic (5.58e-3)" "unprognostic (6.01e-2)" "unprognostic (1.53e-2)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (5.93e-2)" "unprognostic (1.72e-1)" "unprognostic (1.12e-3)" "unprognostic (3.76e-1)" "prognostic favorable (1.12e-6)" "unprognostic (1.21e-1)" "unprognostic (1.74e-1)" "unprognostic (1.20e-1)" "unprognostic (1.83e-2)" 15.7 22.2 8.8 12.2 10.1 13.5 17.1 11.3 9.4 13.3 11.5 14.5 12.0 12.0 9.8 41.0 12.2 18.3 35.0 8.2 11.1 17.9 13.1 25.2 16.0 13.1 11.0 22.2 20.9 33.6 14.9 17.1 11.5 10.2 16.4 6.4 18.7 13.3 22.4 13.3 11.0 15.4 9.9 15.3 22.2 23.4 11.5 24.5 17.6 28.9 22.8 22.5 18.5 11.2 26.8 19.7 23.8 19.6 18.6 57.6 7.6 12.6 36.5 16.4 14.6 11.4 43.6 16.7 22.2 16.1 14.7 24.8 8.7 31.0 15.3 24.1 11.9 15.3 7.0 23.5 25.6 12.7 12.9 37.2 52.1 15.9 43.9 42.9 32.0 31.2 8.5 34.9 27.3 21.7 31.5 22.0 5.5 38.7 28.5 22.7 16.4 19.2 40.5 31.3 13.7 16.1 9.3 14.9 24.4 13.4 12.5 11.0 47.1 20.4 14.1 14.5 19.4 47.3 13.1 16.6 30.4 26.4 9.0 41.7 33.2 110.3 65.1 21.3 103.4 25.5 71.9 60.4 40.2 29.6 52.3 62.6 48.8 71.3 23.7 37.1 100.2 51.5 8.8 10.1 11.3 9.4 8.2 11.1 13.1 11.0 11.5 9.9 11.5 11.2 14.7 22.4 20.9 0.0 2.3 0.0 0.0 0.0 0.0 0.0 12.7 16.9 0.0 0.0 5.0 9.2 0.0 37.4 17.2 0.0 41.1 34.6 0.0 9.2 9.9 6.4 0.0 0.0 0.0 79.2 14.0 3.9 0.0 15.4 5.1 23.8 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 13.5 0.0 0.0 0.0 0.0 62.9 0.0 0.0 1.0 0.0 0.0 12.8 7.3 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 27.0 13.3 52.4 0.0 0.0 SULT2B1 HSST2 ENSG00000088002 "Sulfotransferase family 2B member 1" O00204 19 48552172-48599425 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 286.0;skin 1: 186.5;vagina: 145.9" "Cell type enhanced" "Detected in many" "Prostatic glandular cells: 62.3;Proximal enterocytes: 75.9;Squamous epithelial cells: 56.0;Suprabasal keratinocytes: 137.4;Urothelial cells: 114.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CAPAN-2: 74.2;MCF7: 46.8;OE19: 122.9;T-47d: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041724, HPA043539, HPA076510" Enhanced Enhanced Vesicles,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 21: OE19 - Mitochondria" "Cluster 22: Epithelial cell types - Mixed function" Vesicles Cytosol "HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: " "unprognostic (6.55e-2)" "unprognostic (1.47e-1)" "unprognostic (5.28e-3)" "unprognostic (8.74e-2)" "unprognostic (5.00e-2)" "unprognostic (5.97e-2)" "unprognostic (4.43e-2)" "unprognostic (3.29e-3)" "unprognostic (1.62e-1)" "unprognostic (1.11e-2)" "unprognostic (2.54e-2)" "unprognostic (4.42e-2)" "unprognostic (5.01e-6)" "unprognostic (7.96e-3)" "unprognostic (1.32e-1)" "unprognostic (8.04e-2)" "unprognostic (2.77e-2)" 0.3 0.2 0.5 0.4 0.4 0.1 11.5 0.6 0.8 74.4 0.4 0.8 9.3 0.5 6.8 286.0 1.2 2.7 0.2 0.5 0.5 13.0 0.3 9.4 0.0 0.5 0.7 0.1 0.7 7.9 0.4 1.5 0.5 22.6 0.2 0.0 53.6 3.7 0.4 186.5 18.2 0.1 0.4 0.1 3.5 0.5 0.9 0.4 1.9 0.0 28.3 0.7 145.9 0.5 12.6 15.8 0.0 0.3 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.9 74.2 0.1 0.1 0.0 0.7 3.9 0.1 0.3 0.0 0.5 0.4 0.0 0.5 0.5 0.0 0.0 7.2 0.2 2.1 0.0 0.0 0.1 0.0 0.8 0.1 0.1 0.0 46.8 0.0 0.5 0.0 122.9 0.0 0.1 0.0 0.1 0.0 3.5 0.2 0.1 0.0 6.2 0.3 0.0 36.7 0.1 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.4 0.3 0.5 0.1 0.0 0.3 0.2 0.6 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.5 0.4 0.6 0.8 0.5 0.5 0.5 0.7 0.5 0.4 0.9 0.5 0.4 19.2 0.5 1.0 0.0 24.1 30.5 11.6 0.0 0.0 16.8 12.4 0.6 5.7 40.2 9.2 0.0 3.2 0.0 4.4 0.0 12.2 0.0 15.7 1.4 0.9 4.8 0.0 1.0 1.2 3.1 1.2 2.6 17.5 0.0 0.1 0.0 0.3 0.7 0.0 0.9 12.6 24.4 0.0 4.8 0.9 0.3 0.4 12.4 1.0 0.0 1.6 0.0 0.5 0.8 18.5 7.9 0.0 0.0 62.3 75.9 1.3 6.7 0.6 0.0 0.1 2.2 0.2 11.1 56.0 137.4 1.9 0.6 2.0 9.2 114.6 SUPT3H "SPT3, SPT3L" ENSG00000196284 "SPT3 homolog, SAGA and STAGA complex component" O75486 6 44809317-45377953 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in all" 6 "Astrocytes: 110.7;Early spermatids: 142.2;Excitatory neurons: 286.4;Inhibitory neurons: 405.2;Late spermatids: 183.4;Microglial cells: 124.6;Oligodendrocyte precursor cells: 182.9;Oligodendrocytes: 192.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024371 Enhanced Supported Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA024371: AB_1857660" "unprognostic (5.72e-3)" "unprognostic (7.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.34e-1)" "prognostic favorable (3.55e-4)" "unprognostic (1.07e-2)" "unprognostic (6.15e-5)" "unprognostic (7.46e-2)" "unprognostic (1.75e-1)" "prognostic favorable (1.72e-4)" "unprognostic (1.49e-1)" "unprognostic (2.30e-1)" "unprognostic (2.05e-2)" "unprognostic (3.08e-2)" "unprognostic (1.23e-1)" "unprognostic (8.13e-3)" "unprognostic (4.31e-2)" 2.4 5.1 3.6 1.2 4.1 1.2 2.4 4.8 5.7 4.4 0.0 3.6 2.2 3.5 4.2 2.9 4.1 2.0 1.8 3.9 4.7 4.3 1.6 2.4 1.7 4.5 3.3 5.2 3.8 3.8 3.2 3.4 3.6 4.4 2.3 4.2 7.2 2.1 1.6 1.4 2.4 2.5 1.8 1.8 2.2 8.9 5.7 2.7 4.4 0.5 1.9 3.2 2.4 5.7 5.2 2.4 12.9 6.8 2.7 7.8 4.3 3.2 4.0 7.2 8.9 4.0 4.0 2.0 3.0 1.5 6.2 2.2 9.0 7.1 13.2 5.0 3.6 1.4 1.9 10.4 6.4 3.9 1.5 4.2 5.7 3.7 10.0 20.5 3.7 7.2 4.7 3.7 6.6 1.5 4.0 8.2 4.6 11.2 1.1 8.8 5.7 2.2 10.2 4.2 6.4 3.1 0.7 0.8 10.2 16.7 3.3 3.8 1.3 6.4 0.1 4.6 7.3 7.2 2.2 12.3 5.0 7.9 6.0 0.1 0.3 0.1 2.9 0.5 5.1 1.2 4.4 3.4 1.4 1.6 5.1 4.3 0.2 2.3 0.7 3.9 1.9 1.6 3.6 4.1 4.8 5.7 3.9 4.7 4.5 3.3 3.6 1.8 5.7 5.7 4.5 3.2 4.8 110.7 11.5 1.8 14.5 10.0 8.6 7.4 5.1 6.7 3.0 2.8 7.2 7.3 6.2 11.7 19.7 1.2 11.7 8.4 142.2 5.4 4.5 5.7 8.4 5.9 286.4 3.2 12.3 7.2 6.6 6.3 3.8 16.0 7.1 3.0 8.7 3.3 405.2 2.3 2.0 2.9 5.0 183.4 7.8 4.5 5.4 124.6 10.5 2.8 20.6 182.9 192.9 4.0 2.1 5.3 14.7 11.3 1.9 10.7 8.3 13.5 13.1 6.8 16.0 26.8 22.0 6.2 1.3 8.2 30.7 7.8 3.7 9.3 SURF4 "ERV29, FLJ22993, MGC102753" ENSG00000148248 "Surfeit 4" O15260 9 133361450-133376166 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 325.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064613 Approved Supported "Nuclear membrane,Endoplasmic reticulum,Golgi apparatus,Cytosol" NA Yes 65000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Nuclear membrane, Endoplasmic reticulum, Golgi apparatus" Cytosol "HPA064613: AB_2685299" "prognostic unfavorable (5.85e-4)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (2.04e-2)" "unprognostic (3.40e-2)" "prognostic unfavorable (1.47e-5)" "prognostic unfavorable (8.11e-4)" "unprognostic (1.10e-3)" "unprognostic (3.13e-2)" "unprognostic (1.90e-1)" "unprognostic (5.30e-3)" "unprognostic (1.23e-1)" "unprognostic (9.76e-3)" "unprognostic (7.58e-3)" "unprognostic (1.25e-1)" "unprognostic (2.29e-1)" "unprognostic (4.29e-3)" 97.0 106.4 20.3 38.8 22.5 66.5 76.5 22.1 23.4 70.5 27.9 72.1 79.2 78.5 40.6 77.6 71.1 39.0 74.1 21.5 22.3 67.1 223.8 84.2 29.6 23.6 22.2 61.0 150.4 35.4 88.6 55.4 22.2 69.2 37.9 14.0 86.4 39.5 60.1 63.2 82.2 43.4 22.9 59.6 88.5 49.4 25.8 27.8 68.2 23.3 31.4 62.7 59.4 25.9 59.8 96.4 65.3 90.3 134.8 140.2 127.4 184.1 178.4 127.0 124.7 145.9 84.8 41.1 70.6 254.2 122.9 152.7 75.7 94.4 97.0 86.5 46.3 72.1 87.1 156.5 156.2 124.8 94.1 150.4 85.8 109.3 120.2 101.6 118.6 62.9 89.0 109.8 164.5 131.8 60.1 115.4 72.7 162.8 96.2 41.2 89.9 156.5 100.4 56.3 53.8 65.5 136.4 100.4 95.2 61.5 106.6 75.8 127.5 179.4 64.5 137.3 119.6 56.1 86.4 46.4 166.7 66.6 137.5 43.9 40.8 36.2 51.9 32.8 56.9 15.1 36.3 48.4 32.9 12.1 22.0 34.6 28.4 29.4 31.7 38.9 46.9 68.8 20.3 22.5 22.1 23.4 21.5 22.3 23.6 22.2 22.2 22.9 25.8 25.9 53.5 44.8 48.1 18.9 43.0 60.8 65.8 72.5 46.1 21.9 55.5 43.2 42.6 31.5 47.5 35.0 39.6 167.9 80.4 106.9 19.6 95.7 38.6 28.6 72.8 54.8 75.2 31.1 23.2 118.1 254.4 84.8 78.5 67.7 24.7 49.5 47.5 207.3 85.9 33.7 15.6 107.9 30.5 52.3 50.5 19.7 68.3 50.8 40.9 17.8 53.7 53.3 52.5 22.6 23.8 115.1 65.5 53.0 114.8 106.8 151.3 48.5 23.2 26.9 78.9 51.9 80.6 84.4 47.3 46.1 62.4 325.2 90.5 81.8 81.2 84.2 SYTL2 "CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2" ENSG00000137501 "Synaptotagmin like 2" Q9HCH5 11 85694224-85811159 "Plasma proteins, Predicted intracellular proteins, Transporters" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 74.2;stomach 1: 127.7" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 382.2;granulocytes: 130.8;Intestinal goblet cells: 185.9;Respiratory ciliated cells: 138.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 14.0;MAIT T-cell: 23.7" "Lineage enriched" "Detected in many" 5 "T-cells: 23.7" "Cell line enhanced" "Detected in many" "MCF7: 91.1;OE19: 148.1;RH-30: 175.8;RPTEC TERT1: 124.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039651 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Nucleoplasm, Golgi apparatus" "Plasma membrane" "HPA039651: AB_10795153" "unprognostic (8.07e-3)" "unprognostic (6.72e-3)" "prognostic favorable (2.67e-4)" "unprognostic (9.34e-4)" "unprognostic (6.60e-3)" "unprognostic (2.19e-4)" "unprognostic (2.24e-2)" "unprognostic (5.37e-2)" "unprognostic (5.56e-2)" "unprognostic (5.45e-2)" "unprognostic (1.92e-2)" "unprognostic (2.97e-2)" "unprognostic (2.85e-2)" "unprognostic (4.03e-1)" "unprognostic (1.87e-2)" "unprognostic (9.72e-2)" "prognostic favorable (9.07e-4)" 16.7 9.6 19.3 12.9 24.6 3.3 16.0 8.7 35.7 10.7 11.9 51.7 21.6 9.1 16.3 17.0 7.6 27.8 8.4 29.0 25.1 20.2 6.9 14.8 11.1 26.4 14.0 4.8 2.7 6.4 6.1 18.2 17.9 13.6 74.2 13.3 8.9 9.8 5.1 6.8 25.0 10.2 15.6 10.4 127.7 5.1 13.8 7.1 4.7 2.7 6.8 50.9 7.4 29.1 3.5 8.0 12.2 1.0 2.8 15.4 0.2 30.3 39.4 26.3 59.2 34.7 4.5 0.7 11.1 21.3 38.0 22.3 0.8 2.7 34.5 2.4 0.2 0.0 0.2 0.3 1.8 2.7 0.5 19.6 3.8 56.8 0.8 6.2 0.2 1.0 0.4 0.4 33.6 91.1 0.1 0.9 20.6 148.1 13.6 1.3 175.8 0.1 124.2 46.8 0.3 0.6 6.7 5.4 3.0 10.2 0.6 0.5 0.1 40.8 15.6 25.9 1.5 0.2 0.0 16.1 41.9 0.5 25.7 0.0 0.0 0.0 14.0 0.0 23.7 0.0 2.8 8.4 0.0 0.1 2.3 4.1 0.0 4.6 0.1 1.0 1.1 2.6 19.3 24.6 8.7 35.7 29.0 25.1 26.4 14.0 17.9 15.6 13.8 29.1 7.5 22.4 32.5 15.3 3.0 3.6 11.7 15.8 1.8 10.4 45.4 14.0 2.3 8.6 62.1 68.0 8.4 0.7 45.6 115.2 0.0 9.1 1.2 8.0 2.2 6.4 19.2 4.0 103.9 16.9 0.4 11.5 382.2 2.3 130.8 0.8 5.0 0.5 0.5 1.7 23.2 185.9 2.0 5.9 5.0 0.9 1.8 4.6 10.6 20.6 1.6 14.0 63.8 35.7 91.9 16.5 40.6 30.1 31.6 30.7 16.3 8.6 138.4 8.1 32.9 42.1 59.8 3.6 2.6 2.2 5.7 0.4 50.1 2.3 36.7 60.9 TBC1D31 "Gm85, MGC21654, WDR67" ENSG00000156787 "TBC1 domain family member 31" Q96DN5 8 123041968-123152153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 20.6" "Cell type enhanced" "Detected in many" "Astrocytes: 19.9;Excitatory neurons: 23.4;Inhibitory neurons: 32.0;NK-cells: 24.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 83.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023710 Approved Approved Centrosome NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" Centrosome "HPA023710: AB_1858819" "unprognostic (1.39e-1)" "unprognostic (5.44e-3)" "unprognostic (7.21e-2)" "unprognostic (3.18e-5)" "unprognostic (2.42e-1)" "unprognostic (8.98e-2)" "unprognostic (2.63e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (1.53e-2)" "unprognostic (6.59e-2)" "unprognostic (8.88e-2)" "unprognostic (1.13e-1)" "unprognostic (1.18e-4)" "unprognostic (1.78e-3)" "unprognostic (1.57e-1)" "unprognostic (1.76e-2)" "unprognostic (2.33e-1)" 3.9 2.5 5.8 6.0 7.8 7.4 2.0 20.6 6.6 1.7 5.2 4.2 5.4 2.4 1.4 2.5 4.2 2.2 2.7 7.3 4.1 2.8 3.1 2.5 7.2 4.3 5.5 1.7 3.8 2.9 3.5 1.9 5.1 2.3 3.5 4.9 2.4 1.7 4.4 2.9 4.8 2.7 4.4 5.8 3.4 5.1 6.0 14.4 3.1 2.5 6.1 2.2 1.7 7.3 30.6 19.5 15.4 12.9 5.1 5.5 10.9 17.5 6.4 14.0 12.7 17.9 11.4 11.2 21.5 4.7 9.5 21.1 14.3 7.2 19.7 31.3 31.6 28.8 13.5 8.3 7.7 11.9 20.3 4.4 4.2 11.6 11.9 4.1 10.2 31.0 24.0 23.1 10.2 50.5 37.2 8.1 12.8 26.5 29.8 21.2 14.5 16.8 9.4 11.1 16.8 14.7 31.5 83.2 9.7 9.8 15.8 9.2 8.8 12.8 31.9 11.9 22.1 34.5 58.1 15.1 13.2 20.1 19.0 9.1 10.0 10.6 17.4 12.6 26.6 9.2 10.6 14.3 8.8 8.4 10.8 12.3 5.8 20.5 11.2 7.9 11.6 15.6 5.8 7.8 20.6 6.6 7.3 4.1 4.3 5.5 5.1 4.4 6.0 7.3 2.7 0.0 3.4 19.9 3.7 0.5 1.0 2.4 1.2 2.7 1.0 1.3 14.0 0.0 1.4 1.8 6.2 1.6 10.4 2.4 0.0 1.8 4.9 3.4 3.2 2.4 3.0 12.8 23.4 1.1 2.6 2.6 2.6 1.2 7.6 4.2 1.1 1.8 3.9 0.0 32.0 2.0 0.0 6.6 1.9 2.9 1.5 3.8 1.8 14.0 4.6 1.3 24.7 11.1 13.4 1.0 0.6 1.5 5.8 0.7 1.2 2.2 3.7 5.9 0.0 2.4 2.3 10.9 2.7 4.1 1.3 0.1 12.5 2.5 3.5 0.6 TC2N "C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N" ENSG00000165929 "Tandem C2 domains, nuclear" Q8N9U0 14 91779746-91867536 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 103.0" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 211.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 84.6" "Group enriched" "Detected in many" 47 "NK-cells: 39.2;T-cells: 84.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.1;OE19: 63.8;RT4: 37.3;SK-BR-3: 43.9;T-47d: 22.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA027549 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 58: T-cells - T-cell receptor" "Nucleoplasm, Nuclear bodies" "HPA027549: AB_10603346" "unprognostic (5.36e-2)" "unprognostic (1.95e-1)" "unprognostic (4.70e-2)" "unprognostic (1.51e-1)" "unprognostic (7.17e-3)" "unprognostic (3.34e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-2)" "unprognostic (3.44e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (9.86e-4)" "unprognostic (3.00e-1)" "prognostic favorable (4.13e-5)" "unprognostic (6.82e-2)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.09e-2)" 14.3 2.3 0.1 14.2 0.7 5.1 27.7 0.2 0.5 9.5 1.4 16.5 12.1 11.4 5.1 21.6 11.8 25.2 8.5 0.2 0.3 6.9 2.9 14.4 22.0 3.1 0.5 6.5 103.0 19.8 6.9 1.5 1.6 17.2 15.2 0.5 46.5 7.8 3.1 13.7 14.5 5.8 1.4 11.1 24.9 5.9 0.7 11.5 12.5 1.2 24.5 18.4 13.9 0.7 9.2 1.5 0.0 0.0 1.6 0.0 12.2 0.0 0.2 0.0 0.0 6.5 19.1 6.0 0.4 0.1 0.2 1.0 9.0 9.0 0.0 0.1 4.7 0.0 2.4 0.0 0.0 0.0 0.0 0.2 9.3 0.0 0.5 0.0 0.0 0.5 0.1 4.7 0.0 16.3 0.0 0.0 1.3 63.8 0.0 0.1 0.0 0.0 4.3 37.3 7.0 0.0 0.8 43.9 0.0 2.4 22.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 38.4 0.1 84.6 0.7 42.0 49.0 0.1 0.2 33.6 28.7 1.3 39.2 0.2 0.2 14.8 22.5 0.1 0.7 0.2 0.5 0.2 0.3 3.1 0.5 1.6 1.4 0.7 0.7 10.0 41.7 79.6 0.7 12.4 53.4 31.3 38.1 33.6 0.4 94.3 34.3 0.9 48.6 73.1 25.8 0.0 1.0 39.6 50.2 1.9 73.3 18.5 51.4 13.6 10.9 31.8 1.7 14.4 211.7 3.6 21.2 124.4 118.6 7.0 2.5 5.7 0.6 0.3 0.0 1.8 58.5 48.8 3.0 12.7 32.7 56.8 4.0 60.5 10.3 3.1 3.5 53.5 0.5 1.6 91.7 40.0 12.8 15.6 49.1 13.6 7.5 81.0 0.1 0.0 13.2 4.5 33.8 11.8 45.4 82.5 5.5 111.0 0.1 51.7 86.8 TDRKH TDRD2 ENSG00000182134 "Tudor and KH domain containing" Q9Y2W6 1 151770107-151791416 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, RNA-mediated gene silencing, Spermatogenesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 30.1;testis: 22.2" "Cell type enhanced" "Detected in many" "Early spermatids: 23.9;Late spermatids: 60.4;Spermatocytes: 43.2;Spermatogonia: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016419, HPA019625" Approved Approved Centrosome,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 6: T47d - Mammary gland" "Cluster 25: Spermatids - Spermatogenesis" Cytosol Centrosome "HPA016419: AB_1857870, HPA019625: AB_1857871" "unprognostic (2.27e-3)" "unprognostic (2.89e-1)" "unprognostic (8.60e-2)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.29e-1)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (2.63e-1)" "unprognostic (2.91e-1)" "unprognostic (2.06e-1)" "unprognostic (3.06e-2)" "unprognostic (1.10e-1)" "unprognostic (5.63e-2)" "unprognostic (8.70e-2)" "unprognostic (1.67e-1)" "unprognostic (1.59e-3)" "unprognostic (1.14e-1)" 2.5 3.1 5.1 4.4 5.1 1.4 4.5 7.9 5.8 2.1 2.3 3.2 2.2 1.6 6.0 1.8 2.0 1.9 3.5 5.5 6.0 4.0 3.6 4.4 5.9 7.4 5.8 0.9 3.0 30.1 4.6 3.6 8.2 6.0 4.0 9.6 7.0 5.7 4.2 2.2 2.2 2.8 4.7 6.3 2.9 22.2 6.0 10.0 7.3 4.9 5.4 2.6 1.7 5.4 10.8 9.4 8.1 18.8 0.5 0.8 7.7 1.8 1.0 5.6 3.7 6.1 15.1 12.6 16.3 0.7 13.1 6.4 11.9 12.5 8.5 32.5 8.3 12.6 2.6 4.2 3.4 2.4 2.0 1.0 4.8 11.8 5.0 1.6 5.9 24.3 9.8 11.0 1.8 29.3 20.3 3.9 6.2 16.0 16.0 2.5 5.0 26.2 9.6 5.3 11.7 19.2 13.2 10.5 12.4 14.5 22.9 9.4 2.4 2.6 4.6 8.2 10.2 22.2 29.4 14.1 12.0 10.1 3.6 5.2 0.9 2.0 8.2 4.3 12.5 3.9 7.6 8.3 2.0 3.6 5.6 6.9 0.6 7.7 8.0 5.3 9.9 4.1 5.1 5.1 7.9 5.8 5.5 6.0 7.4 5.8 8.2 4.7 6.0 5.4 1.0 3.2 8.3 2.3 2.5 0.3 2.1 1.5 0.6 3.4 4.4 1.1 4.8 0.0 2.2 7.3 4.2 2.7 2.4 0.7 1.9 3.1 23.9 1.5 0.2 1.7 0.0 2.1 6.6 2.5 2.9 0.5 2.6 1.2 4.5 4.6 1.4 1.6 5.4 6.7 5.9 0.9 2.0 2.6 1.3 60.4 0.3 2.3 1.8 2.8 2.2 1.8 0.0 6.0 8.3 1.9 0.3 2.2 1.9 1.6 0.1 1.4 1.4 3.5 13.1 1.9 1.0 43.2 27.4 0.4 0.1 2.5 2.9 0.6 0.9 1.8 TEX48 ENSG00000230601 "Testis expressed 48" A0A1B0GUV7 9 114666434-114682192 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 36 "testis: 26.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "Karpas-707: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 74: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" "unprognostic (2.70e-1)" "unprognostic (6.41e-2)" "unprognostic (7.83e-2)" "unprognostic (2.53e-1)" "unprognostic (5.10e-2)" "unprognostic (2.33e-2)" "unprognostic (1.70e-1)" "unprognostic (5.11e-2)" "unprognostic (1.51e-1)" "unprognostic (4.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.1 1.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 5.8 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.7 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 THEM5 FLJ37964 ENSG00000196407 "Thioesterase superfamily member 5" Q8N1Q8 1 151847101-151853712 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 24 "skin 1: 158.5" "Cell type enriched" "Detected in some" 18 "Suprabasal keratinocytes: 34.7" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 2.1;cerebral cortex: 4.0;hippocampal formation: 3.0;white matter: 1.0" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 6 "T-cells: 1.7" "Cell line enriched" "Detected in some" 7 "HDLM-2: 57.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "basal ganglia: 13.8" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 44: HDLM-2 - Immune response" "Cluster 28: Keratinocytes - Keratinization" "unprognostic (2.28e-2)" "unprognostic (1.21e-1)" "unprognostic (1.07e-1)" "unprognostic (3.41e-2)" "unprognostic (2.58e-3)" "unprognostic (9.55e-3)" "unprognostic (1.27e-1)" "unprognostic (1.93e-1)" "unprognostic (1.83e-1)" "unprognostic (7.86e-3)" "unprognostic (3.07e-3)" "unprognostic (9.37e-2)" "unprognostic (1.20e-1)" "unprognostic (1.97e-2)" "unprognostic (2.49e-1)" "unprognostic (5.34e-2)" "unprognostic (1.62e-2)" 0.3 1.9 2.1 2.0 0.3 0.5 4.2 0.0 4.0 1.6 0.5 0.4 1.4 0.5 0.0 6.5 0.7 3.1 1.9 3.0 0.0 1.1 0.6 1.3 6.3 0.3 0.0 0.2 1.3 0.0 0.5 0.5 0.2 0.4 0.0 0.7 3.1 0.0 1.3 158.5 0.8 0.0 0.0 1.0 1.9 1.2 0.6 0.1 1.0 0.0 0.3 1.2 3.2 1.0 6.6 0.0 0.1 0.2 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 2.3 0.0 0.0 0.0 57.6 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.3 0.0 1.7 0.2 0.0 7.1 1.2 0.6 0.0 0.2 0.7 0.0 0.0 0.4 0.1 8.6 2.1 1.1 1.4 1.4 2.4 0.0 0.0 0.0 1.6 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.7 0.1 1.7 0.0 0.6 0.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.9 1.7 2.1 0.3 0.0 4.0 3.0 0.0 0.3 0.0 0.2 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.9 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.8 34.7 1.1 0.0 0.0 0.0 0.0 THY1 CD90 ENSG00000154096 "Thy-1 cell surface antigen" P04216 11 119415476-119424985 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 286.8;smooth muscle: 304.7;urinary bladder: 216.7" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 141.6;Excitatory neurons: 116.0;Fibroblasts: 201.9;Inhibitory neurons: 104.1;Muller glia cells: 108.1;Proximal tubular cells: 199.9;Smooth muscle cells: 226.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 461.3;BJ: 738.4;BJ hTERT+: 832.5;fHDF/TERT166: 1330.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003733, CAB068243, CAB068244" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 14000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Plasma membrane" "CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340" "unprognostic (9.98e-2)" "unprognostic (2.71e-1)" "unprognostic (5.13e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (6.87e-4)" "unprognostic (7.43e-2)" "unprognostic (1.43e-3)" "unprognostic (2.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.90e-3)" "unprognostic (3.38e-2)" "unprognostic (3.52e-1)" "prognostic unfavorable (2.40e-6)" "unprognostic (1.75e-2)" "unprognostic (1.90e-2)" "unprognostic (3.03e-2)" "unprognostic (1.14e-2)" 90.6 16.4 97.9 78.6 114.8 0.2 25.6 12.9 286.8 78.9 0.0 35.4 10.2 58.6 27.8 29.4 23.1 101.0 12.9 135.4 73.3 142.2 7.4 21.6 40.4 83.6 37.0 9.2 14.8 39.4 18.1 62.0 60.8 15.5 41.8 25.3 8.5 47.0 3.4 13.9 14.5 304.7 35.4 21.9 17.4 11.4 43.6 73.2 37.9 8.3 35.6 216.7 21.7 108.7 0.7 3.9 108.5 0.1 461.3 331.5 0.3 738.4 832.5 263.6 289.3 0.2 0.2 0.4 0.1 1330.6 121.9 0.9 4.3 1.1 200.7 65.1 0.0 41.5 14.4 0.0 142.7 0.0 0.2 247.5 0.0 335.6 11.6 355.2 0.3 22.6 0.0 0.6 206.5 0.1 0.6 0.1 173.9 0.0 1.4 0.5 50.7 0.3 0.1 0.2 18.1 47.9 0.1 0.4 0.2 32.9 1.0 2.1 0.0 368.6 120.9 107.3 110.1 0.3 19.7 0.4 1.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.9 114.8 12.9 286.8 135.4 73.3 83.6 37.0 60.8 35.4 43.6 108.7 68.2 0.0 1.8 17.3 2.1 17.7 0.3 1.7 0.0 27.2 1.6 40.0 0.9 0.0 0.0 9.2 0.0 1.9 0.2 0.0 21.5 0.9 1.0 5.1 141.6 69.2 0.0 0.0 116.0 0.0 2.6 201.9 1.5 3.2 1.3 0.0 17.5 0.1 4.0 32.0 104.1 0.0 0.0 0.0 25.0 2.7 96.3 2.7 17.8 21.5 0.0 108.1 0.0 64.3 22.7 0.4 0.0 77.5 0.1 0.3 0.0 199.9 0.0 27.5 32.9 9.3 226.6 0.3 0.6 0.2 17.6 4.0 4.5 6.2 0.0 0.6 TMEM117 DKFZp434K2435 ENSG00000139173 "Transmembrane protein 117" Q9H0C3 12 43835967-44389762 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Astrocytes: 65.6;Excitatory neurons: 220.2;Inhibitory neurons: 190.3;Microglial cells: 80.6;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 152.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046223 Uncertain NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA046223: AB_10960636" "unprognostic (1.37e-2)" "unprognostic (2.99e-1)" "unprognostic (4.32e-1)" "unprognostic (2.39e-2)" "unprognostic (3.57e-2)" "unprognostic (7.08e-2)" "unprognostic (3.07e-1)" "unprognostic (7.33e-2)" "prognostic unfavorable (3.94e-4)" "unprognostic (2.89e-1)" "unprognostic (6.26e-2)" "unprognostic (1.99e-3)" "unprognostic (1.74e-2)" "unprognostic (2.30e-2)" "unprognostic (2.65e-1)" "unprognostic (9.20e-3)" "unprognostic (3.80e-1)" 1.8 1.9 0.9 1.2 1.4 0.1 2.7 1.5 2.1 3.8 8.8 3.4 6.0 4.0 2.6 5.8 2.3 3.5 4.2 1.3 1.3 2.2 2.1 1.1 1.4 2.4 1.5 2.5 3.7 4.1 1.7 3.0 2.8 3.5 3.5 2.3 2.1 5.2 3.3 4.0 4.2 4.0 1.4 0.7 2.1 2.4 1.3 0.9 2.3 3.3 2.3 4.1 3.8 2.6 1.2 0.4 4.0 6.7 4.5 9.6 0.1 12.6 6.2 2.3 2.7 10.0 4.3 4.5 0.9 9.0 0.6 6.4 2.6 2.8 1.7 1.9 7.4 1.2 2.5 4.0 1.3 1.8 4.7 5.0 9.9 1.3 0.7 9.2 0.4 0.5 2.2 1.9 4.4 1.1 0.0 1.1 0.8 0.0 2.4 3.0 4.5 1.8 4.5 2.7 0.6 6.1 4.8 1.5 10.2 1.6 0.3 4.7 1.5 3.4 1.1 1.8 3.3 3.4 3.9 2.6 1.7 2.0 1.2 0.0 0.0 0.0 1.2 0.0 1.7 1.0 0.3 1.2 0.0 0.9 0.5 0.6 0.0 0.4 0.0 0.1 0.2 0.4 0.9 1.4 1.5 2.1 1.3 1.3 2.4 1.5 2.8 1.4 1.3 2.6 3.2 0.0 1.3 65.6 8.4 6.5 4.8 3.4 9.6 3.9 2.4 2.8 5.4 2.8 2.5 7.3 4.2 15.0 2.8 6.9 3.9 2.8 25.8 3.9 5.5 2.1 0.0 1.7 220.2 3.0 2.7 3.8 18.3 6.0 2.5 6.0 4.2 2.7 5.6 5.0 190.3 4.2 12.2 3.8 2.5 9.5 6.2 2.1 12.4 80.6 0.1 3.4 3.1 123.1 152.4 2.5 19.2 6.4 11.2 2.1 13.8 1.3 2.7 5.2 0.0 2.2 3.8 1.4 5.5 17.7 12.1 11.5 5.1 2.3 5.0 4.9 TMEM170A "FLJ37611, TMEM170" ENSG00000166822 "Transmembrane protein 170A" Q8WVE7 16 75443054-75465497 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (3.49e-1)" "unprognostic (1.18e-1)" "unprognostic (2.95e-2)" "unprognostic (1.52e-3)" "unprognostic (1.08e-1)" "unprognostic (3.33e-2)" "unprognostic (1.02e-2)" "unprognostic (8.62e-2)" "unprognostic (7.97e-2)" "unprognostic (3.19e-2)" "unprognostic (1.53e-1)" "unprognostic (7.15e-2)" "prognostic favorable (2.36e-9)" "unprognostic (4.37e-2)" "unprognostic (3.41e-1)" "unprognostic (7.80e-2)" "unprognostic (1.53e-3)" 8.2 9.8 7.7 10.6 10.6 36.6 6.0 9.2 9.0 7.7 7.9 12.1 14.5 8.0 6.0 8.4 7.6 7.8 7.2 7.4 9.3 9.2 12.7 8.0 11.9 11.3 10.2 10.2 10.2 3.9 8.7 10.2 9.9 7.6 10.1 14.9 6.5 3.2 3.7 7.8 13.7 6.3 9.3 9.2 7.3 17.4 8.5 6.8 9.7 4.9 9.7 8.1 7.8 16.9 14.2 17.1 21.8 22.3 9.5 7.7 38.9 9.2 5.2 7.4 11.3 35.3 30.7 19.6 17.0 4.4 16.4 25.9 18.3 8.9 13.0 12.0 11.4 10.6 16.4 22.4 6.3 25.3 27.3 6.7 6.8 12.5 9.4 8.7 6.5 22.7 21.8 15.2 3.9 28.8 22.3 16.8 26.1 17.2 9.2 43.5 8.5 15.7 5.1 18.3 12.8 14.9 22.4 7.0 12.6 25.6 9.4 11.6 9.6 12.6 21.4 10.1 10.2 13.7 17.3 60.3 9.8 14.7 14.4 14.5 26.6 38.2 27.9 29.1 36.6 28.9 29.1 31.8 24.0 28.8 30.9 27.3 33.3 25.4 26.9 26.8 23.1 21.6 7.7 10.6 9.2 9.0 7.4 9.3 11.3 10.2 9.9 9.3 8.5 16.9 39.7 19.2 15.0 20.5 49.0 19.9 45.7 37.8 26.7 25.6 37.7 27.1 9.3 40.0 25.3 20.2 37.5 73.0 65.0 86.2 25.4 26.8 40.5 62.5 23.6 37.2 34.1 17.1 17.6 19.3 51.5 24.3 16.8 67.7 28.6 57.3 35.3 24.2 37.2 37.0 15.9 37.6 22.4 31.8 29.7 8.7 24.2 38.3 21.4 11.2 41.2 43.7 42.2 24.1 29.8 23.3 67.6 21.4 29.2 57.5 53.5 30.2 32.4 38.3 32.9 19.9 20.1 88.5 61.8 19.7 20.0 53.4 49.0 36.7 56.0 67.8 TMEM171 PRP2 ENSG00000157111 "Transmembrane protein 171" Q8WVE6 5 73120569-73131809 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 35.6;kidney: 10.8;lymphoid tissue: 14.3;stomach 1: 25.4;thyroid gland: 31.1" "Cell type enhanced" "Detected in many" "Cholangiocytes: 28.6;Distal enterocytes: 106.0;Gastric mucus-secreting cells: 29.6;Ionocytes: 40.7;Paneth cells: 63.4;Proximal enterocytes: 41.9;Undifferentiated cells: 51.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "MAIT T-cell: 24.1;memory CD8 T-cell: 8.2" "Lineage enriched" "Detected in single" 89 "T-cells: 24.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 35.0;LHCN-M2: 66.1;RPTEC TERT1: 51.5;WM-115: 177.2" "Not detected" "Not detected" "Region enhanced" "Detected in some" "spinal cord: 3.7" HPA042308 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA042308: AB_10796901" "unprognostic (7.34e-2)" "unprognostic (4.13e-2)" "unprognostic (1.67e-1)" "unprognostic (7.74e-3)" "unprognostic (2.81e-5)" "unprognostic (1.12e-1)" "unprognostic (1.40e-1)" "unprognostic (1.44e-3)" "unprognostic (1.77e-1)" "unprognostic (1.85e-1)" "unprognostic (4.20e-2)" "unprognostic (1.22e-1)" "prognostic favorable (3.93e-10)" "unprognostic (6.13e-3)" "unprognostic (2.43e-1)" "unprognostic (9.10e-3)" "unprognostic (1.57e-1)" 0.1 0.1 2.0 3.1 3.5 0.0 1.6 1.8 2.8 0.3 1.3 35.6 27.7 0.0 0.7 4.8 0.4 0.8 0.0 2.1 2.5 10.8 2.1 0.2 0.4 1.9 2.9 0.1 0.8 0.9 0.1 0.5 2.2 0.1 33.1 0.1 0.5 3.8 0.7 1.0 19.8 1.2 1.5 14.3 25.4 0.6 2.9 0.5 31.1 0.6 3.0 0.7 0.2 3.7 23.4 1.0 0.0 0.2 7.3 10.3 0.0 7.1 35.0 13.6 23.1 0.7 10.7 0.0 15.0 9.4 2.7 17.3 0.3 1.1 11.2 0.0 3.7 0.0 0.2 0.0 2.7 0.0 1.1 2.2 0.9 18.9 1.6 5.3 8.7 0.0 0.0 0.3 66.1 2.3 0.0 0.1 1.9 0.3 1.4 0.0 0.0 12.5 51.5 0.3 0.1 0.0 5.4 0.2 0.1 3.9 1.2 0.1 0.0 0.2 1.2 19.8 0.4 0.0 0.0 0.0 18.1 0.0 177.2 0.0 0.0 0.0 1.6 0.0 24.1 0.0 0.9 8.2 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.8 2.0 3.5 1.8 2.8 2.1 2.5 1.9 2.9 2.2 1.5 2.9 3.7 0.2 0.0 0.0 0.0 0.6 1.8 0.6 25.4 1.2 0.0 6.8 0.4 0.3 28.6 9.2 7.3 0.0 0.2 0.0 106.0 15.6 6.9 0.0 0.2 0.1 0.9 2.4 0.0 0.3 9.9 0.4 1.4 29.6 0.5 0.0 0.0 0.7 1.5 1.3 0.0 0.3 21.2 40.7 0.0 0.4 0.0 0.0 0.1 1.8 1.9 0.0 0.0 5.2 1.0 9.7 10.4 63.4 0.0 0.1 0.8 41.9 8.9 4.4 0.0 0.0 0.0 0.4 0.2 1.7 6.5 1.7 0.5 1.0 0.0 51.4 1.0 TMPRSS3 "DFNB10, DFNB8" ENSG00000160183 "Transmembrane serine protease 3" P57727 21 42371887-42396091 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 23.7;stomach 1: 14.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 17.7;Cholangiocytes: 24.3;Ductal cells: 16.1;Endometrial ciliated cells: 17.1;Gastric mucus-secreting cells: 23.4;Ionocytes: 16.2;Muller glia cells: 20.4;Respiratory ciliated cells: 39.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 16.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 3.1" "Lineage enriched" "Detected in single" 6 "T-cells: 3.1" "Cell line enriched" "Detected in some" 4 "U-266/84: 274.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 16: U-266 - Nucleosome" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (8.47e-3)" "unprognostic (2.83e-1)" "prognostic unfavorable (3.64e-4)" "unprognostic (2.85e-1)" "unprognostic (2.45e-3)" "unprognostic (3.97e-2)" "unprognostic (1.43e-1)" "unprognostic (8.17e-2)" "unprognostic (9.62e-2)" "unprognostic (4.81e-2)" "unprognostic (2.65e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (8.24e-4)" "unprognostic (2.66e-2)" "unprognostic (2.73e-1)" "unprognostic (8.00e-2)" "unprognostic (1.33e-1)" 0.5 0.3 3.8 0.2 4.0 0.1 8.7 4.0 3.7 6.3 2.0 0.2 1.3 0.7 0.0 0.2 23.7 8.6 0.0 3.4 4.1 2.4 0.5 3.4 0.5 4.9 4.7 0.0 3.0 0.0 1.5 0.2 3.7 0.4 0.1 3.9 9.2 0.4 0.1 0.1 1.1 0.0 3.5 0.4 14.5 0.0 4.7 0.9 2.9 0.0 0.4 1.0 0.0 2.7 4.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 32.9 0.0 66.2 26.5 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.6 0.0 14.0 0.0 1.5 3.5 0.0 0.0 1.0 0.4 0.0 0.0 0.0 2.8 1.5 0.0 0.0 33.9 1.6 0.0 0.0 3.2 0.3 0.1 0.0 1.7 0.0 0.2 0.7 274.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 3.1 0.0 1.7 1.8 0.0 0.0 0.3 0.9 0.3 0.0 0.5 0.0 0.8 0.5 3.8 4.0 4.0 3.7 3.4 4.1 4.9 4.7 3.7 3.5 4.7 2.7 0.1 12.8 3.7 2.3 0.4 0.3 2.3 8.1 0.0 0.2 17.7 9.9 0.6 24.3 10.8 7.3 0.0 0.0 0.1 1.4 5.9 16.1 1.4 17.1 0.4 0.2 0.0 2.7 0.0 13.8 0.1 1.3 23.4 5.2 0.0 0.2 0.4 0.0 0.1 0.0 0.0 2.0 16.2 0.0 0.5 0.6 0.3 0.3 0.0 0.0 0.0 20.4 0.0 0.0 0.1 11.8 1.4 0.0 0.4 2.4 2.9 0.0 39.8 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 1.4 0.1 2.5 5.0 TPBG "5T4, 5T4-AG" ENSG00000146242 "Trophoblast glycoprotein" Q13641 6 82363206-82367420 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 120.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 8 "MAIT T-cell: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 94.6;hTCEpi: 115.2;hTEC/SVTERT24-B: 98.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA010554 Enhanced Approved Nucleoplasm NA NA 310000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "HPA010554: AB_1858206" "unprognostic (3.03e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (6.68e-4)" "unprognostic (1.06e-1)" "unprognostic (4.52e-3)" "unprognostic (7.47e-3)" "unprognostic (8.55e-2)" "unprognostic (3.55e-3)" "unprognostic (8.39e-2)" "unprognostic (3.42e-2)" "unprognostic (8.02e-2)" "unprognostic (4.94e-1)" "unprognostic (3.77e-1)" "unprognostic (7.46e-2)" "unprognostic (1.06e-1)" "unprognostic (1.54e-1)" "unprognostic (5.57e-2)" 19.9 2.5 1.6 3.3 20.6 0.5 17.3 0.4 5.7 24.2 0.6 8.5 3.5 15.8 2.6 26.3 14.9 6.9 9.1 0.2 4.2 10.7 1.5 7.5 1.9 8.2 11.4 6.0 8.3 4.2 14.2 6.2 9.3 15.3 3.0 0.2 20.1 7.0 2.9 15.9 8.0 6.7 3.1 9.9 9.0 3.6 3.6 4.2 15.7 1.9 3.0 35.1 20.2 3.6 17.1 27.6 8.7 21.2 35.2 40.4 17.6 84.9 94.6 16.7 22.0 3.9 26.9 0.0 9.6 39.5 51.9 37.3 10.3 44.6 13.9 0.0 14.5 11.9 13.1 0.8 29.1 0.9 9.2 25.8 115.2 98.5 34.1 12.9 4.5 0.7 2.3 0.2 3.9 37.8 0.0 0.0 12.5 8.8 22.3 0.0 19.4 0.2 24.4 25.8 4.4 16.9 20.9 28.3 0.0 16.2 49.4 3.5 10.8 15.1 15.8 33.5 19.2 0.1 0.0 0.0 71.3 1.3 17.8 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 20.6 0.4 5.7 0.2 4.2 8.2 11.4 9.3 3.1 3.6 3.6 16.4 12.8 6.5 2.3 0.2 67.9 78.2 120.3 68.3 1.1 44.6 24.0 2.1 21.5 62.4 55.2 0.0 42.7 0.4 9.0 0.0 35.8 8.6 29.2 38.7 25.4 1.2 0.0 21.3 45.4 82.5 48.0 14.8 68.0 0.0 3.8 11.0 0.2 3.6 1.7 0.9 20.2 75.3 0.6 11.5 6.5 12.8 2.3 17.8 7.5 0.1 2.1 0.0 2.0 3.2 38.2 17.8 6.0 0.0 51.9 1.9 0.7 29.9 0.3 32.9 55.6 47.0 13.7 11.8 25.2 31.3 65.9 3.5 9.7 10.8 78.8 TRAJ19 ENSG00000211870 "T cell receptor alpha joining 19 (non-functional)" 14 22525263-22525322 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 7.5;retina: 20.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 1.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 1.7;memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Group enriched" "Detected in some" 22 "U-266/84: 2.3;U-698: 2.0" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 16: U-266 - Nucleosome" "unprognostic (2.39e-2)" 0.0 2.2 4.7 2.4 3.9 1.9 1.3 2.8 2.4 0.0 1.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.3 0.0 1.0 7.5 2.9 1.4 0.0 0.0 0.0 0.0 1.0 2.9 0.4 0.8 20.7 0.0 0.0 0.0 3.4 0.0 1.3 0.9 1.9 3.3 0.6 1.3 7.0 0.4 0.0 0.0 1.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.9 1.7 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.3 4.7 3.9 2.8 2.4 0.7 0.7 2.9 1.4 2.9 0.9 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ2 ENSG00000211887 "T cell receptor alpha joining 2 (non-functional)" 14 22544071-22544136 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "retina: 73.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 0.7" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 1.7;memory CD8 T-cell: 2.6" "Lineage enriched" "Detected in single" 27 "T-cells: 2.6" "Cell line enriched" "Detected in some" 9 "JURKAT: 73.0" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "unprognostic (1.43e-1)" 0.0 0.0 0.4 7.4 0.9 2.2 0.0 0.6 1.4 2.3 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 4.9 10.0 1.3 0.7 0.0 0.0 0.0 0.0 0.6 0.5 0.7 4.5 73.1 0.0 0.0 0.0 0.0 8.0 0.0 0.7 15.4 6.7 0.1 0.4 12.9 0.0 0.0 2.7 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 73.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.7 2.6 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.9 0.6 1.4 0.3 0.1 1.3 0.7 0.5 0.7 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ33 ENSG00000211856 "T cell receptor alpha joining 33" 14 22508602-22508658 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "intestine: 8.7;lymphoid tissue: 15.5;retina: 18.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 5 "MAIT T-cell: 2136.5" "Lineage enriched" "Detected in all" 464 "T-cells: 2136.5" "Group enriched" "Detected in some" 8 "MOLT-4: 64.5;U-698: 52.8" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" 0.0 0.0 1.2 15.5 2.6 3.1 0.8 1.7 1.0 0.0 1.8 0.9 8.7 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.6 1.5 0.3 1.3 4.1 1.6 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.8 18.8 0.0 0.0 0.0 0.8 6.5 0.0 1.3 3.1 0.0 0.6 1.7 6.4 0.0 0.0 10.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 52.8 0.0 0.0 0.0 3.0 1.5 1.0 14.7 0.5 2136.5 4.6 104.9 398.8 0.3 1.3 131.6 120.2 2.5 3.4 1.1 1.2 158.4 50.3 1.2 2.6 1.7 1.0 0.3 0.6 1.6 0.7 1.0 1.3 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAV1-2 ENSG00000256553 "T cell receptor alpha variable 1-2" A0A0B4J238 14 21642889-21643578 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 19.3" "Cell type enriched" "Detected in single" 6 "T-cells: 4.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 7 "MAIT T-cell: 2027.8" "Lineage enriched" "Detected in many" 507 "T-cells: 2027.8" "Not detected" "Not detected" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.19e-3)" "unprognostic (1.29e-3)" "unprognostic (1.59e-2)" "unprognostic (1.84e-3)" "unprognostic (5.87e-3)" "unprognostic (1.55e-3)" "unprognostic (3.56e-2)" "unprognostic (8.90e-2)" "unprognostic (6.50e-4)" "unprognostic (3.16e-1)" "unprognostic (1.68e-1)" "unprognostic (1.13e-2)" "unprognostic (2.15e-1)" "unprognostic (1.43e-1)" "unprognostic (8.99e-2)" "unprognostic (8.30e-2)" 0.3 0.7 0.0 4.5 0.0 1.3 0.4 0.0 0.4 0.6 0.0 1.2 1.6 0.3 0.3 0.5 0.7 3.1 0.1 0.0 0.0 0.2 1.1 2.0 7.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 1.1 0.0 0.3 0.0 0.0 0.4 1.3 0.3 0.1 4.6 1.5 0.1 0.0 19.3 0.5 0.0 7.2 2.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.3 0.7 1.0 0.6 2027.8 0.4 44.9 311.2 0.8 0.2 40.9 70.0 3.9 0.3 1.3 1.7 79.5 40.4 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 TRAV9-1 ENSG00000211783 "T cell receptor alpha variable 9-1" A0A075B6T8 14 21811502-21811977 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 16: MAIT-cells - Unknown function" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBV4-2 "TCRBV4S2, TCRBV7S3A2T, TRBV42" ENSG00000211745 "T cell receptor beta variable 4-2" A0A539 7 142345421-142345985 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "lymphoid tissue: 21.0" "Cell type enriched" "Detected in some" 8 "T-cells: 23.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 100.2" "Lineage enriched" "Detected in single" 293 "T-cells: 100.2" "Not detected" "Not detected" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (2.89e-3)" "unprognostic (4.65e-4)" "unprognostic (1.28e-3)" "unprognostic (1.06e-2)" "unprognostic (4.60e-2)" "unprognostic (7.05e-4)" "unprognostic (2.11e-1)" "unprognostic (1.67e-2)" "unprognostic (1.19e-3)" "unprognostic (1.32e-2)" "unprognostic (6.75e-2)" "unprognostic (3.42e-1)" "unprognostic (2.82e-4)" "unprognostic (5.50e-2)" "unprognostic (5.99e-2)" "unprognostic (2.16e-1)" "unprognostic (1.48e-2)" 0.2 0.0 0.0 1.4 0.0 0.6 0.1 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.3 0.2 0.4 5.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 1.5 0.1 0.0 2.3 0.3 0.5 0.0 21.0 0.3 0.0 4.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 100.2 0.0 25.6 27.8 0.1 0.0 23.9 14.4 0.1 0.0 0.2 0.3 44.8 8.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 23.9 0.0 0.0 0.0 TRBV5-3 "TCRBV5S3, TCRBV5S5P, TRBV53" ENSG00000211715 "T cell receptor beta variable 5-3 (non-functional)" 7 142389202-142389668 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 27 "MAIT T-cell: 2.7" "Lineage enriched" "Detected in single" 27 "T-cells: 2.7" "Not detected" "Not detected" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 58: T-cells - T-cell receptor" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBV6-2 "TCRBV13S2A1T, TCRBV6S2, TRBV62" ENSG00000283063 "T cell receptor beta variable 6-2" "A0A0J9YXY3, P0DPF7" 7 142349152-142349664 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 8.2" "Cell type enriched" "Detected in single" 10 "T-cells: 6.2" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 92.1" "Lineage enriched" "Detected in single" 175 "T-cells: 92.1" "Not detected" "Not detected" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" 0.2 0.0 0.0 2.4 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.5 8.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 1.5 0.1 0.0 2.3 0.2 0.0 0.0 4.6 0.3 0.0 5.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 92.1 0.2 24.0 26.4 0.0 0.0 21.7 17.5 0.5 0.0 0.1 0.1 40.3 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 TRBV6-4 "TCRBV13S5, TCRBV6S4, TRBV64" ENSG00000211713 "T cell receptor beta variable 6-4" A0A1B0GX49 7 142380806-142381261 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.2" "Cell type enriched" "Detected in single" 6 "T-cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 13 "MAIT T-cell: 231.6" "Lineage enriched" "Detected in single" 1381 "T-cells: 231.6" "Not detected" "Not detected" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (2.60e-3)" "unprognostic (4.64e-2)" "unprognostic (1.17e-1)" "unprognostic (2.64e-2)" "unprognostic (4.79e-1)" "unprognostic (2.98e-1)" "unprognostic (1.54e-1)" "unprognostic (9.07e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.7 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 231.6 0.0 2.4 17.3 0.0 0.0 4.1 3.0 0.0 0.0 0.0 0.0 4.4 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 TRIM52 RNF102 ENSG00000183718 "Tripartite motif containing 52" Q96A61 5 181254417-181261139 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "HPA054565, HPA056819" Approved Approved "Nucleoli,Intermediate filaments" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoli "Intermediate filaments" "HPA054565: AB_2682525, HPA056819: AB_2683245" "unprognostic (1.21e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-2)" "unprognostic (5.23e-1)" "unprognostic (2.75e-1)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (3.98e-2)" "unprognostic (7.37e-2)" "unprognostic (2.71e-1)" "unprognostic (2.24e-3)" "unprognostic (7.48e-3)" "prognostic unfavorable (3.46e-4)" "unprognostic (2.96e-1)" "unprognostic (6.41e-2)" "unprognostic (1.33e-2)" "prognostic favorable (4.07e-4)" 9.3 10.0 10.8 8.6 10.9 8.7 9.0 14.0 14.4 14.2 11.0 12.2 8.1 10.1 9.1 7.0 12.3 5.5 11.0 10.9 10.8 13.7 11.6 12.1 14.2 11.4 10.5 16.0 15.6 9.2 18.9 5.9 11.6 15.2 6.6 21.5 11.5 7.0 6.7 10.0 13.1 5.3 9.6 18.7 11.0 11.6 11.4 10.8 17.3 3.9 9.7 12.0 10.8 11.7 4.3 4.9 7.8 10.0 13.8 8.7 6.9 4.6 4.1 4.4 3.8 7.1 7.7 9.3 4.9 5.0 12.0 7.8 4.2 6.2 5.1 16.0 8.9 3.6 21.4 6.0 3.3 11.0 7.9 8.7 5.1 4.7 2.7 7.2 5.3 13.5 3.8 21.3 4.6 8.1 6.1 10.0 2.7 4.8 6.3 7.1 4.2 6.4 3.7 5.6 8.8 7.1 6.6 4.7 4.4 6.8 8.8 7.4 6.5 8.8 4.6 4.2 4.4 15.5 8.1 6.3 10.0 9.5 3.5 5.8 2.2 5.2 7.1 1.9 7.9 4.9 7.5 7.8 1.8 3.5 9.2 7.5 2.3 5.1 1.9 2.4 5.5 3.3 10.8 10.9 14.0 14.4 10.9 10.8 11.4 10.5 11.6 9.6 11.4 11.7 11.9 19.2 23.6 6.5 20.5 8.8 6.5 3.1 8.0 27.8 6.7 6.7 9.4 8.6 15.0 7.3 39.6 3.7 28.1 7.2 3.9 3.5 27.2 10.3 14.4 14.0 9.0 8.6 9.5 2.5 1.1 12.6 6.6 11.8 17.7 21.2 7.9 3.5 4.2 28.6 10.5 8.3 2.0 6.0 9.7 5.4 12.8 10.3 5.4 9.4 12.5 17.3 35.0 6.6 8.1 2.3 8.1 9.4 24.9 4.5 8.1 3.4 11.6 42.9 0.0 20.3 13.3 25.2 11.0 5.5 6.1 4.2 25.9 19.0 7.8 4.1 TSPAN15 "NET-7, TM4SF15" ENSG00000099282 "Tetraspanin 15" O95858 10 69451465-69507666 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 125.8;Ductal cells: 125.2;Exocrine glandular cells: 189.3;Pancreatic endocrine cells: 193.4;Paneth cells: 120.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "MAIT T-cell: 19.5" "Lineage enriched" "Detected in many" 6 "T-cells: 19.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 154.7;EFO-21: 211.3;MCF7: 168.0;OE19: 153.2;PC-3: 266.8;SK-BR-3: 134.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044657, HPA071160" Approved Approved "Nuclear bodies,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Nuclear bodies, Plasma membrane" "Vesicles, Cytosol" "HPA044657: AB_10967927, HPA071160: " "unprognostic (2.03e-1)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (1.48e-2)" "unprognostic (9.44e-3)" "unprognostic (6.81e-3)" "prognostic unfavorable (8.00e-4)" "unprognostic (2.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.76e-1)" "unprognostic (8.22e-3)" "unprognostic (2.36e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (8.49e-2)" "unprognostic (4.66e-2)" "unprognostic (6.34e-2)" "unprognostic (3.78e-3)" 70.1 5.3 22.8 15.3 37.6 1.0 61.0 35.0 34.1 16.4 14.9 62.5 38.8 32.6 8.5 10.8 24.6 27.4 16.9 23.6 25.4 25.9 4.6 34.4 8.7 36.9 33.4 3.4 20.0 3.2 6.6 28.1 33.7 34.5 39.4 3.1 26.6 24.7 17.9 10.6 38.8 31.3 30.0 26.7 75.3 9.5 34.5 3.6 14.5 5.6 7.5 46.0 14.9 62.4 51.3 103.9 2.1 0.3 2.3 0.0 12.0 0.2 1.9 2.6 6.8 45.1 154.7 0.0 211.3 2.3 9.2 101.2 7.2 11.5 3.0 42.1 20.4 2.9 3.5 10.0 1.1 0.1 1.8 2.2 3.1 1.4 1.5 7.5 39.4 20.5 1.1 0.0 1.2 168.0 0.6 0.9 2.6 153.2 266.8 4.0 2.1 2.0 29.7 92.9 34.5 13.2 0.6 134.8 17.9 17.3 59.3 2.2 34.5 0.2 0.8 0.1 17.5 1.2 6.1 1.0 1.1 0.1 0.2 0.0 0.0 0.0 2.3 0.0 19.5 0.0 3.1 2.8 3.3 0.0 1.0 0.2 0.0 0.1 0.0 0.2 1.1 0.5 22.8 37.6 35.0 34.1 23.6 25.4 36.9 33.4 33.7 30.0 34.5 62.4 108.8 32.1 6.9 4.9 1.5 3.6 10.9 59.6 2.2 2.9 45.1 15.6 1.7 31.5 29.5 29.5 6.2 2.0 1.6 125.8 3.9 125.2 27.9 25.5 3.8 48.4 40.2 8.0 1.7 189.3 11.9 8.2 71.4 36.6 1.3 2.5 10.4 0.1 25.3 1.7 1.0 106.7 36.7 8.5 16.1 6.6 0.6 9.8 28.4 15.0 15.6 44.7 0.0 11.1 75.3 193.4 120.9 0.0 0.2 50.4 68.3 1.8 27.6 1.5 13.1 39.7 26.8 4.3 18.5 2.9 3.1 3.0 3.9 7.5 66.3 29.6 TTLL1 C22orf7 ENSG00000100271 "Tubulin tyrosine ligase like 1" O95922 22 43039516-43089419 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 39.9;Spermatogonia: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048392 Approved Approved Nucleoli,Mitochondria No No "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoli Mitochondria "HPA048392: AB_2680384" "unprognostic (1.02e-1)" "unprognostic (4.06e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.85e-4)" "unprognostic (6.18e-3)" "unprognostic (4.27e-3)" "prognostic unfavorable (2.34e-5)" "unprognostic (8.22e-2)" "unprognostic (2.16e-2)" "unprognostic (3.29e-1)" "unprognostic (4.47e-3)" "unprognostic (1.82e-1)" "prognostic favorable (1.68e-4)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (2.03e-1)" "unprognostic (3.38e-2)" 4.0 7.2 9.9 2.7 10.0 2.2 4.6 10.0 12.1 4.9 6.9 5.2 1.8 5.8 8.1 3.8 9.8 3.9 8.5 11.0 10.1 5.3 1.7 3.8 3.8 7.6 8.3 5.4 3.6 5.9 9.7 2.7 8.3 4.9 3.1 11.3 4.7 3.8 3.4 4.8 3.1 4.0 7.8 3.2 4.0 13.5 10.7 5.6 7.0 3.7 3.4 4.6 4.8 8.8 0.9 0.8 17.5 12.3 18.8 17.1 0.5 5.8 6.5 3.3 5.6 0.0 2.6 1.0 3.5 10.6 1.8 0.6 1.5 1.5 3.4 1.4 2.7 1.7 0.6 1.6 13.3 4.5 2.2 13.5 21.8 2.0 5.4 14.3 10.7 14.2 0.5 10.8 12.3 5.5 4.3 7.4 2.2 4.6 1.2 9.3 9.2 0.2 6.1 1.5 4.0 8.2 4.6 2.4 16.0 9.1 6.3 7.4 10.1 3.4 2.3 7.7 0.8 3.6 0.7 0.5 9.1 8.2 6.2 4.7 5.5 6.7 10.6 5.9 11.2 2.7 9.8 12.3 9.8 4.5 8.4 10.5 1.2 10.5 4.8 6.5 6.4 5.7 9.9 10.0 10.0 12.1 11.0 10.1 7.6 8.3 8.3 7.8 10.7 8.8 3.8 0.0 2.7 3.9 1.5 2.3 2.4 5.9 2.8 5.1 6.2 7.2 5.0 1.5 5.6 1.8 6.2 2.7 3.4 1.1 15.6 7.3 39.9 12.8 6.6 4.1 0.0 2.1 8.8 4.9 1.3 5.9 3.6 4.1 1.3 9.2 5.7 0.3 4.9 5.0 9.0 3.0 16.2 4.0 2.2 18.2 4.1 2.4 8.8 3.7 4.4 6.4 7.2 4.0 3.8 4.5 6.6 6.0 0.5 2.4 0.6 7.2 20.0 11.5 6.6 5.6 3.7 10.7 32.6 4.8 2.7 0.7 5.9 5.5 1.8 2.2 TUBE1 "dJ142L7.2, FLJ22589, TUBE" ENSG00000074935 "Tubulin epsilon 1" Q9UJT0 6 112070663-112087529 "FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 199.6;Spermatocytes: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-2197: 48.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA032073, HPA032074" Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 18: U-2197 - ECM organization" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA032073: AB_10601773, HPA032074: AB_10601216" "unprognostic (4.79e-2)" "unprognostic (1.61e-1)" "unprognostic (3.76e-2)" "unprognostic (1.29e-1)" "unprognostic (2.22e-2)" "unprognostic (7.36e-2)" "unprognostic (1.22e-1)" "unprognostic (8.36e-3)" "unprognostic (2.18e-1)" "unprognostic (1.04e-1)" "unprognostic (4.99e-3)" "unprognostic (1.70e-1)" "unprognostic (5.15e-3)" "unprognostic (1.64e-1)" "unprognostic (7.68e-2)" "unprognostic (2.50e-1)" "unprognostic (1.59e-3)" 12.3 9.0 9.8 5.0 10.1 4.1 11.0 11.7 16.8 15.6 9.9 11.8 5.0 17.0 8.3 6.8 16.4 8.8 17.5 9.7 10.0 12.3 40.1 7.9 7.3 10.4 10.2 15.2 10.9 7.5 14.4 9.1 10.4 11.0 6.2 10.1 6.7 8.4 5.8 11.3 7.6 10.3 10.2 6.9 11.7 27.1 10.1 4.8 10.6 4.8 5.4 12.6 10.4 11.4 2.1 2.8 7.6 24.0 17.5 9.2 6.3 8.6 13.7 5.9 11.6 4.2 4.2 8.0 5.4 3.6 9.2 6.4 8.7 3.8 12.2 4.1 7.8 2.8 2.0 6.1 25.0 15.4 10.1 10.0 25.1 8.1 20.9 8.5 7.4 22.8 15.6 10.8 4.8 1.7 8.8 20.5 7.6 12.1 5.2 10.3 4.7 5.2 9.0 2.0 11.5 10.1 7.0 6.0 26.4 6.6 4.8 36.5 4.3 5.3 4.9 48.2 9.2 3.2 1.1 8.7 7.7 18.2 13.8 0.0 0.4 1.1 1.1 0.5 3.3 1.5 2.4 1.5 0.8 1.1 3.2 2.7 0.3 1.8 0.8 0.6 2.5 0.9 9.8 10.1 11.7 16.8 9.7 10.0 10.4 10.2 10.4 10.2 10.1 11.4 27.6 6.4 16.7 25.8 13.4 24.6 17.8 12.3 15.4 23.0 15.0 13.3 17.5 11.5 13.5 22.0 35.5 4.1 9.8 6.8 15.6 12.5 199.6 12.1 12.0 16.7 6.1 19.1 58.2 18.0 12.3 18.8 7.7 7.7 16.5 11.5 18.5 71.9 7.2 13.5 68.3 11.4 4.1 6.7 10.2 49.8 15.5 6.2 7.2 21.5 4.6 11.8 9.2 31.7 82.0 12.6 9.0 19.9 10.9 13.2 12.7 25.6 14.6 28.0 19.7 13.3 13.4 97.0 27.0 12.7 12.5 3.3 14.8 35.0 8.0 14.8 TUSC3 "MagT2, MGC13453, MRT22, MRT7, N33, OST3A, SLC58A2" ENSG00000104723 "Tumor suppressor candidate 3" Q13454 8 15417215-15766649 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 472.9;Extravillous trophoblasts: 321.8;Syncytiotrophoblasts: 783.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049851, HPA049974" Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA049851: AB_2680913, HPA049974: AB_2680976" "unprognostic (3.31e-2)" "unprognostic (7.17e-2)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (4.46e-1)" "unprognostic (2.34e-1)" "unprognostic (7.15e-3)" "unprognostic (5.02e-2)" "unprognostic (7.39e-2)" "unprognostic (4.79e-2)" "unprognostic (1.59e-3)" "unprognostic (4.81e-1)" "unprognostic (1.60e-3)" "unprognostic (5.99e-3)" "unprognostic (1.17e-1)" "prognostic favorable (7.86e-4)" "unprognostic (1.55e-1)" 23.3 68.8 18.7 8.4 18.4 0.1 28.3 22.3 17.1 25.0 46.6 14.5 9.3 31.9 100.8 11.8 57.6 16.7 34.9 17.1 48.2 25.2 6.9 18.4 6.8 8.9 11.6 73.6 35.0 54.0 69.6 80.5 8.9 46.4 15.5 40.9 12.1 29.7 4.5 8.2 8.2 32.5 7.7 5.3 10.8 23.2 21.0 7.5 9.5 5.7 5.6 34.0 13.0 8.0 52.1 38.4 104.3 96.7 125.2 126.7 0.2 74.9 168.8 85.2 139.3 0.1 0.1 0.7 24.5 105.9 92.4 39.3 37.5 76.1 116.0 0.1 49.8 0.0 30.1 6.0 51.9 0.2 5.6 111.8 22.8 121.0 43.1 113.7 6.9 15.9 70.9 15.6 123.2 41.2 20.6 0.4 49.2 0.0 33.5 24.8 88.7 0.3 108.3 127.1 40.7 74.6 0.0 40.6 56.5 76.2 49.8 0.2 29.0 71.9 71.3 31.3 36.5 0.0 10.0 0.4 1.2 0.0 102.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 18.4 22.3 17.1 17.1 48.2 8.9 11.6 8.9 7.7 21.0 8.0 88.6 0.0 10.3 13.4 0.6 9.9 61.1 123.5 63.7 50.4 40.0 52.1 47.5 18.6 47.0 79.1 8.4 472.9 0.9 2.1 17.6 179.0 11.5 100.8 48.6 36.2 95.7 0.0 141.0 12.2 321.8 53.4 7.7 35.0 1.3 39.3 7.5 0.0 41.8 32.0 155.3 26.3 95.6 0.0 6.3 7.6 34.8 1.5 24.9 24.4 1.6 35.9 0.0 61.3 3.9 23.8 4.1 23.0 2.6 63.8 0.0 23.7 172.4 28.1 39.5 2.0 49.7 60.9 47.4 26.2 4.1 783.8 1.6 46.6 7.8 51.4 UAP1 "AgX, AGX1, SPAG2" ENSG00000117143 "UDP-N-acetylglucosamine pyrophosphorylase 1" Q16222 1 162561506-162599842 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 678.4;U-251 MG: 463.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014659 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No Yes 48000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Plasma membrane, Cytosol" "HPA014659: AB_1857409" "unprognostic (2.32e-2)" "unprognostic (2.45e-1)" "unprognostic (2.07e-2)" "unprognostic (1.28e-2)" "unprognostic (2.71e-2)" "unprognostic (1.46e-2)" "unprognostic (1.37e-2)" "unprognostic (1.47e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-1)" "unprognostic (1.29e-3)" "unprognostic (4.96e-2)" "prognostic unfavorable (5.12e-5)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "unprognostic (3.51e-1)" "unprognostic (3.45e-2)" 96.0 43.7 12.2 33.7 13.2 51.5 58.8 13.5 14.9 37.1 16.1 65.6 43.9 18.6 29.1 33.9 33.1 39.8 45.1 13.4 13.6 27.0 172.6 36.0 14.1 11.5 16.9 39.9 68.6 12.0 28.9 22.3 11.8 33.3 66.3 20.4 76.6 31.2 41.2 25.0 56.0 24.6 11.6 13.8 55.8 90.9 13.9 11.8 24.4 45.2 22.2 77.9 37.4 11.0 204.6 14.6 39.2 31.5 185.7 147.8 26.8 292.4 107.1 220.7 178.5 38.6 93.5 8.0 64.3 225.8 79.6 35.0 44.7 85.5 359.9 32.4 66.6 36.0 43.8 75.6 87.1 61.8 23.5 69.0 39.8 242.4 678.4 100.6 137.5 62.6 206.1 81.3 298.9 37.4 36.0 40.0 29.2 207.6 64.4 31.9 76.2 99.8 34.8 23.7 41.9 43.4 128.0 78.4 70.4 45.6 38.9 70.0 235.2 110.6 102.5 281.2 463.5 135.0 51.0 67.0 63.4 28.5 71.3 1.4 2.2 11.7 16.7 2.1 20.4 10.7 10.0 17.3 4.6 11.1 9.4 12.0 2.2 8.6 1.2 7.7 5.5 7.2 12.2 13.2 13.5 14.9 13.4 13.6 11.5 16.9 11.8 11.6 13.9 11.0 58.1 6.4 30.2 15.0 42.5 134.7 163.0 47.2 47.8 11.8 59.1 42.7 30.0 27.1 57.4 16.5 8.4 27.2 82.9 94.8 72.4 27.1 78.2 28.6 58.0 35.7 54.9 13.9 12.4 64.7 63.9 195.8 45.9 40.7 33.7 21.3 22.5 98.4 14.5 6.7 12.4 139.4 40.7 10.1 82.2 20.1 50.7 24.6 85.4 3.7 18.2 16.6 41.2 8.0 6.1 73.0 74.5 41.3 152.8 94.6 88.4 26.9 56.0 13.9 19.7 59.4 88.6 212.0 125.9 43.2 81.8 97.7 50.5 18.8 70.4 141.7 UBAC2 "FLJ30548, PHGDHL1, RP11-178C10.1" ENSG00000134882 "UBA domain containing 2" Q8NBM4 13 99200774-99386504 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013448 Approved Approved Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 43: THP-1 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" Cytosol "HPA013448: AB_1855301" "unprognostic (7.04e-2)" "unprognostic (1.19e-1)" "unprognostic (2.43e-1)" "unprognostic (7.30e-3)" "unprognostic (2.23e-1)" "unprognostic (2.79e-3)" "unprognostic (9.48e-3)" "unprognostic (6.50e-3)" "unprognostic (1.58e-1)" "unprognostic (6.95e-2)" "prognostic unfavorable (1.73e-4)" "unprognostic (6.44e-2)" "unprognostic (6.13e-3)" "unprognostic (3.33e-2)" "unprognostic (1.16e-1)" "unprognostic (6.08e-2)" "unprognostic (3.26e-2)" 15.3 13.3 9.0 18.2 9.3 19.6 20.0 7.3 9.2 21.3 9.9 21.5 30.7 19.9 17.9 28.6 27.6 22.6 27.3 10.1 8.4 21.9 27.7 16.9 25.4 10.9 9.6 19.1 17.4 30.0 2.7 29.4 8.8 18.4 22.9 7.6 25.8 17.3 39.0 30.6 23.3 19.7 11.6 20.8 17.7 26.2 12.6 29.3 30.0 38.9 27.3 23.9 8.6 8.8 51.8 26.8 22.4 33.9 52.2 62.8 56.3 25.9 73.3 40.3 36.4 29.2 108.7 19.9 43.8 34.8 27.0 49.2 28.8 41.1 22.0 33.8 33.7 37.2 16.9 22.5 48.7 48.2 28.1 45.9 54.9 24.6 71.0 54.6 38.8 39.6 31.1 13.3 31.6 14.3 32.1 15.3 32.6 104.0 27.0 27.6 24.9 15.2 32.7 29.6 25.2 40.3 21.0 67.8 41.4 39.4 41.5 148.7 30.3 21.9 19.0 20.1 29.5 16.3 12.0 6.6 42.9 71.9 38.3 64.6 53.7 41.9 61.3 57.3 87.3 48.1 53.8 62.6 46.2 55.2 73.6 74.5 48.8 84.6 57.5 57.3 40.2 88.1 9.0 9.3 7.3 9.2 10.1 8.4 10.9 9.6 8.8 11.6 12.6 8.8 28.7 6.4 19.1 58.8 45.3 27.1 26.0 41.7 40.5 27.3 31.2 24.3 23.8 21.5 29.4 23.9 27.1 111.6 48.5 37.3 23.5 44.1 26.0 24.5 21.7 26.4 8.4 31.3 110.9 34.9 84.6 31.6 19.4 21.9 22.2 34.3 17.9 29.1 48.5 32.0 103.0 30.1 40.7 39.1 121.4 22.0 35.1 88.4 30.2 81.5 35.7 48.8 69.0 82.0 73.3 29.0 32.6 50.8 11.7 48.7 48.0 22.6 31.6 21.2 32.9 24.7 32.1 66.2 35.1 31.7 33.1 132.4 66.0 54.4 39.1 34.4 UBR3 "DKFZp434P117, FLJ37422, KIAA2024, ZNF650" ENSG00000144357 "Ubiquitin protein ligase E3 component n-recognin 3" Q6ZT12 2 169827454-170084131 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 71.2;tongue: 87.1" "Cell type enhanced" "Detected in all" "Astrocytes: 162.6;Excitatory neurons: 305.1;Inhibitory neurons: 302.0;Oligodendrocyte precursor cells: 232.2;Oligodendrocytes: 288.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035390 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Nucleoli" "HPA035390: AB_10670699" "unprognostic (1.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.59e-2)" "unprognostic (1.27e-1)" "unprognostic (2.07e-2)" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (3.91e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.26e-1)" "unprognostic (3.19e-2)" "unprognostic (5.56e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (2.18e-1)" 14.2 12.4 4.4 7.7 5.8 7.4 9.2 5.9 8.5 10.9 2.8 8.8 8.1 10.1 6.9 12.8 8.4 9.3 29.4 8.0 3.3 15.2 21.0 8.8 7.2 2.4 2.7 10.2 11.9 21.5 2.1 8.7 3.3 13.1 8.5 21.2 11.5 10.3 71.2 9.2 7.5 11.1 3.2 8.8 9.3 9.7 3.4 9.5 17.9 87.1 7.3 11.0 2.3 8.4 14.8 12.4 12.9 17.1 25.0 19.7 10.8 26.1 15.0 14.7 11.8 19.1 9.1 16.7 22.2 20.5 12.0 19.0 15.5 13.2 18.2 17.4 13.4 61.1 12.6 20.3 12.4 20.4 18.9 11.9 12.1 19.3 12.9 11.7 14.8 8.3 32.4 17.6 25.6 14.0 13.3 10.0 10.1 14.9 10.2 12.6 21.1 17.8 10.5 20.5 25.1 13.7 18.4 16.7 10.6 10.2 10.9 11.4 18.9 22.1 9.0 17.5 16.7 14.2 11.9 15.1 18.2 11.8 12.5 0.0 0.6 0.5 0.9 0.6 1.3 0.6 0.5 0.8 0.9 0.3 0.9 1.2 0.6 0.8 0.5 0.7 1.0 0.4 4.4 5.8 5.9 8.5 8.0 3.3 2.4 2.7 3.3 3.2 3.4 8.4 19.0 44.8 26.9 162.6 16.3 25.9 12.4 14.8 20.5 46.3 15.8 8.9 109.7 17.2 20.0 12.9 81.3 19.7 22.9 17.1 3.9 8.7 7.6 16.8 21.9 26.4 16.7 24.4 305.1 11.0 8.4 22.2 23.4 22.0 16.5 22.7 30.4 39.0 10.2 63.9 302.0 11.3 22.4 20.9 18.7 10.2 25.7 18.7 16.0 110.5 18.7 61.7 14.4 232.2 288.0 10.7 15.0 19.2 21.3 20.9 15.3 10.0 13.4 51.5 26.3 29.0 21.8 12.4 8.6 22.9 29.0 23.0 18.1 17.3 13.2 17.2 ULBP3 RAET1N ENSG00000131019 "UL16 binding protein 3" Q9BZM4 6 150061053-150069121 "Predicted intracellular proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 6.5;testis: 6.3" "Cell type enhanced" "Detected in single" "Gastric mucus-secreting cells: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA056541, HPA063007" Approved Uncertain "Vesicles,Centriolar satellite" "Intracellular and membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 18: U-2197 - ECM organization" "Cluster 59: Non-specific - Transcription" Vesicles "Centriolar satellite" "HPA056541: , HPA063007: AB_2684920" "unprognostic (4.87e-2)" "unprognostic (4.49e-2)" "unprognostic (3.14e-3)" "unprognostic (1.50e-2)" "unprognostic (1.86e-2)" "unprognostic (2.99e-2)" "unprognostic (8.47e-2)" "unprognostic (1.96e-1)" "unprognostic (5.87e-2)" "unprognostic (8.71e-2)" "unprognostic (1.66e-2)" "unprognostic (3.54e-2)" "unprognostic (6.26e-2)" "unprognostic (3.43e-1)" "unprognostic (2.12e-1)" "unprognostic (5.45e-2)" "unprognostic (5.16e-2)" 1.3 1.2 1.6 0.7 1.8 0.7 1.0 1.6 2.4 0.5 0.4 0.8 1.1 1.0 0.9 1.5 2.0 1.3 0.7 1.7 1.4 1.7 1.0 1.5 0.5 0.9 0.9 0.8 0.7 0.9 0.1 0.9 0.9 0.7 0.8 0.8 0.4 0.5 6.5 1.1 0.5 0.5 0.2 0.6 1.9 6.3 1.3 0.5 4.9 0.4 0.9 1.0 0.5 1.9 6.2 2.0 6.5 7.3 1.6 11.9 2.3 6.1 2.6 7.2 8.0 11.0 5.1 0.2 11.8 9.9 10.9 8.3 17.7 20.5 7.7 3.7 7.8 0.6 2.9 0.5 2.5 0.1 1.1 10.2 3.5 15.0 8.1 6.9 9.7 0.2 0.5 0.8 6.3 7.0 0.3 0.5 3.1 2.6 14.8 6.2 5.9 0.3 17.5 12.4 1.2 0.5 12.2 8.2 3.0 3.4 2.5 1.7 5.6 1.2 9.8 20.5 13.3 0.3 0.2 4.1 9.6 3.7 5.1 0.8 0.2 0.2 2.2 0.2 2.9 0.8 1.5 2.4 0.2 0.5 0.8 1.2 1.0 0.6 0.2 0.3 2.3 0.4 1.6 1.8 1.6 2.4 1.7 1.4 0.9 0.9 0.9 0.2 1.3 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 ULK3 "DKFZP434C131, FLJ90566" ENSG00000140474 "Unc-51 like kinase 3" Q6PHR2 15 74836118-74843346 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Autophagy "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 89.7;Horizontal cells: 89.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040474 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 62: Horizontal cells - Visual perception" "HPA040474: AB_2677003" "unprognostic (3.67e-2)" "unprognostic (8.90e-3)" "unprognostic (2.65e-3)" "unprognostic (1.59e-2)" "unprognostic (1.70e-1)" "unprognostic (2.07e-3)" "unprognostic (1.19e-1)" "unprognostic (1.58e-2)" "unprognostic (1.47e-2)" "unprognostic (4.18e-2)" "prognostic favorable (7.47e-4)" "unprognostic (1.97e-2)" "unprognostic (2.70e-2)" "unprognostic (1.30e-2)" "unprognostic (1.63e-1)" "unprognostic (1.16e-1)" "unprognostic (4.97e-3)" 7.1 15.2 29.5 6.4 31.5 2.2 6.1 28.1 32.2 13.6 23.0 12.1 5.0 4.4 3.5 35.7 5.5 4.5 15.9 29.4 27.3 17.6 13.8 8.3 5.8 34.0 26.6 5.7 12.0 16.2 12.5 3.5 35.8 9.9 9.4 15.4 11.5 3.1 21.0 24.7 15.7 4.4 26.1 13.1 10.6 7.1 27.8 6.3 7.6 19.0 7.8 9.4 15.4 30.4 6.7 17.7 7.4 14.4 9.3 6.7 6.0 5.1 7.3 10.1 11.1 7.0 15.4 13.0 8.8 6.2 10.8 4.7 23.1 7.6 4.4 26.1 26.1 30.3 25.0 7.4 14.8 10.3 22.5 9.4 14.0 8.2 7.1 3.5 15.8 16.8 10.3 11.9 7.0 9.4 7.3 6.6 10.0 10.6 8.7 18.6 10.3 23.0 6.0 7.4 16.7 22.3 8.6 9.8 25.6 9.1 11.0 26.8 9.4 16.0 8.9 12.7 10.3 20.7 19.7 9.3 7.4 29.5 12.4 5.2 3.5 1.4 10.9 7.3 8.7 3.3 6.4 9.0 3.7 2.8 7.1 4.8 0.8 5.8 6.1 4.0 9.2 5.1 29.5 31.5 28.1 32.2 29.4 27.3 34.0 26.6 35.8 26.1 27.8 30.4 16.5 9.6 15.3 37.2 11.4 10.1 7.5 6.0 10.2 89.7 18.1 13.6 17.1 14.3 6.7 12.9 16.7 9.2 23.3 46.4 19.6 11.0 1.0 8.9 8.8 10.7 11.4 14.1 64.7 11.7 2.5 9.2 23.4 11.9 21.0 6.2 13.2 13.3 16.1 89.2 56.5 17.5 4.1 7.9 8.2 2.2 13.1 11.2 5.4 18.7 13.2 18.4 29.9 16.6 15.3 12.3 17.9 11.7 8.6 10.4 68.5 16.5 8.0 54.5 0.0 12.9 8.8 9.5 17.3 19.7 21.7 5.7 19.7 12.3 27.9 8.9 UNG "DGU, HIGM4, UDG, UNG1, UNG2" ENSG00000076248 "Uracil DNA glycosylase" P13051 12 109097597-109110992 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 64.9;Spermatogonia: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011605 Uncertain Approved Cytosol NA Yes "Cluster 16: MAIT-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "CAB011605: AB_778737" "unprognostic (4.38e-2)" "unprognostic (3.82e-3)" "unprognostic (1.03e-2)" "unprognostic (1.33e-2)" "unprognostic (4.64e-1)" "unprognostic (4.10e-2)" "prognostic unfavorable (6.40e-4)" "unprognostic (5.68e-3)" "prognostic unfavorable (3.06e-4)" "unprognostic (4.66e-2)" "unprognostic (8.78e-3)" "unprognostic (1.91e-1)" "unprognostic (1.35e-3)" "unprognostic (2.57e-2)" "unprognostic (4.50e-1)" "unprognostic (1.40e-2)" "unprognostic (6.89e-2)" 19.8 56.7 32.4 14.7 32.4 16.0 23.1 30.1 34.8 16.6 27.7 28.0 17.1 14.5 12.7 29.7 15.6 10.4 21.1 29.2 34.9 27.5 32.2 9.6 18.0 32.2 31.4 15.7 12.4 33.2 10.9 17.8 34.1 13.6 29.3 6.8 17.7 17.6 43.0 32.7 18.8 14.5 31.6 16.1 17.7 24.3 33.5 22.8 22.2 33.5 27.0 13.5 20.1 30.8 77.1 77.5 72.8 66.6 118.6 33.8 69.5 44.4 30.1 68.6 52.3 61.7 51.6 100.3 65.1 40.2 35.9 47.6 81.4 46.0 66.4 85.6 150.9 98.1 41.1 105.5 17.7 147.6 58.2 30.7 41.6 33.0 18.3 54.6 50.4 117.8 80.9 32.5 47.0 96.2 136.8 173.6 130.0 124.2 117.7 123.9 109.8 85.9 43.4 95.6 103.3 57.4 79.6 67.8 39.5 94.2 126.2 68.2 26.0 59.1 52.7 39.3 62.5 62.6 145.0 190.5 44.8 97.7 73.8 12.9 2.7 5.0 22.4 5.3 31.6 16.0 25.5 25.6 6.8 17.2 16.4 18.4 0.0 16.5 5.5 4.9 25.5 14.4 32.4 32.4 30.1 34.8 29.2 34.9 32.2 31.4 34.1 31.6 33.5 30.8 26.6 0.0 4.8 16.0 9.2 18.0 11.0 13.2 25.0 2.6 21.7 14.1 12.4 7.2 5.0 42.3 4.2 64.9 12.5 14.7 19.6 14.4 3.4 7.6 15.0 17.7 8.4 32.4 7.0 6.2 38.1 12.6 14.3 9.9 7.6 24.8 20.3 20.8 18.3 5.0 6.2 21.4 10.2 3.8 5.4 4.2 14.0 5.5 14.2 6.5 3.8 15.8 7.2 6.6 4.0 5.0 10.3 14.7 16.7 6.8 9.3 20.2 3.2 3.5 6.6 10.2 11.5 21.9 74.6 37.8 20.9 20.4 15.3 25.7 40.4 9.7 USP13 IsoT-3 ENSG00000058056 "Ubiquitin specific peptidase 13" Q92995 3 179653032-179804366 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 149.2;tongue: 108.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 208.5;Inhibitory neurons: 52.2;Theca cells: 58.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 15.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 93.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004827 Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoplasm, Cytosol" "HPA004827: AB_1080497" "unprognostic (1.00e-2)" "unprognostic (2.09e-1)" "unprognostic (5.82e-2)" "unprognostic (7.14e-2)" "unprognostic (9.94e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (2.40e-5)" "unprognostic (1.76e-1)" "unprognostic (4.55e-2)" "unprognostic (7.79e-2)" "unprognostic (1.69e-3)" "unprognostic (2.22e-2)" "prognostic unfavorable (3.46e-6)" "unprognostic (4.93e-2)" "unprognostic (9.79e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (3.06e-4)" 6.2 11.9 3.9 2.8 13.6 1.5 5.3 8.6 12.0 3.3 0.0 2.9 1.2 5.7 3.4 4.0 3.4 4.5 42.5 3.7 4.7 3.0 4.6 5.4 3.6 11.3 10.5 12.5 4.1 4.0 5.8 2.6 12.7 4.3 2.2 7.1 6.2 2.7 149.2 2.2 1.9 6.3 6.4 2.1 1.7 6.0 8.1 2.4 9.7 108.9 3.5 3.5 2.2 34.4 27.6 11.3 20.0 14.8 8.9 14.1 11.6 18.6 17.4 23.7 18.8 17.1 9.6 35.6 18.0 17.2 27.6 2.6 21.4 9.1 26.4 93.3 14.8 9.0 23.6 14.4 6.3 26.5 1.1 10.5 3.0 18.8 18.5 9.1 16.6 11.9 4.7 43.0 15.7 15.0 22.5 3.0 17.9 1.3 13.1 29.3 20.2 27.4 11.7 7.9 13.0 14.5 14.1 16.9 7.2 5.4 37.0 12.7 24.1 28.6 27.6 23.7 64.1 29.5 21.2 78.3 13.0 15.0 27.2 0.1 0.3 0.0 2.6 0.5 15.6 3.2 1.8 3.8 1.5 0.9 1.2 1.3 0.0 0.0 0.7 4.5 0.7 1.3 3.9 13.6 8.6 12.0 3.7 4.7 11.3 10.5 12.7 6.4 8.1 34.4 45.0 9.6 35.9 14.0 5.3 2.5 1.9 1.4 0.6 13.7 7.1 5.2 208.5 5.7 5.4 1.8 6.2 10.7 5.6 1.4 15.6 1.1 2.6 13.9 11.4 10.1 9.6 5.5 23.2 4.4 2.4 12.0 4.1 2.5 2.5 35.5 22.1 7.6 4.3 16.8 52.2 2.9 0.0 4.8 3.5 3.6 9.3 5.0 14.2 16.9 1.7 7.0 3.1 36.2 42.5 1.0 12.2 9.4 4.5 4.4 0.1 2.7 3.7 10.2 13.1 17.8 12.0 6.1 2.8 4.8 1.6 5.1 4.1 58.8 4.5 1.4 USP31 KIAA1203 ENSG00000103404 "Ubiquitin specific peptidase 31" Q70CQ4 16 23061406-23149270 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.2" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 198.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006937 Uncertain Approved Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol "HPA006937: AB_1080523" "unprognostic (6.45e-2)" "unprognostic (2.42e-1)" "unprognostic (1.08e-1)" "unprognostic (4.43e-3)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (1.23e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-1)" "unprognostic (2.52e-1)" "unprognostic (6.15e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (4.41e-5)" "unprognostic (5.59e-2)" "unprognostic (3.75e-1)" "unprognostic (3.07e-1)" "unprognostic (1.98e-3)" 5.5 2.9 7.5 2.0 23.4 4.3 6.7 18.9 13.0 12.9 0.7 4.2 1.7 11.0 3.8 6.0 5.3 1.9 9.2 10.0 10.5 3.6 5.6 6.1 1.8 22.3 20.3 2.2 4.3 5.5 5.7 3.9 21.3 7.5 2.3 3.2 4.6 4.1 8.9 11.2 2.6 7.5 11.3 1.6 2.6 11.8 20.6 2.6 3.0 8.4 2.5 7.5 7.9 31.2 12.0 12.4 3.5 4.9 6.2 4.8 3.3 4.1 3.7 5.1 6.1 7.9 7.1 4.0 4.2 5.1 8.3 15.2 8.7 15.9 8.4 2.9 3.5 1.6 7.4 16.7 7.8 4.2 4.3 4.1 13.5 9.5 21.8 1.9 9.3 3.9 4.9 12.0 7.1 8.0 2.0 3.5 6.9 3.9 3.8 9.9 9.8 7.9 7.7 17.5 9.3 6.0 6.3 12.4 3.6 3.9 5.0 9.2 5.5 10.3 7.6 5.3 11.2 3.9 7.0 4.2 7.4 5.5 4.2 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.2 0.0 7.5 23.4 18.9 13.0 10.0 10.5 22.3 20.3 21.3 11.3 20.6 31.2 25.9 6.4 3.7 11.1 2.2 66.8 62.7 35.5 44.9 13.7 7.6 19.8 13.6 7.2 10.9 5.5 2.1 13.8 3.6 2.7 0.0 7.0 4.8 20.6 12.8 17.6 4.8 8.2 59.2 8.6 7.5 6.9 2.0 13.2 1.3 23.7 7.5 27.7 4.7 0.0 49.6 3.5 12.2 3.5 10.8 10.4 7.8 5.0 7.2 32.8 3.1 4.0 3.1 31.7 198.7 7.9 2.0 4.5 2.8 32.0 1.5 11.6 17.6 8.1 19.7 8.8 11.2 24.2 57.1 17.4 26.6 7.5 2.9 4.4 6.4 23.9 VILL ENSG00000136059 "Villin like" O15195 3 37988059-38007188 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "intestine: 61.9;stomach 1: 97.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 221.7;Gastric mucus-secreting cells: 192.7;Paneth cells: 139.0;Proximal enterocytes: 165.6" "Cancer enhanced" "Detected in many" "pancreatic cancer: 22.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 25.0;OE19: 78.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA035675, HPA035676" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA035675: AB_10671223, HPA035676: " "unprognostic (7.86e-3)" "unprognostic (7.37e-3)" "unprognostic (1.43e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (1.35e-4)" "prognostic favorable (1.75e-4)" "unprognostic (1.69e-1)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.95e-2)" "unprognostic (3.66e-3)" "unprognostic (5.55e-2)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (7.43e-3)" 5.4 3.7 8.7 11.0 9.0 12.6 6.4 6.6 10.6 9.5 6.4 46.8 61.9 5.7 1.5 7.2 6.7 15.7 6.4 8.6 7.8 5.3 1.4 7.7 9.8 8.3 8.4 6.8 3.4 1.2 5.1 4.1 8.0 16.0 26.6 1.2 5.7 4.0 1.2 9.1 61.7 4.1 8.0 11.8 97.5 5.4 8.2 10.2 7.4 1.4 6.3 17.5 7.4 7.2 8.2 0.1 0.2 0.4 2.8 2.2 0.8 2.3 1.9 2.3 2.2 6.1 25.0 3.9 3.5 1.6 0.0 1.9 1.8 0.2 0.5 0.8 0.0 7.3 0.1 0.6 3.4 7.7 9.5 3.3 2.2 2.2 0.0 0.0 4.5 16.1 7.3 2.3 2.6 0.1 12.4 8.7 0.2 78.4 0.0 4.8 0.0 2.0 0.8 9.8 0.1 0.3 0.0 0.5 1.8 0.0 0.7 12.4 2.8 1.0 0.3 3.0 0.0 1.4 3.1 1.2 0.6 10.9 5.0 0.0 3.2 0.0 6.8 2.0 7.4 3.5 4.4 3.9 2.1 4.6 5.6 4.2 0.1 3.4 1.4 3.8 5.8 4.1 8.7 9.0 6.6 10.6 8.6 7.8 8.3 8.4 8.0 8.0 8.2 7.2 4.9 9.6 7.4 10.4 7.2 2.3 5.7 25.5 6.8 0.9 3.3 2.9 1.9 8.6 46.1 0.0 0.0 3.0 13.3 221.7 0.0 3.4 6.2 1.5 2.7 4.5 9.6 6.1 5.5 16.9 3.4 6.7 192.7 1.5 8.2 6.1 5.3 0.3 2.4 1.7 3.0 64.4 14.2 1.9 2.4 19.9 3.7 4.0 1.8 3.7 4.2 28.1 7.2 2.5 1.2 38.7 139.0 2.6 4.4 6.2 165.6 1.6 40.5 0.8 0.0 4.3 7.1 5.4 3.4 3.1 1.4 1.0 8.1 5.6 50.5 33.4 WDR59 FLJ12270 ENSG00000103091 "WD repeat domain 59" Q6PJI9 16 74871362-75000173 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041084, HPA048218" Approved Approved Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" Cytosol "HPA041084: AB_10793867, HPA048218: AB_2680318" "unprognostic (3.68e-1)" "unprognostic (1.10e-1)" "unprognostic (1.65e-2)" "unprognostic (4.16e-2)" "unprognostic (6.14e-2)" "unprognostic (3.99e-1)" "unprognostic (2.28e-2)" "unprognostic (8.83e-2)" "unprognostic (3.43e-1)" "unprognostic (2.37e-2)" "unprognostic (4.21e-3)" "unprognostic (3.25e-3)" "unprognostic (2.05e-2)" "unprognostic (9.08e-2)" "unprognostic (3.88e-2)" "unprognostic (1.78e-1)" "unprognostic (5.61e-2)" 11.6 19.0 18.2 13.8 22.1 16.1 14.2 18.2 21.3 19.2 15.5 15.3 13.1 16.1 21.1 17.3 14.9 9.7 17.0 17.9 20.0 17.3 35.7 11.1 12.7 19.0 19.3 22.4 16.9 22.6 22.9 14.1 19.8 15.8 14.0 37.9 14.1 11.6 24.8 21.1 16.4 13.2 17.2 15.3 14.2 13.9 20.6 22.3 22.9 17.4 16.0 14.5 17.3 28.5 15.6 23.8 27.1 25.8 20.8 18.7 22.9 9.8 17.0 20.7 23.5 32.3 27.1 21.8 10.6 18.3 19.3 24.6 21.7 23.4 29.3 13.2 23.1 27.9 16.3 52.5 12.6 20.4 32.7 21.8 18.7 25.1 23.7 26.7 21.7 52.5 42.0 10.6 9.9 46.1 31.4 36.4 21.6 34.0 9.7 31.3 11.9 18.3 22.2 13.9 16.5 18.2 28.0 16.2 12.6 28.5 24.5 17.8 19.0 12.9 19.6 14.8 8.5 20.1 29.3 47.2 22.8 14.1 14.3 0.7 0.7 0.7 1.0 0.4 3.4 1.9 1.9 1.5 0.4 1.1 1.2 1.4 0.7 1.0 0.8 0.7 1.0 0.4 18.2 22.1 18.2 21.3 17.9 20.0 19.0 19.3 19.8 17.2 20.6 28.5 9.8 16.0 16.5 77.1 15.0 22.4 20.0 12.7 21.6 38.8 15.0 16.3 17.6 21.5 15.0 22.0 62.6 34.4 9.6 13.1 9.8 13.0 37.4 13.1 14.6 11.8 22.1 21.0 41.5 9.6 16.5 13.6 17.3 20.1 13.3 22.4 17.9 24.6 10.8 20.2 53.8 11.9 12.2 13.2 17.1 79.2 13.4 12.7 8.8 29.0 15.3 11.9 14.4 65.9 88.8 11.9 14.0 11.7 5.9 24.1 17.0 19.6 16.7 55.5 19.7 17.1 9.7 17.7 19.1 16.5 24.2 47.3 15.3 13.8 16.8 23.4 WDR82 "MST107, MSTP107, PRO2730, PRO34047, SWD2, TMEM113, WDR82A" ENSG00000164091 "WD repeat domain 82" Q6UXN9 3 52254434-52288020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 185.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040427 Supported "Nucleoli rim" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoli rim" "HPA040427: AB_2676979" "unprognostic (7.43e-2)" "unprognostic (3.20e-1)" "unprognostic (1.03e-2)" "unprognostic (2.15e-3)" "unprognostic (1.78e-1)" "unprognostic (1.38e-2)" "unprognostic (1.77e-2)" "unprognostic (1.63e-1)" "unprognostic (1.78e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-1)" "unprognostic (2.15e-3)" "unprognostic (2.92e-3)" "unprognostic (9.32e-2)" "unprognostic (2.04e-1)" "unprognostic (8.54e-2)" "unprognostic (1.26e-1)" 40.3 37.8 36.5 46.8 37.0 55.6 33.9 38.1 36.5 48.6 35.9 37.5 33.8 56.2 30.1 46.7 43.8 35.3 48.0 37.9 40.2 28.7 32.6 36.0 57.8 31.4 34.1 54.6 28.1 35.4 22.0 43.3 33.4 41.2 39.1 35.5 31.2 48.7 65.5 37.0 33.6 52.2 34.3 49.1 31.4 33.3 42.7 73.1 40.4 67.0 60.8 47.4 36.1 34.6 46.0 54.3 100.4 75.5 93.7 77.3 50.3 76.6 63.3 74.0 61.1 63.9 44.9 121.4 29.2 82.4 64.8 40.7 139.3 82.2 86.2 88.5 53.3 155.9 67.3 65.8 64.9 148.2 78.6 78.1 79.6 87.3 79.3 68.8 79.0 97.7 70.8 84.8 72.4 46.3 115.6 58.1 91.1 60.0 104.2 58.7 67.0 90.8 77.2 83.1 23.9 100.3 82.1 24.5 47.8 67.4 46.4 58.8 81.6 69.0 78.2 72.9 89.3 82.3 129.1 120.6 59.0 110.6 77.3 9.4 7.4 10.1 15.3 7.5 18.5 8.8 13.9 15.0 6.5 7.0 15.8 16.2 14.2 8.9 12.0 6.1 12.9 9.8 36.5 37.0 38.1 36.5 37.9 40.2 31.4 34.1 33.4 34.3 42.7 34.6 45.9 28.9 42.8 12.1 43.0 51.5 33.9 23.5 34.1 54.6 40.7 41.4 53.1 32.9 26.3 14.7 20.9 28.8 66.2 45.4 13.7 17.4 45.3 62.6 71.0 42.7 44.3 41.2 20.4 18.9 31.2 38.3 31.1 91.5 15.2 51.0 40.0 42.9 32.5 62.2 22.0 35.2 12.2 61.9 40.2 185.1 58.4 43.2 37.4 21.5 50.2 36.5 63.8 15.1 18.1 30.4 30.8 62.8 33.4 40.8 26.0 21.7 21.4 35.0 52.6 53.3 36.6 21.5 30.7 41.5 56.8 30.8 62.5 42.9 40.5 40.3 WDR86 ENSG00000187260 "WD repeat domain 86" Q86TI4 7 151375909-151410727 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix: 23.6;thyroid gland: 29.1" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 17.9;Endometrial ciliated cells: 13.9;Endometrial stromal cells: 22.5;Fibroblasts: 10.0;Microglial cells: 7.5;Muller glia cells: 11.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 14.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 13.7;NTERA-2: 2.6;SCLC-21H: 5.8;SH-SY5Y: 4.1;SuSa: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" "unprognostic (8.93e-3)" "unprognostic (1.83e-2)" "unprognostic (3.13e-4)" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (1.06e-1)" "unprognostic (2.42e-2)" "unprognostic (1.34e-2)" "unprognostic (6.02e-2)" "unprognostic (1.14e-2)" "unprognostic (6.32e-3)" "unprognostic (2.20e-1)" "unprognostic (1.84e-6)" "unprognostic (7.22e-2)" "unprognostic (1.96e-1)" "unprognostic (2.35e-2)" "unprognostic (1.04e-1)" 10.9 1.3 7.0 0.3 4.9 0.1 8.1 0.2 5.4 23.6 6.6 10.5 0.8 9.1 0.2 1.4 19.2 0.9 0.6 5.1 0.4 3.0 0.8 1.3 1.1 2.5 3.3 6.2 0.9 7.6 8.0 2.9 0.9 4.1 0.1 0.4 1.3 4.7 0.5 0.7 3.1 0.4 1.4 18.5 5.8 0.8 0.5 0.2 29.1 0.0 0.1 2.2 6.6 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 4.1 0.0 0.0 0.0 3.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 7.0 4.9 0.2 5.4 5.1 0.4 2.5 3.3 0.9 1.4 0.5 0.4 3.4 0.0 0.5 2.6 1.3 0.0 0.2 1.9 1.2 0.3 3.4 17.9 1.4 0.0 1.5 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 13.9 22.5 1.5 0.0 0.0 1.8 0.0 1.4 10.0 0.5 3.1 0.0 0.7 0.4 0.2 0.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.2 0.5 0.0 7.5 1.2 11.5 1.0 1.5 0.2 0.0 0.0 3.0 0.4 0.0 0.0 0.0 5.4 0.8 0.0 0.2 4.6 0.1 0.5 0.0 0.3 0.8 3.1 0.1 0.0 0.3 WFS1 "DFNA14, DFNA38, DFNA6, DIDMOAD, WFS" ENSG00000109501 "Wolframin ER transmembrane glycoprotein" O76024 4 6269849-6303265 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 131.4;Extravillous trophoblasts: 120.2;Granulosa cells: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 100.4;Hep G2: 83.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029128 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "HPA029128: AB_10603460" "unprognostic (4.27e-2)" "unprognostic (5.05e-2)" "unprognostic (1.58e-1)" "prognostic favorable (1.13e-6)" "unprognostic (7.35e-2)" "unprognostic (1.29e-2)" "unprognostic (2.73e-2)" "unprognostic (6.97e-3)" "unprognostic (2.37e-1)" "unprognostic (1.78e-1)" "unprognostic (8.36e-3)" "unprognostic (5.33e-3)" "unprognostic (6.20e-2)" "unprognostic (5.02e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (3.13e-4)" "unprognostic (3.64e-2)" 39.4 20.2 43.7 6.8 71.2 0.7 36.0 34.3 47.2 51.9 34.5 44.8 12.2 75.4 14.0 11.3 58.6 12.4 64.3 35.9 36.8 16.8 17.1 43.8 5.9 34.4 43.7 87.1 20.1 7.2 50.2 16.6 36.6 34.6 3.4 6.9 14.6 36.3 16.0 26.8 22.0 17.0 33.7 29.3 29.1 31.8 44.1 2.9 48.1 7.5 2.3 57.8 29.1 32.1 14.1 35.3 9.1 33.9 37.2 10.2 100.4 23.0 32.7 15.8 14.6 24.8 37.2 5.5 34.3 26.3 74.8 8.0 6.8 14.2 6.4 5.7 14.1 0.0 11.0 83.0 34.5 0.0 1.1 33.7 18.8 15.0 13.6 12.3 25.3 2.5 0.6 24.3 9.7 28.0 1.1 0.3 13.5 20.3 38.0 3.4 9.6 7.5 6.7 52.4 6.1 15.4 12.2 17.4 13.1 9.6 31.5 0.3 19.9 19.8 22.8 19.1 14.8 26.0 10.1 0.5 23.9 0.2 18.3 0.0 0.7 0.0 2.7 0.9 3.9 2.4 1.3 2.1 0.2 1.2 1.3 1.5 0.0 1.5 1.1 0.4 0.8 1.4 43.7 71.2 34.3 47.2 35.9 36.8 34.4 43.7 36.6 33.7 44.1 32.1 38.4 131.4 12.4 40.5 3.6 2.4 1.9 2.5 2.2 4.9 9.7 6.0 42.5 5.7 5.7 25.8 0.0 22.2 1.0 2.0 0.0 5.5 10.3 18.1 12.6 21.1 33.5 0.0 2.7 4.4 120.2 15.4 13.3 25.5 1.3 71.4 21.4 10.7 19.0 3.3 4.7 5.7 4.1 1.3 2.4 19.1 40.0 2.5 12.4 12.2 0.7 31.7 0.0 9.5 2.4 10.9 1.6 57.9 19.0 4.7 3.7 3.7 12.1 5.0 13.1 3.6 15.1 10.8 14.6 2.2 3.4 39.7 1.6 11.0 4.7 2.1 WNT1 INT1 ENSG00000125084 "Wnt family member 1" P04628 12 48978322-48982620 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Disease variant, Osteogenesis imperfecta, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 4.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 4.1;Gastric mucus-secreting cells: 1.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basal ganglia: 4.5;cerebral cortex: 2.1" "Group enriched" "Detected in some" 8 "gdT-cell: 3.1;MAIT T-cell: 5.1;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.9;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 29 "T-cells: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.1" "Secreted to extracellular matrix" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 58: T-cells - T-cell receptor" "unprognostic (2.02e-2)" "unprognostic (5.80e-3)" "unprognostic (1.23e-1)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (7.65e-3)" "unprognostic (5.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.63e-1)" "unprognostic (1.20e-1)" "unprognostic (4.08e-2)" "unprognostic (4.97e-2)" "unprognostic (1.32e-2)" "unprognostic (1.67e-2)" "unprognostic (1.70e-1)" "unprognostic (7.35e-3)" "unprognostic (2.76e-2)" 0.0 0.0 0.8 0.5 4.5 1.1 0.0 0.0 2.1 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.7 0.2 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.5 0.3 0.7 0.3 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 5.1 0.1 2.0 2.9 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.2 0.5 0.8 4.5 0.0 2.1 0.7 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 YWHAQ "14-3-3, HS1" ENSG00000134308 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta" P27348 2 9583967-9630997 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007925, CAB010286" Approved Supported Nucleoplasm,Cytosol NA NA 49000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 10: Non-specific - Unknown function" Cytosol Nucleoplasm "CAB010286: AB_2218221, HPA007925: AB_1844340" "unprognostic (2.65e-2)" "unprognostic (3.99e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (1.53e-1)" "unprognostic (5.78e-3)" "prognostic unfavorable (9.83e-6)" "unprognostic (4.90e-3)" "unprognostic (2.98e-2)" "unprognostic (5.51e-2)" "unprognostic (6.18e-2)" "unprognostic (1.45e-1)" "unprognostic (2.95e-2)" "unprognostic (6.74e-2)" "unprognostic (9.75e-2)" "unprognostic (1.63e-1)" "unprognostic (4.39e-3)" 144.6 141.0 190.8 106.1 223.2 178.4 153.6 216.5 239.1 177.0 149.4 161.2 119.4 184.3 141.6 187.3 136.5 122.6 218.7 205.1 229.7 140.0 116.3 119.3 132.0 218.6 203.8 163.2 201.5 131.9 112.9 123.2 212.4 161.1 133.0 143.6 120.2 140.2 53.5 121.5 116.2 177.4 203.9 89.8 127.5 144.6 205.7 148.2 137.6 62.1 141.1 144.4 161.8 280.5 316.1 465.2 412.0 400.3 316.6 434.5 385.7 421.6 412.3 432.5 360.2 352.9 269.3 404.4 214.0 608.5 451.3 288.5 462.8 459.7 553.6 1003.0 374.8 378.8 268.9 379.9 241.1 369.1 219.7 295.8 264.5 473.6 305.9 394.9 493.5 285.6 378.5 236.8 539.3 219.3 658.2 374.4 700.7 351.9 527.5 473.0 533.3 497.4 478.8 276.9 390.1 659.9 384.1 392.2 317.3 343.8 244.4 187.0 453.9 539.6 380.7 473.4 654.4 239.3 351.4 526.6 461.8 378.9 458.8 99.5 102.7 120.5 207.8 137.8 255.6 151.9 192.8 223.5 144.2 147.8 103.6 170.1 31.1 252.0 137.0 73.1 208.4 344.1 190.8 223.2 216.5 239.1 205.1 229.7 218.6 203.8 212.4 203.9 205.7 280.5 186.6 51.3 67.3 26.1 144.0 316.7 366.5 339.0 143.4 201.4 198.4 153.7 82.6 90.1 143.4 136.1 27.1 261.6 189.9 209.9 416.7 371.5 281.9 132.9 175.8 191.0 187.1 179.2 57.3 283.7 615.3 242.0 115.2 131.6 125.0 152.5 84.9 97.9 215.3 572.0 45.1 129.2 270.6 111.9 228.3 360.5 174.0 132.3 295.3 30.0 195.0 229.2 155.5 39.7 186.6 261.2 150.9 250.5 187.9 323.7 135.9 278.8 111.7 105.8 197.2 191.5 312.7 432.2 205.8 252.1 355.3 238.6 217.7 252.9 186.5 457.3 ZBTB16 "PLZF, ZNF145" ENSG00000109906 "Zinc finger and BTB domain containing 16" Q05516 11 114059711-114256765 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor" "Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 105.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 134.8;Inhibitory neurons: 125.9;NK-cells: 119.4;Skeletal myocytes: 163.9" "Cancer enhanced" "Detected in many" "prostate cancer: 5.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 23.3;MAIT T-cell: 39.4;naive B-cell: 11.0;NK-cell: 10.9" "Group enriched" "Detected in many" 5 "B-cells: 11.0;NK-cells: 10.9;T-cells: 39.4" "Cell line enhanced" "Detected in some" "ASC diff: 71.5;ASC TERT1: 38.6;HEL: 40.7;HHSteC: 26.6;HSkMC: 26.7;hTCEpi: 30.6;hTERT-HME1: 25.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001499, CAB004540" Uncertain NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "CAB004540: AB_2218941, HPA001499: AB_1079640" "unprognostic (2.21e-1)" "unprognostic (2.17e-1)" "unprognostic (7.30e-2)" "unprognostic (1.18e-1)" "unprognostic (2.53e-1)" "unprognostic (3.05e-1)" "unprognostic (1.25e-2)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (8.79e-4)" "unprognostic (1.68e-1)" "unprognostic (1.18e-1)" "prognostic favorable (2.21e-4)" "unprognostic (2.57e-3)" "unprognostic (2.67e-1)" "unprognostic (1.00e-1)" "unprognostic (5.90e-2)" 55.8 20.8 5.1 3.4 14.9 7.6 32.3 11.7 24.8 25.9 17.7 20.9 0.9 29.6 4.0 28.1 30.9 13.1 28.1 9.9 8.4 10.6 14.5 27.1 8.8 20.1 8.4 51.4 61.7 34.3 6.4 9.6 15.2 15.1 3.3 2.2 13.3 7.0 88.6 28.5 16.3 15.8 4.9 13.2 18.3 4.0 7.1 6.5 29.3 105.8 2.0 29.4 19.7 18.0 0.0 0.0 13.0 0.0 71.5 38.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 40.7 0.0 0.0 26.6 0.9 0.7 26.7 30.6 0.0 25.6 0.0 4.6 5.5 0.1 0.0 0.8 0.0 2.2 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 4.2 1.2 23.3 1.2 39.4 0.4 1.2 3.5 0.1 11.0 1.3 0.6 0.3 10.9 1.2 0.0 0.4 5.7 5.1 14.9 11.7 24.8 9.9 8.4 20.1 8.4 15.2 4.9 7.1 18.0 95.3 22.4 7.7 59.1 16.3 11.1 81.7 7.7 8.6 32.6 12.6 16.8 35.1 42.9 7.1 9.2 0.0 0.1 51.2 0.7 1.9 1.9 21.1 1.7 41.3 49.5 7.2 18.1 134.8 0.9 0.2 59.8 1.1 3.8 14.5 38.2 65.7 50.9 0.8 0.0 125.9 3.7 8.2 27.0 5.3 27.7 89.8 32.1 7.2 65.6 7.6 20.2 119.4 45.8 43.4 0.3 0.1 92.2 17.7 38.6 28.8 6.6 6.8 1.9 105.2 163.9 75.3 0.4 9.9 1.8 6.8 0.3 27.8 0.2 3.5 9.4 ZCCHC14 "BDG29, MGC14139" ENSG00000140948 "Zinc finger CCHC-type containing 14" Q8WYQ9 16 87406246-87493024 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014122 Uncertain "Nuclear membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear membrane" "HPA014122: " "unprognostic (2.04e-2)" "unprognostic (2.84e-1)" "unprognostic (4.62e-2)" "unprognostic (2.67e-1)" "unprognostic (3.99e-1)" "unprognostic (6.74e-2)" "unprognostic (7.44e-2)" "unprognostic (1.69e-1)" "unprognostic (1.46e-1)" "unprognostic (6.41e-2)" "unprognostic (1.20e-1)" "unprognostic (2.88e-2)" "prognostic favorable (1.47e-14)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (7.13e-2)" "unprognostic (2.83e-2)" 12.5 12.9 9.8 6.1 8.3 3.1 10.0 17.1 10.4 12.1 6.3 10.0 13.7 10.5 6.7 9.1 8.7 10.1 10.4 11.4 5.0 10.0 22.0 10.3 5.1 6.1 5.6 15.3 12.3 13.6 10.2 7.5 4.2 7.2 8.0 10.8 8.1 7.2 9.7 11.7 14.0 7.7 3.3 5.3 8.9 35.3 7.0 4.0 12.4 7.9 4.2 10.4 9.6 6.2 12.7 9.1 15.2 19.8 19.5 13.5 9.2 6.2 9.2 7.4 3.7 19.9 11.0 6.8 8.0 12.3 18.5 20.2 14.4 4.8 9.5 2.0 17.6 6.7 13.9 19.9 8.5 1.8 3.2 11.8 9.7 14.1 8.7 11.0 10.4 3.9 15.8 1.9 6.6 13.5 0.3 8.3 11.9 7.7 8.2 17.7 8.1 3.0 13.2 6.9 34.0 42.8 45.7 6.2 26.1 9.3 14.8 14.6 8.4 17.6 13.5 16.3 10.5 3.9 2.5 20.0 8.1 10.7 11.8 0.0 0.1 0.0 0.2 0.0 0.5 0.0 0.2 0.3 0.0 0.0 0.4 0.2 0.2 0.2 0.5 0.0 0.4 0.0 9.8 8.3 17.1 10.4 11.4 5.0 6.1 5.6 4.2 3.3 7.0 6.2 21.4 12.8 12.2 30.0 2.3 18.2 2.6 7.4 6.8 19.6 12.8 11.6 11.1 11.5 12.9 5.5 6.2 3.3 6.7 17.7 3.9 7.0 26.0 11.5 23.7 15.2 21.0 3.2 43.6 8.1 1.9 15.0 10.7 18.6 1.3 17.3 11.4 33.2 5.2 23.5 47.6 14.6 8.2 7.2 10.9 40.2 11.1 7.0 7.2 28.1 2.7 7.1 6.2 46.8 29.7 8.7 7.7 10.1 3.0 3.3 24.6 11.1 9.9 15.1 19.7 12.3 21.8 53.9 22.9 12.1 17.5 3.7 6.3 26.0 15.7 2.6 ZFR2 KIAA1086 ENSG00000105278 "Zinc finger RNA binding protein 2" Q9UPR6 19 3804024-3869038 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 17.0;pituitary gland: 26.1;retina: 10.9;testis: 13.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 33.7;Cone photoreceptor cells: 27.1;Early spermatids: 25.3;Excitatory neurons: 39.3;Horizontal cells: 32.0;Inhibitory neurons: 42.7;Rod photoreceptor cells: 38.5;Spermatocytes: 29.4" "Cancer enhanced" "Detected in some" "cervical cancer: 2.0" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 16.3;NTERA-2: 31.7;SiHa: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043275, HPA055678" Uncertain Approved Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 5: NTERA-2 - Transcription" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "HPA043275: , HPA055678: AB_2682883" "unprognostic (1.74e-3)" "unprognostic (2.32e-3)" "unprognostic (4.05e-3)" "unprognostic (1.51e-2)" "unprognostic (6.60e-3)" "unprognostic (5.47e-4)" "unprognostic (9.12e-2)" "unprognostic (3.87e-2)" "unprognostic (1.18e-2)" "unprognostic (4.92e-2)" "unprognostic (1.97e-3)" "unprognostic (4.29e-2)" "unprognostic (3.58e-1)" "unprognostic (3.58e-1)" "unprognostic (5.81e-2)" "unprognostic (9.20e-2)" "unprognostic (2.18e-2)" 0.2 2.5 9.6 0.4 9.5 0.2 0.1 0.3 17.0 0.3 0.0 0.5 0.0 0.1 0.0 0.1 0.7 0.1 0.3 7.9 10.9 0.2 0.1 0.3 0.2 3.9 3.0 0.1 0.4 2.5 26.1 0.0 4.0 0.4 0.1 10.9 0.1 0.1 0.1 0.2 0.3 0.0 1.3 0.3 0.3 13.4 8.0 0.0 0.3 0.0 0.2 0.1 0.2 5.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.5 0.8 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 31.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.1 0.5 6.9 0.0 0.4 1.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 1.0 0.0 0.0 1.1 0.0 1.2 0.0 0.7 0.5 0.0 0.2 1.0 0.8 0.2 0.4 0.0 0.0 0.2 0.3 9.6 9.5 0.3 17.0 7.9 10.9 3.9 3.0 4.0 1.3 8.0 5.3 0.2 0.0 1.1 2.9 0.2 1.0 0.5 0.1 0.0 33.7 0.2 1.0 1.6 0.0 0.0 0.0 27.1 0.0 1.1 0.0 0.0 0.5 25.3 0.7 0.2 0.5 0.0 0.0 39.3 0.2 0.1 0.2 1.1 0.2 1.3 0.3 0.0 0.1 0.1 32.0 42.7 0.2 0.0 0.0 0.4 11.0 0.9 0.2 1.8 1.9 0.1 4.4 1.0 16.1 4.5 0.2 0.0 0.0 0.3 0.4 0.0 0.3 1.5 38.5 0.0 0.6 0.2 29.4 15.9 0.0 0.1 0.0 1.5 0.1 0.0 0.4 ZNF324 "ZF5128, ZNF324A" ENSG00000083812 "Zinc finger protein 324" O75467 19 58467045-58475436 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 37.0;Horizontal cells: 33.7;Rod photoreceptor cells: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 54.2" HPA039774 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" No No "Cluster 16: MAIT-cells - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nuclear membrane, Cytosol" "HPA039774: AB_10673149" "unprognostic (8.60e-2)" "unprognostic (7.42e-3)" "unprognostic (1.07e-1)" "unprognostic (1.21e-1)" "unprognostic (5.12e-3)" "unprognostic (3.69e-3)" "unprognostic (2.36e-2)" "unprognostic (5.09e-3)" "unprognostic (2.84e-1)" "unprognostic (1.57e-1)" "prognostic favorable (4.74e-5)" "unprognostic (6.39e-2)" "prognostic favorable (1.34e-7)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "prognostic unfavorable (6.99e-4)" "unprognostic (3.56e-1)" 3.4 3.9 4.8 3.4 4.9 6.7 3.7 6.3 6.0 4.6 2.8 4.1 4.3 5.0 3.2 5.9 5.2 2.9 3.4 5.1 4.2 3.1 5.7 3.2 3.1 4.7 3.9 5.8 7.0 4.4 6.6 2.9 3.8 4.6 2.2 3.0 4.7 4.2 3.0 6.6 3.9 3.3 2.9 3.9 4.4 4.4 3.4 6.8 4.8 2.6 2.9 4.4 3.8 4.8 7.8 8.9 5.0 10.1 5.3 5.0 7.2 6.3 6.4 5.6 5.0 8.5 4.2 11.2 5.9 4.3 7.6 9.3 6.4 6.6 2.1 10.5 54.2 6.9 6.7 3.6 4.5 12.3 9.2 3.9 8.5 7.1 3.3 5.1 3.7 7.9 11.4 7.1 6.0 6.0 12.5 6.6 5.4 6.4 12.9 13.9 6.5 7.3 3.8 15.5 11.8 9.5 6.5 10.8 3.8 3.6 4.9 10.1 6.4 17.6 3.9 6.4 11.2 10.4 12.0 5.8 9.5 6.7 6.5 2.3 5.3 8.9 10.5 5.9 11.5 5.8 8.0 11.6 3.8 6.2 12.1 9.7 15.6 7.3 4.5 7.0 8.8 4.2 4.8 4.9 6.3 6.0 5.1 4.2 4.7 3.9 3.8 2.9 3.4 4.8 4.8 0.0 1.7 5.2 8.4 9.1 5.5 3.1 2.2 37.0 10.3 7.5 7.5 2.8 3.8 0.0 25.0 4.8 6.9 9.9 0.0 4.9 1.2 6.3 6.3 5.5 7.8 6.5 5.6 4.1 3.8 6.0 6.6 3.6 1.3 11.3 7.5 3.6 2.9 33.7 6.3 7.9 6.1 2.4 3.7 1.6 12.8 3.2 3.6 7.5 4.1 15.8 7.2 4.5 6.7 4.2 12.4 14.7 5.6 8.0 9.0 2.3 5.8 57.2 6.6 11.7 8.5 19.4 15.8 4.8 13.4 6.7 7.6 11.2 6.3 3.8 ZNF507 "KIAA1084, Zfp507" ENSG00000168813 "Zinc finger protein 507" Q8TCN5 19 32345594-32387667 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030964, HPA049728" Uncertain Supported Nucleoli,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoli Cytosol "HPA030964: AB_10670562, HPA049728: AB_2680864" "unprognostic (3.39e-1)" "unprognostic (3.78e-2)" "unprognostic (6.84e-2)" "unprognostic (2.61e-2)" "unprognostic (2.21e-2)" "unprognostic (1.74e-2)" "unprognostic (1.41e-3)" "unprognostic (1.20e-1)" "unprognostic (3.24e-2)" "unprognostic (4.28e-3)" "unprognostic (7.24e-2)" "unprognostic (7.44e-2)" "unprognostic (1.68e-1)" "unprognostic (2.23e-1)" "unprognostic (1.89e-1)" "unprognostic (2.97e-2)" "unprognostic (1.46e-2)" 5.1 4.2 4.3 4.6 5.7 6.8 6.8 6.4 5.6 5.9 3.4 4.9 5.7 6.8 4.3 5.1 5.9 4.3 5.6 4.4 4.8 4.7 6.3 4.4 6.7 4.7 5.3 9.5 5.3 6.2 3.7 7.0 5.0 5.9 5.3 8.1 6.4 4.7 9.2 4.7 5.9 6.0 4.8 5.2 5.2 13.1 4.7 8.6 10.7 8.7 5.8 4.3 4.1 7.3 10.0 16.2 13.5 8.2 9.3 14.6 11.4 8.5 8.1 7.3 8.1 9.8 7.6 15.1 10.5 7.8 8.3 5.9 19.4 10.5 14.8 10.6 15.3 14.8 8.7 7.7 11.0 12.8 8.0 9.5 8.9 9.0 15.4 8.6 10.9 11.9 21.0 10.7 8.6 5.8 13.5 5.2 14.9 15.0 5.8 14.0 16.1 6.4 5.5 9.9 11.9 10.5 11.2 7.8 10.2 10.7 5.9 9.5 10.4 12.6 13.3 8.0 11.9 10.4 12.9 14.1 8.7 9.3 11.5 0.2 0.0 0.5 1.0 0.0 1.1 0.7 0.8 0.8 0.0 1.0 1.1 0.9 0.5 0.6 0.0 0.1 0.6 0.4 4.3 5.7 6.4 5.6 4.4 4.8 4.7 5.3 5.0 4.8 4.7 7.3 13.3 9.6 17.7 22.5 13.2 2.8 8.8 5.3 13.6 22.2 9.3 7.6 16.1 5.7 9.0 0.0 14.6 10.9 7.7 7.6 1.9 5.6 22.1 10.0 22.7 11.0 9.0 12.4 31.3 5.5 5.3 11.9 12.2 11.4 3.8 17.1 13.6 12.1 3.7 58.9 36.0 11.5 4.1 0.3 1.8 11.0 9.3 0.8 1.8 16.9 0.4 17.2 10.3 31.2 46.6 4.9 8.0 7.2 6.4 12.0 15.6 4.2 16.1 23.5 0.0 16.1 13.9 25.8 18.9 10.9 2.7 8.8 11.3 12.6 11.2 7.6 ZNF541 DKFZp434I1930 ENSG00000118156 "Zinc finger protein 541" Q9H0D2 19 47520685-47555856 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 21.9" "Cell type enhanced" "Detected in some" "Early spermatids: 25.5;Late spermatids: 12.2;Proximal tubular cells: 19.1;Spermatocytes: 37.3;Spermatogonia: 11.7" "Cancer enhanced" "Detected in some" "cervical cancer: 2.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 1.5;SiHa: 5.0;U-87 MG: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058541, HPA076453" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm Cytosol "HPA058541: AB_2683748, HPA076453: AB_2732310" "unprognostic (4.49e-2)" "prognostic favorable (2.94e-4)" "unprognostic (8.33e-2)" "unprognostic (3.09e-1)" "unprognostic (2.74e-1)" "unprognostic (5.92e-5)" "unprognostic (7.98e-2)" "unprognostic (5.19e-3)" "unprognostic (1.38e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-2)" "unprognostic (7.52e-2)" "unprognostic (3.09e-2)" "unprognostic (5.20e-2)" "unprognostic (2.14e-1)" "unprognostic (1.01e-1)" "unprognostic (1.59e-2)" 1.0 3.1 0.3 0.1 0.3 0.1 0.6 0.2 0.8 0.1 0.0 0.8 0.1 0.3 0.0 0.0 0.2 0.2 0.9 0.5 0.0 0.7 0.1 0.1 0.2 0.4 0.1 2.3 0.1 0.1 0.6 0.3 0.4 0.1 0.1 0.5 0.1 0.1 0.5 0.4 0.3 0.2 0.0 0.5 0.1 21.9 0.2 0.1 0.5 0.1 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.5 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.8 0.5 0.0 0.4 0.1 0.4 0.0 0.2 0.2 4.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.5 0.5 0.3 1.8 0.0 0.0 1.8 2.1 0.0 0.3 0.0 0.0 0.0 25.5 0.0 0.1 1.6 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.3 0.0 2.0 6.1 0.4 0.0 0.0 1.5 0.1 0.0 0.0 0.0 12.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.5 19.1 0.0 0.8 0.0 0.0 0.1 37.3 11.7 0.0 0.1 0.0 0.4 0.5 0.0 0.0 ZNF561 MGC45408 ENSG00000171469 "Zinc finger protein 561" Q8N587 19 9604680-9621236 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA055332, HPA062397" Uncertain Approved Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "HPA055332: AB_2682786, HPA062397: AB_2684751" "unprognostic (6.68e-2)" "unprognostic (1.26e-1)" "unprognostic (6.86e-3)" "unprognostic (3.43e-2)" "unprognostic (1.18e-2)" "unprognostic (3.63e-3)" "unprognostic (9.92e-2)" "unprognostic (2.53e-2)" "unprognostic (9.54e-2)" "prognostic favorable (1.31e-4)" "unprognostic (9.21e-2)" "unprognostic (3.34e-2)" "prognostic favorable (1.16e-4)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (3.27e-3)" "unprognostic (2.85e-3)" 8.9 8.8 4.6 8.4 5.5 10.2 17.2 7.2 7.6 13.5 5.3 10.3 8.0 17.9 12.0 16.3 18.5 12.9 9.8 5.7 5.6 12.5 11.2 11.2 10.8 6.2 5.8 20.1 10.4 13.6 7.6 10.5 6.2 17.4 12.8 7.3 9.7 17.6 9.1 14.3 8.5 26.0 4.9 9.7 10.6 6.3 5.8 14.5 15.4 14.6 12.5 18.6 12.1 6.1 14.4 5.7 31.8 24.3 26.2 30.9 28.0 18.9 25.2 23.2 26.1 10.7 6.1 13.2 13.5 19.1 13.3 8.2 21.6 36.1 24.2 18.5 23.3 16.9 12.2 18.9 15.7 20.9 16.0 20.5 55.4 17.4 22.4 36.3 29.7 9.6 19.3 17.4 29.0 6.9 9.4 23.3 25.6 12.3 18.1 11.1 15.8 13.5 20.3 51.7 19.7 19.6 0.4 10.9 14.7 30.1 14.6 14.6 9.3 24.8 8.8 17.2 17.9 20.2 30.2 17.7 12.2 5.6 16.8 4.0 5.1 5.8 4.9 5.1 6.2 2.8 3.9 4.4 4.1 3.9 5.4 4.0 3.4 1.7 2.7 3.6 4.0 3.4 4.6 5.5 7.2 7.6 5.7 5.6 6.2 5.8 6.2 4.9 5.8 6.1 8.2 0.0 7.0 5.9 7.9 13.8 25.2 31.9 16.5 9.4 11.5 16.5 9.8 11.5 17.9 14.7 6.2 8.0 11.0 7.3 3.9 11.1 6.9 11.1 12.1 8.9 11.4 11.6 10.0 6.5 8.5 7.7 12.2 9.0 7.6 25.5 10.8 8.2 10.9 10.1 10.5 7.7 16.2 12.8 5.8 9.7 11.5 8.3 3.6 6.5 12.2 6.3 17.5 17.6 12.0 8.6 6.8 13.2 6.2 10.9 9.8 8.5 30.3 11.9 6.6 9.1 10.4 8.2 10.6 23.6 22.4 6.4 10.2 16.2 7.7 25.9